附录2 2021年PCT国际专利申请统计分析报告

附录2.7 各技术领域的PCT专利申请状况

附录2.7.13 有机化学领域的PCT专利申请状况

第13个技术领域是有机化学。2021年，该领域的PCT专利申请总计8449项（增长率为7.9%），占总申请量的3.2%，是申请量第6多的领域。

2021年，中国局在有机化学领域上申请PCT专利2390项，占该领域申请量的28.3%。美国局在该领域上申请专利2186项，份额为25.9%。日本局申请专利778项，份额为9.2%。欧洲局申请专利1332项，份额为15.8%。

附表2.7.13-1 2021年有机化学领域各专利局的PCT专利申请数量

	专利局	申请数量	占本局比例	占领域比例
1	中国	2390	3.6%	28.3%
2	美国	2186	3.9%	25.9%
3	日本	778	1.6%	9.2%
4	欧洲	1332	3.6%	15.8%
5	韩国	703	3.7%	8.3%
6	国际	436	3.5%	5.2%
7	英国	115	3.3%	1.4%
8	法国	29	1.2%	0.3%
9	加拿大	89	4.8%	1.1%
10	澳大利亚	61	4.0%	0.7%
11	土耳其	10	0.7%	0.1%
12	德国	8	0.6%	0.1%
13	以色列	67	4.8%	0.8%
14	瑞典	7	0.6%	0.1%
15	其他	238	--	2.8%
	小计	8449	--	100%

注：本表按照提交PCT国际专利申请的专利局进行统计。

附图2.7.13-1 2021年有机化学领域各专利局的PCT专利申请数量对比

2021年，在有机化学领域上PCT专利申请最多的机构是兄弟工业株式会社、巴斯夫公司、拜耳股份有限公司。

附表2.7.13-2 2021年有机化学领域的PCT国际专利申请前10机构

	机构名称	国家	机构英文名称	2021
1	兄弟工业株式会社	日本	LG CHEM, LTD.	136
2	巴斯夫公司	德国	BASF SE	92
3	拜耳股份有限公司	德国	BAYER AKTIENGESELLSCHAFT	82
4	豪夫迈罗氏有限公司	瑞士	F. HOFFMANN-LA ROCHE AG	78
5	南京明德新药研发有限公司	中国	MEDSHINE DISCOVERY INC	77
6	先正达植物保护公司	美国	SYNGENTA CROP PROTECTION AG	61
7	百时美施贵宝公司	美国	BRISTOL-MYERS SQUIBB COMPANY	53
8	加州大学	美国	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	52
9	陕西莱特光电材料股份有限公司	中国	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.	47
10	出光兴产株式会社	日本	IDEMITSU KOSAN CO., LTD.	44

注：本表数据按照第一申请人进行统计。

附图2.7.13-2 2021年有机化学领域的PCT国际专利申请前10机构

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。

微信号：chenlixinip5

附表 2021年该领域PCT国际专利申请

ID	Title	Applicant
WO/2021/119716	PREPARATION OF HALOGENATED ALKOXYETHANE	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/119717	PREPARATION OF HALOGENATED ALKOXYETHANE	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/003517	DERIVATIVES OF 4-(IMIDAZO[L,2-A]PYRIDIN-3-YL)-N-(PYRIDINYL)PYRIMIDIN- 2-AMINE AS THERAPEUTIC AGENTS	AUCENTRA THERAPEUTICS PTY LTD
WO/2021/072475	DERIVATIVES OF 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-N-(PYRIDIN-3-YL) PYRIMIDIN-2- AMINE FOR TREATING PROLIFERATIVE DISEASES AND CONDITIONS	AUCENTRA THERAPEUTICS PTY LTD
WO/2021/253067	IMPROVED THROMBIN INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC CONDITIONS	THE UNIVERSITY OF SYDNEY
WO/2021/000017	ANTIBODIES AGAINST CAIX WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTOR	TELIX INTERNATIONAL PTY LTD
WO/2021/000018	ANTIBODIES FOR BINDING PSMA WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTOR	TELIX INTERNATIONAL PTY LTD
WO/2021/012014	DIFLUOROHALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES, METHODS OF PREPARATION, AND USES THEREOF	PHARMAXIS LTD.
WO/2021/012018	INHIBITOR COMPOUNDS	CINCERA THERAPEUTICS PTY LTD
WO/2021/016667	INHIBITORS AND USE THEREOF IN CANCER TREATMENT	THE UNIVERSITY OF SYDNEY
WO/2021/016670	ANTIVIRAL AGENTS AND USES THEREOF	GRIFFITH UNIVERSITY
WO/2021/026601	COMPOSITIONS AND METHODS FOR TREATMENT	MACQUARIE UNIVERSITY
WO/2021/026609	COMPLEMENT C2 BINDING PROTEINS AND USES THEREOF	CSL INNOVATION PTY LTD
WO/2021/042163	METHODS AND AGENTS FOR DETERMINING PATIENT STATUS	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/042169	NITRIFICATION INHIBITORS	THE UNIVERSITY OF MELBOURNE
WO/2021/046612	DETECTION OF HALOCARBONS	MONASH UNIVERSITY
WO/2021/051168	IMAGING AND THERAPEUTIC COMPOSITIONS	THE UNIVERSITY OF MELBOURNE
WO/2021/062482	ANTIVIRAL COMPOUNDS AND THEIR USE	SALUT PRODUCTS PTY LTD
WO/2021/062491	CIBALACKROT RED DYE COMPOUNDS AND METHODS OF USE IN ORGANIC SOLID-STATE LASERS AND OPTO-ELECTRONIC APPLICATIONS	THE UNIVERSITY OF QUEENSLAND
WO/2021/068040	TARGETING EPHA3 AND USES THEREOF	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/072487	SULFONAMIDE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER	TROBIO THERAPEUTICS PTY LTD
WO/2021/081582	ANTIBODIES FOR BINDING PLASMIN	MONASH UNIVERSITY
WO/2021/081601	ANTI-MULLERIAN HORMONE POLYPEPTIDES	MONASH UNIVERSITY
WO/2021/087561	CYTOKINE OR GROWTH FACTOR FUSION PROTEINS	MONASH UNIVERSITY
WO/2021/087568	RADIOLABELLED TARGETING LIGANDS	THE UNIVERSITY OF QUEENSLAND
WO/2021/087575	BINDING PROTEINS TO CUB DOMAIN-CONTAINING PROTEIN (CDCP1)	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/087579	COMPOSITIONS FOR DETECTING ALLOREACTIVE T CELLS	THE UNIVERSITY OF SYDNEY
WO/2021/113899	THERAPEUTIC COMPOSITIONS COMPRISING AN AMYLOID BETA ANTIBODY OR VACCINE FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/102505	IMMUNOGENIC PROTEIN AGAINST GONOCOCCAL INFECTION	GRIFFITH UNIVERSITY
WO/2021/108862	USE OF AN ANTI-FACTOR XII ANTIBODY FOR THE TREATMENT OR PREVENTION OF HEREDITARY ANGIOEDEMA	CSL INNOVATION PTY LTD
WO/2021/113909	NOVEL PEPTIDE HORMONES	THE UNIVERSITY OF SYDNEY
WO/2021/113921	COMPOUNDS AND METHODS FOR THE DIAGNOSIS, IMAGING AND TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS	THE UNIVERSITY OF MELBOURNE
WO/2021/113922	IMPROVED METHOD FOR PREPARING N-(BENZENESULFONYL)-L-PROLYL- L-<i>O</i>-(1-PYRROLIDINYLCARBONYL)TYROSINE	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/119753	COMPOUNDS	CTXT PTY LIMITED
WO/2021/119756	NOVEL CELLULAR DELIVERY METHODS	PYC THERAPEUTICS LIMITED
WO/2021/119761	CXCL10 BINDING PROTEINS AND USES THEREOF	HUDSON INSTITUTE OF MEDICAL RESEARCH
WO/2021/127743	SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF	KYNAN DUKE IP, LLC
WO/2021/127744	COMPOSITIONS AND USES THEREOF	THE UNIVERSITY OF MELBOURNE
WO/2021/127745	COMPOSITIONS AND USES THEREOF	THE UNIVERSITY OF MELBOURNE
WO/2021/146776	DETECTING GUT BARRIER DYSFUNCTION AND/OR CIRRHOSIS	MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED
WO/2021/155426	QUINAZOLINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER	TROBIO THERAPEUTICS PTY LTD
WO/2021/155439	BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF	PHARMAXIS LTD.
WO/2021/159176	ANTIMICROBIAL COMPOUNDS	THE UNIVERSITY OF WOLLONGONG
WO/2021/168509	ADENO-ASSOCIATED VIRUS CAPSID POLYPEPTIDES AND VECTORS	CHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/168521	INHIBITORS OF NECROPTOSIS	ANAXIS PHARMA PTY LTD
WO/2021/179049	TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME	THE UNIVERSITY OF ADELAIDE
WO/2021/184080	COMPOSITIONS AND METHODS FOR TREATING LUPUS	MONASH UNIVERSITY
WO/2021/195716	ANTIBIOTIC CONJUGATES	MONASH UNIVERSITY
WO/2021/217206	HUMAN CYTOMEGALOVIRUS POLYEPITOPE VACCINE COMPOSITION	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/226675	ELECTROLYTES FOR TARGET ION TRANSPORT	DEAKIN UNIVERSITY
WO/2021/237280	NOVEL INHIBIN VARIANTS	MONASH UNIVERSITY
WO/2021/237309	MULTI-STIMULI RESPONSIVE METAL-ORGANIC FRAMEWORKS	THE UNIVERSITY OF SYDNEY
WO/2021/243421	DUAL KINASE-BROMODOMAIN INHIBITORS	MONASH UNIVERSITY
WO/2021/243422	AGONIST ANTI-CD40 ANTIBODIES	SELVAX PTY LTD
WO/2021/248185	A FUSION PROTEIN	THE UNIVERSITY OF QUEENSLAND
WO/2021/248198	HIV-1 ANTIBODIES	THE UNIVERSITY OF MELBOURNE
WO/2021/248203	IL-1 RECEPTOR ANTAGONIST (IL-1 RA) FUSION PROTEINS BINDING TO EXTRACELLULAR MATRIX	MONASH UNIVERSITY
WO/2021/253091	COMPOUNDS FOR AND METHODS OF TREATING DISEASES	ALTERITY THERAPEUTICS LIMITED
WO/2021/253095	SULPHONAMIDE COMPOUNDS	ANAXIS PHARMA PTY LTD
WO/2021/258154	BRANCHED LIPID COMPOUNDS	AXELIA ONCOLOGY PTY LTD
WO/2021/258160	ANTI-VWF ANTIBODIES AND USES THEREOF	MONASH UNIVERSITY
WO/2021/003545	RECOMBINANT PEPTIDES THAT BIND TO A TUMOUR-SPECIFIC ANTIBODY FOR BREAST CANCER AND USE	UNIVERSIDADE FEDERAL DE UBERLÂNDIA
WO/2021/007636	STEREOISOMERS OF THE COMPOUND 3-(BENZO[D][1,3]DIOXOL-5-YL)-7-(1-HYDROXYPROPAN-2-YL)-1-(1<i>H</i>-INDOL-3-YL)-6,7-DIHYDRO-3<i>H</i>-OXAZOL[3,4-A]PYRAZINE-5,8-DIONE AND USE THEREOF AS AN ANTITUMOR AGENT AND PHOSPHODIESTERASE ENZYME INHIBITOR	BIOLAB SANUS FARMACEUTICA LTDA
WO/2021/035325	PROTEIN RECEPTACLE, POLYNUCLEOTIDE, VECTOR, EXPRESSION CASSETTE, CELL, METHOD FOR PRODUCING THE RECEPTACLE, METHOD OF IDENTIFYING PATHOGENS OR DIAGNOSING DISEASES, USE OF THE RECEPTACLE AND DIAGNOSTIC KIT	FUNDAÇÃO OSWALDO CRUZ
WO/2021/056087	RECYCLED HEXANE AND USES THEREOF	BRASKEM S.A.
WO/2021/077194	PROCESS FOR THE PRODUCTION OF ANTITUMOUR PHARMACEUTICAL COMPOSITIONS USING PUSH-PULL BUTADIENES, COMPOUNDS AND USES THEREOF	ANHANGUERA EDUCACIONAL PARTICIPAÇÕES S/A
WO/2021/102541	PROCESS FOR PRODUCING COMPOUNDS, INCLUDING TRIPTANE BY AN ALCOHOL COUPLING REACTION	PETRóLEO BRASILEIRO S.A. - PETROBRAS
WO/2021/119782	GENETICALLY MODIFIED MICROORGANISMS THAT CARRY OUT THE HETEROLOGOUS PRODUCTION OF MODIFIED VERSIONS OF THE SURFACTANT PROTEIN LV-RANASPUMIN-1 (LV-RSN-1), THE MODIFIED VERSIONS OF SAID SURFACTANT PROTEIN, THE SYNTHETIC GENES ENCODING SAID SURFACTANT PROTEIN, THE EXPRESSION CASSETTES CONTAINING SAID SYNTHETIC GENES, AND THE EXPRESSION VECTORS CONTAINING SAID SYNTHETIC GENES	PETRóLEO BRASILEIRO S.A. - PETROBRAS
WO/2021/184097	N-ACYL-HYDRAZONE COMPOUNDS, USE IN THE TREATMENT OF AMYLOID AND NON-AMYLOID DEGENERATIVE AGGREGOPATHIES, AND PHARMACEUTICAL COMPOSITION	FACULDADES CATóLICAS
WO/2021/195734	SYNTHETIC PEPTIDE MIMICS OF THE L1 PROTEIN OF HPV, HPV DIAGNOSIS METHOD, HPV DIAGNOSIS SYSTEM, PHARMACEUTICAL COMPOSITION AND USE THEREOF IN THE TREATMENT OR PREVENTION OF HPV	IMUNOSCAN ENGENHARIA MOLECULAR LTDA
WO/2021/207816	BENZIMIDAZOLE COMPOUND FOR THE TREATMENT OF METABOLIC DISORDERS	ACHé LABORATóRIOS FARMACêUTICOS S.A.
WO/2021/217227	ARTHROPOD REPELLENTS OBTAINED BY CHEMICALLY CONVERTING LACTIC ACID, LACTATES OR OTHER LACTIC ACID DERIVATIVES	UNIVERSIDADE FEDERAL DO PARANá
WO/2021/226695	RECOMBINANT HUMAN ANTIBODIES FOR INHIBITING HUMAN TISSUE KALLIKREIN 7 (KLK7) AND USE IN DISEASES RELATED TO THE PROCESS OF SKIN DESQUAMATION	FUNDAÇÃO UNIVERSIDADE FEDERAL DO ABC - UFABC
WO/2021/258173	PHENOLIC BINUCLEATING LIGANDS, BINUCLEAR METAL COMPOUNDS, MEDICAL-VETERINARY COMPOSITION, PROCESSES FOR SYNTHESIZING BINUCLEATING LIGANDS, PROCESS FOR SYNTHESIZING BINUCLEAR COMPOUNDS, METHOD OF TREATMENT OF NEOPLASMS AND FUNGAL DISEASES AND USE	FACULDADES CATOLICAS
WO/2021/258179	SYNTHETIC MIMOTOPE PEPTIDES OF AN ANTIGENIC PROTEIN FROM M. TUBERCULOSIS, RECOMBINANT ANTIBODY OR FRAGMENT THEREOF, APTAMERS, USE THEREOF IN THE DIAGNOSIS OF TUBERCULOSIS AND METHOD OF DIAGNOSIS OF TUBERCULOSIS	UNIVERSIDADE FEDERAL DE UBERLÂNDIA
WO/2021/046630	ACETYLATION OF CANNABINOIDS USING SULFURIC ACID CATALYST	NEXTLEAF SOLUTIONS LTD
WO/2021/092671	HYGROSCOPIC HYDROGELS, METHODS AND USES THEREOF FOR WATER COLLECTION	UNIVERSITY OF PRINCE EDWARD ISLAND
WO/2021/092672	ANTIBODY-PAYLOAD CONJUGATES WITH ENHANCED DELIVERY DOMAIN AND USES THEREOF	IPROGEN BIOTECH INC.
WO/2021/068051	RADIOLABELED BOMBESIN-DERIVED COMPOUNDS FOR <i>IN VIVO</i> IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS	PROVINCIAL HEALTH SERVICES AUTHORITY
WO/2021/097552	PEPTIDES, COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING SOX9 DIMERIZATION	BROWN, Arthur
WO/2021/000041	IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY	PRECISION NANOSYSTEMS INC.
WO/2021/000053	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/000054	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/007659	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/007660	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/007661	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/007662	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/007663	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/012049	SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS	REPARE THERAPEUTICS INC.
WO/2021/016724	MULTI-VALENT AND MULTI-SPECIFIC NANOPARTICLE PLATFORMS AND METHODS	THE HOSPITAL FOR SICK CHILDREN
WO/2021/026647	LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME	INTEGRATED NANOTHERAPEUTICS INC.
WO/2021/026652	FRIZZLED RECEPTOR ANTIBODIES AND USES THEREOF	MODMAB THERAPEUTICS INC.
WO/2021/026665	ANTIBODIES THAT BIND TO LRP5 PROTEINS AND METHODS OF USE	MODMAB THERAPEUTICS INC.
WO/2021/026666	ANTIBODIES THAT BIND TO LRP6 PROTEINS AND METHODS OF USE	MODMAB THERAPEUTICS INC.
WO/2021/035340	METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES	CANOPY GROWTH CORPORATION
WO/2021/035342	METHODS FOR CONVERTING TETRAHYDROCANNABINOLIC ACID INTO CANNABINOLIC ACID	CANOPY GROWTH CORPORATION
WO/2021/035360	PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER	RISEN (SUZHOU) PHARMA TECH CO., LTD.
WO/2021/046636	CANNABINOID DERIVATIVES, PRECURSORS AND USES	KARE CHEMICAL TECHNOLOGIES INC.
WO/2021/046640	CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME	KARE CHEMICAL TECHNOLOGIES INC.
WO/2021/046653	ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME	CENTRE FOR DRUG RESEARCH AND DEVELOPMENT
WO/2021/062549	REDOX ACTIVE MATERIALS, PROCESSES AND USES THEREOF	KASIS ENVIRONMENTAL LTD.
WO/2021/062557	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/062559	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/068074	MODIFIED EXTRACELLULAR DOMAIN OF GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR (G-CSFR) AND CYTOKINES BINDING SAME	ZYMEWORKS INC.
WO/2021/068080	IMMUNOGENIC PEPTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF MALARIA	THE HOSPITAL FOR SICK CHILDREN
WO/2021/077215	DENDRITIC CELL-TARGETING UNIVERSAL VACCINE FOR INFLUENZA INFECTION	UNIVERSITY OF MANITOBA
WO/2021/081677	CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS	FU, Rui
WO/2021/097557	INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION OF OLEFINS	ARLANXEO CANADA INC.
WO/2021/102567	CANNABIGEROL DERIVATIVES AND USE THEREOF AS CANNABINOID RECEPTOR MODULATORS	CANOPY GROWTH CORPORATION
WO/2021/102568	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/102569	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/102585	RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES	MCMASTER UNIVERSITY
WO/2021/113958	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/113959	CANNABINOID DERIVATIVES	CANOPY GROWTH CORPORATION
WO/2021/108901	NITRO-SUBSITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES	VALORBEC, S.E.C.
WO/2021/108916	PEPTIDES FOR REGULATING GLUCOSE	COOKE AQUACULTURE INC.
WO/2021/113974	HUMANIZED ANTI-GLYCOPROTEIN IB ALPHA (GPIBALPHA) ANTIBODIES	CCOA THERAPEUTICS INC.
WO/2021/113978	ENHANCED PRODUCTION OF HUMIC ACIDS FROM COAL-LIGNITE VIA WATER-OXYGEN SYSTEMS	CARBON OXYTECH INC.
WO/2021/119808	ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/119832	POLYPEPTIDES, PROTEIN COMPLEXES AND METHOD FOR MAKING SAME	KISOJI BIOTECHNOLOGY INC.
WO/2021/155467	3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS	MINDSET PHARMA INC.
WO/2021/155468	PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS	MINDSET PHARMA INC.
WO/2021/155470	PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS	MINDSET PHARMA INC.
WO/2021/155474	CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/168567	CHELATOR COMPOSITIONS FOR RADIOMETALS AND METHODS OF USING SAME	TRIUMF
WO/2021/168575	POLYPEPTIDES DIRECTED AGAINST VIRAL INFECTION AND USES THEREOF	QUADRUMIX BIOTECHNOLOGY INC.
WO/2021/168582	PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME	ELKIMIA INC.
WO/2021/174355	INHIBITORS OF HUMAN HERPESVIRUSES	THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
WO/2021/179064	LIGHT-ACTIVATED PATHOGEN-KILLING MOLECULES AND USES THEREOF	EPIC VENTURES INC.
WO/2021/179074	PURINE COMPOUNDS FOR TREATING DISORDERS	MARVEL BIOTECHNOLOGY
WO/2021/179091	3-(2-(AMINOETHYL)-INDOL-4-OL DERIVATIVES, METHODS OF PREPARATION THEREOF, AND THE USE AS 5-HT2 RECEPTOR MODULATORS	BRIGHT MINDS BIOSCIENCES INC.
WO/2021/207823	NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF	UNIVERSITé DE MONTRéAL
WO/2021/189139	MASKED IL12 FUSION PROTEINS AND METHODS OF USE THEREOF	BLACKLER, Ryan
WO/2021/189141	SOLID DISPERSIONS OF AMORPHOUS 3, 4-DIPHENYL-4, 5-DIHYDRO- 1H-PYRAZOLE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF AS CANNABINOID CB<sb>1</sb> RECEPTOR INHIBITORS	INVERSAGO PHARMA INC.
WO/2021/189143	STABLE HEAVY ISOTOPES IN AMIDE FUNCTIONAL GROUPS AND USES THEREOF	RISEN (SUZHOU) PHARMA TECH CO., LTD.
WO/2021/195751	CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS	KARE CHEMICAL TECHNOLOGIES INC.
WO/2021/195770	ANTIBODIES TO MISFOLDED AMYLOID BETA	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/195781	COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE	REPARE THERAPEUTICS INC.
WO/2021/203195	PROCESS FOR PRODUCING 4,5-DIHYDRO-1<i>H</i>-PYRAZOLES AND INTERMEDIATES	INVERSAGO PHARMA INC.
WO/2021/207826	NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND USES THEREOF	UNIVERSITé DE MONTRéAL
WO/2021/207827	ANTIBODY CONSTRUCTS BINDING 4-1BB AND FOLATE RECEPTOR ALPHA AND USES THEREOF	ZYMEWORKS INC.
WO/2021/212220	RECOMBINANT INTERFERON	ALTUM PHARMACEUTICALS INC.
WO/2021/212230	SUPRASTRUCTURE COMPRISING MODIFIED INFLUENZA HEMAGGLUTININ WITH REDUCED INTERACTION WITH SIALIC ACID	MEDICAGO I NC.
WO/2021/212234	ANTIVIRAL AGENTS, USES THEREOF AND METHODS FOR THEIR PREPARATION	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/217251	IMMOBILIZED SELF-ASSEMBLED PROTEIN MULTIMERS	CCOA THERAPEUTICS INC.
WO/2021/223026	EZH1/2 KNOCKDOWN PEPTIDES, METHODS AND USES THEREOF	UNIVERSITY OF BRITISH COLUMBIA
WO/2021/226707	SALT AND CRYSTAL FORMS OF 4-AMINO-5-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZO[D]IMIDAZOL-2-YL)THIENO[2,3-B]PYRIDIN-6(7H)-ONE	UNIVERSITY HEALTH NETWORK
WO/2021/226711	METHODS OF SYNTHESIZING CANNABIGERGOL, CANNABIGEROLIC ACID, AND ANALOGS THEREOF	CANOPY GROWTH CORPORATION
WO/2021/232162	HETERODIMERIC FC VARIANTS SELECTIVE FOR FC GAMMA RIIB	ZYMEWORKS INC.
WO/2021/232163	IMMUNOGLOBULIN FC REGION VARIANTS COMPRISING STABILITY-ENHANCING MUTATIONS	ZYMEWORKS INC.
WO/2021/248229	NOVEL CRYSTALLINE FORM OF REMDESIVIR	APOTEX INC
WO/2021/243443	METHOD FOR THE PREPARATION OF OLIGONUCLEOTIDES	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
WO/2021/237364	GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS	GIIANT PHARMA INC.
WO/2021/237371	PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS	MCMASTER UNIVERSITY
WO/2021/248231	COMPOUNDS COMPRISING A THREE RING CORE AS PD-1/PD-L1 BLOCKERS	RELIVE THERAPEUTICS INC.
WO/2021/243468	RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/243471	INHIBITORS OF CBL AUTOINHIBITION AND RELATED METHODS	THE HOSPITAL FOR SICK CHILDREN
WO/2021/248235	PROCESS FOR ISOLATION AND PURIFICATION OF THCA FROM CANNABIS	PROTONIFY CORPORATION
WO/2021/248244	REAGENTS AND METHODS FOR ANTIBODY SEQUENCING	RAPID NOVOR, INC.
WO/2021/248247	TRANSFORMING GROWTH FACTOR BETA (TGFβ) BINDING AGENTS AND USES THEREOF	BRISTOL-MYERS SQUIBB TGF BETA INC.
WO/2021/253115	MICROORGANISMS AND METHODS FOR REDUCING BACTERIAL CONTAMINATION	MELIO PEPTIDE SYSTEMS INC.
WO/2021/258190	PAN-EBOLAVIRUS MONOCLONAL ANTIBODY	HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF HEALTH
WO/2021/258199	VANILLIN-DERIVED FLAME RETARDANT MONOMERS, RESINS, PREPOLYMERS, AND POLYMERS	THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
WO/2021/258213	BIFUNCTIONAL SUPERKINES AND USES THEREOF	MEDICENNA THERAPEUTICS INC.
WO/2021/212243	AVERMECTIN-SENSITIVE AND AVERMECTIN-INSENSITIVE SEA LICE <i>GLUCL</i> RECEPTORS AND USES THEREOF AS THERAPEUTIC TARGETS FOR DETECTING ANTIPARASITIC DRUGS AGAINST <i>CALIGUS ROGERCRESSEYI</i>	CENTRO DE ESTUDIOS CIENTíFICOS, CECS
WO/2021/026669	AQUEOUS FORMULATION THAT REDUCES DAMAGE CAUSED BY SPRING FROSTS IN PLANTS AND PRODUCTION METHOD THEREOF	UNIVERSIDAD DE CONCEPCION
WO/2021/102600	BENZYL PIPERAZINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ANTIVIRUS	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/000242	THIENOPYRIMIDINE DERIVATIVES HAVING STEREO CONFIGURATIONS AND USE THEREOF IN MEDICINE	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/000248	METHOD AND APPARATUS FOR CONTINUOUS SYNTHESIS OF CYCLOPROPANE COMPOUNDS	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/000251	ANTIBODY TO LEPTIN RECEPTOR	SHANGHAITECH UNIVERSITY
WO/2021/000297	COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/000330	LIGAND MEDIATED LUMINESCENCE ENHANCEMENT IN CYCLOMETALATED RHODIUM(III) COMPLEXES AND THEIR APPLICATIONS IN HIGHLY EFFICIENT ORGANIC LIGHT-EMITTING DEVICES	SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/003739	TETRAVALENT SYMMETRIC BISPECIFIC ANTIBODY	WUHAN YZY BIOPHARMA CO., LTD.
WO/2021/007701	A METHOD FOR PREPARING LIRAGLUTIDE VIA A SOLID PHASE PEPTIDE SYNTHESIS	SHANGHAI SPACE PEPTIDES PHARMACEUTICAL CO., LTD.
WO/2021/007703	A METHOD FOR PREPARING LIRAGLUTIDE VIA A SOLID PHASE PEPTIDE SYNTHESIS	SHANGHAI SPACE PEPTIDES PHARMACEUTICAL CO., LTD.
WO/2021/007840	CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF	HUAXIASHENGSHENG PHARMACEUTICAL BEIJING CO., LTD.
WO/2021/012092	A NOVEL ANTI-PD-L1 ANTIBODY AND USE THEREOF	BEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/012176	ASIC1 CHANNEL ANTAGONIST ANTIBODY	SHANGHAITECH UNIVERSITY
WO/2021/012195	NANO-ANTIBODY CAPABLE OF BINDING TO SFTSV AND APPLICATION THEREOF	Y-CLONE MEDICAL SCIENCES CO., LTD
WO/2021/007882	ORGANIC COMPOUND OF NITROGEN-CONTAINING HETEROCYCLE, AND ORGANIC ELECTROLUMINESCENT DEVICE	SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/012264	TRIAZOLE SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/012274	PREPARATION METHOD FOR METFORMIN HYDROCHLORIDE	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD
WO/2021/016814	LUMINESCENT GOLD (III) COMPOUND, METHOD FOR PREPARING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME	GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD.
WO/2021/016887	T CELL RECEPTOR FOR RECOGNIZING SSX2 ANTIGEN SHORT PEPTIDE	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/016929	COCRYSTAL FORM A OF ELAGOLIX AND PYRIMETHAMINE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN RENTAI PHARMATECH LTD.
WO/2021/016954	3-ACETYL-5-HYDROXY-B-NORCHOLESTEROL-6-(N-METHYL)THIOSEMICARBAZONE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGXI WONDER PHARMACEUTICAL CO. LTD
WO/2021/016987	PHARMACEUTICAL COMPOUND FOR TREATING COLORECTAL CANCER	EVEREST PHARM. INDUSTRIAL CO., LTD.
WO/2021/022447	T CELL RECEPTOR CAPABLE OF RECOGNIZING AFP ANTIGEN-DERIVED SHORT PEPTIDE	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/022469	CONTINUOUS SYNTHESIS-PURIFICATION INTEGRATED DEVICE AND CONTINUOUS REACTION SYSTEM CONTAINING SAME	JINLIN ASYMCHEM LABORATORIES CO., LTD.
WO/2021/022516	VALSARTAN REFINEMENT METHOD	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD
WO/2021/022550	POLYMERIZATION INHIBITOR COMPOSITIONS AND USES THEREOF	RHODIA OPERATIONS
WO/2021/022565	SUCROSE FATTY ACID ESTER, PREPARATION METHOD AND QUANTITATIVE ANALYSIS METHOD THEREFOR, AND APPLICATION THEREOF	GUANGZHOU CARDLO BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/026672	HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS	NOVARTIS AG
WO/2021/026685	ANTI-VEGF-ANTI-PD1 BISPECIFIC ANTIBODY WITH NEW-TYPE STRUCTURE	ANHUI BIOX VISION BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/012323	ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAID MATERIAL	NANJING TOPTO MATERIALS CO.,LTD.
WO/2021/026800	METHOD FOR SYNTHESIZING DEGARELIX ACETATE	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD.
WO/2021/026803	PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/000380	MODIFIED NUCLEOSIDE, NUCLEOTIDE AND MODIFIED NUCLEIC ACID POLYMER, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/003800	BONE REMODELING REGULATORY POLYPEPTIDES AND USE	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/026884	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/031071	AMIDE DERIVATIVE AND USE THEREOF IN MEDICINE	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/031113	ANTI-BCMA ANTIBODY AND USE THEREOF IN CAR-T FIELD	GENOIMMUNE THERAPEUTICS CO., LTD.
WO/2021/031148	CRYSTAL FORM OF GONADOTROPIN RELEASING HORMONE ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHENZHEN RENTAI PHARMATECH LTD.
WO/2021/031168	CONTINUOUS SYNTHESIS METHOD FOR 2-FLUOROMALONIC ACID DIESTER COMPOUND	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD.
WO/2021/035382	METHOD FORCONTINUOUS SYNTHESIS OF 2-CYCLOPENTENE-1-ONE	LIAONING ASYMCHEM LABORATORIES CO., LTD.
WO/2021/035446	T CELL RECEPTOR FOR RECOGNIZING AFP ANTIGEN SHORT PEPTIDE AND ENCODING SEQUENCE THEREOF	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/017065	PYRROLOPYRAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	SHANGHAI MEDICILON INC.
WO/2021/017066	PYRROLOPYRAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF	SHANGHAI MEDICILON INC.
WO/2021/017067	PYRROLOPYRAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE	SHANGHAI MEDICILON INC.
WO/2021/017068	PYRROLO-PYRAZOL DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	SHANGHAI MEDICILON INC.
WO/2021/017069	PYRROLOPYRAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE	SHANGHAI MEDICILON INC.
WO/2021/035515	SHORT SYNTHETIC PEPTIDE AND THEIR USES FOR TREATING RETINAL DEGENERATIVE DISEASES AND/OR TISSUE INJURIES	TSAO, Yeou-Ping
WO/2021/017071	ANTI-HUMAN ST2 ANTIBODY AND USE THEREOF	BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD
WO/2021/042251	METHOD FOR PREPARATION OF POLYISOCYANATE BY PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING WATERBORNE POLYURETHANE RESIN	WANHUA CHEMICAL GROUP CO., LTD.
WO/2021/042258	BIPYRIDINE IRON COMPLEX, PREPARATION METHOD THEREOF AND APPLICATION IN POLYMERIZATION OF CONJUGATED DIENE	QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/022604	PHARMACEUTICAL COMPOSITION, CRYSTAL FORM OF PROTHIOCONAZOLE, PREPARATION METHOD AND APPLICATION THEREOF	NUTRICHEM COMPANY LIMITED
WO/2021/035788	PYRAZOLE DERIVATIVE AND USE THEREOF	HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/031246	METHOD FOR PREPARING CHIRAL β-HYDROXYLCARBOXYLATE COMPOUND	SHANGHAI SHINE HIGH INTERNATIONAL TRADE CO., LTD.
WO/2021/046678	METHOD FOR SYNTHESISING CHENODEOXYCHOLIC ACID AND APPLICATION THEREFOR	BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
WO/2021/046789	INDAZOLE-CARBOXAMIDE DERIVATIVE AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/017114	CYCLIC COMPOUND AND USE THEREOF, AND ELECTRONIC DEVICE	NINGBO LUMILAN ADVANCED MATERIALS CO., LTD.
WO/2021/042410	SELECTIVE BUTYRYLCHOLINESTERASE INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/042411	AKR1C3 INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT OF SAME, PREPARATION METHOD FOR SAME, AND USES THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/051275	METHOD FOR PERFORMING ADDITION REACTION BETWEEN ACETYLENE AND KETONE COMPOUND	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD.
WO/2021/051351	ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOF	SPH BIOTHERAPEUTICS (HK) LIMITED
WO/2021/051390	BCMA-TARGETED ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR	SHANGHAI GENBASE BIOTECHNOLOGY CO., LTD.
WO/2021/022634	FIVE HINGE REGIONS AND CHIMERIC ANTIGEN RECEPTORS AND IMMUNE CELLS THEREOF	FUDAN UNIVERSITY
WO/2021/017122	BENZODITHIOOXAZINE-BASED HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREFOR AND ORGANIC ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/056188	ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS	PEKING UNIVERSITY
WO/2021/056193	CONTINUOUS PREPARATION METHOD FOR BENZYL ZINC HALIDE AND DERIVATIVES THEREOF	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/056270	SENOLYTIC PRODRUGS AND METHODS OF USE THEREOF	PEKING UNIVERSITY
WO/2021/056302	METHODS AND COMPOSITIONS FOR DNA BASE EDITING	SYNGENTA CROP PROTECTION AG
WO/2021/000434	RED, GREEN AND BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL, SYNTHESIS METHOD THEREFOR AND USE THEREOF	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/056324	GREEN CHEMICAL PREPARATION METHOD FOR ALPHA-TRI-O-ACETYL GLUCURONIC ACID METHYL ESTER BROMO COMPOUND	JINAN SAMUEL PHARMACEUTICAL CO., LTD
WO/2021/056357	METHOD FOR PREPARING ASTAXANTHIN OIL BY COLD PRESSING HAEMATOCOCCUS PLUVIALIS	YUNNAN ALCOM BIOTECH CO., LTD
WO/2021/056382	PREPARATION METHOD FOR ALPHA-PENTA-O-ACETYL MANNOSE	JINAN SAMUEL PHARMACEUTICAL CO., LTD
WO/2021/056466	METHOD FOR PREPARING SECONDARY AROMATIC AMINE	GUANGDONG UNIVERSITY OF PETROCHEMICAL TECHNOLOGY
WO/2021/056598	MMUP MONOMER VARIANT AND APPLICATION THEREOF	QITAN TECHNOLOGY LTD., BEIJING
WO/2021/056599	MNEP MONOMER VARIANT AND APPLICATION THEREOF	QITAN TECHNOLOGY LTD., BEIJING
WO/2021/068108	NKG2D CAR-T CELL, PREPARATION THEREFOR, AND APPLICATION THEREOF	ABLINK BIOTECH CO., LTD
WO/2021/003867	MONOCLONAL ANTIBODY 10G12 AND APPLICATION THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCE
WO/2021/062882	METHOD FOR SYNTHESIZING ROSAVIN	JINAN SAMUEL PHARMACEUTICAL CO., LTD.
WO/2021/027045	ANTI-TUMOUR COMPOUND BASED ON JWA GENE ACTIVATION AND HER2 DEGRADATION, PREPARATION METHOD THEREFOR, AND USE THEREOF	ZHOU, Jianwei
WO/2021/068179	NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES	BAYER ANIMAL HEALTH GMBH
WO/2021/056610	HIGH AFFINITY ANTIBODIES TO CD39 AND USES THEREOF	SHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/012407	OPTICAL COUPLING OUTPUT MATERIAL AND PREPARATION METHOD THEREFOR, AND ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/068251	GIP AND GLP-1 DUAL AGONIST POLYPEPTIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OF SAME, AND USES THEREOF	SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
WO/2021/012411	METHOD FOR PREPARING GUAIACOL PRODUCT FROM LIGNIN BY MEANS OF STEAM-ASSISTED PYROLYSIS	INSTITUTE OF CHEMICAL INDUSTRY OF FORESTRY PRODUCTS, CHINESE ACADEMY OF FORESTRY
WO/2021/072622	CONTINUOUS POST-TREATMENT METHOD AND DEVICE FOR PENEM COMPOUND	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/072724	PEPTIDE AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY DISEASES AND PAIN	PELL BIO-MED TECHNOLOGY CO., LTD
WO/2021/012424	METHOD FOR PREPARING HIGH-CONTENT MOGROSIDE MONOMER PRODUCT, AND USE THEREOF	HUNAN AIDALUN TECHNOLOGY CO., LTD.
WO/2021/000455	HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREFOR AND ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/072771	TEGAFUR COCRYSTAL	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/072774	METHOD FOR SYNTHESIZING SEVOFLURANE	LUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/000456	METHOD FOR REALIZING METHANATION OF CARBON DIOXIDE AT ROOM TEMPERATURE USING HYDROGEN STORAGE ALLOY HYDRIDE	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/077242	CASPOFUNGIN SYNTHESIS METHOD AND INTERMEDIATE THEREOF	LUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/077250	ANTI-PD-L1 ANTIBODY AND PHARMACEUTICAL USE THEREOF	KYINNO BIOTECHNOLOGY (BEIJING) CO., LTD.
WO/2021/022676	ANTIBODY AGAINST FACTOR XIA IN ACTIVATED FORM OF COAGULANT FACTOR XI, PREPARATION METHOD THEREFOR AND USE THEREOF	MAB-LEGEND BIOTECH CO., LTD.
WO/2021/056646	METHOD FOR CATALYZING ANTI-MARKOVNIKOV HYDROAMINATION REACTION OF OLEFIN AND AMINE	BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/077317	OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREFOR	MABPLEX INTERNATIONAL CO., LTD.
WO/2021/077351	METHOD FOR PREPARING TELMISARTAN IMPURITY J	JIANGSU ZHONGBANG PHARMACEUTICAL CO., LTD.
WO/2021/003890	METHOD FOR PREPARING TETRODOTOXIN ESTERIFIED PRODUCT	ZHAO, Jihong
WO/2021/077424	PREPARATION METHOD FOR TRANS-CYCLOBUTANE PHTHALATE AND DERIVATIVE THEREOF	JINLIN ASYMCHEM PHARMACEUTICALS CO., LTD.
WO/2021/081714	METHOD FOR CONTINUOUSLY PREPARING MAP PENEM INTERMEDIATE	JINLIN ASYMCHEM PHARMACEUTICALS CO., LTD.
WO/2021/000467	FLUORESCENT COMPOUND FOR DETECTION OF ISOCYANATE SUBSTANCES, PREPARATION METHOD THEREFOR AND USE THEREOF AS TEST-PAPER-TYPE DETECTION PROBE	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/081743	METHOD FOR RECOVERING CATECHOL FROM O-ETHOXYPHENOL REACTION LIQUID	SHANGHAI INSTITUTE OF TECHNOLOGY
WO/2021/068304	PHOSPHORUS-CONTAINING ACTIVE ESTER COMPOUND AND PREPARATION METHOD THEREFOR	SUZHOU JUFENG ELECTRICAL INSULATION SYSTEM CO., LTD.
WO/2021/081880	HYBRIDOMA CELL STRAIN AND APPLICATION THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/081881	FUNCTIONAL CARBOHYDRATE MOLECULE BASED ON TDG MOLECULAR SCAFFOLD, AND PREPARATION METHOD THEREFOR	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/081923	2-PYRIDYLAMINE DERIVATIVE USED AS FUNGICIDE	JIANGSU FLAG CHEMICAL INDUSTRY CO., LTD.
WO/2021/087709	(1-5)-GAL-(1-6)-MAN GLYCOPROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF	JINAN SAMUEL PHARMACEUTICAL CO., LTD
WO/2021/022690	NUCLEOSIDE SALT AND PREPARATION METHOD THEREFOR	JINAN MUTIAN BIOTECHNOLOGY CO., LTD
WO/2021/046995	METHOD FOR PREPARING 5-HYDROXYMETHYL FURFURAL BY CATALYZING HEXOSE WITH IONIC LIQUID	DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES
WO/2021/046996	METHOD FOR IMPROVING SYNTHESIS EFFICIENCY OF 5-HYDROXYMETHYLFURFURAL	DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES
WO/2021/008014	SPIRO (3,3'-PHENYLPYRROLIDINE OXYINDOLE) LIVER X RECEPTOR MODULATOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	MW CANNABIS PHARMACEUTICAL INC.
WO/2021/087839	TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND APPLICATION THEREOF	GENOIMMUNE THERAPEUTICS CO., LTD.
WO/2021/087840	TUMOR IMMUNOTHERAPY POLYPEPTIDE AND APPLICATION THEREOF	GENOIMMUNE THERAPEUTICS CO., LTD.
WO/2021/012478	HYDROGENATION ANNULE [12] AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR	TSINGHUA UNIVERSITY
WO/2021/012479	HYDROGENATED CYCLIC [8] AROMATIC HYDROCARBON COMPOUND AND PREPARATION METHOD THEREFOR	TSINGHUA UNIVERSITY
WO/2021/087897	BODIPY-BASED HIGH-EFFICIENCY REAL-TIME BIOLOGICAL THIOL FLUORESCENT DETECTION PROBE	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/092719	FUSION PROTEIN THAT TARGETS ANTIGEN-SPECIFIC T CELLS TO INDUCE DIFFERENTIATION THEREOF INTO MEMORY STEM CELLS	WANG, Shengdian
WO/2021/042535	METHOD FOR PREPARING TEZACAFTOR INTERMEDIATE II	SUZHOU VIGONVITA LIFE SCIENCES CO., LTD.
WO/2021/088105	CONDUCTIVE MATERIAL, LIGHT-EMITTING DEVICE AND PREPARATION METHOD FOR LIGHT-EMITTING DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/056754	METHOD FOR PREPARING ANTIBODY-DRUG CONJUGATE INTERMEDIATE BY MEANS OF ACID METHOD AND APPLICATION THEREOF	MABPLEX INTERNATIONAL CO., LTD.
WO/2021/092919	NICOTINAMIDE MONONUCLEOTIDE INTERMEDIATE AND METHOD FOR SYNTHESIZING NICOTINAMIDE MONONUCLEOTIDE	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/003945	POLYPEPTIDE APTAMER SPECIFICALLY RECOGNIZING ARGININE AND APPLICATION	INSTITUTE OF SUBTROPICAL AGRICULTURE ECOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/097619	GLUCOSAMINE SULFATE CHLORIDE DOUBLE SALT AND PREPARATION METHOD THEREFOR	JIANGSU SHUANGLIN MARINE BIOLOGICAL PHARMACEUTICAL CO., LTD
WO/2021/097650	COCRYSTAL OF ORLISTAT AND AMINO ACID, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	ZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097676	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/027172	HOLE TRANSPORT MATERIAL AND PREPARATION METHOD THEREFOR, AND ORGANIC LIGHT-EMITTING DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/036022	PET/CT TRACER HAVING SELECTIVITY FOR DIFFERENT LUNG CANCER CELLS, PREPARATION METHOD THEREFOR AND USE THEREOF	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/097781	PYRIDINE METHYLENE PIPERIDINE DERIVATIVE AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/042579	PREPARATION SYSTEM AND PROCESS FOR 1,4-BUTANEDIOL	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047036	ENHANCED SYSTEM AND PROCESS FOR PREPARING CYCLOHEXENE BY HYDROGENATING BENZENE	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047039	MICRO-INTERFACE STRENGTHENING REACTION SYSTEM FOR PREPARING ETHYLENE GLYCOL BASED ON ETHYLENE HYDRATION METHOD AND PROCESS SPECIFICATION	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047042	REACTION SYSTEM AND PROCESS FOR PREPARING BUTANOL AND OCTANOL BASED ON MICROINTERFACE-ENHANCED CARBONYLATION OF PROPYLENE	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047050	ENHANCED CARBONYLATION REACTION SYSTEM AND PROCESS	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047051	REACTION SYSTEM AND PROCESS FOR ENHANCING HYDROGENATION OF DIMETHYL OXALATE DURING PREPARATION OF ETHYLENE GLYCOL FROM COAL	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO., LTD.
WO/2021/047052	SYSTEM AND PROCESS FOR ENHANCING TOLUENE OXIDATION	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047053	SYSTEM AND PROCESS FOR PRODUCING PHTHALIC ACID BY STRENGTHENING XYLENE OXIDATION	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/047055	ETHERIFICATION-FREE SYSTEM AND PROCESS FOR PREPARING EPOXYPROPANE BY STRENGTHENING PROPYLENE EPOXIDATION	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO., LTD
WO/2021/047056	ENHANCED REACTION SYSTEM AND PROCESS FOR PREPARING ACETIC ACID BY MEANS OF CARBONYLATION METHANOL	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/097800	ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF	ABL BIO INC.
WO/2021/102618	NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS	INVENTISBIO CO., LTD.
WO/2021/031431	PROCESS FOR PREPARING FLUOROBENZENE BY DIRECT FLUORINATION	FUJIAN YONGJING TECHNOLOGY CO., LTD
WO/2021/036047	PROCESS FOR PREPARING FLUOROBENZENE AND BENZOIC ACID HYPOFLUORITE	FUJIAN YONGJING TECHNOLOGY CO., LTD
WO/2021/036048	PROCESS FOR PREPARING FLUOROBENZENE DERIVATIVES AND BENZOIC ACID HYPOFLUORITE DERIVATIVES	FUJIAN YONGJING TECHNOLOGY CO., LTD
WO/2021/097875	BIO-BASED INTRINSIC FLAME-RETARDANT EPOXY RESIN PRECURSOR EMPLOYING NATURAL FLAVONOID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	NINGBO INTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/036057	METHOD FOR PREPARING NESIRITIDE BY MEANS OF SOLID-LIQUID COMBINATION SYNTHESIS	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/102737	A GENETIC STRAIN FOR PRODUCING 3-AMINOISOBUTYRIC ACID	NANJING NUTRABUILDING BIO-TECH CO., LTD.
WO/2021/036060	PROCESS FOR PREPARING FLUOROBENZENE AND CATALYST THEREFORE	FUJIAN YONGJING TECHNOLOGY CO., LTD
WO/2021/093029	NEW PROCESS FOR SYNTHESIS OF 2,3,3,3-TETRAFLUOROPROPENE (1234YF) AND 2,3-DICHLORO-1,1,1-TRIFLUOROPROPANE (243DB)	FUJIAN YONGJING TECHNOLOGY CO., LTD
WO/2021/102774	AMINE DERIVATIVE SERVING AS SSAO/VAP-1 INHIBITOR AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/068380	PREPARATION OF DEGRADATION COMPOUND TARGETING BTK PROTEIN, AND APPLICATION THEREOF IN TREATING AUTOIMMUNE DISEASES AND TUMORS	TSINGHUA UNIVERSITY
WO/2021/036063	CYCLIC PEPTIDE FROM NOVEL BONE MORPHOGENETIC PROTEIN 2, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	HANGZHOU HUIBO SCIENCE AND TECHNOLOGY CO., LTD
WO/2021/102875	METHOD FOR REMOVING N-NITROSO COMPOUND FROM PENDIMETHALIN	ZHONG, Xijun
WO/2021/102896	ORGANIC COMPOUNDS	GIVAUDAN SA
WO/2021/056811	IMINE SALT DERIVATIVE AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR NICOTINE	SHENZHEN HELGETECH CO. LTD.
WO/2021/102918	METHOD FOR PREPARING CARBOCISTEINE	WUHAN GRAND HOYO CO., LTD.
WO/2021/102919	PEPTOID COMPOUND AND DETECTION CHIP COUPLED ON SURFACE THEREOF WITH PEPTOID COMPOUND	BOE TECHNOLOGY GROUP CO., LTD.
WO/2021/022731	METHOD FOR PREPARING INTERMEDIATE OF ULTRAVIOLET LIGHT ABSORBER UV-1600	RIANLON CORPORATION
WO/2021/003974	METHOD FOR PREPARING PROPYLENE CARBONATE ON THE BASIS OF CARBON DIOXIDE RAW MATERIAL	HUIZHOU KAIMEITE GASES CO., LTD
WO/2021/051661	RECOMBINANT CANINE PD-1 FUSION PROTEIN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING VJT BIO CO., LTD.
WO/2021/108974	COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF	GANNEX PHARMA CO., LTD
WO/2021/103058	HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREOF, AND ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/103059	USE OF AROMATIC ALCOHOL AS SILK FIBROIN INDUCER AND METHOD FOR TREATING SILK FIBROIN	SIMATECH INCORPORATION
WO/2021/103060	HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREFOR, AND ORGANIC LIGHT EMITTING DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/108999	METHOD FOR CONTINUOUS SYNTHESIS OF 4-ETHOXY-1,1,1-TRIFLUORO-3-BUTEN-2-ONE	LIAONING ASYMCHEM LABORATORIES CO., LTD.
WO/2021/082181	SET8 LYSINE METHYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	HAINAN YILING MEDICAL INDUSTRY & DEVELOPMENT CO.LTD
WO/2021/109099	METHOD FOR PREPARING ISOSORBIDE 5-MONONITRATE BY USING MICRO-CHANNEL CONTINUOUS FLOW REACTOR	LUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/109109	PROCESS FOR CONVERTING AMIDE TO AMINE	RHODIA OPERATIONS
WO/2021/072942	PREPARATION METHOD FOR ZINC TARTRATE AND APPLICATION THEREOF IN STABILIZER	HUIZHOU AIMSEA NEWWAY TECHNOLOGY CO., LTD
WO/2021/114012	AMLODIPINE MESYLATE MONOHYDRATE, PREPARATION METHOD THEREFOR AND USE THEREOF	KUNMING SINOWAY NATURAL PHARMACEUTICALS CO., LTD.
WO/2021/114021	PREPARATION METHOD FOR OPTICALLY ACTIVE CITRONELLAL	WANHUA CHEMICAL GROUP CO., LTD.
WO/2021/114037	CYCLIC ADENOSINE MONOPHOSPHATE FLUORESCENT PROBE BASED ON FLUORESCENT BRIGHTNESS WIDTH VARIATION	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/017362	DECHLORINATION METHOD OF CHLORO-SUBSTITUTED AROMATIC COMPOUND (R <sb>1</sb>-X <sb>M</sb>) USING COPPER AS CATALYST	XIAMEN UNIVERSIT
WO/2021/109177	IMMUNOGLOBULIN BINDING PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF	GUANGZHOU KONCEN BIOSCIENCE CO., LTD.
WO/2021/027200	GENETICALLY ENGINEERED CELLS AND USES THEREOF	CURE GENETICS CO., LTD.
WO/2021/114092	METHOD FOR PREPARING DIMETHYL CARBONATE	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/042616	ANTITUMOR ACTIVE PEPTIDE AND APPLICATION THEREOF	TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF THE CHINESE ACADEMY OF SCIENCES
WO/2021/114156	PETAL PURPLE SPOT PROTEIN AND CODING GENE THEREOF	INSTITUTE OF BIOTECHNOLOGY, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/114166	PROCESS FOR PREPARING N-SUBSTITUTED ALKANOLAMINES AND/OR N-SUBSTITUTED DIAMINES FROM GLYCOLALDEHYDE	RHODIA OPERATIONS
WO/2021/036096	STACKED ONLINE SWITCHABLE FLUIDIZED BED PROCESS FOR PRODUCING PROPYLENE BY USING PROPANE DEHYDROGENATION	ZHEJIANG SATELLITE ENERGY CO., LTD
WO/2021/036097	PROCESS FOR PREPARING PROPYLENE BY DEHYDROGENATION BASED ON COUNTERCURRENT CONTACT BETWEEN COMBINED REACTION FEEDSTOCK AND CATALYST REGENERATION	ZHEJIANG SATELLITE ENERGY CO., LTD
WO/2021/036098	PROPANE DEHYDROGENATION PROCESS INVOLVING CATALYST REGENERATION AND REACTOR DOUBLE-ONLINE SWITCHING	ZHEJIANG SATELLITE ENERGY CO., LTD
WO/2021/068403	ACTIVE PEPTIDES FOR PROMOTING OSTEOBLAST PROLIFERATION, AND USE THEREOF	TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF THE CHINESE ACADEMY OF SCIENCES
WO/2021/114200	PREPARATION METHOD FOR SUGAR ESTERS	GUANGZHOU CARDLO BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/114207	PRODUCTION OF BENZENE DERIVATIVES	RHODIA OPERATIONS
WO/2021/103171	PREPARATION METHOD FOR PHTHALOCYANINE NANOSPHERES, AND COLOR FILTER	TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD.
WO/2021/031471	METHOD FOR PREPARING CARBETOCIN	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/072958	METHOD FOR PREPARING METAL-ORGANIC FRAMEWORK MATERIAL, AND USE THEREOF	GUANGDONG INSTITUTE OF ANALYSIS (CHINA NATIONAL ANALYTICAL CENTER, GUANGZHOU)
WO/2021/056850	EUTECTIC CRYSTAL FORMED BY APIXABAN AND CARBOXYLIC ACID, AND PREPARATION METHOD THEREFOR	ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
WO/2021/114227	AMINE-CONTAINING TRANSFECTION REAGENT, PREPARATION METHOD THEREFOR, AND TRANSFECTION COMPLEX	SUZHOU RIBO LIFE SCIENCE CO., LTD.
WO/2021/114313	ION CHANNEL ANTAGONISTS/BLOCKERS AND USES THEREOF	SHANGHAI EAST HOSPITAL
WO/2021/114314	NOVEL HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES	TONGJI UNIVERSITY
WO/2021/000527	TRICYCLIC XOR INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/088209	CAPSAICIN HAPTEN AND ARTIFICIAL ANTIGEN FOR DETECTING ILLEGAL COOKING OIL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION (SHENZHEN HEALTH INSPECTION CENTER, SHENZHEN INSTITUTE OF PREVENTIVE MEDICINE)
WO/2021/000530	BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	EXCELMAB INC.
WO/2021/120019	COMPOSITION FOR IMMUNIZATION AND PREPARATION METHOD THEREFOR	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/088214	SHORT PEPTIDE EXP AND SHORT PEPTIDE-BASED DRUG DELIVERY SYSTEM AND EXTRACELLULAR VESICLE RECOVERY KIT	TIANJIN MEDICAL UNIVERSITY
WO/2021/097980	CASPASE-3 INHIBITOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/120045	HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/120063	METHOD FOR CONTINUOUSLY SYNTHESIZING TAZOBACTAM INTERMEDIATE	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/120064	ETHOXY METHYLENE MALONONITRILE CONTINUOUS SYNTHESIS METHOD	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/120090	PROCESS FOR SYNTHESIS OF TWIN-TAIL TRIAMINES	SOLVAY SA
WO/2021/120095	MONOCLONAL ANTIBODY AGAINST POLYMERASE AND USE THEREOF	BGI SHENZHEN
WO/2021/120127	METHOD FOR PREPARING CHOLESTEROL, DERIVATIVE AND ANALOGUE THEREOF	HUNAN KEREY PHARMACEUTICAL CO., LTD.
WO/2021/114362	HOLE TRANSPORT MATERIAL AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/022761	HALOGEN SUBSTITUTED COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WANG, Mingchun
WO/2021/088222	METHOD FOR SYNTHESIZING IMIDAZOLE ADDITIVE	SHIJIAZHUANG SUNTEC-CHEM CO., LTD.
WO/2021/088223	METHOD FOR SYNTHESIZING DEUTERATED COMPOUND IN AQUEOUS PHASE SOLVENT	HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/017384	DIHYDRO-PYRROLO-PYRIMIDINE SELECTIVE JAK2 INHIBITOR	SHANGHAI XUNHE PHARMACEUTICAL TECHNOLOGY CO. LTD.
WO/2021/000543	METHOD FOR SYNTHESIZING ETELCALCETIDE	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/127965	METHOD FOR RECYCLING VORICONAZOLE ENANTIOMER	LIU, Jie
WO/2021/127986	NICOTINE PREPARATION METHOD	SHENZHEN RELX TECHNOLOGY CO., LTD.
WO/2021/128063	DEEP OXIDATION OLEFIN CATALYST, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NANJING COJINA ADVANCED MATERIALS DEVELOPMENT INSTITUTE CO., LTD.
WO/2021/128220	SODIUM TAURATE PREPARATION METHOD	WANHUA CHEMICAL GROUP CO., LTD.
WO/2021/109292	USE OF GOLD COMPOUND IN PREPARATION OF ANTIBACTERIAL AGENT	SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/128254	METHOD FOR PREPARING HEPARINASE III	SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
WO/2021/103256	CONTINUOUS SYNTHESIS METHOD FOR 2-CHLOROPYRIMIDINE-4-FORMIC ACID COMPOUND	TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD.
WO/2021/103257	CONTINUOUS PREPARATION METHOD FOR 2-AMINO-PYRROLE-3-CARBOXYLATE	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD.
WO/2021/114424	METHOD FOR PREPARING TRIFLUOROHYDROCARBYL SULFONE COMPOUND	ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD.
WO/2021/109297	ETELCALCETIDE INTERMEDIATE AND METHOD FOR SYNTHESIZING ETELCALCETIDE	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/134143	METHOD FOR PREPARING DIAZOXIDE	SOOCHOW UNIVERSITY
WO/2021/051709	OSMIUM COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN UNIVERSITY
WO/2021/031501	DOMINANT EPITOPE PEPTIDE OF HLA-A0201-RESTRICTING KIF15-SPECIFIC ANTI-TUMOR CTL	LIAONING ZHONGJIAN MEDICAL TECHNOLOGY CO., LTD.
WO/2021/134180	METHOD FOR CRYOPRESERVING BLOOD COAGULATION FACTOR VIII INTERMEDIATE PRODUCT	SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD.
WO/2021/134242	NEW CRYSTAL FORM OF FLUCARBAZONE-SODIUM	JIANGSU ROTAM CHEMISTRY CO., LTD
WO/2021/134272	TRIPTOLIDE ACRYLATE, PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/027237	METHOD FOR PREPARING SUPERCRITICAL CARBON DIOXIDE THICKENER FOR EXPLOITATION OF TIGHT OIL AND GAS RESERVOIRS	SOUTHWESTERN PETROLEUM UNIVERSITY
WO/2021/134407	METHOD FOR EXTRACTING CRUDE PRODUCT OF GLYCYRRHIZIC ACID AND GLYCYRRHIZIC FLAVONE FROM LICORICE AND PURIFYING TO OBTAIN GLYCYRRHIZINATE	CHINA MEHECO CO., LTD
WO/2021/134408	PREPARATION, IMPURITY REMOVAL AND PURIFICATION METHODS FOR GLYCYRRHIZIC ACID MONOVALENT SALT	CHINA MEHECO CO., LTD
WO/2021/134512	NEW FUNCTION AND USE OF CRYPTOID CRAB ANTIMICROBIAL PEPTIDE SCYREPROCIN	XIAMEN UNIVERSITY
WO/2021/134602	LOW SULFUR DIESEL BLOCKAGE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/056922	ARYL SULFIDE CONTAINING BENZYLAMINE STRUCTURE, SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG KANGQIAO BIO-TECHNOLOGY CO., LTD
WO/2021/082278	FLUORINE-CONTAINING α-DIIMINE NICKEL COMPLEXES FOR PREPARING POLYOLEFIN ELASTOMER AND INTERMEDIATES, AND PREPARATION METHOD AND USE	XLINK TECHNOLOGY CO., LTD. (HANGZHOU)
WO/2021/088243	THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AND PREPARATION METHOD THEREFOR	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/128465	RAMA TRANSCRIPTION FACTOR MUTANT FOR PROMOTING PRODUCTION OF N-ACETYLGLUCOSAMINE AND APPLICATION THEREOF	JIANGNAN UNIVERSITY
WO/2021/036158	ORGANIC SMALL MOLECULE HOLE INJECTION/TRANSPORT MATERIAL AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/120350	INTERLEUKIN-2 DERIVATIVE	LETO LABORATORIES CO., LTD
WO/2021/138847	MACROLIDE COMPOUND AND ITS USE OF TREATMENT CHRONIC RESPIRATORY DISEASE	BEIJING CONTINENT PHARMACEUTICALS CO., LTD.
WO/2021/134820	NEW ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE	NANJING TOPTO SEMICONDUCTOR MATERIAL CO., LTD.
WO/2021/027250	DETECTION MATERIAL, PREPARATION METHOD AND APPLICATION OF ANTI-NMDAR AUTOANTIBODY IN HUMAN BODY FLUID	SHAANXI MYBIOTECH CO., LTD.
WO/2021/027251	MATERIAL FOR DETECTING ANTI-MOG AUTOANTIBODY IN HUMAN BODY FLUID, PREPARATION METHOD THEREFOR AND USE THEREOF	SHAANXI MYBIOTECH CO., LTD.
WO/2021/022788	COMPOSITION OF 5-FLUOROURACIL AND REFINING METHOD THEREFOR	SHANGHAI XUDONG HAIPU PHARMACEUTICAL CO., LTD
WO/2021/138908	γ-VALEROLACTONE PREPARATION METHOD	UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/103298	THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL, PREPARATION METHOD THEREFOR AND ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/142573	FUSION PROTEIN AND PREPARATION METHOD AND APPLICATION THEREOF	DING, Bang
WO/2021/142581	GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHENGZHOU YUHEYUAN BIOTECHNOLOGY CO., LTD
WO/2021/142671	MONOCLONAL ANTIBODY FOR ECHOVIRUS 30	JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)
WO/2021/142672	ANTI-ECHO30 ANTIBODY, AND CORRESPONDING NUCLEIC ACID, VECTOR, HOST CELL AND COMPOSITION THEREOF	JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)
WO/2021/114460	METHOD FOR PRODUCING P-ACETAMIDOBENZENESULFONYL CHLORIDE BY MEANS OF DOUBLE-TEMPERATURE-ZONE TWO-STAGE METHOD BASED ON CONTINUOUS FLOW REACTION	SHANDONG JINDE NEW MATERIAL CO., LTD
WO/2021/142710	GANODERMA LUCIDUM MYCELIUM ANTIHYPERTENSIVE PEPTIDE AND PREPARATION METHOD THEREFOR	CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY
WO/2021/036193	PREPARATION METHOD FOR LOSARTAN	ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
WO/2021/012659	COMPOUND WITH ANDROGEN RECEPTOR DEGRADATION ACTIVITY	SHANGHAI MEIZER PHARMACEUTICALS CO., LTD.
WO/2021/056936	POLYKETONE COMPOUNDS HAVING TRANS-DECALIN RING AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	QINGDAO AGRICULTURAL UNIVERSITY
WO/2021/047139	POLYAMINO SURFACTANT, PREPARATION METHOD THEREFOR AND USE THEREOF	KENTE CATALYSTS INC.
WO/2021/142835	STRENGTHENED RECEPTOR FOR IMPROVING IMMUNE CELL FUNCTION	CHINEO MEDICAL TECHNOLOGY CO., LTD.
WO/2021/082294	PREPARATION OF AND METHOD FOR IMMUNOMODULATORY PEPTIDE	FU ZHOU UNIVERSITY
WO/2021/093172	HBV INHIBITOR AND USE THEREOF	XI'AN XINTONG PHARMACEUTICAL RESEARCH CO., LTD.
WO/2021/146903	CRYSTAL FORM OF NITROGEN-CONTAINING COMPOUND	SUZHOU SINOVENT PHARMACEUTICALS CO., LTD.
WO/2021/147025	ANTI 2019-NCOV VACCINE	THE UNIVERSITY OF HONG KONG-SHENZHEN HOSPITAL
WO/2021/155518	ANTI-HPV T CELL RECEPTORS AND ENGINEERED CELLS	TCRCURE BIOPHARMA CORP
WO/2021/147123	COMPOUND HAVING ANTISPORULANT ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF	CHENGDU BIOBEL COMPANY LIMITED
WO/2021/155612	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/031533	METHOD FOR SYNTHESIZING N-SUBSTITUTED PHENYL-5-HYDROXYMETHYL-2-OXAZOLIDINONE	HANGZHOU DIKE TECHNOLOGIES CO., LTD.
WO/2021/159235	SINGLE DOMAIN ANTIBODY FOR PCSK9 AND APPLICATION THEREOF	BGI SHENZHEN
WO/2021/159300	ADHESIVE COMPOSITION, LAMINATE, AND PACKAGE	DIC CORPORATION
WO/2021/159372	USE OF JAK INHIBITORS IN PREPARATION OF DRUGS FOR TREATING JAK KINASE-RELATED DISEASES	ZHUHAI UNITED LABORATORIES CO., LTD.
WO/2021/098049	THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DIODE PREPARED BY USING SAME	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/103317	HOLE TRANSPORT MATERIAL HAVING SPIROBISACRIDINE CORE AND ORGANIC LIGHT-EMITTING DIODE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/103318	P-TYPE DOPANT AND ORGANIC LIGHT-EMITTING DIODE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/098050	HOLE TRANSPORT MATERIAL HAVING DIHYDROPHENAZINE CORE AND ORGANIC LIGHT-EMITTING DIODE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/103319	HOLE TRANSPORT MATERIAL TAKING ETHYLENE BIS-ACRIDINE AS CORE AND ORGANIC LIGHT-EMITTING DIODE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/163828	PROCESS METHOD FOR EFFICIENTLY PREPARING L-CARNOSINE-ENRICHED COMPOUND	SHANGHAI HUIWEN BIOTECH CORP., LTD.
WO/2021/159546	POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF	ZHUHAI TENGBAI PHARMACEUTICAL CO., LTD.
WO/2021/088265	IMIDAZO PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF	SUN YAT-SEN UNIVERSITY
WO/2021/163921	NEW COMPOUND AND USE THEREOF	DAICEL CORPORATION
WO/2021/163972	GLP-1 AGONIST POLYPEPTIDE COMPOUNDS AND SALTS THEREOF, SYNTHESIS METHOD, AND USE	SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
WO/2021/163989	ANTI-BAFF RECEPTOR ANTIBODIES AND USES THEREOF	YINNUOLAI BIOTECH LTD.
WO/2021/114480	METHOD OF REDUCING CARBON DEPOSIT ON CATALYST IN UTILIZATION OF HFC-23 AS RESOURCE	ZHEJIANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD.
WO/2021/114481	METHOD FOR IMPROVING STABILITY OF CATALYST IN RECYCLING HFC-23	ZHEJIANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD
WO/2021/088274	(S)1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE SYNTHESIS METHOD	ENANTIOTECH CORPORATION LIMITED
WO/2021/103327	PREPARATION METHOD FOR APREPITANT INTERMEDIATE IMPURITY	ENANTIOTECH CORPORATION LIMITED
WO/2021/012671	HIGHLY EFFICIENT PREPARATION METHOD FOR PROGESTERONE WITH LOW POLLUTION	ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
WO/2021/164045	A PROCESS FOR PREPARING ALKYNYL-CONTAINING COMPOUND AND INTERMEDIATE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/082310	RICE PEPTIDE HAVING WHITENING FUNCTION, AND PREPARATION METHOD THEREFOR	CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD.
WO/2021/082311	PEA PEPTIDE HAVING SUPPLEMENTARY BLOOD GLUCOSE REDUCING FUNCTION AND PREPARATION METHOD THEREFOR	CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD.
WO/2021/012673	METHOD FOR PREPARING TRENBOLONE ACETATE	ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
WO/2021/168734	MONOCLONAL ANTIBODY OF MATRIX METALLOPROTEINASE 1, DETECTION KIT AND DETECTION METHOD THEREOF	S&T BIOMED CO., LTD.
WO/2021/164052	THIENO[2,3-D]PYRIMIDINE HIV-1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SHAN DONG UNIVERSITY
WO/2021/164053	PYRIDO[2,3-D]PYRIMIDINE HIV-1 REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHAN DONG UNIVERSITY
WO/2021/168875	HELICOBACTER PYLORI FERRITIN-BASED NOVEL CORONAVIRUS S PROTEIN DOUBLE-REGION SUBUNIT NANOVACCINE	SUN YAT-SEN UNIVERSITY
WO/2021/174475	ORGANIC COMPOUNDS	GIVAUDAN SA
WO/2021/174487	METHOD FOR PREPARING TEREPHTHALATE	WANG, Qunpeng
WO/2021/174522	A METHOD FOR THE ALKYLATION OF AMINES	RHODIA OPERATIONS
WO/2021/174523	A METHOD FOR PREPARING ALKYLATED AMINES	RHODIA OPERATIONS
WO/2021/174532	ACCEPTOR MATERIAL OF NITROGEN-CONTAINING HETEROCYCLIC TRAPEZOIDAL FUSED RING, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES
WO/2021/168903	S-SUBSTITUTED-THIOSEMICARBAZONE STRUCTURE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF	JIANGSU RENMING BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/134915	PTTRAP1 BI-SPECIFIC FUSION PROTEIN AND APPLICATION THEREOF	GUIDON PHARMACEUTICS, INC.
WO/2021/042694	ANTI-VEGF SINGLE-DOMAIN ANTIBODY AND USE THEREOF	SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/174567	NOVEL CORONAVIRUS S PROTEIN DOUBLE-REGION SUBUNIT NANO-VACCINE BASED ON BACTERIAL COMPLEX	SUN YAT-SEN UNIVERSITY
WO/2021/179246	ANTIBODIES TARGETING TALAROMYCES MARNEFFEI MP1P PROTEIN AND METHODS OF USE THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/179274	ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS	SUZHOU ZANRONG PHARMA LTD.
WO/2021/184154	COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA	FLASH THERAPEUTICS, LLC
WO/2021/174594	ANTI-NOVEL CORONAVIRUS MONOCLONAL ANTIBODY AND APPLICATION THEREOF	SHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/174595	MONOCLONAL ANTIBODY FOR RESISTING NOVEL CORONAVIRUS AND USE THEREOF	SHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/012689	PHENYLTHIOPHENE SULFONAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSITITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/134921	FLAZASULFURON CRYSTAL FORM AND PREPARATION METHOD THEREFOR	DALIAN JOIN KING FINE CHEMICAL CO., LTD.
WO/2021/051766	METHOD FOR SYNTHESIZING OCTREOTIDE	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/088296	NOVEL PREPARATION METHOD FOR 4-THIOCYANO-1,4,5-TRISUBSTITUTED 1,2,3-TRIAZOLE	DALIAN UNIVERSITY OF TECHNOLOGY
WO/2021/073038	O-HYDROXYBENZOIC ACID POLYGLYCOL ESTER COMPOUND, AND SYNTHETIC PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF	XINXIANG HAIYING BIOTECHNOLOGY CO., LTD.
WO/2021/184339	OXAZOLIDINONE COMPOUND AND METHODS OF USE THEREOF AS AN ANTIBACTERIAL AGENT	MERCK SHARP & DOHME CORP.
WO/2021/184391	METHOD FOR EARLIER SCREENING OF NOVEL CORONAVIRUS	GUANGZHOU KANGRUN BIOTECHNOLOGY CO., LTD.
WO/2021/189160	ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF	TSB THERAPEUTICS (BEIJING) CO., LTD.
WO/2021/189245	BIFUNCTIONAL FUSION PROTEIN BINDING TO CORONAVIRUS, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	TAIZHOU MABTECH PHARMACEUTICAL CO., LTD
WO/2021/164097	BIOLOGICAL PRODUCT FOR PREVENTING NOVEL CORONAVIRUS	SYNO (SHENZHEN) BIOMEDICAL RESEARCH CO., LTD.
WO/2021/073044	ENVIRONMENT-FRIENDLY SYNTHESIS METHOD FOR DIBENZOTHIAZOLE DISULFIDE AS RUBBER VULCANIZATION ACCELERATOR	TSINGHUA UNIVERSITY
WO/2021/012698	DIBROMOBENZYL DERIVATIVE, STEREOISOMER OR SALT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHENGDU SHIBEIKANG BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/056996	SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF	PEKING UNIVERSITY
WO/2021/012700	COMPOUND FOR ENCAPSULATION FILM AND COMPOSITION THEREOF, AND FILM, ORGANIC LIGHT-EMITTING DEVICE AND ENCAPSULATION METHOD	JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD.
WO/2021/179353	NKG2D-TARGETED CHIMERIC ANTIGEN RECEPTOR, CHIMERIC ANTIGEN RECEPTOR T CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN BINDEBIOTECH CO., LTD
WO/2021/189343	HYDRATE OF DIMETHYLAMINOMICHELIOLIDE FUMARATE AND PREPARATION METHOD THEREFOR AND USE THEREOF	ACCENDATECH
WO/2021/093250	FGFR4-TARGETED SINGLE-CHAIN ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, CHIMERIC ANTIGEN RECEPTOR T CELL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN BINDEBIOTECH CO., LTD
WO/2021/151265	PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/022819	ISOMERIZATION FEATURE-BASED PURIFICATION METHOD OF PUNICALAGIN	XINJIANG TECHNICAL INSTITUTE OF PHYSICS & CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/184415	HELICOBACTER PYLORI FERRITIN-BASED NOVEL CORONAVIRUS S PROTEIN SINGLE-REGION SUBUNIT NANOVACCINE	SUN YAT-SEN UNIVERSITY
WO/2021/008170	FLAVONE DERIVATIVE, PREPARATION METHOD THEREFOR, APPLICATION THEREOF, AND SKIN WHITENING PRODUCT COMPRISING SAME	SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY.
WO/2021/155634	ANTI-HUMAN-TSLP ANTIBODY AND USE THEREOF	BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD
WO/2021/155635	ANTI-CD3 AND ANTI-CD123 BISPECIFIC ANTIBODY AND USE THEREOF	BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD
WO/2021/134943	FLAZASULFURON CRYSTAL FORM AND PREPARATION METHOD THEREFOR	DALIAN JOIN KING FINE CHEMICAL CO., LTD.
WO/2021/195953	METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/195968	BOTULINUM TOXIN TYPE A COMPLEX, AND FORMULATION THEREOF AND USAGE METHOD THEREFOR	OBI PHARMA, INC.
WO/2021/168988	SYNTHESIS METHOD FOR FLUORINE-CONTAINING CHIRAL AMINE COMPOUND	ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
WO/2021/036256	METHOD FOR SYNTHESIZING HIV PROTEASE INHIBITOR INTERMEDIATE COMPOUNDS	SHENZHEN CATALYS TECHNOLOGY CO., LTD
WO/2021/047166	METHOD FOR SYNTHESIZING TRANYLCYPROMINE INTERMEDIATE	SHENZHEN CATALYS TECHNOLOGY CO., LTD
WO/2021/057009	N-HETEROCYCLIC PLANAR OPTICAL COUPLING OUTPUT MATERIAL AND PREPARATION METHOD THEREFOR	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/179371	NOVEL CORONAVIRUS N-S DOMINANT EPITOPE FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, EXPRESSION PROTEIN, MICROORGANISM, APPLICATION THEREOF AND KIT	HEBEI GENSURE BIOTECH LIC.
WO/2021/008173	SPIRO (3,3’-ISOPROPYL PYRROLIDINE OXINDOLE) LIVER X RECEPTOR REGULATOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD.
WO/2021/120450	THERMALLY-ACTIVATED DELAYED FLUORESCENCE GREEN LIGHT POLYMER MATERIAL AND PREPARATION METHOD THEREFOR	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/134965	SEPARATION AND PURIFICATION PROCESS FOR CANNFLAVIN A	YUNNAN HEMPMON PHARMACEUTICALS CO., LTD.
WO/2021/196225	MOLECULAR ANTAGONIST OF GASTRIC INHIBITORY POLYPEPTIDE, COMPOSITIONS COMPRISING MOLECULAR ANTAGOIST OF GASTRIC INHIBITORY POLYPEPTIDE, AND METHOD FOR TREATMENT OF DISEASES USING THE SAME	HJB (HANGZHOU) CO., LTD.
WO/2021/189528	THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AND SYNTHESIS METHOD THEREFOR, AND ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/203255	ORGANIC AMINE PURIFICATION METHOD	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/203256	COMPOSITIONS AND METHODS TO INHIBIT FOULING OF AMMONIUM SALTS	ECOLAB USA INC.
WO/2021/142953	THIOETHER TRIAZOLE COMPOUND OR PPESTICIDALLY ACCEPTABLE SALT THEREOF, COMPOSITION AND USE THEREOF	HAILIR PESTICIDES AND CHEMICALS GROUP
WO/2021/128648	METHOD FOR PREPARING OXAMIDE FROM DIMETHYL OXALATE	WUZHENG ENGINEERING (SHANGHAI) CO., LTD.
WO/2021/189530	COLOR RESIST MATERIAL, OPTICAL FILTER, AND PREPARATION METHOD FOR COLOR RESIST MATERIAL	TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD.
WO/2021/042721	METHOD FOR PREPARING M-TRIFLUOROMETHYLPHENOL	ZHEJIANG WEIHUA NEW MATERIAL CO., LTD.
WO/2021/012717	ANTITUMOR COMPOUND USED AS AXL INHIBITOR AND USE THEREOF	NANJING HUAWE MEDICINE TECHNOLOGY GROUP CO., LTD.
WO/2021/168998	METHOD FOR PREPARING 2,5-TETRAHYDROFURAN DIMETHANOL FATTY ACID DIESTER AND APPLICATION THEREOF IN DIESEL ADDITIVE	ZHEJIANG SUGAR ENERGY TECHNOLOGY CO., LTD.
WO/2021/042723	GLUTAMINASE GLS1 INHIBITOR CONTAINING TRIAZOLE STRUCTURE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/203409	NOVEL NON-HYGROSCOPIC LOW-VARIABILITY CRYSTALLINE FORM FOR TREATMENT OF HEPATITIS C	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.
WO/2021/189553	THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, PREPARATION METHOD THEREFOR AND ORGANIC ELECTROLUMINESCENT DEVICE	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/207870	METHOD FOR PREPARING ATOSIBAN	XIAMEN SPACE PEPTIDES PHARMACEUTICAL CO., LTD.
WO/2021/012721	NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/196268	ANTIBODY HAVING NEUTRALIZING ACTIVITY AGAINST CORONAVIRUS, AND USE THEREOF	SANYOU BIOPHARMACEUTICALS CO., LTD.
WO/2021/012722	SODIUM 3-HYDROXYBUTYRATE PRODUCT AND PREPARATION METHOD THEREFOR	EFFEPHARM (SHANGHAI) CO., LTD
WO/2021/189561	HOLE TRANSPORT MATERIAL AND SYNTHESIS METHOD THEREFOR	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/196274	FLUORESCENT MATERIAL AND SYNTHESIS METHOD THEREFOR	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/155639	IGY FOR RESISTING SARS-COV-2 AND OTHER CORONAVIRUSES, SMALL MOLECULE ANTIBODY THEREOF AND USE THEREOF	SHENZHEN JASON INTELLIGENT BIOENGINEERING LTD.
WO/2021/027304	ANALGESIC COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/207948	ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF	TSB THERAPEUTICS (BEIJING) CO., LTD.
WO/2021/207962	ANTIBODIES TO SARS-CORONAVIRUS (COVID-19) S1 SPIKE PROTEIN	ACTIVE MOTIF SHANGHAI LIMITED
WO/2021/027306	DIHYDROARTEMISININ-STEROID CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF	YUN BAI YAO ZHENG WU TECHNOLOGY (SHANGHAI) CO., LTD
WO/2021/208023	ACETONITRILE PURIFICATION PROCESS FOR ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETER	FTSCI (HUBEI) SCIENCE AND TECHNOLOGY CO., LTD
WO/2021/208055	CRYSTAL FORM OF THIOFURAN PYRIDAZINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY
WO/2021/042732	OSTEOGENIC GROWTH PEPTIDE CARBON-TERMINAL PENTAPEPTIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHAANXI HUIKANG BIO-TECH CO., LTD.
WO/2021/208106	FUSION PEPTIDE FOR TREATING AUTOIMMUNE DISEASE	BEIJING ZEQIN BIOMEDICAL CO., LTD
WO/2021/098136	CLASS OF MULTI-MIXED COMPOSITE SALT MONOMERS HAVING ANTI-OXIDATION STABILITY AND POLYBENZODIAZOLE LIQUID CRYSTAL POLYMERS, AND PREPARATIONS AND APPLICATIONS THEREOF	JIN, Ningren
WO/2021/012726	METHOD FOR SYNTHESIZING BENZOIMIDAZOQUINAZOLINONE COMPOUND	JIANGNAN UNIVERSITY
WO/2021/203467	APPLICATION OF LIPOPEPTIDE COMPOUND AGAINST NOVEL CORONAVIRUS	DALIAN BITEOMICS, INC.
WO/2021/022831	RECTIFICATION PROCESS OF 2,2-DIMETHYL-1,3-PROPANEDIOL	BEIJING HEYIJITONG TECHNOLOGY CO., LTD.
WO/2021/031594	AROMATIC RING COMPOUND	YUNNAN DIANQING BIOTECHNOLOGY CO., LTD.
WO/2021/120476	METHOD FOR PREPARING 5-HYDROXYMETHYLFURFURAL	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/134992	MODIFIED MALEIMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENGYI TECHNOLOGY CO., LTD.
WO/2021/031599	METHOD FOR PREPARING DRUG TOXIN PNU-159682 OF ANTIBODY DRUG CONJUGATE, AND INTERMEDIATE THEREIN	LEVENA BIOPHARMA CO., LTD.
WO/2021/212460	METHOD FOR AUTOCATALYTIC PREPARATION OF 2,5-FURANDICARBOXALDEHYDE OXIME	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/184492	MONOCLONAL ANTIBODY FOR DETECTING GRAPE ABORTION-RELATED TRANSCRIPTION FACTOR AND USE THEREOF	ZHENGZHOU FRUIT RESEARCH INSTITUTE, CAAS
WO/2021/212535	METHOD FOR REFINING BENZHEXOL HYDROCHLORIDE	JIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/212536	METHOD FOR PREPARING 4-(3-CHLORO-4-FLUOROANILINE)-6-ACETOXY-7-METHOXY QUINAZOLINE HYDROCHLORIDE	JIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/217396	COMPUTATIONAL METHODS FOR THERAPEUTIC ANTIBODY DESIGN	SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
WO/2021/217479	APPLICATION OF CAMP FLUORESCENT PROBE G-FLAMP1	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/217508	COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2α AND THEIR METHODS OF USE	NOVARTIS AG
WO/2021/073070	PREPARATION METHOD FOR BISPHENOL PHOSPHATE HYDROXYL ALUMINUM SALT NUCLEATING AGENT	SHANXI INSTITUTE OF CHEMICAL INDUSTRY (LTD.)
WO/2021/196332	SUBSTITUTED BISPHENOL PHOSPHATE ESTER ALUMINUM SALT NUCLEATING AGENT, MANUFACTURING METHOD THEREFOR, AND APPLICATION THEREOF	SHANXI INSTITUTE OF CHEMICAL INDUSTRY (LTD.)
WO/2021/217537	CRYSTAL FORM OF LENVATINIB FREE BASE AND PREPARATION METHOD THEREFOR	TIANJIN CREATRON BIOTECHNOLOGY CO., LTD.
WO/2021/217574	TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTION	WATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD.
WO/2021/217579	BRIVARACETAM AND METHOD FOR PREPARING INTERMEDIATE THEREOF	SHANGHAI SYNCORES TECHNOLOGIES INC. LTD.
WO/2021/223048	ANTIBODY-DRUG CONJUGATE AND PREPARATION THEREOF	SHANGHAI MIRACOGEN INC.
WO/2021/223079	NANO ANTIBODY AND USE THEREOF	CROPEDIT BIOTECHNOLOGY INC.
WO/2021/217685	SIX-MEMBERED RING-CONTAINING NUCLEOSIDE COMPOUND AND PREPARATION METHOD THEREFOR	NANTONG WEISHUN BIOTECHNOLOGY CO., LTD
WO/2021/184502	METHOD FOR PREPARING 16ALPHA-HYDROXYPREDNISOLONE	ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
WO/2021/217690	METHOD FOR EXTRACTING POLYOL FROM FERMENTATION PROCESS	SUZHOU SUZHEN BIOENGINEERING CO., LTD
WO/2021/223145	IMPROVED ACETONITRILE PURIFICATION PROCESS FOR ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY INSTRUMENT	FTSCI (HUBEI) BIOTECH CO., LTD.
WO/2021/196340	METHOD FOR LIQUID-SOLID PHASE CATALYTIC SYNTHESIS OF 1-BUTENE-3,4-DIOL	CHANGSHU CHANGEL CHEMICAL CO.LTD
WO/2021/189604	METHOD FOR PREPARING SEA CUCUMBER PROTEIN PEPTIDE, AND USE THEREOF	CHENLAND NUTRITIONALS, INC.
WO/2021/223156	DIBORON GLYCOL ESTER, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF, AND APPLICATION THEREOF	SHANGHAI INSITITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/031622	METHOD FOR EXTRACTING AND SEPARATING DIHYDROMYRICETIN FROM AMPELOPSIS GROSSEDENTATA TEA	SONG, Kunyuan
WO/2021/042754	INDUSTRIAL PRODUCTION METHOD FOR EXTRACTING TEA POLYPHENOLS FROM GREEN TEA	SONG, Kunyuan
WO/2021/068501	METHOD FOR SYNTHESIZING MYRICETIN	SONG, Kunyuan
WO/2021/051827	APOPTOSIS PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	NANJING HUAWE MEDICINE TECHNOLOGY GROUP CO., LTD.
WO/2021/196349	ORGANIC ACID SALT OF NICOTINAMIDE RIBOSIDE, COMPOSITION THEREOF AND PREPARATION METHOD THEREFOR	SHENZHEN DIECKMANN TECH CO., LTD
WO/2021/226814	SMALL-MOLECULE COMPOUND SPAM1 FOR UP-REGULATING NEUROPEPTIDE PACAP AND RECEPTOR PAC1-R THEREOF, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	YU, Rongjie
WO/2021/226845	CHELATING AGENT, CLEANING AGENT, AND METHOD FOR PREPARING CHELATING AGENT	NANJING ALL-PLUS.CHEMICAL CO.,LTD.
WO/2021/212568	NOVEL CORONAVIRUS SPECIFIC ANTIGEN PEPTIDE AND USE THEREOF	SUZHOU FANGKE BIOTECHNOLOGY CO., LTD
WO/2021/135035	HIGH-PERFORMANCE SKY-BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/226984	TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1 AND PD-L1	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/217734	FUSED RING COMPOUND USED AS KETOHEXOKINASE INHIBITOR	GUANGZHOU BOJI MEDICAL & BIOTECHNOLOGICAL CO., LTD.
WO/2021/232200	IL-12 ARMORED IMMUNE CELL THERAPY AND USES THEREOF	GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY CO., LTD.
WO/2021/232232	METHOD FOR PREPARING AMANTADINE	SHANDONG HOLLY PHARMACEUTICAL CO., LTD.
WO/2021/232367	3-VINYL INDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	SI CHUAN UNIVERSITY
WO/2021/120522	PREPARATION METHOD FOR VITAMIN K<sb>1</sb> HAVING DIFFERENT CIS-TRANS ISOMER PROPORTIONS AND INTERMEDIATE HALOGENATED PHYTOL THEREOF	NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO. LTD
WO/2021/073099	METHOD FOR PRODUCING IBUPROFEN BY MEANS OF MULTISTAGE CONTINUOUS REACTION CRYSTALLIZATION	SHANDONG XINHUA PHARMACEUTICAL CO., LTD.
WO/2021/017597	METHOD FOR PREPARING PYRIMIDINE SALICYLIC ACID OXIME ESTER COMPOUND AND USE THEREOF AS HERBICIDE	CHANGZHOU UNIVERSITY
WO/2021/232453	PROCESS METHOD AND SYSTEM FOR CO-PRODUCTION OF PROPANE DEHYDROGENATION DEVICE AND ETHYLENE DEVICE	SHANGHAI SUPEZET ENGINEERING TECHNOLOGY CORP., LTD
WO/2021/237483	PROCESS METHOD AND SYSTEM FOR CO-PRODUCTION OF PROPANE DEHYDROGENATION UNIT AND ETHYLENE UNIT	SHANGHAI SUPEZET ENGINEERING TECHNOLOGY CORP., LTD
WO/2021/051861	METHOD FOR PREPARING ULARITIDE	HYBIO PHARMACEUTICAL CO.,LTD.
WO/2021/103454	DESALINATION METHOD USING LYOPHILIZATION PRINCIPLE	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103456	REACTION SYSTEM AND METHOD FOR PREPARING ADIPONITRILE BY MEANS OF AMMONIATION OF ADIPIC ACID	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/103457	SYNTHETIC SYSTEM AND METHOD FOR PREPARING HEXAMETHYLENEDIAMINE BY ADIPONITRILE HYDROGENATION	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/103458	SOLID-PHASE SYNTHESIS METHOD FOR DEGARELIX	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103459	MICRO-INTERFACE ENHANCED CUMENE-BASED PHENOL PREPARING SYSTEM AND PROCESS	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/103460	SYSTEM AND PROCESS FOR PREPARATION OF ETHYLBENZENE BY INTENSIFIED REACTION OF BENZENE AND ETHYLENE	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/103461	ENHANCED REACTION SYSTEM AND PROCESS FOR PREPARING ISOALDEHYDE BY MEANS OF CARBONYLATION OF OLEFIN	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/237516	SARS-COV-2 ANTIBODY AND APPLICATION THEREOF	SHANGHAI JEMINCARE PHARM CO., LTD.
WO/2021/120526	DOUBLE-TARGET CHIMERIC ANTIGEN RECEPTOR FOR SIMULTANEOUSLY TARGETING MESOTHELIN AND FAP, AND USE THEREOF	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/237534	ANTIBODY AGAINST NOVEL CORONAVIRUS, ANTIBODY COMBINATION, PREPARATION METHOD, AND DETECTION KIT CONTAINING SAME	JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)
WO/2021/189639	ENHANCED REACTION SYSTEM AND PROCESS FOR PROPYLENE HYDRATION CATALYZED BY IONIC LIQUID	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/196383	EXTERNAL MICRO-INTERFACE UNIT ENHANCED REACTION SYSTEM AND PROCESS FOR PRODUCTION OF PTA FROM PX	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/196384	REACTION ENHANCEMENT SYSTEM AND PROCESS FOR PRODUCING PTA BY PX HAVING BUILT-IN MICRO-INTERFACE UNIT	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/208199	REACTION SYSTEM AND METHOD FOR AMMOXIMATION AND TERT-BUTYL ALCOHOL RECOVERY	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/208200	BUILT-IN MICRO-INTERFACE AMMOXIMATION REACTION SYSTEM AND METHOD	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/208201	EXTERNAL MICRO-INTERFACE AMMOXIMATION REACTION SYSTEM AND METHOD	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/227136	ENHANCED REACTION SYSTEM AND METHOD FOR PREPARING CYCLOHEXANONE BY SELECTIVE HYDROGENATION OF BENZENE	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/227137	EXTERNAL MICRO-INTERFACE STRENGTHENING SYSTEM AND METHOD FOR PREPARING CYCLOHEXANONE BY ESTERIFICATION METHOD	NANJING YANCHANG REACTION TECHNOLOGY RESEARCH INSTITUTE CO. LTD
WO/2021/057061	SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF	PEKING UNIVERSITY
WO/2021/227138	MONOCLONAL ANTIBODY FOR NOVEL CORONAVIRUS, OR ANTIGEN BINDING PART THEREOF	JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)
WO/2021/237717	BISPECIFIC ANTIBODY AGAINST CLDN18.2 AND CD3	WUHAN YZY BIOPHARMA CO., LTD.
WO/2021/243480	TRIAZOLE SULFONAMIDE DERIVATIVE, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/068530	Z-TYPE SOLANONE, PREPARATION METHOD THEREFOR, AND USE	CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
WO/2021/068531	ACANTHOPAGRUS SCHLEGELII ANTIBACTERIAL PEPTIDE AS-HEPC3<sb>(48-56)</sb>, AND USE THEREOF	XIAMEN UNIVERSITY
WO/2021/243528	USE OF DRW1 PROTEIN IN REGULATION AND CONTROL OF PLANT HEIGHT AND SEED SIZE OF RICE	BIOTECHNOLOGY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/047212	POTASSIUM ION FLUORESCENT PROBE, PREPARATION METHOD AND APPLICATION THEREOF	SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA.
WO/2021/000684	COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/017620	DEVICE AND METHOD FOR CONTINUOUSLY EXTRACTING AND DRYING BUTENONE	XIAMEN KINGDOMWAY VITAMIN INC.
WO/2021/227146	N-[8-(2-HYDROXYBENZOYL)AMINO]MONOPOTASSIUM OCTANOATE CRYSTAL COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF	TAIZHOU PUKAI PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/243596	AMINOPYRIMIDINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/000687	PREPARATION METHOD FOR CRYSTAL FORM OF PAC-1	BEIJING SCICURECANCER TECHNOLOGY CO., LTD.
WO/2021/109507	STSCI PROTEIN FOR CHANGING SELF-CROSSLINKING INCOMPATIBILITY OF DIPLOID POTATO MATERIALS	AGRICULTURAL GENOMICS INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/022890	CYCLOHEXANAMINE D<sb>3</sb>/D<sb>2</sb> RECEPTOR PARTIAL AGONIST	SHANGHAI XUNHE PHARMACEUTICAL TECHNOLOGY CO.LTD.
WO/2021/057082	PYRIDINE SULFONAMIDE PHOSPHATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI XUNHE PHARMACEUTICAL TECHNOLOGY CO. LTD.
WO/2021/169081	METHOD FOR REFINING OMEPRAZOLE	NANJING COSTAR BIOTECHNOLOGY RESEARCH INSTITUTE CO., LTD.
WO/2021/017642	IMPROVED METHOD FOR PREPARING MALEATE SALT OF PARA-SUBSTITUTED CIS-CYCLOHEXYLAMINO NITRILE	HEBEI LANSHENG BIOTECH CO., LTD
WO/2021/243695	TCR-T CELL THERAPY TARGETING EPSTEIN-BARR VIRUS	GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY CO., LTD.
WO/2021/004209	EUTECTIC OF CALCIUM DIHYDROPYRIDINE ANTAGONIST AND PREPARATION METHOD THERFOR AND APPLICATION THEREOF	FUDAN UNIVERSITY
WO/2021/248256	PYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR, USE THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/017645	RACEMIC PREPARATION METHOD FOR CHIRAL β-AMINO ACID AND DERIVATIVE THEREOF	ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.
WO/2021/248271	PROCESS AND SYSTEM FOR PURIFICATION OF CITRIC ACID	ENTEGRIS, INC.
WO/2021/248276	ANTI-SAR-COV-2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/248279	ANTIBODIES AGAINST SARS-COV-2 S1 SPIKE PROTEIN	ACTIVE MOTIF SHANGHAI LIMITED
WO/2021/212627	RECOMBINANT HUMAN COLLAGEN AND CONSTRUCTION METHOD THEREFOR	NANTONG UNIVERSITY
WO/2021/017649	METHOD FOR PURIFYING 4-CYANOPYRIDINE BY MEANS OF MELTING AND CRYSTALLIZING	ANHUI REDPONT BIOTECHNOLOGY CO.LTD.
WO/2021/051899	CYANO-SUBSTITUTED CYCLIC HYDRAZINE DERIVATIVE AND APPLICATION THEREOF	VIVAVISION (SHANGHAI) LTD
WO/2021/109530	PROCESS FOR PREPARING ALCOHOL BY HYDROLYSIS OF METAL ORGANIC PRODUCT	SHANGYU NHU BIO-CHEM CO., LTD.
WO/2021/139092	LIGAND COMPOUND, AND FUNCTIONALIZED METAL-ORGANIC FRAMEWORK COMPOUND PREPARED BY SAME, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SUN YAT-SEN UNIVERSITY
WO/2021/109533	METHOD FOR PREPARING MONOPHENOL COMPOUND AND CO-PRODUCING CELLULOSE BY CATALYTICALLY OXIDIZING BIOMASS BY TRANSITION METAL OXIDE	GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES
WO/2021/217805	ORGANIC MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/164155	CRYPTOTANSHINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN RESISTING NEUROINFLAMMATION AND NEUROPROTECTION	OCEAN UNIVERSITY OF CHINA
WO/2021/253162	PREPARATION METHOD FOR BRIVARACETAM	ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
WO/2021/253172	METHOD FOR INDUCING ANTI-NOVEL CORONAVIRUS NEUTRALIZING ANTIBODY USING RECEPTOR RECOGNITION DOMAIN	SHANGHAI PUBLIC HEALTH CLINICAL CENTER
WO/2021/253180	METHYL (R) -2- (FLUOROMETHYL) -5-OXO-4-PHENYL-4, 5, 6, 7-TETRAHYDRO-1H-CYCLOPENTA [B] PYRIDINE-3-CARBOXYLATE AND METHYL (R) -2- (FLUOROMETHYL) -5-OXO-4-PHENYL-1, 4, 5, 7-TETRAHYDROFURO [3, 4-B] PYRIDINE-3-CARBOXYLATE AS CAV1.2 ACTIVATORS	NOVARTIS AG
WO/2021/237820	P-TYPE ORGANIC SEMICONDUCTOR MATERIAL, PREPARATION METHOD AND DISPLAY PANEL	WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
WO/2021/208223	ACETANILIDE COMPOUND, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF	WUYI UNIVERSITY
WO/2021/128764	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/253305	PREPARATION METHOD FOR DL-LYSINE	SUZHOU YUANFANG CHEMICAL CO., LTD.
WO/2021/253306	METHOD FOR PREPARING DL-PROLINE	SUZHOU YUANFANG CHEMICAL CO., LTD.
WO/2021/000736	SUBSTITUTED BENZOYL-PYRAZOLE COMPOUND, AND APPLICATION THEREOF IN AGRICULTURE	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/196415	TARGETING-SPECIFIC POLYPEPTIDE AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/217824	METHOD FOR PREPARING NATURAL FLAVONE SELENIUM	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/217825	METHOD FOR PREPARING DISELENIDE COMPOUND	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/253335	ANTI-SOLUBLE CD14 SUBTYPE ANTIBODY, KIT AND USE THEREOF	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
WO/2021/036433	NITROGEN-CONTAINING COMPOUND, PHOTOELECTRIC CONVERSION DEVICE, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/253360	ACTIVATABLE PROCYTOKINES	PROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/253361	SEMI-SYNTHESIS METHOD FOR APIGENIN	BONTAC BIO-ENGINEERING (SHENZHEN) CO.,LTD
WO/2021/253362	METHOD FOR PREPARING NICOTINAMIDE MONONUCLEOTIDE BY USING NICOTINAMIDE AS RAW MATERIAL	BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD.
WO/2021/253370	SYSTEM AND METHOD FOR PREPARING METHANOL	ZHOU, Lianhui
WO/2021/042814	ALKYL THIOETHER ETHYL HYDROXIMIC ACID BENEFICIATION AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF	CENTRAL SOUTH UNIVERSITY
WO/2021/253376	PREPARATION METHOD FOR PHOSPHAMIDE COMPOUND USED FOR SYNTHESIZING CHIRAL DRUG	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.
WO/2021/253410	PIF1-LIKE HELICASE AND APPLICATION THEREOF	QITAN TECHNOLOGY LTD., BEIJING
WO/2021/109542	DIARYL PHOSPHINE OXIDE COMPOUND CONTAINING SUBSTITUENT GROUPS AND PREPARATION METHOD THEREFOR	SHANDONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/000755	SMALL-MOLECULE REGULATOR OF TLR8	TSINGHUA UNIVERSITY
WO/2021/008308	FUSION PROTEIN AND COMPOSITION FOR TREATING ANIMAL TUMORS	BEIJING KENUOKEFU BIOTECHNOLOGY CO., LTD.
WO/2021/258250	USE OF INTERFERENCE POLYPEPTIDE IN PREPARATION OF ANTI-SARS-COV-2 DRUG	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/237841	USE OF ORGANIC MEMBRANE IN HEMP EXTRACTION	GUILIN LAYN NATURAL INGREDIENTS CORP
WO/2021/227206	DIETHYLAMINE-CONTAINING AZINE HYDRAZINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/258272	COMPOUNDS AND THEIR USES AS MIF INHIBITORS	NANJING IMMUNOPHAGE BIOTECH CO., LTD.
WO/2021/143048	3,4-DIHYDROXY-N-(1'-BENZYL-2'-HYDROXYETHYL)-2-METHYLPYRIDINE CHLORIDE, AND PREPARATION AND APPLICATION THEREOF	HANGZHOU ZEDE PHARMA-TECH CO. LTD.
WO/2021/223301	PREPARATION METHOD FOR WATER-SOLUBLE FLORFENICOL AMINO ACID ESTER SALT	CHINA AGRICULTURAL UNIVERSITY
WO/2021/159648	BETA-CORONAVIRUS ANTIGEN, PREPARATION METHOD THEREFOR AND USE THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/000767	IMPROVED FIX FUSION PROTEIN AND CONJUGATE AND USE THEREOF	ZHENGZHOU GENSCIENCES INC
WO/2021/012864	DOMINANT SALT FORMS OF PYRIMIDINE DERIVATIVES, AND CRYSTAL FORMS THEREOF	GUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/022932	α-SUBSTITUTED PHENYL STRUCTURE-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR, AND DISINFECTANT	ZHENGZHOU UNIVERSITY
WO/2021/000785	PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS SELECTIVE INHIBITORS OF JANUS KINASE 1	SHENZHEN AMAZING GENETECH CO., LTD
WO/2021/135099	METHOD FOR PURIFYING CANNABIDIOL	JIANGSU HANBON SCIENCE AND TECHNOLOGY CO., LTD
WO/2021/253478	PHOTOSENSITIVE PHOTORESIST RESIN MONOMER CONTAINING POLYCYCLIC β-KETONE STRUCTURE, AND METHOD FOR SYNTHESIZING SAME	XUZHOU B&C CHEMICAL CO., LTD
WO/2021/022938	METHOD FOR PREPARING METAL-ORGANIC FRAMEWORK USING SOLID WASTE FROM METALLURGICAL MINE	UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING
WO/2021/000813	MONOCLONAL ANTIBODY TARGETING PD-1 AND USE THEREOF	FANG, Shubin
WO/2021/232543	METHOD FOR SEPARATING COENZYME Q10 BY MEANS OF USING SUPERCRITICAL FLUID CHROMATOGRAPHY SYSTEM	INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL LIMITED
WO/2021/008338	AURORA KINASE INHIBITOR AND USE THEREOF	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/000855	MALT1 INHIBITORS AND USES THEREOF	QILU REGOR THERAPEUTICS INC.
WO/2021/000862	AKR1C3 INHIBITOR AND MEDICAL USE	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/000863	ORGANIC SILICON COUPLING AGENT AND PREPARATION METHOD THEREFOR	BEIHANG UNIVERSITY
WO/2021/135127	METHOD FOR PREPARING (2S,3S)-3-AMINO-BICYCLO[2.2.2]OCTANE-2-CARBOXYLATE	GUANGDONG RAFFLES PHARMATECH CO., LTD
WO/2021/000865	ISOXAZOLINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/000867	ISOXAZOLINE COMPOUND AND APPLICATION THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/135133	METAL TIN CYCLIZED PERYLENE IMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF	DALIAN UNIVERSITY OF TECHNOLOGY
WO/2021/077794	PREPARATION AND APPLICATION OF SOLUBLE TIM-3 RECOMBINANT PROTEIN AND MUTANT PROTEIN THEREOF	ZHEJIANG UNIVERSITY
WO/2021/036495	NOVEL PHENYLACETIC ACID DERIVATIVE, PREPARATION METHOD THEREOF AND USE THEREOF AS DRUG	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/114639	NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR	HC SYNTHETIC PHARMACEUTICAL CO., LTD.
WO/2021/082501	EXPECTORANT COMPOUND AND PREPARATION METHOD AND USE THEREOF	HC SYNTHETIC PHARMACEUTICAL CO., LTD.
WO/2021/000884	2-AMINOPYRIMIDINE COMPOUND AND APPLICATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/000885	QUINAZOLINE DERIVATIVES, PREPARATION PROCESS AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/000886	PERTUSSIS TOXIN BINDING PROTEIN	SUZHOU ALPHAMAB CO., LTD.
WO/2021/135137	MITOCHONDRIAL G-QUADRUPLEX DNA-TARGETED FLUORESCENT PROBE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUN YAT-SEN UNIVERSITY
WO/2021/082504	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/008374	NOVEL COMPOUND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	TSINGHUA UNIVERSITY
WO/2021/000912	COMPOUND FOR INHIBITING EGFR KINASE AND PREPARATION METHOD AND USE THEREOF	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/004379	FLUORESCENTLY LABELED NUCLEIC ACID AND SYNTHESIS METHOD THEREFOR	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/000925	PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF	BEIGENE, LTD.
WO/2021/004388	CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF	SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
WO/2021/004391	C-MYC PROTEIN INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU KINTOR PHARMACEUTICALS, INC.
WO/2021/000933	PYRIMIDINONE COMPOUNDS AS CHYMASE INHIBITORS AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/000934	CRYSTAL FORM OF BENZIMIDAZOLE-2-ONE COMPOUND, SOLVATE THEREOF, CRYSTAL FORM OF SOLVATE THEREOF, AND PREPARATION METHOD THEREFOR	MEDSHINE DISCOVERY INC.
WO/2021/000935	HPK1 INHIBITORS AND USES THEREOF	QILU REGOR THERAPEUTICS INC.
WO/2021/004400	IMMUNE CELL EXPRESSING CD3 ANTIBODY-RECEPTOR COMPLEX AND USE THEREOF	CURE GENETICS CO., LTD
WO/2021/004401	CRYSTAL FORM OF KEY INTERMEDIATE OF BTK KINASE INHIBITOR AND PREPARATION METHOD THEREFOR	SHANGHAI ZAIQI BIO-TECH CO., LTD.
WO/2021/000957	HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	BEIJING GUOHONG BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/004421	ALKYNE DERIVATIVE, PREPARATION METHOD FOR SAME, AND USES THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/031716	ANTI-PD-L1 SINGLE DOMAIN ANTIBODIES	ZHEJIANG DOER BIOLOGICS CORPORATION
WO/2021/036514	PPAR γ/δ DUAL AGONIST, PREPARATION METHOD THEREOF AND USE THEREOF IN PREPARING A DRUG	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/036515	METHOD FOR SYNTHESIZING ALKENYL BORATE COMPOUND	LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES
WO/2021/004446	ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF	STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/253523	SYNTHETIC PEPTIDE BRAP AND USE THEREOF IN PREPARATION OF ANTI-INFLAMMATORY MEDICINE FOR COVID-19	TAIAN CITY QIHANG BIOTECHNOLOGY CO.
WO/2021/004456	IMPROVED GENOME EDITING SYSTEM AND USE THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/004467	COMPOUND AS PORCUPINE INHIBITOR AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/012947	FGF21 FC FUSION PROTEIN, GLP-1 FC FUSION PROTEIN, AND COMBINATION THERAPEUTIC AGENT COMPRISING SAME AND USE THEREOF	AMPSOURCE BIOPHARMA SHANGHAI INC.
WO/2021/012949	1,2-BIS(DIPHENYLPHOSPHINOALKYLAMIDO)-1,2-DISUBSTITUTED ETHANE AND SYNTHESIS AND USE THEREOF	ZHEJIANG UNIVERSITY
WO/2021/004480	ANTI-CD47/ANTI-PD-1 BISPECIFIC ANTIBODY, PREPARATION METHOD AND USE THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/004482	SUBSTITUTED PYRAZOLOQUINAZOLONE COMPOUND AND APPLICATION THEREOF	IMPACT THERAPEUTICS, INC
WO/2021/004487	THIAZOLIDINEDIONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/077806	MULTI-SPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GAO, Xin
WO/2021/004494	ANTI-C5 HUMANIZED MONOCLONAL ANTIBODY HAVING LOW IMMUNOGENICITY AND LOW ADCC/CDC FUNCTION, AND USE THEREOF	ABMAX BIOTECHNOLOGY CO. LTD.
WO/2021/237891	AN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND A FUSION PROTEIN CONTAINING THE SAME	BEIJING VDJBIO CO., LTD.
WO/2021/031736	MULTIFUNCTIONAL ANTIBODY, PREPARATION FOR SAME, AND USES THEREOF	SHENGHE (CHINA) BIOPHARMACEUTICAL CO., LTD.
WO/2021/004498	GLUCOPYRANOSYL DERIVATIVES AND THEIR USES	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/143073	PREPARATION METHOD FOR SEMAGLUTIDE	SHENZHEN JYMED TECHNOLOGY CO., LTD.
WO/2021/008441	BTK INHIBITOR CONTAINING 5-AZASPIROHEPTANE	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/017789	Aβ<sb>42</sb> AGGREGATION-INDUCED LUMINESCENCE FUSION AND CONSTRUCTION AND APPLICATION THEREOF	TIANJIN UNIVERSITY OF SCIENCE& TECHNOLOGY
WO/2021/017790	ALPHA-SYNUCLEIN AGGREGATION INDUCED LUMINESCENCE SYSTEM AND CONSTRUCTION AND USE THEREOF	TIANJIN UNIVERSITY OF SCIENCE& TECHNOLOGY
WO/2021/004516	METHOD FOR PREPARING 2-INDOLINOSPIRONE COMPOUND AND INTERMEDIATE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/057190	QUINOLINE COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SUN SAIL PHARMACEUTICAL SCIENCE TECHNOLOGY CO LTD
WO/2021/008454	FERRITIN HEAVY CHAIN SUBUNIT-BASED DRUG CARRIER	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/008455	RET SELECTIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SHOUYAO HOLDINGS (BEIJING) CO., LTD.
WO/2021/004531	CRYSTALLINE FORM OF CXCR2 ANTAGONIST AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/004533	OXAZOLE COMPOUND AS MULTI-TARGETED INHIBITOR OF IRAK4 AND BTK	MEDSHINE DISCOVERY INC.
WO/2021/008463	CLDN18.2 ANTIBODY AND USE THEREOF	FUTUREGEN BIOPHARMACEUTICAL (BEIJING) CO., LTD.
WO/2021/004535	CINNOLINES AS INHIBITORS OF HPK 1	NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD.
WO/2021/004539	COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES	XIAMEN UNIVERSITY
WO/2021/017793	METHOD FOR PREPARING CHEMICALLY SYNTHESIZED ACIDIC POLYPEPTIDE	SHENZHEN JYMED TECHNOLOGY CO., LTD.
WO/2021/184609	METHOD FOR PREPARING MILRINONE INTERMEDIATE	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/203572	1,2-BIS(4-PYRIDYL)ETHANE-ACIPIMOX CO-CRYSTAL	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/017795	α,β-UNSATURATED KETONE DERIVATIVE, PREPARATION METHOD AND USE AS MEDICINE	NINGXIA MEDICAL UNIVERSITY
WO/2021/008485	ISOXAZOLINE DERIVATIVES AND THEIR USES IN AGRICULTURE	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/008491	BIPHENYL DERIVATIVES FOR BLOCKING PD-1/PD-L1 INTERACTION, PREPARATION METHOD THEREFOR AND USE THEREOF	ABBISKO THERAPEUTICS CO., LTD.
WO/2021/004547	HETEROCYCLIC COMPOUNDS AS INHIBITORS OF HPK1	GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD.
WO/2021/008512	COMPOUND AS NMT INHIBITOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/008516	PHENYL-CONTAINING COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NATIONAL PHARMACEUTICAL ENGINEERING RESEARCH CENTER
WO/2021/008519	FUSION PROTEIN OF ETA ANTIBODY AND TGF-β TRAP AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	GMAX BIOPHARM LLC
WO/2021/008523	ANTI-TIGIT ANTIBODIES AND APPLICATION THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/008549	NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/217893	ANTIBODY BINDING TO TIGIT ANTIGEN, PREPARATION METHOD THEREFOR AND USE THEREOF	ACROIMMUNE BIOTECH CO., LTD.
WO/2021/008559	BISPECIFIC ANTIBODIES AGAINST PD-1 AND LAG-3	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/077812	UMBILICAL CORD MESENCHYMAL STEM CELL FACTOR FREEZE-DRIED POWDER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGSU CELL TECH MEDICAL RESEARCH INSTITUTE CO., LTD.
WO/2021/008577	ANTI-CD47/ANTI-CTLA-4 BISPECIFIC ANTIBODY AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/174745	METHOD FOR PREPARING ISOINDIGO COMPOUND BY ORGANIC CATALYTIC ISATIN SELF-CONDENSATION	DALIAN UNIVERSITY OF TECHNOLOGY
WO/2021/017880	CLASS OF TRIAROMATIC COMPOUNDS TARGETING BIFUNCTIONAL PHOSPHORYLATION SITE OF STAT3 AND APPLICATIONS THEREOF	SHANGHAI YUYAO BIOTECH LTD.
WO/2021/008588	CLASS OF PYRIMIDINE QUINOLINE DERIVATIVES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SYMEPILIN PHARMACEUTICALS CO., LTD.
WO/2021/057207	METHOD FOR PRODUCING TRIS(1,3-DICHLOROPROPYL)PHOSPHATE	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD
WO/2021/008590	ISOLATED ANTIGEN-BINDING PROTEIN AND APPLICATION THEREOF	DINGFU BIOTARGET CO., LTD.
WO/2021/031756	METHOD FOR SYNTHESIZING CARBOXYLIC ACID OR KETONE COMPOUNDS FROM ALCOHOL OR ALDEHYDE USING OXYGEN OR OXYGEN IN AIR AS OXIDANT	ZHEJIANG UNIVERSITY
WO/2021/017883	FUSION PROTEIN FOR PREPARING SINGLE-CELL CHIP-SEQ LIBRARY AND APPLICATION THEREOF	PEKING UNIVERSITY
WO/2021/063075	ALBIZIAE CORTEX LIGNAN COMPOUND AND APPLICATION THEREOF	JIANGNAN UNIVERSITY
WO/2021/013060	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 51 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013061	HUMANIZED ANTI-VEGFR2 ANTIBODY AND APPLICATION THEREOF	SINOCELLTECH LTD
WO/2021/013062	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013064	HUMANIZED VEGFR2 ANTIBODY AND APPLICATION THEREOF	SINOCELLTECH LTD
WO/2021/013065	HUMANIZED ANTI-VEGF FAB ANTIBODY FRAGMENT AND USE THEREOF	SINOCELLTECH LTD
WO/2021/013067	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013068	POLYPEPTIDE COMPLEX FOR CONJUGATION AND USE THEREOF	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/013069	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013070	CHIMERIC HUMAN PAPILLOMAVIRUS 35 TYPE L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013071	POLYVALENT IMMUNOGENICITY COMPOSITION FOR HUMAN PAPILLOMAVIRUS	SINOCELLTECH LTD
WO/2021/013072	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 39 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013073	CHIMERIC PAPILLOMAVIRUS L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013075	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013076	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013077	CHIMERIC HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013078	CHIMERIC HUMAN PAPILLOMA VIRUS 52 TYPE L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013079	CHIMERIC HUMAN PAPILLOMAVIRUS 56-TYPE L1 PROTEIN	SINOCELLTECH LTD
WO/2021/013080	HUMANIZED ANTI-VEGF MONOCLONAL ANTIBODY	SINOCELLTECH LTD
WO/2021/013083	TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF	BEIGENE, LTD.
WO/2021/013084	FUSED RING PYRIMIDINE AMINO COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/013085	PEPTIDE AMIDE SALT, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/013086	DEUTERATED PEPTIDE AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/008607	SUBSTITUTED 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVE AND PREPARATION METHOD, HERBICIDAL COMPOSITION AND APPLICATION THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/017892	METHOD AND COMPOSITION FOR ANTI-CD73 ANTIBODIES AND VARIANTS	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/008610	ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/013131	HEMOGLOBIN-BASED THERAPEUTIC AGENTS	CHEER GLOBAL LIMITED
WO/2021/013135	A METHOD OF TREATING HBV INFECTION BY USING ANTI-PRE-S1 HBV ANTIBODIES	HUAHUI HEALTH LTD.
WO/2021/027502	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/013142	ANTI-4-1BB ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND BISPECIFIC ANTIBODY	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/042890	HETEROCYCLIC COMPOUND AND APPLICATION THEREOF AS TRK KINASE INHIBITOR	LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/047292	NOVEL METHOD FOR CO-PRODUCTION OF CARBOXYLIC ACID BASED ON OXYGEN OXIDATION AND ε-CAPROLACTONE	ZHEJIANG UNIVERSITY
WO/2021/027503	TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND INTERMEDIATE AND USE THEREOF	LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/174748	METHOD FOR PREPARING VISIBLE LIGHT CATALYZED DICHLORINE ADDITION PRODUCT OF ALIPHATIC OLEFIN	SOOCHOW UNIVERSITY
WO/2021/013155	NOVEL GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	SICHUAN UNIVERSITY
WO/2021/237904	VENOM-BASED PEPTIDE AND APPLICATION THEREOF	UNIVERSITY OF MACAU
WO/2021/013163	HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN	TAIPEI MEDICAL UNIVERSITY
WO/2021/135178	ENHANCED T-CELL RECEPTOR STAR AND APPLICATION THEREOF	CHINA IMMUNOTECH (BEIJING) BIOTECHNOLOGY CO., LTD.
WO/2021/013209	MACROCYCLIC DERIVATIVES AS FACTOR XIA INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/023016	THIAZOLIDONE DERIVATIVE OF LOVATINIB ACID AND APPLICATION THEREOF	JIANGSU QIANZHIKANG BIOLOGICAL MEDICINE SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/031784	BISPECIFIC ANTIBODY TARGETING CD3 AND CD20 AND USE THEREOF	YANG, Yang
WO/2021/013215	ANTI-CD47/ANTI-LAG-3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/017996	PHENYLPIPERAZINE QUINAZOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	JINAN UNIVERSITY
WO/2021/013217	A TEIXOBACTIN ANALOGUE AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/031788	PHENYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, USE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/018003	EGFR INHIBITOR, COMPOSITION, AND PREPARATION METHOD THEREFOR	BETTA PHARMACEUTICALS CO., LTD
WO/2021/135181	NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/018009	EGFR INHIBITOR, COMPOSITION, AND PREPARATION METHOD THEREFOR	BETTA PHARMACEUTICALS CO., LTD
WO/2021/018012	IRAK4 KINASE INHIBITOR AND PREPARATION METHOD THEREFOR	ZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/018017	PYRIMIDINE COMPOUND ACTING ON EGFR AND ERBB2	MEDSHINE DISCOVERY INC.
WO/2021/013234	CYCLIC DINUCLEOTIDES AS STING AGONISTS	BEIGENE, LTD.
WO/2021/018018	DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INIDBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE	BEIGENE, LTD.
WO/2021/018023	SMALL MOLECULE GLP-1 RECEPTOR MODULATOR	THE TITAN LEADING MED. TECH INC
WO/2021/018035	HUMANIZED ANTI-IL17A ANTIBODY AND USE THEREOF	SINOCELLTECH LTD
WO/2021/013250	HETEROCYCLIC AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/018044	SGLT2/DPP4 INHIBITOR AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/018047	PYRIDINE DERIVATIVE AS FGFR AND VEGFR DUAL INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/135183	ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/103614	PREPARATION METHOD FOR AND USE OF N-BIS(DIMETHYLAMINO)-1,3-DIMETHYLIMIDAZOLINE	JINING KANGSHENG RAINBOW BIOTECHNOLOGY CO. LTD
WO/2021/018085	PREPARATION METHOD FOR HEXAHYDROFUROFURANOL DERIVATIVE, AND INTERMEDIATE OF THE DERIVATIVE AND PREPARATION METHOD THEREFOR	ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.
WO/2021/013269	BIFUNCTIONAL MOLECULES WITH IL-7 ACTIVITY	I-MAB BIOPHARMA CO., LTD.
WO/2021/018099	H2O2-RESPONSIVE CROSSLINKING NEAR-INFRARED MOLECULAR PROBE FOR TUMOR MICROENVIRONMENT AND USE THEREFOR	SOOCHOW UNIVERSITY
WO/2021/042911	MAGL INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/189738	FUNCTIONAL MATERIAL PREPARED BASED ON MILK PROTEIN CONCENTRATE	JIANGNAN UNIVERSITY
WO/2021/018105	SUBSTITUTED PYRIMIDINEDIONE COMPOUNDS AND USES THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/018112	PREPARATION METHOD OF 1,6-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/018114	ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/018118	COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 PROTEINS	JANSSEN PHARMACEUTICA NV
WO/2021/018135	HETEROCYCLYL ALKYL SUBSTITUTED DICHLOROBENZOYL COMPOUNDS AND APPLICATIONS THEREOF	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/103617	T-CELL RECEPTOR OF HLA-A11-RESTRICTED HEPATITIS B VIRUS HBC <sb>141-151</sb> EPITOPE PEPTIDE, AND APPLICATION THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/179512	ANTI-INFLUENZA VIRUS COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/027566	PREPARATION METHOD FOR OXAZEPINE COMPOUND	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/179513	INFLUENZA VIRUS NEURAMINIDASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/027567	COMBINATION OF EP4 RECEPTOR ANTAGONIST AND PD-1 INHIBITOR FOR CANCER TREATMENT	SHANGHAI YUYAO BIOTECH LTD.
WO/2021/018157	PREPARATION AND APPLICATION OF MIXED-LIGAND NICKEL(II) COMPLEX CONTAINING BISOXAZOLINE-DERIVED NITROGEN HETEROCYCLIC CARBENE LIGAND AND PHOSPHITE LIGAND	SOOCHOW UNIVERSITY
WO/2021/018165	PYRIDINE BENZAMIDE DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICINAL APPLICATIONS THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/018168	ANTI-BCMA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/018172	ADENOSINE RECEPTOR ANTAGONIST	ADLAI NORTYE BIOPHARMA CO., LTD.
WO/2021/018173	ADENOSINE RECEPTOR ANTAGONIST	ADLAI NORTYE BIOPHARMA CO., LTD.
WO/2021/093374	METHOD FOR SYNTHESIZING ARGATROBAN HYDRATE	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/018191	METHOD FOR TREATING AUTOIMMUNE DISEASE BY IL-17 ANTAGONIST	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/018194	HETEROCYCLIC COMPOUNDS AS BCR-ABL INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018195	NOVEL TRICYCLIC COMPOUNDS AS BCR-ABL INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018207	COMPOUNDS FOR TREATING AND/OR PREVENTING HEPATITIS B VIRUS INFECTIONS, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI ZHIMENG BIOPHARMA INC.
WO/2021/018226	HETEROCYCLIC COMPOUND AND APPLICATION THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/018238	DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/018239	DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/073198	CONTINUOUS PRODUCTION METHOD FOR AMINO TRIMETHYLENE PHOSPHONIC ACID CRYSTAL	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD
WO/2021/073199	CONTINUOUS PRODUCTION METHOD FOR HYDROXYETHYLENE DIPHOSPHONIC ACID CRYSTALS	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD
WO/2021/082567	USE OF SOYBEAN BROAD-SPECTRUM DISEASE RESISTANCE RELATED GENE	NORTHEAST INSTITUTE OF GEOGRAPHY AND AGROECOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/237932	TCR ENRICHED CLONOTYPES AND ACQUISITION METHOD AND APPLICATION THEREFOR	HUNAN YUANPIN CELL TECHNOLOGY CO., LTD
WO/2021/135207	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/023098	ANTI-TNFR2 ANTIBODY AND USE THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/018270	HOST COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	ZHEJIANG HUADISPLAY OPTOELECTRONICS CO., LTD
WO/2021/057256	HETEROCYCLIC NITROGEN COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/023100	DEOXYCHOLIC ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	DU, Jessica Xinyun
WO/2021/258500	PREPARATION METHOD FOR FAVIPIRAVIR AND DERIVATIVE THEREOF	HANGZHOU HUANGSEN BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/023104	1H-[1, 2, 3]TRIAZOLO[4, 5-H] QUINAZOLINE COMPOUNDS ACTING AS PROTEIN KINASE INHIBITORS	CHENGDU SYNOWEST BIOTECHNOLOGY S.R.L.
WO/2021/023105	IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVE USED AS TLR8 AGONIST	BEIGENE, LTD.
WO/2021/018287	SPIROAROMATIC COMPOUND, PREPARATION AND APPLICATION THEREOF	ETERN BIOPHARMA (SHANGHAI) CO., LTD.
WO/2021/027594	IMIDAZOLOPYRIMIDINE COMPOUNDS COMPRISING FUSED RING GROUP, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/114691	NITROGEN-CONTAINING RING-FUSED COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/042922	PREPARATION METHOD FOR TETRAGALLOYLGLUCOSE	TEA RESEARCH INSTITUTE, GUANGDONG ACADEMY OF AGRICULTURAL SCIENCE
WO/2021/023116	HIGH AFFINITY T-CELL RECEPTOR CAPABLE OF IDENTIFYING NY-ESO-1 ANTIGEN	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/036683	AROMATIC AMINE COMPOUND, COATING LAYER MATERIAL AND LIGHT EMITTING ELEMENT	TORAY ADVANCED MATERIALS RESEARCH LABORATORIES (CHINA) CO., LTD.
WO/2021/023117	ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND USES THEREOF	AKESO PHARMACEUTICALS, INC.
WO/2021/082573	ANTI-IL-4R SINGLE-DOMAIN ANTIBODY AND USE THEREOF	SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/023119	CO-CRYSTAL OF MELITRACEN AND FLUPENTIXOL AND PREPARATION METHOD THEREFOR	NHWA PHARMA. CORPORATION
WO/2021/018298	INDOLO-SEVEN-MEMBERED ACYLOXIME COMPOUNDS AS PARP INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/023140	AFFINITY PEPTIDE OF PD-L1-IGV AND APPLICATION THEREOF	ZHENGZHOU UNIVERSITY
WO/2021/023143	METHOD FOR PREPARING PHARMACEUTICAL INTERMEDIATE OF RELUGOLIX	SUZHOU PENGXU PHARMATECH CO., LTD
WO/2021/023144	FLUORENOXIME ESTER COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	(CHAN-N) CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD.
WO/2021/023154	TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/057264	COMPOUND, PHOTOELECTRIC CONVERSION DEVICE, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/027614	MODIFIED NUCLEOSIDE AND SYNTHESIS METHOD THEREFOR	STEMIRNA THERAPEUTICS CO., LTD.
WO/2021/082579	METHOD FOR PRODUCING LIGHT AROMATIC	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/023192	A CRYSTALLINE FORM AND B CRYSTALLINE FORM OF PYRAZINE-2(1H)-KETONE COMPOUND AND PREPARATION METHOD THEREOF	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/023193	PYRAZINE-2(1H)-KETONE COMPOUND PREPARATION METHOD	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/023194	CRYSTAL FORMS C AND E OF PYRAZIN-2(1H)-ONE COMPOUND AND PREPARATION METHOD THEREFOR	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/023195	CRYSTAL FORM D OF PYRAZINE-2(1H)-KETONE COMPOUND AND PREPARATION METHOD THEREFOR	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/023204	USE OF CDK4/6 INHIBITOR IN COMBINATION WITH MULTI-TARGET TYROSINE KINASE INHIBITOR IN PREPARING MEDICAMENT FOR TREATING TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/023207	JAK KINASE INHIBITOR AND USE THEREOF	JIANGSU CAREPHAR PHARMACEUTICAL CO., LTD.
WO/2021/023209	NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUNDS, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	APPLIED PHARMACEUTICAL SCIENCE, INC.
WO/2021/027647	BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	THE NATIONAL INSTITUTES OF PHARMACEUTICAL RESEARCH&DEVELOPMENT CO., LTD. (NIP)
WO/2021/023213	SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/189750	CINNAMOYL AMINO ACID COMPOUNDS AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/023230	METHOD FOR SYNTHESIZING A PHOSPHORUS-CONTAINING SILICON-CONTAINING ORGANIC OR INORGANIC INTERNAL-HYBRIDIZED ACTIVATED MONOMER, AND USE THEREOF	XIAMEN UNIVERSITY
WO/2021/023233	EGFR PROTEIN DEGRADANT AND ANTI-TUMOR APPLICATION THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/212691	MITOCHONDRIA TARGETING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANDONG UNIVERSITY
WO/2021/027662	ANTIBODIES BINDING VISTA AND USES THEREOF	BEIJING MABWORKS BIOTECH CO., LTD
WO/2021/023247	KRAS MUTANT PROTEIN INHIBITOR	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/027674	DEVELOPMENT AND USE OF ANTIBODY CONTAINING TUMOR THERAPEUTIC AGENT	CHENGDU CONMED BIOSCIENCES CO., LTD
WO/2021/184649	METHOD FOR PREPARING FLORFENICOL INTERMEDIATE AND COMPOUND OBTAINED BY METHOD	HEADING (NANJING) PHARMTECHNOLOGIES CO., LTD.
WO/2021/023271	CRYSTAL FORM OF COMPOUND AS PROSTACYCLIN RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR	MEDSHINE DISCOVERY INC.
WO/2021/023272	CRYSTALLINE FORM OF ATR INHIBITOR AND USE THEREOF	SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
WO/2021/023274	HUMANIZED ANTI-TNFα ANTIBODY AND USE THEREOF	SINOCELLTECH LTD
WO/2021/027687	CHIMERIC ANTIGEN RECEPTOR AND IMMUNE EFFECTOR CELL EXPRESSING CHIMERIC ANTIGEN RECEPTOR	BOYUAN RUNSHENG PHARMA (HANGZHOU) CO., LTD.
WO/2021/023292	SUBSTITUTED PYRAZOLYL PYRAZOLE BISAMIDE COMPOUND OR PESTICIDE ACCEPTABLE SALT OR COMPOSITION THEREOF, AND USE THEREOF	HAILIR PESTICIDES AND CHEMICALS GROUP CO., LTD.
WO/2021/057279	ODORRANA TORMOTA IMMUNOMODULATORY PEPTIDE AND USE THEREOF	SOOCHOW UNIVERSITY
WO/2021/027721	IMMUNOMODULATOR	HITGEN INC.
WO/2021/027722	IMMUNOMODULATOR	HITGEN INC.
WO/2021/027724	IMMUNOMODULATOR	HITGEN INC.
WO/2021/027729	IMMUNOMODULATOR	HITGEN INC.
WO/2021/027744	3-HYDROXY-5-PREGNANE-20-ONE DERIVATIVE AND USE THEREOF	NANJING NORATECH PHARMACEUTICALS CO., LTD.
WO/2021/027758	GENETICALLY ENGINEERED CELLS AND USES THEREOF	CURE GENETICS CO., LTD.
WO/2021/027762	ORAL HYPOGLYCEMIC PEPTIDE, FATTY ACID DERIVATIVE AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143114	RECOMBINANT COLLAGEN AND RECOMBINANT COLLAGEN SPONGE MATERIAL	SHAANXI HUIKANG BIO-TECH CO., LTD.
WO/2021/027792	VMAT2 INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG LUYE PHARMACEUTICAL CO., LTD.
WO/2021/027795	CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/237945	METHOD FOR PREPARING 3,6-DICHLOROPYRAZINE-2-CARBONITRILE	NANJING CHEMPION BIOTECHNOLOGY CO., LTD.
WO/2021/027807	METHOD FOR PREPARING AZELAIC ACID	CORUM INC.
WO/2021/031930	ANTIBODY MUTANT AND APPLICATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/027813	METHOD OF PREPARING ASENAPINE	ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
WO/2021/120644	LOW-CARBON ALKANE DEHYDROGENATION PROCESS METHOD, DEVICE, AND REACTION SYSTEM	REZEL CATALYSTS CORPORATION
WO/2021/031952	OXYGEN-SUBSTITUTED SIX-MEMBERED RING PYRIMIDINE COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF	GENFLEET THERAPEUTICS (SHANGHAI) INC.
WO/2021/027850	ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF	I-MAB BIOPHARMA CO., LTD.
WO/2021/027851	TROP2 ANTIBODY, PREPARATION METHOD THEREFOR, AND CONJUGATE AND USE THEREOF	XDCEXPLORER (SHANGHAI) CO., LTD.
WO/2021/031960	2-AMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	SHANGHAI ZHIMENG BIOPHARMA INC.
WO/2021/073231	PREPARATION METHOD FOR ESLICARBAZEPINE	ZHEJIANGJIUZHOUPHARMACEUTICALCO., LTD.
WO/2021/147302	INTERMEDIATE OF APIXABAN AND PREPARATION METHOD THEREFOR	ZHEJIANGJIUZHOUPHARMACEUTICALCO., LTD.
WO/2021/088449	METHOD FOR PRODUCING AMINO TRIMETHYLENE PHOSPHONIC ACID	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD.
WO/2021/027867	CHIMERIC ANTIGEN RECEPTOR, CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF	FUNDAMENTA THERAPEUTICS CO., LTD
WO/2021/031984	CARBOXYLIC ACID OXIME ESTER COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/027911	NOVEL SPIROCYCLIC K-RAS G12C INHIBITOR	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/036814	PYRAZOLE DERIVATIVE AND USE THEREOF	HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/031997	DIHYDROPYRIMIDINE DERIVATIVE AND USE THEREOF	TIBET TIANSHENG TAIFENG PHARMACEUTICAL CO., LTD.
WO/2021/031998	RECOMBINANT POLYPEPTIDES AND USES THEREOF	LAN, Keng-Li
WO/2021/031999	PRODRUG OF MYCOPHENOLIC ACID AND METHOD FOR PREPARATION THEREOF	SHANGHAI INNOFORTUNE BOITECH CO. LTD.
WO/2021/032004	AZAHETEROARYL COMPOUND AND APPLICATION THEREOF	SHANGHAI BLUERAY BIOPHARMA CO., LTD.
WO/2021/027933	METHOD FOR PREPARING 3-MERCAPTOPROPIONIC ACID	HEBEI HOFMANN NEW MATERIAL TECHNOLOGY CO. LTD
WO/2021/027937	CRYSTALLINE AND AMORPHOUS SOLIDS OF RELUGOLIX AND PREPARATION METHOD THEREFOR	ZHEJIANG EAZY PHARMCHEM CO., LTD
WO/2021/027943	PYRIMIDINOPYRIDAZINONE DERIVATIVE AND MEDICAL USE THEREOF	NANJING SHUNXIN PHARMACEUTICALS CO., LTD. OF CHIATAI TIANQING PHARMACEUTICAL GROUP
WO/2021/032020	HIGH-AFFINITY T-CELL RECEPTOR FOR RECOGNIZING AFP	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/243851	LIGNIN-BASED BLOCK COPOLYMER MOLECULAR-GRADE COMBINED POLYETHER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF FLEXIBLE POLYURETHANE FOAM MATERIALS	ZHEJIANG GLORY HOME FURNISHINGS CO., LTD
WO/2021/135261	AROMATIC AMINE COMPOUND AND APPLICATION THEREOF IN OPTOELECTRONIC DEVICE	ZHEJIANG UNIVERSITY
WO/2021/032033	PYRIDAZINOL COMPOUND, DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/027953	PREPARATION METHOD FOR DIPHENYLMETHANE DIISOCYANATE	INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/036845	SUBSTITUTED BENZOYL COMPOUND AND APPLICATION THEREOF	DONGGUAN HEC PESTICIDES R&D CO., LTD.
WO/2021/032057	AGRICULTURAL FUNGICIDE, USE THEREOF AND PREPARATION METHOD THEREFOR	ZHEJIANG XINNONG CHEMICAL CO., LTD.
WO/2021/036851	NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND PHOTOELECTRIC CONVERSION DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/184673	COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATION THEREOF	CELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/088456	CONTINUOUS PRODUCTION METHOD FOR BIQUATERNARY AMMONIUM SALT	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD.
WO/2021/088457	METHOD FOR PRODUCING DIETHYLENETRIAMINEPENTA(METHYLENE-PHOSPHONIC ACID)	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD
WO/2021/088458	KRAS MUTANT PROTEIN INHIBITOR	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/088459	METHOD FOR PRODUCING AMINO TRIMETHYLENE PHOSPHONIC ACID AS WATER TREATMENT AGENT	SHANDONG TAIHE WATER TREATMENT TECHNOLOGIES CO., LTD.
WO/2021/032074	BENZAMIDE FUSED AROMATIC RING DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/032075	A PRODRUG PLATFORM USEFUL TO DELIVER AMINES, AMIDES AND PHENOLS	SHANGHAI CHANGCHENGYIYAOKEJI COMPANY LIMITED
WO/2021/032088	METHOD FOR PREPARING L-ERYTHROBIOPTERIN COMPOUND	SHANGHAI FOREFRONT PHARMA CO., LTD.
WO/2021/120653	COFACTOR-SUBSTRATE PROBE PLATFORM FOR FAST QUANTITATIVE DETECTION OF TUMOR HYPOXIA RELATED ENZYME	DALIAN UNIVERSITY OF TECHNOLOGY
WO/2021/203608	VEGFR2-TARGETED METASTATIC CANCER VACCINE	NEWISH TECHNOLOGY (BEIJING) CO., LTD.
WO/2021/032116	IMMUNOCYTOKINE, PREPARATION FOR SAME, AND USES THEREOF	SHANGHAI YICHEN BIOMED CO. LTD
WO/2021/227291	ABAMECTIN B2A SOLVATED CRYSTAL	HEBEI VEYONG BIO-CHEMICAL CO., LTD
WO/2021/032129	KINASE INHIBITOR, PREPARATION THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	HUNAN WARRANT PHARMACEUTICAL CO., LTD
WO/2021/032130	BCMA ANTIBODY	HANGZHOU SUMGEN BIOTECH CO., LTD.
WO/2021/169199	α-CARBONYL ALKENYL ESTER COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGXI NORMAL UNIVERSITY
WO/2021/032148	AMINOPYRAZINE COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF	BEIGENE, LTD.
WO/2021/032156	METHOD FOR SYNTHESIZING CARBOXY-CONTAINING ANTHRAQUINONE DERIVATIVE, OBTAINED DERIVATIVE, AND BATTERY SYSTEM COMPRISING SAME	CHINA SALT JINTAN CO., LTD.
WO/2021/032157	NOVEL ANTI-CLDN18.2 ANTIBODIES	MABSPACE BIOSCIENCES (SUZHOU) CO., LIMITED
WO/2021/057346	IMMUNOGENIC PEPTIDE FRAGMENT OF METALLOPROTEINASE ADAMTS-7 AND APPLICATION THEREOF IN RESISTING AGAINST ATHEROSCLEROSIS AND RELATED DISEASES	PEKING UNIVERSITY
WO/2021/032159	BLUMEA BALSAMIFERA MONOTERPENE SYNTHASE BBTPS3 AND RELATED BIOLOGICAL MATERIALS THEREOF AND USE THEREOF	SICHUAN HONGDA PHARMACEUTICAL CO., LTD.
WO/2021/032161	HALOGEN-SUBSTITUTED PHENYLATE COMPOUND AND APPLICATIONS THEREOF	HINOVA PHARMACEUTICALS INC.
WO/2021/032170	TETRACYCLIC COMPOUND USED AS CDC7 INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/032173	ANTI-CD73 ANTIBODY AND APPLICATION THEREOF	HARBOUR BIOMED (SHANGHAI) CO., LTD.
WO/2021/032174	ANTI-CD47 ANTIGEN BINDING PROTEIN, AND APPLICATION THEREOF	HARBOUR BIOMED (SHANGHAI) CO., LTD.
WO/2021/036924	HIGH-AFFINITY TCR FOR RECOGNIZING SSX2 ANTIGEN	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/179540	METHOD FOR PREPARING VADADUSTAT AND INTERMEDIATE THEREOF	DONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/036929	HUMANIZED ANTIBODIES AGAINST PD-L1	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/036953	PHENYLPYRROLIDINE COMPOUND	HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE INC.
WO/2021/036965	ISOPHTHALAMIDE COMPOUND AND USE THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/036966	BISAMIDE COMPOUND AND APPLICATION THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/032209	ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/036998	BILE ACID DERIVATIVE, COMPOSITION AND APPLICATION THEREOF	SHENZHEN YUNHE PHARMACEUTICAL TECHNOLOGY PARTNERSHIP (LIMITED)
WO/2021/037007	ANTI PD-L1 ANTIBODY AND USE THEREOF	REMEGEN CO., LTD.
WO/2021/068658	ACTIVE ESTER COMPOUND AND PREPARATION METHOD THEREFOR	SUZHOU JUFENG ELECTRICAL INSULATION SYSTEM CO., LTD
WO/2021/037018	DIHYDROQUINAZOLINE OR TETRAHYDROQUINAZOLINE COMPOUND AND INTERMEDIATES, PREPARATION METHODS AND USE THEREOF	NANGENE BIOMEDICAL CO., LTD.
WO/2021/037022	METHOD FOR PREPARING 4-METHYL-5-ALKOXY OXAZOLE	SHANDONG NHU FINE CHEMICAL SCIENCE AND TECHNOLOGY COMPANY LTD.
WO/2021/047386	NANO-ANTIBODY TARGETING CAIX ANTIGEN AND APPLICATION THEREOF	BIOTHEUS INC.
WO/2021/243856	METHOD FOR EXTRACTING MYRICA RUBRA LEAF PROANTHOCYANIDINS	ZHEJIANG UNIVERSITY
WO/2021/098319	6-BENZYLIDENE-2-ARYL ETHYNYL CYCLOHEXENONE DERIVATIVES, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	NANTONG UNIVERSITY
WO/2021/120672	PLASMA MEMBRANE INTRINSIC AQUAPORIN FOR ABSORBING AND TRANSPORTING NEONICOTINOID INSECTICIDES, AND CODING GENE AND USE THEREFOR	JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/139170	PLASMA MEMBRANE INTRINSIC AQUAPORIN FOR ABSORBING AND TRANSPORTING NEONICOTINOID INSECTICIDES, AND CODING GENE AND USE THEREFOR	JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/037037	NOVEL ANTI-CD39 ANTIBODIES	ELPISCIENCE (SUZHOU) BIOPHARMA, LTD.
WO/2021/037059	CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF	ADVANCHL BIOTECHNOLOGY SERVICE CENTER (SHANGHAI)
WO/2021/037090	NAPHTHYLAMINE COMPOUND AND BIOLOGICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	HENAN RADIOMEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/047391	METHOD FOR SYNTHESIZING ACETIC ACID BY LOW-PRESSURE METHANOL CARBONYLATION	PUJING CHEMICAL INDUSTRY CO., LTD
WO/2021/047392	PROCESS METHOD FOR PREPARING ACETIC ACID BY CARBONYLATING METHANOL BY MEANS OF REACTOR THERMALLY COUPLED WITH RECTIFYING TOWER	PUJING CHEMICAL INDUSTRY CO., LTD
WO/2021/037109	THIOSUCCINYL-CROSSLINKED HEMOGLOBIN ANALOGS AND METHODS OF USE AND PREPARATION THEREOF	BILLION KING INTERNATIONAL LTD.
WO/2021/174775	METHOD FOR PREPARING 3-[(2,3-DIHYDROTHIENO[3,4-B]-1,4-DIOXIN-2-YL)METHOXY]-PROPIONIC ACID	NORTH MINZU UNIVERSITY
WO/2021/248696	SEPARATION AND PURIFICATION METHOD FOR N-ACETYLGLUCOSAMINE	JIANGSU HEVI BIOTECH CO., LTD.
WO/2021/037127	BENZIMIDAZOLE SUBSTITUTION-BASED PHENYL N-BUTYRAMIDE COMPOUND AND PREPARATION METHOD THEREFOR	TOPHARMAN SHANGHAI CO., LTD.
WO/2021/103700	NITROREDUCTASE RESPONSIVE HYPOXIA PROBE COMPOUND, AND PREPARATION AND APPLICATION THEREOF	MENGCHAO HEPATOBILIARY HOSPITAL OF FUJIAN MEDICAL UNIVERSITY
WO/2021/037156	CRYSTAL OF CARCINOGENIC FUSED KINASE INHIBITOR AND APPLICATIONS THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/037160	TUMOR ENZYME-RESPONSIVE RECOMBINANT PYROPTOSIS PROTEIN DELIVERY SYSTEM AND ANTITUMOR USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/037179	STING PATHWAY MODULATOR AND USE THEREOF	MEDSPRING INTERNATIONAL LTD
WO/2021/037183	PRODRUG COMPOUNDS AND USES THEREOF FOR TREATMENT OF CANCER	RISEN (SUZHOU) PHARMA TECH CO., LTD.
WO/2021/037184	FUSION PROTEIN TARGETING PD-L1 AND TGF-β AND USE THEREOF	NANJING SHUNXIN PHARMACEUTICALS CO., LTD. OF CHIATAI TIANQING PHARMACEUTICAL GROUP
WO/2021/037185	TYROSINE KINASE INHIBITOR HAVING LOW IMPURITY CONTENT	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/043077	SUBSTITUTED PYRAZINE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/037187	POLYPEPTIDE AND APPLICATION THEREOF	HDL SOLUTIONS OTTAWA
WO/2021/037197	MONOCLONAL ANTIBODY WHICH TARGETS TFPI	SUZHOU ALPHAMAB CO., LTD.
WO/2021/128917	CONTINUOUS AMMONOLYSIS REACTION SYSTEM, PREPARATION METHOD FOR TAURINE ALKALI METAL SALT AND TAURINE	ZHEJIANG NHU PHARMACEUTICAL CO., LTD.
WO/2021/037198	DEUTERATED COMPOUND AND USE THEREOF IN CANCER TREATMENT	RISEN (SUZHOU) PHARMA TECH CO., LTD.
WO/2021/037205	COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF	SUZHOU RIBO LIFE SCIENCE CO., LTD.
WO/2021/037219	PYRAZOLE DERIVATIVE FOR FGFR INHIBITOR AND PREPARATION METHOD THEREFOR	ETERN BIOPHARMA (SHANGHAI) CO., LTD.
WO/2021/227306	ANTI-CD73 ANTIBODY AND USE THEREOF	BIOTHEUS INC.
WO/2021/227307	ANTI-CD73 ANTIBODY AND USE THEREOF	BIOTHEUS INC.
WO/2021/052152	DIMER IMMUNOADHESIN, PHARMACEUTICAL COMPOSITION AND USE THEREOF	PHARCHOICE THERAPEUTICS INC
WO/2021/047406	TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/047407	BIARYL COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/043114	SUBSTITUTED THIADIAZINONE DIOXIDE AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND APPLICATION THEREFOR	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/043115	PIPERIC ACID DERIVATIVE AND APPLICATION THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/043116	BIPHENYL COMPOUNDS, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/063145	TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF	NEUSCO BIOTECH LIMITED
WO/2021/082714	NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/135335	LIVER-TARGETING COMPOUND HAVING THYROID HORMONE RECEPTOR AGONIST CHARACTERISTICS AND PHARMACEUTICAL COMPOSITION THEREOF	KYLONOVA (XIAMEN) BIOPHARMA CO., LTD.
WO/2021/043152	PYRIMIDINE DERIVATIVE AS WEE1 INHIBITOR	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/093426	METHOD FOR SYNTHESIZING HYDROXYBENZYLAMINE	TAIZHOU CHUANGYUAN INDUSTRIAL TECHNOLOGY CO., LTD
WO/2021/159691	N,N-DIETHYL-10-UNDECENAMIDE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN REPELLING MOSQUITOS	INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/103728	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	ZHEJIANG HUADISPLAY OPTOELECTRONICS
WO/2021/208331	METHOD FOR PREPARING 3-CARBONYL-BICICLO[2,2,2]OCTANE-2-CARBOXYLATE	GUANGDONG RAFFLES PHARMATECH CO., LTD,
WO/2021/043169	ANTIBODY THAT BINDS SPECIFICALLY TO B-CELL MATURATION ANTIGEN AND USE THEREOF	ABLINK BIOTECH CO., LTD
WO/2021/043185	A COMPOUND AS A THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/043187	METHOD FOR PREPARING BORON SALT OF DIPEPTIDE OF VALINE-PROLINE	BALMXY PHARMACEUTIC CO. LTD
WO/2021/043188	MIXTURE CONTAINING METHIONINE HYDROXY ANALOG AND OLIGOMER THEREOF, AND PREPARATION METHOD THEREFOR	BLUESTAR ADISSEO NANJING CO., LTD
WO/2021/043190	ISOXAZOLO[5,4-H]QUINAZOLINE COMPOUNDS AS PROTEIN KINASE INHIBITORS	CHENGDU SYNOWEST BIOTECHNOLOGY S.R.L.
WO/2021/043194	HALOGENATED TETRACYCLIC TRITERPENE DERIVATIVE, PREPARATION AND APPLICATION THEREOF	SHANGHAI KING-X BIOTECH CO., LTD.
WO/2021/043200	METHOD FOR PREPARING QUINAZOLINE DERIVATIVE AND CRYSTALLIZATION THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/043203	ANTI-CXCR2 ANTIBODIES AND USES THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/043206	ANTI-TIGIT IMMUNOSUPPRESSANT AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/088495	CRYSTAL FORM I OF CURCUMIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WENZHOU MEDICAL UNIVERSITY
WO/2021/043208	3, 5-DISUBSTITUTED PYRAZOLE COMPOUNDS AS KINASE INHIBITORS AND USES THEREOF	IMPACT THERAPEUTICS, INC
WO/2021/043209	RET INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/043217	COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/043220	ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/043221	ANTIBODIES BINDING TSLP AND USES THEREOF	BIOSION INC.
WO/2021/043229	TUMOR-TARGETING RECOMBINANT BIFUNCTIONAL FUSION PROTEIN AND APPLICATION THEREOF	FUDAN UNIVERSITY
WO/2021/043245	HYDANTOIN DERIVATIVE	ONO PHARMACEUTICAL CO., LTD.
WO/2021/135346	NEW CRYSTAL FORM OF ACALABRUTINIB, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/232619	CRYSTAL FORM OF TAFAMIDIS FREE ACID, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/043260	PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR	HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE INC.
WO/2021/169233	ANTIBIOTIN ANTIBODY AND APPLICATION THEREOF	HANGZHOU BIOLYNX TECHNOLOGY CO., LTD.
WO/2021/043261	ANTI-PD-1 SINGLE-DOMAIN ANTIBODY, DERIVED PROTEIN THEREOF, AND MEDICAL USE THEREOF	BEIJING TUO JIE BIOPHARMACEUTICAL CO., LTD.
WO/2021/057451	ANTIBODY FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF AGAINST ANTI-TUMOR	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/043284	HIGH-AFFINITY T CELL RECEPTOR THAT RECOGNIZES SSX2	GUANGDONG XIANGXUE LIFE SCIENCES, LTD.
WO/2021/047466	CRYSTAL FORM OF P53-MDM2 INHIBITOR AND PREPARATION METHOD THEREFOR	LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/047470	METHOD FOR PREPARING PEPTIDE AMIDE COMPOUND AND INTERMEDIATE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/052207	COLOUR TUNABLE LUMINESCENT BIDENTATE PLATINUM (II) COMPLEXES FOR PROBING MISMATCH DNA	THE UNIVERSITY OF HONG KONG
WO/2021/047490	METHOD FOR PREPARING DEXIBUPROFEN	HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD
WO/2021/047491	METHOD FOR SIMULTANEOUSLY SEPARATING CANNABIDIVARIN AND CANNABIGEROL	SHANGHAI TAUTO BIOTECH CO., LTD.
WO/2021/143157	PEPTIDE FRAGMENTS, MONOCLONAL ANTIBODY, COLLOIDAL GOLD TEST STRIP AND DETECTION METHOD FOR DETECTING APOSTICHOPUS JAPONICAS OLIGOPEPTIDES	DALIAN DEEP BLUE PEPTIDE TECHNOLOGY RESEARCH AND DEVELOPMENT CO., LTD.
WO/2021/068698	ISO-CITRATE DEHYDROGENASE (IDH) INHIBITOR	SHANGHAI METON PHARMACEUTICAL CO., LTD
WO/2021/258551	RATIOMETRIC FLUORESCENT OXYGEN DETECTION MATERIAL WITH ULTRA-LOW DETECTION LIMIT AND HIGH SENSITIVITY	ZHENGZHOU UNIVERSITY
WO/2021/047507	METHOD FOR IDENTIFYING SUBSTANCE CAPABLE OF AFFECTING AGING	ZHEJIANG BAISHOUKANGDI CO. LTD.
WO/2021/047524	CLASS OF FUNCTIONAL MOLECULES TARGETING PROTEOLYSIS PATHWAYS, PREPARATION AND APPLICATION THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/047525	SALT OF BENZOTHIOPYRONE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/047528	MALEATE OF NICOTINYL ALCOHOL ETHER DERIVATIVE, CRYSTAL FORM THEREOF, AND APPLICATION THEREOF	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/052225	CHEMICAL SEMI-SYNTHESIS METHOD FOR ARTEMISININ	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/077926	INDUSTRIALIZABLE METHOD FOR LEACHING XANTHOPHYLL AND QUERCETAGETIN FROM MARIGOLD	CHENGUANG BIOTECH GROUP CO., LTD.
WO/2021/248718	ANTI-HUMAN INTERLEUKIN 23 MONOCLONAL ANTIBODY AND APPLICATION THEREOF	QYUNS THERAPEUTICS CO., LTD.
WO/2021/143159	METHOD FOR PREPARING LIRAGLUTIDE	SHENZHEN JYMED TECHNOLOGY CO., LTD.
WO/2021/169241	METHOD FOR PREPARATION AND IN-SITU SEPARATION OF OLIGOMERIC RICINOLEATE	NANKAI UNIVERSITY
WO/2021/047547	NOVEL TRICYCLIC AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/047553	AROMATIC HETEROCYCLIC COMPOUND HAVING TRICYCLIC STRUCTURE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/047555	PREPARATION OF AROMATIC HETEROCYCLIC DERIVATIVE AS IMMUNOMODULATOR AND APPLICATION THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/047556	NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/047558	SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING SAME	WUHAN YZY BIOPHARMA CO., LTD.
WO/2021/128946	ANTI-SPA5 PROTEIN MONOCLONAL ANTIBODY, USE THEREOF AND KIT CONTAINING SAME	CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
WO/2021/128947	ANTI-MNTC PROTEIN ANTIBODY, USE THEREOF AND KIT CONTAINING SAME	CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
WO/2021/128948	ANTI-MHI<sb>N2</sb> PROTEIN ANTIBODY, AND USE THEREOF AND KIT CONTAINING SAME	CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
WO/2021/128949	ANTI-MSEB PROTEIN ANTIBODY, APPLICATION THEREOF AND KIT CONTAINING SAME	CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
WO/2021/082752	PREPARATION METHOD FOR 1-NITRO-2-ETHYL-4-FLUOROBENZENE	ACCELA CHEMBIO CO., LTD.
WO/2021/047565	METHOD FOR PREPARING (R)-PRAZIQUANTEL AND CHIRAL INTERMEDIATE THEREOF, AND COMPOSITION	TONGLI BIOMEDICAL CO., LTD.
WO/2021/047572	GSK-3β/CHE DOUBLE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/047581	HEXAHYDROBENZOPYRAZOLE DERIVATIVE AND PREPARATION THEREFOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/047583	TRICYCLIC PYRAZOLE DERIVATIVE AND PREPARATION THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/047584	SUBSTITUTED (2-AZABICYCLO [3.1.0] HEXAN-2-YL) PYRAZOLO [1, 5-a] PYRIMIDINE AND IMIDAZO [1, 2-b] PYRIDAZINE COMPOUNDS AS TRK KINASES INHIBITORS	FOCHON PHARMACEUTICALS, LTD.
WO/2021/047588	TALL OIL FATTY ACID IMIDAZOLINE SULFONATE SURFACTANT AND PREPARATION METHOD THEREFOR	CHINA RESEARCH INSTITUTE OF DAILY CHEMISTRY CO., LTD
WO/2021/120717	ANTICANCER COMPOUND AND MEDICAL USE THEREOF	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/047599	HUMANIZED ANTI-CLAUDIN 18.2 (CLDN18.2) ANTIBODIES	BEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/047603	SYNTHESIS METHOD APPLIED TO KRAS INHIBITOR DRUG HETEROCYCLIC INTERMEDIATE	CHIRAL QUEST (SUZHOU) CO., LTD.
WO/2021/037278	A-D-A CONJUGATED MOLECULE, PREPARATION METHOD THEREFOR, USE THEREOF IN ORGANIC SOLAR CELL, AND ORGANIC SOLAR CELL	UZHOU QIANXUN NEW ENERGY TECHNOLOGY CO. LTD
WO/2021/047616	OXYNITRIDE HETEROCYCLIC HEPTANE-BASED SPIRO COMPOUND, INTERMEDIATE AND PREPARATION METHOD THEREFOR	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/047622	PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/047627	FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/047646	SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF	IMPACT THERAPEUTICS, INC
WO/2021/047648	NEW PEPTIDES	JIANGYIN USUN PHARMACEUTICAL CO., LTD.
WO/2021/047656	HERBICIDE RESISTANT PLANT	INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/052268	MAGNOLOL DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052270	HONOKIOL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052271	MAGNOLOL DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052272	MAGNOLOL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052277	RECOMBINANT HUMAN NEUREGULIN DERIVATIVES AND USE THEREOF	ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
WO/2021/135387	AMORPHOUS ALLOY-BASED PROCESS FOR USE IN SUPERCRITICAL CO<sb>2</sb> HYDROGENATION	SHANGHAI NORMAL UNIVERSITY
WO/2021/047672	TRITERPENOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING NUCLEAR RECEPTOR SUBFAMILY 4 GROUP MEMBER 1-MEDIATED DISEASE	IXMEDICINE CO., LTD
WO/2021/047674	BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR	MEDSHINE DISCOVERY INC.
WO/2021/047677	IRAK4 KINASE INHIBITOR AND PREPARATION THEREOF AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/189780	ORGANIC COMPOUND, AND APPARATUS AND ELECTRONIC DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/057540	GLP-1 COMPOUND	BEIJING LEPU PHARMACEUTICAL TECHNOLOGY CO. , LTD
WO/2021/057541	EXENATIDE ANALOG	CHENGDU AODA BIOTECHNOLOGY CO., LTD
WO/2021/114787	METHOD OF SYNTHESIZING TERIPARATIDE IMPURITY F	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/114788	TERIPARATIDE IMPURITY F	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/052307	ANTI-B7-H3 ANTIBODY AND APPLICATION THEREOF	NANJING SANHOME PHARMACEUTICAL CO., LTD.
WO/2021/057550	ORGANIC COMPOUND AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/052328	PREPARATION METHOD FOR POLYOXYMETHYLENE DIMETHYL ETHER AND MIXTURE THEREOF	SHANDONG CHENXIN NEW ENERGY CO., LTD.
WO/2021/103749	LEFT-HANDED BICYCLIC MORPHOLINE AND SALT THEREOF, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATION	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/052349	GIPR ANTIBODY AND FUSION PROTEIN BETWEEN SAME AND GLP-1, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	GMAX BIOPHARM LLC
WO/2021/052353	HYDROXAMIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/184706	METHOD FOR ADJUSTING EMPTY BED AIR VELOCITY IN FLUIDIZED BED	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/052367	HETEROTRINUCLEAR METAL ORGANIC ALKYNE COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF	FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES
WO/2021/052370	METHODS AND COMPOSITIONS FOR TISSUE REGENERATION	INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/052402	CAMPTOTHECIN DERIVATIVE AND CONJUGATE THEREOF	SICHUAN BAILI PHARMACEUTICAL CO., LTD
WO/2021/143181	METHOD FOR PREPARING OXAZOLE COMPOUND	SHANGYU NHU BIOLOGICAL CHEMICAL CO., LTD.
WO/2021/057597	BISSULFONATE COMPOUND, PREPARATION METHOD THEREFOR, ELECTROLYTE SOLUTION AND ENERGY STORAGE DEVICE	GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD.
WO/2021/052447	CRYSTAL FORM OF HEPATITIS B SURFACE ANTIGEN INHIBITOR AND APPLICATION THEREOF	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/169255	ANTI-SARS-COV-2 INFECTION PROTEIN AND VACCINE	WEST VAC BIOPHARMA CO., LTD.
WO/2021/052461	ANTI-ALPHA-HEMOLYSIN ANTIBODY AND USE THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/052465	ANTI-HUMAN CD38 ANTIBODY AND APPLICATION THEREOF	SHANGHAI PUREMAB BIO-TECH CO., LTD.
WO/2021/114801	IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/103769	COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/103770	COMPOUND AND APPLICATION THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/114802	PREPARATION OF TETRADENTATE PLATINUM(II) COMPLEX AND USE THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/120741	METAL COMPLEX AND APPLICATION THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/120742	PLATINUM METAL COMPLEX AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/128982	O^C^N^N-TYPE TETRADENTATE PLATINUM (II) COMPLEX, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/063201	ANTI-PD-1 ANTIBODY AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/052499	FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/253662	ANTI-FXII NANOBODY OR ANTIGEN BINDING FRAGMENT THEREOF AND USE THEREOF	NINGBO COMGEN BIOTECH CO., LTD.
WO/2021/103779	METHOD FOR PREPARING 3-HYDROXYPROPIONITRILE	SHANDONG NHU FINE CHEMICAL SCIENCE AND TECHNOLOGY COMPANY LTD.
WO/2021/052501	HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/063207	JNK INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/057696	HETEROARYL COMPOUND AND APPLICATION THEREOF	LONGTAISHEN MEDICAL TECHNOLOGY (NANJING) CO., LTD.
WO/2021/073372	HYBRID ANTIMICROBIAL PROTEIN HAVING STRONG BACTERICIDAL EFFECT, AND APPLICATION THEREOF	JIANGXI YUANSHENG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/073373	AMIDE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF	CAC NANTONG CHEMICAL CO., LTD.
WO/2021/057726	SCREENING OF FC SPECIFICALLY BINDING TO FCγR BY USING MAMMALIAN DISPLAY	NANKAI UNIVERSITY
WO/2021/109684	CAPTURING MAGNETIC BEAD FOR CAPTURING WEAKLY INTERACTING PROTEIN MOLECULE BY EMPLOYING PHOTOAFFINITY COVALENT ATTACHMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	NANJING NORMAL UNIVERSITY
WO/2021/057782	HETEROCYCLIC DERIVATIVE AND USE THEREOF	NANJING TRANSTHERA BIOSCIENCES CO., LTD.
WO/2021/057785	IRAK INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD.
WO/2021/057791	CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/057796	SUBSTITUTED FUSED TRICYCLIC DERIVATIVE, AND COMPOSITION AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/073385	BORON-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME	BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD
WO/2021/057813	SULFIMIDE PHOTO-ACID GENERATOR, PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING METHOD, USE OF PHOTOSENSITIVE RESIN COMPOSITION	CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD.
WO/2021/057818	FXIA INHIBITORS AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/057822	ANTI-ROR1 ANTIBODIES AND PREPARATION METHOD AND USES THEREOF	IMMUTHER PHARMTECH (SHANGHAI) CO., LTD.
WO/2021/057823	ROR1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR THERAPEUTIC APPLICATIONS	IMMUTHER PHARMTECH (SHANGHAI) CO., LTD.
WO/2021/057826	RECOMBINANT INTERLEUKIN-15 ANALOG	LETO LABORATORIES CO., LTD
WO/2021/057832	KRAS MUTANT PROTEIN INHIBITOR	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/057834	CRYSTAL FORM OF ESTER COMPOUND AND PREPARATION METHOD THEREFOR	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/147361	ZINC ION COMPLEX PEPTIDE, AND COMPLEX AND USE THEREOF	GUANGZHOU UNIVERSITY
WO/2021/068752	FUSION PROTEIN CONTAINING HUMAN INTERLEUKIN-10 AND FC FRAGMENT AND MEDICAL USE THEREOF	BEIJING DONGFANG BIOTECH CO., LTD.
WO/2021/057836	NOVEL ANTI-PD-L1 ANTIBODIES	WUXI BIOLOGICS (SHANGHAI) CO. LTD.
WO/2021/057840	SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF	PEKING UNIVERSITY
WO/2021/068755	COMPOUND HAVING BRD4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF	HAIHE BIOPHARMA CO., LTD.
WO/2021/057852	OXAZOLINE COMPOUND, SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF	NANKAI UNIVERSITY
WO/2021/057853	AZA-QUINOLINE COMPOUNDS AND USES THEREOF	NOVARTIS AG
WO/2021/135443	2,3,5-TRIMETHYLHYDROQUINONE SYNTHESIS METHOD AND DEVICE	SHANGYU NHU BIOLOGICAL CHEMICAL CO., LTD.
WO/2021/057866	SINGLE DOMAIN ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR COMPRISING ANTIBODY STRUCTURE	CURE GENETICS CO., LTD
WO/2021/082826	USE OF GINKGOLIDE A IN THE TREATMENT OF AUTISM	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/057867	CLASS OF CDK INHIBITOR BASED ON ORGANIC ARSINE, PREPARATION METHOD AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/057872	PROTAC SMALL MOLECULE COMPOUND AND APPLICATION THEREOF	ZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/212740	CLASS OF COMPOUNDS HAVING INDOLINE SKELETON, PREPARATION METHOD AND MEDICAL USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/057877	SUBSTITUTED AROMATIC FUSED RING DERIVATIVE AND COMPOSITION COMPRISING SAME, AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/057882	EGFR INHIBITOR, COMPOSITION AND PREPARATION METHOD THEREFOR	BETTA PHARMACEUTICALS CO., LTD.
WO/2021/174813	HYDROGENATED CYCLIC AZA-, OXA- OR HYBRID AZA/OXA-BELT[N]AROMATIC HYDROCARBON AND PREPARATION METHOD THEREFOR	TSINGHUA UNIVERSITY
WO/2021/120767	BELT[N]ARENE TROPYLIUM COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	TSINGHUA UNIVERSITY
WO/2021/103795	OXIDIZED RING BELT [8] AROMATIC HYDROCARBON DERIVATIVE AND PREPARATION METHOD THEREFOR	TSINGHUA UNIVERSITY
WO/2021/057890	2H-BENZOPYRAN DERIVATIVES AS CRAC INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/057893	PYRAZOLOPYRIDINE COMPOUNDS AS SELECTIVE BTK KINASE INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/068761	HUMANIZED MONOCLONAL ANTIBODY TARGETING BCMA AND HAVING HUMAN MONKEY CROSS-REACTIVITY	SUZHOU QIN PHARMACEUTICALS CO., LTD.
WO/2021/057910	PEPTIDYLARGININE DEIMINASE INHIBITOR AND USE THEREOF	NANJING TRANSTHERA BIOSCIENCES CO., LTD.
WO/2021/073402	CARRIER PROTEIN WITH SITE-DIRECTED MUTATION AND USE THEREOF IN PREPARATION OF VACCINE	CANSINO BIOLOGICS INC.
WO/2021/057915	EP300/CBP INHIBITOR	HINOVA PHARMACEUTICALS INC.
WO/2021/103798	METHOD FOR PREPARING LACTONE COMPOUND	ZHEJIANG UNIVERSITY
WO/2021/057930	A NOVEL ANTI-PD-L1/ANTI-LAG-3 BISPECIFIC ANTIBODY AND USES THEREOF	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/063276	MACROCYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/057944	METHOD FOR PREPARING GLUFOSINATE-AMMONIUM HYDANTOIN INTERMEDIATE AND ANALOGUE THEREOF	LIER CHEMICAL CO., LTD.
WO/2021/057945	METHOD FOR PREPARING GLUFOSINATE-AMMONIUM HYDANTOIN INTERMEDIATE AND ANALOGUE THEREOF	LIER CHEMICAL CO., LTD.
WO/2021/098379	PHENYLALANINE-AMIDATED NUCLEOTIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGDONG ZHONGKE MEDICINE R&D LIMITED
WO/2021/057963	RET INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/068773	GROUP OF TETRAHYDROINDOLOQUINAZOLINE COMPOUNDS AND USE THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/057970	RET INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/057975	MUTANT IDH2 INHIBITOR AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/057978	ANTI-VHH DOMAIN ANTIBODIES AND USE THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/057991	BINDING MOLECULE SPECIFIC FOR LIF AND USE THEREOF	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/057992	METHOD FOR PRODUCING P-XYLENE AND ETHYLBENZENE FROM C<sb>8</sb> AROMATIC HYDROCARBON CONTAINING ETHYLBENZENE	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/057994	PYRAZOLE COMPOUND AND USE THEREOF	SUZHOU ARK BIOPHARMACEUTICAL CO., LTD
WO/2021/129016	METHOD FOR DESALTING POLYPEPTIDES	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/057998	PREPARATION METHOD FOR PYRROLOAMINOPYRIDAZINONE COMPOUND	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/077994	CRYSTAL FORM OF HYPOXIA-INDUCIBLE FACTOR-PROLYL HYDROXYLASE INHIBITOR	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/063313	FC VARIANT HAVING ALTERED EFFECTOR FUNCTION AND FUSION PROTEIN THEREOF	SHENZHEN FEIPENG BIOLOGICAL PHARMACEUTICAL CO. LTD
WO/2021/058000	ANTI-HUMAN CLAUDIN 18.2 ANTIBODY AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/058001	CRYSTAL FORM OF FIVE-MEMBERED N HETEROCYCLIC COMPOUND, AND APPLICATION THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/058002	CRYSTALLINE FORM OF CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N HETERO FIVE-MEMBERED RING, AND APPLICATION THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135456	ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/063330	CD3-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF	HARBOUR BIOMED (SUZHOU) CO., LTD.
WO/2021/063335	ERK1/2 PROTEIN KINASE INHIBITOR AND USE THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/063336	CLDN18.2-TARGETING ANTIBODY, PREPARATION METHOD THEREFOR, AND USE THEREOF	HARBOUR BIOMED (SUZHOU) CO., LTD.
WO/2021/058017	DEGRADATION OF ANDROGEN RECEPTOR (AR) BY CONJUGATION OF AR ANTAGONISTS WITH E3 LIGASE LIGAND AND METHODS OF USE	BEIGENE, LTD.
WO/2021/058018	INHIBITORS OF KRAS G12C	BEIGENE, LTD.
WO/2021/155670	BISPECIFIC CHIMERIC ANTIGEN RECEPTOR FOR TREATING HEMATOLOGICAL TUMOR COMPLICATED WITH HIV INFECTION	WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/023314	METHOD FOR USING HYDRIDE AT ROOM TEMPERATURE TO CONVERT CARBONATE TO PRODUCE METHANE	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/063346	KRAS G12C INHIBITOR AND APPLICATION THEREOF	SHANGHAI DE NOVO PHARMATECH CO., LTD.
WO/2021/063347	COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANDONG LUYE PHARMACEUTICAL CO., LTD.
WO/2021/063349	ANTIBODY TARGETING BCMA, BISPECIFIC ANTIBODY, AND USE THEREOF	HARBOUR BIOMED (SUZHOU) CO., LTD.
WO/2021/063350	FUSION PROTEIN AND APPLICATION THEREOF	HARBOUR BIOMED (SUZHOU) CO., LTD.
WO/2021/063352	ANTI-PD-L1 ANTIGEN BINDING PROTEIN, AND APPLICATION THEREOF	HARBOUR BIOMED (SHANGHAI) CO., LTD.
WO/2021/058024	LSD1 INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/058027	PYRROLO HETEROARYL DERIVATIVE OR CONJUGATE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/063362	SULFO-SUBSTITUTED BIARYL COMPOUND OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHANGHAI LITEDD CO., LTD.
WO/2021/063367	RESMETIROM CRYSTAL FORM AND PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/212755	ANTI-NOVEL CORONAVIRUS ANTIBODY AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHENGDU YUKANG BIOTECHNOLOGY CO., LTD.
WO/2021/063373	TRPV1 AGONIST AND PREPARATION METHOD THEREFOR AND USE THEREOF	NANJING DELOVA BIOTECH CO. LTD.
WO/2021/068815	CARBOXYLIC ACID ESTER COMPOUND AND APPLICATION THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/068816	ALKENE-CONTAINING AMIDE COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/068820	ALKENE-CONTAINING CARBOXYLATE COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/068828	CHEMILUMINESCENCE SUBSTRATE HAVING HIGH LUMINESCENCE INTENSITY, LONG WAVELENGTH, AND GOOD STABILITY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/135482	WATER-SOLUBLE CONJUGATED POLYMER FOR PHOTOTHERMAL THERAPY, POLYMERIZED MONOMER THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/068841	ANTIBODIES BINDING 4-1BB AND USES THEREOF	NANJING LEADS BIOLABS CO., LTD.
WO/2021/238007	BIFUNCTIONAL COMPOUND AND PHARMACEUTICAL COMPOSITION CAPABLE OF INDUCING DEGRADATION OF CORE SUBUNITS OF PRC2 PROTEIN COMPLEX, AND USE	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/063404	COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/073439	PYRAZINE DERIVATIVE FOR INHIBITING SHP2 ACTIVITY	HANGZHOU REX PHARMACEUTICAL CO., LTD
WO/2021/043322	AZEPINO PYRIMIDINE DERIVATIVES AND MEDICAL USE THEREOF	NANJING SHUNXIN PHARMACEUTICALS CO., LTD. OF CHIATAI TIANQING PHARMACEUTICAL GROUP
WO/2021/212762	THREE-DIMENSIONAL MOLDING MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ZHUHAI SAILNER 3D TECHNOLOGY CO., LTD.
WO/2021/068866	HETEROCYCLIC COMPOUNDS AS STING MODULATORS	BEIGENE, LTD.
WO/2021/068867	COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATION	COTHERA BIOSCIENCE, INC.
WO/2021/068871	B7-H3 NANOBODY AND PREPARATION METHOD THEREFOR AND USE THEREOF	DARTSBIO PHARMACEUTICALS LTD.
WO/2021/068884	POLYPEPTIDE DERIVATIVE, NANOFIBER AND APPLICATION THEREOF	NANKAI UNIVERSITY
WO/2021/098399	POLYPEPTIDE DERIVATIVE CAPABLE OF SIMULATING BIOLOGICAL ACTIVITY OF PLATELET-DERIVED GROWTH FACTOR, NANOFIBER AND APPLICATION THEREOF	NANKAI UNIVERSITY
WO/2021/068898	NOVEL KRAS G12C PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/078020	SMALL MOLECULE COMPOUND	TECHNODERMA MEDICINES PTE LTD
WO/2021/078021	SMALL MOLECULAR COMPOUND	TECHNODERMA MEDICINES PTE LTD
WO/2021/078022	SMALL MOLECULE COMPOUND	TECHNODERMA MEDICINES PTE LTD
WO/2021/078023	SMALL MOLECULE COMPOUND	TECHNODERMA MEDICINES PTE LTD
WO/2021/073456	MACROCYCLIC AND CAGE-LIKE MOLECULES BASED ON BIPHENYLARENE AND DERIVATIVE COMPOUNDS, SYNTHESIS METHOD THEREFOR AND USE THEREOF	TIANJIN NORMAL UNIVERSITY
WO/2021/068938	T CELL RECEPTOR RECOGNISING KRAS MUTATION AND ENCODING SEQUENCE THEREOF	XLIFESC, LTD.
WO/2021/068943	SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF	CHENGDU MFS PHARMA. CO., LTD.
WO/2021/088590	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/093494	PRODUCTION PROCESS CAPABLE OF INDUSTRIALLY SYNTHESIZING DYDROGESTERONE	GUANGXI NORMAL UNIVERSITY
WO/2021/068949	ANTI-HUMAN TROP-2 ANTIBODY AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/068950	AMIDE COMPOUND AND MEDICAL USE THEREOF AS STING INHIBITOR	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068952	BENZODIHYDROPYRAN COMPOUND TARGETING ALDO-KETO REDUCTASE 1C3	MEDSHINE DISCOVERY INC.
WO/2021/068953	SUBSTITUTED TRICYCLIC COMPOUND AS PRMT5 INHIBITOR AND USE THEREOF	NANJING SANHOME PHARMACEUTICAL CO., LTD.
WO/2021/068962	POLYPEPTIDE FOR DISEASES RELATED TO ANGIOGENESIS AND LYMPHANGIOGENESIS AND USE THEREOF	TANAKA, Junmi
WO/2021/109712	COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF	GANNEX PHARMA CO., LTD.
WO/2021/109713	USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES	GANNEX PHARMA CO., LTD.
WO/2021/073487	ISOXAZOLINE COMPOUND HAVING OPTICAL ACTIVITY AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/082901	PHENYLISOXAZOLINE COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/073491	DIHYDROIMIDAZO PYRIMIDO PYRIMIDINONE COMPOUND	IMPACT THERAPEUTICS, INC
WO/2021/073494	THE SALTS OF A COMPOUND AND THE CRYSTALLINE FORMS THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/073498	EGFR INHIBITOR, COMPOSITION, AND METHOD FOR PREPARATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/243919	ANTIBODIES BINDING LAG3 AND USES THEREOF	BEIJING MABWORKS BIOTECH CO., LTD.
WO/2021/248763	METHOD FOR PREPARING LANINAMIVIR	BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
WO/2021/248764	METHOD FOR PREPARING LANINAMIVIR OCTANOATE INTERMEDIATE BY MEANS OF ONE-POT SYNTHESIS	BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
WO/2021/218041	ERIBULIN AND PREPARATION METHOD FOR INTERMEDIATE THEREOF	BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
WO/2021/143222	HIGH-PERFORMANCE HOLE TRANSPORT MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/088616	CRYSTAL FORM OF ELAGOLIX ACID SULFATE, PREPARATION THEREOF AND APPLICATION THEREOF	SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/073592	SALT TYPES, CRYSTAL FORMS, AND PREPARATION METHODS FOR BENZOPYRAZOLE COMPOUNDS AS RHO KINASE INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/073593	AMINOPYRIMIDINE COMPOUND AS CDK2/4/6 TRIPLE INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/073600	CRYSTAL FORM OF LRRK2 INHIBITOR AND PREPARATION METHOD THEREFOR	GUIZHOU INOCHINI TECHNOLOGY CO., LTD
WO/2021/073603	BENZOPHENANTHRIDINE ALKALOIDS AND THEIR METHODS OF USE	CHENGDU ANTICANCER BIOSCIENCE, LTD.
WO/2021/114864	β-CARBOLINE CYCLOKETENE DERIVATIVE BASED ON DUAL RESPONSE TO PH AND GSH, AND USE THEREOF	NANTONG UNIVERSITY
WO/2021/078073	N-CONTAINING DERIVATIVE OF SUBSTITUTED PHENOL HYDROXY ACID ESTER, AND PREPARATION AND USE THEREOF	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/073611	OX40/PD-L1 BISPECIFIC ANTIBODY	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/218053	VARIABLE REGION SEQUENCE OF SPECIFIC ANTI-CLOTHIANIDIN ANTIBODY, AND PREPARATION AND APPLICATION OF ANTI-CLOTHIANIDIN RECOMBINANT INTACT ANTIBODY	ZHEJIANG UNIVERSITY
WO/2021/073623	METHOD FOR PREPARING ISOQUINOLINONE COMPOUNDS	SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/082958	NITROGEN-CONTAINING COMPOUNDS, ELECTRONICS AND ELECTRONIC DEVICES	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129072	ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/073626	CHIMERIC ANTIGEN RECEPTOR AND T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS THEREIN	BEIJING MENLO BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/078076	NOVEL CRYSTALLINE FORM OF ACETYLATED ELTROMBOPAG AND PREPARATION METHOD THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/078077	NEW CRYSTAL FORM OF ACETYLATED ELTROMBOPAG AND PREPARATION METHOD THEREFOR	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/073629	COMPOUND HAVING EFFECT OF AGONIZING SIRT6 ACETYLATION ACTIVITY, SIRT6 AGONIST AND USE THEREOF	SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/032218	HETEROCYCLIC THR-β RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREFOR	SUZHOU VINTAGENCE PHARMA CO. LTD.
WO/2021/073639	SELECTIVE HYDROGENATION METHOD FOR ACETYLENE POST-HYDROGENATION PROCESS USING CRUDE HYDROGEN AS HYDROGEN SOURCE	PETROCHINA COMPANY LIMITED
WO/2021/073640	SELECTIVE HYDROGENATION METHOD FOR ALKYNE IN C2 FRACTION	PETROCHINA COMPANY LIMITED
WO/2021/135516	ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/135517	ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/147398	PREPARATION METHOD FOR CHIRAL OXOAZACYCLOALKANE COMPOUND HAVING HIGH OPTICAL PURITY	XIN FA PHARMACEUTICAL CO., LTD
WO/2021/135523	ADDITIVE USED IN METHIONINE PREPARATION PROCESS, AND METHIONINE PREPARATION METHOD	ZHEJIANG NHU CO., LTD.
WO/2021/078120	COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES	NOVARTIS AG
WO/2021/078123	RECOMBINANT PROTEIN TARGETING PD-1 AND TGFβ	NANJING LEADS BIOLABS CO., LTD.
WO/2021/203673	NITROGEN CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING SAME, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/109737	OXYGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF	SHANGHAI YINGLI PHARMACEUTICAL CO., LTD
WO/2021/078132	INHIBITORS OF MTOR-MEDIATED INDUCTION OF AUTOPHAGY	SIRONAX LTD
WO/2021/129082	METHOD FOR SYNTHESIZING α-ACRYLIC ACID COMPOUND BY USING PALLADIUM TO CATALYZE CARBON DIOXIDE AND ALKYNE	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/159727	ZMPHYCS MUTANT PROTEIN RELATED TO FLOWERING PERIOD OF MAIZE, ENCODING GENE, RECOMBINANT VECTOR AND USE THEREOF	SOUTH CHINA AGRICULTURAL UNIVERSITY
WO/2021/078135	PYRROLE AMIDE COMPOUND AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/078137	PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/078141	NOVEL PURINE DERIVATIVE, INTERMEDIATE AND APPLICATION THEREOF IN PREPARING ANTICANCER MEDICINE	SUZHOU RAYMON PHARMACEUTICALS COMPANY, LTD.
WO/2021/078150	PENTACYCLIC TRITERPENE TGR5 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR AND USES THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/083011	BRIDGED CYCLOFORMYLPYRIDINE DERIVATIVE AND USE THEREOF	BROADENBIO CO., LTD.
WO/2021/078174	CHIRAL SULFUR OXIDE-CONTAINING ARYL FORMAMIDE COMPOUND AND SALT THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND APPLICATION	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/248767	CLASS OF COMPOUNDS FOR INCREASING SENSITIVITY OF PCA DRUG-RESISTANT CELLS TO ANTAGONIST AND USE THEREOF	LEADINGEN BIOTECH INC.
WO/2021/143246	ORGANIC ELECTROLUMINESCENT DEVICE AND FUSED RING-BASED AROMATIC AMINE COMPOUNDS	GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD.
WO/2021/083018	PREPARATION METHOD FOR AND APPLICATION OF 3-SUBSTITUTED CHIRAL SPIRO AMINOPHOSPHINE LIGAND ON PYRIDINE RING	ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
WO/2021/083022	METHOD FOR PRODUCING PROPYLENE CARBONATE OR ETHYLENE CARBONATE	WU, Jianhua
WO/2021/139315	PEG-MODIFIED POLYPEPTIDE CAPABLE OF INHIBITING GP96, PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING COMINGHEALTH BIO TEC CO., LTD.
WO/2021/212785	FULLY HUMAN MONOCLONAL ANTIBODY AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/120835	NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/083030	NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/223376	CHIMERIC ANTIGEN RECEPTOR, MACROPHAGE EXPRESSING SAME, METHOD FOR ADJUSTING MACROPHAGE POLARIZATION, AND USE THEREOF	ZHEJIANG UNIVERSITY
WO/2021/135542	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/120838	ORGANIC COMPOUND, ELECTRONIC DEVICE, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/078217	TETRACENE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/078219	NOVEL ANTI-CD47 ANTIBODIES AND USES THEREOF	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/078221	DIHYDROPYRIMIDINE COMPOUND AND USE THEREOF IN DRUG	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/078227	FUSED HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/078249	ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/218073	METHOD FOR PREPARING BENZIMIDAZOLONE IN AQUEOUS SOLVENT	SHANDONG HUIHAI PHARMACEUTICAL& CHEMICAL CO., LTD.
WO/2021/114893	METHOD FOR PREPARING 5-ACETYL ACETYLAMINOBENZIMIDAZOLONE	SHANDONG HUIHAI PHARMACEUTICAL& CHEMICAL CO., LTD.
WO/2021/093556	METHOD FOR PREPARING HYDROXYL COMPOUND, DEUTERATED COMPOUND THEREOF, AND TRITIATED COMPOUND THEREOF	FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES
WO/2021/129102	HETEROCYCLIC COMPOUND, SYNTHESIS METHOD THEREFOR, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/078274	PYRIDAZINONE OR PYRIDAZINE COMPOUND AND DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/083060	FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/078285	CYCLOALKYL-BASED AND HETEROCYCLOALKYL-BASED INHIBITORS, PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/078293	3-N-CYCLOPROPYLMETHYL-2-FLUOROBENZAMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	CAC NANTONG CHEMICAL CO., LTD.
WO/2021/248770	GENETICALLY ENCODED FORMALDEHYDE REACTIVE UNNATURAL AMINO ACID, PREPARATION METHOD AND APPLICATION THEREOF	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/037289	RECOMBINANT FUSION POLYPEPTIDE AND USE THEREOF	NANJING ANJI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/037290	FUSION POLYPEPTIDE AND USE THEREOF	NANJING ANJI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/037291	FUSION POLYPEPTIDE HAVING MULTIFUNCTIONAL ACTIVITIES AND USE THEREOF	NANJING ANJI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/037292	POLYPEPTIDE AND USE THEREOF	NANJING ANJI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/083072	HUMAN COLLAGEN 17-TYPE POLYPEPTIDE, PRODUCTION METHOD THEREFOR AND USE THEREOF	SHANXI JINBO BIO-PHARMACEUTICAL CO., LTD.
WO/2021/043337	POLYPEPTIDE AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/043338	POLYPEPTIDE HAVING IMMUNE CHECK-POINT ANTAGONISTIC ACTIVITY AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/043339	PD-L1 ANTAGONIST POLYPEPTIDE AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/120850	USE OF ADEFOVIR DIPIVOXIL AND STRUCTURAL ANALOG THEREOF FOR TREATING PSEUDORABIES VIRUS	XIAMEN UNIVERSITY
WO/2021/129112	ANTIBODY-CONJUGATED DRUG FOR CLAUDIN 6 AND APPLICATION THEREOF	GUANGZHOU MEDICAL UNIVERSITY
WO/2021/083135	Bcl-2 INHIBITORS	BEIGENE, LTD.
WO/2021/109754	PREPARATION METHOD FOR 1,2,3-TRIMERCAPTOPROPANE	SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD.
WO/2021/093585	METHOD FOR PREPARING DICYANONORBORNANE	SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD.
WO/2021/083167	SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	GENFLEET THERAPEUTICS (SHANGHAI) INC.
WO/2021/083182	URICOSURIC AGENT, SYNTHETIC METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/083185	PYRIMIDINE-CONTAINING PIPERIDINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/083186	PIPERIDINAMINE COMPOUND CONTAINING FUSED RING PYRIMIDINE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/083190	KERATIN BD-1, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083191	KERATIN BD-2, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083192	KERATIN BD-3, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083193	KERATIN BD-4, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/083198	KERATIN BD-5, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083200	KERATIN BD-6, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/083201	KERATIN BD-10, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083202	KERATIN BD-11, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/083203	KERATIN BD-13, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083204	KERATIN BD-14, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/083205	KERATIN BD-15, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/083206	KERATIN BD-17, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/083209	SSAO INHIBITORS AND USE THEREOF	ECCOGENE (SHANGHAI) CO., LTD.
WO/2021/083246	MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/083248	ANTI-TSPAN8 MONOCLONAL ANTIBODY AND USE THEREOF	SHANGHAI GENERAL HOSPITAL
WO/2021/120874	N-(3-HYDROXYPYRIDINE-2-CARBONYL)GLYCINE-BASED ANTITUMOR DRUG SENSITIZER AND APPLICATION THEREOF	ZHEJIANG UNIVERSITY
WO/2021/083271	STABLE PREPARATION CONTAINING ANTI-PD-L1 ANTIBODY	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/169359	BENZODIHYDROFURO HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/129138	METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY MEANS OF COMBINATORIAL CATALYSIS WITH ARYL BIDENTATE PHOSPHINE LIGAND	NANJING CHENGZHI CLEAN ENERGY CO. LTD.
WO/2021/083300	HIGH-CARBON ALKANE DIAMINE TEREPHTHALATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	KUNSHAN BOKE CHEMICALS CO., LTD.
WO/2021/083301	PRODUCTION AND PURIFICATION METHOD FOR POLYPEPTIDE	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/088721	COMPOUND HAVING ANTI-AGING AND DISCOLORATION RESISTANCE EFFECTS AND PREPARATION METHOD THEREFOR	SENNICS CO., LTD.
WO/2021/083310	ANTI-CANCER COMPOUNDS ACTING AS NON-PGP SUBSTRATE	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/083311	ACID ADDITION SALT OF RORγ REGULATOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/159754	METHOD FOR PREPARING LIDOCAINE INTERMEDIATE α-CHLOROACETYL-2,6-DIMETHYLANILINE AND LIDOCAINE WITHOUT ADDING ADDITIONAL ALKALI	ZHENGZHOU YUANLI BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/083319	THIOPHENE DERIVATIVES AS XANTHINE OXIDASE INHIBITORS AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/179638	PURIFICATION METHOD FOR ELECTRONIC-GRADE ETHYLENE CARBONATE, AND PURIFICATION APPARATUS	SHANDONG HI-TECH SPRING MATERIAL TECHNOLOGY CO., LTD.
WO/2021/083328	POLYSUBSTITUTED ISOINDOLINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/083330	AMINO-IMINE METAL COMPLEX AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/083335	PD-L1 BINDING MOLECULE	SANYOU BIOPHARMACEUTICALS CO., LTD.
WO/2021/083345	PREPARATION METHOD FOR PYRAZOLOPYRIMIDINE COMPOUND AND INTERMEDIATE THEREOF	SIMCERE PHARMACEUTICAL CO. LTD.
WO/2021/083347	USE OF QUINAZOLINE DERIVATIVE OR SALT THEREOF OR PHARMACEUTICAL COMPOSITION THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/083350	DIIMINE METAL COMPLEX, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/120890	PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/083363	HIGH-AFFINITY TCR FOR KRAS G12V RECOGNITION	XLIFESC, LTD.
WO/2021/129155	PROCESS FOR SYNTHESIZING COMPOSITE PIPERAZINE-BASED HEAVY METAL CHELATING AGENT TDDP	YANTAI ZHONGKE RONGDA NEW MATERIAL CO. LTD
WO/2021/088742	SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/088753	BENZOTHIAZOLE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF	NORTHWEST A&F UNIVERSITY
WO/2021/088756	OXIME ETHER COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/120895	METHOD FOR PREPARING POLYMERCAPTO PENTAERYTHRITHIOL DERIVATIVE	SHANDONG EFIRM BIOCHEMISTRY AND ENVIRON MENTAL PROTECTION CO., LTD.
WO/2021/120896	PREPARATION METHOD FOR NORBORNANE DIMETHYLAMINE	SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD.
WO/2021/088758	OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	FUDAN UNIVERSITY
WO/2021/088762	LIVER TARGETING DRUG, PHARMACEUTICAL COMPOSITION AND USE THEREOF	DU, Jessica Xinyu
WO/2021/083380	EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/120898	ICD INDUCER-IDO INHIBITOR CONJUGATE, AND PREPARATION METHOD AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/083383	NITROGEN-CONTAINING FUSED CYCLIC COMPOUND AS STING REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI RINGENE BIOPHARMA INC.
WO/2021/043341	NOVEL MICROPEPTIDE HMMW AND APPLICATION THEREOF	NANJING ANJI BIOTECHNOLOGY CO., LTD.
WO/2021/088787	QUINAZOLINE COMPOUND USED AS AXL INHIBITOR	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.
WO/2021/093633	LONG-ACTING INTERLEUKIN-2 FOR TARGETING REGULATORY T CELLS AND USE THEREOF IN TREATMENT OF AUTOIMMUNE DISEASES	PEKING UNION MEDICAL COLLEGE HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES AND PEKING UNION MEDICAL COLLEGE
WO/2021/139370	AMIDE COMPOUND AND APPLICATION THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/120900	METHOD FOR PREPARING RECOMBINANT HUMAN NERVE GROWTH FACTOR	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/093639	ANTI-VARICELLA-ZOSTER VIRUS ANTIBODY	ZHUHAI TRINOMAB BIOTECHNOLOGY CO., LTD.
WO/2021/088805	BIASED AGONIST AND MEDICAL USE THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/088838	BINDING MOLECULE SPECIFICALLY FOR CD39 AND USE THEREOF	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/088839	IMIDAZOLIDINONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/088845	IMIDAZOLIDINONE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/088856	SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/088859	INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF	JINAN UNIVERSITY
WO/2021/088885	COMPOUND TARGETING TYPE I PRMT, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SICHUAN UNIVERSITY
WO/2021/088901	COMPOUNDS AS CD73 INHIBITORS	BIOARDIS LLC
WO/2021/088904	ANTI-HUMAN PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) ANTIBODY AND USE THEREOF	SIMCERE BIO-PHARMACEUTICAL TECHNOLOGY., LTD.
WO/2021/088911	3,6-DIAZABICYCLO[3.1.1]HEPTANE DERIVATIVE AS RET KINASE INHIBITOR	HANGZHOU BANGSHUN PHARMACEUTICAL CO., LTD
WO/2021/088920	BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/088938	TETRAHYDROPYRIDOPYRIMIDINE-BASED INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/088944	USE OF ESCHERICHIA COLI MOLECULAR CHAPERONE GROEL/ES IN ASSISTING SYNTHESIS OF PLANT RUBISCO	INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY
WO/2021/232694	METHOD FOR NICKEL-BASED CATALYTIC SYNTHESIS OF 3-DECARBAMOYL CEFUROXIME ACID	SHANDONG JINCHENG KERUI CHEMICAL CO., LTD.
WO/2021/088945	COMPOUND AS SHP2 INHIBITOR AND USE THEREOF	NANJING SANHOME PHARMACEUTICAL CO., LTD.
WO/2021/109791	METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL	JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD.
WO/2021/088980	ACC INHIBITOR AND USE THEREOF	NANJING RUIJIE PHARMA CO., LTD.
WO/2021/088987	SALT FORM SERVING AS SELECTIVE HER2 INHIBITOR, AND CRYSTAL FORMS AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/088992	TETRAHYDROISOQUINOLINE SPIRO COMPOUND AS PRMT5 INHIBITOR	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/088999	COMPOUND HAVING THERAPEUTIC EFFICACY FOR LIVER DISEASE	JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
WO/2021/089011	COMPOUND WITH BISHYDRAZIDE STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/227401	SARS-COV-2 ANTIGEN POLYPEPTIDE, RECOMBINANT ADENO-ASSOCIATED VIRUS THEREOF, AND APPLICATION IN PREPARATION OF VACCINE	HENGDA BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/089030	USE OF LIPID IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT THEREOF	INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/093695	POLYPEPTIDE COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF	CHENGDU SINTANOVO BIOTECHNOLOGV CO., LTD.
WO/2021/093697	COMPOSITE OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND NEP INHIBITOR AND PREPARATION METHOD THEREFOR	SHENZHEN SALUBRIS PHARMACEUTICALS CO.LTD
WO/2021/068986	USE OF MODIFIED GLP-1 ANALOGUE DIMERS OF DIFFERENT CONFIGURATIONS AND PREPARATION METHOD THEREFOR IN TREATING TYPE 2 DIABETES	NANJING FINEPEPTIDE BIOPHARMACEUTICAL CO., LTD
WO/2021/089032	TRICYCLIC DIHYDROIMIDAZOPYRIMIDONE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHANGHAI SIMR BIOTECHNOLOGY CO., LTD
WO/2021/093701	8-SUBSTITUTED STYRYL XANTHINE DERIVATIVES AND USES THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/135647	MULTIMERIZATION DELIVERY SYSTEM FOR INTRACELLULAR DELIVERY OF MOLECULE	XIAMEN UNIVERSITY
WO/2021/089049	METHOD AND DEVICE THEREOF FOR IMPROVING SELECTIVITY OF OXYGENATE CONVERSION TO LOW-CARBON OLEFIN	LUOYANG WEIDA PETROCHEMICAL ENGINEERING CO., LTD.
WO/2021/089055	ZIKA/DENGUE VACCINE AND APPLICATION THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/089056	SYNTHESIS OF β,γ-AMINO ACID N-CARBOXYL THIOCARBONYL ANHYDRIDE MONOMER, POLYMERIZATION REACTION, PREPARATION OF POLYMER, AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/093720	PYRAZOLE[1,5-A]PYRIDINE-3-NITRILE COMPOUND AND PHARMACEUTICAL USE THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/093724	NOVEL 2,3-HYDRINDENE DERIVATIVE COMPOUND, PREPARATION METHOD AND APPLICATION	WUHAN OPTICS VALLEY YATAI PHARMACEUTICAL RESEARCH INSTITUTE CO, LTD
WO/2021/218110	BENZOTHIAZOLYL BIARYL COMPOUND, AND PREPARATION METHOD AND USE	SHANGHAI RINGENE BIOPHARMA CO., LTD.
WO/2021/093753	MOLECULE CAPABLE OF BINDING TO HUMAN 4-1BB, AND APPLICATION OF MOLECULE	HEFEI HANKEMAB BIOTECHNOLOGY CO., LTD
WO/2021/093758	PYRIMIDO DERIVATIVE AND APPLICATION THEREOF IN MEDICINE	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/093760	TGF-β RECEPTOR-CONTAINING FUSION PROTEIN AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/238088	N-[8-(2-HYDROXYBENZOYL)AMINO]POTASSIUM OCTANOATE CRYSTAL POLYMORPH, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SCIWIND BIOSCIENCES CO., LTD.
WO/2021/104021	NEW CRYSTAL FORM OF TROPIFEXOR AND PREPARATION METHOD THEREFOR	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/104022	NOVEL CRYSTALLINE FORM OF TROPIFEXOR AND PREPARATION METHOD THEREFOR	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/093779	IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ESTER AGONIST, AND PREPARATION THEREFOR AND APPLICATION THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/109819	POLYSUBSTITUTED SPIROBIFLUORENYL COMPOUND, HOLE TRANSPORT MATERIAL COMPOSITION, AND OPTOELECTRONIC DEVICE	CHANGZHOU TRONLY E-RAY OPTOELECTRONICS MATERIAL CO., LIMITED
WO/2021/139395	HIGH-EFFICIENCY LOW-TOXICITY ANTI-CANCER COMPOUND SYNTHESIZED BY AUTOCATALYSIS IN CELLS AND LIVING BODIES AND SYNTHESIS METHOD FOR ANTI-CANCER COMPOUND	NANJING NORMAL UNIVERSITY
WO/2021/093795	ROCK INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/093809	CRYSTAL FORM OF TAFAMIDIS AND PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/093817	IMMUNOMODULATORY COMPOUNDS, COMPOSITION AND APPLICATION THEREOF	HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
WO/2021/093820	AMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/098593	SECOEMESTRIN C PREPARATION METHOD AND USE THEROF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/093839	PYRROLOPYRIMIDINE COMPOUND AS BTK INHIBITOR AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/184789	EPRISTERIDE IMPURITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
WO/2021/098597	HUMANIZED 4-1BB MONOCLONAL ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF	SOUND BIOPHARMACEUTICALS CO. LTD.
WO/2021/109836	TEA SAPONIN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	JIANGSU YIPIANYE HIGH-TECH TECHNOLOGY CO., LTD
WO/2021/093846	NOVEL TETRACYCLIC HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF	TUOJIE BIOTECH (SHANGHAI) CO., LTD.
WO/2021/093849	A NOVEL ANTIBODY AGAINST TIGIT	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/093854	DEVICE AND METHOD FOR PREPARING BATTERY-GRADE METHYL ETHYL CARBONATE	SHANDONG SHIDA SHENGHUA CHEMICAL GROUP CO., LTD
WO/2021/093860	SUBSTITUTED BIS-TRICYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	NANJING ZHIHE MEDICINE TECHNOLOGY CO., LTD.
WO/2021/104052	PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	CHENGDU CONMED BIOSCIENCES CO., LTD
WO/2021/104053	DEVELOPMENT AND APPLICATION OF THERAPEUTIC AGENTS FOR TSLP-RELATED DISEASES	CHENGDU CONMED BIOSCIENCES CO., LTD
WO/2021/104072	HYDROGEN PEROXIDE-RESPONSIVE KEAP1-NRF2 PPI INHIBITOR PRODRUG, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/147484	2-(1,2,4-TRIAZOLYL)BENZOYL ARYLAMINE ACTIVE COMPOUND FOR INHIBITING WHEAT TAKE-ALL PATHOGEN	HENAN AGRICULTURAL UNIVERSITY
WO/2021/093883	DUAL RECEPTOR-ACTING AGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITION THEREOF	JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
WO/2021/093887	COMPOSITE AFFINITY COLUMN FOR PURIFYING FUMONISINS B1, ANGUIDIN, T-2 TOXIN, ZEARALENONE AND VOMITOXIN	OIL CROPS RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/203700	ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 4 MONOCLONAL ANTIBODY, AND PREPARATION METHOD AND APPLICATION THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/109854	IMMUNE USE OF PSEUDOMONAS AERUGINOSA TOXINS EXOS AND EXOT, AND PREPARATION METHOD THEREFOR	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/109862	LIGHT-SENSITIVE LIVING CELL RIBONUCLEIC ACID FLUORESCENT PROBE	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/174910	METHOD FOR MAXIMIZING ETHYLENE OR PROPENE PRODUCTION	ZHEJIANG COMY ENVIRONMENT TECHNOLOGY CO., LTD
WO/2021/120953	METHOD FOR SYNTHESIZING 1,7-NAPHTHYRIDINE DERIVATIVE	CHENGDA PHARMACEUTICALS CO., LTD.
WO/2021/098671	UREIDO-CONTAINING BENZIMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/129233	METHOD FOR PREPARING NATURAL FERULIC ACID BY USING ORYZANOL-CONTAINING SAPONIN AS RAW MATERIAL	HUNAN HUACHENG BIOTECH, INC
WO/2021/098680	METHOD FOR PREPARING ORYZANOL BY USING SOAPSTOCK CONTAINING ORYZANOL AS RAW MATERIAL	HUNAN HUACHENG BIOTECH, INC
WO/2021/120957	METHOD FOR PREPARING TAURINE AND METHOD FOR RECOVERING MOTHER LIQUOR THEREOF	ZHEJIANG NHU COMPANY LTD.
WO/2021/098691	PYRROLOTRIAZINE COMPOUNDS ACTING AS MNK INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/098703	COMPOUND AS HIGHLY SELECTIVE ROS1 INHIBITOR AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/232712	NOVEL CORONAVIRUS IGM/IGG MAGNETIC MICROPARTICLE CHEMILUMINESCENCE IMMUNOASSAY KIT	BIOSCIENCE (CHONGQING) DIAGNOSTIC TECHNOLOGY CO., LTD
WO/2021/098712	PREPARATION METHOD FOR CHLOROHOMOSERINE ALKYL ESTER	LIER CHEMICAL CO., LTD.
WO/2021/098715	PHENOTHIAZINE FERROPTOSIS INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHENGDU HENGHAO INVESTMENT CO., LTD.
WO/2021/129241	APPLICATION OF SALIDROSIDE DERIVATIVE IN SKIN-WHITENING AGENT FOR EXTERNAL USE	SHANGHAI CHENGMU BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/098716	CRYSTAL FORMS OF FUSED RING COMPOUND, AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	HANGZHOU YUSHENG MEDICAL TECHNOLOGY CO. LTD
WO/2021/098720	ANTI-PCSK9 ANTIBODY AND USE THEREOF	AD PHARMACEUTICALS CO., LTD.
WO/2021/098725	SYNTHETIC METHOD FOR NMN DERIVATIVE AND MEDICAL APPLICATIONS OF NMN AND ITS DERIVATIVE	TSINGHUA UNIVERSITY
WO/2021/098732	1',2'-DIHYDRO-3'H-SPIRO[CYCLOBUTANE 1,4'-ISOQUINOLINE]-3'-ONE DERIVATIVE AND APPLICATION THEREOF	NHWA PHARMA. CORPORATION
WO/2021/098734	SUBSTITUTED QUINOLINOPYRROLIDONE COMPOUND AS ATM INHIBITOR AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/164351	NITROOXYDERIVATIVE OF ROCK KINASE INHIBITOR	VIVAVISION (SHANGHAI) LTD
WO/2021/098737	FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF	SHUJING BIOPHARMA CO., LTD.
WO/2021/258625	ANTI-SAR-COV-2 (COVID-19) FULLY HUMANIZED MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/098745	PREPARATION AND APPLICATION OF A CLASS OF PROTEIN RECEPTOR KINASE INHIBITORS	SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD.
WO/2021/129246	MONOCLONAL ANTIBODY OF COXSACKIE VIRUS A10 TYPE SOLID VIRUS AND USE THEREOF	SINOVAC BIOTECH CO., LTD.
WO/2021/129247	MONOCLONAL ANTIBODY OF COXSACKIEVIRUS A6 TRUE VIRUS AND USE THEREOF	SINOVAC BIOTECH CO., LTD.
WO/2021/098748	METHODS OF CANCER TREATMENT WITH ANTI-OX40 ANTIBODY IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS	BEIGENE (BEIJING) CO., LTD.
WO/2021/098749	METHODS OF CANCER TREATMENT WITH ANTI-OX40 ANTIBODY IN COMBINATION WITH RADIATION	BEIGENE (BEIJING) CO., LTD.
WO/2021/098750	METHODS OF CANCER TREATMENT WITH ANTI-OX40 ANTIBODY IN COMIBINAITON WITH TLR AGONISTS	BEIGENE (BEIJING) CO., LTD.
WO/2021/098757	METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH ANTI-TIGIT ANTIBODIES	BEIGENE, LTD.
WO/2021/098758	METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH ANTI-TIM3 ANTIBODIES	BEIGENE, LTD.
WO/2021/104146	THREE FUSED RING DERIVATIVE-CONTAINING SALT OR CRYSTAL FORM AND PHARMACEUTICAL COMPOSITION THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/196655	COMPOUND CONTAINING BENZIMIDAZOLE STRUCTURE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/223398	CRYSTAL FORM FOR TREATING LIVER DISEASE AND USE THEREOF	XI'AN XINTONG PHARMACEUTICAL RESEARCH CO., LTD.
WO/2021/098774	METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH ANTI-PD1 OR ANTI-PDL1 ANTIBODIES	BEIGENE, LTD.
WO/2021/098777	METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH PI3 KINASE DELTA INHIBITORS	BEIGENE, LTD.
WO/2021/243974	FUSION PROTEIN OF SARS-COV-2 AND VACCINE COMPOSITION THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE OF TRADITIONAL CHINESE MEDICINE)
WO/2021/098809	BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR	MEDSHINE DISCOVERY INC.
WO/2021/098810	COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR	MEDSHINE DISCOVERY INC.
WO/2021/098811	PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/098813	PYRIMIDOPYRROLE SPIRO COMPOUNDS AND DERIVATIVES THEREOF AS DNA-PK INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/098817	DIOXOPIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFORE AND PHARMACEUTICAL USE THEREOF	SHENZHEN SALUBRIS PHARMACEUTICALS CO.LTD
WO/2021/120982	METHOD FOR PREPARING M-PHENYLENEDIAMINE	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/098822	BISPECIFIC ANTIBODIES	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/169433	SARS-COV-2 RECOMBINANT N PROTEIN, AND PREPARATION METHOD AND PURIFICATION METHOD THEREFOR	SHENZHEN YHLO BIOTECH CO., LTD
WO/2021/169434	SARS-COV-2 RECOMBINANT RBD PROTEIN, AND PREPARATION METHOD THEREFOR	SHENZHEN YHLO BIOTECH CO., LTD
WO/2021/098834	PSMA ANTIBODY AND USE THEREOF	SHANGHAI YICHEN BIOMED CO.LTD
WO/2021/109883	METHOD FOR USE IN PREPARING OBETICHOLIC ACID	BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
WO/2021/098840	SULFONYLUREA RING SUBSTITUTED MONOCYCLIC β-LACTAM ANTIBIOTICS	MEDSHINE DISCOVERY INC.
WO/2021/098843	ABAMECTIN EXTRACTION METHOD	NINGXIA TAIYICIN BIOTECH CO., LTD.
WO/2021/098844	IMMUNOMODULATOR	HITGEN INC.
WO/2021/098847	CLINDAMYCIN PHOSPHATE PURIFICATION METHOD	NINGXIA TAIYICIN BIOTECH CO., LTD.
WO/2021/098850	CRYSTAL FORM OF NUCLEOPROTEIN INHIBITOR AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/098851	ANTI-CTLA4/OX40 BISPECIFIC ANTIBODIES AND USES THEREOF	EUCURE (BEIJING) BIOPHARMA CO., LTD
WO/2021/098854	BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
WO/2021/098859	AZA SEVEN-MEMBERED RING INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/098872	ALLOPREGNENOLONE PHOSPHONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	SHANGHAI CAERULUM PHARMA DISCOVERY
WO/2021/104186	NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS	INVENTISBIO CO., LTD.
WO/2021/227436	ANTIFUNGAL COMPOUND, SYNTHESIS METHOD AND USE THEREOF	WUXI NO.2 PEOPLE'S HOSPITAL
WO/2021/104199	AMINOXY ACID-BASED ANTI-CANCER STEM CELL COMPOUNDS AND METHODS THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/135725	ORGANIC COMPOUND, ELECTRONIC DEVICE AND ELECTRONIC APPARATUS USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/098882	CD7-CAR-T CELL AND PREPARATION AND APPLICATION THEREOF	PERSONGEN BIOTHERAPEUTICS (SUZHOU) CO., LTD.
WO/2021/098883	COMPOUND USED AS EGFR KINASE INHIBITOR AND USE THEREOF	TYK MEDICINES, INC.
WO/2021/098885	α-FLUOROCHALCONE DERIVATIVES AND APPLICATION THEREOF	ALPHA-FLUORO-CHALCONE TYPE COMPOUND AND APPLICATION THEREOF
WO/2021/120992	TRIAZOLE DERIVATIVES AND APPLICATION THEREOF	SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD.
WO/2021/143354	PROCESSING METHOD FOR PREPARING 3-METHYL-3-BUTENYL-1-OL FROM FORMALIN SOLUTION AND ISOBUTENE BY MEANS OF REACTOR	CHINA CATALYST HUABANG (DONGYING) CO., LTD.
WO/2021/104256	HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD
WO/2021/104257	CRYSTALLINE FORM OF ACETYLCHOLINESTERASE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/135732	POLYMYXIN B COMPONENT OR SALT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL CO., LTD.
WO/2021/227439	ARYL GLUCOSIDE DERIVATIVE	SHANGHAI ZHEYE BIOTECHNOLOGY CO., LTD.
WO/2021/227440	A CLASS OF ARYL GLUCOSIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI ZHEYE BIOTECHNOLOGY CO., LTD.
WO/2021/227441	ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG	SHANGHAI ZHEYE BIOTECHNOLOGY CO., LTD.
WO/2021/104277	PYRIMIDOIMIDAZOLE COMPOUNDS USED AS DNA-PK INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/104288	1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	KPC PHARMACEUTICALS, INC
WO/2021/179683	METHOD FOR PREPARING ERIBULIN INTERMEDIATE	SHENGDING PHARMA
WO/2021/104294	CRYSTAL FORMS OF OCTAHYDROPYRROLO [3,4-c] PYRROLE DERIVATIVES	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/104302	ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE THEREOF	AKESO BIOPHARMA, INC.
WO/2021/104305	NITROGEN-CONTAINING POLYCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/104326	MONOCLONAL ANTIBODY FOR DETECTION OF CAR-T CELLS, KIT AND APPLICATION	SUZHOU BIOSWAN LABORATORIES, INC.
WO/2021/109913	ANTIMALARIAL DIMER IMMUNOADHESIN, PHARMACEUTICAL COMPOSITION, AND USE	PHARCHOICE THERAPEUTICS INC
WO/2021/109914	DIMERIC IMMUNE FUSION PROTEIN, PHARMACEUTICAL COMPOSITION AND USE	PHARCHOICE THERAPEUTICS INC
WO/2021/104353	CRYSTAL FORM OF QUINOLINONE COMPOUND AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/104355	IMPURITIES OF HETEROCYCLIC BORONIC ACID COMPOUNDS AND CONTROL METHOD THEREOF	HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD
WO/2021/135750	ORGANIC COMPOUND, APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/104391	OLEANANE CINNAMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/104413	FUSED PYRIDINE RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/104416	COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE	MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
WO/2021/223422	ANTI-HIV POLYPEPTIDE MODIFIED WITH HIGH MOLECULAR PEG, PREPARATION THEREFOR, AND USE THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/068991	METHOD FOR PREPARING DIOSGENIN BY TERNARY TWO-PHASE ALUMINUM CHLORIDE HYDROLYSIS	SOUTH CHINA AGRICULTURAL UNIVERSITY
WO/2021/104421	AMORPHOUS FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/104427	CRYSTALLINE FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/104430	A NOVEL ANTI-CD3/ANTI-EGFR BISPECIFIC ANTIBODY AND USES THEREOF	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/104431	KRAS G12C INHIBITOR COMPOUND AND USE THEREOF	SUZHOU SINOVENT PHARMACEUTICALS CO., LTD.
WO/2021/104432	L-ORNITHINE COMPOSITE SALT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WUHAN GRAND HOYO CO., LTD.
WO/2021/104434	TGFβ/PD-L1 BISPECIFIC BINDING PROTEINS	SHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/104441	POLYAROMATIC COMPOUND AS EGFR KINASE INHIBITOR	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/135765	SALT CONVERSION METHOD FOR GLP-1 ANALOGUE	HYBIO PHARMACEUTICAL (WUHAN) CO., LTD.
WO/2021/129308	METHOD FOR PURIFYING GLP-1 ANALOG	HYBIO PHARMACEUTICAL (WUHAN) CO., LTD
WO/2021/104461	DIAZAINDOLE DERIVATIVE AND USE THEREOF AS CHK1 INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/121012	AMINO DITHIOPERACID THIOESTER COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF	FUDAN UNIVERSITY
WO/2021/104470	ANTI-HBV 1,7-NAPHTHYRIDINE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/258641	PREPARATION METHOD FOR NEAR-INFRARED FLUORESCENT TRACER USED FOR DIAGNOSING METASTATIC LYMPH NODE	NANJING NUOYUAN MEDICAL DEVICES CO., LTD
WO/2021/104483	SULFONIC ACID QUATERNARY AMMONIUM SALT COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF	BEIJING YAOCHENG HUIREN TECHNOLOGY CO., LTD.
WO/2021/104486	COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF	WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/104488	TRI-HETEROCYCLIC COMPOUND AS JAK INHIBITOR, AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104496	SEPARATED ANTIGEN AXL BINDING PROTEIN AND USE THEREOF	SUMGEN MAB (BEIJING) BIOTECH CO., LTD.
WO/2021/104503	METHOD FOR PREPARING CARBONYL SULFONE	SOOCHOW UNIVERSITY
WO/2021/109944	WEAK ALKALINE CABAZITAXEL DERIVATIVE AND FORMULATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/104506	CYCLIC SULFONE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	INSTITUTE OF MATERIA MEDICA , CHINESE ACADEMY OF MEDICAL SCICENCES
WO/2021/104507	SUBSTITUTED PHENOXYAMIDE DERIVATIVE, USE THEREOF AND DRUGS FOR TREATING PARKINSON'S DISEASE	YUE, Qianao
WO/2021/104509	METHOD FOR TREATING SILK FIBROIN WITH AROMATIC ALCOHOL AND USE THEREOF IN PREPARATION OF SILK-FIBROIN-CONTAINING MATERIAL	SIMATECH INCORPORATION
WO/2021/109953	FUSION PROTEIN OF ANTI-C3D TARGETING SINGLE-CHAIN ANTIBODY AND DAF, AND APPLICATION	BEIJING COMPLEMENT THERAPEUTICS.LTD
WO/2021/104515	SUBSTITUTED M-TERPHENYL COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	DISCOVERY (SHENZHEN) NEW MEDICINES DEVELOPMENT CO. LTD
WO/2021/109968	FUSION PROTEIN OF ANTI-C3D TARGETED SINGLE-CHAIN ANTIBODY AND CD59, AND APPLICATION THEREOF	BEIJING COMPLEMENT THERAPEUTICS.LTD
WO/2021/135783	METHOD FOR PREPARING ANDROGRAPHOLIDE DERIVATIVE BY USING INDUSTRIAL CHROMATOGRAPHIC TECHNOLOGY	JIANGXI QINGFENG PHARMACEUTICAL CO., LTD.
WO/2021/218148	10-(S)-17-HYDROGEN-7-DEHYDRO-ANDROGRAPHOLIDUME, INDUSTRIAL CHROMATOGRAPHY-BASED PREPARATION METHOD THEREFOR, AND USE THEREOF	JIANGXI QINGFENG PHARMACEUTICAL CO., LTD.
WO/2021/223425	METHOD FOR REFINING DABIGATRAN CRUDE PRODUCT	JIANGXI GUOYAO PHARMACEUTICAI, LLC
WO/2021/121022	NEGATIVE DIELECTRIC LIQUID CRYSTAL COMPOUND, PREPARATION THEREFOR, AND APPLICATION THEREOF	BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD
WO/2021/109977	CHIMERIC ANTIGEN RECEPTOR T CELL WHICH CAN BE EFFICIENTLY PREPARED AND SAFELY USED, PREPARATION METHOD THEREFOR AND USE THEREOF	HEBEI SENLANG BIOTECHNOLOGY
WO/2021/248853	POLYPEPTIDE VACCINE COUPLED WITH TLR7 AGONIST FOR NOVEL CORONAVIRUS AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/139452	ORGANIC ELECTRONIC MATERIAL CONTAINING NITROGEN ATOM HETEROCYCLIC RING, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI CHUANQIN NEW MATERIAL CO., LTD
WO/2021/110004	WEAK ACIDIC PACLITAXEL DERIVATIVE ACTIVE DRUG-LOADING LIPOSOME, PREPARATION THEREFOR AND USE THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/110009	NOVEL AURORA KINASE INHIBITOR AND USE THEREOF	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/110010	NOVEL PYRROLE COMPOUND	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/110011	COMBINATION OF IAP INHIBITORS AND PARP OR MEK INHIBITORS OR OTHER CHEMOTHERAPEUTIC AGENTS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/110061	PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION	JIANGYIN USUN PHARMACEUTICAL CO., LTD.
WO/2021/110063	NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE	JIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/129337	ORGANIC COMPOUND AND ORGANIC ELECTRONIC DEVICE	GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD.
WO/2021/110076	OXAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE	SHENZHEN SALUBRIS PHARMACEUTICALS CO.LTD
WO/2021/147521	TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	CHENGDU NEWSUN CROP SCIENCE CO., LTD.
WO/2021/110081	SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE AMINO ACID DERIVATIVE AND USE THEREOF	HANGZHOU HUADONG MEDICINE GROUP PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD
WO/2021/110082	METHOD FOR PREPARING MONOOLEFIN BY MEANS OF HYDROGENATION OF DIOLEFIN	SINOPEC JINLING PETROCHEMICAL CO., LTD.
WO/2021/115188	HISTONE DEACETYLASE, AND PROTEASOME DUAL-TARGET INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/110094	MITOCHONDRION/RIBONUCLEIC-ACID-TARGETING TRANSFERABLE PHOTOACTIVE PROBE AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/110095	ANTI-GPC3 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/110102	METHODS OF CANCER TREATMENT USING BCL-2 INHIBITOR	BEIGENE, LTD.
WO/2021/110106	BISPECIFIC FUSION PROTEIN FOR TUMOR TREATMENT	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/110107	COMBINATION OF BISPECIFIC FUSION PROTEIN AND ANTI-Her2 ANTIBODY FOR TUMOR TREATMENT	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/110110	ANTIBODY FC REGION HAVING ENHANCED FCγRIIB AFFINITY	SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/115195	DITHIOCARBAMATE COPPER-ZINC BIMETALLIC COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF	LIMIN CHEMICAL CO., LTD.
WO/2021/110122	COMBINATION THERAPY OF CDK4/6 INHIBITOR	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/258650	METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN	GUANGZHOU BIOPHARMACEUTICAL R&D CENTER OF JINAN UNIVERSITY CO., LTD
WO/2021/110125	ECHINOCANDIN ANALOGUES AND PREPARATION METHOD THEREFOR	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/110126	ANTIBODY AGAINST HUMAN CYTOMEGALOVIRUS AND USE THEREOF	ZHUHAI TRINOMAB BIOTECHNOLOGY CO., LTD.
WO/2021/110135	CRYSTAL FORM AS INHIBITOR OF ACC1 AND ACC2, AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/110138	CRYSTAL FORM OF THIENO[2,3-C]PYRIDAZINE-4(1H)-ONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/110141	BIARYL COMPOUND AS PAN-RAF KINASE INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/110142	SUBSTITUTED IMIDAZOLECARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS	HENAN NORMAL UNIVERSITY
WO/2021/129359	METHOD FOR PURIFYING DOUBLE-END AMINOSILOXANE	CHEMVON BIOTECHNOLOGY CO., LTD
WO/2021/208459	IMMUNE AGONISTS	SHENZHEN UNIVERSITY
WO/2021/115225	PYRAZOLE-CONTAINING POLYCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/110168	SPIRO COMPOUND SERVING AS ERK INHIBITOR, AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/129364	METHOD FOR PREPARING LURASIDONE HYDROCHLORIDE	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/110169	THIAZOLOLACTAM COMPOUND AS ERK INHIBITOR AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/135841	ORGANIC ELECTROLUMINESCENCE DEVICE AND AROMATIC COMPOUND CONTAINING FUSED-RING	GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD.
WO/2021/110177	RHEIN DERIVATIVE AND ANTIVIRAL USE THEREOF	CHINA INSPECTION SCIENCE PHARMACEUTICAL (BEIJING) GROUP CO., LTD
WO/2021/121068	MACROMOLECULE FOR PROMOTING INTAKE OF ANTICANCER DRUG, AND COMPOSITION CONTAINING SAME AND USE THEREOF IN PREPARATION OF ANTICANCER DRUG	NANKAI UNIVERSITY
WO/2021/115237	GREEN AND BROAD-SPECTRUM PROTEIN CROSS-LINKING METHOD	LANZHOU UNIVERSITY
WO/2021/115240	ANTI-TSLP ANTIBODY AND USES THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/129377	METHOD FOR TREATING BYPRODUCT HYDROGEN CHLORIDE IN FLUORINE-CONTAINING OLEFIN PRODUCTION PROCESS	LI, Hongfeng
WO/2021/115258	FGFR-TARGETED ANTAGONISTIC SHORT PEPTIDE	WENZHOU MEDICAL UNIVERSITY
WO/2021/115264	METHOD FOR PREPARING LEVULINIC ACID BY MOLTEN SALT HYDRATE-BASED CELLULOSE HYDROLYSIS	SHANDONG UNIVERSITY OF TECHNOLOGY
WO/2021/115286	SIX-MEMBERED AND FIVE-MEMBERED AROMATIC RING DERIVATIVE CONTAINING NITROGEN HETEROATOMS WHICH CAN BE USED AS SHP2 INHIBITOR	CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
WO/2021/115303	ANTI-CLAUDIN18.2 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/179711	PROCESS FOR EXTRACTING COMPOUNDS FROM DENDROBIUM NOBILE AND USE THEREOF	INSTITUTE OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY, CHINESE ACADEMY OF TROPICAL AGRICULTURAL SCIENCES
WO/2021/115333	FUSION PROTEIN AND ENGINEERED IMMUNE CELL EXPRESSING SAME AND APPLICATION OF ENGINEERED IMMUNE CELL	CURE GENETICS CO., LTD
WO/2021/115335	COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/135886	TRANSAMINASE MUTANT, IMMOBILIZED TRANSAMINASE AND USE IN PREPARATION OF SITAGLIPTIN	ABIOCHEM BIOTECHNOLOGY CO., LTD.
WO/2021/115372	VORTIOXETINE PRODRUG AND USE THEREOF	NHWA PHARMA. CORPORATION
WO/2021/115375	NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/115380	COMPOUND HAVING NEUROPROTECTIVE EFFECT, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI ZHIMENG BIOPHARMA, INC.
WO/2021/115392	FUSION PROTEIN, AMINO ACID SEQUENCE AND CODING NUCLEOTIDE SEQUENCE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN AGRICULTURAL UNIVERSITY
WO/2021/115400	PREPARATION METHOD FOR IMIDAZOLINONE COMPOUND	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/115401	FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF	CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
WO/2021/135891	PRAZIQUANTEL SYNTHESIS METHOD	JIANGSU CHENGXIN PHARMACEUTICAL CO., LTD.
WO/2021/115404	ANTI-CD38 ANTIBODY AND USE THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/115413	NEUROMUSCULAR-BLOCKING DRUG AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/121146	CRYSTAL FORM A OF AMINOPYRIMIDINE MESYLATE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	BETA PHARMA (SUZHOU), LTD.
WO/2021/115432	NOVEL QUINAZOLINE-CONTAINING COMPOUND, AND INTERMEDIATE THEREOF AND USE THEREOF	SUZHOU ACESOLA PHARMACEUTICAL CO., LTD.
WO/2021/258663	PREPARATION METHOD FOR RHODIUM OCTANOATE DIMER	SHANGHAI OURCHEM BIO-TECHNOLOGY CO., LTD
WO/2021/139482	CARBOXYLIC ACID DERIVATIVE-SUBSTITUTED IMINO ARYL COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/143412	METHOD AND DEVICE FOR PREPARING ADIPONITRILE	ZHEJIANG NHU COMPANY LTD.
WO/2021/143414	CRYSTAL FORM OF PONESIMOD, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/115444	MONOCYCLIC β-LACTAM COMPOUND AND USE THEREOF	SUZHOU SINOVENT PHARMACEUTICALS CO., LTD.
WO/2021/238161	LOW-IRON AQUEOUS PHOSPHOLIPID AND METHOD FOR ISOLATING LOW-IRON AQUEOUS PHOSPHOLIPID FROM SOYBEAN OIL SLUDGE	INNER MONGOLIA BOBEYMAN TECHNOLOGY CO. LTD
WO/2021/143418	CRYOGENIC SEPARATION PROCESS FOR DEHYDROGENATION OF PROPANE INTO PROPYLENE	ZHEJIANG SATELLITE ENERGY CO., LTD
WO/2021/115456	BI-FUNCTIONAL ANTIBODY AGAINST PD-L1 AND TGFβ	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/115457	PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN JINGTAI TECHNOLOGY CO., LTD.
WO/2021/115465	ANTIBODIES BINDING RANKL AND USES THEREOF	BIOSION INC.
WO/2021/115468	METHOD FOR CONSTRUCTING ANTIBODY COMPLEMENTARITY DETERMINING REGION LIBRARY	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/115489	NOVEL HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES	TONGJI UNIVERSITY
WO/2021/121204	ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/121210	FUSED-RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/121215	OPTIMIZED ANTI-CD3 ARM IN THE GENERATION OF T-CELL BISPECIFIC ANTIBODIES FOR IMMUNOTHERAPY	SHANDONG BOAN BIOTECHNOLOGY CO., LTD.
WO/2021/129465	RESMETIROM CRYSTAL, PREPARATION METHOD FOR SAME, AND USES THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/143430	BMS-986165 HYDROCHLORIDE CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/121228	SINGLE DOMAIN ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/129467	BMS-986165 CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/121230	COMPOUND, APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME	BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD
WO/2021/135938	HETEROCYCLIC SULFOXIMINE COMPOUND AND INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	NANGENE BIOMEDICAL CO., LTD.
WO/2021/121239	METHOD FOR PREPARING CHOLESTEROL, DERIVATIVE THEREOF, AND ANALOG THEREOF	HUNAN KEREY PHARMACEUTICAL CO., LTD
WO/2021/212880	METHOD FOR ASYMMETRICALLY PREPARING NICOTINE	SHENZHEN CATALYS TECHNOLOGY CO., LTD
WO/2021/121250	BCMA BINDING ANTIBODY AND USE THEREOF	SHENZHEN FEIPENG BIOLOGICAL THERAPY CO. LTD
WO/2021/121261	COMPOUND FOR INHIBITING AND INDUCING DEGRADATION OF EGFR KINASE	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/121270	METHOD FOR PURIFYING SGLTS INHIBITOR AND APPLICATION THEREOF	YOUNGENE THERAPEUTICS CO., LTD
WO/2021/121276	FUSED TETRACYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/155716	PYRIDOPYRIMIDINONE COMPOUND AND APPLICATION THEREOF	GUANGZHOU BEBETTER MEDICINE TECH CO LTD
WO/2021/121282	PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS WITH IMMUNOMODULATORY FUNCTION	SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD.
WO/2021/147575	NEW CARBON GLYCOSIDE GLYCOSYLTRANSFERASE AND USE THEREOF	CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES
WO/2021/121294	TRIAZOLOPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF	SHANGHAI SIMR BIOTECHNOLOGY CO., LTD.
WO/2021/139498	ISOXAZOLINE OXIME CARBOXYLATE COMPOUND, PREPARATION METHOD THEREFOR, AND HERBICIDAL COMPOSITION AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/139499	PREPARATION METHOD FOR AND APPLICATION OF CHIRAL SPIROCYCLIC PHOSPHINE-NITROGEN-PHOSPHINE TRIDENTATE LIGAND AND IRIDIUM CATALYST THEREOF	ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
WO/2021/169512	POLYPEPTIDE COMPOUND AND APPLICATION THEREOF IN PREVENTION OR TREATMENT OF DIABETES OR DIABETES COMPLICATION	SUN YAT-SEN UNIVERSITY
WO/2021/244007	RICE MALE FERTILITY REGULATORY GENE, MUTANT OF RICE MALE FERTILITY REGULATORY GENE, USE THEREOF AND METHOD FOR REGULATING RICE FERTILITY	HAINAN BOLIAN RICE GENE TECHNOLOGY CO., LTD.
WO/2021/121321	FUSION PROTEIN THAT IMPROVES GENE EDITING EFFICIENCY AND APPLICATION THEREOF	EAST CHINA NORMAL UNIVERSITY
WO/2021/121327	SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES	JANSSEN PHARMACEUTICA NV
WO/2021/121330	HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/121362	FURANEOL GLYCOSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	FUDAN UNIVERSITY
WO/2021/121363	HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS	JANSSEN PHARMACEUTICA NV
WO/2021/121367	KRAS MUTANT PROTEIN INHIBITORS	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/121371	KRAS G12C INHIBITOR AND PHARMACEUTICAL USE THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/121373	ANTI-HUMAN PROGRAMMED DEATH -1 (PD-1) MONOCLONAL ANTIBODY	GUANGDONG FEIPENG PHARMACEUTICAL CO., LTD
WO/2021/121390	HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND APPLICATION THEREOF	SUZHOU SINOVENT PHARMACEUTICALS CO., LTD.
WO/2021/121393	ANTIBACTERIAL AND MINERALIZING COATING ON TOOTH SURFACES FOR PREVENTION OF DENTAL CARIES	THE UNIVERSITY OF HONG KONG
WO/2021/121396	TRICYCLIC COMPOUND THAT ACTS AS PLASMA KALLIKREIN INHIBITOR AND USE THEREOF	CHENGDU KANGHONG PHARMACEUTICAL CO. , LTD.
WO/2021/121397	SUBSTITUTED ALKYNYL HETEROCYCLIC COMPOUND	SHOUYAO HOLDINGS (BEIJING) CO., LTD.
WO/2021/083409	ANTI-CD97 MONOCLONAL ANTIBODY, VARIABLE REGION AND CONSTANT REGION SEQUENCES THEREOF, AND ANTI-BRAIN TUMOR APPLICATION	HENAN UNIVERSITY
WO/2021/104529	MACROLIDE BREFELDIN A ESTER DERIVATIVE, AND USE	OCEAN UNIVERSITY OF CHINA
WO/2021/121417	LACTIC ACID OPTICAL PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/129559	T CELL RECEPTOR FUSION PROTEIN AND USE THEREOF	NANJING BIOHENG BIOTECH CO., LTD
WO/2021/129561	CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
WO/2021/129565	CRYSTALLINE FORMS OF (S) -1- (1-ACRYLOYLPYRROLIDIN-3-YL) -3- ( (3, 5-DIMETHOXYPHENYL) ETHYNYL) -5- (METHYLAMINO) -1H-PYRAZOLE-4-CARBOXAMIDE	BEIJING INNOCARE PHARMA TECH CO., LTD.
WO/2021/121420	BENZOPYRAZOLE COMPOUND AND INTERMEDIATE, PREPARATION METHOD, AND APPLICATION THEREOF	JIANGSU KDN PHARMACEUTICAL TECHNOLOGY CO. LTD.
WO/2021/136006	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129579	HEME DERIVATIVE AND PREPARATION METHOD AND USE THEREOF	AOYU BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/129580	METHOD FOR PREPARING ISAVUCONAZONIUM SULFATE	SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD.
WO/2021/078312	CYCLOALKYL AND HETERO-CYCLOALKYL INHIBITORS, PREPARATION METHODS THEREFOR, AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/129584	PD-L1 ANTAGONIST COMPOUND	ADLAI NORTYE BIOPHARMA CO., LTD.
WO/2021/129587	SALT FORM AND CRYSTAL FORM OF MUTANT IDH1 INHIBITOR AND PREPARATION METHOD THEREFOR	KPC PHARMACEUTICALS, INC
WO/2021/129589	NEW CRYSTAL FORM OF KD-025 AND PREPARATION METHOD THEREFOR	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/129596	QUINOLINE COMPOUND AND APPLICATION THEREOF	SKYRUN PHARMA CO., LTD.
WO/2021/129602	SUBSTITUTED POLYCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHIJIAZHUANG DISCOVERY MEDICINE THCHNOLOGY CO., LTD
WO/2021/129605	ANTIBODY AGAINST CHEMOKINE CX3CL1 AND APPLICATION THEREOF	SHANGHAI PUREMAB BIO-TECH CO., LTD.
WO/2021/129621	PYRAZOLE COMPOUNDS	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/129629	ZESTE ENHANCER HOMOLOGUE 2 INHIBITOR AND USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/129639	ORGANIC COMPOUND AND APPLICATION, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING ORGANIC COMPOUND	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129651	2-[4-[(E)-(2-KETOCYCLOHEXENYL)METHYL]PHENYL]PROPIONIC ACID CRYSTAL FORM AND PREPARATION METHOD THEREFOR	HUNAN JIUDIAN PHARMACEUTICAL CO., LTD.
WO/2021/129653	PROTEIN DEGRADATION AGENT COMPOUND PREPARATION METHOD AND APPLICATION	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/129655	NOVEL ANTI-FGFR2B ANTIBODIES	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
WO/2021/129656	NOVEL ANTI-FGFR2B ANTIBODIES	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
WO/2021/136034	ORGANIC COMPOUND, USE THEREOF AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129672	NOVEL ANTI-FGFR2B ANTIBODIES	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
WO/2021/136040	PREPARATION AND APPLICATIONS OF CHIMERIC ANTIGEN RECEPTOR T-CELL CO-EXPRESSING IMMUNOMODULATORY MOLECULE	EAST CHINA NORMAL UNIVERSITY
WO/2021/129697	ANTI-SIRPα MONOCLONAL ANTIBODIES AND USES THEREOF	LANOVA MEDICINES LIMITED COMPANY
WO/2021/129720	COLUMBAMINE PREPARATION METHOD AND COLUMBAMINE	SHENZHEN INSTITUTE OF GERIATRICS
WO/2021/136055	NITROGEN-CONTAINING ORGANIC COMPOUND, USE THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129723	ANTIFUNGAL WATER-SOLUBLE PRODRUG AND PREPARATION METHOD THEREFOR	SHANGHAI YINGNUOFUCHENG BIOTECHNOLOGY CO., LTD.
WO/2021/129724	ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129737	COMPOUND HAVING KHK INHIBITORY EFFECT	MEDSHINE DISCOVERY INC.
WO/2021/129747	MAGNOLOL AND SULFORAPHANE CONJUGATE, AND PREPARATION METHOD THEREFOR	SHENZHEN INSTITUTE OF GERIATRICS
WO/2021/136064	NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129765	CLAUDIN18.2 BINDING MOIETIES AND USES THEREOF	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/129779	NOVEL AMPHIPHILIC PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF	LI, Ying
WO/2021/227507	METHOD FOR PREPARING IMIPENEM ACTIVE PHARMACEUTICAL INGREDIENT	SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD.
WO/2021/129783	PREPARATION METHOD FOR AND APPLICATION OF DEMETHYLENEBERBERINE	SHENZHEN INSTITUTE OF GERIATRICS
WO/2021/136082	POLYPEPTIDE ENCODED BY BNLF2B GENE IN EB VIRUS AND DETECTION USE THEREOF	XIAMEN UNIVERSITY
WO/2021/129799	INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/174967	NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/129817	PYRIMIDINE-BASED COMPOUND HAVING INHIBITORY EFFECT OF KETOHEXOKINASE (KHK)	MEDSHINE DISCOVERY INC.
WO/2021/129820	SPIRO RING-CONTAINING QUINAZOLINE COMPOUND	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/129824	NEW-TYPE K-RAS G12C INHIBITOR	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/129827	BENZO FUSED RING-BASED COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/129841	COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF	TYK MEDICINES, INC.
WO/2021/129843	USE OF TRIAZOLOTRIAZINE DERIVATIVE IN TREATMENT OF DISEASES	ZHEJING VIMGREEN PHARMACEUTICALS, LTD.
WO/2021/232791	METHOD FOR PREPARING EFFICIENT ANTI-TUMOR ACTIVE POLYPEPTIDE TUBULYSIN M	SHENZHEN INSTITUTE OF GERIATRICS
WO/2021/227512	METHOD FOR PREPARING NATURAL ACTIVE POLYPEPTIDE TUBULYSIN U	SHENZHEN INSTITUTE OF GERIATRICS
WO/2021/136121	METHOD FOR PREPARING CYSTEIC ACID-CONTAINING POLYPEPTIDE	JIANGSU GENSCRIPT BIOTECH CO., LTD.
WO/2021/143498	DEUCRAVACITINIB CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/139547	CHIMPANZEE ADENOVIRUS TYPE-3 (CHAD3)-BASED EXPRESSION VECTOR AND CONSTRUCTION METHOD THEREFOR	IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
WO/2021/129872	ANTI-OX40 ANTIBODY AND USE THEREOF	HIFIBIO (HK) LIMITED
WO/2021/104532	BREFELDIN A DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	OCEAN UNIVERSITY OF CHINA
WO/2021/129874	ANTI-OX40 ANTIBODY AND USE THEREOF	NANKAI UNIVERSITY
WO/2021/136197	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/196775	REDUCING AGENT MONOMER FOR PREPARING STYRENE-ACRYLIC EMULSION BY MEANS OF OXIDATION-REDUCTION AT NORMAL TEMPERATURE, AND SYNTHESIS METHOD THEREFOR	CHANGZHOU UNIVERSITY
WO/2021/196777	POLYMERIZABLE SURFACTANT WITH REDUCIBILITY AND PREPARATION METHOD THEREFOR	CHANGZHOU UNIVERSITY
WO/2021/136219	BTK INHIBITORS	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
WO/2021/147623	SIGNAL PEPTIDE MUTANT FOR IMPROVING SECRETION OF HETEROLOGOUS PROTEIN, CONSTRUCTION METHOD THEREFOR AND USE THEREOF	TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/136223	FUSION PROTEINS OF GLP-1 AND GDF15 AND CONJUGATES THEREOF	BEIJING QL BIOPHARMACEUTICAL CO., LTD.
WO/2021/136227	HETERODIMER INDUCED BY CH3 STRUCTURAL DOMAIN MODIFICATION, PREPARATION METHOD THEREFOR AND USE THEREOF	ZHOU, Yi
WO/2021/136238	FUSED RING COMPOUND AND APPLICATION THEREOF	WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/136244	TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	THE NATIONAL INSTITUTES OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT (NIP)
WO/2021/136249	BISPECIFIC ANTIBODY INDUCED BY FAB MODIFICATION, PREPARATION METHOD THEREFOR AND USE THEREOF	ZHOU, Yi
WO/2021/143511	N, O TYPE MULTIDENTATE FUNCTIONAL MONOMER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ION IMPRINTING MATERIAL	WUHAN SEPENRICH TECHNOLOGIES CO., LTD
WO/2021/136277	HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/136293	INSULIN DERIVATIVE	GAN & LEE PHARMACEUTICALS
WO/2021/136296	INSULIN DERIVATIVE	GAN & LEE PHARMACEUTICALS
WO/2021/136302	INSULIN DERIVATIVE	GAN & LEE PHARMACEUTICALS
WO/2021/136303	LONG-ACTING GLP-1 COMPOUND	GAN & LEE PHARMACEUTICALS
WO/2021/136308	ANTIBODIES BINDING BCMA AND USES THEREOF	BIOSION INC.
WO/2021/136323	ANTIBODIES BINDING BCMA AND USES THEREOF	SALUBRIS (CHENGDU) BIOTECH CO., LTD.
WO/2021/136326	ARYL AMIDE COMPOUND AND APPLICATION THEREOF IN MEDICINE	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/136333	METHOD FOR PREPARING COUMARIN COMPOUND, 3 POSITION OF WHICH IS SUBSTITUTED WITH AMIDOALKYL AND PRODUCTS AND RELATED INTERMEDIATES THEREOF	FOSUN ORINOVE PHARMATECH, INC.
WO/2021/136339	AMIDE COMPOUND WITH BICYCLIC STRUCTURE AND USE THEREOF IN DRUG	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/136345	JAK INHIBITOR COMPOUND AND USE THEREOF	LU, Liang
WO/2021/136354	BIPHENYL DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/253794	MAYTANSINE DERIVATIVE, SYNTHESIS METHOD THEREFOR AND USE THEREOF	SHAN DONG UNIVERSITY
WO/2021/136390	BLOOD COAGULATION FACTOR XIA INHIBITOR	SHANGHAI JINGXIN BIOMEDICAL CO., LTD.
WO/2021/136392	LAG-3 ANTIBODY AND MEDICAL USE THEREOF	SHANGHAI HAILU BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/136429	BENZOPYRAZOLE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/136431	BENZO[D][1,2,3]TRIAZOLE ETHER COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/136461	PURINE DERIVATIVE AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/136462	FURAN DERIVATIVES AND APPLICATION THEREOF IN MEDICINE	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/136463	PURINE DERIVATIVE AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/136464	NOVEL AMIDE COMPOUNDS AND USES THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/139595	RORγT INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/136475	A DRUG CONJUGATE AND APPLICATIONS THEREOF	GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
WO/2021/136477	COCRYSTAL OF DIHYDROCHLORIDE OF COMPOUND I AND PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/147642	METHODS, MODELS AND SYSTEMS RELATED TO ANTIBODY IMMUNOGENICITY	BIO-THERA SOLUTIONS, LTD.
WO/2021/136482	METHOD FOR PREPARING PF06651600 AND INTERMEDIATE USED THEREIN	JIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/136483	ANTI-TROP2 ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND APPLICATION OF THE SAME	GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
WO/2021/136489	ANTI PD-L1 ANTIBODY AND USE THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/136491	CRYSTALLINE FORM OF DIPEPTIDYL PEPTIDASE IV INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/136503	ANTI-GITR ANTIBODIES AND USES THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/139599	RORγT INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/136521	POLYPEPTIDE AND USE THEREOF	DONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/136538	ENHANCED CART CELL PROMOTING SOLID TUMOR INFILTRATION, PREPARATION METHOD THEREFOR, AND CELL MEDICATION THEREOF	EAST CHINA NORMAL UNIVERSITY
WO/2021/203768	PYRIMIDO DICYCLO DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/203772	ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 INHIBITORS,COMPOSITIONS AND USES THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/139615	METHOD FOR PREPARING TRETINOIN	SHANDONG LIANGFU PHARMACEUTICAL CO., LTD
WO/2021/169606	AVERMECTIN B2A DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA AGRICULTURAL UNIVERSITY
WO/2021/139621	METHOD FOR PREPARING GLYCOSIDE COMPOUND	SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED
WO/2021/136550	ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF	CAFA THERAPEUTICS LIMITED
WO/2021/143572	PREPARATION METHOD FOR PEGYLATED BIOMOLECULES HAVING CONTROLLABLE BINDING SITES	JENKEM TECHNOLOGY CO., LTD. (TIANJIN)
WO/2021/143573	DISUBSTITUTED PEGYLATED INTERLEUKIN 2, PREPARATION METHOD THEREFOR AND USE THEREOF	JENKEM TECHNOLOGY CO., LTD. (TIANJIN)
WO/2021/143576	LECTIN-MAGNETIC CARRIER CONJUGATE COMPLEX FOR ISOLATING GLYCOSYLATED EXOSOMES FROM CLINICAL SAMPLES	BEIJING HOTGEN BIOTECH CO, LTD.
WO/2021/139647	BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF	ABBISKO THERAPEUTICS CO., LTD.
WO/2021/190076	ANTI-TUMOR COMPOUND CAPABLE OF OVERCOMING CISPLATIN RESISTANCE, PREPARATION THEREFOR, AND APPLICATION THEREOF	SOUTHEAST UNIVERSITY
WO/2021/139678	PYRIDOPYRIMIDINE KRAS G12C MUTANT PROTEIN INHIBITOR	GUANGZHOU BIOTING PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/139682	ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF	HIFIBIO (HK) LIMITED
WO/2021/139687	APPLICATION OF COMBINATION OF ANTI-CD47 ANTIBODY AND ANTI-CD20 ANTIBODY IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING TUMORS	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/139698	T CELL RECEPTOR FOR IDENTIFYING HPV ANTIGEN AND CODING SEQUENCE THEREOF	XLIFESC, LTD.
WO/2021/139699	T CELL RECEPTOR FOR RECOGNIZING AFP AND CODING SEQUENCE THEREOF	XLIFESC, LTD.
WO/2021/139717	DEUTERATED THIENOPYRIDINE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/139720	PURIFICATION METHOD FOR ADALIMUMAB AND STABLE COMPOSITION THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/139740	TETRAHYDROCANNABINOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/139741	CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/139744	CONJUGATES OF FUSION PROTEINS OF GLP-1 AND FGF21	BEIJING QL BIOPHARMACEUTICAL CO., LTD.
WO/2021/143617	CYCLOHEXADIENE OXIME ETHER COMPOUND, SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF	ZHENGZHOU INSTITUTE OF CHIRAL DRUGS RESEARCH CO., LTD
WO/2021/139748	SPIROCYCLIC TETRAHYDROQUINAZOLINES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/139756	TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/139758	NEW POLYPEPTIDE COMPLEX	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/139761	PEPTIDE HAVING AFFINITY TO PD-1 AND APPLICATION THEREOF	ZHENGZHOU UNIVERSITY
WO/2021/139763	FGF21 MUTANT PROTEIN AND FUSION PROTEIN THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/139766	PEPTIDE INTERACTING WITH TOLL-LIKE RECEPTOR 2 AND THE COMPOSITION COMPRISING THE SAME	HUANG, Chih-Hung
WO/2021/139775	PYRIDONE COMPOUND AND APPLICATION	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/139776	ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME AND METHODS OF USING THE SAME	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139777	ANTI-TIGIT ANTIBODIES AND USAGE METHOD	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139780	ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME AND METHODS OF USING THE SAME	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139794	CRYSTAL FORM OF PYRROLIDINYL UREA DERIVATIVE AND APPLICATION THEREOF	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/139795	METHOD FOR PREPARING PYRROLIDINYL UREA DERIVATIVE	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/139797	ENTRECTINIB CRYSTAL FORM AND PREPARATION METHOD THEREFOR	ARIZEST (SHANGHAI) PHARMATECH CO., LTD.
WO/2021/258723	METHOD FOR SYNTHESIZING LITHOCHOLIC ACID WITH BA AS RAW MATERIAL	JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD.
WO/2021/155733	POLYPEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	FUDAN UNIVERSITY
WO/2021/139814	QUINOLINE IMIDAZOLE COMPOUND AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/248909	ISOQUINOLINE COMPOUND, MANUFACTURING METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/147697	SIDEROPHORE-DIHYDROFOLATE REDUCTASE INHIBITOR CONJUGATE AND APPLICATION THEREOF	JASAN BIO MEDICINE (JIAXING) CO., LTD
WO/2021/139817	POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR	HANGZHOU INNOGATE PHARMA CO., LTD.
WO/2021/147699	PYRIDOHETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/143677	FUSED RING SUBSTITUTED AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE THEREOF	QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.
WO/2021/143680	HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/143693	ARYL OR HETEROARYL PYRIDONE OR PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/143695	ANTI-TUMOR FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGDONG TAIHE MEDICINE SCIENCE & TECHNOLOGY CO., LTD
WO/2021/143701	PYRIMIDINE-4(3H)-KETONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE AND PHARMACOLOGY	BEIJING INNOCARE PHARMA TECH CO., LTD.
WO/2021/143706	SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS	ECCOGENE (SHANGHAI) CO., LTD.
WO/2021/143712	METHOD FOR PREPARING L-GLUFOSINATE-AMMONIUM INTERMEDIATE	LIER CHEMICAL CO., LTD.
WO/2021/143713	METHOD FOR PREPARING INTERMEDIATE OF L-GLUFOSINATE-AMMONIUM	LIER CHEMICAL CO., LTD.
WO/2021/143727	MICROORGANISM THAT PRODUCES LYSINE AND METHOD FOR PRODUCING LYSINE	TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/143729	COMPOUND, COMPOSITION AND FUNCTIONAL MOLECULE WITH MULTI-TARGET INHIBITING EFFECT AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/143733	FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF	DING, Bang
WO/2021/143753	ATX INHIBITOR BASED ON INDOLE MOTHER NUCLEUS, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/143762	NOVEL COMPOUNDS AS INHIBITORS OF PCSK9	SHENGKE PHARMACEUTICALS (JIANGSU) LTD.
WO/2021/143792	PIPERIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143801	AZABICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/143803	OPTICALLY PURE OXASPIRO-SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/169658	SMALL MOLECULE FLUORESCENT PROBE AND APPLICATION THEREOF IN CHROMOSOME ANALYSIS AND CYTOGENETICS	CHEN, Sijie
WO/2021/143810	POLYPEPTIDE COMPOUND AND USE THEREOF	ZHUHAI UNITED LABORATORIES CO., LTD.
WO/2021/143811	MEDICAL SALT OF TETRAZOLE COMPOUND AND CRYSTALLINE FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/143812	METHOD FOR PREPARING N-(β-L-RHAMNOPYRANOSYL)FERULAMIDE AND USE THEREOF	SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
WO/2021/143816	FUSED IMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/143819	CRYSTAL FORM OF POLYCYCLIC ANAPLASTIC LYMPHOMA KINASE INHIBITOR	SHANDONG XUANZHU PHARMA CO., LTD.
WO/2021/143821	FUSED HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/143822	BICYCLIC IMIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/143823	PYRIDINE OR PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/143829	NON-PERIPHERAL QUATERNARY AMMONIUM GROUP MODIFIED ZINC PHTHALOCYANINE AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF	FUZHOU UNIVERSITY
WO/2021/143841	PHARMACEUTICAL COMPOSITION OF TRICYCLIC PDE3/PDE4 DUAL INHIBITOR COMPOUND	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/143843	CRYSTAL OF PDE3/PDE4 DUAL INHIBITOR AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/169661	4-POSITION CATION DOUBLE SUBSTITUTED BODIPY COMPOUNDS, PREPARATION METHODS THEREFOR, AND USE THEREOF	FUDAN UNIVERSITY
WO/2021/143853	TETRAHYDRONAPHTHO[1,2-B]FURAN-2(3H)-ONE COMPOUND AND CRYSTAL RESEARCH THEREOF	SHANGHAI QINGDONG BIOTECHNOLOGY CO., LTD.
WO/2021/143858	ANTI-NKp30 ANTIBODIES AND METHODS OF USE	BEIGENE, LTD.
WO/2021/143875	CRYSTAL FORM OF AZAINDOLE DERIVATIVE AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/143885	FUSED TETRACYCLIC COMPOUND AND APPLICATION THEREOF IN MEDICINE	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/159918	SUPERFLUORESCENT CERIUM (III)-CONTAINING CHELATE APPLICABLE TO PHOTOELECTRIC DEVICES AND HAVING A DUAL CAPTURE MECHANISM AND ULTRA-SHORT DECAY TIME	SICHUAN KNOWLEDGE EXPRESS INSTITUTE FOR INNOVATIVE TECHNOLOGIES CO., LTD
WO/2021/147790	PYRAZOLO[1,5-A]PYRAZINE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
WO/2021/143898	NEW CRYSTAL FORM OF COMPLEX OF ARB METABOLITE AND NEP INHIBITOR AND METHOD FOR PREPARATION THEREOF	SHENZHEN SALUBRIS PHARMACEUTICALS CO.LTD
WO/2021/143902	METHOD AND ANTIBODY FOR DETECTING HBCAG	XIAMEN INNODX BIOTECH CO., LTD
WO/2021/147818	5-HT2A RECEPTOR ANTAGONIST AND APPLICATION THEREOF IN TREATING CENTRAL NERVOUS SYSTEM DISEASES	HAN YUAN MEDI-PHARM CO., LTD.
WO/2021/147829	A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF	WUXI BIOLOGICS (SHANGHAI) CO. LTD.
WO/2021/143914	ACTIVATED ANTI-OX40 ANTIBODY, PRODUCTION METHOD THEREFOR AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/147837	ANTI-LAG3 MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/143922	CRYSTAL FORM AND SALT FORM OF BROMINE DOMAIN PROTEIN INHIBITOR AND PREPARATION METHOD THEREFOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/169673	PD-1-BASED VACCINES AGAINST CORONAVIRUS INFECTION	VERSITECH LIMITED
WO/2021/147846	PHARMACEUTICAL COMPOSITION CONTAINING ANTI-BTLA ANTIBODY AND USE THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/143923	BORONIC ACID DERIVATIVES	SHOUYAO HOLDINGS (BEIJING) CO., LTD.
WO/2021/143924	BORIC ACID DERIVATIVE	SHOUYAO HOLDINGS (BEIJING) CO., LTD.
WO/2021/143925	DIARYLTHIOHYDANTOIN COMPOUND AS AR ANTAGONIST	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/143927	COMPOUND ACTING AS BCR-ABL INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/147857	A NOVEL WASH BUFFER SOLUTION FOR AFFINITY CHROMATOGRAPHY	WUXI BIOLOGICS (SHANGHAI) CO., LTD
WO/2021/143931	SPECIFIC HOST FACTOR FOR HEPATITIS B VIRUS INFECTION AND USE THEREOF	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/143932	SPECIFIC HOST FACTOR OF HEPATITIS B VIRUS INFECTION, AND USE THEREOF	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/143934	MULTISPECIFIC ANTI-CLAUDIN-18.2 CONSTRUCTS AND USES THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/147869	LIRAGLUTIDE DERIVATIVE AND PREPARATION METHOD THEREFOR	NINGBO KUNPENG BIOTECH CO., LTD.
WO/2021/147879	SHP2 INHIBITOR AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/115494	NOVEL CRYSTALLINE FORMS OF FLUFENACET, METHODS FOR THEIR PREPARATION AND USE OF THE SAME	JIANGSU ROTAM CHEMISTRY CO., LTD
WO/2021/175029	A NOVEL FORM OF METRAFENONE, A PROCESS FOR ITS PREPARATION AND USE OF THE SAME	JIANGSU ROTAM CHEMISTRY CO., LTD
WO/2021/147882	DIBENZOFURAN DERIVATIVE CATHEPSIN K INHIBITOR, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
WO/2021/147886	PHARMACEUTICAL COMPOSITION AND USE THEREOF	ZHANG, Jinyu
WO/2021/147889	ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	KANGPU BIOPHARMACEUTICALS, LTD.
WO/2021/147894	PREPARATION METHOD FOR GLUFOSINATE AMMONIUM	LIER CHEMICAL CO., LTD.
WO/2021/147909	5HT2A RECEPTOR ANTAGONIST AND MEDICAL APPLICATION THEREOF	HANG YUN MEDICAL TECHNOLOGIES CO., LTD.
WO/2021/147917	APPLICATION OF SYSTEMATIC TARGETING MOLECULE AND DRUG COMPLEX THEREOF IN CONSTRUCTING DRUG DELIVERY SYSTEM	FUDAN UNIVERSITY
WO/2021/147929	MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF	NANJING BIOHENG BIOTECH CO., LTD
WO/2021/159939	FULLY HUMAN MONOCLONAL ANTIBODY AGAINST COMPLEMENT C3 MOLECULES AND APPLICATION THEREOF	BEIJING COMPLEMENT THERAPEUTICS. LTD
WO/2021/147937	ANTI-ST2 ANTIBODY AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/147940	PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD.
WO/2021/147941	BCMA-BINDING PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	HARBOUR BIOMED (SUZHOU) CO., LTD.
WO/2021/147947	SYNTHESIS AND USE OF CLASS OF RESPIRATORY SYNCYTIAL VIRUS INHIBITORS	SUZHOU ARK BIOPHARMACEUTICAL CO., LTD
WO/2021/147952	PYRIMIDOPYRROLE COMPOUND	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/147953	PYRIMIDO FIVE-MEMBERED RING DERIVATIVE AND APPLICATION THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/147954	SEMG2 ANTIBODY AND USE THEREOF	SHANGHAI BIOTROY BIOTECHNIQUE CO., LTD.
WO/2021/147965	MACROCYCLIC COMPOUND SERVING AS KRAS INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/147967	MACROCYCLIC COMPOUND SERVING AS KRAS INHIBITOR	MEDSHINE DISCOVERY INC.
WO/2021/147968	IRAK4 INHIBITOR CRYSTAL AND PREPARATION METHOD THEREFOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/147971	COMPOUND FOR TREATING ALZHEIMER’S DISEASE	XIAMEN UNIVERSITY
WO/2021/147974	NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/147982	AMORPHOUS FORM OR CRYSTALLINE FORM OF 2-INDOLINOLINOLOLYLSPIRONONE COMPOUNDS OR THEIR SALTS, SOLVENT COMPLEXES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/147984	ANTI-ANGPTL3 ANTIBODY AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/147986	CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/147993	ANTI-TROP-2 ANTIDODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/147996	SALT OF ARYLAMINOPURINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/148006	HETERODIMERIC PROTEINS WITH FC MUTATIONS	ADAGENE AG
WO/2021/148010	PYRAZOLO HETEROARYL RING COMPOUND AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/159946	HUMANIZED SINGLE-CHAIN ANTIBODY AGAINST COMPLEMENT C3 MOLECULE AND APPLICATION THEREOF	BEIJING COMPLEMENT THERAPEUTICS.LTD
WO/2021/104542	USE OF RICE GENE OSATL15 IN ADJUSTING PESTICIDE ABSORPTION AND TRANSPORT	SOUTH CHINA AGRICULTURAL UNIVERSITY
WO/2021/115495	SMALL-MOLECULE SULFUR-CONTAINING HETEROCYCLIC COMPOUND	VIVAVISION BIOTECH, INC.
WO/2021/184958	ANGIOGENESIS INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
WO/2021/148032	PREPARATION OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE INHIBITOR AND USE THEREOF	ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/208559	LEAD COMPOUND TARGETING INTERACTION BETWEEN IMMUNE NODES PD-1 AND SHP-2 AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/253833	HYDRATE ACCELERATOR, HYDRATE AND PREPARATION METHOD THEREFOR	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/232846	ZWITTERIONIC POLYPEPTIDE AND DERIVATIVES THEREOF, AND NANO-DRUG BASED ON SAME	ZHEJIANG UNIVERSITY
WO/2021/244051	11-O-MOGROL OXIME ETHER DERIVATIVE AND PREPARATION METHOD THEREFOR	HUNAN HUACHENG BIOTECH, INC
WO/2021/164521	FULLY HUMANIZED MONOCLONAL ANTIBODY THAT RESISTS COMPLEMENT C5 MOLECULE AND APPLICATION THEREOF	BEIJING COMPLEMENT THERAPEUTICS.LTD
WO/2021/155766	POLYMORPH OF EP4 RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI YUYAO BIOTECH LTD.
WO/2021/164527	HUMANIZED SINGLE-CHAIN ANTIBODY OF ANTI-COMPLEMENT C5 MOLECULE AND APPLICATION THEREOF	BEIJING COMPLEMENT THERAPEUTICS. LTD
WO/2021/203811	BENZOTHIAZINONE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF AS ANTI-TUBERCULOSIS DRUG	SOOCHOW UNIVERSITY
WO/2021/203812	BENZOTHIAZINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF AS ANTI-TUBERCULOSIS DRUG	SOOCHOW UNIVERSITY
WO/2021/258733	10-UNDECYLENYLAMINO METHYL ETHYL PROPIONATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN REPELLING MOSQUITOS	INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/190142	ANTI-TUMOR COMPOUNDS, AND PREPARATION AND USE THEREOF	SOUTHEAST UNIVERSITY
WO/2021/203816	METHOD FOR PRODUCING AROMATIC HYDROCARBON AND/OR LIQUID FUEL FROM LIGHT HYDROCARBON	CHINA ENERGY INVESTMENT CORPORATION LIMITED
WO/2021/159993	INHIBITORS OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE (IRAK) /FMS-LIKE RECEPTOR TYROSINE KINASE (FLT3), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/164538	MULTI-TARGET TYROSINE KINASE INHIBITOR	SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD.
WO/2021/155781	BENZENE SULFONAMIDE COMPOUND CONTAINING FIVE-MEMBERED HETEROCYCLE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCE
WO/2021/143936	INDOLE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143937	PYRROLE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/148043	NITROPHENYL ETHER COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/155791	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/129891	POLYPEPTIDE ABLE TO BIND WITH CD4 AND USE THEREFOR	Y-CLONE MEDICAL SCIENCE CO. LTD
WO/2021/110181	POLYPEPTIDE ABLE TO BIND WITH CD47 AND USE THEREFOR	Y-CLONE MEDICAL SCIENCE CO. LTD
WO/2021/169762	NEUTRAL MITOCHONDRIAL FLUORESCENCE MARKER BASED ON NITROGEN-CONTAINING HETEROCYCLE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/160012	SMALL MOLECULAR COMPOUND SPECIFICALLY DEGRADING TAU PROTEIN AND USE THEREOF	SHANGHAI QIANGRUI BIOTECH CO., LTD.
WO/2021/179861	ADENO-ASSOCIATED VIRUS VECTOR AND USE THEREOF	HUIGENE THERAPEUTICS CO., LTD.
WO/2021/175079	P-PHENYLENEDIAMINE LSD1 INHIBITOR AND PREPARATION METHOD THEREFOR	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/164572	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/218275	METHOD FOR SYNTHESIZING AND REFINING 4-FLUOROBENZOYLACETONITRILE	NANJING YUANSHU PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/169768	METHOD FOR IN VITRO ASSEMBLY OF VIRUS-LIKE PARTICLES OF FOOT-AND-MOUTH DISEASE AND USE THEREOF	LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES
WO/2021/155830	ANTI-HPV T CELL RECEPTORS AND ENGINEERED CELLS	TCRCURE BIOPHARMA CORP.
WO/2021/169769	AROMATIC COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/155841	HETEROCYCLIC GLP-1 AGONISTS	GASHERBRUM BIO, INC.
WO/2021/164576	ANTI-CORONAVIRUS INFECTION MEDICINE AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/160038	CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF	SICHUAN UNIVERSITY
WO/2021/179866	APPLICATION OF N-BUTYLLITHIUM IN CATALYZING CYANOSILYLATION REACTION OF KETONE AND SILANE	SOOCHOW UNIVERSITY
WO/2021/179867	USE OF N-BUTYLLITHIUM FOR CATALYZING CYANOSILANIZATION REACTION OF ALDEHYDE AND SILANE	SOOCHOW UNIVERSITY
WO/2021/129894	TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR	VONSUN PHARMATECH CO., LTD.
WO/2021/155861	HUMAN THYMUS STROMAL LYMPHOPOIETIN MONOCLONAL ANTIBODY AND APPLICATION THEREOF	IPHASE THERAPEUTICS LIMITED
WO/2021/155864	COMPOUNDS AND PHARMACEUTICAL USES THEREOF	SYNEURX INTERNATIONAL (TAIWAN) CORP.
WO/2021/253846	DEPROTONATED β-KETIMINE LITHIUM COMPOUND AND PREPARATION METHOD THEREFOR	SOOCHOW UNIVERSITY
WO/2021/253847	USE OF DEPROTONATED PHENYL BRIDGED Β-KETIMINE LITHIUM COMPOUND IN HYDROBORATION REACTION	SOOCHOW UNIVERSITY
WO/2021/238302	INTERLEUKIN 29 MUTANT PROTEIN	SCIWIND BIOSCIENCES CO., LTD.
WO/2021/160087	QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/212974	RACEMIC AND CHIRAL 3-(2,3-BUTADIENYL)OXYINDOLINONE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	FUDAN UNIVERSITY
WO/2021/160109	DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	GENFLEET THERAPEUTICS (SHANGHAI) INC.
WO/2021/160116	ANTI-FCRN ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF	BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/160127	HETEROCYCLIC GLP-1 AGONISTS	GASHERBRUM BIO, INC.
WO/2021/164661	2-PHENYLCYCLOPROPYLMETHYLAMINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/164663	GLP-1 AGONIST POLYPEPTIDE COMPOUND AND SALT THEREOF, SYNTHESIS METHOD THEREFOR AND USE THEREOF	SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
WO/2021/160132	HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD.
WO/2021/164665	ARGININE FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/164666	TRYPTOPHAN OPTICAL PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/164668	PYRUVIC ACID OPTICAL PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/160133	ANTI-BCMA ANTIBODY, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF	HUNAN ACEMAB CORPORATION LIMITED
WO/2021/179880	NITROGEN-CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE AND APPARATUS COMPRISING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/160134	PREPARATION METHOD FOR AND CRYSTAL FORM OF 3-ARYLOXY-3-FIVE-MEMBERED HETEROARYL-PROPYLAMINE COMPOUND	ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
WO/2021/160138	ANTIGEN BINDING PROTEIN OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR AND APPLICATION THEREOF	ZHANG, Xitian
WO/2021/160146	IMMUNE CHECKPOINT TIM3-TARGETING BINDING PEPTIDE AND APPLICATION THEREOF	BEIJING INSTITUTE FOR CANCER RESEARCH
WO/2021/160147	USE OF PYRIDO[1,2-A]PYRIMIDINONE COMPOUND IN TREATING LYMPHOMA	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/164677	INHIBITOR CAPABLE OF RESISTING FUSION OF RESPIRATORY SYNCYTIAL VIRUS	CHENGDU AODA BIOTECHNOLOGY CO., LTD
WO/2021/160153	HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF	SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD.
WO/2021/160154	CLDN18.2 ANTIBODY AND USE THEREOF	SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD.
WO/2021/160155	CLAUDIN 18.2 ANTIBODY AND USE THEREOF	SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD.
WO/2021/164692	ISOLATED PROTEIN THAT BINDS TO ANTIGEN PSMA AND USE THEREOF	HARBOUR BIOMED (SHANGHAI) CO., LTD
WO/2021/164694	ANTIBODY SCREENING METHOD	INSTITUTE OF BIOPHYSICS, CHINESE ACADEMY OF SCIENCES
WO/2021/164697	SUBSTITUTED AMIDE DERIVATIVE AND COMPOSITION THEREOF AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/164701	FUSION PROTEINS AND USES THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/179884	OLEANOLIC ACID DERIVATIVE HAVING CONJUGATED DIENE STRUCTURE C RING, AND PREPARATION METHOD THEREFOR AND USE THEREOF	DING, Ye
WO/2021/164718	2,6-DISUBSTITUTED 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, AND PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	KPC PHARMACEUTICALS, INC
WO/2021/164722	ANTI-IL-2 ANTIBODY, AND ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164735	HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/164741	PHENYL BISAMIDE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/164742	QUINOLINE COMPOUNDS	GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
WO/2021/164746	SUBSTITUTED ARYL COMPOUND	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/164749	INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR TYROSINE KINASE INHIBITOR AND USES THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/164765	PREPARATION AND USE OF IMMUNOSTIMULATORY COUPLING COMPLEX WHICH IS DELIVERED AND ACTIVATED IN TARGETED MANNER	YAFEI SHANGHAI BIOLOGY MEDICINE SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/164768	CROSS-LINKING LIGAND, METHOD FOR PATTERNING NANOPARTICLE LAYER, QUANTUM DOT LIGHT-EMITTING DEVICE AND DISPLAY DEVICE	BOE TECHNOLOGY GROUP CO., LTD.
WO/2021/175123	1,4-NAPHTHOQUINONE COMPOUND FOR RESISTING NOVEL CORONAVIRUS AND MEDICAL USE THEREOF	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/164786	CRYSTALLINE FORM OF JAK INHIBITOR AND APPLICATION THEREOF	ZHUHAI UNITED LABORATORIES CO., LTD.
WO/2021/169913	PDE4 INHIBITOR COMPOUND AND MEDICAL USE THEREOF	SUZHOU LONGBIOTECH PHARMACEUTICALS CO., LTD.
WO/2021/164789	CRYSTAL FORM OF PYRAZOLOPYRIMIDINE COMPOUND AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/169925	FUSION PROTEIN AND APPLICATION THEREOF	SHANDONG SHUNFENG BIOTECHNOLOGY CO., LTD.
WO/2021/169929	IMPURITY REMOVAL AND PURIFICATION METHOD FOR BONDED STATE AROMATIC SUBSTANCE	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/169932	HUMANIZED MONOCLONAL ANTIBODY FOR 2019 NOVEL CORONAVIRUS AND USE THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/169933	NOVEL USE OF MULTIKINASE INHIBITOR	NANJING TRANSTHERA BIOSCIENCES CO., LTD.
WO/2021/169934	MRI CONTRAST AGENT, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGZHOU PINGLAN MEDICAL TECHNOLOGY CO., LTD.
WO/2021/169948	TIM3 BINDING MOLECULE AND APPLICATION THEREOF	SUZHOUEVERHEALTH BIOMEDICAL CO, .LTD
WO/2021/169958	1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2	OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD.
WO/2021/169963	AROMATIC COMPOUND AND USE THEREOF IN PREPARING ANTINEOPLASTIC DRUGS	SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD.
WO/2021/169977	NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF	NANJING BIOHENG BIOTECH CO., LTD
WO/2021/169982	ANTIBODY TARGETING EPCAM, AND PREPARATION AND APPLICATION THEREOF	HARBOUR BIOMED (SHANGHAI) CO., LTD
WO/2021/169986	A BIFUNCTIONAL FUSION PROTEIN AND USES THEREOF	WUXI BIOLOGICS (SHANGHAI) CO. LTD.
WO/2021/169990	KRAS INHIBITORS FOR TREATING CANCERS	TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
WO/2021/170001	OXALIPLATIN-FLAVONOID DRUG EUTECTIC CRYSTAL, PREPARATION METHOD THEREFOR AND USE THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/208602	BENZOTRIAZOLE DERIVATIVE CORROSION INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	ANMEI TECHNOLOGY CO., LTD
WO/2021/170008	NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/218319	PREPARATION AND APPLICATION OF BENZIMIDAZOLE DERIVATIVE HAVING FLUORINE-CONTAINING SUBSTITUENT	YUNBAIYAO ZHENGWU SCIENTIFIC (SHANGHAI) CO. LTD.
WO/2021/170020	ANTIBODIES BINDING IL4R AND USES THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/170021	GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/170034	AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	INNORNA CO., LTD.
WO/2021/175147	PROSTATE-SPECIFIC MEMBRANE ANTIGEN-BINDING LIGAND CONJUGATE AND APPLICATION THEREOF	SHANGHAI THERAGNOVA MEDICAL TECHNOLOGIES CO., LTD
WO/2021/238312	METHOD FOR PURIFYING PROGESTERONE	ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
WO/2021/170046	TYK-2 INHIBITOR	BEIGENE, LTD.
WO/2021/203861	ANTI-IGF-1R ANTIBODY AND APPLICATIONS THEREOF	SUZHOU PRO-HEAL PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/175155	THIENOPYRIMIDINE DERIVATIVE AND PREPARATION METHOD THEREFOR	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/170067	ANTI-CD137 CONSTRUCT AND USE THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170068	ANTI-CD137 CONSTRUCTS, MULTISPECIFIC ANTIBODY AND USES THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170070	USES OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR	NANJING TRANSTHERA BIOSCIENCES CO., LTD.
WO/2021/170071	ANTI-CD137 CONSTRUCTS, MULTISPECIFIC ANTIBODY AND USES THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/160185	MOLECULARLY MODIFIED STRUCTURES OF GLP-1R ACTIVATORS AND USE OF DIMERS THEREOF IN TREATING METABOLIC DISEASES	NANJING FINEPEPTIDE BIOPHARMACEUTICAL CO., LTD
WO/2021/170076	COMPOUNDS AS CDK2/4/6 INHIBITORS	FOCHON PHARMACEUTICALS, LTD.
WO/2021/170077	COMBINATION OF ANTI-DC47 ANTIBODY AND ANTI-VEGF ANTIBODY AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/185051	FUSION PROTEIN WITH SIGNIFICANTLY PROLONGED HALF-LIFE FOR TREATMENT OF OCULAR ANGIOGENESIS DISEASES	ZHEJIANG DOER BIOLOGICS CORPORATION
WO/2021/170082	ANTI-CD47/ANTI-PD-L1 ANTIBODY AND APPLICATIONS THEREOF	NANJING SANHOME PHARMACEUTICAL CO., LTD.
WO/2021/203864	INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF	ZHEJIANG DOER BIOLOGICS CORPORATION
WO/2021/170109	TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE	CULLGEN (SHANGHAI) , INC.
WO/2021/170111	TUMOR IMMUNE ENHANCER, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	WUXI PLB THERAPEUTICS TECHNOLOGY LIMITED. CO
WO/2021/170113	METHOD FOR TREATING CORONAVIRUS BY USING ACE-2-FC FUSION PROTEIN	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/170115	T-CELL RECEPTOR RECOGNIZING HPV	XLIFESC, LTD.
WO/2021/170116	T CELL RECEPTOR RECOGNIZING AFP	XLIFESC, LTD.
WO/2021/170117	T CELL RECEPTOR RECOGNIZING AFP ANTIGEN SHORT PEPTIDE AND ENCODING SEQUENCE THEREOF	XLIFESC, LTD.
WO/2021/253868	METHOD FOR HYDROBORATION OF CARBONATE	SOOCHOW UNIVERSITY
WO/2021/170131	SOLUBLE ACE2 AND FUSION PROTEIN, AND APPLICATIONS THEREOF	HUAHUI HEALTH LTD.
WO/2021/175173	PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA AND FORMULATION CONTAINING THE PHARMACEUTICAL COMPOSITION	GUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/175183	BORON CARRYING AGENT FOR INTEGRATED TUMOR DIAGNOSIS AND TREATMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	PEKING UNIVERSITY
WO/2021/175191	ANTI-TIM-3 ANTIBODY AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/175196	PYRROLIDINE INTEGRIN MODULATOR AND USE THEREOF	T2YC CO., LTD.
WO/2021/170146	PREPARATION OF NEW-TYPE ANTI-CD19 ANTIBODY AND CD19-CAR-T CELL, AND USE THEREOF	FUZHOU TCELLTECH BIOTECHNOLOGY CO., LTD.
WO/2021/175199	AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF IN DRUG	SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD.
WO/2021/196949	CRYSTALLINE FORM A OF GLP-1 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
WO/2021/185072	CRYSTAL FORM OF AROMATIC VINYL DERIVATIVES, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/196951	PHARMACEUTICALLY ACCEPTABLE ACID SALT OF FREE BASE OF GLP-1 RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR	HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD.
WO/2021/175223	BENZO 2-AZASPIRO[4.4]NONANE COMPOUND AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/175224	ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/175225	TRICYCLIC COMPOUNDS AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/175234	BENZOTHIAZOLE COMPOUND AND MEDICAL USE	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/175249	QUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANDONG UNITED PESTICIDE INDUSTRY CO., LTD.
WO/2021/175251	QUANTUM DOT LIGAND AND PREPARATION METHOD THEREFOR, LIGHT-EMITTING DEVICE AND PREPARATION METHOD THEREFOR, AND DISPLAY DEVICE	BOE TECHNOLOGY GROUP CO., LTD.
WO/2021/175270	NOVEL HPK1 INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/175271	NOVEL HPK1 INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/175283	SYNTHESIS OF NOVEL EP4 ANTAGONIST AND USE IN CANCERS AND INFLAMMATIONS	HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE INC.
WO/2021/175290	HETEROCYCLIC COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/175296	INTERMEDIATE OF REMDESIVIR AND PREPARATION METHOD THEREFOR	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/179996	SOLID FORM OF CITRATE OF IMIDAZOPYRAZINE COMPOUND	CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
WO/2021/180002	METHOD FOR PREPARING ALKYL HYDROXYL ACID ESTER AND USE THEREOF	HUANG, Edwin, W.
WO/2021/180006	VINYL-SUBSTITUTED PYRIDINE COMPOUNDS	MEDSHINE DISCOVERY INC.
WO/2021/175316	AMINO PYRIMIDO PYRAZOLE OR PYRROLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/175317	CRYSTAL OF TRICYCLIC COMPOUND ACTING ON CRBN PROTEIN AND PREPARATION METHOD THEREFOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/180008	TRI-AROMATIC RING COMPOUND CONTAINING UREA STRUCTURE AND USE THEREOF	JINAN UNIVERSITY
WO/2021/175321	CRYSTALLINE FORMS OR AMORPHOUS FORMS OF N- (PHENYL SULFONYL) BENZAMIDE COMPOUNDS OR ITS SALTS OR SOLVATES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/238328	COMPOUND CONTAINING HYDROXAMIC ACID, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/180023	ELASTASE INHIBITOR PRODRUG AND USE THEREOF	SUZHOU ARK BIOPHARMACEUTICAL CO., LTD
WO/2021/244089	SARS-COV-2 SPIKE PROTEIN BINDING MOLECULE AND APPLICATION THEREOF	SHENZHEN IMMUNOTHERAPY BIOTECH CO., LTD.
WO/2021/180040	BENZO FIVE-MEMBERED CYCLIC COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/180072	HETEROCYCLIC COMPOUNDS FOR INHIBITING TYK2 ACTIVITIES	BEIJING INNOCARE PHARMA TECH CO., LTD.
WO/2021/180080	COMPOUND FOR TREATING MYOPIC EYE AND PREPARATION METHOD THEREFOR	ANHUI HEALSTAR PHARMACEUTICAL CO., LTD
WO/2021/180081	DEUTERATED PENTAZOCINE, PREPARATION METHOD THEREFOR AND USE THEREOF	ANHUI HEALSTAR PHARMACEUTICAL CO., LTD
WO/2021/180088	AFRICAN SWINE FEVER VIRUS CHIMERIC PROTEIN, VACCINE COMPOSITION, PREPARATION METHOD, AND APPLICATION	PULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/180093	USE OF PYRROLOPYRIMIDINE COMPOUND FOR TREATING HEMOPHAGOCYTIC SYNDROME	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/180103	DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE	BEIGENE, LTD.
WO/2021/180107	COMPOUNDS USEFUL AS KINASE INHIBITORS	FOCHON PHARMACEUTICALS, LTD.
WO/2021/180111	PHARMACEUTICAL COMBINATION COMPRISING PYRIDINO[1,2-A]PYRIMIDINONE COMPOUND	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/180143	JAK KINASE INHIBITOR AND PREPARATION AND APPLICATION THEREOF	MINGHUI PHARMACEUTICAL (SHANGHAI) LIMITED
WO/2021/180147	INFLUENZA VIRUS INHIBITOR	BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD
WO/2021/180150	METHOD FOR PRODUCING LIGHT OLEFIN FROM OXYGEN-CONTAINING COMPOUND	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/180160	BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF	SUZHOU KINTOR PHARMACEUTICALS, INC.
WO/2021/180181	PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/180193	PYRAZOLE CARBOXYLATE COMPOUND AND USE THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/180195	METHOD FOR CONVERTING METHANOL IN FLUIDIZED BED REACTOR	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/185168	METHANOL-TO-OLEFIN CONVERSION METHOD	CHINA PETROLEUM & CHEMICAL CORPORATION
WO/2021/258784	L-2-HYDROXYGLUTARATE BIOSENSOR BASED ON SPECIFIC TRANSCRIPTIONAL REGULATION FACTOR, AND USE THEREOF	SHANDONG UNIVERSITY
WO/2021/180215	GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/180218	MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF	PEKING UNIVERSITY
WO/2021/227641	METHOD FOR PREPARING CHIRAL 4-ARYL-β-AMINO ACID DERIVATIVE	ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY
WO/2021/180233	POLYPEPTIDE, POLYPEPTIDE VACCINE AND APPLICATION THEREOF	ICARBONX (ZHUHAI) COMPANY LIMITED
WO/2021/185192	TEGOPRAZAN ANALOGUES AND SYNTHETIC METHOD THEREOF	HK INNO.N CORPORATION
WO/2021/160188	NOVEL MODIFIED STRUCTURE OF GROWTH HORMONE RELEASE HORMONE-LIKE PEPTIDE AND DIMERIZATION PREPARATION AND USE THEREFOR	NANJING FINEPEPTIDE BIOPHARMACEUTICAL CO., LTD
WO/2021/180235	INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/190337	SALT FORM AND CRYSTAL FORM OF COMPOUND AS SMO INHIBITOR, AND PREPARATION METHOD THEREFOR	GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
WO/2021/180238	COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF	TYK MEDICINES (ZHENGZHOU), INC.
WO/2021/190346	FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF	FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD.
WO/2021/185233	KRAS MUTANT PROTEIN INHIBITORS	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/143954	CRYSTALLINE FORM OF FLUVATINIB OR FLUVATINIB METHANESULFONATE AND PREPARATION METHOD THEREFOR	CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD
WO/2021/185238	FUSED BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/197051	METHOD FOR EFFICIENTLY SEPARATING AND PURIFYING RECOMBINANT HUMAN COAGULATE FACTOR VIII FC FUSION PROTEIN	AMPSOURCE BIOPHARMA SHANGHAI INC.
WO/2021/185256	SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/197057	SYNTHESIS METHOD FOR SYNTHESIZING OXETANE DERIVATIVE BY MICROREACTOR	CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD.
WO/2021/197058	METHOD FOR SYNTHESIZING OXETANE COMPOUND BY MICROREACTOR	CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD.
WO/2021/213087	ETHOXY/PROPOXY MODIFIED PYRAZOLINE ORGANIC MATTER, APPLICATION THEREOF, PHOTOCURABLE COMPOSITION, AND PHOTORESIST	CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD.
WO/2021/213088	SYSTEM AND METHOD FOR CONVERTING LIGHT ALKANE INTO AROMATIC COMPOUND	CHINA ENERGY INVESTMENT CORPORATION LIMITED
WO/2021/197063	OLIGOPEPTIDE HAVING BLOOD PRESSURE REDUCING EFFECT, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOUTH CHINA AGRICULTURAL UNIVERSITY
WO/2021/185273	SIRPα-TARGETING ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, AND PREPARATION AND APPLICATION THEREOF	L&L BIOPHARMA CO., LTD.
WO/2021/190380	ORGANIC COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/185291	PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME	MEDSHINE DISCOVERY INC.
WO/2021/185297	EGFR TYROSINE KINASE INHIBITOR AND USE THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/185298	EGFR TYROSINE KINASE INHIBITOR AND USE THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/185304	METHOD FOR PREPARING LONG ALIPHATIC CHAIN DIACID DERIVATIVE AND APPLICATION THEREOF	DONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/185305	INDAZOLE DERIVATIVE AND MEDICAL USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/203938	COMPOUND FOR TREATING GOUT, PREPARATION METHOD THEREFOR, AND USE THEREOF	NKD PHARMA CO., LTD
WO/2021/185312	CRYSTALLINE FORM OF TLR8 AGONIST	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/175335	ISOPAUCIFLORAL F PHOSPHATE COMPOUND AND PHARMACEUTICAL USE THEREOF	FUDAN UNIVERSITY
WO/2021/185335	HYDROPHILIC DIISOCYANATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	FOSHAN JINGXIN HUIMING TECHNOLOGY CO., LTD.
WO/2021/185337	BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF	REMEGEN CO., LTD.
WO/2021/185346	ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF	TSB THERAPEUTICS (BEIJING) CO. LTD.
WO/2021/185348	SUBSTITUTED ACRYLAMIDE DERIVATIVE AND COMPOSITION AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/190413	COMPOUND FOR TARGETED DEGRADATION OF FOCAL ADHESION KINASE AND MEDICAL APPLICATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/185361	INTERLEUKIN-2 MUTANT AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/185362	INTERLEUKIN-2 MUTANT AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/190417	NOVEL AMINOPYRIMIDINE EGFR INHIBITOR	QILU PHARMACEUTICAL CO., LTD.
WO/2021/185368	HIGH-AFFINITY TCR FOR RECOGNIZING AFP ANTIGEN	XLIFESC, LTD.
WO/2021/227655	COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE	BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD
WO/2021/190425	TRANSFORMING GROWTH FACTOR-β RECEPTOR INHIBITOR	ADLAI NORTYE BIOPHARMA CO., LTD.
WO/2021/190431	DEVELOPMENT AND APPLICATION OF IMMUNE CELL ACTIVATOR	BIO-THERA SOLUTIONS, LTD.
WO/2021/190437	ANTIBODIES AGAINST AREG AND ITS USE	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/190441	CD47/HUMANIZED CD47 ANTIBODY OR ANTIGEN BINDING FRAGMENT OR IMMUNOLOGICALLY ACTIVE FRAGMENT THEREOF AND USE THEREOF	BETAPHARMA (SUZHOU) , LTD.
WO/2021/218491	NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/213109	ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/213111	SNAIL INHIBITOR, DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/190467	SPIRO RING-CONTAINING QUINAZOLINE COMPOUND	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/190480	ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/190500	PREPARATION AND APPLICATION OF CROSS-NEUTRALIZING ANTIBODY OF SARS-COV-2 AND SARS-COV	SINOCELLTECH LIMITED
WO/2021/190502	PYRIDOPYRIMIDINONE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/232932	PREPARATION METHOD FOR HIGH-PURITY GRANATIN A	XINJIANG TECHNICAL INSTITUTE OF PHYSICS & CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/190550	CHIMERIC ANTIGEN RECEPTOR CONTAINING PROTECTIVE PEPTIDE, AND USE THEREOF	SHANGHAI SIMNOVA BIOTECHNOLOGY CO., LTD.
WO/2021/190551	CHIMERIC ANTIGEN RECEPTOR THAT BINDS TO CD19 AND USE THEREOF	SHANGHAI SIMNOVA BIOTECHNOLOGY CO., LTD.
WO/2021/197159	MACROCYCLIC COMPOUNDS THAT SERVE AS DNA-PK INHIBITORS	MEDSHINE DISCOVERY INC.
WO/2021/190564	ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/190565	CARBAZOLE OXIME ESTER COMPOUND, PREPARATION METHOD, COMPOSITION, AND USE	TSENG, Jerry
WO/2021/190567	DIPHENYL SULFIDE KETONE OXIME ESTER COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION AND USE THEREOF	TSENG, Jerry
WO/2021/190569	LOW-MIGRATION HINDERED PHENOL ANTIOXIDANT COMPOUND, PREPARATION METHOD AND COMPOSITION	TSENG, Jerry
WO/2021/197171	ANTI-GDF15 NEUTRALIZING MONOCLONAL ANTIBODY AND USE THEREOF	THE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/190580	BISPECIFIC POLYPEPTIDE COMPLEXES, COMPOSITIONS, AND METHODS OF PREPARATION AND USE	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/190583	ANTI-PSMA ANTIBODY-EXATECAN ANALOGUE CONJUGATE AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190586	B7H3 ANTIBODY-EXATECAN ANALOGUE CONJUGATE AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190587	BROAD-SPECTRUM MICROCYSTIN MONOCLONAL ANTIBODY AND PREPARATION METHOD THEREFOR	TSINGHUAUNIVERSITY
WO/2021/190601	CYCLOPHILIN INHIBITORS AND USES THEREOF	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/190602	PREPARATION METHOD FOR ANTIBODY MEDICAMENT CONJUGATE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190603	CYCLOPHILIN INHIBITORS AND USES THEREOF	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/190604	PREPARATION OF CYCLOSPORIN DERIVATIVES	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/197211	METHOD FOR SEPARATING C8 AROMATIC HYDROCARBON ISOMER MIXTURE	ZHEJIANG UNIVERSITY
WO/2021/190615	COMPOUNDS AS CASEIN KINASE INHIBITORS	GRITSCIENCE BIOPHARMACEUTICALS CO., LTD.
WO/2021/190622	ANTIBODIES BINDING SIGLEC15 AND USES THEREOF	BIOSION INC.
WO/2021/190623	SALT AND CRYSTALLINE FORMS OF FGFR4 INHIBITOR AND USES THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/190636	EFFICACIOUS DOSE FOR HER2 BISPECIFIC ANTIBODY	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/190642	COMPOSITION AND PRODUCT MADE THEREFROM	SHENZHEN LCYBETEL BIOLOGICAL TECHNOLOGY CO.，LTD
WO/2021/190643	ARECA NUT-FLAVORED PRODUCT	SHENZHEN LCYBETEL BIOLOGICAL TECHNOLOGY CO.，LTD
WO/2021/190645	ARECOLINE SALT, PREPARATION METHOD THEREFOR AND PRODUCT THEREOF	SHENZHEN LCYBETEL BIOLOGICAL TECHNOLOGY CO.，LTD
WO/2021/197248	SYSTEM AND METHOD FOR CONTINUOUSLY PURIFYING BIOPHARMACEUTICAL PRODUCT	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/197249	SYSTEM AND METHOD FOR CONTINUOUS PURIFICATION OF TARGET MOLECULES	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/197250	NOVEL COMPOUND AS REARRANGED DURING TRANSFECTION KINASE INHIBITOR	NANJING INNOCARE PHARMA TECH CO., LTD.
WO/2021/197276	Amide compounds and uses thereof	HUTCHISON MEDIPHARMA LIMITED
WO/2021/197283	SYNTHETIC PEPTIDE AMIDE COMPOUND AND ITS USE IN THE FIELD OF MEDICINE	CHENGDU SINTANOVO BIOTECHNOLOGY CO., LTD.
WO/2021/197295	CRYSTALLINE FORM OF MACROCYCLIC INDOLE DERIVATIVE AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/197303	METHOD FOR PREPARING LONG-CHAIN FATTY DIACID MONOBENZYL ESTER, AND USE THEREOF	DONGGUAN HEC BIOPHARMACEUTICAL R & D CO., LTD.
WO/2021/204018	COMPOUNDS POSSESSING PTP1B INHIBITORY ACTIVITY, AND APPLICATION THEREOF	INSTITUTE OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY, CHINESE ACADEMY OF TROPICAL AGRICULTURAL SCIENCES
WO/2021/197338	CRYSTAL FORM OF NITROXOLINE PRODRUG, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/197339	CRYSTAL FORM OF QUINOPYRROLIDINE-2-ONE COMPOUND SERVING AS ATM INHIBITOR AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/197340	ANTIBODY AND FUSION PROTEIN FOR TREATING CORONAVIRUSES AND USE THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/197344	CRYSTAL FORM OF DIAZASPIROPYRAN COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/227687	PLATFORM FOR CONSTRUCTING CORONAVIRUS ANTIBODIES	BIOTHEUS INC.
WO/2021/197358	ANTI-PD-L1 AND PD-L2 ANTIBODY AND DERIVATIVES AND USE THEREOF	BIOTHEUS INC.
WO/2021/197359	PLATFORM FOR CONSTRUCTING MULTISPECIFIC ANTIBODY	BIOTHEUS INC.
WO/2021/197363	2-ALKYNYL MANNOSE DERIVATIVE AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/197389	APPLICATIONS OF PI4K INHIBITOR IN INTRACELLULAR PROTEIN MISFOLDING-RELATED DISEASES AND LYSOSOMAL STORAGE DISEASES	NUO-BETA PHAMARCEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD
WO/2021/197393	ANTI-HUMAN CD47 ANTIBODY AND ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/197396	DEUTERATED OXOPHENYLARSINE COMPOUND AND USE THEREOF	NUO-BETA PHAMARCEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD
WO/2021/197401	ANTIGEN-BINDING POLYPEPTIDE BINDING TO CD47, AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/143957	NOVEL COMPOUND AND PREPARATION METHOD AND USE THEREFOR	NANTONG UNIVERSITY
WO/2021/204059	ENTECAVIR MONOPHOSPHATE ALANINAMIDE PHENOLIC ESTER AND MEDICAL USE THEREOF	BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
WO/2021/208750	CD22-TARGETED CHIMERIC ANTIGEN RECEPTOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
WO/2021/197452	CRYSTAL FORM OF FREE ALKALI OF NITROGEN-CONTAINING AROMATIC DERIVATIVES	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/197464	FUSED IMIDAZOLE DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/197467	MULTI-TARGET ANTI-TUMOR COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD.
WO/2021/218570	METHOD FOR SYNTHESIZING INDOLE DERIVATIVE CAPABLE OF EFFICIENTLY DEGRADING PERFLUORINATED COMPOUND AND APPLICATION THEREOF	NANJING UNIVERSITY
WO/2021/197483	FULLY HUMAN ANTI-HUMAN CD22 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF	NANJING IASO BIOTHERAPEUTICS CO., LTD.
WO/2021/197486	NOVEL SPIRO COMPOUND AND APPLICATION THEREOF IN DRUG	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/218574	ANTIBODY BINDING TO HUMAN NGF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/204111	AMINOPYRIMIDINE COMPOUND AS DNA-PK INHIBITOR AND DERIVATIVES THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/197499	OCTAHYDROPYRAZINODIAZANAPHTHYRIDINE DIONE COMPOUNDS	MEDSHINE DISCOVERY INC.
WO/2021/204142	BILE ACID DERIVATIVE SALT, CRYSTAL STRUCTURE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF	XI’AN BIOCARE PHARMA LTD.
WO/2021/204159	MENIN INHIBITORS AND METHODS OF USE FOR TREATING CANCER	AGIOS PHARMACEUTICALS, INC.
WO/2021/208787	TARGET POLYPEPTIDE USED FOR SCREENING DRUGS AND SCREENING METHOD THEREFOR	XU, Rongzhen
WO/2021/204170	ACTIVE PEPTIDE DERIVED FROM EUPOLYPHAGA SINENSIS WALKER AND HAVING BLOOD LIPID LOWERING FUNCTION, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SCHOOL OF PHARMACY, BIN ZHOU MEDICAL UNIVERSITY
WO/2021/204175	LIPID NANOPARTICLE COMPOSITION	SUZHOU ABOGEN BIOSCIENCES CO., LTD.
WO/2021/204185	BENZO[D]AZEPINE DERIVATIVE AS INHIBITOR OF AGGRECANASE-2, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
WO/2021/204193	SIRT1 RECEPTOR AGONIST AND MEDICAMENT COMPRISING SAME	CATCH BIO-SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/204198	CHIMERIC POLYPEPTIDE AND USE THEREOF	CURE GENETICS CO., LTD
WO/2021/218588	NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/244134	ANTI-HUMAN PD-1 ANTIBODY AND USE THEREOF	HRAIN BIOTECHNOLOGY CO., LTD.
WO/2021/204252	TETRACYCLIC COMPOUND AS HEPATITIS B SURFACE ANTIGEN INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/204258	AZABICYCLO COMPOUND AS HEPATITIS B SURFACE ANTIGEN INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208818	PHOSPHORYLATED PROTEIN LABELING REAGENT CONTAINING EQUAL-WEIGHT STABLE ISOTOPES, PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG PHOBIOLOGY TECH CO., LTD
WO/2021/244136	REFINEMENT METHOD FOR NITROMETHANE	HUBEI GRAND FUCHI PHARMACEUTICAL & CHEMICALS CO., LTD.
WO/2021/204281	ANTI-CD47 ANTIBODY AND USES THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/204287	HIGH-AFFINITY TCR FOR RECOGNIZING HPV16	XLIFESC, LTD.
WO/2021/208838	ANTIBODIES BINDING CTLA4 AND USES THEREOF	BIOSION INC.
WO/2021/208839	PURIFICATION OF BISPECIIFC ANTIBODIES	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/208850	NITROIMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	NANJING CHANGAO PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LIMITED
WO/2021/208865	ARYL-FUSED ISOSELENAZOLE COMPOUND CONTAINING TETRAZINE SUBSTITUENT, SYNTHESIS METHOD THEREFOR, AND USE THEREOF	KEAISE MEDICINE WUHAN CORP.
WO/2021/175338	PSMA COMBINER AND USE THEREOF	FUDAN UNIVERSITY SHANGHAI CANCER CENTER
WO/2021/208881	ANTIBODY TO HUMAN INTERLEUKIN-4 RECEPTOR Α, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAIMABGEEKBIOTECH.CO., LTD.
WO/2021/208911	NOVEL MEDICAL USE OF MDM2 INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/208918	TRICYCLIC COMPOUNDS AS EGFR INHIBITORS	QILU PHARMACEUTICAL CO., LTD.
WO/2021/208927	ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY	ZHUHAI TRINOMAB BIOTECHNOLOGY CO., LTD.
WO/2021/208928	ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY	ZHUHAI TRINOMAB BIOTECHNOLOGY CO., LTD.
WO/2021/249008	METHOD FOR PREPARING EPSILON-CAPROLACTONE BY USING IN-SITU PEROXIDE	ZHEJIANG UNIVERSITY
WO/2021/253954	ANALGESIC	ANHUI HEALSTAR PHARMACEUTICAL CO., LTD
WO/2021/249011	HIV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249012	CORONAVIRUS VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249013	VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/208945	BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI ZHONGZE THERAPEUTICS, CO. LTD.
WO/2021/208951	β-DIKETONE CERIUM (IV) COMPOUND, AND PREPARATION AND USE THEREOF	HUBEI GURUN TECHNOLOGY CO., LTD
WO/2021/208963	BCL-2 INHIBITOR	BEIGENE, LTD.
WO/2021/213245	ANTIBODY OR ANTIGEN-BINDING FRAGMENT, PREPARATION METHOD AND PHARMACEUTICAL USES THEREFOR	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/209019	ANTI-OX40 ANTIBODY AND USES THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/209020	ANTI-OX40 ANTIBODY AND USES THEREOF	HUTCHISON MEDIPHARMA LIMITED
WO/2021/164793	COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF	TYK MEDICINES (ZHENGZHOU). INC.
WO/2021/209035	NOVEL CORONAVIRUS T CELL EPITOPE PEPTIDE, AND PMHC AND PREPARATION AND APPLICATION THEREOF	JINAN UNIVERSITY
WO/2021/209039	QUINAZOLINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
WO/2021/218669	METHOD FOR REALIZING HIGH-EFFICIENCY CIRCULATION OF VANADIUM AND SULFURIC ACID WITH TRACE DMSO TO CATALYZE BIOMASS IN ORDER TO PREPARE FORMIC ACID	XI'AN JIAOTONG UNIVERSITY
WO/2021/209049	PD-1 MUTANT POLYPEPTIDE, AND PREPARATION THEREFOR AND USE THEREOF	NANTONG YICHEN BIOPHARMA. CO. LTD.
WO/2021/209055	IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/213288	ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/209066	SPECIFIC ANTIGEN BINDING MOLECULE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/213317	HPK1 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/213329	ANTIBODY BINDING WITH SPECIFIC EPITOPE IN HUMAN IL-4Rα AND APPLICATIONS OF ANTIBODY	SUZHOU CONNECT BIOPHARMACEUTICALS, LTD.
WO/2021/218684	TETRAVALENT BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR, AND USE THEREOF	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/227782	ANTI-PD-1 AND PD-L1 TETRAVALENT BISPECIFIC ANTIBODY	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/213353	AMIDE OR SULFONAMIDE DERIVATIVE AND USE THEREOF	SUZHOU NHWA PHARMACEUTICAL RESEARCH CO., LTD.
WO/2021/213358	BORON-CONTAINING COMPOUNDS AND APPLICATION THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/213380	SOLID FORM OF PYRAZINE SUBSTITUTED NICOTINAMIDE, AND PREPARATION AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/213393	METHOD OF TREATING SHIP1-MEDIATED DISEASES USING PELOROL DERIVATIVES	ZEBRAPEUTICS INC.
WO/2021/213421	FUSION PROTEIN MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/213434	ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/213435	SINGLE VARIABLE DOMAIN ANTIBODY TARGETING HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1) AND DERIVATIVE THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/213437	ACE2-FC FUSION PROTEIN AND USE THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/213445	SULTAM DERIVATIVES AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/213453	LENVATINIB MESYLATE CRYSTAL FORM XI AND PREPARATION METHOD THEREFOR	CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.
WO/2021/218752	SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/218755	SHP2 INHIBITOR, AND COMPOSITION AND USE THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/213460	TRICYCLIC KINASE INHIBITOR	SHANDONG XUANZHU PHARMA CO., LTD.
WO/2021/213466	ANTI-CD73 ANTIBODY AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/213475	ANTI-CD73-ANTI-PD-1 BISPECIFIC ANTIBODY AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/213476	PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF	SHENZHEN JINGTAI TECHNOLOGY CO., LTD.
WO/2021/213478	ANTI-HUMAN B7-H3 MONOCLONAL ANTIBODY AND APPLICATION THEREOF	FOSUN KITE BIOTECHNOLOGY CO., LTD
WO/2021/213486	CRYSTAL FORM OF DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/213493	CRYSTAL FORM OF DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/223604	T CELL ANTIGEN RECEPTOR, MULTIMERIC COMPLEX THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA IMMUNOTECH (BEIJING) BIOTECHNOLOGY CO., LTD
WO/2021/213500	COMPOUNDS AND PHARMACEUTICAL USES THEREOF	SYNEURX INTERNATIONAL (TAIWAN) CORP.
WO/2021/213511	BISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES	VIRTUOSO BINCO, INC.
WO/2021/218829	ORGANIC COMPOUND, DEVICE USING SAME, AND ELECTRONIC APPARATUS	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/213518	COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES	FUDAN UNIVERSITY
WO/2021/218833	CRYSTAL OF M RECEPTOR ANTAGONIST AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING SHOWBY PHARMACEUTICAL CO., LTD.
WO/2021/213521	CBP/EP300 INHIBITOR AND USE THEREOF	PHARMABLOCK SCIENCES (NANJING) , INC.
WO/2021/218862	MODIFIED IMMUNOGLOBULINS	BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD
WO/2021/218863	1,5-DIHYDRO-2,4-BENZODIAZEPINE-3-ONE DERIVATIVE AND APPLICATION THEREOF	NHWA PHARMA. CORPORATION
WO/2021/218874	BISPECIFIC ANTIBODY TARGETING HUMAN CLAUDIN AND HUMAN PDL1 PROTEINS, AND APPLICATION THEREOF	QURE BIOTECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/218879	SARS-COV-2 NEUTRALIZING ANTIBODY AND PREPARATION AND USE THEREOF	SINOCELLTECH LIMITED
WO/2021/218883	TGFβR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFβR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEIN	SINOCELLTECH LIMITED
WO/2021/218892	BIVALENT PLATINUM COMPOUND HAVING NOVEL STRUCTURE AND USE THEREOF	WEIHAI HAILING BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/218895	BIFUNCTIONAL PROTEIN AGAINST PD-1 AND TGF-β	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/218896	ECTEINASCIDIN DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/233082	4(1H)-PYRIDONE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD
WO/2021/218912	COMPOUNDS CONTAINING BENZOSULTAM	MEDSHINE DISCOVERY INC.
WO/2021/218930	CO-AMORPHOUS SUBSTANCE OF CELECOXIB AND PREGABALIN AND PREPARATION METHOD THEREFOR	NHWA PHARMA. CORPORATION
WO/2021/218939	FUSED RING COMPOUND AND APPLICATION THEREOF IN MEDICINE	BETTA PHARMACEUTICALS CO., LTD
WO/2021/227865	PREPARATION METHOD AND APPLICATION OF A SERIES OF HEMICYANINE FLUORESCENT MARKERS HAVING HIGH OPTICAL STABILITY	SOOCHOW UNIVERSITY
WO/2021/218947	ANTI-NOVEL CORONAVIRUS MONOCLONAL ANTIBODY AND APPLICATION THEREOF	PEKING UNIVERSITY
WO/2021/218948	CRYSTAL FORMS OF SULFONAMIDE COMPOUND AND PREPARATION METHOD THEREFOR	CRYSTAL PHARMATECH CO., LTD.
WO/2021/218953	ANTIBODY AGAINST HUMAN COMPLEMENT PROTEIN (C5) AND APPLICATION THEREOF	SHANGHAI PUREMAB BIO-TECH CO., LTD.
WO/2021/233094	INTERFERON-κ MUTANT AND PREPARATION METHOD THEREFOR	LETO LABORATORIES CO., LTD
WO/2021/218988	PRDX1 AGONIST AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/218992	SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF IN MEDICINE	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/218997	SUBSTITUTED FIVE-MEMBERED AZA-RING COMPOUND AND USE THEREOF IN DRUG	DONGGUAN HEC NEW DRUG R&D CO., LTD.
WO/2021/227875	METHOD FOR PREPARING ACETALDEHYDE FROM ACETYLENE UNDER CATALYSIS OF ZAPO MOLECULAR SIEVE	BOZUN INVESTMENT GROUP LIMITED
WO/2021/219019	HETEROCYCLIC GLP-1 AGONISTS	GASHERBRUM BIO, INC.
WO/2021/223647	COMPOSITIONS AND METHODS FOR MAKING AND USING VACCINES AGAINST COVID-19	THE UNIVERSITY OF HONG KONG
WO/2021/223650	NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/227882	AROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN DRUG	SICHUAN DAOZHEN TECHNOLOGY CO., LTD
WO/2021/249057	HETEROCYCLIC COMPOUND AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/219046	ANTIGEN BINDING CONSTRUCTS TARGETING HER2 AND USES THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219048	BISPECIFIC ANTIBODY TARGETING NKG2A AND PD-L1, AND APPLICATION	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/219065	CRYSTAL OF TRIFLUOROMETHYL/CHLORO DISUBSTITUTED SULFONAMIDE SELECTIVE BCL-2 INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219070	DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE	BEIGENE, LTD.
WO/2021/219071	PROCESS FOR PREPARING PROTAC BTK DEGRADERS	BEIGENE (BEIJING) CO., LTD.
WO/2021/219072	PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR	SHANGHAI KECHOW PHARMA, INC
WO/2021/219078	HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/219088	PYRIMIDINE-BASED TRICYCLIC COMPOUND AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219089	SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS	INSILICO MEDICINE IP LIMITED
WO/2021/219090	QUINOXALINE DIONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/219091	QUINOXALINONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/219092	PHARMACEUTICAL COMPOSITIONSCONTAINING ANTI-CD47 ANTIBODIES	I-MAB BIOPHARMA CO., LTD.
WO/2021/219100	COMPOUND CONTAINING FUSED TRICYCLIC STRUCTURE	HANGZHOU INNOGATE PHARMA CO., LTD.
WO/2021/219101	APPLICATION OF HETEROCYCLIC COMPOUND	GUANGZHOU JOYO PHARMATECH CO., LTD
WO/2021/219114	SEQUENCING METHOD, ANALYSIS METHOD THEREFOR AND ANALYSIS SYSTEM THEREOF, COMPUTER-READABLE STORAGE MEDIUM, AND ELECTRONIC DEVICE	GENEMIND BIOSCIENCES COMPANY LIMITED
WO/2021/244199	β-LACTAM COMPOUND, USE THEREOF AND PREPARATION METHOD THEREFOR	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/219121	DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD	YANG SHENG TANG COMPANY, LTD.
WO/2021/254005	IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	ABBISKO THERAPEUTICS CO., LTD.
WO/2021/219127	BISPECIFIC ANTIBODY TARGETING HER2 AND PD-1 AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/227895	NITRIC OXIDE DONOR-TYPE RIPASUDIL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/227897	NITRIC OXIDE DONOR TYPE NETARSUDIL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/227898	NITRIC OXIDE DONOR TYPE FASUDIL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/219134	PHENYLPROPIONAMIDE COMPOUND AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/219135	INOSITOL DERIVATIVE AND USE THEREOF	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/238587	MICROMOLECULAR OXATHIAZINE DERIVATIVE AND USE THEREOF	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/238588	OXATHIAZINE COMPOUND AND USE THEREOF	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/219140	JAK2 INHIBITOR AND APPLICATION THEREOF	BIOPOLAR HONGYE (NANTONG) PHARMACEUTICAL CO.LTD
WO/2021/227904	POLYCYCLIC AMIDE DERIVATIVE AS CDK9 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ALPHAMA BIOTECHNOLOGY CO., LTD.
WO/2021/223688	ORGANIC COMPOUND, USE, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/227906	PYRIDINE ACETAMIDE DERIVATIVE SERVING AS CDK INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SUZHOU ALPHAMA BIOTECHNOLOGY CO., LTD.
WO/2021/223699	3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF	ONO PHARMACEUTICAL CO., LTD.
WO/2021/223707	IMPROVED CHIMERA CONSISTING OF T-CELL RECEPTOR AND CO-STIMULATORY MOLECULES	CHINA IMMUNOTECH (BEIJING) BIOTECHNOLOGY CO., LTD
WO/2021/223718	ALDEHYDE GROUP COMPOUNDS PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/223719	ANTIBODY DIRECTED AGAINST CD19 ANTIBODY, AND PREPARATION THEREFOR AND APPLICATION THEREOF	GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD.
WO/2021/223720	HUMANIZED CD19 ANTIBODY AND USE THEREOF	GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD.
WO/2021/227938	AMINO ACID DERIVATIVE CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG STRUCTURE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD.
WO/2021/227940	ANTI-TIGIT ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF	HUABO BIOPHARM (SHANGHAI) CO., LTD.
WO/2021/223736	COMPOUNDS AS BCL-2 INHIBITORS	FOCHON PHARMACEUTICALS, LTD.
WO/2021/233133	COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF	TYK MEDICINES, INC.
WO/2021/223748	CRYSTAL FORM OF MACROCYCLIC TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR	SHANDONG XUANZHU PHARMA CO., LTD.
WO/2021/223751	SYNTHESIS METHOD FOR ANTI-TUMOR COMPOUND AND INTERMEDIATE THEREOF	NANJING TRANSTHERA BIOSCIENCES CO., LTD.
WO/2021/227989	POLYPEPTIDE DERIVATIVE HAVING DUAL RECEPTOR AGONISTIC ACTION AND USE THEREOF	TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD.
WO/2021/228000	PREPARATION OF BIARYL RING-LINKED AROMATIC HETEROCYCLIC DERIVATIVE AS IMMUNOMODULATOR AND USE THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/238622	COMPOUND AND APPLICATION THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/233147	PREPARATION AND USE OF TETRADENTATE PLATINUM(II) COMPLEX	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/238623	ONCN QUADRIDENTATE LIGAND-CONTAINING PLATINUM COMPLEX AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DIODE	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/244222	METAL COMPLEX AND USE THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/254026	TETRADENTATE METAL COMPLEX AND USE THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/258875	METAL IRIDIUM COMPLEX AND USE THEREOF	GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
WO/2021/228006	CEFOTAXIME-MAGNESIUM COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	CHENGDE MEDICAL COLLEGE
WO/2021/228007	CEFOPERAZONE MAGNESIUM COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHENGDE MEDICAL COLLEGE
WO/2021/228008	CEFUROXIME MAGNESIUM COMPOUND, COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	CHENGDE MEDICAL COLLEGE
WO/2021/228009	PIPERACILLIN MAGNESIUM COMPOUND, COMPOSITION, PREPARATION METHOD AND USE	CHENGDE MEDICAL COLLEGE
WO/2021/228028	SOS1 INHIBITOR CONTAINING PHOSPHORUS	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/228034	PREPARATION METHOD OF (5-FLUORO-2, 3-DIHYDROBENZOFURAN-4-YL) METHANAMINE OR ITS SALT, AND INTERMEDIATES THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/228052	BIOLOGICAL MACROMOLECULAR TARGET-SPECIFIC COMPLEMENT INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI COMGEN PHARMACEUTICAL CO., LTD.
WO/2021/228091	ST2 ANTIGEN BINDING PROTEIN	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/228092	NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF	CHANG GUNG MEMORIAL HOSPITAL, LINKOU
WO/2021/228111	ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/228114	BORON-NITROGEN COMPOUND, ORGANIC ELECTROLUMINESCENCE COMPOSITION, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME	JI HUA LABORATORY
WO/2021/244244	OXADIAZOLE COMPOUND AND APPLICATION THEREOF	SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY
WO/2021/228123	COMPOUND FOR ADJUSTING ACTIVITY OF NMDA RECEPTOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	BEIJING GREATWAY PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/228150	CANNABINOID DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/228159	BRIDGED CYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION CONTAINING SAME AND USE THEREOF	NEUSCO BIOTECH LIMITED
WO/2021/228161	ALKOXLYALKYL-SUBSTITUTED HETEROCYCLIC INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/228167	METHOD FOR ENHANCING IMMUNOGENICITY OF ANTIGEN BY FORMING FC FRAGMENT FUSION PROTEIN GLYCOCONJUGATE	SINOCELLTECH LIMITED
WO/2021/228173	AZEPINE FUSED RING COMPOUNDS AND MEDICAL USES THEREOF	THE NATIONAL INSTITUTES OF PHARMACEUTICAL R&D CO., LTD
WO/2021/228186	ANDROGRAPHOLIDE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS THEREOF IN ANTINEOPLASTIC DRUG AND ANTIVIRAL DRUG	SHENZHEN BAY LABORATORY
WO/2021/228210	PYRROLIDINE COMPOUND AND USE THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/228215	BIARYL COMPOUND CAPABLE OF SERVING AS RORγ REGULATOR	SHANGHAI LITEDD CO., LTD.
WO/2021/228216	BIARYL COMPOUND CAPABLE OF SERVING AS RORγ MODULATOR	SHANGHAI LITEDD CO., LTD.
WO/2021/228217	ANILINE COMPOUND USED AS RORγ REGULATOR	SHANGHAI LITEDD CO., LTD.
WO/2021/228218	ANTI-CD25 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND MEDICAL USES THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/228223	DEUTERATED AKT KINASE INHIBITOR	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.
WO/2021/233227	COMPOUNDS AS PROTEIN KINASE INHIBITORS	FOCHON PHARMACEUTICALS, LTD.
WO/2021/228236	DEUTERATED TETRAHYDROTHIENO[3,4-D]PYRIMIDINEDIONE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/249116	CORONAVIRUS VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/228248	FUSED AZA-HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/228253	MUTANT PROTEIN FOR PROLIFERATING REGULATORY T CELL	SHANGHAI GP BIOTECH CO., LTD.
WO/2021/233236	SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND USE THEREOF	BEIJING FINDCURE BIOSCIENCES, LTD.
WO/2021/233244	FERRITIN HEAVY CHAIN SUBUNIT-BASED CONJUGATES AND APPLICATION THEREOF	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/233246	ANTIBODIES BINDING IL6R AND USES THEREOF	BIOSION INC.
WO/2021/233260	HUMAN IL-15 MUTANT AND USE THEREOF	SIMCERE (SHANGHAI) PHARMACEUTICAL CO., LTD.
WO/2021/233296	SOLID FORM OF MACROCYCLIC COMPOUND, PREPARATION THEREFOR AND USE THEREOF	SHENZHEN TARGETRX, INC.
WO/2021/233302	FUSED RING DERIVATIVES AND USE THEREOF IN PHARMACY	MEDSHINE DISCOVERY INC.
WO/2021/233311	ORGANIC COMPOUND, ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/233312	FULLY-AUTOMATIC PROTEIN PURIFICATION SYSTEM DEVICE AND USE THEREOF	THE INSTITUTE OF BIOPHYSICS OF THE CHINESE ACADEMY OF SCIENCES
WO/2021/233314	METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF	GREEN VALLEY (SHANGHAI) PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/233317	IL-12 ARMORED IMMUNE CELL THERAPY AND USES THEREOF	GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY CO., LTD.
WO/2021/209072	PROTEIN/POLYPEPTIDE SEQUENCING METHOD USING AEROLYSIN NANOCHANNELS	NANJING UNIVERSITY
WO/2021/233349	PYRIDINE DERIVATIVE AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/249143	INHIBITOR POLYPEPTIDE COMPOUND TARGETING FIBRONECTIN-DERIVED PEPTIDES AND USE THEREOF	SHENZHEN TURIER BIOTECH CO., LTD.
WO/2021/213538	GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONIST AND USE THEREOF	SHANGHAI INNOFORTUNE BOITECH CO.LTD
WO/2021/233371	COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION	BETTA PHARMACEUTICALS CO., LTD
WO/2021/244297	PD-L1 CYCLIC PEPTIDE INHIBITOR CONTAINING HYDRAZIDE STRUCTURE	NANJING LEEWE BIOPHARMACEUTICAL CO., LTD.
WO/2021/233376	2,4,6-TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AS ATR KINASE INHIBITORS	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/233394	RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS INCLUDING PIPERAZINE HETEROCYCLIC AMIDE UREAS	SIRONAX LTD.
WO/2021/233396	AZETIDINE CYCLIC UREAS	SIRONAX LTD.
WO/2021/233397	PIPERAZINE CYCLIC UREAS	SIRONAX LTD.
WO/2021/233406	COMPOSITIONS COMPRISING DICHLOROACETIC ACID, PROCESSES FOR PREPARING SAME AND USES THEREOF	CHANGZHOU SYNTHEALL PHARMACEUTICALS CO., LTD.
WO/2021/233408	ANTI-α-HEMOLYSIN ANTIBODY AND STABILIZING PREPARATION THEREOF	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
WO/2021/244323	CRYSTAL FORM OF UPADACITINIB, PREPARATION METHOD THEREFOR, AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/233411	FUSION PROTEIN FOR REVERSING TUMOR MICROENVIRONMENT AND USE THEREOF	CHONGQING PRECISION BIOTECH CO., LTD.
WO/2021/244328	ANTI-PD-L1 AND HER2 BISPECIFIC ANTIBODY	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/233427	FUSED RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF	GUANGZHOU FERMION TECHNOLOGY CO., LTD.
WO/2021/233428	NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATION	GUANGZHOU FERMION TECHNOLOGY CO., LTD.
WO/2021/233433	ANTI-SARS-COV-2 SPIKE PROTEIN MONOCLONAL ANTIBODY	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/233434	NEW CRYSTAL FORM OF BICTEGRAVIR SODIUM AND PREPARATION METHOD THEREFOR	SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD.
WO/2021/238817	MACROCYCLIC JAK INHIBITOR AND USE THEREOF	BIOPOLAR HONGYE (GUANGDONG) PHARMACEUTICAL CO. LTD.
WO/2021/238818	MACROCYCLIC JAK INHIBITOR AND USES THEREOF	BIOPOLAR HONGYE (GUANGDONG) PHARMACEUTICAL CO. LTD.
WO/2021/238827	EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF	HONGYUN BIOTECH CO., LTD.
WO/2021/238831	ANTI-CLDN18.2 ANTIBODIES AND DIAGNOSTIC USES THEREOF	MABSPACE BIOSCIENCES (SUZHOU) CO., LIMITED
WO/2021/238834	ARYLFORMAMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF	THE NATIONAL INSTITUTES OF PHARMACEUTICAL R&D CO., LTD
WO/2021/238835	CRYSTAL FORMS OF (2E)-N-[4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7-METHOXY-6-QUINAZOLINYL]-4-(1-PIPERIDINYL)-2-BUTENAMIDE, AND PREPARATION METHOD THEREFOR	CRYSTAL PHARMATECH. CO., LTD.
WO/2021/238839	PREPARATION METHOD FOR (4-ISOPROPOXY-2-METHYL) PHENYL ISOPROPYL KETONE	ADAMA MAKHTESHIM LTD.
WO/2021/238841	REGULATORY GENE FOR IMPROVING UTILIZATION RATE OF AND TOLERANCE TO CAPRIC ACID IN STREPTOMYCES ROSEOSPORUS, AND USE THEREOF	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/238842	HER2 AFFIBODY, DIAGNOSTIC OR THERAPEUTIC NUCLIDE-LABELED SUBSTANCE, AND PREPARATION METHOD FOR NUCLIDE-LABELED SUBSTANCE AND APPLICATION OF NUCLIDE-LABELED SUBSTANCE	BEIJING INSTITUTE FOR CANCER RESEARCH
WO/2021/238854	MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/244345	CYANINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	NANJING GENVIVO BIOTECH CO., LTD.
WO/2021/238875	COLLETOTRICHUM TRANSCRIPTION FACTOR CSATF1 AND USE THEREOF	HAINAN UNIVERSITY
WO/2021/244346	PIPERAZINONE SUBSTITUTE OR DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION	SICHUAN UNIVERSITY
WO/2021/238881	TRIAZOLONE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/233454	NOVEL TRICYCLIC AROMATIC HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD.
WO/2021/238886	ANTIBODIES SPECIFICALLY RECOGNIZING NERVE GROWTH FACTOR AND USES THEREOF	STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/238903	ENHANCED SYNTHETIC T-CELL RECEPTOR AND ANTIGEN RECEPTOR	CHINA IMMUNOTECH (BEIJING) BIOTECHNOLOGY CO., LTD
WO/2021/238904	FC-CD80 FUSION PROTEIN AND CONJUGATE THEREOF, AND USE THEREOF	BEIJING BEYOND BIOTECHNOLOGY CO., LTD
WO/2021/238908	SALT AND CRYSTAL FORM OF HETEROARYL DERIVATIVE, AND PREPARATION METHOD THEREFOR	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/238910	ANTI-CORONAVIRUS SPIKE PROTEIN ANTIBODIES AND USES THEREOF	GUO, Bingshi
WO/2021/238932	MULTI-SPECIFIC ANTIBODY AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/238947	METHOD FOR PREPARING QUINONE COMPOUND	SHANGHAITECH UNIVERSITY
WO/2021/238962	METHOD FOR PREPARING GLP-1 RECEPTOR AGONIST	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
WO/2021/238963	PREPARATION METHOD FOR (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)METHYL PROPIONATE DIACID SALT	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
WO/2021/238964	METHOD FOR PREPARING GLP-1 RECEPTOR AGONIST FREE BASE	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
WO/2021/238965	METHOD FOR PREPARING METHYL (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYLPROPIONATE AND SALT THEREOF	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
WO/2021/238975	LIGHT-EMITTING DEVICE, DISPLAY PANEL, AND DISPLAY DEVICE	BOE TECHNOLOGY GROUP CO., LTD.
WO/2021/244371	ANTI-PD-L1/VEGF FUSION PROTEIN	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/238999	FLUOROPYRROLOPYRIDINE COMPOUND AND APPLICATION THEREOF	SHENZHEN LIFE FOUNTAIN BIOTECH CO., LTD
WO/2021/239014	ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIES	SINGLE CELL TECHNOLOGY, INC.
WO/2021/239026	ANTIBODY AGAINST CLAUDIN18.2 AND USE THEREOF	HANGZHOU BANGSHUN PHARMACEUTICAL CO., LTD
WO/2021/258979	PREPARATION METHOD FOR AROMATIC ETHER COMPOUND	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/239046	RHFGF21 FUSION PROTEIN, POLYNUCLEOTIDE ENCODING RHFGF21 FUSION PROTEIN, COMPOSITION CONTAINING RHFGF21 FUSION PROTEIN, AND USE OF RHFGF21 FUSION PROTEIN	JIANGSU KANIONREAL BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/239049	NOVEL GLUTAMINE ANALOGS	JACOBIO PHARMACEUTICALS CO., LTD.
WO/2021/254121	INDUSTRIAL EXTRACTION METHOD OF CANNABIDIOL	CHENGUANG BIOTECH GROUP CO., LTD.
WO/2021/244391	SMALL-MOLECULE GLP-1R AGONIST AND USE THEREOF	SHANXI MEDICAL UNIVERSITY
WO/2021/244392	ANTI-PD1×PDL1 BISPECIFIC ANTIBODY	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/239058	FUSED TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF	GENFLEET THERAPEUTICS (SHANGHAI) INC.
WO/2021/239068	HETEROCYCLIC COMPOUNDS AS STING MODULATORS	BEIGENE, LTD.
WO/2021/239077	MLL1 INHIBITORS AND ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/239082	DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF	BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/239088	SARS-COV-2 NEUTRALIZING ANTIBODIES AND USES THEREOF	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/244416	PYRIDINYL MORPHOLINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI ZHONGZE THERAPEUTICS, CO. LTD.
WO/2021/239115	GLP-1/GLUCAGON DUAL AGONIST FUSION PROTEIN	DONGGUAN YUNJING BIOTECHNOLOGY CO., LTD
WO/2021/239116	GLP-1/GLUCAGON DUAL AGONIST FUSION PROTEIN	DONGGUAN YUNJING BIOTECHNOLOGY CO., LTD
WO/2021/239117	MODIFIED PROTEINS AND PROTEIN DEGRADERS	CULLGEN (SHANGHAI) , INC.
WO/2021/244430	COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS	NANJING RUIJIE PHARMA CO., LTD.
WO/2021/239126	STEREOSELECTIVE SYNTHESIS OF INTERMEDIATE FOR PREPARATION OF HETEROCYCLIC COMPOUND	TAIGEN BIOTECHNOLOGY CO., LTD.
WO/2021/244442	ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME	SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.
WO/2021/239133	PYRIMIDINE COMPOUND AS AXL INHIBITOR	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.
WO/2021/244463	SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN BAY LABORATORY
WO/2021/244486	SIGNAL CONVERSION RECEPTOR AND USE THEREOF	SHANGHAI GENCELLS THERAPEUTICS CO., LTD.
WO/2021/254133	SMALL MOLECULE COMPOUND	TECHNODERMA MEDICINES PTE LTD
WO/2021/249234	BENZOTHIAZOLE DERIVATIVE AND APPLICATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/244502	POLYARYL COMPOUND AND USE	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/244504	PROTEIN DRUG BINDING IMMUNOSUPPRESSIVE MOLECULE PD-L1	GUANGDONG SHENGSAI BIOTECHNOLOGY INC., LIMITED
WO/2021/244505	NEW PYRAZINE COMPOUND	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/249237	TRIEPOXYHEXAHYDROCHROMONE A, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES
WO/2021/244529	RADIOLABELED BORON-CONTAINING COMPOUND, PREPARATION METHOD AND APPLICATION	NEUBORON MEDTECH LTD.
WO/2021/244542	3,4-DIHYDROISOQUINOLINE COMPOUND AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/244552	ANTI-PDL1×KDR BISPECIFIC ANTIBODY	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/244553	TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1 AND EGFR	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/244554	ANTI-PDL1×EGFR BISPECIFIC ANTIBODY	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/244555	CHIRAL INTERMEDIATE AND PREPARATION METHOD THEREFOR	SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD.
WO/2021/244558	SMALL MOLECULE COMPOUND AND APPLICATION THEREOF IN PREPARATION OF ANTI-TUMOUR METASTASIS DRUGS	EXPLORING HEALTH, LLC.
WO/2021/244559	SMALL MOLECULAR COMPOUND AND USE THEREOF IN PREPARING ANTI-TUMOR METASTASIS DRUGS	EXPLORING HEALTH, LLC.
WO/2021/244560	AMINOPYRIMIDINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/249258	DEUTERATED PYRIDOPYRIMIDINONES AND THEIR USE AS HIGHLY SELECTIVE CYCLIN-DEPENDENT KINASE 2 INHIBITORS	ZENTAUR THERAPEUTICS INTERNATIONAL LIMITED
WO/2021/244582	NOVEL THYROID HORMONE β RECEPTOR AGONIST	CHENGDU KANGHONG PHARMACEUTICAL CO., LTD.
WO/2021/244587	ANTI-PD-L1/TGF-β FUSION PROTEIN	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/244590	ANTI-B7-H3 ANTIBODY AND PREPARATION THEREFOR AND USE THEREOF	MINGHUI PHARMACEUTICAL (SHANGHAI) LIMITED
WO/2021/233461	NOVEL CRYSTAL FORM OF BENZOTHIAZOLE COMPOUND AND PREPARATION METHOD THEREFOR	CRYSTAL PHARMATECH CO., LTD.
WO/2021/244601	NEUTRALIZING ANTIBODY OF SARS-COV-2 VIRUS AND APPLICATION THEREOF	SHANDONG BOAN BIOTECHNOLOGY CO., LTD.
WO/2021/244603	INHIBITORS OF KRAS G12C PROTEIN AND USES THEREOF	SHANGHAI ANTENGENE CORPORATION LIMITED
WO/2021/244608	PYRIDO[2,3-B] [1,4] OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4] OXAZEPINES AS IAP ANTAGONISTS	BEIGENE, LTD.
WO/2021/244609	COMPOUND HAVING MACROCYCLIC STRUCTURE AND USE THEREOF	CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
WO/2021/244610	METHOD FOR SEPARATING PHENOLIC GLUCOSIDE COMPOUND FROM SEMINIS JUGLANDIS SEPTUM	JIANGNAN UNIVERSITY
WO/2021/244623	FERRITIN-ACE-2 SHORT PEPTIDE NANODRUG	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/244624	HETEROCYCLYL-SUBSTITUTED PERYLENE AMIDE COMPOUND AND USE THEREOF	BEIJING WENHAIYANG INDUSTRY & TRADING CO., LTD
WO/2021/244626	CHIMERIC ANTIGEN RECEPTOR TARGETING CLDN18.2 AND USE THEREOF	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/244634	IMIDAZOPYRIDINE COMPOUND AND USE THEREOF	WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY
WO/2021/244635	METABOLITE AT POSITION 21 OF FENLEAN, AND PREPARATION AND USE THEREOF	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/244637	TOPICAL ADMINISTRATION OF 2- (DIETHYLAMINO) ETHYL 2- (4-ISOBUTYLPHENYL) PROPIONATE FOR TREATMENT OF DISEASES	YU, Chongxi
WO/2021/244638	FENLEAN 7 POSITION METABOLITE, AND PREPARATION AND USE THEREOF	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/249305	BIPHENYL COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/244645	FIVE-MEMBERED HETEROAROMATIC IMIDAZOLE COMPOUND AND USE THEREOF	SCIWIND BIOSCIENCES CO., LTD
WO/2021/244653	TCR-T CELL THERAPY TARGETING EPSTEIN-BARR VIRUS	GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY CO., LTD.
WO/2021/244654	ACTIVATION INDUCED CYTOKINE PRODUCTION IN IMMUNE CELLS	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/249319	TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF	SHENZHEN BO LI JIAN MEDICINE CO., LTD.
WO/2021/249324	ALKENYL PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	HONGYUN BIOTECH CO., LTD.
WO/2021/259049	INDOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/249337	DIMETHYLSULFOXIMINE DERIVATIVE	MEDSHINE DISCOVERY INC.
WO/2021/244659	ISOTOPE-SUBSTITUTED SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF	ETERN BIOPHARMA (SHANGHAI) CO., LTD.
WO/2021/259051	METHOD FOR IMPROVING SYNTHESIS PROCESS OF HYPIDONE FREE BASE	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/249364	NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS	WANG, Jinping
WO/2021/249367	NEW CRYSTAL FORM OF P-TOLUENESULFONATE SALT OF DIAZABICYCLIC COMPOUND AND PREPARATION METHOD THEREFOR	CRYSTAL PHARMATECH CO., LTD.
WO/2021/249395	SOLID STATE FORMS OF CYANTRANILIPROLE	ADAMA MAKHTESHIM LTD.
WO/2021/249396	THE PROCESS OF PREPARATION OF ANTHRANILAMIDES	ADAMA MAKHTESHIM LTD.
WO/2021/259060	KETOROLACO DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF	NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/249417	HETEROCYCLIC COMPOUND AND DERIVATIVE THEREOF	SCINNOHUB PHARMACEUTICAL CO., LTD
WO/2021/249443	INSULIN GLARGINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	NINGBO KUNPENG BIOTECH CO., LTD.
WO/2021/249449	SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/249450	SALT FORM, CRYSTAL FORM, PHARMACEUTICAL COMPOSITION AND USE OF TYROSINE KINASE INHIBITOR	BETTA PHARMACEUTICALS CO., LTD
WO/2021/249451	CORONAVIRUS VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249454	VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249455	HIV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/254235	SYNTHETIC METHOD OF (S)-2-AMINOBUTANAMIDE	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/249463	BICYCLIC COMPOUND AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/249468	PREPARATION METHOD FOR CHLORINATED COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/249475	FUSED QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/249505	INSULIN DEGLUDEC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	NINGBO KUNPENG BIOTECH CO., LTD.
WO/2021/249507	QUADRIDENTATE RING METAL PLATINUM (II) COMPLEX BASED ON CARBOXYL COORDINATION AND COMPRISING PYRIDYL ACRIDINE AND USE THEREOF	ZHE JIANG UNIVERSITY OF TECHONOLOGY
WO/2021/254254	ORGANIC ARSENIC-BASED TYPE II PYRUVATE KINASE INHIBITOR AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/249514	TETRADENTATE CYCLOMETALATED PLATINUM (II) COMPLEX BASED ON OXYGEN ATOM LINKAGE AND CONTAINING PHENYL ACRIDINE AND APPLICATION THEREOF	ZHEJIANG UNIVERSITY OF TECHONOLOGY
WO/2021/249517	A MOLECULAR GLUE REGULATING CDK12-DDB1 INTERACTION TO TRIGGER CYCLIN K DEGRADATION	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/249519	PYRIDINE-PYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/259077	SUBSTITUTED PYRAZINE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/249522	PYRIDONE-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	SHANGHAI HANSOH BIOMEDICAL CO., LTD.
WO/2021/249529	INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS	NUCMITO PHARMACEUTICALS CO., LTD.
WO/2021/249533	ESTROGEN RECEPTOR MODULATOR COMPOUND AND USE THEREOF	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/249534	PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD
WO/2021/249542	ANTIBODIES BINDING TNFR2 AND USES THEREOF	NANJING LEADS BIOLABS CO., LTD.
WO/2021/249545	METHOD FOR ONE-STEP PREPARATION OF POLYETHER HAVING TRANS-FUSED POLYCYCLIC ETHER FRAMEWORK STRUCTURE	NANKAI UNIVERSITY
WO/2021/249547	ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF	BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
WO/2021/249549	CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/249555	FUSION POLYPEPTIDE	BEIJING VDJBIO CO., LTD.
WO/2021/249558	PTERIDONE DERIVATIVE AS RSK INHIBITOR AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/249563	ARYL OR HETEROARYL PYRIDONE OR PYRIMIDONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.
WO/2021/249564	SEMAGLUTIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NINGBO KUNPENG BIOTECH CO., LTD.
WO/2021/254321	NOVEL FLUORESCENT COMPOUND HAVING LARGE STOKES SHIFT	NANJING GENSCRIPT BIOTECH CO., LTD.
WO/2021/254333	SYNTHETIC T CELL RECEPTOR AND ANTIGEN RECEPTOR COMPLEX AND APPLICATION THEREOF	CHINA IMMUNOTECH (BEIJING) BIOTECHNOLOGY CO., LTD
WO/2021/249566	BENZO SIX-MEMBERED RING DERIVATIVE AND USE THEREOF	SHANDONG BIOPOLAR DICHANG PHARMACEUTICAL CO., LTD.
WO/2021/254372	METHOD FOR PREPARING HEXAFLUORO-1,3-BUTADIENE AND INTERMEDIATE THEREOF	ZHEJIANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD
WO/2021/254384	NOVEL PYRIDO[2,3-D]PYRIMIDINE-7(8H)-ONE DERIVATIVE	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/259101	ANTI-HER2 MONOCLONAL ANTIBODY LYOPHILIZED PREPARATION AND PREPARATION METHOD	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/254389	PYRAZOLO[3,4-D]PYRIMIDINE-3-KETONE DERIVATIVE AS WEE-1 INHIBITOR	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/254403	METHODS AND COMPOSITIONS RELATED TO NEUTRALIZING ANTIBODIES AGAINST HUMAN CORONAVIRUS	HIFIBIO (HANGZHOU) CO., LTD.
WO/2021/254409	PHARMACEUTICAL COMPOSITION OF COMPLEX AND PREPARATION METHOD THEREFOR	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
WO/2021/254416	INDANONE COMPOUND AND USE THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/254417	BICYCLIC COMPOUND AND APPLICATION THEREOF	BETTA PHARMACEUTICALS CO., LTD
WO/2021/254445	CRYSTAL FORM OF GABA INHIBITOR AND PREPARATION METHOD THEREFOR	DONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/254449	CRYSTALLINE FORM OF SHP2 INHIBITOR, AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF	ETERN BIOPHARMA (SHANGHAI) CO., LTD.
WO/2021/254453	AMINOPYRIDINE COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/254456	CRYSTAL FORM OF 2-METHYL-2-PROPANOL AND AMINO-SUBSTITUTED ARYL COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/254458	HIGH-AFFINITY T-CELL RECEPTOR FOR RECOGNIZING HPV ANTIGEN	XLIFESC, LTD.
WO/2021/254464	SUBSTITUTED QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF	HONGYUN BIOTECH CO., LTD.
WO/2021/254469	METHOD FOR SYNTHESIS OF ROXADUSTAT AND INTERMEDIATE THEREOF, AND INTERMEDIATE THEREOF	JUMPCAN (SHANGHAI) MEDICAL TECHNOLOGY CO., LTD
WO/2021/254470	6-OXO-3,6-DIHYDROPYRIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/254479	MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE	SHANGHAI BAO PHARMACEUTICALS CO., LTD.
WO/2021/259160	ANTIBODIES SPECIFICALLY RECOGNIZING C5A AND USES THEREOF	STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/254481	ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/254483	BRUTON’S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR	SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD.
WO/2021/259162	ANTI-TROP2 ANTIBODY	SICHUAN BAILI PHARM CO.LTD
WO/2021/259163	PREPARATION METHOD FOR FUSED PYRAZOLE-TYPE COMPOUND	SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD.
WO/2021/254493	CYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF	INNOVSTONE THERAPEUTICS LIMITED
WO/2021/259173	APPLICATION OF PTPN2 INHIBITOR FOR KRAS MUTANT TUMOR	RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/259199	ANTI-CD73 ANTIBODY AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/259200	ANTI-ANG-2 ANTIBODY AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/259201	NUCLEIC ACID LIGAND AND USE THEREOF	NUHIGH BIOTECHNOLOGIES CO., LTD.
WO/2021/259203	PREPARATION METHOD FOR CDK4/6 INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/259206	DNA VACCINE FOR SARS-COV-2 VIRUS AND USE THEREOF	ALEX (BEIJING) BIOTECHNOLOGY CO., LTD
WO/2021/259208	TYK-2 INHIBITOR	BEIGENE, LTD.
WO/2021/259224	TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF	SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD.
WO/2021/259226	POLYPEPTIDE SPECIFICALLY BOUND TO CD123 PROTEIN, POLYPEPTIDE COMPLEX, CO-DELIVERY SYSTEM, PREPARATION METHODS THEREFOR AND APPLICATIONS THEREOF	INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/259227	ANTI-CD38 ANTIBODY AND USE THEREOF	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/259304	ANTIBODIES AND METHODS FOR TREATING CLAUDIN-ASSOCIATED DISEASES	ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD.
WO/2021/259309	GLP-1 RECEPTOR AGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD.
WO/2021/259315	SALT OF COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SALT	SHENZHEN FORWARD PHARMACEUTICALS LIMITED CO.
WO/2021/259316	CRYSTALLINE FORM OF COMPOUND	SHENZHEN FORWARD PHARMACEUTICALS LIMITED CO.
WO/2021/259331	EIGHT-MEMBERED N-CONTAINING HETEROCYCLIC COMPOUND	MEDSHINE DISCOVERY INC.
WO/2021/259335	HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED DISEASES	HUAHUI HEALTH LTD.
WO/2021/223780	USE OF BENZISOSELAZOLE DERIVATIVE FOR ANTI-CORONAVIRUS AND CONTROL OF INTERSTITIAL LUNG DISEASE (ILD) RELATED TO CORONAVIRUS	SHANGHAI YUANXI MEDICINE CORP.
WO/2021/228284	NOVEL STING AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF	TSINGHUA UNIVERSITY
WO/2021/254529	BICYCLIC COMPOUND	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/185391	INHIBITORS OF CYTOKININ OXIDASE DERIVED FROM 1-[2-(HYDROXYALKYL)PHENYL]-3-YLUREA, USE THEREOF AND PREPARATIONS CONTAINING THESE DERIVATIVES	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/018324	HETEROLEPTIC COMPLEXES OF COPPER WITH OSAJIN OR POMIFERIN AND THEIR UTILIZATION FOR THE PREPARATION OF DRUGS FOR THE TREATMENT OF TUMOUR DISEASES	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/233485	MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/047698	POLYPEPTIDES MIMICKING EPITOPE OF BROADLY NEUTRALIZING ANTIBODY VRC01 AS ANTIGENS FOR A VACCINE PREVENTING HIV-1 INFECTION	BIOTECHNOLOGICKY USTAV AVCR, V. V. I.
WO/2021/083438	INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I.
WO/2021/104547	COMPOUNDS FOR MODIFICATION OF NEGATIVELY CHARGED CARRIER SURFACE, METHOD OF THEIR PREPARATION AND USE THEREOF	UNIVERZITA KARLOVA
WO/2021/170154	PROCESS FOR THE PURIFICATION OF CARGLUMIC ACID AND INTERMEDIATE OF THIS PROCESS	SCALE UP LABORATORY, S.R.O.
WO/2021/164795	PYRAZOLE-INDOLE CONJUGATES FOR PHOTODYNAMIC TREATMENT OF CANCER AND BACTERIAL INFECTIONS	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/197519	COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I.
WO/2021/204309	CASEIN-DERIVED PENTAPEPTIDE AND COMPOSITION COMPRISING THEREOF AND TOPICAL USE THEREOF	CONTIPRO A.S.
WO/2021/004561	RUBELLA VIRUS SPIKE CONSTRUCT	INSTITUT VIRION-SERION GMBH WüRZBURG
WO/2021/013278	PROCESS FOR PREPARING A COUMARIN-CAGED FORSKOLIN DERIVATIVE, FORSKOLIN DERIVATIVE AND USE OF SAID FORSKOLIN DERIVATIVE	FORSCHUNGSZENTRUM JüLICH GMBH
WO/2021/083459	PROCESS FOR THE SYNTHESIS OF DOPA COMPRISING A PHOTOLABILE PROTECTIVE GROUP, AND INTERMEDIATES FOR THE PREPARATION THEREOF	CHIRACON GMBH
WO/2021/151435	METHOD FOR N-METHYLATION OF PRIMARY AND SECONDARY AMINES	TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG
WO/2021/160220	ANTIVIRAL SUBSTANCES WITH A WIDE SPECTRUM OF ACTIVITY	UNIVERSITÄT ZU LüBECK KÖRPERSCHAFT DES ÖFFENTLICHEN RECHTS
WO/2021/228301	PROCESS FOR THE SYNTHESIS OF ISOCYANATES	TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG
WO/2021/244705	SILYLATED OLIGOGERMANES AND POLYCYCLIC SILICON-GERMANIUM COMPOUNDS, PROCESS OF PREPARING SAME AND THEIR USE FOR PRODUCING A SI- AND GE-CONTAINING SOLID	JOHANN WOLFGANG GOETHE-UNIVERSITÄT
WO/2021/197553	SYNTHETIC MHC CLASS II PROTEIN	JACOBS UNIVERSITY BREMEN GGMBH
WO/2021/083470	A TOILET FLUSH VALVE FOR FLUSHING WITH SLUDGE-FILLED WATER, USE OF AN IMPREGNATED ROPE AND USE OF A SILICONE GASKET	ECOBETA A/S
WO/2021/254574	CD38 ANTIBODIES FOR THE TREATMENT OF HUMAN DISEASES	Y-MABS THERAPEUTICS, INC.
WO/2021/129915	GBD-SSTAD-SSTAD RECOMBINANT PROTEIN AND METHOD FOR PRODUCING AND USING SAME	LUNIN, Vladimir Glebovich
WO/2021/001044	PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF ELTROMBOPAG OR SALT THEREOF	F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
WO/2021/037384	RECOMBINANT CHORIONIC GONADOTROPIN, PROCEDURE FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME	SYNTEX S.A.
WO/2021/043402	NEW PLATINUM IV COMPLEXES WITH SUBSTANTIALLY INCREASED ANTITUMOR EFFICACY	VUAB PHARMA A.S.
WO/2021/073736	NEW AROMATIC MONOTHIOKETALS AS ODORIFEROUS SUBSTANCES	SYMRISE AG
WO/2021/004648	PROCESS FOR CONVERTING ORGANOSILANES	WACKER CHEMIE AG
WO/2021/110234	COMPOSITIONS COMPRISING HYPER HARMONIZED HYDROXYL MODIFIED FULLERENE SUBSTANCES	FIELDPOINT (CYPRUS) LIMITED
WO/2021/110256	PROCESS FOR PREPARING TRIMETHYLCHLOROSILANE	WACKER CHEMIE AG
WO/2021/110264	SILIRANE-FUNCTIONALISED COMPOUNDS, IN PARTICULAR ORGANOSILICON COMPOUNDS, FOR PREPARING SILOXANES	WACKER CHEMIE AG
WO/2021/110265	SILIRANE COMPOUNDS AS STABLE SILYLENE PRECURSORS AND THEIR USE IN THE CATALYST-FREE PREPARATION OF SILOXANES	WACKER CHEMIE AG
WO/2021/115560	NEW FYN AND VEGFR2 KINASE INHIBITORS	ROTTAPHARM BIOTECH S.R.L.
WO/2021/115586	HYDROSILYLABLE MIXTURE INCLUDING STRONG ELECTRON DONORS, AS CATALYST ADDITIVE	WACKER CHEMIE AG
WO/2021/121647	METAL COMPLEXES OF MACROCYCLES AND/OR ISOPRENOIDS AND/OR LINEAR TETRAPYRROLES BY MECHANOCHEMISTRY (GRINDING OR MILLING), PREPARATION METHOD THEREOF, SUNSCREEN/CONCEALER/UV ABSORBER THEREOF, SELF-ASSEMBLED COATING MATERIAL THEREOF, SUPERAMPHIPHILIC MATERIAL OR SURFACES THEREOF, HAIR DYEING THEREOF AND OTHER USES THEREOF	RAMIREZ RIOS, Liliana Patricia
WO/2021/083546	PROCESS AND PLANT FOR PRODUCING METHANOL FROM HYDROGEN-RICH SYNTHESIS GAS	L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (AIR LIQUIDE SA)
WO/2021/089183	PROCESS AND PLANT FOR PRODUCING MONOETHYLENE GLYCOL	LINDE GMBH
WO/2021/098989	A NEW ANTIBIOTIC SELECTIVELY KILLS GRAM-NEGATIVE PATHOGENS	JUSTUS-LIEBIG-UNIVERSITÄT GIEßEN
WO/2021/148110	HBV SPECIFIC TCR LIBRARY AND ITS USE AS PERSONALISED MEDICINE	LION TCR PTE. LTD.
WO/2021/155897	MARKER SET FOR THE DIAGNOSIS AND TREATMENT OF CANCER	MVZ PROF. NIENDORF PATHOLOGIE HAMBURG-WEST GMBH
WO/2021/160249	HYDRATED CRYSTALLINE POLYNUCLEAR METAL COMPLEX, HYDRATED CRYSTALLINE POLYNUCLEAR METAL COMPLEX INCLUDING A GUEST COMPOUND ANALYTE AND ITS USE IN A METHOD FOR DETERMINING MOLECULAR STRUCTURE OF THE GUEST COMPOUND ANALYTE	MERCK PATENT GMBH
WO/2021/160265	BISPECIFIC ANTIBODIES AGAINST CD9 AND CD137	UCB BIOPHARMA SRL
WO/2021/160266	BISPECIFIC ANTIBODIES BINDING HVEM AND CD9	UCB BIOPHARMA SRL
WO/2021/160267	BISPECIFIC ANTIBODIES AGAINST CD9 AND CD7	UCB BIOPHARMA SRL
WO/2021/160268	BISPECIFIC ANTIBODIES AGAINST CD9	UCB BIOPHARMA SRL
WO/2021/160269	ANTI CD44-CTLA4 BISPECIFIC ANTIBODIES	UCB BIOPHARMA SRL
WO/2021/032323	FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES	GALAPAGOS NV
WO/2021/164880	PHENAZINE-BASED COMPOUNDS AND USE THEREOF AS REDOX FLOW BATTERY ELECTROLYTE	CMBLU ENERGY AG
WO/2021/170225	PROCESS FOR PREPARING ALKOXYSIL(OX)ANES FROM HYDRIDOSILICON COMPOUNDS	WACKER CHEMIE AG
WO/2021/170226	HALOGENATED TETRASILYL BORANATES	WACKER CHEMIE AG
WO/2021/175437	A NEW CLASS OF FLAVIVIRUS PROTEASE INHIBITORS	UNIVERSITÄT HEIDELBERG
WO/2021/083554	3-((<i>R</i>)-2-(AMINO-2-PHENYLETHYL)-1-(2-FLUORO-6-TRIFLUOROMETHYL BENZYL)-5-IODO-6-METHYL-1<i>H</i>-PYRIMIDINE-2,4-DIONE OR A SALT THEREOF, PROCESS FOR ITS PREPARATION, AND ITS USE IN THE SYNTHESIS OF ELAGOLIX	MOEHS IBERICA, S.L.
WO/2021/037401	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/190727	COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION	F. HOFFMANN-LA ROCHE AG
WO/2021/197597	METAL ORGANIC COMPOUNDS	UMICORE AG & CO. KG
WO/2021/197598	ORGANOMETALLIC COMPOUNDS	UMICORE AG & CO. KG
WO/2021/197629	METHOD FOR PRODUCING OXIDIZED LIGNINS AND SYSTEM FOR PRODUCING OXIDIZED LIGNINS	ROCKWOOL INTERNATIONAL A/S
WO/2021/197636	METHOD FOR PRODUCING OXIDIZED LIGNINS AND SYSTEM FOR PRODUCING OXIDIZED LIGNINS	ROCKWOOL INTERNATIONAL A/S
WO/2021/204380	ESTERS AS FRAGRANCE COMPOUNDS	SYMRISE AG
WO/2021/209127	NOBLE METAL-FREE HYDROSILYLATABLE MIXTURE	WACKER CHEMIE AG
WO/2021/213627	OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS	SYMRISE AG
WO/2021/213661	METHOD FOR THE DEHYDROGENATION AND METHYLATION OF SILANES WITH METHYL CHLORIDE	WACKER CHEMIE AG
WO/2021/213663	PROCESS FOR PREPARING ALDEHYDES FROM 1,3,5 TRIOXANES	WACKER CHEMIE AG
WO/2021/219192	METHOD FOR PRODUCING ESTERS OF HOMOVANILLIC ACID	SYMRISE AG
WO/2021/043452	METHOD FOR PROCESSING A GASEOUS COMPOSITION	THYSSENKRUPP INDUSTRIAL SOLUTIONS AG
WO/2021/228352	A FRAGRANCE COMPOSITION	SYMRISE AG
WO/2021/104684	IMPROVED PROCESS FOR PREPARING AQUEOUS SOLUTIONS OF 4-AMMONIUM-ALKYLPIPERIDINE-1-YLOXYL SALTS FOR USE IN CHARGE STORAGE UNITS	EVONIK OPERATIONS GMBH
WO/2021/104685	IMPROVED METHOD FOR PRODUCING 4-METHYLAMMONIUM-2,2,6,6 TETRAMETHYLPIPERIDINYLCHLORIDES	EVONIK OPERATIONS GMBH
WO/2021/104686	PROCESS FOR PREPARING AQUEOUS SOLUTIONS OF 4-AMMONIUM-ALKYLPIPERIDINE-1-YLOXYL SALTS WITH A LOW SALT CONTENT FOR USE IN CHARGE STORAGE UNITS	EVONIK OPERATIONS GMBH
WO/2021/008783	A PROCESS FOR THE SYNTHESIS OF UREA	CASALE SA
WO/2021/004719	PROCESS FOR PRODUCTING ALKYLMETHACRYLATES AND OPTIONAL METHACRYLIC ACID	RÖHM GMBH
WO/2021/001128	CHEMICAL INHIBITORS OF ID PROTEINS FOR THE TREATMENT OF CANCER AND OTHER DISEASES	UNIVERSITÄT HEIDELBERG
WO/2021/004760	PROCESS FOR THE DI-O-ALKYLATION OF 1,3-DIOLS TO 1,3-DIETHERS	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/001240	HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF A RU-PNN COMPLEX	BASF SE
WO/2021/001244	PEPTIDE ACETALS FOR STABILISING ENZYMES	BASF SE
WO/2021/008840	FUSION TOXIN PROTEINS FOR TREATMENT OF DISEASES RELATED TO CMV INFECTIONS	KØBENHAVNS UNIVERSITET
WO/2021/008843	METASTABLE CRYSTAL MODIFICATION AND METHOD FOR THE PRODUCTION THEREOF (I)	ALZCHEM TROSTBERG GMBH
WO/2021/008844	METASTABLE CRYSTAL MODIFICATION AND METHOD FOR THE PRODUCTION THEREOF (II)	ALZCHEM TROSTBERG GMBH
WO/2021/008845	METHOD FOR PRODUCING A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (III)	ALZCHEM TROSTBERG GMBH
WO/2021/008846	METHOD FOR PRODUCING A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV)	ALZCHEM TROSTBERG GMBH
WO/2021/001289	IMMUNOCONJUGATES COMPRISING A MUTANT INTERLEUKIN-2 AND AN ANTI-CD8 ANTIBODY	F. HOFFMANN-LA ROCHE AG
WO/2021/001328	PROCESS FOR MANUFACTURING (S)-3-HYDROXY-1-(1H-INDOL-5-YL)-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 3,5-DIFLUORO-BENZYLAMIDE	MERCK PATENT GMBH
WO/2021/001330	HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/001331	SUBSTITUTED THIOPHENE CARBOXAMIDES AND DERIVATIVES THEREOF AS MICROBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/001350	2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN	MOEHS IBERICA, S.L.
WO/2021/001351	PLASMODIUM ANTIBODIES	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/001367	SERPIN PRODUCTION	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001368	SERPIN PRODUCTION	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001404	TREATMENT AND PREVENTION OF ISCHEMIC DISEASES AND/OR ISCHEMIC TISSUE DAMAGES	JULIUS-MAXIMILIANS-UNIVERSITAET-WUERZBURG
WO/2021/058154	NOVEL PLATINUM COMPLEX	HERAEUS DEUTSCHLAND GMBH & CO. KG
WO/2021/001414	PEPTIDE-MHC COMPLEXES	IMMUNOCORE LIMITED
WO/2021/001420	PRODRUGS OF MODULATORS OF THE NMDA RECEPTOR	H. LUNDBECK A/S
WO/2021/001423	MODULATORS OF THE NMDA RECEPTOR	H. LUNDBECK A/S
WO/2021/001424	METHOD FOR THE PURIFICATION OF ANILINE	COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
WO/2021/001453	ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS	LEAD PHARMA HOLDING B.V.
WO/2021/004885	NOVEL ALLERGEN	PHADIA AB
WO/2021/004895	CRYSTALLINE FORMS OF AN ORALLY AVAILABLE, SELECTIVE KIT AND PDGFR KINASE INHIBITOR	SANDOZ AG
WO/2021/004897	METHOD FOR REDUCING THE CONCENTRATION OF SO<sb>3</sb> IN A REACTION MIXTURE COMPRISING METHANE SULFONIC ACID AND SO<sb>3</sb>	BASF SE
WO/2021/001510	ANALYSIS FOR BLOOD GROUP ANTIGENS DACY/YCAD	IMUSYN GMBH & CO. KG
WO/2021/004912	STREPTOMYCES CLAVULIGERUS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/001522	A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO STABILITY OF COAGULATION FACTOR VIII	CSL BEHRING LENGNAU AG
WO/2021/001525	PROCESS FOR PURIFYING C1-INH	CSL BEHRING GMBH
WO/2021/004923	CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/008902	TWIN-MONOMER COMPOSITION AND DIELECTRIC FILM THEREOF	BASF SE
WO/2021/004940	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS	GALECTO BIOTECH AB
WO/2021/004947	METHOD FOR PREPARATION OF ACETOACETATE ESTER COMPOUNDS	LONZA SOLUTIONS AG
WO/2021/004968	MICROBIOCIDAL PICOLINAMIDE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/004973	SYNTHESIS OF A-AMANITIN AND ITS DERIVATIVES	PURE BIOORGANICS SIA
WO/2021/004975	MODIFIED IgA ANTIBODY PROTEINS	UNIVERSITETET I OSLO
WO/2021/004977	PROCESS FOR THE DEPROTECTION OF OLIGONUCLEOTIDES	F. HOFFMANN-LA ROCHE AG
WO/2021/005009	ANTIBODIES BINDING IGC2 OF IGSF11 (VSIG3) AND USES THEREOF	IOMX THERAPEUTICS AG
WO/2021/005019	TAU EPITOPE AND BINDING MOLECULES	GEN2 NEUROSCIENCE LIMITED
WO/2021/005034	NEW HETEROCYCLIC COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/005043	MACROCYCLIC SPIROCYCLE DERIVATIVES AS MCL-1 INHIBITORS	JANSSEN PHARMACEUTICA NV
WO/2021/005081	PROCESS OF PREPARING 2-(PHENYLIMINO)-1,3-THIAZOLIDIN-4-ONES	BAYER AKTIENGESELLSCHAFT
WO/2021/005082	PROCESS OF PREPARING 2-(PHENYLIMINO)-1,3-THIAZOLIDIN-4-ONES	BAYER AKTIENGESELLSCHAFT
WO/2021/005086	METHOD FOR REDUCING THE CONCENTRATION OF SO3 IN A REACTION MIXTURE COMPRISING A SULFONIC ACID AND SO3	GRILLO-WERKE AG
WO/2021/259505	NOBLE METAL COMPLEXES COMPRISING DIOLEFIN AND C6-C18 MONOCARBOXYLATE LIGANDS FOR SURFACE COATING	HERAEUS DEUTSCHLAND GMBH & CO. KG
WO/2021/005108	MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE	MEDIGENE IMMUNOTHERAPIES GMBH
WO/2021/005109	2-(2,4,5-TRIMETHYLCYCLOHEX-2-EN-1-YL)ACETALDEHYDE AND DERIVATIVES AND THEIR USE AS AROMA CHEMICALS	BASF SE
WO/2021/005125	COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF	3B PHARMACEUTICALS GMBH
WO/2021/005131	COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF	3B PHARMACEUTICALS GMBH
WO/2021/005137	PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRAZOLE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/013561	PESTICIDAL PYRAZOLE AND TRIAZOLE DERIVATIVES	BASF SE
WO/2021/009002	NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES	MELCHIOR MATERIAL AND LIFE SCIENCE FRANCE
WO/2021/005165	TETRAHYDROISOQUINOLINE COMPOUNDS	ALLINKY BIOPHARMA
WO/2021/009026	METHYL 2-[(4-METHOXYIMINO-TETRALIN-6-YL]PROP-2-ENOATE DERIVATIVES, CHROMANE, ISOCHROMANE, 6,7,8,9-TETRAHYDROBENZO[7]ANNULENE, 1H-ISOBENZOFURANE AND INDANE ANALOGUES THEREOF, AND SIMILAR COMPOUNDS, AS AGROCHEMICAL FUNGICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/009034	3-[2(R)-AMINO-2-PHENYLETHYL]-5-(2-FLUORO-3-METHOXYPHENYL)-1-[2-FLUORO-6-(TRIFLUOROMETHYL)BENZYL]-6-METHYL-1H-PYRIMIDINE-2,4(1H,3H)-DIONE HYDROCHLORIDE SALT (I) IN SOLID FORM, PROCESS FOR PREPARING SAME, AND USE THEREOF IN THE SYNTHESIS OF ELAGOLIX	MOEHS IBERICA, S.L.
WO/2021/009047	ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO SAID CELLS	F. HOFFMANN-LA ROCHE AG
WO/2021/009048	HERBICIDAL CYCLOHEXANEDIONE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/005214	NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/005222	INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE	IDORSIA PHARMACEUTICALS LTD
WO/2021/204407	G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)	SORBONNE UNIVERSITé
WO/2021/009068	N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME	SCENIC IMMUNOLOGY B.V.
WO/2021/005232	INTRANASAL ADMINISTRATION OF NEUTRALISING ANTIVIRAL ANTIBODIES	UMC UTRECHT HOLDING B.V.
WO/2021/009081	BINDING AGENTS AND USES THEREOF	JANSSEN PHARMACEUTICA NV
WO/2021/009087	PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL	INTERQUIM, S.A.
WO/2021/018560	PROCESS FOR PREPARING ALKYLENE GLYCOL FROM A CARBOHYDRATE SOURCE COMPRISING HEMICELLULOSE, CELLULOSE AND LIGNIN	AVANTIUM KNOWLEDGE CENTRE B.V.
WO/2021/009146	ANTIBODIES BINDING TO NKG2D	F. HOFFMANN-LA ROCHE AG
WO/2021/013640	A PROCESS FOR THE CONTINUOUS PRODUCTION OF EITHER ACROLEIN OR ACRYLIC ACID AS THE TARGET PRODUCT FROM PROPENE	BASF SE
WO/2021/018572	AIR-STABLE NI(0)-OLEFIN COMPLEXES AND THEIR USE AS CATALYSTS OR PRECATALYSTS	STUDIENGESELLSCHAFT KOHLE MBH
WO/2021/009187	CANINIZED ANTIBODIES AGAINST CANINE CTLA-4	INTERVET INTERNATIONAL B.V.
WO/2021/009188	CANINIZED ANTIBODIES TO HUMAN AND CANINE CTLA-4	INTERVET INTERNATIONAL B.V.
WO/2021/009204	NOVEL INHIBITORS OF KALLIKREIN PROTEASES AND USES THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/009206	COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE, A DISPLAY DEVICE AND A LIGHTING DEVICE COMPRISING THE SAME	NOVALED GMBH
WO/2021/009209	SUBSTITUTED AMINO TRIAZOLES USEFUL AS CHITINASE INHIBITORS	ONCOARENDI THERAPEUTICS S.A.
WO/2021/009212	ANTIBACTERIAL QUINOLONE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/009229	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/009232	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/009242	HYBRID HTIRNA/NANOPARTICLE COMPLEX AND USE THEREOF FOR TREATING A DISEASE OF THE DIGESTIVE SYSTEM	COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
WO/2021/009251	SPECIFIC ACKR2 MODULATORS FOR USE IN THERAPY	LUXEMBOURG INSTITUTE OF HEALTH (LIH)
WO/2021/009263	ANTIBODIES HAVING SPECIFICITY FOR CD38 AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/013689	LYOPHILIZED ANTIBODY FORMULATION	ICHNOS SCIENCES SA
WO/2021/009306	IMPROVED PROCESS FOR PREPARING OZANIMOD	SYNTHON B.V.
WO/2021/009307	METHOD AND FACILITY FOR PRODUCING A TARGET COMPOUND	LINDE GMBH
WO/2021/009310	METHOD AND FACILITY FOR PRODUCING A TARGET COMPOUND	LINDE GMBH
WO/2021/009311	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/009312	METHOD AND FACILITY FOR PRODUCING A TARGET COMPOUND	LINDE GMBH
WO/2021/009322	METHOD FOR SELECTING HYBRIDOMA CELLS FROM A PLURALITY OF HYBRIDOMA CELLS BY MEANS OF A BIRA EXPRESSION VECTOR	NEW/ERA/MABS GMBH
WO/2021/009334	SUBSTITUTED PYRIDAZINONES AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/009335	SUBSTITUTED PYRIDAZINONES AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/018630	METHOD AND SYSTEM FOR THE SYNTHESIS OF METHANOL	BALTHASAR, Wolff
WO/2021/013719	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/013720	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/013721	5-AMINO SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PEST CONTROL AGENTS	BAYER AKTIENGESELLSCHAFT
WO/2021/013733	ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION	ABIVAX
WO/2021/013735	PARP1 INHIBITORS	ASTRAZENECA AB
WO/2021/009366	METHOD FOR PREPARATION OF DECOLORIZED ACETOACETYLATED ETHYLENE GLYCOL	LONZA SOLUTIONS AG
WO/2021/013742	5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE	JANSSEN PHARMACEUTICA NV
WO/2021/013746	AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER	GENMAB A/S
WO/2021/009374	IONIC LIQUID-TYPE COMPOUNDS AND THEIR METHODS OF PREPARATION AND USES	UNIVERSITE DE REIMS CHAMPAGNE ARDENNE
WO/2021/013775	METHOD FOR PRODUCING ORTHO-METALLATED METAL COMPOUNDS	MERCK PATENT GMBH
WO/2021/018651	OLIGOMERIZATION PROCESS USING A RECYCLE OF GASEOUS HEADSPACE	IFP ENERGIES NOUVELLES
WO/2021/013795	METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS, NICOTINAMIDE RIBOFURANOSIDE SALTS AS SUCH, AND USES THEREOF	BIOSYNTH AG
WO/2021/013799	SUBSTITUTED N-PHENYL URACILS, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS	BAYER AKTIENGESELLSCHAFT
WO/2021/013800	SUBSTITUTED N-PHENYL-N-AMINOUARCILS AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL AGENTS	BAYER AKTIENGESELLSCHAFT
WO/2021/013826	METHOD FOR OBTAINING AMORPHOUS REMIMAZOLAM BESYLATE	MOEHS IBERICA, S.L.
WO/2021/013830	N-METHYL, N-(6-(METHOXY)PYRIDAZIN-3-YL) AMINE DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR THE TREATMENT OF INFLAMMATORY AIRWAY OR FIBROTIC DISEASES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/013832	1-(6-(METHOXY)PYRIDAZIN-3-YL)CYCLOPROPANE-1-CARBOXAMIDE DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR THE TREATMENT OF INFLAMMATORY AIRWAY DISEASES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/013833	N-METHYL, N-(6-(METHOXY)PYRIDAZIN-3-YL) AMINE DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR THE TREATMENT OF INFLAMMATORY AIRWAY OR FIBROTIC DISEASES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/013848	CONTINUOUS HYDROFORMYLATION PROCESS WITH CATALYST SUBSTITUTION	OQ CHEMICALS GMBH
WO/2021/013864	4-(IMIDAZO[1,2-A]PYRIDIN-3-YL) -PYRIMIDINE DERIVATIVES	MERCK PATENT GMBH
WO/2021/028171	THIRD GENERATION DENDRIMER, PROCESS FOR PRODUCTION THEREOF AND USE THEREOF	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/018699	CANNABINOID RECEPTOR SUBTYPE 2 STIMULATOR INHIBITING ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/013910	PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES	GLOBACHEM NV
WO/2021/018715	EXTRACTION OF ALIPHATIC ALCOHOLS	EVONIK OPERATIONS GMBH
WO/2021/018717	A METHOD OF EXTRACTING CARBONIC ACID, ALIPHATIC ACIDS, ESTERS AND ALCOHOLS FROM AN AQUEOUS MEDIUM	EVONIK OPERATIONS GMBH
WO/2021/013932	POLYPEPTIDES FOR TREATMENT OF AML	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/013969	3-[(HYDRAZONO)METHYL]-N-(TETRAZOL-5-YL)-BENZAMIDE AND 3-[(HYDRAZONO)METHYL]-N-(1,3,4-OXADIAZOL-2-YL)-BENZAMIDE DERIVATIVES AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/013978	TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER	BAYER AS
WO/2021/013986	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/013993	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/013996	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/013997	PROCESS FOR THE SYNTHESIS OF N-ALKYL-4-PYRIDINAMINES	MEDICHEM, S.A.
WO/2021/013998	MAGNETIC BACTERIA, NON-THERAPEUTIC AND THERAPEUTIC USES THEREOF	PARIS SCIENCES ET LETTRES - QUARTIER LATIN
WO/2021/014001	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/014022	CAR-CD123 VECTOR AND USES THEREOF	OSPEDALE PEDIATRICO BAMBINO GESU'
WO/2021/018820	HETEROARYL-SUBSTITUTED PYRAZOLO-PYRIDINE PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH	HEPAREGENIX GMBH
WO/2021/018826	CYCLIC DIONES AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/018833	CYCLOHEXANEDIONES AS HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/018834	CYCLIC DIONES AS HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/018849	PYRAZOLE DERIVATIVES FOR CONTROLLING ARTHROPODS	BAYER ANIMAL HEALTH GMBH
WO/2021/018857	3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS	LES LABORATOIRES SERVIER
WO/2021/018858	6,7-DIHYDRO-5H-PYRIDO[2,3-C]PYRIDAZINE DERIVATIVES AND RELATED COMPOUNDS AS BCL-XL PROTEIN INHIBITORS AND PRO-APOPTOTIC AGENTS FOR TREATING CANCER	LES LABORATOIRES SERVIER
WO/2021/023569	PURIFICATION OF AROMA CHEMICALS	BASF SE
WO/2021/018869	1,2,4-OXADIAZOL-5-ONE DERIVATIVES FOR THE TREATMENT OF CANCER	BASILEA PHARMACEUTICA INTERNATIONAL AG
WO/2021/023572	HERBICIDAL AMIDES	BASF SE
WO/2021/023582	RECOVERY OF WATER-FREE METHANESULFONIC ACID FROM THE BOTTOM STREAM OF A DISTILLATION COLUMN	BASF SE
WO/2021/023583	PROCESS FOR THE PRODUCTION OF ALKANESULFONIC ACIDS	BASF SE
WO/2021/018925	ANTIBODIES BINDING TO GPRC5D	F. HOFFMANN-LA ROCHE AG
WO/2021/018941	METHODS OF TREATING CANCER	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/018948	QUINAZOLIN-4-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS	JANSSEN PHARMACEUTICA NV
WO/2021/018951	PHTHALAZIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS	JANSSEN PHARMACEUTICA NV
WO/2021/019005	METHOD FOR THE TREATMENT A COMPOSITION COMPRISING NATURAL VANILLIN	RHODIA OPERATIONS
WO/2021/023619	METHODS FOR PURIFYING ANTIBODIES	UCB BIOPHARMA SRL
WO/2021/023624	NOVEL IL-17B ANTIBODIES	OREGA BIOTECH
WO/2021/023627	HYDROGENATION OF IMINES WITH RU COMPLEXES	FIRMENICH SA
WO/2021/023634	PROCESS FOR THE SYNTHESIS OF PITOLISANT HCl	PROCOS S.P.A.
WO/2021/019051	INHIBITORS OF HUMAN ATGL	KARL-FRANZENS-UNIVERSITÄT GRAZ
WO/2021/019071	AMINOTHIOLESTER COMPOUNDS AND USES THEREOF	ADVANCED BIODESIGN
WO/2021/023657	MODIFIED BI SPECIFIC ANTI CD3 ANTIBODIES	IMMATICS BIOTECHNOLOGIES GMBH
WO/2021/023658	ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A	IMMATICS BIOTECHNOLOGIES GMBH
WO/2021/019094	MODIFIED FC-REGIONS TO ENHANCE FUNCTIONAL AFFINITY OF ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF	SCANCELL LIMITED
WO/2021/019095	BINDING MEMBERS	SCANCELL LIMITED
WO/2021/023693	PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE	NICOX S.A.
WO/2021/023719	A PEPTIDE BINDING TO TAU-PROTEIN	HOCHSCHULE FüR ANGEWANDTE WISSENSCHAFTEN COBURG
WO/2021/023721	CAR T-CELLS AGAINST BCMA FOR THE TREATMENT OF MULTIPLE MYELOMA	FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA
WO/2021/023751	MONTELUKAST ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME	GENETIC S.P.A.
WO/2021/023765	FURAN, THIOPHENE OR Y-LACTAM SESTERTERPENE TETRONIC ACIDS USEFUL AS ANTIVIRAL COMPOUNDS AGAINST INFECTIONS CAUSED BY HUMAN ADENOVIRUS	UNIVERSIDADE DA CORUÑA
WO/2021/023793	ANTI BDCA-2 ANTIBODIES	CAPELLA BIOSCIENCE LTD
WO/2021/023803	A PROCESS FOR THE PREPARATION OF DICARBOXYLIC ACIDS	BASF SE
WO/2021/023804	PERSONALIZED TREATMENT OF OPHTHALMOLOGIC DISEASES	F. HOFFMANN-LA ROCHE AG
WO/2021/028300	POLYISOCYANATE AND PROCESS FOR PREPARING THE SAME	COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
WO/2021/037516	ORGANIC CARBONATE PRODUCTION PROCESS	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/023813	5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS	DOMAIN THERAPEUTICS
WO/2021/028309	NOVEL ANTI-TROPONINT ANTIBODIES	F. HOFFMANN-LA ROCHE AG
WO/2021/023818	2-ACETYLPYRROLINE PRECURSOR	FIRMENICH SA
WO/2021/028316	2-PHENOXY-PYRIMIDINE DERIVATIVES AS HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/023840	MOLECULE HAVING A NITRILE OXIDE FUNCTION	ARKEMA FRANCE
WO/2021/023843	IMPROVED SYNTHETIC METHODS OF MAKING (2<i>H</i>-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/028323	(2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/023858	TrkB POSITIVE ALLOSTERIC MODULATORS	UNIVERSITé DE STRASBOURG
WO/2021/028346	TSHR LIGAND BINDING DOMAIN AND METHODS USING SAID DOMAIN	FORSCHUNGSVERBUND BERLIN E.V.
WO/2021/028362	SHP2 INHIBITORS	IRBM S.P.A.
WO/2021/023888	QUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS	B.C.I. PHARMA
WO/2021/028365	STABLE POLYMORPHIC FORM OF 6-FLUORO-9-METHYL-9H-B-CARBOLINE AND USES THEREOF	AUDIOCURE PHARMA GMBH
WO/2021/023891	STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION	UNIVERSITÄT BERN
WO/2021/023892	A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES	BELYNTIC GMBH
WO/2021/028375	BENAZOLIN-CHOLINE AND ITS USE IN THE AGROCHEMICAL FIELD	BAYER AKTIENGESELLSCHAFT
WO/2021/032519	METHOD FOR PURIFICATION OF ISOSORBIDE	BASF SE
WO/2021/028404	PEPTIDES DERIVED FROM SORTILIN	UNIVERSITE DE LIMOGES
WO/2021/043541	TAPE ACCELERATOR AND USE THEREOF, SOLID INSULATING MATERIAL, AND ANHYDRIDE-FREE INSULATION SYSTEM	SIEMENS AKTIENGESELLSCHAFT
WO/2021/028419	SUBSTITUTED 3-(2-HETEROARYLOXYPHENYL)ISOXAZOLINES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES	BAYER AKTIENGESELLSCHAFT
WO/2021/028421	SUBSTITUTED (2-HETEROARYLOXYPHENYL)ISOXAZOLINES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES	BAYER AKTIENGESELLSCHAFT
WO/2021/028506	NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE	COTY INC.
WO/2021/043556	PROCESS FOR PREPARING ALKENES	THYSSENKRUPP INDUSTRIAL SOLUTIONS AG
WO/2021/028518	PROCESS OF PREPARING 2-(PHENYLIMINO)-3-ALKYL-1,3-THIAZOLIDIN-4-ONES	BAYER AKTIENGESELLSCHAFT
WO/2021/028521	REDUCTION OF THE ODOR OF MONOTHIOCARBONATE COMPOUNDS BY ADDITION OF OXIDANTS	BASF SE
WO/2021/028522	PROCESS FOR THE PURIFICATION OF ORGANIC SULFUR COMPOUNDS	BASF SE
WO/2021/032588	MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS	INFLAZOME LIMITED
WO/2021/032590	NEW BED MATERIAL FOR THERMOLYTIC FRAGMENTATION OF SUGARS	HALDOR TOPSØE A/S
WO/2021/032591	MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS	INFLAZOME LIMITED
WO/2021/043560	PROCESS OF PREPARING ALCOHOLS	THYSSENKRUPP INDUSTRIAL SOLUTIONS AG
WO/2021/028570	2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/028579	METHOD FOR PRODUCING ENGINEERED TIRC7 SPECIFIC T-REGULATORY CELLS (TREGS)	NEKONAL S.A.R.L.
WO/2021/032672	BRANCHED ALKANES AND PROCESS FOR PREPARING SAME	GLOBAL BIOENERGIES
WO/2021/032673	CARBONYL COMPOUNDS, METHODS FOR PREPARING SAME AND USES THEREOF	GLOBAL BIOENERGIES
WO/2021/032675	ESTERIFIED OR ETHERIFIED COMPOUNDS, PROCESSES FOR PRODUCING SAME AND USES THEREOF	GLOBAL BIOENERGIES
WO/2021/032679	BRANCHED AND FUNCTIONALIZED ALKANES AND PROCESS FOR PREPARING SAME	GLOBAL BIOENERGIES
WO/2021/037614	PESTICIDALLY ACTIVE PYRAZINE-AMIDE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/032819	PREPARATION OF UREA SOLUTION AND FACILITY TO DO SO	YARA INTERNATIONAL ASA
WO/2021/032826	COMPOSITION OF BHET AND USE THEREOF	IONIQA TECHNOLOGIES B.V.
WO/2021/037660	SIMPLIFIED WORKUP OF THE REACTOR DISCHARGE OF AN OXIDATIVE ESTERIFICATION	RÖHM GMBH
WO/2021/037669	PROCESS FOR PRODUCING METHACROLEIN FROM FORMALDEHYDE AND PROPIONALDEHYDE AND PRODUCTION PLANT THEREFOR	RÖHM GMBH
WO/2021/037671	METHOD FOR PRODUCING METHACROLEIN FROM FORMALDEHYDE AND PROPIONALDEHYDE, AND PRODUCTION PLANT THEREFOR	RÖHM GMBH
WO/2021/037672	A PROCESS FOR PRODUCING 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/037675	PROCESS FOR PRODUCING 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/037677	PROCESS FOR PRODUCING 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/037680	A PROCESS FOR OBTAINING 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/037682	A PROCESS FOR PURIFYING CRUDE 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/037683	A PROCESS FOR PURIFYING 4,4'-DICHLORODIPHENYL SULFONE	BASF SE
WO/2021/032857	COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER	AC BIOSCIENCE SA
WO/2021/032860	ANTI-C7 ANTIBODY OR ANTIBODY FRAGMENT	UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD
WO/2021/037738	TEXTURING <i>L. LACTIS</i> WITH UNIQUE EPS GENE CLUSTERS	CHR. HANSEN A/S
WO/2021/037747	TEXTURIN<i>G L. LACTIS </i>WITH NIZO B40-LIKE EPS GENE CLUSTERS	CHR. HANSEN A/S
WO/2021/037755	DETOMIDINE HYDROCHLORIDE MONOHYDRATE	SACHSE, Andreas
WO/2021/037759	NOVEL COMPOUNDS FOR SKIN LIGHTENING	UNILEVER GLOBAL IP LIMITED
WO/2021/037777	PROCESS FOR PREPARING BISPHENOLE A (BPA) IN THE PRESENCE OF HYDROXYACETONE	COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
WO/2021/037797	(C)CRYSTAL COMPOSITION (CC) COMPRISING 4,4'-DICHLORODIPHENYLSULFONE CRYSTALS (C)	BASF SE
WO/2021/037806	2,2,6-TRIMETHYL-4,5-DIHYDRO-3H-OXEPINE AS AROMA INGREDIENT	BASF SE
WO/2021/043616	STRIGOLACTONE DERIVATIVES AS PLANT GROWTH REGULATOR COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/043631	INTERMEDIATES USEFUL FOR PREPARING IDURONIC ACID CONTAINING DI- AND POLYSACCHARIDES	HEPOLIGO SOLUTIONS APS
WO/2021/037868	NOVEL QUINAZOLINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/037883	ANTIBODIES AND THE USES THEREOF	DIACCURATE
WO/2021/037942	COMPSTATIN ANALOGUES AND THEIR MEDICAL USES	ZP SPV 3 K/S
WO/2021/043654	POLYPHOSPHAZENE AND MOLDING COMPOUND CONTAINING THE POLYPHOSPHAZENE	COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
WO/2021/037990	METHOD FOR THE HYDROGENATION OF AROMATIC NITRO COMPOUNDS	COVESTRO DEUTSCHLAND AG
WO/2021/038023	CR2 BINDING PROTEINS AND THEIR USE IN MEDICAL THERAPY	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/038031	TCR CONSTRUCTS SPECIFIC FOR EBV-DERIVED ANTIGENS	MAX-DELBRüCK-CENTRUM FüR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
WO/2021/038033	T-CELL MOBILIZING CXCL10 MUTANT WITH INCREASED GLYCOSAMINOGLYCAN BINDING AFFINITY	ANTAGONIS BIOTHERAPEUTICS GMBH
WO/2021/038034	ACTIVITY BASED PROBES	UNIVERSITY OF DUNDEE
WO/2021/038068	ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/038072	NOVEL TEMPERATURE-OPTMIZED BACILLI	CHR. HANSEN A/S
WO/2021/043703	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/043755	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/043810	ANTI-FUCOSYL-GM1 ANTIBODIES	SCANCELL LIMITED
WO/2021/047978	PROCESS FOR THE PREPARATION OF Α-METHYL-[4-(NITRO)-2-(TRIFLUOROMETHYL)]-BENZYL NITRATE	BASF AGRO B.V.
WO/2021/043849	AMHRII-BINDING ANTIBODY DRUG CONJUGATES AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS	GAMAMABS PHARMA
WO/2021/043850	TRICYCLIC JANUS KINASE (JAK) INHIBITORS AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES	UNIVERSITÄT BERN
WO/2021/043863	FUSION PROTEINS AND USES THEREOF	SYNKLINO APS
WO/2021/043870	SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS	MISSION THERAPEUTICS LIMITED
WO/2021/052768	PHOSPHONIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION	ZSCHIMMER & SCHWARZ MOHSDORF GMBH & CO. KG
WO/2021/043933	ANTIBODIES SPECIFIC FOR IL20-RB AND USES THEREOF FOR THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/043966	NLRP3 INHIBITORS	INFLAZOME LIMITED
WO/2021/043973	SIDEROPHORE CEPHALOSPORIN CONJUGATES AND USES THEREOF	NABRIVA THERAPEUTICS GMBH
WO/2021/043992	STING INHIBITORS AND THEIR THERAPEUTIC USES	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/043994	SYNTHESIS METHOD USING CARBENES IN AN AQUEOUS MEDIUM AND APPLIED TO BIOMOLECULES	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/044004	OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS	SANOFI
WO/2021/044005	ANTI-CD73 ANTIBODIES	SYMPHOGEN A/S
WO/2021/044008	Bispecific binding agent that binds to CD117/c-KIT and CD3	UNIVERSITÄT ZüRICH
WO/2021/044014	ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF	Y-BIOLOGICS INC.
WO/2021/044016	METHOD FOR PURIFYING 2-(FLUOROALKYL OR FLUOROALKOXY)-4,5-DICYANOIMIDAZOLES	ARKEMA FRANCE
WO/2021/044027	METHODS OF IMPROVING SEED SIZE AND QUALITY	INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/044029	COMPOSITIONS AND METHODS FOR REDUCING CHROMATIN CONTENT OF BIOLOGICAL PREPARATIONS	BIA SEPARATIONS D.O.O.
WO/2021/044039	SSEA-4 BINDING MEMBERS	SCANCELL LIMITED
WO/2021/048036	4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/048067	STABLE CRYSTALLINE APALUTAMIDE IN PURE FORM, AND PROCESS FOR THE PREPARATION THEREOF	OLON S.P.A.
WO/2021/048154	METAL COMPLEXES, MANUFACTURING METHOD THEREOF, FLAME-RETARDANT POLYMER COMPOSITION COMPRISING THE SAME AND THEIR USE	CLARIANT INTERNATIONAL LTD
WO/2021/048210	IMPROVED PROCESS FOR PREPARING CYCLOPROPYL COMPOUNDS FROM ALKENES	SALTIGO GMBH
WO/2021/048212	IMPROVED PROCESS FOR PREPARING EPOXIDES FROM ALDEHYDES OR KETONES	SALTIGO GMBH
WO/2021/048241	RADIOLABELED COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/048242	4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/048274	TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES	HUMMINGBIRD BIOSCIENCE HOLDINGS PTE. LTD.
WO/2021/048279	MANAGEMENT OF CONDITIONS OTHER THAN MULTIPLE SCLEROSIS IN OFATUMUMAB-TREATED PATIENTS	NOVARTIS AG
WO/2021/048280	TREATMENT OF RMS BY SWITCHING THERAPY	NOVARTIS AG
WO/2021/048284	THIAZOLE AND DIPHENYL SUBSTITUTED SULFOXIDES FOR USE IN IMPROVING COGNITION FUNCTIONS AND AGAINST ADDICTIONS TO SUBSTANCES	RED BULL GMBH
WO/2021/048285	MEDICINAL PREPARATION FOR TREATING FIBROSIS WITH ANTI BSP ANTIBODIES	IMMUNDIAGNOSTIK AG
WO/2021/058292	BIO-BASED ACRYLATE MONOMER	HENKEL AG & CO. KGAA
WO/2021/058293	METHOD FOR PURIFYING METHYL METHACRYLATE OF LOW-BOILING COMPONENTS	RÖHM GMBH
WO/2021/048330	RECOMBINANT IGG FC MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-MEDIATED KIDNEY DISORDERS	CSL BEHRING LENGNAU AG
WO/2021/019104	A PRODUCTION HOST FOR PRODUCING HUMAN MILK OLIGOSACCHARIDES	BASF SE
WO/2021/048342	ANTIBACTERIAL COMPOUNDS	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/048364	PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE	SOLVAY SA
WO/2021/048368	PROCESS FOR MANUFACTURING AN AQUEOUS HYDROGEN PEROXIDE SOLUTION	SOLVAY SA
WO/2021/048423	BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT OF CANCER	GENMAB A/S
WO/2021/052892	PIPERIDINYL AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/052894	METHOD FOR PRODUCING ISOCYANATES	COVESTRO DEUTSCHLAND AG
WO/2021/058314	METHOD FOR PRODUCING ALKYL METHACRYLATES WITH IMPROVED WATER AND ACID FLOW	RÖHM GMBH
WO/2021/052924	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/052942	SOLIDIFICATION OF HEXYL 2-[4-(DIETHYLAMINO)-2-HYDROXYBENZOYL]BENZOATE	BASF SE
WO/2021/069184	COMPOUNDS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
WO/2021/052995	TREATMENT OF CANCER COMPRISING ADMINISTRATION OF V<i>γ</i>9V<i>ẟ</i>2 T CELL RECEPTOR BINDING ANTIBODIES	LAVA THERAPEUTICS B.V.
WO/2021/053046	PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
WO/2021/053110	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR AND SULFOXIMINE CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/053134	IL-10/FC FUSION PROTEINS USEFUL AS ENHANCERS OF IMMUNOTHERAPIES	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/053158	NOVEL HISTONE METHYLTRANSFERASE INHIBITORS	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/053161	PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/053175	SALTS OF OMECAMTIV MECARBIL AND SOLID FORMS THEREOF	SYNTHON B.V.
WO/2021/053189	SALTS OF OMECAMTIV MECARBIL AND SOLID FORMS THEREOF	SYNTHON B.V.
WO/2021/053199	SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST LILRB2	INVECTYS
WO/2021/058406	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/053205	CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS	FLORATEK PHARMA AG
WO/2021/053207	COMBINATION OF A POXVIRUS ENCODING HPV POLYPEPTIDES AND IL-2 WITH AN ANTI-PD-L1 ANTIBODY	TRANSGENE
WO/2021/058425	METHOD OF MAKING AND/OR ISOLATING ISOIDIDE, COMPRISING SELECTIVE ESTERIFICATION OF A MIXTURE OF DIANHYDROHEXITOL ISOMERS	BASF SE
WO/2021/053242	BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA	NOMAD BIOSCIENCE GMBH
WO/2021/058444	HETEROCYCLIC COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/058445	NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/063730	PROCESS FOR MANUFACTURING ALKANESULFONIC ACIDS	BASF SE
WO/2021/058457	IMPROVED ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES IN PRESENCE OF A CHIRAL IRIDIUM CATALYST AND AN ADDITIVE	BAYER AKTIENGESELLSCHAFT
WO/2021/058458	PROCESS COMPRISING THE USE OF NEW IRIDIUM CATALYSTS FOR ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES	BAYER AKTIENGESELLSCHAFT
WO/2021/058483	PROCESS FOR PRODUCING LIGNIN COMPONENTS FROM LIGNOCELLULOSIC BIOMASS	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/063760	PROCESS FOR THE DISTILLATION OF ISOCYANATES	COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
WO/2021/058558	GNCC AND/OR PCC AS A CATALYTIC CARRIER FOR METAL SPECIES	OMYA INTERNATIONAL AG
WO/2021/058563	DAP10/DAP12 FUSION POLYPEPTIDES	KING'S COLLEGE LONDON
WO/2021/063768	PROCESS FOR MANUFACTURING ALKANESULFONIC ACIDS	BASF SE
WO/2021/058660	ANTI-ADSORPTION SOLUTION	UNIVERSITEIT GENT
WO/2021/058711	ANTIGEN BINDING PROTEINS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/058716	PROCESS FOR PREPARING (15ΑLPHA,16ΑLPHA,17ΒETA)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) AND INTERMEDIATES OF SAID PROCESS	INDUSTRIALE CHIMICA S.R.L.
WO/2021/058718	ANTI-CSF-1R ANTIBODY	ROCHE DIAGNOSTICS GMBH
WO/2021/063821	PYRIMIDINEDIONE DERIVATIVES	BAYER AKTIENGESELLSCHAFT
WO/2021/058729	ANTI-MüLLERIAN INHIBITING SUBSTANCE TYPE I RECEPTOR ANTIBODIES AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/063831	OXIDATION OF SANTALENE TO SANTALOL	ISOBIONICS B.V.
WO/2021/058759	ORGANIC SEMICONDUCTOR LAYER, ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME AND COMPOUNDS THEREFOR	NOVALED GMBH
WO/2021/058763	ANTI-MüLLERIAN INHIBITING SUBSTANCE ANTIBODIES AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/058795	SENESCENT CELL-ASSOCIATED ANTIGEN-BINDING DOMAINS, ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS COMPRISING THE SAME, AND USES THEREOF	STARK LABS
WO/2021/058805	PRE-TREATMENT OF LIGNOCELLULOSIC FEEDS FOR THE PRODUCTION OF GLYCOLS	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/058808	PRE-TREATMENT OF LIGNOCELLULOSIC FEEDS FOR THE PRODUCTION OF GLYCOLS	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/063852	SUBSTITUTED PYRIMIDINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION	F. HOFFMANN-LA ROCHE AG
WO/2021/063853	PROCESS FOR PREPARING DIALKYL CARBONATE AND ALKANEDIOL	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/063856	SUBSTITUTED 3,4-DIHYDROQUINAZOLINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION	F. HOFFMANN-LA ROCHE AG
WO/2021/063863	MODULATING SUGAR AND AMINO ACID CONTENT IN A PLANT (SULTR3)	PHILIP MORRIS PRODUCTS S.A.
WO/2021/063870	VINYL-ETHERS AND METHODS OF THEIR PRODUCTION	HENKEL AG & CO. KGAA
WO/2021/063880	PREPARATION OF 2-CHLORO-1-(2-CHLOROTHIAZOL-5-YL)ETHANONE	BASF SE
WO/2021/063914	4-QUINOLINONE ANTIBACTERIAL COMPOUNDS	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/063915	ANTIBACTERIAL COMPOUNDS	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/064047	A METHOD FOR OBTAINING A LIGNIN OIL COMPOSITION USING A COMPRESSED GAS AND ACID ASSISTED PROCESS	VERTORO B.V.
WO/2021/064052	NEOMYCIN BASED COMPOUNDS, AND PHARMACEUTICAL USE THEREOF	UNIVERSITé COTE D'AZUR
WO/2021/064066	ELUTION OF MONOCLONAL ANTIBODIES IN PROTEIN A AFFINITY CHROMATOGRAPHY	MERCK PATENT GMBH
WO/2021/064077	SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS	BAYER AKTIENGESELLSCHAFT
WO/2021/064079	PURIFICATION OF PROTEINS AND VIRAL INACTIVATION	MERCK PATENT GMBH
WO/2021/064137	MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/064141	INHIBITORS OF DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1B	TOLREMO THERAPEUTICS AG
WO/2021/078492	PROCESS FOR PREPARING GLYCEROL CARBONATE (METH)ACRYLATE	EVONIK OPERATIONS GMBH
WO/2021/064165	PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB<sb>1</sb> RECEPTOR AGONISTS	UNIVERSITAT DE BARCELONA
WO/2021/064166	CRYSTALLINE FORMS OF BEMPEDOIC ACID	SYNTHON B.V.
WO/2021/064175	COMPOUNDS FOR PREVENTING MIGRATION OF CANCER CELLS	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/073900	METHODS FOR THE IMPROVED FORMATION OF ACARBOSE	BAYER AKTIENGESELLSCHAFT
WO/2021/064189	PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS	DOMAIN THERAPEUTICS
WO/2021/064191	METHOD FOR DETECTING, LOCALISING AND QUANTIFYING MDR PROTEINS	BIOMARQUEURS
WO/2021/089255	METHOD FOR OLIGOMERISING OLEFINS IN AN OLIGOMERISATION REACTOR	IFP ENERGIES NOUVELLES
WO/2021/064199	NOVEL ALKYNYL AMINOBORANES, PROCESS FOR PREPARING SAME AND USES THEREOF	UNIVERSITE DE BORDEAUX
WO/2021/064205	METHOD FOR PREPARING ALKENYL AMINOBORANES AND THEIR DERIVATIVES, AND USES THEREOF	UNIVERSITE DE BORDEAUX
WO/2021/064250	ANTIMICROBIAL PEPTIDES	UNIVERSITY OF PLYMOUTH
WO/2021/069487	ANTIBODIES AGAINST INFECTIOUS PATHOGENS AND METHOD FOR PRODUCTION THEREOF	UNIVERSITÄT ZU KÖLN
WO/2021/069502	METHOD FOR THE PRODUCTION OF A CATALYTICALLY ACTIVE DNA MOLECULE HAVING IMPROVED ACTIVITY AND ITS USE IN A METHOD OF TREATING ASTHMA	STERNA BIOLOGICALS GMBH & CO. KG
WO/2021/069508	ANTIBODIES HAVING SPECIFICITY FOR NECTIN-4 AND USES THEREOF	UNIVERSITé D'AIX-MARSEILLE
WO/2021/069569	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/069570	ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2a FOR THE TREATMENT OF HEART FAILURE	UNIVERSITA` DEGLI STUDI DI MILANO-BICOCCA
WO/2021/069575	HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES	BAYER ANIMAL HEALTH GMBH
WO/2021/069595	COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE, A DISPLAY DEVICE AND A LIGHTING DEVICE COMPRISING THE SAME	NOVALED GMBH
WO/2021/069632	USE OF AN ANTI-CCR7 ANTIBODY IN COMBINATION THERAPIES WITH A BTK INHIBITOR AND/OR BCL2- INHIBITOR FOR TREATING HEMATOLOGICAL MALIGNANCIES	CATAPULT THERAPEUTICS B.V.
WO/2021/069670	PD1 AND VEGFR2 DUAL-BINDING AGENTS	ULTRAHUMAN EIGHT LIMITED
WO/2021/069692	CONJUGATE COMPOUNDS FOR PREVENTING AND/OR TREATING HBV AND/OR HDV INFECTIONS, LIVER DISEASES AND FOR TARGETING NTCP	UNIVERSITÄT HEIDELBERG
WO/2021/069700	CRYSTALLINE SOLVATED FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5- ((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO-1,2,3,4- TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA	MYOVANT SCIENCES GMBH
WO/2021/069701	ATF6 MODULATORS AND USES THEREOF	BLACK BELT TX LTD
WO/2021/069711	CRYSTALLINE FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5- ((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO- 1,2,3,4-TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'- METHOXYUREA	MYOVANT SCIENCES GMBH
WO/2021/069721	ATF6 MODULATORS AND USES THEREOF	BLACK BELT TX LTD
WO/2021/074072	PROCESS FOR THE PREPARATION OF (2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-HYDROXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXYLATE BY RACEMATE SEPARATION BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS	BAYER AKTIENGESELLSCHAFT
WO/2021/078563	PROCESS FOR THE PRODUCTION OF CYCLIC GUANIDINE DERIVATES	BASF SE
WO/2021/074077	PROCESS FOR PRODUCING ACYLOXYMETHYL ESTERS OF (4S)-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXYLIC ACID	BAYER AKTIENGESELLSCHAFT
WO/2021/074078	PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE BY RESOLUTION OF RACEMATES BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS	BAYER AKTIENGESELLSCHAFT
WO/2021/074079	PHOTOCHEMICAL PROCESS FOR PRODUCING (4R,4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXAMIDE	BAYER AKTIENGESELLSCHAFT
WO/2021/074106	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/074108	PROCESS OF PREPARING 1,1'-DISULFANDIYLBIS(4-FLUORO-2-METHYL-5-NITROBENZOL)	BAYER AKTIENGESELLSCHAFT
WO/2021/074138	SYNTHESIS OF 6-METHYL-N1-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL)BENZENE-1,3-DIAMINE	ESCO ASTER PTE. LTD.
WO/2021/074157	TREATMENT OF CANCER WITH ILT-2 INHIBITORS	INNATE PHARMA
WO/2021/074182	PRODUCTION OF BIOPRODUCT IN A HOST CELL	INBIOSE N.V.
WO/2021/074196	THIENOPYRIMIDONES AS TRPA1 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/074210	PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/074211	RENEWABLE MONOMER AND POLYMER THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/074227	2-METHYL-AZA-QUINAZOLINES	BAYER AKTIENGESELLSCHAFT
WO/2021/074249	CELL LINE FOR TCR DISCOVERY AND ENGINEERING AND METHODS OF USE THEREOF	ETH ZURICH
WO/2021/074251	PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER	SENTINEL ONCOLOGY LIMITED
WO/2021/078615	A PROCESS FOR THE CONVERSION OF LIGHT ALKANES TO AROMATIC COMPOUNDS WITH IMPROVED SELECTIVITY	HALDOR TOPSØE A/S
WO/2021/078616	PROCESS FOR THE EPOXIDATION OF PROPENE	EVONIK OPERATIONS GMBH
WO/2021/074275	EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE	UNIVERSITE DE RENNES 1
WO/2021/078619	PROCESS FOR THE EPOXIDATION OF PROPENE	EVONIK OPERATIONS GMBH
WO/2021/074279	SPIRO-FUSED TRICYCLIC MAP4K1 INHIBITORS	BAYER AKTIENGESELLSCHAFT
WO/2021/074281	SUBSTITUTED AZACYLES AS TRMP8 MODULATORS	GIVAUDAN SA
WO/2021/074286	INFLUENZA VIRUS VACCINES AND USES THEREOF	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/074309	1-(3-QUINOLYL)-3,4-DIHYDROISOQUINOLINE DERIVATIVES AS FUNGICIDES FOR COMBATING SPECIFIC PHYTOPATHOGENS	SYNGENTA CROP PROTECTION AG
WO/2021/074311	1-(3-QUINOLYL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS FUNGICIDES FOR COMBATING SPECIFIC PHYTOPATHOGENS	SYNGENTA CROP PROTECTION AG
WO/2021/074313	CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR INTERLEUKIN-23 RECEPTOR	SANGAMO THERAPEUTICS FRANCE
WO/2021/078631	METHODS FOR TREATING AND/OR PREVENTING HYPERSOMNIAS	UNIVERSITé DE LAUSANNE
WO/2021/074325	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/074351	SELECTIVE LIGANDS FOR TAU AGGREGATES	KARIN & STEN MORTSTEDT CBD SOLUTIONS AB
WO/2021/074363	AMINE CO-INITIATOR MIXTURE	LAMBSON LIMITED
WO/2021/074365	ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS	LEAD PHARMA HOLDING B.V.
WO/2021/074367	ENHANCED DISEASE RESISTANCE OF CROPS BY DOWNREGULATION OF REPRESSOR GENES	KWS SAAT SE & CO. KGAA
WO/2021/074376	NOVEL HUMAN THERAPEUTIC MONOCLONAL ANTIBODIES AND USES THEREOF	UNIVERSITE DE TOURS
WO/2021/074379	BACTERIAL DELIVERY OF VIRUSES INTO EUKARYOTIC CELLS	REDBIOTEC AG
WO/2021/074392	VISUAL DETECTION OF PBD INDUCED DNA CROSSLINKS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/074429	COMPOUNDS FOR TARGETED DEGRADATION OF CARRIER PROTEINS AND USES THEREOF	CEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074443	ANTI-VIRAL AND HEPATIC-TARGETED DRUGS	AI-BIOPHARMA
WO/2021/074449	COMPOUNDS FOR IMMUNOMODULATION	FUNDACIó INSTITUT D'INVESTIGACIó BIOMèDICA DE BELLVITGE (IDIBELL)
WO/2021/078695	NEW FORMULATIONS OF FOSFOMYCIN WITH REDUCED SODIUM CONTENT FOR PARENTERAL USE AND METHODS OF PRODUCING THE SAME	SANDOZ AG
WO/2021/078698	PROCESSES FOR MAKING TETRAZOLINONE COMPOUNDS	BASF SE
WO/2021/083735	PROCESS FOR THE PRODUCTION OF 1,6-ANHYDRO SUGARS	HEPOLIGO SOLUTIONS APS
WO/2021/078774	SPECIFIC BINDING MOLECULES	IMMUNOCORE LIMITED
WO/2021/078786	NANODISC-SPECIFIC ANTIGEN-BINDING CHIMERIC PROTEINS	VIB VZW
WO/2021/078811	NOVEL HETEROCYCLIC COMPOUNDS	FLORATEK PHARMA AG
WO/2021/078831	COMPOUNDS THAT CAN BE USED IN AN ORGANIC ELECTRONIC DEVICE	MERCK PATENT GMBH
WO/2021/078834	CHIMERIC ACID-ALPHA GLUCOSIDASE POLYPEPTIDES AND USES THEREOF	GENETHON
WO/2021/078935	CULTURE MEDIA FOR MYCOPLASMA	FUNDACIó CENTRE DE REGULACIó GENòMICA
WO/2021/083807	ARTIFICIAL ANTIGEN PRESENTING MOLECULES AND THEIR USES	UNIVERSITAET HEIDELBERG
WO/2021/078979	PROCESS FOR THE PREPARATION OF (Z,2E)-5-[1-(4-CHLOROPHENYL)PYRAZOL-3-YL]OXY-2-METHOXYIMINO-N,3-DIMETHYL-PENT-3-ENAMIDE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/151532	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/083839	CONVERSION OF METHANE INTO ETHYLENE USING ISOMORPHOUS METAL-SUBSTITUTED ZEOLITE FRAMEWORK CATALYST	TOTAL SE
WO/2021/079002	NOVEL ANTI-NOGO-A ANTIBODIES	NOVAGO THERAPEUTICS AG
WO/2021/083908	DRY POWDER FORMULATIONS OF THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES AND METHODS OF USE THEREOF	MEDIMMUNE LIMITED
WO/2021/083936	PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/099079	SOLVATES OF ABSCISIC ACID AND LIQUID COMPOSITIONS CONTAINING ABSCISIC ACID	CLARIANT INTERNATIONAL LTD
WO/2021/083949	BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER	F. HOFFMANN-LA ROCHE AG
WO/2021/083968	NUTRITIONALLY-OPTIMISED COLLAGEN PEPTIDE	GELITA AG
WO/2021/089395	GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS	NERVIANO MEDICAL SCIENCES S.R.L.
WO/2021/083996	SYNTHESIS OF 3-NITRO-N-(2,2,2-TRIFLUOROETHYL)-4-PYRIDINAMINE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/083998	SYNTHESIS OF 3-({5-CHLORO-1-[3-(METHYLSULFONYL)PROPYL]-1<i>H</i>-INDOL-2 YL} METHYL)-1-(2,2,2-TRIFLUOROETHYL)-1,3-DIHYDRO-2<i>H</i>-IMIDAZO[4,5-C]PYRIDIN-2-ONE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/084063	ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS	MORPHOSYS AG
WO/2021/084104	TETRAVALENT ANTIBODY MOLECULES	BIOINVENT INTERNATIONAL AB
WO/2021/089482	NEW TRANSITION METAL CATALYST	DSM IP ASSETS B.V.
WO/2021/084133	AAV VECTOR VARIANTS FOR OCULAR GENE DELIVERY	UNIVERSITÄT BERN
WO/2021/089559	ANTI IL-33 THERAPEUTIC AGENT FOR TREATING RENAL DISORDERS	MEDIMMUNE LIMITED
WO/2021/094162	PROCESS FOR HETEROGENEOUS ISOMERIZATION OF ALPHA-OLEFINS	EVONIK OPERATIONS GMBH
WO/2021/089609	MULTISPECIFIC ANTIBODY	NUMAB THERAPEUTICS AG
WO/2021/089673	SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS	BAYER AKTIENGESELLSCHAFT
WO/2021/094184	PROCESS AND PLANT FOR THE PRODUCTION OF ε-CAPROLACTAM AND AMMONIUM SULFATE ON INDUSTRIAL SCALE	CAP III B.V.
WO/2021/089683	INHIBITORS OF ADRENORECEPTOR ADRAC2	BAYER AKTIENGESELLSCHAFT
WO/2021/089695	POLYPEPTIDES	AFFIBODY AB
WO/2021/089730	APPLICATION OF BORON DIPYRROMETHENE DERIVATIVES IN ANTI-TUMOR AND ANTI-BACTERIAL THERAPY	BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG
WO/2021/089748	MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES	AMGEN RESEARCH (MUNICH) GMBH
WO/2021/094208	SUBSTITUTED IMIDAZO PYRIMIDINE EP3 ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/089766	PROCESS FOR THE PREPARATION OF FERRIC ORGANIC COMPOUNDS	QUíMICA SINTéTICA, S.A.
WO/2021/089850	ANTIBODY VARIANT COMBINATIONS AND USES THEREOF	GENMAB B.V.
WO/2021/089854	TREATMENT OF MULTIPLE MYELOMA	NATIONAL UNIVERSITY OF IRELAND, GALWAY
WO/2021/089862	NEW PROCESS OF EXTRACTING PROTEIN	AFFIBODY AB
WO/2021/094247	NEW CHEMICAL PROCESS FOR MAKING 6-CHLORO-4-(4-FLUORO-2-METHYLPHENYL)PYRIDIN-3-AMINE A KEY INTERMEDIATE OF NT-814	KANDY THERAPEUTICS LIMITED
WO/2021/089872	COMPOUNDS	SMALL PHARMA LTD
WO/2021/089873	METHOD OF SYNTHESIS	SMALL PHARMA LTD
WO/2021/089875	THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22	CYTOKI PHARMA APS
WO/2021/089878	METHOD FOR PREPARING DEXMEDETOMIDINE	NORCHIM
WO/2021/094269	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/094301	HYDROPYRAZINO[1,2-B]ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/094308	NEW SEROLOGICAL MARKER FOR THE LATENT FORM OF TOXOPLASMOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/094312	PYRROLIDINE AND BICYCLOHETEROARYL CONTAINING OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/094409	DERIVATIZATION OF BETA-LACTAM ANTIBIOTICS FOR MASSSPEC MEASUREMENTS IN PATIENT SAMPLES	F. HOFFMANN-LA ROCHE AG
WO/2021/094410	DERIVATIZATION OF BETA-LACTAM ANTIBIOTICS AS CALIBRATORS/ISTD IN MASSSPEC MEASUREMENTS	F. HOFFMANN-LA ROCHE AG
WO/2021/094416	7-PYRIMIDINE-2-YL-OXY-INDAZOLE DERIVATIVES AND THEIR USE AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/094434	SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/094435	HOMOGENEOUS MUTEINS OF THE HUMAN IL-27 ALPHA-SUBUNIT	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/094436	SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/110378	PROCESS TO CONTINUOUSLY PREPARE A CYCLIC CARBONATE	NEW GREEN WORLD B.V.
WO/2021/094447	PROCESS TO CONTINUOUSLY PREPARE A CYCLIC CARBONATE	NEW GREEN WORLD B.V.
WO/2021/094487	VARIANT NISIN PEPTIDES	UNIVERSITY COLLEGE CORK
WO/2021/094504	HERBICIDAL THIAZOLE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/094505	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/094535	ORGANOMETALLIC SALT OF NITROPRUSSIDE ACTING AS AN NO-RELEASING AGENT	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/094545	ANTI-SIGLEC-9 ANTIBODY MOLECULES	MEMO THERAPEUTICS AG
WO/2021/099240	PYRIMIDONE DERIVATIVES CONTAINING TWO FUSED BICYCLIC RINGS	BASF SE
WO/2021/099243	BLEACH ACTIVATOR HAVING A CATIONIC GROUP AND DETERGENT OR CLEANING PRODUCT CONTAINING SAME	HENKEL AG & CO. KGAA
WO/2021/099255	PROCESS FOR REMOVING POLY(PROPYLENE OXIDE) FROM PROPYLENE OXIDE BY MEMBRANE SEPARATION	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/094608	CHROMOGRANIN A-DERIVED PEPTIDES AND USES THEREOF	OSPEDALE SAN RAFFAELE S.R.L.
WO/2021/094620	TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF	ENTHERA S.R.L.
WO/2021/099284	HYDRO-1H-PYRROLO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/099285	TRIAZATRICYCLE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/104924	METHOD FOR SEPARATING AN EFFLUENT OBTAINED IN AN OLIGOMERIZATION STEP	IFP ENERGIES NOUVELLES
WO/2021/104925	METHOD FOR NEUTRALIZING A CATALYTIC COMPOSITION CONTAINED IN AN EFFLUENT FROM AN OLIGOMERIZATION STEP	IFP ENERGIES NOUVELLES
WO/2021/099303	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/099347	ANTIBODIES TARGETING, AND OTHER MODULATORS OF, THE CD276 ANTIGEN, AND USES THEREOF	DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
WO/2021/099360	PRAME TCR RECEPTORS AND USES THEREOF	MEDIGENE IMMUNOTHERAPIES GMBH
WO/2021/099384	IRON N-HETEROCYCLIC CARBENE COMPOUNDS	WÄRNMARK, Kenneth
WO/2021/099406	SPIRO(ISOBENZOFURANAZETIDINE) COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/099418	ANTI-CD117 ANTIBODIES AND METHODS OF USE THEREOF	INTERNATIONAL - DRUG - DEVELOPMENT - BIOTECH
WO/2021/104982	PROCESS FOR PREPARING OLIGO ETHYLENE GLYCOL METHYL ETHER BORATE	BASF SE
WO/2021/099456	ZEOLITE CATALYZED PROCESS FOR THE AMINATION OF PROPYLENE OXIDE	BASF SE
WO/2021/099484	ARCHAEAL PEPTIDE RECOMBINASE – A NOVEL PEPTIDE LIGATING ENZYME	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/099518	NOVEL COMPOUNDS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH THE AGGREGATION OF ALPHA-SYNUCLEIN	MODAG GMBH
WO/2021/099527	PYRROLIDINE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/099528	ELUATE COLLECTION DURING ANTIBODY CHROMATOGRAPHY	MORPHOSYS AG
WO/2021/099529	METHOD FOR EXTRACTING A PROTEIN FROM A PRECIPITATE AND METHOD FOR PRECIPITATING IMPURITIES	CSL BEHRING AG
WO/2021/099534	ALKYL HALIDES CONVERSION INTO C3-C5 ALPHA OLEFINS	TOTAL SE
WO/2021/099536	METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY	MORPHOSYS AG
WO/2021/099539	ALKYL HALIDES CONVERSION INTO ACYCLIC C3-C6 OLEFINS	TOTAL SE
WO/2021/099543	PROCESS FOR CONVERTING ONE OR MORE METHYL HALIDES TO ACYCLIC C3-C6 OLEFINS	TOTAL SE
WO/2021/099548	PROCESS FOR CONVERTING ONE OR MORE METHYL HALIDES INTO ETHYLENE AND PROPYLENE	TOTAL SE
WO/2021/099551	PROCESS FOR CONVERTING ONE OR MORE METHYL HALIDES INTO C3-C5 ALPHA OLEFINS	TOTAL SE
WO/2021/099554	PROCESS OF PREPARING ARACHIDONOYLETHANOLAMINE ANALOGUES	TRAVECTA THERAPEUTICS PTE. LTD.
WO/2021/099574	IGFBP3 ANTIBODIES AND THERAPEUTIC USES THEREOF	ENTHERA S.R.L.
WO/2021/099576	NOVEL IMMUNOTHERAPIES TARGETING PD-1 WITH ANTI-PD-1/IL-15 IMMUNOCYTOKINES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/099579	MACROCYCLIC INDOLE DERIVATIVES AS MCL-1 INHIBITORS	JANSSEN PHARMACEUTICA NV
WO/2021/099580	MACROCYCLIC SULFONYL DERIVATIVES AS MCL-1 INHIBITORS	JANSSEN PHARMACEUTICA NV
WO/2021/099621	NANOPARTICLE-LIKE DELIVERY SYSTEM	EVOX THERAPEUTICS LTD
WO/2021/110445	PROCESS FOR THE PURIFICATION OF A MIXTURE COMPRISING N-ALKYL-HYDROXYLAMMONIUM SALTS	BASF SE
WO/2021/105038	SHELF LIFE- AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS	BASF SE
WO/2021/105069	CONDENSED THIOPHENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR (HIF) INHIBITORS	MERCK PATENT GMBH
WO/2021/105072	1,8-NAPHTHYRIDIN-2-ONE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/105091	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/105101	[(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS	BAYER AKTIENGESELLSCHAFT
WO/2021/105115	SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION	BAYER AKTIENGESELLSCHAFT
WO/2021/105116	SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION	BAYER AKTIENGESELLSCHAFT
WO/2021/105117	SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION	BAYER AKTIENGESELLSCHAFT
WO/2021/105147	COCRYSTALS OF STEROID AND SECOSTEROID COMPOUNDS AND COMPOSITIONS COMPRISING THEM	CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L.
WO/2021/110498	PREPARATION OF SUBSTITUTED AROMATIC CARBOXAMIDES	BASF SE
WO/2021/105261	TRPM8 MODULATORS	GIVAUDAN SA
WO/2021/105317	BENZYLAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5	ORIGO BIOPHARMA, S.L.
WO/2021/105334	PIPERIDINE-2, 6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF	CAPTOR THERAPEUTICS S.A.
WO/2021/105335	PIPERIDINE-2, 6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF	CAPTOR THERAPEUTICS S.A.
WO/2021/105337	PROCESS FOR THE PREPARATION (9S)-2-BROMO-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPINE	F. HOFFMANN-LA ROCHE AG
WO/2021/105356	KETO-AMMONIUM COMPOUNDS	RHODIA OPERATIONS
WO/2021/105376	IMPROVED PROCESS FOR PREPARING UNSYMMETRICAL DIALKYL SULFIDES	SALTIGO GMBH
WO/2021/105389	TREATMENT FOR PHYSIOLOGICAL IRON OVERLOAD	KYMAB LIMITED
WO/2021/105399	PROCESS FOR THE PREPARATION OF 5-CHLORO-PYRIDINE-2-CARBOXYLIC ACIDS AND CARBOXYLATES WITH 3-SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/105412	IMPROVED PROCESS FOR PREPARING BROMOCHLOROMETHANE	SALTIGO GMBH
WO/2021/105438	POSITIVE ALLOSTERIC MODULATORS OF THE CALCIUM-SENSING RECEPTOR	VIB VZW
WO/2021/110565	METHOD FOR THE PREPARATION OF METHANOL	HALDOR TOPSØE A/S
WO/2021/110574	ALKYNYL-(HETEROARYL)-CARBOXAMIDE HCN1 INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/115813	PROCESS FOR PRODUCING 1,4-BUTANEDIOL, GAMMA-BUTYROLACTONE AND TETRAHYDROFURAN IN THE GAS PHASE WHILE AVOIDING POLYMERIC DEPOSITS	BASF SE
WO/2021/148174	METHOD FOR THE SIMULTANEOUS PRODUCTION OF SODIUM AND POTASSIUM ALCOHOLATES	EVONIK FUNCTIONAL SOLUTIONS GMBH
WO/2021/148175	METHOD FOR THE ENERGY-EFFICIENT PRODUCTION OF SODIUM AND POTASSIUM ALCOHOLATES	EVONIK FUNCTIONAL SOLUTIONS GMBH
WO/2021/105497	SMALL-MOLECULE NADPH OXIDASE 2 INHIBITORS	UNIVERSITY OF COPENHAGEN
WO/2021/121925	PROCESS FOR THE PRODUCTION OF OLEOCANTHAL, OLEACEIN AND THEIR ANALOGUES	NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS
WO/2021/110609	PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS	BCN PEPTIDES, S.A.
WO/2021/110614	HYDROPYRIDO[1,2-α]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/110627	PROCESS FOR REMOVING AN ETHER ALKANOL IMPURITY FROM AN ORGANIC CARBONATE STREAM	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/110647	BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47	LAMKAP BIO BETA AG
WO/2021/110656	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/110680	ENOL ETHER PROPERFUME	FIRMENICH SA
WO/2021/110688	METHOD FOR MANUFACTURING (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANOL	DEASYL SA
WO/2021/110720	METAL COMPLEXES	MERCK PATENT GMBH
WO/2021/110741	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/110764	BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV	UNIVERSITÄT ZU KÖLN
WO/2021/110773	APPARATUS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES AND PROCESS FOR THE PREPARATION THEREOF	BACHEM AG
WO/2021/110790	PD(I) COMPLEXES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS ANTITUMOUR AGENTS	UNIVERSITA' CA' FOSCARI
WO/2021/115907	SEPARATION OF N-METHYLETHYLENEDIAMINE FROM EDA-CONTAINING MIXTURES	BASF SE
WO/2021/110816	POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFα AND IL-23	ABLYNX NV
WO/2021/110834	COMPOUNDS AND METHODS FOR AMINE OXIDASE IMAGING	ETH ZURICH
WO/2021/110845	OPTIMIZED GIP PEPTIDE ANALOGUES	ANTAG THERAPEUTICS APS
WO/2021/110859	ONE STEP PROCESS FOR THE PREPARATION OF PHENYL ETHYL AMINE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/115925	METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY A PHYTOPATHOGENIC MICROORGANISM OF THE GENUS MACROPHOMINA SPP	SYNGENTA CROP PROTECTION AG
WO/2021/115926	METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PEANUT PLANTS BY PHYTOPATHOGENIC MICROORGANISMS	SYNGENTA CROP PROTECTION AG
WO/2021/110873	ANTIBODIES AGAINST LIF AND USES THEREOF	MEDIMMUNE LIMITED
WO/2021/110890	PYRIDINIUM DERIVATIVES AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/110891	PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC AMINO COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/110893	PROCESS AND INTERMEDIATES FOR THE PRODUCTION OF FORMULA (I)	ASTRAZENECA AB
WO/2021/115945	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/110929	CRYSTALLINE FORMS OF SODIUM SALT OF BEMPEDOIC ACID	SYNTHON B.V.
WO/2021/110930	COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT	UNIVERSITEIT ANTWERPEN
WO/2021/110933	METHOD FOR PREPARATION OF LIGNIN OLIGOMERS	BASF SE
WO/2021/110935	Anti-oxMIF/anti-CD3 BISPECIFIC ANTIBODY CONSTRUCTS	ONCOONE RESEARCH & DEVELOPMENT GMBH
WO/2021/110995	NOVEL MOLECULES FOR THERAPY AND DIAGNOSIS	AC IMMUNE SA
WO/2021/110997	N-(3-(5-(PYRIMIDIN-4-YL)THIAZOL-4-YL)PHENYL)SULFONAMIDE COMPOUNDS AND THEIR USES AS BRAF INHIBITORS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/115997	PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/111003	HUMANIZED CLDN18.2 ANTIBODIES	SOTIO A.S.
WO/2021/116005	NEW FYN AND VEGFR2 KINASE INHIBITORS	ROTTAPHARM BIOTECH S.R.L.
WO/2021/122103	METHOD FOR REDUCING THE ACID CONTENT IN HUMAN MILK OLIGOSACCHARIDES	BASF SE
WO/2021/116050	NEW BRAF INHIBITORS AS PARADOX BREAKERS	F. HOFFMANN-LA ROCHE AG
WO/2021/116055	NEW METHYLQUINAZOLINONE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/116074	CRYSTALLINE FORM OF A 7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID DERIVATIVE	SANOFI
WO/2021/116079	PEPTIDES BINDING TO LDL-RECEPTOR AS CARRIERS FOR CROSSING THE BLOOD BRAIN BARRIER	UNIVERSITé DE MONS
WO/2021/116099	PROCESS FOR PREPARING 1-INDANONE COMPOUNDS BY INTRAMOLECULAR FRIEDEL-CRAFTS REACTION OF ALPHA,ALPHA-DIALKYLMALONATE DERIVATIVES	FIRMENICH SA
WO/2021/116110	METHOD FOR MANUFACTURING A FIBRINOGEN PREPARATION	BIOTEST AG
WO/2021/116128	PROCESS FOR PREPARING CYANOACETATES	HENKEL IP & HOLDING GMBH
WO/2021/116165	MANUFACTURING OF PROTECTED DO3A	BRACCO IMAGING SPA
WO/2021/116178	PYRAZOLOTRIAZINES	BAYER AKTIENGESELLSCHAFT
WO/2021/116225	ACRIDINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER, ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING THE SAME	NOVALED GMBH
WO/2021/122249	SYNTHESIS OF N-VINYL COMPOUNDS BY REACTING CYLIC NH-COMPOUNDS WITH ACETYLENE IN PRESENCE OF HOMOGENOUS CATALYST	BASF SE
WO/2021/116243	A METHOD OF FORMING A CONJUGATE OF A SULFONAMIDE AND A POLYPEPTIDE	SANOFI
WO/2021/116252	GLYCOSYLATED SINGLE CHAIN IMMUNOGLOBULIN DOMAINS	VIB VZW
WO/2021/116257	THIENOPYRIMIDINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/116259	AROMATIC AMIDO DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/116273	METHOD FOR CONTINUOUS PROTEIN RECOVERING	BAXALTA INCORPORATED
WO/2021/116277	NEW ANTIBODY BLOCKING HUMAN FCGRIIIA AND FCGRIIIB	INSTITUT PASTEUR
WO/2021/116290	COMPOUNDS FOR TREATMENT OF EYE DISEASES	AARHUS UNIVERSITET
WO/2021/116292	NOVEL INSULIN ANALOGUES AND USES THEREOF	NOVO NORDISK A/S
WO/2021/116337	MULTISPECIFIC BINDING MOLECULES COMPRISING LTBR AND EDB BINDING DOMAINS AND USES THEREOF	CILAG GMBH INTERNATIONAL
WO/2021/116341	TRPV1 EPITOPES AND ANTIBODIES	OBLIQUE THERAPEUTICS AB
WO/2021/130028	PROCESS FOR THE PREPARATION OF HYDROPEROXY ALCOHOLS USING A HETEROGENOUS CATALYST	DEMETA
WO/2021/122356	PROCESS FOR PREPARING FLURALANER	KRKA, D.D., NOVO MESTO
WO/2021/116398	GLYCOSYLATED POLYPEPTIDES	FRESENIUS KABI DEUTSCHLAND GMBH
WO/2021/116444	INTERLEUKIN 2 CHIMERIC CONSTRUCTS	ILTOO PHARMA
WO/2021/116446	FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)	RYVU THERAPEUTICS S.A.
WO/2021/116448	METHOD FOR INCREASING COLD OR FROST TOLERANCE IN A PLANT	KWS SAAT SE & CO. KGAA
WO/2021/116451	HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)	RYVU THERAPEUTICS S.A.
WO/2021/116462	DESIGNED ANKYRIN REPEAT DOMAINS WITH ALTERED SURFACE RESIDUES	MOLECULAR PARTNERS AG
WO/2021/116469	RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE	MOLECULAR PARTNERS AG
WO/2021/116470	RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE	MOLECULAR PARTNERS AG
WO/2021/122415	FUROINDAZOLE DERIVATIVES	BAYER AKTIENGESELLSCHAFT
WO/2021/122436	PROCESS FOR THE PREPARATON OF HYDROQUINONES	DSM IP ASSETS B.V.
WO/2021/122437	FORMATION OF 2,3,5-TRIMETHYLHYDROQUINONE FROM 2,3,6-TRIMETHYLPHENOL	DSM IP ASSETS B.V.
WO/2021/122439	FORMATION OF ALPHA TOCOPHEROL FROM 2,3,6-TRIMETHYLPHENOL	DSM IP ASSETS B.V.
WO/2021/122441	PROCESS FOR THE PREPARATION OF PIPERIDINE COMPOUNDS	BASF SE
WO/2021/130042	CHIMERIC ANTIGEN RECEPTORS THAT BIND TO PROSTATE SPECIFIC MEMBRANE ANTIGEN	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/122484	METHOD FOR PRODUCING POLYSULPHANE-SILANES BY MEANS OF PHASE TRANSFER CATALYSIS	EVONIK OPERATIONS GMBH
WO/2021/122535	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/122538	AROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/122551	S. AUREUS ANTIGENS AND COMPOSITIONS THEREOF	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/122558	SUBSTITUTED 4-METHYLENE-TETRAHYDROPYRANS, 4-METHYL-DIHYDROPYRANS AND 4-METHYL-TETRAHYDROPYRANS AND USE THEREOF AS AROMA CHEMICALS	BASF SE
WO/2021/130057	DEHYDROGENATION PROCESS	DSM IP ASSETS B.V.
WO/2021/130058	FUNCTIONALISATION OF 1,3-ALPHA-DIENES (I)	DSM IP ASSETS B.V.
WO/2021/130059	FUNCTIONALISATION OF 1,3-ALPHA-DIENES (II)	DSM IP ASSETS B.V.
WO/2021/122584	APPARATUS AND METHOD FOR UTILIZING OFF-GASES FROM A POWER-TO-X SYSTEM	SIEMENS AKTIENGESELLSCHAFT
WO/2021/122594	ALDIMINES AND USES THEREOF	BOSTIK SA
WO/2021/122625	METHOD FOR PRODUCING DI- AND POLYISOCYANATES OF THE DIPHENYLMETHANE SERIES	COVESTRO DEUTSCHLAND AG
WO/2021/122645	PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/122674	2,4-DIETHYLOCTA-2,6-DIENAL AND ITS USE AS AROMA CHEMICAL	BASF SE
WO/2021/122702	METHOD FOR PRODUCING METAL ALCOHOLATES	BASF SE
WO/2021/122719	LARGE SCALE PROCESS FOR THE PREPARATION OF 5-BROMOPYRIDIN-3-YL-3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]- 1-THIO-ALPHA-D-GALACTOPYRANOSIDE AND A CRYSTALLINE FORM THEREOF	GALECTO BIOTECH AB
WO/2021/148202	METHODS FOR INCREASING HYDROFORMYLATION CATALYST PREFORMING RATES	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/122726	ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES	BRACCO IMAGING SPA
WO/2021/122729	ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES	BRACCO IMAGING SPA
WO/2021/122738	METHODS AND COMPOSITIONS FOR MODULATING THE GLYCOSYLATION PROFILE OF PROTEINS	MERCK PATENT GMBH
WO/2021/122740	POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/122744	SYNTHESIS OF AMANIN AND ITS DERIVATIVES	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/122745	4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE	CARRICK THERAPEUTICS LIMITED
WO/2021/122752	PROCESS FOR PREPARING [3-CHLORO-2-[3-[2-[1-(2-CHLOROACETYL)-4-PIPERIDYL]THIAZOL-4-YL]-4,5-DIHYDROISOXAZOL-5-YL]PHENYL] METHANESULFONATE	BAYER AKTIENGESELLSCHAFT
WO/2021/122757	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/122793	SULFATED DISACCHARIDES AS ENHANCERS OF TRANSMUCOSAL DRUG UPTAKE	NORINVENT AB
WO/2021/122853	PROCESS FOR THE SEPARATION OF GLYCOLS	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/122866	BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT	OSE IMMUNOTHERAPEUTICS
WO/2021/122906	ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE	INTERVET INTERNATIONAL B.V.
WO/2021/122911	ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE	INTERVET INTERNATIONAL B.V.
WO/2021/122941	CALCIUM BOPTA COMPLEX	BRACCO IMAGING SPA
WO/2021/122943	BINDING PROTEINS FOR THE ENZYME ACID ALPHA GLUCOSIDASE (GAA) AND USES THEREOF	NAVIGO PROTEINS GMBH
WO/2021/122955	PROCESS FOR PRODUCING CYCLOHEXANOL AND CYCLOHEXANONE	PERFORMANCE POLYAMIDES, SAS
WO/2021/122975	SUBSTITUTED THIOPHENE CARBOXAMIDES AND DERIVATIVES THEREOF AS MICROBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/122976	SUBSTITUTED THIOPHENE CARBOXAMIDES AND DERIVATIVES THEREOF	BAYER AKTIENGESELLSCHAFT
WO/2021/122986	THIENYLOXAZOLONES AND ANALOGUES	BAYER AKTIENGESELLSCHAFT
WO/2021/122997	COMPOUNDS FOR PROVIDING A LONG-LASTING FLORAL AND FRUITY ODOR	FIRMENICH SA
WO/2021/122998	EFFICIENT GENE DELIVERY TOOL WITH A WIDE THERAPEUTIC MARGIN	FREIE UNIVERSITÄT BERLIN
WO/2021/123036	CHROMATOGRAPHIC SEPARATION OF METALS USING DOTA-BASED CHELATORS	NUCLEAR RESEARCH AND CONSULTANCY GROUP
WO/2021/123049	RAPESEED PROTEIN COMPOSITION WITH HIGH PROTEIN QUALITY	DSM IP ASSETS B.V.
WO/2021/123050	RETRO-INVERSO PEPTIDES	HERANTIS PHARMA OYJ
WO/2021/123051	SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF	BAYER AKTIENGESELLSCHAFT
WO/2021/123055	A PROCESS FOR THE PREPARATION OF TRIBUTYLTIN CHLORIDE WITH HIGH PURITY	PMC VLISSINGEN, B.V
WO/2021/123073	APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION	GE HEALTHCARE LIMITED
WO/2021/123074	METHODS OF SEQUENCING BY SYNTHESIS USING A CONSECUTIVE LABELING SCHEME	F. HOFFMANN-LA ROCHE AG
WO/2021/123076	PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF	GENFIT
WO/2021/123090	EXPRESSION OF SEQUENCE-ENGINEERED LAMBDA ANTIBODY LIGHT CHAINS	KYMAB LIMITED
WO/2021/123091	CANINE INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODIES	INTERVET INTERNATIONAL B.V.
WO/2021/123092	BISPECIFIC CANINIZED ANTIBODIES FOR TREATING ATOPIC DERMATITIS	INTERVET INTERNATIONAL B.V.
WO/2021/123094	BISPECIFIC CANINIZED ANTIBODIES AND BISPECIFIC BINDING PARTNERS FOR TREATING ATOPIC DERMATITIS	INTERVET INTERNATIONAL B.V.
WO/2021/123096	REACTIVE PHOSPOROUS CONTANING FLAME RETARDANT AND INTRINSICALLY FLAME RETARDANT POLYMER OBTAINABLE BY POLYCONDENSATION WITH IT	POLYTECHNYL S.A.S.
WO/2021/123099	REASSORTED ISA VIRUS	INTERVET INTERNATIONAL B.V.
WO/2021/123116	ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF	SKINOSIVE
WO/2021/123145	SIGMA-1 RECEPTOR LIGANDS AND USES THEREOF	UNIVERSITE DE STRASBOURG
WO/2021/123162	COCRYSTALS OF PTEROSTILBENE AND COMPOSITIONS COMPRISING THEM	CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L.
WO/2021/123173	IL-37 FUSION PROTEINS AND USES THEREOF	F. HOFFMANN-LA ROCHE AG
WO/2021/123186	MULTI-SPECIFIC ANTIBODY WITH BINDING SPECIFICITY FOR HUMAN IL-13 AND IL-17	UCB BIOPHARMA SRL
WO/2021/123189	PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID FROM ETHERS OF 5-HYDROXYMETHYLFURFURAL	FURANIX TECHNOLOGIES B.V.
WO/2021/123190	ANTIBODY WITH BINDING SPECIFICITY FOR HUMAN IL-13.	UCB BIOPHARMA SRL
WO/2021/123203	ORGANIC ACID AND THERMAL TREATMENT OF PURIFIED 2,5-FURANDICARBOXYLIC ACID	FURANIX TECHNOLOGIES B.V.
WO/2021/123206	WATER AND THERMAL TREATMENT OF PURIFIED 2,5-FURANDICARBOXYLIC ACID	FURANIX TECHNOLOGIES B.V.
WO/2021/123237	2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE	OXFORD DRUG DESIGN LIMITED
WO/2021/123240	PROCESS FOR THE SYNTHESIS OF 2,5-FURANDICARBOXYLIC ACID	NOVAMONT S.P.A.
WO/2021/123244	MULTI-SPECIFIC ANTIBODIES	UCB BIOPHARMA SRL
WO/2021/123266	ANTI-MALARIAL AGENTS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/123272	NEW SILICON-BASED MATERIAL, THEIR PREPARATION AND APPLICATIONS	TOTAL SE
WO/2021/123288	PROCESS AND INTERMEDIATES FOR THE PREPARATION OF UPADACITINIB	CRYSTAL PHARMA, S.A.U.
WO/2021/123294	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/123307	POLYPEPTIDES HAVING PROTEOLYTIC ACTIVITY AND USE THEREOF	NOVOZYMES A/S
WO/2021/123320	A COMPOSITION AND ITS USE FOR A UNIVERSAL THERAPY AGAINST TUMOR CELLS	DR. KALALI PROF. MOSTAFAZADEH DIPL. ING. MIEDL (KMM) GESELLSCHAFT BüRGERLICHEN RECHTS
WO/2021/123360	NANOBODY EXCHANGE CHROMATOGRAPHY	VIB VZW
WO/2021/123372	NOVEL COMPOUNDS AND THEIR USE	DEBIOPHARM INTERNATIONAL S.A.
WO/2021/123383	NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES	GE HEALTHCARE AS
WO/2021/123388	NOVEL NICOTINAMIDE DI-NUCLEOTIDE DERIVATIVES AND USE THEREOF	NUVAMID SA
WO/2021/123391	GENETICALLY MODIFIED CLOSTRIDIUM STRAINS AND USES THEREOF	EXOMNIS BIOTECH B.V.
WO/2021/123394	G PROTEIN-COUPLED RECEPTOR MODULATORS AND A PHARMACEUTICAL COMPOSITION	UNIVERSITY OF COPENHAGEN
WO/2021/130161	ALKYLAROMATIC CONVERSION CATALYST SYSTEM	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/130162	CO-CRYSTAL OF KETOPROFEN AND ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF	DOMPE' FARMACEUTICI SPA
WO/2021/130163	A PROCESS FOR THE SYNTHESIS OF MELPHALAN	INDENA S.P.A.
WO/2021/136722	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/130250	NEW MESOTHELIN SPECIFIC CHIMERIC ANTIGEN RECEPTORS (CAR) FOR SOLID TUMORS CANCER IMMUNOTHERAPY	CELLECTIS
WO/2021/136734	CARRIER MATRIX COMPRISING DODECIN PROTEIN	JOHANN WOLFGANG GOETHE-UNIVERSITÄT
WO/2021/130316	ETHER CARBOXYLIC ACID COMPOSITION	KAO CHEMICALS GMBH
WO/2021/136736	METHOD FOR OBTAINING A MAMMALIAN CELL LINE THAT EXPRESSES A RECOMBINANT EQUINE CHORIONIC GONADOTROPIN (RECG), THE RECOMBINANT CELL LINES PRODUCING RECG, LARGE-SCALE RECG PRODUCTION METHOD, RECG, FORMULATIONS CONTAINING RECG, NUCLEIC ACIDS ENCODING FOR RECG AND USES	UNIVERSIDAD NACIONAL DEL LITORAL
WO/2021/136742	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/130380	TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF	BASF SE
WO/2021/130383	METHOD FOR THE PRODUCTION OF BISPECIFIC FCYRIII X CD30 ANTIBODY CONSTRUCT	AFFIMED GMBH
WO/2021/140044	PROCESS FOR THE PREPARATION OF C3-5 SATURATED ALIPHATIC CARBOXYLIC ACIDS	BASF SE
WO/2021/136780	METHOD FOR DETERMINING 5-METHYLCYTOSINE CONFIGURATIONS IN DNA	TECHNISCHE UNIVERSITÄT DORTMUND
WO/2021/136803	NEW PqsR INVERSE AGONISTS	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/136805	NOVEL PqsR INVERSE AGONISTS	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/197661	MINERAL FIBRE PRODUCT	ROCKWOOL INTERNATIONAL A/S
WO/2021/136839	PROTEIN SEPARATION	TECHNOLOGICAL UNIVERSITY DUBLIN
WO/2021/136840	IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6	PEPTINOV
WO/2021/213700	PROCESS FOR PREPARING METHANOL	L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET EXPLOITATION DES PROCEDES GEORGES CLAUDE
WO/2021/140063	PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL	SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
WO/2021/144162	PROCESS FOR PREPARING CYCLIC CARBONATES WITH AN EXOCYCLIC VINYLIDENE GROUP	BASF SE
WO/2021/140122	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/140130	NEW 4-1BBL TRIMER-CONTAINING ANTIGEN BINDING MOLECULES	F. HOFFMANN-LA ROCHE AG
WO/2021/140140	COMPOUND AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE	ALPHABETA AB
WO/2021/140173	METHODS AND USES FOR TREATING FIBROTIC SOLID TUMORS WITH BAGS INHIBITORS	BIOUNIVERSA S.R.L.
WO/2021/140190	MULTISPECIFIC ANTIBODIES THAT BIND BOTH MAIT AND TUMOR CELLS	BIOMUNEX PHARMACEUTICALS
WO/2021/140202	METHODS FOR TREATING PEMPHIGUS DISORDERS	ARGENX BV
WO/2021/140203	NEW IMMUNOSTIMULATORS AND USE THEREOF IN IMMUNOTHERAPY	UNIVERSITE DE NANTES
WO/2021/140205	METHODS FOR GENERATING ANTIBODIES AND ANTIBODY FRAGMENTS AND LIBRARIES COMPRISING SAME	CONFO THERAPEUTICS N.V.
WO/2021/140209	RSPO1 PROTEINS AND THEIR USE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/140222	ANTI-CD40 ANTIBODIES AND COMPOSITIONS	SYMPHOGEN A/S
WO/2021/148262	PROCESS FOR PREPARING METHANOL FROM CARBON DIOXIDE AND HYDROGEN WITH QUANTITATIVE CARBON DIOXIDE UTILIZATION	BASF SE
WO/2021/130390	SCAFFOLD PROTEINS AND THERAPEUTIC NANOCONJUGATES BASED ON NIDOGEN	UNIVERSITAT AUTòNOMA DE BARCELONA
WO/2021/156024	A PROCESS FOR PRODUCING LOW-BIURET UREA	CASALE SA
WO/2021/144264	CRYSTALLINE FORM OF THE HERBICIDE METHYL 4-AMINO-3-CHLORO-5-FLUORO-6-(7-FLUORO-1H-INDOL-6-YL)PICOLINATE	BAYER AKTIENGESELLSCHAFT
WO/2021/144287	3-BENZOYL-1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS MKK4 INHIBITORS FOR TREATING LIVER DISEASES	HEPAREGENIX GMBH
WO/2021/151669	REACTOR CONCEPT AND PROCESS FOR PREPARING ETHYLENE OXIDE FROM ETHANOL	CLARIANT INTERNATIONAL LTD
WO/2021/151670	PROCESS FOR PREPARING ETHYLENE OXIDE FROM ETHANOL	CLARIANT INTERNATIONAL LTD
WO/2021/144342	EXPRESSION OF OVALBUMIN AND ITS NATURAL VARIANTS	THE PROTEIN BREWERY B.V.
WO/2021/144354	PESTICIDALLY-ACTIVE BICYCLIC HETEROAROMATIC COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/144359	METHOD AND SYSTEM FOR PRODUCING ONE OR MORE OLEFINS	LINDE GMBH
WO/2021/144362	PREPARATION OF BUPRENORPHINE	RIVER STONE BIOTECH APS
WO/2021/144363	ANTIGENIC REACTIVITY OF A PEPTIDE MIMICKING THE GLYCAN LOOP OF FLAVIVIRUSES ENVELOPE PROTEIN	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/144388	PROCESS FOR THE SYNTHESIS OF NANGIBOTIDE	FRESENIUS KABI IPSUM S.R.L.
WO/2021/144395	CARBOXYLIC DITHIOCARBAMIC ACID ANHYDRIDE COMPOUNDS AND COMPOSITIONS THEREOF	FUNDACIó INSTITUT CATALà D'INVESTIGACIó QUíMICA (ICIQ)
WO/2021/144422	METHODS TO DECREASE IMPURITIES FROM RECOMBINANT PROTEIN MANUFACTURING PROCESSES	F. HOFFMANN-LA ROCHE AG
WO/2021/144439	QUINOXALINE DERIVATIVES	GRüNENTHAL GMBH
WO/2021/144440	QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR	GRüNENTHAL GMBH
WO/2021/148411	MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING FIBROSIS, HYPERTROPHY OR HEART FAILURE	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/148419	METHOD FOR RECOVERING DIISOCYANATES FROM DISTILLATION RESIDUES	COVESTRO DEUTSCHLAND AG
WO/2021/148420	NOVEL HETEROCYCLIC COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/148426	ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS	BASF SE
WO/2021/148431	CHEMICAL PROCESS FOR THE PREPARATION OF HERBICIDAL PYRIDAZINE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/148524	MONOCLONAL ANTIBODIES AGAINST NEONATAL NAV1.5	CELEX ONCOLOGY INNOVATIONS LIMITED
WO/2021/148547	HBV SPECIFIC TCR LIBRARY AND ITS USE AS PERSONALISED MEDICINE	LION TCR PTE. LTD.
WO/2021/148556	PARTICLES OF (AZIRIDINYL HYDROXY)-FUNCTIONAL ORGANIC COMPOUNDS	COVESTRO (NETHERLANDS) B.V.
WO/2021/148594	CHEMICAL SYNTHESIS OF THE PEPTIDIC PART OF BIOACTIVE NATURAL PRODUCTS	NOSOPHARM
WO/2021/148598	METHOD FOR THE PREPARATION OF N-MONOFLUOROALKYL TROPANES AND THEIR USE	ROTOP RADIOPHARMACY GMBH
WO/2021/148610	HMO PRODUCTION	GLYCOM A/S
WO/2021/148614	HMO PRODUCTION	GLYCOM A/S
WO/2021/148615	HMO PRODUCTION	GLYCOM A/S
WO/2021/148628	OXALAMIDE SUBSTITUTED HETEROCYCLIC COMPOUNDS AS MODULATORS OF THE ARYL HYDROCARBON RECEPTOR (AHR)	PHENEX PHARMACEUTICALS AG
WO/2021/148639	PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/148661	COMPOSITIONS FOR TREATING EPITHELIAL BARRIER FUNCTION DISORDERS	ENTEROME
WO/2021/148664	OXYNTOMODULIN MIMETICS	KEYBIOSCIENCE AG
WO/2021/151813	PROCESS FOR DEHYDROGENATION OF A HYDROCARBON FEED STOCK IN A FIXED BED REACTOR	HALDOR TOPSØE A/S
WO/2021/156085	A PROCESS FOR THE PRODUCTION OF SULFUR CONTAINING SILANES BY UTILIZATION OF PHASE TRANSFER CATALYSIS	EVONIK OPERATIONS GMBH
WO/2021/151822	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/148681	ANTIBODIES SPECIFICALLY BINDING THE CARBOXYMETHYLATED CATALYTIC SUBUNIT OF PROTEIN PHOSPHATASE 2A	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/151853	POLYPEPTIDES HAVING IMPROVED PROPERTIES	CHIESI FARMACEUTICI S.P.A.
WO/2021/151870	METHOD FOR CATALYTICALLY PRODUCING AN ALKYL FORMATE	FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/151871	METHOD FOR PRODUCING OXYMETHYLENE ETHER	FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/151908	PROCESS FOR THE SYNTHESIS OF BUPRENORPHINE	AZAD PHARMA AG
WO/2021/151919	PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS	GLOBACHEM NV
WO/2021/151922	BENZIMIDAZOLE DERIVATIVES	MERCK PATENT GMBH
WO/2021/151926	PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC AMINO COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/151976	[(1,4,5-TRISUBSTITUTED-1H-PYRAZOL-3-YL)SULFANYL]ACETIC ACID DERIVATIVES, SALTS THEREOF, AND USE THEREOF AS HERBICIDAL INGREDIENTS	BAYER AKTIENGESELLSCHAFT
WO/2021/152023	SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS	SENSIENT FRAGRANCES, S.A.
WO/2021/152055	PROCESS FOR THE MANUFACTURE OF HALOALKYL SUBSTITUTED PYRIDINE COMPOUNDS	SOLVAY SA
WO/2021/152066	BISPECIFIC FACTOR VIII MIMETIC ANTIBODIES	NOVO NORDISK A/S
WO/2021/152113	SUBSTITUTED 2,3-BENZODIAZEPINES DERIVATIVES	BAYER AKTIENGESELLSCHAFT
WO/2021/152121	REDUCTION OF ADSORPTION	LEUKOCARE AG
WO/2021/152131	CO-CRYSTALS AND SALTS OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE	ABIVAX
WO/2021/152149	RAS INHIBITORS AND METHODS OF USING THE SAME	JAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/160448	LOW-PRESSURE HYDROFORMYLATION OF DIISOBUTENE	BASF SE
WO/2021/156170	ANTIBODIES AGAINST KLK5	UCB BIOPHARMA SRL
WO/2021/156171	ANTIBODIES AGAINST KLK5	UCB BIOPHARMA SRL
WO/2021/152165	MACROCYCLIC RIP2-KINASE INHIBITORS	ONCODESIGN S.A.
WO/2021/156174	PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES	BASF SE
WO/2021/156175	PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES	BASF SE
WO/2021/156178	[1,3]DIAZINO[5,4-D]PYRIMIDINES AS HER2 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/156180	[1,3]DIAZINO[5,4-D]PYRIMIDINES AS HER2 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/156214	REARRANGEMENT OF DIMETHYLPHENYLACYLATES USING ZEOLITES	DSM IP ASSETS B.V.
WO/2021/160468	PROCESS FOR THE PREPARATION OF 1-[4-NITRO-2-(TRIFLUOROMETHYL)PHENYL]-ALKANONES	BASF AGRO B.V.
WO/2021/160470	PREPARATION OF AROMATIC CARBONYL COMPOUNDS BY CATALYTIC OXIDATION WITH MOLECULAR OXYGEN	BASF SE
WO/2021/156244	MODIFIED FILAMINS AND THEIR USES	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/156323	MATERIALS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
WO/2021/156331	USE OF IONIC POLYMERS FOR HYDROLYSIS OF PROTEINS AND PROTEIN-CONTAINING FEEDSTOCK	EMBION TECHNOLOGIES SA
WO/2021/156370	COMPOSITIONS THAT REDUCE TEMPLATE THREADING INTO A NANOPORE	F. HOFFMANN-LA ROCHE AG
WO/2021/160520	POLYMORPHS OF ELAFIBRANOR	GENFIT
WO/2021/156406	PROCESS FOR PREPARING 8-HYDROXY-9,10-DIOXO-ANTHRACENE-1-CARBOXYLIC ACID	PILI
WO/2021/156461	COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME, A USE OF SAID COMPOUNDS AND A METHOD FOR OBTAINING AN INTERMEDIATE PRODUCT	FILECLO SP. Z O.O.
WO/2021/156489	ENGINEERED POLYPEPTIDES DERIVED FROM VARIABLE DOMAIN OF ADENOVIRUS PENTON BASE	IMOPHORON LIMITED
WO/2021/165082	PROCESS FOR PREPARING ALKYLENE GLYCOL MIXTURE FROM A CARBOHYDRATE SOURCE WITH DECREASED SELECTIVITY FOR POLYOL SIDE PRODUCTS	AVANTIUM KNOWLEDGE CENTRE B.V.
WO/2021/165084	PROCESS FOR PREPARING ALKYLENE GLYCOL MIXTURE FROM A CARBOHYDRATE SOURCE WITH INCREASED SELECTIVITY FOR GLYCEROL	AVANTIUM KNOWLEDGE CENTRE B.V.
WO/2021/160564	ALLULOSE CONCENTRATES IN SOLID AMORPHOUS FORM	SAVANNA INGREDIENTS GMBH
WO/2021/160575	STABILIZED SILANE COMPOSITION	EVONIK OPERATIONS GMBH
WO/2021/170391	PROCESS AND PLANT FOR THE SYNTHESIS OF UREA	CASALE SA
WO/2021/160602	MONOACYLGLYCEROL LIPASE MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/170397	PROCESS FOR RECOVERING ACRYLIC ACID	BASF SE
WO/2021/160617	SPIROCYCLIC INHIBITORS OF HEPATITIS B VIRUS	IRBM S.P.A.
WO/2021/160649	PROCESS FOR THE SYNTHESIS OF <i>S</i>-BEFLUBUTAMID USING ASYMMETRIC HYDROGENATION	CHEMINOVA A/S
WO/2021/160654	NANOMATERIALS COATED WITH CALIXARENES	UNIVERSITE LIBRE DE BRUXELLES
WO/2021/160670	3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL	GLYCOSCIENCE, S.L.
WO/2021/160680	PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/160701	ALLULOSE IN CRYSTALLINE FORM	SAVANNA INGREDIENTS GMBH
WO/2021/160716	HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/160718	HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/165144	PROCESS FOR MAKING SOLID METHYLGLYCINE DIACETATE ALKALI METAL SALTS	BASF SE
WO/2021/160807	AGENT FOR TREATMENT AND PROPHYLAXIS OF A POST-ISCHEMIC TISSUE DAMAGE	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTÄT
WO/2021/160813	OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF	FERRER INTERNACIONAL, S.A.
WO/2021/160825	FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS	PHILOCHEM AG
WO/2021/160838	LILRB3 ANTIBODY MOLECULES AND USES THEREOF	BIOINVENT INTERNATIONAL AB
WO/2021/160864	NEW FROTHERS FOR MINERALS RECOVERY AND METHODS OF MAKING AND USING SAME	SOLVAY SA
WO/2021/165187	PROCESS OF PREPARING 2-(PHENYLIMINO)-3-ALKYL-1,3-THIAZOLIDIN-4-ONES	BAYER AKTIENGESELLSCHAFT
WO/2021/165195	HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/190817	BRANCHED ALKANES AND OLEFINS AND PROCESS FOR PRODUCING SAME	GLOBAL BIOENERGIES
WO/2021/160887	CORONA VIRUS VACCINE	IMMUNOR AS
WO/2021/170449	VITAMIN K2 SYNTHESIS	DSM IP ASSETS B.V.
WO/2021/165233	ACYLATION OF TYROSINE UNITS IN PEPTIDE COMPOUNDS	UNIVERSIDAD DEL PAíS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/165245	COMPOUNDS	INFLAZOME LIMITED
WO/2021/165248	ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF	FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
WO/2021/170464	HERBICIDAL MALONAMIDES	BASF SE
WO/2021/165339	PREPARATION OF A NONSTEROIDAL ANALGESIC	DIPHARMA FRANCIS S.R.L.
WO/2021/165346	GCN2 MODULATOR COMPOUNDS	BLACK BELT TX LTD
WO/2021/165353	MUSCLE-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF	VRIJE UNIVERSITEIT BRUSSEL
WO/2021/165370	MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1	JANSSEN PHARMACEUTICA NV
WO/2021/165395	AFFINITY LIGAND FOR THE SOLUBLE PART OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3)	NAVIGO PROTEINS GMBH
WO/2021/165417	MODIFIED FC REGIONS	ADIVO GMBH
WO/2021/165465	DETECTION METHOD OF CIRCULATING BMP10 (BONE MORPHOGENETIC PROTEIN 10)	UNIVERSITEIT MAASTRICHT
WO/2021/165469	2,3,5-SUBSTITUTED PYRROLO[2,3-<i>B</i>]PYRIDINES AS ERBB MODULATORS USEFUL FOR TREATING CANCER	PEARLRIVER BIO GMBH
WO/2021/165497	2,3,5-SUBSTITUTED PYRROLO[2,3-B]PYRIDINES AS ERBB MODULATORS USEFUL FOR TREATING CANCER	PEARLRIVER BIO GMBH
WO/2021/170531	METHOD FOR OBTAINING ALPHA-1 PROTEINASE INHIBITOR	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/165533	NOVEL ERYTHROPARVOVIRUS ASSOCIATED WITH RESPIRATORY DISTRESS IN EQUINE	INTERVET INTERNATIONAL B.V.
WO/2021/170540	LEUCINE-RICH REPEAT KINASE 2 ALLOSTERIC MODULATORS	VIB VZW
WO/2021/165542	NOVEL PHENAZINE-BASED COMPOUNDS	CMBLU ENERGY AG
WO/2021/170600	PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/170615	ADDITIVE MIXTURES FOR RHEOLOGY MODIFICATION OF POLYMERS	BASF SE
WO/2021/170620	SYNTHESIS OF GLYCOSYL FLUORIDES	CARBOCODE S.A.
WO/2021/175670	A NEW CLASS OF FLAVIVIRUS PROTEASE INHIBITORS	UNIVERSITÄT HEIDELBERG
WO/2021/170631	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/170658	HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6	TES PHARMA S.R.L.
WO/2021/170666	CHIMERIC RECEPTORS FOR USE IN ENGINEERED CELLS	QUELL THERAPEUTICS LIMITED
WO/2021/175681	NOVEL NON-IMMUNOGENIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	CANVAX BIOTECH SL
WO/2021/170678	RECOMBINANT CALPROTECTIN	BüHLMANN LABORATORIES AG
WO/2021/170695	PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER	BASF SE
WO/2021/175689	HERBICIDAL PHENYLURACILS	BASF SE
WO/2021/170719	PROCESS FOR THE PREPARATION OF PANOBINOSTAT	FLAMMA SPA
WO/2021/175701	PROCESS FOR MANUFACTURE OF A COMPLEXING AGENT	BASF SE
WO/2021/170750	COMBINATION THERAPIES BASED ON CTLA4 AND IL-17B INHIBITORS	OREGA BIOTECH
WO/2021/170754	RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF	SEDERMA
WO/2021/170774	NEW MACROCYCLIC COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM	LES LABORATOIRES SERVIER
WO/2021/170782	EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF	UNIVERSITÄT ULM
WO/2021/170797	PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS	ITEOS BELGIUM SA
WO/2021/170839	USE OF APROTININ AS A CARRIER TO PRODUCE A RECOMBINANT PROTEIN, POLYPEPTIDE OR PEPTIDE IN ALGAE	ALGANELLE
WO/2021/170864	SUSTAINABLE PROCESS FOR THE MANUFACTURE OF 1,1,4,4-TETRAMETHOXY-2-BUTENE	DSM IP ASSETS B.V.
WO/2021/170868	ALBINO3-LIKE GENE INVOLVED IN VIRUS RESISTANCE	RIJK ZWAAN ZAADTEELT EN ZAADHANDEL B.V.
WO/2021/170876	ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY OR PREVENTION OF SHOCK	ADRENOMED AG
WO/2021/175788	NEW METHOD AND COMPOUND FOR PROSTATE CANCER DIAGNOSIS	EXOSOME MEDICAL INTERNATIONAL AB
WO/2021/170880	ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OF PATIENTS IN SHOCK	ADRENOMED AG
WO/2021/170881	PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/175809	ANTIMICROBIAL TARGET	THE UNIVERSITY OF SHEFFIELD
WO/2021/175822	PESTICIDALLY AMIDINE-SUBSTITUTED BENZOIC ACID AMIDE COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/185564	PROCESS FOR QUENCHING OFFGAS OF MELAMINE SYNTHESIS	CASALE SA
WO/2021/175848	ALPHA-METHYL-SUBSTITUTED DIAZABICYCLO[4.3.1] DECANE DERIVATES FOR TREATMENT OF PSYCHIATRIC DISORDERS	TECHNISCHE UNIVERSITÄT DARMSTADT
WO/2021/175855	OXIME ESTER PHOTOINITIATORS	BASF SE
WO/2021/175864	HYDROBORATION-OXIDATION PROCESS	FIRMENICH SA
WO/2021/175878	GALACTO-OLIGOSACCHARIDE HAVING A TERMINAL MANNOSE RESIDUE, ITS PREPARATION AND APPLICATION	FRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/175901	ARYLCYCLOHEXYLAMINE DERIVATIVES AND PROCESS FOR PREPARING SAME	TECHNISCHE HOCHSCHULE KÖLN
WO/2021/175908	PROCESS AND SYSTEM FOR PRODUCING A TARGET COMPOUND	LINDE GMBH
WO/2021/175913	MONOACYLGLYCEROL LIPASE INHIBITORS	STICHTING HET NEDERLANDS KANKER INSTITUUT – ANTONI VAN LEEUWENHOEK ZIEKENHUIS
WO/2021/175954	ANTIBODIES HAVING SPECIFICITY FOR BTNL8 AND USES THEREOF	IMCHECK THERAPEUTICS SAS
WO/2021/175959	PROCESS FOR THE PREPARATION OF 5-CHLORO-3-ALKYLSULFANYL-PYRIDINE-2-CARBOXYLIC ACID AMIDES AND CARBOXYLATES	SYNGENTA CROP PROTECTION AG
WO/2021/175974	PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS	SANOFI
WO/2021/180562	BENZOXAZINE DERIVATIVES VITRIMERS	LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST)
WO/2021/176009	PROCESS FOR PREPARING PERFUMING INTERMEDIATE	FIRMENICH SA
WO/2021/176034	MEMBRANE UBIQUITIN LIGASES TO TARGET PROTEIN DEGRADATION	UMC UTRECHT HOLDING B.V.
WO/2021/176042	THERAPEUTIC AGENTS	KING'S COLLEGE LONDON
WO/2021/176049	PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12	BAYER AKTIENGESELLSCHAFT
WO/2021/176064	SOLID FORMS OF TEZACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF	QUíMICA SINTéTICA, S.A.
WO/2021/176072	PEPTIDES TARGETING SHP2 AND USES THEREOF	UNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/176075	NOVEL IMMUNOGLOBULIN BINDING POLYPEPTIDES	NAVIGO PROTEINS GMBH
WO/2021/176090	PROTEASE-PROCESSED MOLECULES	SANOFI
WO/2021/180611	PREPARATION OF COPPER (I) 5-NITROTETRAZOLATE (DBX-1) FROM BIS(ETHYLENEDIAMINE) COPPER (II) NITROTETRAZOLATE	QINETIQ LIMITED
WO/2021/180655	2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS	OM PHARMA SA
WO/2021/180676	MuSK AGONIST ANTIBODY	ARGENX IIP BV
WO/2021/209199	INFLUENZA VIRUS-LIKE PARTICLES (VLPS)	ÖSTERREICHISCHE AGENTUR FüR GESUNDHEIT UND ERNÄHRUNGSSICHERHEIT GMBH
WO/2021/180770	PHOSPHINE OXIDE DERIVATIVES AND USE THEREOF	BCH BRüHL - CHEMIKALIEN HANDEL GMBH
WO/2021/180782	CYCLIC PEPTIDES	LIFEARC
WO/2021/180823	VARIANTS OF SAC7D AND THEIR USE IN CANCER THERAPY	AFFILOGIC
WO/2021/180874	METHOD FOR PREPARING BENZAMIDE COMPOUND	DALIAN CHEMPHY CHEMICAL CO., LTD.
WO/2021/180893	PROCESS FOR RECOVERING STYRENE MONOMER FROM A STYRENE-CONTAINING POLYMER	INDAVER
WO/2021/180929	AFFINITY MATURED AND HUMANIZED BINDING DOMAINS TARGETING ROR2	JULIUS-MAXIMILIANS-UNIVERSITÄT WüRZBURG
WO/2021/180952	FUSED PYRIMIDINE COMPOUNDS AS KCC2 MODULATORS	ASTRAZENECA AB
WO/2021/180959	ENZYME FOR CONVERTING CHLOROGENIC ACID INTO ISOCHLOROGENIC ACID	UNIVERSITE DE LORRAINE
WO/2021/180966	BCL-2 FAMILY PROTEINS MODULATING COMPOUNDS FOR CANCER TREATMENT	CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE
WO/2021/185712	HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/185732	METHOD AND DEVICE FOR PURIFYING VISCOUS AND/OR SOLID ISOCYANATES FROM A PRODUCT FLOW FROM ISOCYANATE SYNTHESIS	COVESTRO DEUTSCHLAND AG
WO/2021/185748	COCRYSTALS OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCABAMOYL)CYCLOPENTANE CARBOXYLIC ACID	PALOBIOFARMA, S.L.
WO/2021/190980	MULTIMERS FOR VIRAL STRAIN EVOLUTION	QUADRUCEPT BIO LIMITED
WO/2021/185789	CONDENSED PYRIDINE DERIVASTIVES SUBSTITUED BY AMIDE FUNCTIONS AS ACSS2 INHIBITORS	MERCK PATENT GMBH
WO/2021/185793	TETRAZOLE DERIVATIVES	MERCK PATENT GMBH
WO/2021/185806	CRYSTAL FORMS OF METHYL(2R,4R)-4-[[(5S)-3-(3,5-DIFLUOROPHENYL)-5-VINYL-4H-ISOXAZOLE-5-CARBONYL]AMINO]TETRAHYDROFURAN-2-CARBOXYLATE AND THEIR HERBICIDAL SYNERGISTIC EFFECTS	BAYER AKTIENGESELLSCHAFT
WO/2021/185878	SALTS AND CRYSTALLINE FORMS OF A TAAR1 AGONIST	F. HOFFMANN-LA ROCHE AG
WO/2021/185879	CATALYTIC PROCESS FOR PREPARING AN α,β-ETHYLENICALLY UNSATURATED CARBOXYLIC ACID SALT	BASF SE
WO/2021/197852	CRYSTALLINE FORM OF OZANIMOD HYDROCHLORIDE	SYNTHON B.V.
WO/2021/185934	ANTIBODIES BINDING TO B7H4	GENMAB A/S
WO/2021/191035	DIOXAZOLINES AND THEIR USE AS HERBICIDES	BASF SE
WO/2021/191042	PROCESS FOR INHIBITING THE UNDESIRED FREE-RADICAL POLYMERIZATION OF ACRYLIC ACID PRESENT IN A LIQUID PHASE P	BASF SE
WO/2021/185968	FRAGMENTS OF HLYA AND USES THEREOF	NUMAFERM GMBH
WO/2021/185986	FERRITIN VARIANTS WITH INCREASED STABILITY, COMPLEXATION ABILITY AND TRANSFERRIN RECEPTOR AFFINITY	CELLIS AG
WO/2021/185996	VEGF DIMER MOLECULES AND COLUMNS COMPRISING A VEGF DIMER MOLECULE AS WELL AS USES, PRODUCTION METHODS AND METHODS INVOLVING THE SAME	UNIVERSITÄT ZU KÖLN
WO/2021/191058	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/191062	PROCESS FOR THE PREPARATION OF (R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL) BENZOIC ACID OR A SALT THEREOF	ROTTAPHARM BIOTECH S.R.L.
WO/2021/191078	USE OF SUBSTITUTED CINNAMIC ACID ESTERS AS STABILISERS FOR ORGANIC MATERIALS, STABILISED ORGANIC MATERIAL, METHOD FOR STABILISING ORGANIC MATERIALS AND SPECIFIC CINAMIC ACID ESTERS	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/186052	ATTENUATED MYCOPLASMA BACTERIA	FUNDACIó CENTRE DE REGULACIó GENòMICA
WO/2021/186056	CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/186071	NGR CONJUGATES AND USES THEREOF	OSPEDALE SAN RAFFAELE S.R.L.
WO/2021/191105	METHODS FOR ISOMERIZING ALPHA OLEFINS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/191109	LOW INTAKE CESIUM AND PARTHENOCARPY PLANTS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/191113	PROCESS FOR PRODUCING PARA-EUGENOL AND/OR ORTHO-EUGENOL	RHODIA OPERATIONS
WO/2021/191117	MATERIALS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
WO/2021/197880	PROCESS FOR PREPARATION OF OPTICALLY ENRICHED ISOXAZOLINES	BASF SE
WO/2021/191134	H<sb>2</sb>O<sb>2</sb> WITHOUT DIBC FOR PO PRODUCTION	BASF SE
WO/2021/197888	PROCESS FOR PRODUCTION OF TERPENOID-INTERMEDIATES	DSM IP ASSETS B.V.
WO/2021/197889	PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES	DSM IP ASSETS B.V.
WO/2021/197890	PROCESS FOR PRODUCTION OF VITAMIN A	DSM IP ASSETS B.V.
WO/2021/191167	TYPE XIX COLLAGEN ASSAY	NORDIC BIOSCIENCE A/S
WO/2021/191183	CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/191194	REUSE OF INTEIN-BOUND RESINS FOR PROTEIN PURIFICATION	MERCK PATENT GMBH
WO/2021/191202	PROCESS FOR THE PRODUCTION OF FERROPORTIN INHIBITORS	VIFOR (INTERNATIONAL) AG
WO/2021/191219	N-PHENYL-3-MERCAPTOPROPANAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/191220	METHODS FOR TREATING ATOPIC DERMATITIS AND RELATED DISORDERS	MEDIMMUNE LIMITED
WO/2021/197953	METHOD FOR THE HYDROFORMYLATION OF OLEFINS	BASF SE
WO/2021/191288	PROCESS FOR THE PREPARATION OF HEXAMETHYLENEDIAMINE BY HYDROGENATION OF ADIPONITRILE WITH REDUCED FORMATION OF DIAMINOCYCLOHEXANE	BASF SE
WO/2021/191289	PROCESS FOR THE PREPARATION OF HEXAMETHYLENEDIAMINE BY HYDROGENATION OF ADIPONITRILE IN THE PRESENCE OF RANEY NICKEL AND A BASIC CO-CATALYST	BASF SE
WO/2021/198014	IMPROVED SAFE METHOD FOR TANDEM C-4 OXIDATION TO METHACRYLIC ACID	RÖHM GMBH
WO/2021/198020	3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/191359	MONOACYLGLYCEROL LIPASE MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/191366	BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME	GENETIC S.P.A.
WO/2021/191376	TRIAZOLONE COMPOUNDS	ASTRAZENECA AB
WO/2021/191378	5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AGAINST CANCER	ASTRAZENECA AB
WO/2021/191379	5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AGAINST CANCER	ASTRAZENECA AB
WO/2021/191380	TRIAZOLONE COMPOUNDS	ASTRAZENECA AB
WO/2021/198034	ANTIBODY THAT BINDS TO VEGF AND PDGF-B AND METHODS OF USE	F. HOFFMANN-LA ROCHE AG
WO/2021/191384	ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/191390	AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/198040	METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES.	DNA SCRIPT
WO/2021/191391	AMINOCYCLOBUTANES AS MONOACYLGLYCEROL LIPASE MODULATORS	JANSSEN PHARMACEUTICA NV
WO/2021/198064	IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS
WO/2021/191424	AUTONOMOUS KNOB DOMAIN PEPTIDES	UCB BIOPHARMA SRL
WO/2021/191426	PROTEIN COMPRISING AT LEAST ONE REGULATORY T CELL ACTIVATING EPITOPE	BIOTEST AG
WO/2021/186087	TRIMETHYLPLATINUM(IV) IODIDE	UMICORE AG & CO. KG
WO/2021/198124	BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAMS	F. HOFFMANN-LA ROCHE AG
WO/2021/254671	NEW AMMONIUM COMPOUNDS USEFUL AS SURFACTANTS	RHODIA OPERATIONS
WO/2021/198149	SUBSTITUTED 3-PHENOXYAZETIDIN-1-YL-PYRAZINES HAVING GPR52 AGONISTIC ACTIVITY	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/198157	RNA COMPOSITIONS TARGETING CLAUDIN-18.2	BIONTECH SE
WO/2021/198160	LARGE SCALE PROCESS FOR PREPARING 1,2,4, 6-TETRA-0-ACETYL-3-AZID0-3-DE0XY-D-GALACT0PYRAN0SIDE	GALECTO BIOTECH AB
WO/2021/198163	CD3-FUSION PROTEIN AND USES THEREOF	MEDIGENE IMMUNOTHERAPIES GMBH
WO/2021/198166	GAS TO OLEFINS PROCESS WITH COPRODUCTION OF HYDROGEN TOGETHER WITH HEAT INTEGRATION PROCESS	TOTAL SE
WO/2021/204577	IMIDAZO-PYRIMIDONE COMPOUNDS AS PESTICIDES	BASF SE
WO/2021/198168	GAS TO HYDROGEN PROCESS WITH CO-PRODUCTION OF CARBON	TOTAL SE
WO/2021/198172	GAS TO OLEFINS PROCESSES WITH COPRODUCTION OF HYDROGEN	TOTAL SE
WO/2021/198175	GAS TO OLEFINS PROCESS WITH COPRODUCTION OF HYDROGEN TOGETHER WITH ELECTRIFIED REACTIONAL SECTION	TOTAL SE
WO/2021/191465	FUNCTIONALISED BRANCHED OLEFINS AND METHOD FOR PRODUCING SAME	GLOBAL BIOENERGIES
WO/2021/198188	QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER	ENYO PHARMA
WO/2021/204585	PROCESS FOR PRODUCING ACETIC ACID	INEOS ACETYLS UK LIMITED
WO/2021/198204	SPLIT CH2 DOMAINS	SANOFI
WO/2021/198213	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/204589	SUBSTITUTED THIAZOLOPYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES	BAYER AKTIENGESELLSCHAFT
WO/2021/198239	BIOMIMETIC G-QUARTET COMPOUNDS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/198260	METHOD FOR THE PRODUCTION AND PURIFICATION OF MULTIVALENT IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS	ABLYNX NV
WO/2021/198283	INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR	JANSSEN PHARMACEUTICA NV
WO/2021/204610	ENERGY EFFICIENT BIODIESEL PRODUCTION FROM NATURAL OR INDUSTRIAL WASTE OIL	BASF SE
WO/2021/198324	MODIFIED LATENCY ASSOCIATED PROTEIN CONSTRUCT	STEALTHYX THERAPEUTICS LIMITED
WO/2021/198335	BISPECIFIC ANTIBODIES COMPRISING A MODIFIED C-TERMINAL CROSSFAB FRAGMENT	F. HOFFMANN-LA ROCHE AG
WO/2021/204626	ARYL AND HETEROARYL-CARBOXAMIDE SUBSTITUTED HETEROARYL COMPOUNDS AS TYK2 INHIBITORS	ALMIRALL, S.A.
WO/2021/209265	TRICYCLIC PESTICIDAL COMPOUNDS	BASF SE
WO/2021/198385	METHODS AND TOOLS FOR STUDYING ENTEROENDOCRINE CELLS	KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN
WO/2021/198386	CONTINUOUS CRYSTALLISATION METHOD	GE HEALTHCARE AS
WO/2021/204646	POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
WO/2021/209268	BETA-LACTAMS AND THEIR USE AS HERBICIDES	BASF SE
WO/2021/209269	A PROCESS FOR PREPARATION OF SUBSTITUTED ENAMINE COMPOUNDS	DSM IP ASSETS B.V.
WO/2021/204665	SUBSTITUTED ISOPHTHALIC ACID DIAMIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/204666	SUBSTITUTED ISOPHTHALIC ACID DIAMIDES AND THEIR USE AS HERBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/204667	SUBSTITUTED ISOPHTHALIC ACID DIAMIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/204669	SUBSTITUTED ISOPHTHALIC ACID DIAMIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/198479	PRODUCTION OF LIGHT OLEFINS VIA OXYCHLORINATION	TOTAL SE
WO/2021/204706	5-HALOALKOXY-PYRIMIDINE COMPOUNDS AS HERBICIDES	SYNGENTA CROP PROTECTION AG
WO/2021/204707	TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH IL-33 AXIS BINDING ANTAGONISTS	MEDIMMUNE LIMITED
WO/2021/198490	A PROTEIN COMPLEX COMPRISING AN IMMUNOCYTOKINE	PIERRE FABRE MEDICAMENT
WO/2021/204711	PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS	PROVEPHARM LIFE SOLUTIONS
WO/2021/204712	PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS	PROVEPHARM LIFE SOLUTIONS
WO/2021/198525	(S,Z)-3,7-DIMETHYLNON-6-EN-1-OL AND ITS USE AS FRAGRANCE	GIVAUDAN SA
WO/2021/204774	Pd-CATALYZED AMINATION OF FLUORINATED ARYL CHLORIDES	BASF SE
WO/2021/204822	MICROBIOCIDAL QUINOLINE DIHYDRO-(THIAZINE)OXAZINE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/204823	(1 H-INDOL-5-YL)ACRYLAMIDE DERIVATIVES AS INHIBITORS OF TEAD PROTEINS AND THE HIPPO-YAP1/TAZ SIGNALING CASCADE FOR THE TREATMENT OF CANCER	SANOFI
WO/2021/213800	[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/204855	MICROBIOCIDAL QUINOLINE DIHYDROPYRROLOPYRAZINE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/204856	N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS	MISSION THERAPEUTICS LIMITED
WO/2021/204857	MICROBIOCIDAL QUINOLINE DIHYDRO-(THIAZINE)OXAZINE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/204878	USE OF CDON INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/204884	3-(4-ALKENYL-PHENYL)-3-PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/204896	MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS	ITEOS BELGIUM SA
WO/2021/204911	NEOEPITOPE IMMUNOTHERAPY WITH APC TARGETING UNIT	EVAXION BIOTECH A/S
WO/2021/204930	SUBSTITUTED CONDENSED AZINES AS ANTHELMINTIC COMPOUNDS	BAYER ANIMAL HEALTH GMBH
WO/2021/204952	NEW ANTI-MALARIAL AGENTS	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/205001	PEPTIDES AND USES THEREOF	MARCONI, Alessandra
WO/2021/205023	PROCESS FOR THE PREPARATION OF SILODOSIN	MINAKEM
WO/2021/209345	AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS	FIRMENICH SA
WO/2021/209356	COMBINATION TREATMENT FOR CANCER	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/209357	COMBINATION TREATMENT FOR CANCER INVOLVING ANTI-ICOS AND ANTI-PD1 ANTIBODIES, OPTIONALLY FURTHER INVOLVING ANTI-TIM3 ANTIBODIES	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/209358	COMBINATION TREATMENT FOR CANCER BASED UPON AN ICOS ANTIBODY AND A PD-L1 ANTIBODY TGF-BETA-RECEPTOR FUSION PROTEIN	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/213828	METHOD FOR THE MANUFACTURE OF α,β-UNSATURATED KETONES	SENSIENT FRAGRANCES, S.A.
WO/2021/209377	A PROCESS FOR THE PREPARATION OF 4-CYANOBENZOYL CHLORIDES	BASF SE
WO/2021/209383	HERBICIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/209396	COMPOUNDS FOR PROVIDING A LONG-LASTING ODOR	FIRMENICH SA
WO/2021/209397	LILY OF THE VALLEY ODORANT	FIRMENICH SA
WO/2021/209415	HYDROGENATION OF L-SORBOSE	BASF SE
WO/2021/209473	BIPHENYL DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/209475	SULFAMOYLAMIDE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/209477	CRYSTALLINE FORMS OF 4-[(7-CHLORO-2-METHOXYBENZO[B][1,5]NAPHTHYRIDIN-10-YL)AMINO]-2,6-BIS(PYRROLIDIN-1-YLMETHYL)PHENOL AND SALTS THEREOF	MERCK PATENT GMBH
WO/2021/209481	INDAZOLE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/209484	BENZIMIDAZOLE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/209485	BENZIMIDAZOLE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/209486	SPECIFICALLY SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/209490	CYCLAMINEPHENYLAMINOQUINOLINES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/209495	ANTI-FLT3 ANTIBODIES AND COMPOSITIONS	SYMPHOGEN A/S
WO/2021/219375	PROCESS OF MAKING N,N'-DIACETYL-L-CYSTINE	UNILEVER IP HOLDINGS B.V.
WO/2021/219377	PROCESS OF MAKING N,N-DIACETYL-L-CYSTINE DISODIUM SALT FROM CYSTINE AND ACETYL CHLORIDE IN METHANOL IN THE PRESENCE OF SODIUM HYDROXIDE	UNILEVER IP HOLDINGS B.V.
WO/2021/209498	COMBINATION THERAPY OF ATRA OR OTHER RETINOIDS WITH IMMUNOTHERAPEUTIC AGENTS BINDING TO BCMA	JULIUS-MAXIMILIANS-UNIVERSITÄT WüRZBURG
WO/2021/209540	BIOMARKER OF FIBROSIS	NORDIC BIOSCIENCE A/S
WO/2021/219399	NOVEL 12-EPI-MUTILIN COMPOUNDS, PROCESS FOR PREPARING THE SAME AND USES THEREOF	NABRIVA THERAPEUTICS GMBH
WO/2021/209617	PROCESS FOR THE SYNTHESIS OF LOFEXIDINE	MEDICHEM, S.A.
WO/2021/213929	PESTICIDALLY ACTIVE SUBSTITUTED 1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/244801	METAL-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME	BEEOLED GMBH
WO/2021/219409	METHOD FOR PRODUCING HYDROXYALKYL(METH)ACRYLIC ACID ESTERS BY OXIDATIVE SPLITTING OF METHACROLEIN ACETALS	RÖHM GMBH
WO/2021/213952	BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM	F. HOFFMANN-LA ROCHE AG
WO/2021/213972	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/213978	2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS	BAYER AKTIENGESELLSCHAFT
WO/2021/219418	PREPARATION OF AROMATIC CARBOXYAMIDES BY PALLADIUM-CATALYZED CARBONYLATION REACTION	BASF SE
WO/2021/213984	PREPARATION OF 7-DEHYDROCHOLESTEROL USING SPECIFIC AROMATIC SOLVENTS	DSM IP ASSETS B.V.
WO/2021/213988	ORGANIC SOLVENT NANOFILTRATION OF 7-DEHYDROCHOLESTEROL OR 25-HYDROXY-7-DEHYDROCHOLESTEROL OR THEIR OH PROTECTED FORMS	DSM IP ASSETS B.V.
WO/2021/219424	PREPARATION OF AROMATIC CARBOXYAMIDES BY A PALLADIUM-CATALYZED CARBONYLATION REACTION	BASF SE
WO/2021/214019	SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION	BAYER AKTIENGESELLSCHAFT
WO/2021/214020	SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION	BAYER AKTIENGESELLSCHAFT
WO/2021/214022	CITRULLINATED NUCLEOPHOSMIN PEPTIDES AS CANCER VACCINES	SCANCELL LIMITED
WO/2021/214039	SPLA2HGIB-BINDING MOLECULES AND USES THEREOF	DIACCURATE
WO/2021/214048	DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND 5-LIPOXYGENASE	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/214054	INTERFERON ALPHA 2 VARIANTS AND USES THEREOF	UNIVERSITÄT DUISBURG-ESSEN
WO/2021/214073	ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS	NOVARTIS AG
WO/2021/214080	ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS	NOVARTIS AG
WO/2021/214090	KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS	F. HOFFMANN-LA ROCHE AG
WO/2021/214117	HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF	IOMX THERAPEUTICS AG
WO/2021/214122	PURIFICATION OF LOWER OLEFINS	CLARIANT INTERNATIONAL LTD
WO/2021/219457	METHOD FOR OXIDIZING 5-HYDROXYMETHYLFURFURAL	IFP ENERGIES NOUVELLES
WO/2021/214136	RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/214143	PROCESS FOR THE PREPARATION OF OMEGA-ALKANEDIOL MONONITRATE	DSM IP ASSETS B.V.
WO/2021/214144	PROCESS FOR THE PREPARATION OF ALPHA,OMEGA-ALKANEDIOL MONONITRATE	DSM IP ASSETS B.V.
WO/2021/214145	PROCESS FOR NITRATE ESTER FORMATION OF AN ALPHA,OMEGA-ALKANEDIOL MONOACYLATE	DSM IP ASSETS B.V.
WO/2021/214146	PROCESS FOR THE ACYLATION OF AN ALPHA, OMEGA-ALKANEDIOL	DSM IP ASSETS B.V.
WO/2021/214243	SULFUR EXTRUSION FROM DISULFIDES BY CARBENES	UNIVERSITÄT HEIDELBERG
WO/2021/224018	CO-EMULSIFIER WHICH READILY MICELLISES IN WATER	SYNGENTA CROP PROTECTION AG
WO/2021/214277	ENZYME AND PATHWAY MODULATION WITH SULFHYDRYL COMPOUNDS AND THEIR DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/214278	REGIOSELECTIVE OXIDATION OF HETEROCYCLIC ALPHA-AMINO AMIDES	PHARMAZELL GMBH
WO/2021/214284	TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3	JANSSEN PHARMACEUTICA NV
WO/2021/219513	PESTICIDAL COMPOUNDS	BASF SE
WO/2021/214299	NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRAL INFECTIONS AND RESPIRATORY COMPLICATIONS, IN PARTICULAR CAUSED BY INFLUENZAVIRUS OR CORONAVIRUS	NUVAMID SA
WO/2021/214306	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/214308	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/214309	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/214310	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/214315	PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/214329	COMPOSITION COMPRISING AN IGE ANTIBODY	KING'S COLLEGE LONDON
WO/2021/219523	PROCESS FOR THE PREPARATION OF A CHIRAL PIPERAZINE-2-CARBOXYLIC ACID	F. HOFFMANN-LA ROCHE AG
WO/2021/219527	1-PYRAZINYLPYRAZOLYL-3-OXYALKYL ACIDS AND THEIR DERIVATIVES, AND THEIR USE FOR CONTROL OF UNDESIRED PLANT GROWTH	BAYER AKTIENGESELLSCHAFT
WO/2021/224040	CONDENSED ISOXAZOLINE DERIVATIVES AND THEIR USE AS HERBICIDES	BASF SE
WO/2021/224044	METHOD FOR BREAKING DOWN MICHAEL ADDUCTS CONTAINED IN A FLUID F AND FORMED DURING THE PREPARATION OF ACRYLIC ACID	BASF SE
WO/2021/224045	CONTINUOUS PROCESS FOR THE PRODUCTION OF ALKANES	BASF SE
WO/2021/219558	YEAST STRAINS FOR REDUCING CONTAMINATION BY LACTIC ACID BACTERIA	UNIVERSITé LIBRE DE BRUXELLES
WO/2021/219578	ANTIBACTERIAL 8-PHENYLAMINO-3-(PYRAZOL-4-YL)IMIDAZO[1,2-A]PYRAZINE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/219594	SPIROUREA DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/224063	METAL-FREE METHOD FOR OXIDATIVE CLEAVAGE OF VIC-DIOLS TO CARBOXYLIC ACIDS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/219637	CRYSTALLINE FORMS OF GEPOTIDACIN	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/219647	METHOD FOR THE CONTINUOUS SYNTHESIS OF PARACETAMOL	IPSOMEDIC
WO/2021/219661	ALKYLAMINOPROLINE DERIVATIVES AS ALFA-2-DELTA-1 BLOCKERS	ACONDICIONAMIENTO TARRASENSE
WO/2021/219663	ESTER ESTOLIDE COMPOSITION AND METHOD FOR PRODUCING ESTER ESTOLIDES	TOTAL MARKETING SERVICES
WO/2021/219664	ANTI-BACTERIAL AND ANTI-VIRAL COMPOUNDS	UNIVERSITé DE GENèVE
WO/2021/219731	BICYCLIC KINASE INHIBITORS AND USES THEREOF	IOMX THERAPEUTICS AG
WO/2021/219775	MICROBIOCIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/219778	MICROBIOCIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/219780	MICROBIOCIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/224102	MICROBIOCIDAL COMPOUNDS	SYNGENTA CROP PROTECTION AG
WO/2021/219784	NEW TRIAZINOINDOLE COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/219786	ANTI-TOXIN SECRETORY IGA2 PREPARATION	HIMMLER, Gottfried
WO/2021/219807	PD-L1 VARIANTS WITH IMPROVED AFFINITY TOWARDS PD-1	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/219810	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/219813	ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES	SYDDANSK UNIVERSITET
WO/2021/219818	BISPECIFIC PROTEIN	HOBER BIOTECH AB
WO/2021/219828	NEW IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4	PERHA PHARMACEUTICALS
WO/2021/219849	AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS	IDORSIA PHARMACEUTICALS LTD
WO/2021/219871	ANTI-CD103 ANTIBODIES	ADURO BIOTECH HOLDINGS, EUROPE B.V.
WO/2021/219872	ANTIBODY AND USES THEREOF	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/228594	HETEROCYCLIC COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS	BASF SE
WO/2021/224184	PROCESSES FOR THE PRODUCTION OF ISOMERICALLY PURE OR ENRICHED CIS-CLOMIPHENE	PCAS
WO/2021/224186	NEW PYRIDINE DERIVATIVES AS RADIOSENSITIZERS	INSTITUT CURIE
WO/2021/219897	BETACORONAVIRUS PROPHYLAXIS AND THERAPY	VACCIBODY AS
WO/2021/224217	CO-CRYSTAL OF KETOPROFEN, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE	DOMPE' FARMACEUTICI SPA
WO/2021/224220	PYRIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS	BAYER AKTIENGESELLSCHAFT
WO/2021/224280	SYNTHESIS OF A SICKLE CELL DISEASE AGENT AND INTERMEDIATES THEREOF	DIPHARMA FRANCIS S.R.L.
WO/2021/224291	TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS	MERCK PATENT GMBH
WO/2021/224295	A PROCESS FOR PRODUCING D-BIOTIN INTERMEDIATES	DSM IP ASSETS B.V.
WO/2021/224310	KERATIN HYDROLYSATE HIGH IN FREE AMINO ACIDS AND HIGH IN FREE TYROSINE, METHOD FOR OBTAINING AND USING SAME FOR ANIMAL FEED AND PLANT NUTRITION	BRETAGNE CHIMIE FINE
WO/2021/224316	EXPRESSION OF COLLAGEN PEPTIDE COMPONENTS IN PROCARYOTIC SYSTEMS	GELITA AG
WO/2021/224320	NEW MACROCYCLIC LRRK2 KINASE INHIBITORS	LES LABORATOIRES SERVIER
WO/2021/224323	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/224366	HUMANIZED ANTI-C5A ANTIBODIES	INFLARX GMBH
WO/2021/224368	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/228673	PROCESS FOR PREPARATION OF OPTICALLY ENRICHED ISOXAZOLINES	BASF SE
WO/2021/148683	PEPTIDES AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS	IMCYSE SA
WO/2021/224409	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS	SYNGENTA CROP PROTECTION AG
WO/2021/224451	PEPTIDE TAGS AND BINDING PARTNERS	ADAPTVAC APS
WO/2021/224483	A PROCESS AND APPARATUS FOR PREPARING A PURIFIED STYRENE COMPOSITION FROM STYRENE CONTAINING FEEDSTOCK	SULZER MANAGEMENT AG
WO/2021/224487	A PROCESS AND APPARATUS FOR PREPARING A PURIFIED STYRENE COMPOSITION FROM STYRENE CONTAINING FEEDSTOCK	SULZER MANAGEMENT AG
WO/2021/224489	NOVEL COMPOUNDS FOR DIAGNOSIS	AC IMMUNE SA
WO/2021/224491	TRILOBINE DERIVATIVES AND THEIR USE THEREOF IN THE TREATMENT OF MALARIA	INSTITUT PASTEUR
WO/2021/224501	RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA	QURETECH BIO AB
WO/2021/228734	TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS	BAYER AKTIENGESELLSCHAFT
WO/2021/228795	NEW TRIAZOLYL DERIVATIVES AS GABA A ALPHA5 PAM	F. HOFFMANN-LA ROCHE AG
WO/2021/233732	METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS	EVONIK OPERATIONS GMBH
WO/2021/228836	RECOMBINANT PROTEINS WITH OX40 ACTIVATING PROPERTIES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/228840	A FRAGRANCE COMPOSITION	SYMRISE AG
WO/2021/228904	NEUTRALIZING ANTIBODIES BINDING TO THE SPIKE PROTEIN OF SARS-COV-2 SUITABLE FOR USE IN THE TREATMENT OF COVID-19, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF	ACADEMISCH MEDISCH CENTRUM
WO/2021/233752	TRPA1 ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH PAIN AND INFLAMMATION	BAYER AKTIENGESELLSCHAFT
WO/2021/228945	QUINAZOLINE COMPOUNDS AS INHIBITORS OF PREMATURE TERMINATION CODONS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/228977	METHOD FOR OPERATING A PLANT FOR CONTINUOUS PRODUCTION OF AN ISOCYANATE	COVESTRO DEUTSCHLAND AG
WO/2021/228978	METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES	ASTRAZENECA AB
WO/2021/228987	COMBINATION THERAPY FOR TTR AMYLOIDOSIS	NEURIMMUNE AG
WO/2021/228992	NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY	RIGSHOSPITALET
WO/2021/228999	NEOANTIGENIC EPITOPES ASSOCIATED WITH SF3B1 MUTATIONS	INSTITUT CURIE
WO/2021/233766	COMPOUNDS BINDING TENASCIN-C (TNC) FOR USE IN THE TREATMENT OF DISEASES	UNIVERSITE DE STRASBOURG
WO/2021/229025	DIBENZYLIDENE ALDITOL DERIVATIVES, COMPOSITION COMPRISING THEM, AND THEIR USE IN COSMETICS	L'OREAL
WO/2021/229031	PEPTIDE VACCINES FOR THE PREVENTION OF FOOT-AND-MOUTH DISEASE	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS
WO/2021/229050	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/233783	PROCESS OF PREPARING BUTYL-(5S)-5-({2-[4-(BUTOXYCARBONYL)PHENYL]ETHYL}[2-(2-{[3-CHLORO-4'-(TRIFLUOROMETHYL)[BIPHENYL]-4-YL]METHOXY}PHENYL)ETHYL]AMINO)-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLATE	BAYER AKTIENGESELLSCHAFT
WO/2021/229067	MULTISPECIFIC PROTEINS	MOLECULAR PARTNERS AG
WO/2021/229075	A MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR AND ITS USE IN TRACKING CELLS	OSPEDALE SAN RAFFAELE S.R.L.
WO/2021/229076	RECOMBINANT CD40 BINDING PROTEINS AND THEIR USE	MOLECULAR PARTNERS AG
WO/2021/233787	HERBICIDAL CINNOLINE DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/233800	AZACOUMARIN AND AZATHIOCOUMARIN DERIVATIVES FOR USE IN OPTICALLY ACTIVE DEVICES	MERCK PATENT GMBH
WO/2021/233805	PROCESS FOR PURIFYING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER	BASF SE
WO/2021/229103	MULTI-SPECIFIC IMMUNE MODULATORS	APOGENIX AG
WO/2021/233839	METHOD FOR PREPARING ACRYLIC ACID FROM β-PROPIOLACTONE	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/233852	CGAS INHIBITING TRIAZOLOPYRIMIDONE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/233854	NEW MALONITRILE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/233861	AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS	BAYER AKTIENGESELLSCHAFT
WO/2021/233882	PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/233884	CONTINUOUS PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/233887	METHOD FOR PREPARING TOLUYLENE DIAMINE MIXTURES	COVESTRO DEUTSCHLAND AG
WO/2021/233896	THERAPEUTIC POTENTIAL OF PEPTIDES FROM THE "NETRIN-LIKE" DOMAIN OF THE FRZB PROTEIN	UNIVERSITE DE LORRAINE
WO/2021/233913	NOVEL COV-2 ANTIBODIES	R.G.C.C. HOLDINGS AG
WO/2021/233930	NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE	LANXESS ORGANOMETALLICS GMBH
WO/2021/233994	SOCE INHIBITORS AND THERAPEUTIC USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/234003	BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY	F. HOFFMANN-LA ROCHE AG
WO/2021/234004	IMIDAZOLIUM REAGENT FOR MASS SPECTROMETRY	F. HOFFMANN-LA ROCHE AG
WO/2021/239558	PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN	ESTEVE PHARMACEUTICALS, S.A.
WO/2021/239568	PREPARATION OF SUBSTITUTED 4-(N'-HYDROXYCARBAMIMIDOYL)BENZOIC ACIDS	BASF SE
WO/2021/234077	PHOTOOXIDATION OF 2,3,5-TRIMETHYLPHENOL	DSM IP ASSETS B.V.
WO/2021/234078	PHOTOOXIDATION OF 2,3,6-TRIMETHYLPHENOL	DSM IP ASSETS B.V.
WO/2021/234080	PHOTOOXIDATION OF PHENOLIC COMPOUNDS	DSM IP ASSETS B.V.
WO/2021/234081	CHEMICAL PROCESS	SYNGENTA CROP PROTECTION AG
WO/2021/234082	CHEMICAL PROCESS	SYNGENTA CROP PROTECTION AG
WO/2021/234104	SYNTHETIC SINGLE DOMAIN LIBRARY	INSTITUT CURIE
WO/2021/234110	SINGLE DOMAIN ANTIBODIES AND THEIR USE IN CANCER THERAPIES	INSTITUT CURIE
WO/2021/239584	RECOMBINANT PROTEINS BASED ON FIBRINOGEN	SARTORIUS LAB INSTRUMENTS GMBH & CO. KG
WO/2021/234130	COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS	EXSYMOL
WO/2021/234157	ANTIMICROBIAL PROTEINS AND PEPTIDES WITH STRESS RESISTANCE INDUCING ACTIVITY	UNIVERSITAT JAUME I
WO/2021/239641	A PROCESS FOR THE OXIDATION OF PRIMARY ALCOHOLS TO CARBOXYLIC ACIDS	ETH ZüRICH
WO/2021/239642	PEPTIDES CAPABLE OF INDUCING ANOREXIC HORMONES, COMPOSITIONS AND USES THEREOF	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/239673	SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/244894	POLYMERIZATION INHIBITORS	BASF SE
WO/2021/239695	THIAZOLOXIME AND OXAZOLOXIME DERIVATIVES AS REACTIVATORS OF ORGANOPHOSPHOROUS NERVE AGENT (OPNA)-INHIBITED HUMAN ACETYLCHOLINESTERASE FOR THE TREATMENT OF NERVOUS AND/OR RESPIRATORY FAILURE AFTER INTOXICATION WITH OPNA	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/239727	4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/254734	METHOD FOR PREPARING AN N-ACYL AMINO ACID BY DIRECT AMIDIFICATION OF A FATTY ACID AT HIGH TEMPERATURE	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/239743	IL-17A MODULATORS	SANOFI
WO/2021/239745	IL-17A MODULATORS	SANOFI
WO/2021/239811	GAS TO METHANOL WITH COPRODUCTION OF HYDROGEN	TOTAL SE
WO/2021/239835	Method for preparing 2-chloro-N-(1-cyanocyclopropyl)-5-[2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'h-1,3'-bipyrazol-4-yl]benzamide	VETOQUINOL SA
WO/2021/239862	MACROCYCLIC 7-PYRAZOL-5-YL-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1	JANSSEN PHARMACEUTICA NV
WO/2021/239863	N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION	MISSION THERAPEUTICS LIMITED
WO/2021/239885	COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/239891	AIR-STABLE IMIDO ALKYLIDENE COMPLEXES AND USE THEREOF IN OLEFIN METATHESIS REACTIONS	VERBIO VEREINIGTE BIOENERGIE AG
WO/2021/244952	MICROBIOCIDAL DERIVATIVES	SYNGENTA CROP PROTECTION AG
WO/2021/249786	SARS-COV2 DIAGNOSTIC POLYPEPTIDES AND METHODS	AVACTA LIFE SCIENCES LIMITED
WO/2021/239928	TREATMENT OF CARDIOMETABOLIC DISEASE WITH INHIBITORS OF TYPE I INTERFERON SIGNALLING	ASTRAZENECA AB
WO/2021/239949	HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN	DEUTSCHES ZENTRUM FüR NEURODEGENERATIVE ERKRANKUNGEN E. V. (DZNE)
WO/2021/239955	PROCESS AND PLANT FOR THE SYNTHESIS OF UREA	CASALE SA
WO/2021/239956	ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES	GENEURO SA
WO/2021/244997	NOVEL IMIDAZOPYRAZNE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/249800	SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AS FUNGICIDES	BASF SE
WO/2021/245051	ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245055	ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245070	ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF	SANOFI
WO/2021/245083	HETEROCYCLYL PYRIDINES AS NOVEL FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/245087	HETEROCYCLYL PYRIMIDINES AND TRIAZINES AS NOVEL FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/245089	METHOD FOR CAPILLARY ISOELECTRIC FOCUSING SEPARATION OF POLYPEPTIDES	BIOMOTIF AB
WO/2021/245130	IL-2 SEQUENCES AND USES THEREOF	ASCENDIS PHARMA ONCOLOGY DIVISION A/S
WO/2021/245148	COMPLEX CONTAINING BETAINE, TRANSITION METAL AND SULFATE	BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH
WO/2021/245186	N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS	MISSION THERAPEUTICS LIMITED
WO/2021/245192	NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF	TOPADUR PHARMA AG
WO/2021/249877	INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF TOLVAPTAN AND ITS DERIVATIVES	CAMBREX PROFARMACO MILANO S.R.L.
WO/2021/245220	PROCESS FOR THE PREPARATION OF TICAGRELOR	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/245221	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/245228	PROCESS FOR PURIFYING A MIXTURE OF DIOLS	NOVAMONT S.P.A.
WO/2021/249887	PRODUCTION PROCESS FOR AMINO ALCOHOLATES	COVESTRO DEUTSCHLAND AG
WO/2021/245240	MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB	PIERIS PHARMACEUTICALS GMBH
WO/2021/245253	PREPARATION OF HIGHLY PURE AMORPHOUS DAPAGLIFLOZIN	KRKA, D.D., NOVO MESTO
WO/2021/254798	PROCESS FOR THE PREPARATION OF ASENAPINE IN THE FORM OF ITS FREE BASE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/249892	SUBSTITUTED AMINO-PYRIMIDINES	F. HOFFMANN-LA ROCHE AG
WO/2021/249893	NOVEL IMIDAZO-PYRAZINE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/249896	NOVEL IMIDAZOPYRAZINE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/249904	AMINO-PYRIMIDINE CYCLO-AMIDES	F. HOFFMANN-LA ROCHE AG
WO/2021/249908	AMINO-PYRIMIDINE AMIDES	F. HOFFMANN-LA ROCHE AG
WO/2021/249909	1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS	MISSION THERAPEUTICS LIMITED
WO/2021/249913	2'-(QUINOLIN-3-YL)-5',6'-DIHYDROSPIRO[AZETIDINE-3,4'-PYRROLO[1,2-B]PYRAZOLE]-1-CARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS AS MAP4K1 (HPK1) INHIBITORS FOR THE TREATMENT OF CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/249928	USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS V	BASF SE
WO/2021/254811	IMPROVED PROCESS TO PRODUCE SPECIFIC α,β-UNSATURATED CARBOXYLATES	DSM IP ASSETS B.V.
WO/2021/249995	AZABICYCLYL-SUBSTITUTED HETEROCYCLES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/250002	THERMAL OXIDATIVE COUPLING OF METHANE PROCESS USING RENEWABLE ENERGY WITH POSSIBLE CO-PRODUCTION OF HYDROGEN	TOTAL SE
WO/2021/250026	USE OF ANTI-GPVI ANTIBODIES FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME	ACTICOR BIOTECH
WO/2021/250028	METHODS FOR DETECTING AND TREATING COVID PATIENTS REQUIRING INTENSIVE CARE	INSTITUT GUSTAVE ROUSSY
WO/2021/250030	PROCESS AND PLANT FOR PRODUCING PROPYLENE	LINDE GMBH
WO/2021/250059	METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/250067	A PROCESS FOR THE PURIFICATION OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE	FLAMMA SPA
WO/2021/250069	PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE	CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
WO/2021/250097	ANTI-BK VIRUS ANTIBODY MOLECULES	MEMO THERAPEUTICS AG
WO/2021/250102	MACROCYCLIC 2-AMINO-3-FLUORO-BUT-3-ENAMIDES AS INHIBITORS OF MCL-1	JANSSEN PHARMACEUTICA NV
WO/2021/250163	PROCEDURE FOR OBTAINING GADOTERATE MEGLUMINE FROM HIGH-PURITY TETRAXETAN (DOTA) AND ITS USE IN THE PREPARATION OF INJECTABLE GALENICAL FORMULATIONS	JUSTESA IMAGEN S.A.U.
WO/2021/250164	ENOL ETHER PROPERFUME	FIRMENICH SA
WO/2021/250174	SYNTHESIS OF (2S,5R)-5-(2-CHLOROPHENYL)-1-(2'-METHOXY-[1,1'-BIPHENYL]-4-CARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID	EPICS THERAPEUTICS
WO/2021/250180	HEMI (L)-TARTRATE FORMS OF 3-({5-CHLORO-1-[3-(METHYLSULFONYL)PROPYL]-1H-INDOL-2 YL} METHYL)-1-(2,2,2-TRIFLUOROETHYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/250191	IMPROVED DEMINERALIZATION OF FERMENTATION BROTHS AND PURIFICATION OF FINE CHEMICALS SUCH AS OLIGOSACCHARIDES	BASF SE
WO/2021/250197	METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD	CYXONE AB
WO/2021/250226	CYCLIC PEPTIDE INHIBITORS OF PSD-95 AND USES THEREOF	UNIVERSITY OF COPENHAGEN
WO/2021/254896	PROCESS FOR PREPARING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE ENABLED BY A CATALYTIC ASYMMETRIC HANTZSCH ESTER REDUCTION	BAYER AKTIENGESELLSCHAFT
WO/2021/254920	PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/254979	CHEMOKINE-SELECTIVE CXCR4 ECTODOMAIN-DERIVED (POLY)PEPTIDE	LUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/254981	PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE	ADVERIO PHARMA GMBH
WO/2021/254984	INDENOAZANAPHTHALENES	MERCK PATENT GMBH
WO/2021/255011	PROCESS FOR THE MANUFACTURE OF ALKYLAMIDOTHIAZOLES	DSM IP ASSETS B.V.
WO/2021/255029	MEANS AND METHODS TO IMPROVE YEAST FERMENTATION EFFICIENCY	VIB VZW
WO/2021/255052	PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL	GIVAUDAN SA
WO/2021/255067	METHOD FOR IDENTIFYING COMPOUNDS INFLUENCING VIRUS RECEPTOR BINDING	VIRAVAXX AG
WO/2021/255071	3-(PYRIDAZIN-4-YL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE DERIVATIVES AS FUNGICIDES FOR CROP PROTECTION	BAYER AKTIENGESELLSCHAFT
WO/2021/255073	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
WO/2021/255085	SMALL MOLECULE MODULATORS OF IL-17	LEO PHARMA A/S
WO/2021/255086	SMALL MOLECULE MODULATORS OF IL-17	LEO PHARMA A/S
WO/2021/255089	1,3,4-OXADIAZOLE PYRIMIDINES AND 1,3,4-OXADIAZOLE PYRIDINES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/255091	1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/259732	MULTI-COMPONENT COMPOUNDS COMPRISING ZANUBRUTINIB AND A BENZOIC ACID DERIVATIVE	SANDOZ AG
WO/2021/255127	HETERODIMERIC RELAXIN FUSIONS AND USES THEREOF	MEDIMMUNE LIMITED
WO/2021/255137	PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES	F. HOFFMANN-LA ROCHE AG
WO/2021/255138	IMMUNE ACTIVATING FC DOMAIN BINDING MOLECULES	F. HOFFMANN-LA ROCHE AG
WO/2021/255142	ANTIBODIES BINDING TO CD3	F. HOFFMANN-LA ROCHE AG
WO/2021/255143	ANTIBODIES BINDING TO CD3 AND FOLR1	F. HOFFMANN-LA ROCHE AG
WO/2021/255146	ANTIBODIES BINDING TO CD3 AND CEA	F. HOFFMANN-LA ROCHE AG
WO/2021/255155	ANTIBODIES BINDING TO CD3 AND CD19	F. HOFFMANN-LA ROCHE AG
WO/2021/255169	1,3,4-OXADIAZOLE PYRIMIDINES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/255170	1,3,4-OXADIAZOLE PYRIMIDINES AS FUNGICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/255174	SMALL MOLECULE MODULATORS OF IL-17	LEO PHARMA A/S
WO/2021/255180	SALTS OF BEMPEDOIC ACID	SYNTHON B.V.
WO/2021/255212	BRAF DEGRADERS	F. HOFFMANN-LA ROCHE AG
WO/2021/255213	HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF BRAF	F. HOFFMANN-LA ROCHE AG
WO/2021/255221	SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT ENCODING ANTIGENS OF SPECIFIC VIRUS LINEAGES	INTERVET INTERNATIONAL B.V.
WO/2021/255225	SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT COMPRISING FIRST, SECOND AND THIRD NUCLEIC ACID SEQUENCES ENCODING DISTINCT NEURAMINIDASE ANTIGENS OF THE VIRUS	INTERVET INTERNATIONAL B.V.
WO/2021/259798	((((3-HALOPHENYL)(PHENYL)METHYL)SULFINYL)METHYL)THIOPHENE COMPOUNDS AND DIASTEREOMERIC FORMS THEREOF FOR USE IN IMPROVING COGNITIVE FUNCTIONS	RED BULL GMBH
WO/2021/255257	N-LINKED MACROCYCLIC 7-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1	JANSSEN PHARMACEUTICA NV
WO/2021/255258	N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1	JANSSEN PHARMACEUTICA NV
WO/2021/255272	ROOT-KNOT NEMATODE RESISTANCE CONFERRING GENE	RIJK ZWAAN ZAADTEELT EN ZAADHANDEL B.V.
WO/2021/255279	D I H YD ROOXAZO LE AND THIOUREA DERIVATIVES MODULATING THE NLRP3 INFLAMMASOME PATHWAY	AC IMMUNE SA
WO/2021/255280	SCREENING METHOD FOR EFFECTIVE TARGET - E3 LIGASE COMBINATIONS	UMC UTRECHT HOLDING B.V.
WO/2021/255287	PHYTOSPHINGOSINE DERIVATIVES AS ADJUVANTS IN IMMUNE STIMULATION	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/255291	FATTY ACID COMPLEXES OF CORONAVIRUS SPIKE PROTEIN AND THEIR USE	THE UNIVERSITY OF BRISTOL
WO/2021/259815	AMIDOPYRIMIDONE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/259831	SULFONE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/259852	PROCESS FOR PREPARING 5-(ALKOXYCARBONYL)-AND 5-(CARBOXAMIDE)-1-ARYL-1,2,4-TRIAZOLE DERIVATIVES	BAYER AKTIENGESELLSCHAFT
WO/2021/259860	ANTI-INFLAMMATORY COMPOUNDS AND METHODS FOR THEIR MANUFACTURE	BIOHORM, S.L.
WO/2021/259880	ANTI-IL-36 ANTIBODIES AND METHODS OF USE THEREOF	ALMIRALL, S.A.
WO/2021/259881	NUCLEOSIDES AND NUCLEOTIDES WITH 3' ACETAL BLOCKING GROUP	ILLUMINA CAMBRIDGE LIMITED
WO/2021/259890	AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2	F. HOFFMANN-LA ROCHE AG
WO/2021/259902	ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND POLYPEPTIDES BLOCKING THE SIRPΑ-CD47 INNATE IMMUNE CHECKPOINT	MORPHOSYS AG
WO/2021/259907	PROCESS FOR THE PREPARATION OF ORTHO-HALOGENATED PHENYLALANINE COMPOUNDS	LES LABORATOIRES SERVIER
WO/2021/259997	NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES	BAYER ANIMAL HEALTH GMBH
WO/2021/260029	COMPOSITIONS AND METHODS FOR PARASITE CONTROL	PHILIP MORRIS PRODUCTS S.A.
WO/2021/260052	BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2)	NAVIGO PROTEINS GMBH
WO/2021/260064	ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES	F. HOFFMANN-LA ROCHE AG
WO/2021/260071	COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES	UNIVERSITE DE FRANCHE COMTE
WO/2021/260072	COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES	UNIVERSITE DE FRANCHE COMTE
WO/2021/260074	CROSS-LINKING METHODS	THE UNIVERSITY OF BATH
WO/2021/260075	BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2)	NAVIGO PROTEINS GMBH
WO/2021/260090	CYCLOBUTYL-UREA DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/260092	QUINOXALINE DERIVATIVES AS ANTI-CANCER DRUGS	ASTRAZENECA AB
WO/2021/260107	FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION	STEALTH LABELS BIOTECH AB
WO/2021/260118	LIQUID MIXTURES OF PROPOXYLATED PARA-TOLUIDINES	SALTIGO GMBH
WO/2021/260144	USES, METHODS AND PRODUCTS RELATING TO OLIGOMERIC LIPOPOLYSACCHARIDE BINDING PROTEINS	UNIVERSITETET I OSLO
WO/2021/260163	SERPIN PRODUCTION	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/260206	CHEMOKINE RECEPTOR ANTIBODIES BINDING SULFATED TRD MOTIFS	BAYER AKTIENGESELLSCHAFT
WO/2021/260232	METHODS FOR THE PREPARATION OF LINKER PAYLOAD CONSTRUCTS	SYNAFFIX B.V.
WO/2021/214348	COMPOUNDS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
WO/2021/069766	VIRAL PROTEINS WITH ANTIBACTERIAL ACTIVITY AGAINST <i>ESCHERICHIA COLI</i>	UNIVERSIDAD DE ALICANTE
WO/2021/209652	NEW COMPOSITION FOR USE TO TREAT AND PREVENT INFECTIONS BY COVID-19 AND OTHER CORONAVIRUSES	DERMOPARTNERS,S.L.
WO/2021/229109	NEW TRIGLYCERIDE OBTAINED FROM A MACROCYBE TITANS EXTRACT, CLINICAL APPLICATIONS AND PRODUCTION METHOD	BIO TECH STARE CLOBAL S.R.L.
WO/2021/001587	4-HYDROXYPHENYL PHOSPHONIUM SALTS WITH ANTI-PARASITIC PROPERTIES	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/019118	MONOCLONAL ANTIBODY AGAINST <i>N. CERANAE</i> AND HYBRIDOMA THAT PRODUCES SAME	FUNDACIóN UNIVERSITARIA SAN PABLO-CEU
WO/2021/069773	COMPOUND FOR DETECTING SENESCENT CELLS AND USE THEREOF	UNIVERSITAT POLITèCNICA DE VALèNCIA
WO/2021/099659	PEPTIDES CONTAINING D-ALANINE (D-ALA) OR RELATED AMINO ALCOHOLS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS
WO/2021/111021	MAGNETIC NANOPARTICLES STABILISED WITH DENDRITIC CARBOSILANE SYSTEMS AND USES THEREOF	UNIVERSIDAD DE ALCALá
WO/2021/111022	SULFATED PHENYLHYDRAZIDE DERIVATIVES AS ANTIVIRAL AGENTS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/144494	MUSHROOM TYROSINASE AS A HEPATITIS C VIRUS INHIBITOR	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/148702	TITANIUM-IRON MOF SOLID, PROCESS FOR OBTAINING IT AND USE THEREOF FOR THE DEGRADATION OF COMPOUNDS	UNIVERSITAT DE VALèNCIA
WO/2021/152197	8-METOXY-2-OXO-1,2-DIHYDROCYCLOPENTA[DE]QUINOLINE DERIVATIVES AND USE THEREOF AS REAGENTS FOR LABELLING LANTHANIDE LUMINESCENCE	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/152199	HALOACETAMIDES DERIVED FROM LANTHANIDE ANTENNAS AND USE THEREOF AS REAGENTS FOR LABELLING LANTHANIDE LUMINESCENCE	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/152200	TRANSITION METAL COMPLEXES FOR THE REVERSIBLE ACTIVATION OF AMMONIA AND PRIMARY AMINES, CARBON MONOXIDE AND PHENYLACETYLENE, AND FOR THE REVERSIBLE DEHYDROGENATION OF ALCOHOLS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/152201	ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES OF SAME AND USE AS BIOMARKERS	UNIVERSITAT DE LES ILLES BALEARS
WO/2021/180992	METHOD FOR PRODUCING OLEOCANTHAL	SANTA CRUZ INGENIERíA, S.L.U.
WO/2021/250296	FORMYLATION OF INDOLIZINES AND DETECTION OF NITRITES	UNIVERSIDAD DE ALICANTE
WO/2021/191483	METHOD FOR CELL NANOCOATING AND IMMUNOISOLATION	UNIVERSIDAD DE VALLADOLID
WO/2021/198548	MONOCLONAL ANTIBODY AND POLYCLONAL ANTIBODY AND OXYTOCIN QUANTIFICATION METHOD BASED ON SAME	UNIVERSIDAD DE MURCIA
WO/2021/234200	BINARY COMPLEX OF AN ORGANIC ZINC CHELATE AND FLAVONOIDS AND COMPOSITION COMPRISING IT FOR STIMULATING THE IMMUNE SYSTEM AND ENHANCING RESISTANCE TO VIRAL OR BACTERIAL INFECTIOUS DISEASES	UNIVERSIDAD DE VALLADOLID
WO/2021/250299	SYNTHETIC MULTI-EPITOPE CHIMERA AS A VACCINE AND TREATMENT FOR LEISHMANIASIS IN MAMMALS	UNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/240041	METHOD FOR PRODUCING 3,4-DIHYDROXYPHENYLGLYCOL (DHPG)	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/245318	METHOD FOR TREATING RESPIRATORY TRACT INFECTIONS CAUSED BY VIRUSES	CONICET - CONSEJO NACIONAL DE INVESTIGACIONES CIENTíFICAS Y TéCNICAS
WO/2021/255319	NEW BODIPY DYES FOR PHOTODYNAMIC TERAGNOSIS BASED ON ACCUMULATION IN MITOCHONDRIA	UNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/058876	RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS	NESTE OYJ
WO/2021/058877	RENEWABLE CHEMICAL PRODUCTION ENGAGING METATHESIS AND MICROBIAL OXIDATION	NESTE OYJ
WO/2021/069806	AN ONCOLYTIC VIRUS VECTOR CODING FOR VARIANT INTERLEUKIN-2 (VIL-2) POLYPEPTIDE	TILT BIOTHERAPEUTICS OY
WO/2021/144499	PRODUCTION OF MONO-ETHYLENE GLYCOL	UPM-KYMMENE CORPORATION
WO/2021/165584	A METHOD FOR PREPARING AN ORGANOMETALLIC SALT COMPOSITION, AS WELL AS THE USE OF THE COMPOSITION IN A LUBRICANT ADDITIVE	AB NANOL TECHNOLOGIES OY
WO/2021/170913	TRICYCLIC MODULATORS OF PP2A	RAPPTA THERAPEUTICS OY
WO/2021/198563	RECOVERING MONO-PROPYLENE GLYCOL	UPM-KYMMENE CORPORATION
WO/2021/214382	TREATMENT OF DISEASES WITH CLEVER-1 INHIBITION IN COMBINATION WITH AN INTERLEUKIN INHIBITOR	FARON PHARMACEUTICALS OY
WO/2021/209689	COMPOUNDS AND COMPOSITIONS FOR TREATING SWEET POTATO AGAINST SWEET POTATO PATHOGENIC VIRUSES	HELSINGIN YLIOPISTO
WO/2021/219933	HETEROAZEOTROPIC EXTRACTIVE DISTILLATION METHOD AND APPARATUS	CHEMPOLIS OY
WO/2021/229145	METHOD FOR THE PREPARATION OF ANDROGEN RECEPTOR ANTAGONISTS AND INTERMEDIATES THEREOF	ORION CORPORATION
WO/2021/229147	METHOD FOR PRODUCING NITROFURANTOIN ANHYDRATE, AND PRODUCT THEREOF	FERMION OY
WO/2021/229152	CYP11A1 INHIBITORS	ORION CORPORATION
WO/2021/250323	ANTI-COX-2 AUTOANTIBODY AS A DIAGNOSTIC MARKER, AND METHODS, KITS AND USES RELATED THERETO	HELSINGIN YLIOPISTO
WO/2021/009422	METHOD FOR SELF-ASSEMBLY OF A PROTEIN ON A SUBSTRATE IN A THREE-DIMENSIONAL HONEYCOMB STRUCTURE	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/005294	N-FORMYLHYDROXYLAMINES AS NEPRILYSIN (NEP) INHIBITORS, IN PARTICULAR AS MIXED INHIBITORS OF AMINOPEPTIDASE N (APN) AND NEPRILYSIN (NEP)	PHARMALEADS
WO/2021/053289	METHOD FOR OXIDATIVE CLEAVAGE OF OLEFINS USING A HALOOXODIPEROXOMETALLATE AS A CATALYST	DEMETA
WO/2021/064312	METHOD FOR PREPARING MERCAPTANS BY SULFHYDROLYSIS OF SULFIDES	ARKEMA FRANCE
WO/2021/074544	CAPPED ALKOXYLATED ALCOHOLS	ARKEMA FRANCE
WO/2021/074555	OENOLOGICAL YEASTS FOR CONTROLLING THE ACID CONTENT OF WINES AND METHODS FOR SELECTING SUCH YEASTS	BIOLAFFORT
WO/2021/084185	METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE IMINE FUNCTION BY A SPECIFIC CONDENSATION REACTION, AND PARTICULAR APPLICATION OF SAID METHOD IN THE FIELD OF DYEING	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/079069	ENERGETIC AMINO ACID SALTS WITH HIGH OXYGEN BALANCE	ARIANEGROUP SAS
WO/2021/084197	METHOD FOR EVALUATING BROMINATED FLAME RETARDERS	ARKEMA FRANCE
WO/2021/111090	FUNGUS STRAIN HAVING DECREASED VISCOSITY	IFP ENERGIES NOUVELLES
WO/2021/116608	PROCESS FOR THE CONTINUOUS PREPARATION OF HEAVY ALKYL ACRYLATES	ARKEMA FRANCE
WO/2021/116617	PROCESS FOR INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL)METHYL)PROPANOYL)-L-ALANINE	PHARMALEADS
WO/2021/123599	NOVEL SULFOBETAINE MONOMERS, PROCESS FOR PREPARING SAME, AND USES THEREOF	SPCM SA
WO/2021/123627	ADALIMUMAB VARIANTS HAVING REDUCED IMMUNOGENIC POTENTIAL	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/123656	PROCESS FOR PREPARING DIESTERS FROM UNSATURATED FATTY ALCOHOLS AND DIESTERS THUS OBTAINED	TOTAL MARKETING SERVICES
WO/2021/123665	NPR1 DETECTION FOR EVALUATING THE ACTIVATION OF PLANT DEFENSE MECHANISMS	STAPHYT
WO/2021/130451	CHEMICAL COMPOUNDS TARGETING THE EYE AND USE THEREOF IN THE TREATMENT OF EYE DISEASES	BIOPHYTIS
WO/2021/130454	DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -
WO/2021/152266	ANTI-G-PROTEIN ALPHA ANTIBODY	CISBIO BIOASSAYS
WO/2021/156578	NEW PATHWAY FOR THE SYNTHESIS OF SINAPOYL MALATE, OF SINAPINE AND OF ANALOGUES THEREOF, AND USE THEREOF AS ANTIMICROBIAL MOLECULES	INSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT - AGROPARISTECH
WO/2021/165617	METHOD FOR PRODUCING AN IODOFLUOROALKANE COMPOUND	ARKEMA FRANCE
WO/2021/205090	METHOD FOR PURIFYING (METH)ACRYLIC ACID	ARKEMA FRANCE
WO/2021/214414	METHODS FOR INHIBITING FUSARIUM MYCOTOXIN PRODUCTION	INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/234249	METHOD FOR RECOVERING HEAVY BY-PRODUCTS FROM ACRYLIC ACID AND ESTERS OF SAID ACID BY THERMAL CRACKING WITH PARTIAL CONDENSATION	ARKEMA FRANCE
WO/2021/229185	BACTERIAL STRAINS AND METHOD FOR PRODUCING OLIGOSACCHARIDES	INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE
WO/2021/229188	NOVEL FLUORESCENT COMPOUNDS FOR LABELLING TUMOUR TISSUE	PROIMAGING
WO/2021/234251	XANTHENE DERIVATIVES, MIXTURES COMPRISING SAME, MANUFACTURING METHOD AND CORRESPONDING USES	ARKEMA FRANCE
WO/2021/234260	FIELD METHOD FOR DETECTING THE PRESENCE AND MULTI-RESISTANCE OF A PEST, IN PARTICULAR ZYMOSEPTORIA TRITICI, IN CEREAL CROPS	ANOVA-PLUS
WO/2021/255387	METHOD FOR PRODUCING AMINOUNDECANOIC ACID AND AMINODECANOIC ACID	ARKEMA FRANCE
WO/2021/028645	PLASMA KALLIKREIN INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/032934	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/032935	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/156584	KV3 MODULATORS	AUTIFONY THERAPEUTICS LIMITED
WO/2021/028649	PLASMA KALLIKREIN INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/032938	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/001653	ANTIBODIES AND METHODS OF USE	OXFORD BIOTHERAPEUTICS LTD
WO/2021/005339	NOVEL CANCER ANTIGENS AND METHODS	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/009509	AMORPHOUS UMBRALISIB MONOTOSYLATE	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/009514	PROCESS FOR THE PREPARATION OF RIDINILAZOLE AND CRYSTALLINE FORMS THEREOF	SUMMIT (OXFORD) LIMITED
WO/2021/014167	SOLID FORMS OF N-TERT-BUTYL-4[[2-(5-CHLORO-2-HYDROXY-PHNEYL)ACETYL]AMINO]PYRIDINE-2-CARBOXAMIDE	ENTERPRISE THERAPEUTICS LIMITED
WO/2021/014172	PYRIDINE DERIVATIVES AS CALCIUM-ACTIVATED CHLORIDE CHANNEL MODULATORS	ENTERPRISE THERAPEUTICS LIMITED
WO/2021/023982	PYRENOID-LIKE STRUCTURES	THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/023987	CHIMERIC CYTOKINE RECEPTOR	AUTOLUS LIMITED
WO/2021/023993	MOLECULAR COMPLEXES	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/023994	MOLECULAR COMPLEXES	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/023996	METHOD	UCL BUSINESS LTD
WO/2021/028669	NOVEL COMPOSITION COMPRISING ANTIBODIES	ARECOR LIMITED
WO/2021/028670	DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER	ARTIOS PHARMA LIMITED
WO/2021/028678	POLYMORPH OF VENETOCLAX AND METHOD FOR PREPARING THE POLYMORPH	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/032952	PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/032961	EX VIVO GAMMA DELTA T CELL POPULATIONS	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/032992	PHARMACEUTICAL COMPOUNDS	REVIRAL LIMITED
WO/2021/038204	CRYSTALLINE FORMS OF IVOSIDENIB	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/038232	PBP BINDING BICYCLIC PEPTIDE LIGANDS	BICYCLETX LIMITED
WO/2021/048567	NEW COMPOUNDS AND METHODS	BENEVOLENTAI BIO LIMITED
WO/2021/053346	EPIGENETIC PROFILING METHOD	THE UNIVERSITY OF BIRMINGHAM
WO/2021/058973	IL-15 FUSION PEPTIDES USED TO TREAT CANCER	PROSTATE CANCER RESEARCH CENTRE
WO/2021/064402	PLANTS HAVING A MODIFIED LAZY PROTEIN	UNIVERSITY OF LEEDS
WO/2021/064421	TREATMENT	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/064428	HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES	BICYCLETX LIMITED
WO/2021/069913	ANTI-CANCER LEUCIN-RICH PEPTIDES AND USES THEREOF	KING'S COLLEGE LONDON
WO/2021/074606	MODULATING OPSIN SIGNALING LIFETIME FOR OPTOGENETIC APPLICATIONS	THE UNIVERSITY OF MANCHESTER
WO/2021/074620	[1,4]OXAZEPINO[2,3-C]QUINOLINONE DERIVATIVES AS BCL6 INHIBITORS	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/079120	ENGINEERED REGULATORY T CELL	UCL BUSINESS LTD
WO/2021/079121	BENZODIAZEPINE DERIVATIVES FOR TREATING A RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION	REVIRAL LIMITED
WO/2021/079140	MOLECULAR MATERIALS BASED ON PHENOXYAZINE CORE FOR HETEROJUNCTION ORGANIC SOLAR CELLS	SUMITOMO CHEMICAL CO., LTD
WO/2021/079141	PHOTOACTIVE MATERIALS	SUMITOMO CHEMICAL CO., LTD
WO/2021/079149	CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HLA	UCL BUSINESS LTD
WO/2021/084260	CRYSTALLINE ENTRECTINIB ANHYDRATE AND MONOHYDRATE FORMS; CRYSTALLINE ENTRECTINIB THF, NITROMETHANE, ISOPROPYL ACETATE AND METHANOL SOLVATE FORMS; PROCESSES FOR PREPARING A CRYSTALLINE ENTRECTINIB ANHYDRATE FORM	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/084264	ISOQUINOLINE DERIVATIVES AS SIK2 INHIBITORS	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/084265	ISOQUINOLINE DERIVATIVES AS SIK2 INHIBITORS	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/084266	BICYCLIC NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF SALT-INUCED KINASE SIK2	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/084274	AN EXTRACELLULAR VESICLE	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/084275	FACTOR VIII POLYPEPTIDE	FREELINE THERAPEUTICS LIMITED
WO/2021/084276	FACTOR VIII CONSTRUCT	FREELINE THERAPEUTICS LIMITED
WO/2021/084277	TRANSCRIPTION REGULATORY ELEMENTS	FREELINE THERAPEUTICS LIMITED
WO/2021/084280	PHARMACEUTICAL COMPOUNDS	REVIRAL LIMITED
WO/2021/090030	GPR52 MODULATOR COMPOUNDS	HEPTARES THERAPEUTICS LIMITED
WO/2021/094763	ERAP1 MODULATORS	GREY WOLF THERAPEUTICS LIMITED
WO/2021/099767	ALCOHOL DEHYDROGENASE	IMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/099793	1-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS	INFEX THERAPEUTICS LIMITED
WO/2021/105669	ANTIBODIES	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/105706	PHOTOACTIVE COMPOSITION	SUMITOMO CHEMICAL CO., LTD
WO/2021/111121	ANTIMICROBIAL PEPTIDES	KING'S COLLEGE LONDON
WO/2021/111124	POLYHETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS	STORM THERAPEUTICS LIMITED
WO/2021/111142	POLYMORPHS OF TRIAZOLE ANTIFUNGAL COMPOUND PC945	PULMOCIDE LIMITED
WO/2021/116686	METHYL 2-ALLYL-1 -METHYL-3-OXOINDOLINE-2-CARBOXYLATE AND 9A-ALLYL-1,2,3,9A-TETRAHYDRO-9H-PYRROLO[1,2-A]INDOL-9-ONE DERIVATIVES AND RELATED COMPOUNDS FOR USE AS FLUORESCENT MARKERS FOR LABELLING OF DRUGS, AMINO ACIDS AN PROTEINS	UNIVERSITY OF LANCASTER
WO/2021/116699	REVERSIBLY INHIBITED BINDING MOLECULES	PRECISION IMMUNOTHERAPEUTICS LIMITED
WO/2021/116706	COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α<sb>1</sb>-ANTITRYPSIN DEFICIENCY	Z FACTOR LIMITED
WO/2021/116707	4-((2-OXOPYRI DIN-1 (2H)-YL)METHYL)BENZAMIDES FOR TREATING ALPHA1 -ANTITRYPSIN DEFICIENCY	Z FACTOR LIMITED
WO/2021/116710	COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY	Z FACTOR LIMITED
WO/2021/123767	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17	BICYCLETX LIMITED
WO/2021/123769	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17	BICYCLETX LIMITED
WO/2021/123770	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17	BICYCLETX LIMITED
WO/2021/123771	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17	BICYCLETX LIMITED
WO/2021/123775	ENGINEERED PLATELETS FOR TARGETED DELIVERY OF A THERAPEUTIC AGENT	JPV01 LTD
WO/2021/123785	DNA POLYMERASE THETA INHIBITORS	ARTIOS PHARMA LIMITED
WO/2021/123798	1H-PYRAZOLO[3,4-D]PYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PLATINUM-RESISTANT CANCER	IMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/123814	TREATMENT OF CHRONIC PAIN	UCL BUSINESS LTD
WO/2021/130492	CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES	SITRYX THERAPEUTICS LIMITED
WO/2021/130502	CD163 ANTIBODIES OR BINDING PROTEINS	ECO ANIMAL HEALTH LTD.
WO/2021/144582	MODIFIED THIOXANTHONE PHOTOINITIATORS	LINTFIELD LIMITED
WO/2021/148786	ISOINDOLINE DERIVATIVES WHICH BIND TO AN ATP BINDING SITE	NEOPHORE LIMITED
WO/2021/148793	PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES EXHIBITING CDK INHIBITORY ACTIVITY	CYCLACEL LIMITED
WO/2021/148811	HDAC DEGRADER	UNIVERSITY OF LEICESTER
WO/2021/156636	TRIAZOLE DERIVATIVES WITH ANTIFUNGAL ACTIVITY	KING'S COLLEGE LONDON
WO/2021/161045	HORIZONTAL CELLS	UCL BUSINESS LTD
WO/2021/170977	CRYSTALLINE FORMS OF VOXELOTOR, AND PROCESSES FOR THE PREPARATION THEREOF	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/171002	NOVEL ANTIBODIES	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/176199	ANTIBIOTICS	ASTON UNIVERSITY
WO/2021/171025	COMPOSITIONS AND METHODS	KING'S COLLEGE LONDON
WO/2021/171029	PBP3 BINDING BICYCLIC PEPTIDE LIGANDS	BICYCLETX LIMITED
WO/2021/176213	PROCESS FOR THE PREPARATION OF CYCLOPENTADIENIDE-BASED ANSA LIGANDS	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/176216	SALTS AND POLYMORPHIC FORMS OF 6-CHLORO-7-(4-(4-CHLOROBENZYL)PIPERAZIN-1-YL)-2-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-3H-IMIDAZO[4,5-B]PYRIDINE	ELLIPSES PHARMA LTD
WO/2021/181091	IL-10 MUTEINS	UNIVERSITY OF DUNDEE
WO/2021/181111	SYSTEM FOR COVALENTLY LINKING PROTEINS	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/181121	STABILISED VIRAL FUSION PROTEINS	OXFORD UNIVERSITY INNOVATION LIMTIED
WO/2021/186190	CORONAVIRUS ANTIBODY	IMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/191607	TRBC BETA ANTIBODY CONJUGATE	AUTOLUS LIMITED
WO/2021/205144	ORGANIC ACID ADDITION SALTS OF S-PINDOLOL	ACTIMED THERAPEUTICS LTD
WO/2021/198692	TERPENOPHENOLIC COMPOUNDS AND THEIR USE	PHYTOTHERAPEUTIX LTD
WO/2021/198707	ANTIBODIES	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/205166	A METHOD OF GENERATING A LIBRARY OF POPULATIONS OF CELLS COMPRISING A TRANSGENE INTEGRATED INTO THE GENOME AT A TARGET LOCUS	AUTOLUS LIMITED
WO/2021/205175	MOLECULE	AUTOLUS LIMITED
WO/2021/205176	CELL	AUTOLUS LIMITED
WO/2021/209775	ANTIGEN POOL	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/214460	HETERODIMERIC PROTEINS	PETMEDIX LTD
WO/2021/214469	H4 ANTAGONIST COMPOUNDS	HEPTARES THERAPEUTICS LIMITED
WO/2021/214470	TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS	C4X DISCOVERY LIMITED
WO/2021/214471	PROTEINACEOUS PARTICLE	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/214472	TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS	C4X DISCOVERY LIMITED
WO/2021/224606	SINGLE DOMAIN ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN	THE ROSALIND FRANKLIN INSTITUTE
WO/2021/224636	ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR	ADORX THERAPEUTICS LIMITED
WO/2021/229238	ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS	BICYCLETX LIMITED
WO/2021/229244	PROCESS FOR THE SYNTHESIS OF N-BUTYLOXYCARBONYL-3-(4-IMIDAZOL-1-YLMETHYLPHENYL)-5-ISO-BUTYLTHIOPHENE-2-SULFONAMIDE	VICORE PHARMA AB
WO/2021/234392	POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN	ALCHEMAB THERAPEUTICS LTD
WO/2021/250399	4-ETHYNYLPYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS	IP2IPO INNOVATIONS LIMITED
WO/2021/250419	BTLA ANTIBODIES	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/250428	TREM2 CHIMERIC RECEPTOR	QUELL THERAPEUTICS LIMITED
WO/2021/250435	PHARMACEUTICAL COMPOSITION COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE	BECKLEY PSYTECH LIMITED
WO/2021/255427	FIBRES	COAL PRODUCTS LIMITED
WO/2021/255429	PROCESS FOR PREPARING N,N-DIMETHYL-4-((6-OXOPYRIMIDIN-1(6H)-YL)METHYL)BENZAMIDE FROM 4-((6-OXOPYRIMIDIN-1(6H)-YL)METHYL)BENZOIC ACID, AND CRYSTALLINE FORMS OF THE BENZAMIDE	Z FACTOR LIMITED
WO/2021/255436	4-((6-OXOPYRIMIDIN-1(6H)-YL)METHYL)BENZOIC ACID AS AN INDUCER OF Z A1 AT SECRETION FOR TREATING AATD	Z FACTOR LIMITED
WO/2021/260394	POLYNUCLEOTIDE	FREELINE THERAPEUTICS LIMITED
WO/2021/123848	PROCESS FOR THE PREPARATION OF A CHIRAL PROSTAGLANDIN ENOL INTERMEDIATE AND INTERMEDIATE COMPOUNDS USEFUL IN THE PROCESS	CHINOIN GYóGYSZER éS VEGYéSZETI TERMéKEK GYáRA ZRT.
WO/2021/024020	COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF CANCER	ASTELLAS PHARMA INC.
WO/2021/090046	HUMANIZED ANTI-CA IX ANTIBODIES AND METHODS OF THEIR USE	MABPRO A.S.
WO/2021/105759	NEW METAL-ORGANIC FRAMEWORKS AND THEIR USE FOR ENCAPSULATION OF FLUORESCENT DYES	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/130515	STRUCTURALLY SIMPLIFIED DIAZONAMIDE ANALOGS AS ANTIMITOTIC AGENTS	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/148836	NAPHTHALENE BASED LITHIUM COMPOUNDS, A PROCESS FOR THEIR PREPARATION, THEIR USE AS SOLID ORGANIC CATALYST, AND THEIR USE IN RECHARGEABLE NON-AQUEOUS LITHIUM-AIR BATTERY CELLS	TOYOTA MOTOR EUROPE
WO/2021/214502	PROCESS FOR PREPARING A PHTHALAZINONE DERIVATIVE AND INTERMEDIATES THEREOF	IDIENCE CO., LTD.
WO/2021/214503	CRYSTALLINE FORMS OF PHTHACAZ1NONF COMPOUND	IDIENCE CO., LTD.
WO/2021/111179	SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/014213	IMMUNOTHERAPY FOR POLYOMAVIRUSES	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/014220	PLATELET-FACILITATED DELIVERY OF THERAPEUTIC COMPOUNDS	CSTS HEALTH CARE INC.
WO/2021/009566	N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN -2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)	ZOMAGEN BIOSCIENCES LTD
WO/2021/019305	METHOD OF MAKING GLYCEROL CARBONATE (METH)ACRYLATE AND CURABLE COMPOSITIONS BASED THEREON	ARKEMA FRANCE
WO/2021/024039	COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN AND DEPENDANCE DISORDERS	RIPPLE THERAPEUTICS CORPORATION
WO/2021/024041	CONTROLLED RELEASE DRUG DIMERS	RIPPLE THERAPEUTICS CORPORATION
WO/2021/009568	BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF	2692372 ONTARIO, INC.
WO/2021/038292	CENTRALLY ACTIVE P38ALPHA INHIBITING COMPOUNDS	SYNOVO GMBH
WO/2021/044213	BLOCKING CHIMERIC ANTIGEN RECEPTORS FOR PREVENTION OF UNDESIRED ACTIVATION OF EFFECTOR AND REGULATORY IMMUNE CELLS	MIGAL-GALILEE RESEARCH INSTITUTE LTD.
WO/2021/048618	1,4-DIHYDROBENZO[D]PYRAZOLO[3,4-F][1,3]DIAZEPINE DERIVATIVES AND RELATED COMPOUNDS AS LRRK2, NUAK1 AND/OR TYK2 KINASE MODULATORS FOR THE TREATMENT OF E.G. AUTOIMMUNE DISEASE	ORIGENIS GMBH
WO/2021/048620	1,4-DIHYDROBENZO[D]PYRAZOLO[3,4-F][1,3]DIAZEPINE DERIVATIVES AND RELATED COMPOUNDS AS LRRK2, NUAK1 AND/OR TYK2 KINASE MODULATORS FOR THE TREATMENT OF E.G. AUTOIMMUNE DISEASE	ORIGENIS GMBH
WO/2021/053396	METHOD FOR THE PREPARATION OF A COMPOSITION ENRICHED IN 2-METHYL-BUT-2-ENE AND USE FOR MAKING A POLYMER	TOTAL RAFFINAGE CHIMIE
WO/2021/053402	SULFONAMIDE DERIVATIVES AS CTPS1 INHIBITORS	STEP PHARMA S.A.S.
WO/2021/053403	SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS	STEP PHARMA S.A.S.
WO/2021/074683	BISPECIFIC ANTI-PD-L1 AND ANTI-FCRN POLYPEPTIDES	AVACTA LIFE SCIENCES LIMITED
WO/2021/074695	PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.	AVACTA LIFE SCIENCES LIMITED
WO/2021/090062	ANTI-MESOTHELIN ERIBULIN ANTIBODY-DRUG CONJUGATES AND METHODS OF USE	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/099832	ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/094830	NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/094832	HETEROCYCLIC NMDA ANTAGONISTS	TAKEDA PHARAMACEUTICAL COMPANY LIMITED
WO/2021/099837	ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/099838	ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS	ILDGNG PHARMACEUTICAL CO., LTD.
WO/2021/099842	PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF	2692372 ONTARIO INC.
WO/2021/123902	COMBINATION OF ANTI TIM-3 ANTIBODY MBG453 AND ANTI TGF-BETA ANTIBODY NIS793, WITH OR WITHOUT DECITABINE OR THE ANTI PD-1 ANTIBODY SPARTALIZUMAB, FOR TREATING MYELOFIBROSIS AND MYELODYSPLASTIC SYNDROME	NOVARTIS AG
WO/2021/123904	POLYMERIC FATTY ACID COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID-BASED SUBSTRATES, ESPECIALLY HAIR	MOMENTIVE PERFORMANCE MATERIALS GMBH
WO/2021/079196	METTL3 MODULATORS	ACCENT THERAPEUTICS, INC
WO/2021/019310	PROCESS FOR THE PREPARATION OF LULICONAZOLE	OPTIMUS DRUGS PVT LTD
WO/2021/001695	AN IMPROVED PROCESS FOR THE PREPARATION OF TENELIGLIPTIN HYDROBROMIDE HYDRATE	ACCORD LIFE SPEC PRIVATE LIMITED
WO/2021/038306	SELENOPHENOCHROMENE PHOSPHONIC ACIDS, PREPARATION AND USE AS ANTIPROLIFERATIVE AGENTS	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/205216	TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES	H. LUNDBECK A/S
WO/2021/069975	A CONTINUOUS FLOW SYNTHESIS METHOD FOR THE MANUFACTURE OF ISONIAZID	NELSON MANDELA UNIVERSITY
WO/2021/014229	SELECTIVE BCRP/ABCG2 TRANSPORTER INHIBITORS AS AGENTS TO ABOLISH RESISTANCE TO ANTI-CANCER AGENTS	UNIVERSITE GRENOBLE ALPES
WO/2021/245440	CATALYTIC AND CONTINUOUS THERMOCHEMICAL PROCESS OF PRODUCTION OF VALUABLE DERIVATIVES FROM ORGANIC MATERIALS AND/OR WASTE	CMP-CIMENTOS MACEIRA E PATAIAS , S.A.
WO/2021/220043	METHOD OF SYNTHESIS AND BIOMEDICINAL APPLICATIONS OF NOVEL HETEROCYCLIC BISMUTHINE	KANT, Ravi
WO/2021/001713	PROCESS FOR THE PREPARATION OF (<i>S</i>)-NETARSUDIL, ITS SALTS & POLYMORPHS	MICRO LABS LIMITED
WO/2021/001739	TRANSLATIONAL ENHANCERS AND RELATED METHODS	EFFECTOR THERAPEUTICS, INC.
WO/2021/005484	PYRROLIDINE COMPOUNDS, ITS SALT AND USE IN THE PREPARATION OF UPADACITINIB THEREOF	MANKIND PHARMA LTD.
WO/2021/005508	METHODS FOR PRODUCING TRIS(HALOSULPHONYL)METHANE OR SALTS OF SAME	SCE FRANCE
WO/2021/005512	COMPOUNDS HAVING A FUNGICIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI	ISAGRO S.P.A.
WO/2021/005545	A PROCESS FOR OBTAINING INDOXACARB CRYSTALS WITH SPECIFIC PURITY AND ENANTIOMERIC RATIO	GHARDA CHEMICALS LIMITED
WO/2021/005546	ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1	CADILA HEALTHCARE LIMITED
WO/2021/009627	SELECTIVE PRODUCTION OF ETHYLENE FROM METHANE	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/005581	NOVEL ARID5A PEPTIDE INHIBITORS	KING FAISAL UNIVERSITY
WO/2021/005583	CAMPTOTHECIN DERIVATIVES WITH A DISULFIDE MOIETY AND A PIPERAZINE MOIETY	SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
WO/2021/009676	IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS	PFIZER INC.
WO/2021/024054	COMBINATION THERAPY TO ACHIEVE ENHANCED ANTIMICROBIAL ACTIVITY	INTERNATIONAL BUSINESS MACHINES CORPORATION
WO/2021/048646	BIORECEPTOR MOLECULES, THE USE OF BIORECEPTOR MOLECULES, SENSORS CONTAINING ELECTRODES MODIFIED WITH THE SAID BIORECEPTOR MOLECULES AND THE DETECTION METHOD OF SARS-COV-2 VIRUS	SENSDX SPóŁKA AKCYJNA
WO/2021/161083	AN EFFICIENT PROCESS FOR PREPARATION OF ACYL DERIVATIVES OF ALKYLENEDIOXYBENZENES	ANTHEA AROMATICS PRIVATE LIMITED
WO/2021/014365	MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS AND USES THEREOF	LUPIN LIMITED
WO/2021/014380	ARGINASE INHIBITORS AND METHODS OF USE THEREOF	ASTRAZENECA AB
WO/2021/014385	MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/019373	NITENIN ANALOGUE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CHRONIC AND ACUTE PAIN	SEA4US - BIOTECNOLOGIA E RECURSOS MARINHOS, LDA.
WO/2021/014389	ANTI-MGLUR5 ANTIBODIES AND USES THEREOF	H. LUNDBECK A/S
WO/2021/019386	ANTI-HK2 CHIMERIC ANTIGEN RECEPTOR (CAR)	JANSSEN BIOTECH, INC.
WO/2021/019389	PROTEINS COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES	JANSSEN BIOTECH, INC.
WO/2021/014415	SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2)	CURADEV PHARMA PVT. LTD.
WO/2021/044230	PROCESS FOR THE SYNTHESIS OF THE SODIUM SALT OF 4-[[(L<i>R</i>)-2-[5-(2-FLUORO-3-METHOXYPHENYL)-3-[[2-FLUORO-6-(TRIFLUOROMETHYL)-PHENYL]METHYL]-3,6-DIHYDRO-4-METHYL-2,6-DIOXO-1(2<i>H</i>)-PYRIMIDINYL]-1- PHENYLETHYL]AMINO]-BUTANOIC ACID (ELAGOLIX SODIUM SALT) AND INTERMEDIATES OF SAID PROCESS	INDUSTRIALE CHIMICA S.R.L.
WO/2021/019448	PROCESS FOR THE PREPARATION OF TRANSTHYRETIN DISSOCIATION INHIBITOR	HONOUR (R&D)
WO/2021/019473	MHC CLASS II MOLECULES AND METHODS OF USE THEREOF	UNIVERSITY HEALTH NETWORK
WO/2021/019474	MHC CLASS II MOLECULES AND METHODS OF USE THEREOF	UNIVERSITY HEALTH NETWORK
WO/2021/019475	MHC CLASS II MOLECULES AND METHODS OF USE THEREOF	UNIVERSITY HEALTH NETWORK
WO/2021/024114	4'-ETHYNYL-2'-DEOXYADENOSINE DERIVATIVES AND THEIR USE IN HIV THERAPY	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/019507	PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN	LEXICON PHARMACEUTICALS, INC.
WO/2021/019509	CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN	LEXICON PHARMACEUTICALS,INC.
WO/2021/024133	BIOPHARMACUETICAL COMPOSITIONS AND RELATED METHODS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/024135	AN IMPROVED PROCESS FOR PREPARATION OF METHYL (2E)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	COROMANDEL INTERNATIONAL LIMITED
WO/2021/144625	THE ORAL SYNERGISTIC COMPOSITION AND ITS PROCESS FOR THE PREPARATION	MANEESH PHARMACEUTICALS LTD
WO/2021/019514	HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF	INTEGRAL BIOSCIENCES PVT. LTD.
WO/2021/024202	PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT	PROCOS S.P.A.
WO/2021/024208	TPP-DERIVATIVES FOR MITOCHONDRIA-TARGETED CANCER THERAPIES	LUNELLA BIOTECH, INC.
WO/2021/028787	IMMUNE COMPOSITION COMPRISING RESPIRATORY SYNCYTIAL VIRUS (RSV) G POLYPEPTIDE	ADVACCINE (SUZHOU) BIOPHARMACEUTICALS CO. LTD.
WO/2021/024209	ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF	APRINOIA THERAPEUTICS INC.
WO/2021/028791	AN IMPROVED PROCESS OF PREPARATION OF IVOSIDENIB	ALEMBIC PHARMACEUTICALS LIMITED
WO/2021/033066	A FORMULATION OF INSULIN BASED ON CRYSTAL-SEEDING IN HYDROGELS AND METHOD THEREOF	LAMARK BIOTECH PVT LIMITED
WO/2021/028806	HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS	NOVARTIS AG
WO/2021/028810	SULFINIC ACID COMPOUNDS AS FREE FATTY ACID RECEPTOR AGONISTS	INORBIT THERAPEUTICS AB
WO/2021/048655	INTEGRATED SYSTEMS AND METHODS FOR PRODUCING 1,3-BUTADIENE VIA EXTRACTIVE DISTILLATION, DISTILLATION, AND/OR SELECTIVE HYDROGENATION	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/048657	RECOVERY OF ISOPRENE AND CPD FROM A PYGAS STREAM	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/028854	PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/033098	PROCESS FOR THE PREPARATION OF APALUTAMIDE	DR. REDDY’S LABORATORIES LIMITED
WO/2021/033129	MULTIFUNCTIONAL CYCLIC ORGANIC CARBONATES AS CURING AGENTS FOR ORGANIC COMPOUNDS HAVING PHENOLIC HYDROXYL GROUPS	PREFERE RESINS HOLDING GMBH
WO/2021/038374	OXIDATIVE DEHYDROGENATION COPRODUCTION	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/033133	NOVEL OXADIAZOLE COMPOUNDS CONTAINING 5- MEMBERED HETEROAROMATIC RING FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI	PI INDUSTRIES LTD.
WO/2021/033141	FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS	PI INDUSTRIES LTD.
WO/2021/033153	PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/038391	PROCESS FOR PURIFYING TEREPHTHALIC ACID	INVISTA NORTH AMERICA S.A R.L
WO/2021/038394	APPARATUS FOR PURIFYING TEREPHTHALIC ACID	INVISTA NORTH AMERICA S.A R.L
WO/2021/033159	PYRAZINO [1,2-B]QUINAZOLINE-3,6-DIONES DERIVATIVES, THEIR PRODUCTION AND USES THEREOF	CIIMAR - CENTRO INTERDISCIPLINAR DE INVESTIGAÇÃO MARINHA E AMBIENTAL
WO/2021/033165	PROCESS FOR SYNTHESIS OF PYRAZOLIDINONE COMPOUNDS	GHARDA CHEMICALS LIMITED
WO/2021/033166	PROCESS FOR SYNTHESIS OF PYRAZOLIDINONE COMPOUNDS	GHARDA CHEMICALS LIMITED
WO/2021/038406	PROCESS FOR TREATING POLYALKYLAROMATIC HYDROCARBONS	VERSALIS S.P.A.
WO/2021/038419	KINASE INHIBITORS AND METHODS OF SYNTHESIS AND TREATMENT	INSILICO MEDICINE IP LIMITED
WO/2021/038431	AN IMPROVED PROCESS FOR THE PREPARATION OF ETELCALCETIDE HYDROCHLORIDE	AURO PEPTIDES LTD
WO/2021/038452	NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES	UNIVERSITA' DEGLI STUDI DI PALERMO
WO/2021/044262	LIGHT-EMITTING DEVICE, DISPLAY DEVICE, ELECTRONIC APPLIANCE, ORGANIC COMPOUND, AND ILLUMINATOR	SEMICONDUCTOR ENERGY LABORATORY CO., LTD.
WO/2021/038490	SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/038501	ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS	PI INDUSTRIES LTD.
WO/2021/038506	HALOGENATED COMPOUNDS, PROCESS AND USES THEREOF	CIIMAR - CENTRO INTERDISCIPLINAR DE INVESTIGAÇÃO MARINHA E AMBIENTAL
WO/2021/038509	4'-ETHYNYL-2'-DEOXYADENOSINE DERIVATIVES AND THEIR USE IN HIV THERAPY	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/038523	ORGANOMETALLIC COMPOUNDS FOR THE DEPOSITION OF HIGH PURITY TIN OXIDE AND DRY ETCHING OF THE TIN OXIDE FILMS AND DEPOSITION REACTORS	SEASTAR CHEMICALS ULC
WO/2021/048678	METHODS OF TREATMENT USING OMALIZUMAB	NOVARTIS AG
WO/2021/038540	CYCLOALKYLIDENE CARBOXYLIC ACIDS AND DERIVATIVES AS BTK INHIBITORS	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
WO/2021/048693	AROMATIZATION CATALYST WITH IMPROVED ISOMERIZATION, REACTOR CONFIGURATIONS AND USE THEREOF	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/044302	INDUSTRIAL PROCESS FOR THE PREPARATION OF HIGH PURITY ESTETROL	RICHTER GEDEON NYRT.
WO/2021/105779	NEW SOLID FORMS OF DAPAGLIFLOZIN	ALPARIS, S.A. DE C.V.
WO/2021/059058	8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/044373	ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS	AVECTAS LIMITED
WO/2021/048725	ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF	BIOTHEUS INC.
WO/2021/048743	ANTI-IL-23P19 ANTIBODY FORMULATIONS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/048750	BIORECEPTOR MOLECULES, THE USE OF BIORECEPTOR MOLECULES, SENSORS CONTAINING ELECTRODES MODIFIED BY THE SAID BIORECEPTOR MOLECULES, AND METHOD OF DETECTING BACTERIA AND VIRUSES	SENSDX SA
WO/2021/255512	NOVEL SUBSTITUTED FLAVAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF	AZISTA INDUSTRIES PRIVATE LIMITED
WO/2021/053507	2-AMINO-S6-SUBSTITUTED THIOPURINE COMPOUNDS AS INHIBITORS OF THE ENPP1 PROTEIN	ATEN PORUS LIFESCIENCES PVT. LTD.
WO/2021/059086	ORGANIC COMPOUND, OPTICAL DEVICE, LIGHT EMITTING DEVICE, LIGHT EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE	SEMICONDUCTOR ENERGY LABORATORY CO., LTD.
WO/2021/059087	STEAM GENERATION IN OXIDATIVE DEHYDROGENATION	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/053556	NKG2D FUSION PROTEINS AND USES THEREOF	NOVARTIS AG
WO/2021/053559	ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES	NOVARTIS AG
WO/2021/053578	IMPROVED PURIFICATION PROCESSES FOR LIRAGLUTIDE	DR. REDDY’S LABORATORIES LIMITED
WO/2021/053591	METHODS OF TREATING AUTOIMMUNE DISEASES USING INTERLEUKIN-17 (IL-17) ANTAGONISTS	NOVARTIS AG
WO/2021/053617	MLL1 INHIBITORS AND ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/059136	POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES)	PFIZER INC.
WO/2021/059146	PROCESS FOR PREPARING (R)-4-AMINOINDANE AND CORRESPONDING AMIDES	ISAGRO S.P.A.
WO/2021/059160	PROCESS FOR PREPARING 5-(FLUORO-4-IMINO-3-METHYL)-1-TOSYL-3,4 DIHYDROPYRIMIDINE -(1H)-ONE	ADAMA MAKHTESHIM LTD.
WO/2021/123933	NOURIN GENE-BASED RNA MOLECULAR NETWORK: NOVEL EARLY DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR CORONARY ARTERY DISEASE, UNSTABLE ANGINA, STEMI/NSTEMI AND HEART FAILURE	NOUR HEART, INC.
WO/2021/123934	CYCLOCREATINE PHOSPHATE: A NOVEL BIOENERGETIC THERAPY TO PREVENT AND TREAT ISCHEMIA-INDUCED AND AGING-RELATED CARDIOVASCULAR AND NEURODEGENERATIVE DISEASES	NOUR HEART, INC.
WO/2021/064527	CATALYTIC CONVERSION OF CARBON DIOXIDE	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/059220	PROCESS FOR THE PRODUCTION OF 5-(4-((2 <i>S</i>,5 <i>S</i>)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1 <i>H</i>-1,2,4-TRIAZOL-3-AMINE	ONCOARENDI THERAPEUTICS S.A.
WO/2021/064530	DICARBOXYLIC ACID COMPOUNDS. INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/064561	AN IMPROVED PROCESS FOR THE PREPARATION OF ELAGOLIX SODIUM	NEULAND LABORATORIES LIMITED
WO/2021/064569	RADIOLABELLED MGL PET LIGANDS	JANSSEN PHARMACEUTICA NV
WO/2021/064570	N-SUBSTUTUTED-6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/064571	N-SUBSTITUTED-4-OXO-3,4-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/064590	DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR	PFIZER INC.
WO/2021/064593	LIPOPEPTIDES, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION, AND LIPOPEPTIDES FOR USE AS A DRUG	UNIWERSYTET WARSZAWSKI
WO/2021/033172	PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE	EUROFINS ADVINUS LIMITED
WO/2021/064629	SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH	GLYCOM A/S
WO/2021/064671	METHODS FOR PRODUCING BIOTHERAPEUTICS WITH INCREASED STABILITY BY SEQUENCE OPTIMIZATION	JANSSEN BIOTECH, INC.
WO/2021/064677	INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/064688	ADENOVIRUS VECTORS AND USES THEREOF	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/074739	AN INDUSTRIAL SCALE PROCESS FOR THE PREPARATION OF PROTHIOCONAZOLE	HIKAL LIMITED
WO/2021/070054	INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/070091	5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS	NOVARTIS AG
WO/2021/070107	IFIT POLYPEPTIDES AND USES FOR TREATING TUBERCULOSIS INFECTION	STELLENBOSCH UNIVERSITY
WO/2021/070113	AN IMPROVED PROCESS FOR 4-(HYDROXYMETHYL)-5-METHYL-1,3-DIOXOL-2-ONE	PIRAMAL PHARMA LIMITED
WO/2021/079223	REMOVAL OF ELECTROLUMINESCENCT MATERIALS FROM SUBSTRATES	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/070124	ALTERNATE PROCESSES FOR THE PREPARATION OF OMECAMTIV MECARBIL	DR. REDDY’S LABORATORIES LIMITED
WO/2021/070132	BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/070152	COUMARIN GLYOXYLATES FOR LED PHOTOCURING	IGM RESINS ITALIA S.R.L.
WO/2021/074799	SYNTHESIS OF 2-(2-AMINOETHOXY) ETHANOL	SAFAEI-GHOMI, Javad
WO/2021/074842	IMPROVED PROCESS FOR THE PREPARATION OF DIROXIMEL FUMARATE AND SOLID FORMS THEREOF	DR. REDDY’S LABORATORIES LIMITED
WO/2021/074897	SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODY	JANSSEN BIOTECH, INC.
WO/2021/074898	MALIC ENZYME INHIBITORS	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
WO/2021/079328	PEPTIDES WITH CELL DAMAGE PROTECTION ACTIVITY AND LIPOSOMIAL FORMULATIONS	I.R.A. ISTITUTO RICERCHE APPLICATE S.P.A.
WO/2021/079337	PHARMACEUTICAL FORMULATION OF ANTI-HER2 ANTIBODY AND PREPARATION THEREOF	CADILA HEALTHCARE LIMITED
WO/2021/116789	ANTI-INTERLEUKIN 1 BETA ANTIBODIES FOR TREATMENT OF SICKLE CELL DISEASE	NOVARTIS AG
WO/2021/079356	COMPOUNDS AND METHODS FOR PROMOTING PLANT GROWTH	KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/084429	ESCHERICHIA<i> COLI </i>COMPOSITIONS AND METHODS THEREOF	PFIZER INC.
WO/2021/084498	FLUORINATED QUINOLINE, QUINOXALINE AND BENZO[B][1,4]OXAZINE DERIVATIVES AS DIHYDROOROTATE DEHYDROGENASE (DHODH) INHIBITORS FOR THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISEASES	JANSSEN BIOTECH, INC.
WO/2021/084500	FLUORINATED QUINOLINE AND QUINOXALINE DERIVATIVES AS DIHYDROOROTATE DEHYDROGENASE (DHODH) INHIBITORS FOR THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISEASES	JANSSEN BIOTECH, INC.
WO/2021/090172	COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING NEURODEGENERATIVE DISEASES AND/OR A CLINICAL CONDITION THEREOF	CK BIOTECHNOLOGY CO.
WO/2021/090183	LIQUID MELPHALAN COMPOSITION	INTAS PHARMACEUTICALS LTD.
WO/2021/090187	HUMANIZED ANTI-CA IX ANTIBODIES AND METHODS OF THEIR USE	MABPRO A.S.
WO/2021/090194	TREATMENT OF MALARIA USING HISTONE DEACETYLASE (HDAC) INHIBITORS	FOUNDATION FOR NEGLECTED DISEASE RESEARCH
WO/2021/123950	BUTADIENE HEAT INTEGRATION PROCESS	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/090245	PYRROLIDINE AND PIPERIDINE COMPOUNDS	YUHAN CORPORATION
WO/2021/090272	METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE	GENMAB A/S
WO/2021/090282	NOVEL OXADIAZOLE COMPOUNDS CONTAINING FUSED HETEROCYCLYL RINGS FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI	PI INDUSTRIES LTD.
WO/2021/094902	PHARMACEUTICAL COMPOSITIONS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS	DR. REDDY'S LABORATORIES LIMITED
WO/2021/094903	1-(4-(4-(5-PHENYL-4,5-DIHYDROISOXAZOL-3-YL)THIAZOL-2-YL)PIPERIDIN-1-YL)-ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FUNGICIDES FOR CROP PROTECTION	PI INDUSTRIES LTD.
WO/2021/094904	4-(4-(4,5-DIHYDROISOXAZOL-3-YL)THIAZOL-2-YL) PIPERIDINE SULFILIMINE AND SULFOXIMINE DERIVATIVES AND RELATED COMPOUNDS AS FUNGICIDES FOR CROP PROTECTION	PI INDUSTRIES LTD.
WO/2021/094905	1 -(4-(4-(5-PHENYL-4,5-DIHYDROISOXAZOL-3-YL)THIAZOL-2-YL)PIPERIDIN-1 -YL)-ETHAN-1 -ONE DERIVATIVES AND RELATED COMPOUNDS AS FUNGICIDES FOR CROP PROTECTION	PI INDUSTRIES LTD.
WO/2021/094960	PHOTOPOLYMERIZABLE ANTIBACTERIAL MONOMER	UNIVERSITA' DEGLI STUDI DI TRIESTE
WO/2021/095015	SOLID FORMS OF TEZACAFTOR, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF	LAURUS LABS LIMITED
WO/2021/099929	A CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF HYDROXAMIC ACID	UPL LIMITED
WO/2021/099944	ANTI-CD79 CHIMERIC ANTIGEN RECEPTORS, CAR-T CELLS, AND USES THEREOF	JANSSEN BIOTECH, INC.
WO/2021/100019	PRODRUGS OF ABIRATERONE	SUVEN LIFE SCIENCES LIMITED
WO/2021/100022	ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF	ABL BIO INC.
WO/2021/100029	PRODRUGS OF FULVESTRANT	KASHIV BIOSCIENCES, LLC
WO/2021/105864	METHOD FOR BIOMATERIAL PURIFICATION AND KITS THEREOF	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/105887	SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE	EMP BIOTECH GMBH
WO/2021/105898	STRIGOLACTONE ANALOGS AND METHODS OF USING	KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/105906	ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE	GAIN THERAPEUTICS SA
WO/2021/105908	HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE	GAIN THERAPEUTICS SA
WO/2021/105916	SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS	AURIGENE DISCOVERY TECHNOLOGIES LIMITED
WO/2021/105960	SUBSTITUTED TRICYCLIC COMPOUNDS	LUPIN LIMITED
WO/2021/111282	TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST COMPOSITION	SABIC SK NEXLENE COMPANY PTE. LTD.
WO/2021/116820	AN IMPROVED PROCESS FOR THE PREPARATION OF BENOXAPROFEN	AUROBINDO PHARMA LIMITED
WO/2021/111311	NOVEL ADAMANTANE DERIVATIVES AS INHIBITORS OF FOCAL ADHESION KINASE	SAMJIN PHARMACEUTICAL CO., LTD.
WO/2021/111317	PROCESS FOR THE PREPARATION OF POLYAMINOCARBOXYLIC ACIDS AND CHELATE COMPOUNDS THEREOF	VALAGRO S.P.A.
WO/2021/111322	SUBSTITUTED NUCLEOSIDE ANALOGS AS PRMT5 INHIBITORS	LUPIN LIMITED
WO/2021/111351	NOVEL SUBSTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES	CADILA HEALTHCARE LIMITED
WO/2021/111377	METHODS OF TREATING LICHEN PLANUS USING INTERLEUKIN-17 (IL-17) ANTAGONISTS	NOVARTIS AG
WO/2021/124004	REMOVAL OF CARBON MONOXIDE, OXYGEN AND ACETYLENE FROM AN OXIDATIVE DEHYDROGENATION PROCESS	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/116874	SOLID FORMS OF 2-((4-((S)-2-(5-CHLOROPYRIDIN-2-YL)-2-METHYLBENZO[D] [1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-BENZO[D] IMIDAZOLE-6-CARBOXYLIC ACID, 1,3-DIHYDROXY-2-(HYDROXYMETHYL)PROPAN-2-AMINE SALT	PFIZER INC.
WO/2021/111425	PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS	TAVANTA THERAPEUTICS HUNGARY INCORPORATED
WO/2021/124008	METHOD OF PURIFYING ALPHA-OLEFIN AND COMPOSITION FOR PURIFYING ALPHA-OLEFIN THEREFOR	SABIC SK NEXLENE COMPANY PTE. LTD.
WO/2021/116935	6-SUBSTITUTED, 22-CYANO HYODEOXYCHOLANIC ANALOGUES AND USES THEREOF	PRECISION BIO-THERAPEUTICS S.R.L.
WO/2021/116943	VARIANT ONCOLYTIC VACCINIA VIRUS AND METHODS OF USE THEREOF	IGNITE IMMUNOTHERAPY, INC.
WO/2021/116979	PROCESS FOR THE PREPARATION OF LASMIDITAN AND OF A SYNTHESIS INTERMEDIATE	OLON S.P.A.
WO/2021/116980	SYSTEMS AND METHODS FOR MTBE PRODUCTION	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/116999	COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS	FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
WO/2021/117014	SMALL MOLECULE INHIBITORS OF FUNGAL HYPHAE AND BIOFILM FORMATION	UNIVERSITY OF SHARJAH
WO/2021/124066	PROCESS FOR THE PREPARATION OF BRIVARACETAM	GLENMARK LIFE SCIENCES LIMITED
WO/2021/124073	ANTIBODIES SPECIFIC FOR CD47, PD-L1, AND USES THEREOF	PFIZER INC.
WO/2021/124104	SELECTIVE CDK4/6 INHIBITOR CANCER THERAPEUTICS	LUNELLA BIOTECH, INC.
WO/2021/124106	SELECTIVE CDK4/6 INHIBITOR CANCER THERAPEUTICS	LUNELLA BIOTECH, INC.
WO/2021/124149	PROCESS FOR PURIFYING BIS(2-HYDROXYETHYL)TEREPHTHALATE	GARBO S.R.L.
WO/2021/124155	BENZIMIDAZOLE DERIVATIVES	PFIZER INC.
WO/2021/124158	EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES	PFIZER IRELAND PHARMACEUTICALS
WO/2021/137083	METHODS AND SYSTEMS FOR PROCESSING PENTANES	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/124219	SEPARATING AROMATIC ISOMERS USING AQUEOUS SOLUTIONS OF CUCURBITURIL MACROCYCLES	KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/130626	PROCESS OF MAKING FLUOROOLEFINS BY THERMAL DECOMPOSITION OF FLUORINATED IONOMERS	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/130630	CO-CRYSTALS OF ROXADUSTAT AND PROCESS THEREOF	GLENMARK LIFE SCIENCES LIMITED
WO/2021/124242	PROCESS FOR PRODUCING DIENES	VERSALIS S.P.A.
WO/2021/124269	A COMPOUND FOR THE DETERMINATION OF THE PROTEIN FKBP12 AND A SENSOR UNIT COMPRISING IT	UNIVERSITà DEGLI STUDI DI FIRENZE
WO/2021/124295	METHOD OF PURIFYING BOTULINUM TOXIN	GALDERMA HOLDING SA
WO/2021/130645	AN IMPROVED PROCESS FOR PREPARATION OF LIRAGLUTIDE	SHILPA MEDICARE LIMITED
WO/2021/130653	A COMPOSITION COMPRISING S-ARRESTIN PEPTIDES	APITOPE INTERNATIONAL NV
WO/2021/130686	A CATALYST FOR PRODUCING LIGHT OLEFINS FROM CATALYTIC CRACKING OF HYDROCARBON HAVING 4 TO 7 CARBON ATOMS	PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED
WO/2021/130717	METHOD FOR PURIFYING BIOLOGICALLY ACTIVE PEPTIDE BY USING PROTEIN A AFFINITY CHROMATOGRAPHY	ABL BIO INC.
WO/2021/130718	TARGETED INTEGRATION IN MAMMALIAN SEQUENCES ENHANCING GENE EXPRESSION	SELEXIS SA
WO/2021/130723	NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA	CADILA HEALTHCARE LIMITED
WO/2021/130731	SUBSTITUTED TRICYCLIC COMPOUNDS	LUPIN LIMITED
WO/2021/137134	ISOTHIOCYANATE AND ISOSELENOCYANATE COMPOUNDS	ALMA MATER STUDIORUM - UNIVERSITà DI BOLOGNA
WO/2021/137137	CHLORINATED FLUOROAROMATICS AND METHODS OF USING SAME	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/137144	AN EFFICIENT PROCESS FOR THE PREPARATION OF ERTUGLIFLOZIN L-PYROGLUTAMIC ACID AND INTERMEDIATES THEREOF	HIKAL LIMITED
WO/2021/137172	PROCESS FOR METHANOL PRODUCTION FROM INERT-RICH SYNTHESIS GAS	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/140416	MODIFIED IL-2 POLYPEPTIDES AND USES THEREOF	BRIGHT PEAK THERAPEUTICS AG
WO/2021/148884	ANTI-WUHAN CORONAVIRUS ANTIBODIES	TYCHAN PTE. LTD.
WO/2021/152393	BIOLUMINESCENT COMPOSITIONS AND USES THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-DAR-TTO
WO/2021/152400	COMPOSITIONS COMPRISING PIG STOMACH MUCINS AND USES THEREOF	GNUBIOTICS SCIENCES SA
WO/2021/161099	PROCESS FOR THE SYNTHESIS OF <i>S</i>-BEFLUBUTAMID FROM (<i>R</i>)-2-AMINOBUTANOIC ACID	CHEMINOVA A/S
WO/2021/161100	PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID	CHEMINOVA A/S
WO/2021/161101	PREPARATION OF <i>S</i>-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID	CHEMINOVA A/S
WO/2021/161105	P2X3 MODULATORS	BELLUS HEALTH COUGH INC.
WO/2021/161109	PREPARATION OF A P2X3 ANTAGONIST	BELLUS HEALTH COUGH INC.
WO/2021/191684	COMPOSITION AND METHOD	HAEMALOGIX PTY LTD
WO/2021/198780	FORMS OF 5-({[2-AMINO-3-(4-CARBAMOYL-2,6-DIMETHYL-PHENYL)-PROPIONYL]-[1-(4-PHENYL-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-METHOXY-BENZOIC ACID	ALLERGAN HOLDINGS UNLIMITED COMPANY
WO/2021/198782	PROCESS FOR THE SYNTHESIS OF ETHYLENE GLYCOL	FAIRBRICS SAS
WO/2021/214550	SYNTHESIS OF A MONOACYLGLYCEROL LIPASE INHIBITOR	H. LUNDBECK A/S
WO/2021/224680	SUBSTITUTED BENZOTRIAZINONE METABOLITES OF A GPR139 AGONIST	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/229297	METHODS OF PRODUCING PLANT PROTEIN FROM FOOD WASTE USING MICROALGAE	SOPHIE'S BIONUTRIENTS PTE. LTD.
WO/2021/224686	NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES	MOLECULAR PARTNERS AG
WO/2021/234449	TETRAHYDROCOCANNABINOLIC ACID COCRYSTALS	EBERS TECH INC.
WO/2021/220061	HETERODIMER COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS	RIPPLE THERAPEUTICS CORPORATION
WO/2021/234450	1-((1H-PYRAZOL-4-YL)METHYL)-3-(PHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR THE TREATMENT OF E.G. DEPRESSION	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/234451	3-((1H-PYRAZOL-4-YL)METHYL)-6'-(PHENYL)-2H-(1,2'-BIPYRIDIN)-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR USE IN A METHOD OF TREATMENT OF E.G. DEPRESSION	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/229302	SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME	ARBUTUS BIOPHARMA CORPORATION
WO/2021/240240	ADAPTER MOLECULES TO RE-DIRECT CAR T CELLS TO AN ANTIGEN OF INTEREST	ANTION BIOSCIENCES SA
WO/2021/229306	MULTISPECIFIC ANTIBODIES TARGETING CD38 AND BCMA AND USES THEREOF	VIRTUOSO BINCO,INC.
WO/2021/250461	SUBSTITUTED ISOQUINOLINYLMETHYL AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME	ARBUTUS BIOPHARMA CORPORATION
WO/2021/250466	SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF	ARBUTUS BIOPHARMA CORPORATION
WO/2021/255525	PROCESS TO PREPARE A CO GRANULE OF METHYLGLYCINE N,N DIACETIC ACID SALTS EMPLOYING A CRUMBLY PHASE COMPOSITION OF METHYLGLYCINE N,N DIACETIC ACID SALTS	NOURYON CHEMICALS INTERNATIONAL B.V.
WO/2021/260434	α-SYNUCLEIN PROTOFIBRIL-BINDING ANTIBODIES	BIOARCTIC AB
WO/2021/140471	METHOD FOR SYNTHESIS OF 2'-ALKYL- OR 2'-ALKENYL- OR 2'-ALKYNYL-4'-FLUORO-ADENOSINE DERIVATIVES AND INTERMEDIATES THEREOF	JANSSEN BIOPHARMA, INC.
WO/2021/140475	ANTI-PROPERDIN ANTIBODIES AND PREPARATION THEREOF	CADILA HEALTHCARE LIMITED
WO/2021/140480	METHOD FOR THE PREPARATION OF ARAMCHOL	ICE S.P.A.
WO/2021/140485	PLASMIN-RESISTANT PEPTIDES FOR TREATING STROKE AND RELATED CONDITIONS	NONO INC.
WO/2021/140488	A METHOD FOR PREPARING BOVINE MYOGLOBIN USING <i>ESCHERICHIA COLI</i>	INTRON BIOTECHNOLOGY, INC.
WO/2021/140489	A METHOD FOR PREPARING PORCINE MYOGLOBIN USING <i>ESCHERICHIA COLI</i>	INTRON BIOTECHNOLOGY, INC.
WO/2021/144678	HYDROFLUORETHERS AND METHODS OF USING SAME	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/148934	AN IMPROVED HYDROGENATION PROCESS USING A TRANSITION METAL COMPLEX CATALYST	PI INDUSTRIES LTD.
WO/2021/148935	A TRANSITION METAL COMPLEX COMPOUND	PI INDUSTRIES LTD.
WO/2021/148939	IRON COMPLEXES AND SALTS THEREOF AS CONTRAST AGENTS FOR MRI	CAGE CHEMICALS S.R.L.
WO/2021/148940	ODORANTS AND COMPOSITIONS COMPRISING ODORANTS	S H KELKAR AND COMPANY LIMITED
WO/2021/148955	UTILIZATION OF PLANT PROTEIN HOMOLOGUES IN CULTURE MEDIA	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
WO/2021/152435	PROCESS FOR PREPARATION OF 5-BROMO-1, 2, 3-TRICHLOROBENZENE	HIKAL LIMITED
WO/2021/149015	MULTISPECIFIC ANTIBODIES, COMPOSITIONS COMPRISING THE SAME, AND VECTORS AND USES THEREOF	APRILBIO CO., LTD.
WO/2021/152443	A CONTINUOUS FLOW PROCESS FOR PREPARATION OF ACEPHATE AND ITS INTERMEDIATES	UPL LIMITED
WO/2021/156707	SYSTEMS AND METHODS FOR ENHANCING THE EXTRACTIVE SECTION OPERABILITY AND MODIFYING SOLVENT HEAT RECOVERY CYCLE IN THE SEPARATION OF C<sb>4</sb> MIXTURES	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/152463	PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME	KOTIN, Oleg Arkadyevich
WO/2021/156720	CHO CELL EXPRESSING IL-15 HETERODIMERS	NOVARTIS AG
WO/2021/152548	COMBINATION THERAPY FOR TREATMENT OF CANCER AND CANCER METASTASIS	BENITAH, Salvador Aznar
WO/2021/161127	ORGANIC COMPOUND, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE, ELECTRONIC APPARATUS, LIGHT EMITTING APPARATUS, AND LIGHTING APPARATUS	SEMICONDUCTOR ENERGY LABORATORY CO., LTD.
WO/2021/152564	IMPURITY FORMATION REDUCTION DURING PRODUCT REFINING	INVISTA TEXTILES (U.K.) LIMITED
WO/2021/156776	SIMPLE MANUFACTURING AND PURIFICATION TECHNOLOGY FOR HIGH PURITY PROPOFOL	CHODANKAR, Nandkumar
WO/2021/156846	ANTIBACTERIAL COMPOSITIONS FOR PREVENTING ANTIBIOTIC RESISTANCE IN BACTERIA BY INHIBITION OF SOS RESPONSE	TELSCIE GENETICS (OPC) PRIVATE LIMITED
WO/2021/161170	SEPARATION PROCESS TO OBTAIN HIGH PURITY 1-BUTENE	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/161197	ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR	CRISPR THERAPEUTICS AG
WO/2021/161199	ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUNDS WITH HIGHLY- STRUCTURED ALKYL BRANCHES	CHEVRON ORONITE COMPANY LLC
WO/2021/161200	PROCESS FOR PREPARATION OF ARTHROPODICIDAL ANTHRANILAMIDE COMPOUNDS	UPL LIMITED
WO/2021/161206	NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS	HETERO LABS LIMITED
WO/2021/161222	COMPOUNDS USEFUL IN INHIBITING DIACYLGLYCEROL O-ACYLTRANSFERASE AND METHODS OF MAKING AND USING THE SAME	INORBIT THERAPEUTICS AB
WO/2021/161232	PROCESS FOR PREPARATION OF SOLRIAMFETOL AND INTERMEDIATES THEREOF	LUPIN LIMITED
WO/2021/165818	PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 2-FLUORO-N-METHYL-4-[7-QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-B][1,2,4]TRIAZIN-2YL]BENZAMIDE	NOVARTIS AG
WO/2021/161292	PEPTIDES FOR TARGETING LRP6-OVEREXPRESSED CELLS	RISMANI, Elham
WO/2021/165834	5-(3-(ETHYLSULFONYL)PYRIDIN-2-YL)-PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS PESTICIDE AND INSECTICIDE AGENTS FOR CROP PROTECTION	PI INDUSTRIES LTD.
WO/2021/165914	ANTI D-DIMER RECOMBINANT ANTIBODIES, METHODS AND USES THEREOF	GRIFOLS DIAGNOSTIC SOLUTIONS INC.
WO/2021/165927	2-CYANOPYRROLDINES, -PIPERIDINES OR -DAZEPINES AS HYPERGLYCEMIC AGENTS	WOCKHARDT BIO AG
WO/2021/165928	<i>ESCHERICHIA COLI </i>COMPOSITIONS AND METHODS THEREOF	PFIZER INC.
WO/2021/171165	PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES	NOVARTIS AG
WO/2021/171201	METHOD OF MAKING TEREPHTHALIC ACID	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/186271	PERFLUORINATED ALLYL ETHERS AND PERFLUORINATED ALLYL AMINES AND METHODS OF MAKING AND USING THE SAME	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/176311	AN IMPROVED PURIFICATION PROCESS FOR RANIBIZUMAB	LUPIN LIMITED
WO/2021/171257	ANTI-AXL ANTIBODIES AND COMPOSITIONS	SYMPHOGEN A/S
WO/2021/171264	DOSING OF A BISPECIFIC ANTIBODY THAT BINDS CD123 AND CD3	NOVARTIS AG
WO/2021/176328	PROCESS FOR THE PURIFICATION OF INDOLE CARBAZOLE ALKALOIDS	INDENA S.P.A.
WO/2021/176336	USE OF ANTI-FAM19A1 ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES	NEURACLE SCIENCE CO., LTD.
WO/2021/176362	ANTIGEN-BINDING MOLECULES AND USES THEREOF	SCOUT BIO, INC.
WO/2021/176366	INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/176381	A METHOD FOR PREPARATION OF DIASTEREOMERIC LACTATE SALTS OF 1-(1-NAPHTHYL)ETHYL AMINE AND PURE ENANTIOMERS OF 1-(1-NAPHTHYL)ETHYL AMINE	EMBIO LIMITED
WO/2021/176407	A METHOD FOR PREPARING A SOLID FORM OF BISPHENOL F	ADITYA BIRLA CHEMICALS (THAILAND) LTD. (ADVANCED MATERIALS)
WO/2021/181233	CD80-FC FUSION PROTEIN AND USES THEREOF	PFIZER INC.
WO/2021/181235	ANTIBACTERIAL PROTEIN HAVING LYTIC ACTIVITY TO BACILLUS GENUS AND METHOD FOR PREPARING THE SAME	INTRON BIOTECHNOLOGY, INC.
WO/2021/181274	PROCESS FOR PREPARING 5-FLUORO-4-IMINO-3-METHYL-1-(TOLUENE-4-SULFONYL)-3,4-DIHYDRO-1H-PYRIMIDIN-2-ONE	ADAMA MAKHTESHIM LTD.
WO/2021/181290	A SHORT AND EFFICIENT METHOD FOR PRODUCING (1R,3R)-2,2-DIMETHYL-3-(Z)-PROP-1-EN-1-YL) CYCLOPROPANE CARBOXYLIC ACID AND ESTERS	PAREKH, Sandip J.
WO/2021/181349	CRYSTALLIZATION OF 2'-FL	GLYCOM A/S
WO/2021/181353	ANTIMICROBIAL PROTEIN FOR USE IN THE MEDICAL FIELD	DELPHINUS BIOTECH S.R.L.
WO/2021/181355	ANTIMICROBIAL PROTEIN AND RELATIVE USES	DELPHINUS BIOTECH S.R.L.
WO/2021/181360	NOVEL SALTS OF QUINOLONE COMPOUNDS	CADILA HEALTHCARE LIMITED
WO/2021/181361	PHARMACEUTICAL COMPOSITIONS OF LIPOIC ACID CHOLINE ESTER SALTS AND METHODS OF TREATMENT USING SAME	NOVARTIS AG
WO/2021/186324	BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS	NOVARTIS AG
WO/2021/186328	SYNTHESIS OF 3'N NUCLEOSIDES THROUGH OXIME INTERMEDIATES AND RELATED COMPOUNDS	JANSSEN BIOPHARMA, INC.
WO/2021/234468	CURCUMIN DIHYDROPYRIDONE DERIVATIVES WITH ANTI-CANCER ACTIVITY	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/191819	ANTI-TN-MUC1 CHIMERIC ANTIGEN RECEPTORS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/191830	METHODS AND REAGENTS FOR SYNTHESIZING NUCLEOSIDES AND ANALOGUES THEREOF	SIMON FRASER UNIVERSITY
WO/2021/191832	PROCESS FOR THE PREPARATION OF PROPOFOL	FRESENIUS KABI ONCOLOGY LTD.
WO/2021/191836	HCVM PENTAMER BINDING ANTIBODIES	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/191837	1,3-DIHYDRO-2<i>H</i>-PYRROLO[3,4-C]PYRIDINE DERIVATIVES AS GABAA Α5 RECEPTOR MODULATORS	RICHTER GEDEON NYRT.
WO/2021/191838	NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABA<sb>A</sb> α5 RECEPTOR MODULATORS	RICHTER GEDEON NYRT.
WO/2021/191848	PREPARATION OF NEOSAXITOXIN	THE CAWTHRON INSTITUTE TRUST BOARD
WO/2021/191866	CATALYSTS FOR SELECTIVE OXIDATION OF METHANOL TO DIMETHOXYMETHANE AND RELATED METHODS	KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/191872	HETEROARYL-SUBSTITUTED MACROCYCLIC FLU ENDONUCLEASE INHIBITORS	JANSSEN BIOPHARMA, INC.
WO/2021/191876	SYNTHESIS OF METHYL 2-FLUOROACRYLATE	VIFOR (INTERNATIONAL) LTD.
WO/2021/191882	ANTIMALARIAL AGENT, METHODS AND USES THEREOF	UNIVERSIDADE DO MINHO
WO/2021/198883	SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS	JANSSEN BIOPHARMA, INC.
WO/2021/205290	COMPOUNDS AND METHOD OF TREATING COVID-19	PFIZER INC.
WO/2021/198955	COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS	NUEVOLUTION A/S
WO/2021/198956	COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS	NUEVOLUTION A/S
WO/2021/198958	NUCLEIC ACID POLYMERS	JANSSEN BIOPHARMA, INC.
WO/2021/209851	FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/205298	COMPOUNDS AND METHODS FOR THE TREATMENT OF COVID-19	PFIZER INC.
WO/2021/198999	EPITOPE-BASED VACCINES FOR TREATMENT OF CORONAVIRUS ASSOCIATED DISEASES	AXON NEUROSCIENCE SE
WO/2021/199006	ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING AND REDUCING NEGATIVE EFFECTS OF A CORONAVIRUS INCLUDING COVID-19	BIOCON LIMITED
WO/2021/205322	CRYSTALLINE FORMS OF 3-CYANO-1-[4-[6-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRAZIN-4-YL]-1H-PYRAZOL-1-YL]CYCLOBUTANEACETONITRILE, AND USE THEREOF	PFIZER INC.
WO/2021/205325	ANTI-GUCY2C ANTIBODIES AND USES THEREOF	PFIZER INC.
WO/2021/209859	MONOMERS, POLYMERS, AND ARTICLES FOR BIOMATERIAL CAPTURE	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/205351	PROCESS FOR PREPARATION OF ARACHIDIC ACID	AURIGENE PHARMACEUTICAL SERVICES LTD. (APSL)
WO/2021/205354	NOVEL NATURE-INSPIRED ANTICANCER AND ANTIBACTERIAL MOTIFS AND PHARMACEUTICAL COMPOSITION THEREOF	UNIVERSITY OF SHARJAH
WO/2021/205361	ANTI-CD98 ANTIBODIES AND USES THEREOF	JANSSEN BIOTECH, INC.
WO/2021/205372	ANTIBACTERIAL LIPOPEPTIDES, PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION COMPRISING THEM, AND USES THEREOF	UNIWERSYTET WARSZAWSKI
WO/2021/205383	MONOCLONAL ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF FOR SUPPRESSING CD73 IMMUNE CHECKPOINT AND USES THEREOF	APRILBIO CO., LTD.
WO/2021/205388	AN IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE SIDE CHAIN	FRESENIUS KABI ONCOLOGY LIMITED
WO/2021/205401	RECOMBINANT PROTEINS COMPRISING FELINE GRANULOCYTE COLONY-STIMULATING FACTOR AND ANTIGEN BINDING FRAGMENT FOR SERUM ALBUMIN, AND USES THEREOF	APRILBIO CO., LTD.
WO/2021/214587	ANTI-TNF ALPHA AGENT FOR TREATING VIRAL INFECTIONS	JANSSEN BIOTECH, INC.
WO/2021/209930	SETD7 EPIGENETIC MODULATORS	BIORCHESTRA CO., LTD.
WO/2021/209944	ODORANTS AND COMPOSITIONS COMPRISING ODORANTS	S H KELKAR AND COMPANY LIMITED
WO/2021/209953	SYSTEMS, MATERIALS, AND METHODS FOR REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC) FOR MONITORING FORMATION OF MULTI-SPECIFIC MOLECULES	JANSSEN BIOTECH, INC.
WO/2021/214612	CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/214685	METHOD FOR THE SYNTHESIS OF A CHOLANE DERIVATIVE	BAR PHARMACEUTICALS SOCIETA' A RESPONSABILITA' LIMITATA
WO/2021/229331	COMPOUNDS COMPRISING PERFLUORINATED GROUP, PHOTOINITIATOR GROUP, AND AMIDE LINKING GROUP	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/214716	MERS-COV INHIBITOR PEPTIDES	KING FAISAL UNIVERSITY
WO/2021/220120	NOVEL COMPOUNDS USEFUL AS POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS	RHIZEN PHARMACEUTICALS AG
WO/2021/220140	MATERIALS AND METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS	JANSSEN BIOTECH, INC.
WO/2021/220170	COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2-ALPHA AND THEIR METHODS OF USE	NOVARTIS AG
WO/2021/220183	IMIDAZOPYRIMIDINES AS MODULATORS OF IL-17	JANSSEN PHARMACEUTICA NV
WO/2021/220185	AZALACTAM COMPOUNDS AS HPK1 INHIBITORS	PFIZER INC.
WO/2021/220215	ENGINEERED IMMUNOGLOBULINS	NOVARTIS AG
WO/2021/220218	IMMUNOGLOBULIN VARIANTS	NOVARTIS AG
WO/2021/220219	REACTIVE SILANE COMPOUND, COATING COMPOSITION AND USE THEREOF	CHEMSTREAM BVBA
WO/2021/224802	MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3- METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND METHODS OF USE THEREOF	ADAMA MAKHTESHIM LTD.
WO/2021/224830	SALTS OF NEUROCEUTICALS AND USES THEREOF	SYNEURX INTERNATIONAL (TAIWAN) CORP.
WO/2021/224833	BIO-NANOCOMPOUND AS AN AGENT FOR NUCLEATING AQUEOUS-BASED COMPOUNDS AND PRODUCTION METHOD THEREOF	UNIVERSIDAD DE LOS ANDES
WO/2021/224849	MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH	CRISPR THERAPEUTICS AG
WO/2021/224850	MASK PEPTIDES AND MASKED ANTI-PTK7 ANTIBODIES COMPRISING SUCH	CRISPR THERAPEUTICS AG
WO/2021/224864	NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF	ALECTOS THERAPEUTICS INC.
WO/2021/224865	NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF	ALECTOS THERAPEUTICS INC.
WO/2021/234497	PROCESS FOR THE PURIFICATION OF 2 MERCAPTOBENZOTHIAZOLE	NITREX CHEMICALS INDIA LIMITED
WO/2021/250480	SUBSTITUTED GUANIDINO AND AMIDINO REAGENTS AND THE USE THEREOF FOR PROTEIN DENATURATION	WATERS TECHNOLOGIES CORPORATION
WO/2021/229499	MYRISTOYL DERIVATIVES OF 9-AMINO-DOXYCYCLINE FOR TARGETING CANCER STEM CELLS AND PREVENTING METASTASIS	LUNELLA BIOTECH, INC.
WO/2021/229507	METHODS, THERAPIES AND USES FOR TREATING CANCER	PFIZER INC.
WO/2021/229518	SARS-COV-2 GENOMIC SEQUENCES AND POLYPEPTIDES FOUR A DOUBLE USE IN A VACCINE AND IN A TEST FOR SKIN CELL-MEDIATED IMMUNITY TO SARS-COV-2	SEKKAL, Faycal
WO/2021/229521	JNK3 INHIBITORY PEPTIDES	UNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/229540	SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS-COV-2 VIRUS	UNIVERSIDAD AUSTRAL DE CHILE
WO/2021/234543	SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF	CHINOOK THERAPEUTICS CANADA, INC.
WO/2021/234544	CRYSTALLINE FORM OF LNP023	NOVARTIS AG
WO/2021/234547	SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF	CHINOOK THERAPEUTICS CANADA, INC.
WO/2021/234550	NOVEL NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF	ANYGEN CO., LTD.
WO/2021/234579	USE OF RESISTIN AS A TRIMERIZATION PARTNER FOR EXPRESSION OF TRIMERIC PROTEINS	NATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/234593	METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED FC DOMAINS	JANSSEN BIOTECH, INC.
WO/2021/234608	DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE	CYBIN IRL LIMITED
WO/2021/234654	PCSK9-INHIBITING COMPOUNDS	UNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/240331	PROCESS FOR THE PREPARATION OF 3,5-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE	HIKAL LIMITED
WO/2021/240337	COVALENT MODIFIERS OF EIF4E INHIBITING COMPOUNDS	EFFECTOR THERAPEUTICS, INC.
WO/2021/255552	AMINO ACID-BASED POLYMERIZABLE COMPOUNDS AND OPHTHALMIC DEVICES PREPARED THEREFROM	JOHNSON & JOHNSON VISION CARE, INC.
WO/2021/240356	PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES	PFIZER INC.
WO/2021/240369	COMPOSITIONS COMPRISING AN ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME	SANOFI BIOTECHNOLOGY
WO/2021/250492	FORMING ACETIC ACID BY THE SELECTIVE OXIDATION OF LIGHT HYDROCARBONS	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/250493	FORMING ACETIC ACID BY THE SELECTIVE OXIDATION OF METHANE	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/250495	LIMITING ACETIC ACID PRODUCTION IN ETHANE ODH PROCESS	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/245504	PROCESS FOR THE PREPARATION OF VERAPAMIL	GLENMARK LIFE SCIENCES LIMITED
WO/2021/240423	DIHYDROOROTATE DEHYDROGENASE INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/240424	INDAZOLE AND BENZOISOXAZOLE DIHYDROOROTATE DEHYDROGENASE INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/240429	BENZOFURAN AND BENZOPYRAN DIHYDROOROTATE DEHYDROGENASE INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/240471	PRODUCTION AND USE OF PLASTICIZERS BASED ON 2,4-ISOMER OF FURANDICARBOXYLIC ACID DIESTERS	BRASKEM S.A.
WO/2021/245579	INHIBITORS OF PROTEIN FUCOSYLATION AND USES THEREOF	SIMON FRASER UNIVERSITY
WO/2021/245580	CHIMERIC ANTIGEN RECEPTOR COMPRISING PA63 DOMAIN 4 VARIANT AS EXTRACELLULAR BINDING DOMAIN, AND USE THEREOF	MJCELL BIO CO., LTD.
WO/2021/250511	T-CELL RECEPTOR BINDING TO MR1, AND USE THEREOF	EUTILEX CO., LTD.
WO/2021/245603	ANTI-CD70 ANTIBODIES AND USES THEREOF	CRISPR THERAPEUTICS AG
WO/2021/250521	4-OXO-3,4-DIHYDROQUINAZOLINON COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS	ARRAY BIOPHARMA INC.
WO/2021/245619	METHODS FOR TREATING SEVERE ASTHMA IN PATIENTS WITH NASAL POLYPOSIS	ASTRAZENECA AB
WO/2021/250531	4-(4,5-DIHYDRO-1H-PYRAZOL-1-YL)PYRIMIDINE COMPOUND AS CANNABINOID RECEPTOR (CB1 RECEPTOR) ANTAGONISTS AND PHARMACEUTICAL COMPOSITION INCLUDING SAME	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/250533	METHODS OF TREATMENT USING OMALIZUMAB OR LIGELIZUMAB	NOVARTIS AG
WO/2021/250541	SPIRO COMPOUNDS AS MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF	PFIZER INC.
WO/2021/250558	PROCESS FOR THE PREPARATION OF FLUOXASTROBIN AND INTERMEDIATES THEREOF	UPL LIMITED
WO/2021/250565	AN IMPROVED PROCESS FOR PREPARATION OF EMPAGLIFLOZIN AND ITS CRYSTALLINE POLYMORPH	HIKAL LIMITED
WO/2021/250568	MITIGATING NATURALLY OCCURRING RADIOACTIVE MATERIAL IN OXIDATIVE DEHYDROGENATION	NOVA CHEMICALS (INTERNATIONAL) S.A.
WO/2021/250594	ANTI-CTLA4 MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS	NANTBIO, INC.
WO/2021/250603	PROCESS FOR PRODUCING THERMALLY STABILIZED LIGNIN	STORA ENSO OYJ
WO/2021/250604	PROCESS FOR PRODUCING CARBON FROM HEAT TREATED LIGNIN	STORA ENSO OYJ
WO/2021/250610	PROCESS FOR HYDROCARBON DEHYDROGENATION	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/250614	SELECTIVE CDK4/6 INHIBITOR CANCER THERAPEUTICS	LUNELLA BIOTECH, INC.
WO/2021/250624	NOVEL CRYSTALLINE COMPOUND OF VADADUSTAT	OLON S.P.A.
WO/2021/250625	GBS FERRITIN NANOPARTICLES	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/250626	DOCK TAG SYSTEM	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/250635	ACID SALTS OF FLUOROQUINOLONE CARBOXYLIC ACID BASED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME	VYOME THERAPEUTICS INC.
WO/2021/255607	METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[B]PYRIDINE-3-CARBOXYLATES AND METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE-3-CARBOXYLATES AS CAV1.2 ACTIVATORS	NOVARTIS AG
WO/2021/255608	METHYL 2-METHYL-5-OXO-1,4,5,7-TETRADHYDROFURO[3,4- B]PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS	NOVARTIS AG
WO/2021/250643	COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME	OTI LUMIONICS INC.
WO/2021/260498	AN IMPROVED PURIFICATION PROCESS FOR THE PREPARATION OF ERTUGLIFLOZIN AND ERTUGLIFLOZIN L-PYROGLUTAMIC ACID CO-CRYSTAL	AUROBINDO PHARMA LIMITED
WO/2021/255671	METHOD FOR PRODUCING AROMATIC DICARBOXYLIC ACID USING IRON CO‑CATALYST	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/255698	HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND	IDEMITSU KOSAN CO., LTD.
WO/2021/260510	HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE	PFIZER INC.
WO/2021/260519	COCRYSTALS DERIVATIVES OF APIXABAN	SAVOI, Guilherme
WO/2021/260532	STEREOTYPIC NEUTRALIZING VH CLONOTYPES AGAINST SARS-COV-2 RBD IN COVID-19 PATIENTS AND THE HEALTHY POPULATION	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/260562	METHOD FOR SYNTHESISING MACROMOLECULES IN SOLUTION FROM CARBOHYDRATE DERIVATIVE UNITS	STRAINCHEM
WO/2021/260609	PROCESS FOR THE MANUFACTURE OF 1,4-DISUBSTITUTED PYRIDAZINE COMPOUNDS	NOVARTIS AG
WO/2021/260617	AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE	HIKAL LIMITED
WO/2021/250648	NITRILE-CONTAINING ANTIVIRAL COMPOUNDS	PFIZER INC.
WO/2021/033176	SCALED-UP METHODS FOR PURIFYING ANTIBODIES	ARIEL SCIENTIFIC INNOVATIONS LTD.
WO/2021/005588	PROCESS FOR PRODUCING A SOLUTION OF AMMONIUM CARBAMATE	A.Y. LABORATORIES LTD.
WO/2021/001825	METHIONINE METABOLIC PATHWAY INHIBITORS	MIGAL GALILEE RESEARCH INSTITUTE LTD.
WO/2021/001840	PROKARYOTIC EXPRESSION SYSTEM AND METHODS OF USING THE SAME	SEEVIX MATERIAL SCIENCES LTD.
WO/2021/005599	HETERODIMERS AND METHODS OF USE THEREOF	KAHR MEDICAL LTD.
WO/2021/005604	LONG-ACTING IGF-1 OR IGF-1 VARIANTS AND METHODS OF PRODUCING SAME	OPKO BIOLOGICS LTD.
WO/2021/005607	ANTIBODIES WITH REDUCED IMMUNOGENICITY	NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/014437	PROCESS FOR THE PREPARATION OF BIPHENYLAMINES	ADAMA MAKHTESHIM LTD.
WO/2021/019537	PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PYROXASULFONE	ADAMA AGAN LTD.
WO/2021/024253	PROCESS FOR THE PREPARATION OF FLUENSULFONE	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/024260	NOVEL PERIPHERAL CANNABINOID-1 RECEPTOR ANTAGONISTS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
WO/2021/028929	DELIVERY PEPTIDES AND METHODS OF USING THE SAME	NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/038571	A SINGLE-DOMAIN ANTIBODY FOR TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)	NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/044430	ANTI-FIBROTIC COMPOUNDS AND USE THEREOF	HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
WO/2021/059287	LIGHT INDUCED CATALYTIC C-H OXYGENATION OF ALKANES	ARIEL SCIENTIFIC INNOVATIONS LTD.
WO/2021/070176	TWO-FILM ASSEMBLY FOR THE PREPARATION OF LIGNIN BASED FLAME RETARDANT POLYMERIC MATERIALS	DAREN LABORATORIES & SCIENTIFIC CONSULTANTS LTD.
WO/2021/084526	ENGINEERED AUTOTROPHIC BACTERIA FOR CO2 CONVERSION TO ORGANIC MATERIALS	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/084532	DOLASTATIN 10 ANALOG	ARIEL SCIENTIFIC INNOVATIONS LTD.
WO/2021/095031	INSECT CONTROL NANOBODIES AND USES THEREOF	IBI-AG INNOVATIVE BIO INSECTICIDES LTD.
WO/2021/105988	ANTIBODIES TO CARBOHYDRATE ANTIGENS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/105989	CHIMERIC ANTIGEN RECEPTOR TO CARBOHYDRATE ANTIGENS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/106000	PROCESS FOR MAKING BIARYL-BRIDGED CYCLIC PEPTIDES	B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
WO/2021/111443	COMPOSITION AND METHOD FOR TREATING CANCER	CARMEL - HAIFA UNIVERSITY ECONOMIC CORP LTD.
WO/2021/117037	TARGETING IL-13 RECEPTOR ALPHA 1 IN ATOPIC DERMATITIS AND ALLERGIC DISEASES	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/149040	ANTI-IDE ANTIBODIES AND USES OF SAME	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/137245	CONUS-BASED TOXIN PEPTIDES, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF IN MODULATING NMDA RECEPTORS	TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
WO/2021/144793	METHODS FOR IDENTIFYING ANTI CLOSTRIDIAL NEUROTOXIN COMPOUNDS	THE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/144796	SOLID STATE FORM OF PYROXASULFONE	ADAMA AGAN LTD.
WO/2021/149053	MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/152584	METHODS OF ANALYZING CELL MEMBRANES	ARIEL SCIENTIFIC INNOVATIONS LTD.
WO/2021/152592	METHODS OF TREATING CANCER	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/156870	MIXTURE OF 3-HEXEN-1-OL ISOMERS AND A PROCESS OF PREPARING SAME	AGAN AROMA & FINE CHEMICALS LTD.
WO/2021/165959	CHEMILUMINESCENCE PROBES FOR TUBERCULOSIS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/176456	PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PYROXASULFONE	ADAMA AGAN LTD.
WO/2021/181379	COMPOSITIONS AND METHODS FOR TREATING OSTEOLYSIS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/186427	ANTI- <i>MUC1-SEA</i> ANTIBODIES	BIOMODIFYING, LLC
WO/2021/181396	SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY	BIOND BIOLOGICS LTD.
WO/2021/186431	PEPTIDE ANALOGS AND USE OF SAME IN TREATING DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH A MUTANT P53 PROTEIN	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/191900	METHODS FOR TREATING INFECTIOUS DISEASES CAUSED BY CORONAVIRUS	KAMADA LTD.
WO/2021/229561	ANTI<i>-</i>SARS-COV-2 ANTIBODIES	THE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/205448	CO-CRYSTALS OF ANTIOXIDANTS AND ACTIVE INGREDIENTS AND USE OF ANTIOXIDANTS AS STABILIZER	ADAMA AGAN LTD.
WO/2021/205455	SARS-COV2 CORONAVIRUS RECONSTITUTED RBM AND USES THEREOF	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/210000	MONOCLONAL ANTIBODY AND USES THEREOF FOR THE TREATMENT AND DIAGNOSIS OF MULTIDRUG-RESISTANT PATHOGENIC BACTERIAL INFECTIONS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/214758	CCL24 INHIBITORS IN THE TREATMENT OF COVID-19	CHEMOMAB LTD.
WO/2021/214759	METHOD OF TREATMENT USING ANTI-CCL24 ANTIBODY	CHEMOMAB LTD.
WO/2021/214762	BIOACTIVE PHENOLATE IONIC COMPLEXES	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
WO/2021/214780	MODIFIED SPIDER SILK FIBER AND USE THEREOF	SEEVIX MATERIAL SCIENCES LTD.
WO/2021/214781	COSMETIC COMPOSITIONS COMPRISING DRAGLINE SPIDER SILK	SEEVIX MATERIAL SCIENCES LTD.
WO/2021/224913	PRECURSOR TRI-SPECIFIC ANTIBODY CONSTRUCTS AND METHODS OF USE THEREOF	IMMUNORIZON LTD.
WO/2021/224927	COMPOSITION FOR USE IN THE TREATMENT OF APOL1-ASSOCIATED DISEASE	RAMBAM MED-TECH LTD.
WO/2021/229571	IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF	METABOMED LTD
WO/2021/229583	FUSED PYRAZOLE AND IMIDAZOLE BASED COMPOUNDS AND USE THEREOF AS GLI1 INHIBITORS	GLIXOGEN THERAPEUTICS LTD.
WO/2021/234694	LIPID PARTICLES FOR NUCLEIC ACID DELIVERY AND CLINICAL APPLICATIONS OF SAME	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/234699	MAdCAM-1 POLYPEPTIDES AND USES THEREOF	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/245660	COMPOSITON FOR SAMPLING BODY FLUIDS AND SECRETIONS FOR DETECTING PATHOGENIC AGENTS NUCLEIC ACIDS AND FOR DISINFECTION	OFEK ESHKOLOT RESEARCH AND DEVELOPMENT LTD.
WO/2021/245669	ABNORMAL CANNABIDIOL (ABN-CBD) ACID DERIVATIVES AND USES THEREOF	EPM (IP), INC.
WO/2021/245671	CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF	EPM (IP), INC.
WO/2021/245672	CANNABIGEROLIC ACID (CBGA) DERIVATIVES AND USES THEREOF	EPM (IP), INC.
WO/2021/245675	CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF	EPM (IP), INC.
WO/2021/245676	CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF	EPM (IP), INC.
WO/2021/250656	HUMAN ANTI-GRP94 ANTIBODIES AND USES	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/250662	UBIQUITIN HIGH AFFINITY PEPTIDES, AND METHODS OF USING SAME, AND IDENTIFYING SAME	TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
WO/2021/255723	MULTIFUNCTIONAL IMMUNOTHERAPEUTIC MONOCLONAL ANTIBODY COMPLEXES AND CONJUGATES	SLAVIN, Shimon
WO/2021/255737	HYDROXYNORKETAMINE ANALOGUES, COMPOSITIONS COMPRISING SAME AND METHODS OF USE THEREOF	SPIRIFY PHARMA INC.
WO/2021/260685	MODIFIED CXCL10 FOR IMMUNOTHERAPY OF CANCER DISEASES	TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
WO/2021/260686	CXCL9 AND VARIANTS THEREOF FOR IMMUNOTHERAPY OF CANCER DISEASES	TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
WO/2021/260696	MULTI SUBUNIT PROTEIN MODULES, CELLS EXPRESSING SAME AND USES THEREOF	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/028935	HETEROCYCLIC COMPOUNDS, AND THEIR USE AS ALLOSTERIC MODULATORS OF 5-HYDROXYTRYPTAMINE 2C RECEPTOR (5-HT2CR)	DR REDDY'S INSTITUTE OF LIFE SCIENCES
WO/2021/137249	A PROCESS FOR PREPARING 2-CHLORO-N-{[4-(PYRIMIDIN-2-YLSULFAMOYL)PHENYL] CARBAMOTHIOYL} BENZAMIDE AND THE PHARMACEUTICAL UTILITY THEREOF	SOMADE, Prakash Maruti
WO/2021/171301	A PROCESS FOR SYNTHESIS OF HIGH PURITY 1-[3-(TRIFLUOROMETHYL)PHENYL]ETHANONE OXIME	LAXMI ORGANIC INDUSTRIES LTD
WO/2021/234717	MAGNESIUM NANOPARTICLES TO CAPTURE AND CONVERT CO2 TO METHANE, METHANOL OR FORMIC ACID OR OTHER FUELS OR CHEMICALS	TATA INSTITUTE OF FUNDAMENTAL RESEARCH
WO/2021/005618	SYNTHESIS OF CHOLESTEROL AND VITAMIN D3 FROM PHYTOSTEROLS	FERMENTA BIOTECH LIMITED
WO/2021/005619	IMPROVED, COST EFFECTIVE PROCESS FOR SYNTHESIS OF VITAMIN D3 AND ITS ANALOGUE CALCIFEDIOL FROM ERGOSTEROL	FERMENTA BIOTECH LIMITED
WO/2021/001855	TITLE OF THE INVENTION:A NEW PROCESS FOR SYNTHESIZING C2 BRIDGED CYCLOPENTADIENYL LIGANDS AND CORRESPONDING ANSA-METALLOCENE CATALYSTS	HALDIA PETROCHEMICALS LIMITED
WO/2021/001858	IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/009774	PRODUCTION OF MALIC ACID	THIRUMALAI CHEMICALS LIMITED
WO/2021/014463	METAL-FREE SOLVENT-FREE SYNTHESIS OF FUSED-PYRIDO HETEROCYCLES AND BIOMEDICAL APPLICATIONS	CHELVAM, Venkatesh
WO/2021/019555	A PROCESS FOR THE PREPARATION OF 4-AMINO-2-HYDROXY-4-OXOBUTANOIC ACID AND PRODUCT PREPARED THEREFROM	INDIAN COUNCIL OF MEDICAL RESEARCH
WO/2021/019558	AN EFFICIENT METHOD FOR SYNTHESIS OF 5-(3-PYRIDYL)-2,2'-BITHIOPHENE(SENSITIZER)	FERMENTA BIOTECH LIMITED
WO/2021/019559	SYNTHESIS OF 5-(3-PYRIDYL)-2,2'-BITHIOPHENE(SENSITIZER)	FERMENTA BIOTECH LIMITED
WO/2021/250685	CLOG FREE CONDENSATION PROCESS FOR PET LIKE POLYMER PYROLYSIS VAPOUR	DIXIT, Suhas
WO/2021/019565	SYNTHETIC NUCLEOTIDE SEQUENCES ENCODING INSECTICIDAL CRYSTAL PROTEIN AND USES THEREOF	DCM SHRIRAM LIMITED
WO/2021/224934	PROCESS FOR PREPARATION OF TERT-BUTYLAMINE AND PROPIONIC ACID SALTS FROM N-TERTIARY BUTYL ACRYLAMIDE	PRACHI SPECIALTIES
WO/2021/024271	CONTINUOUS FLOW PROCESS AND APPARATUS FOR <i> </i>MANUFACTURE OF <i>DL-</i>2-NITRO-1-BUTANOL	INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IIT MADRAS)
WO/2021/024275	A PROCESS FOR SELECTIVE OXIDATION OF <i>ORTHO</i>-CRESOL AND CATALYST THEREOF	YADAV, Ganapati Dadasaheb
WO/2021/117053	AN IMPROVED PROCESS FOR PREPARATION OF PURE ALDOXIME	DR. SILVIU PHARMACHEM PVT. LTD.
WO/2021/033200	A PROCESS FOR PREPARATION OF SULTONES	SRF LIMITED
WO/2021/038582	A PHENYLMETHANONE FUNCTIONALIZED CARBAZOLE, A PROCESS FOR PREPARATION AND USE THEREOF	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/038586	IMPROVED PROCESS FOR THE PREPARATION OF TEZACAFTOR INTERMEDIATE	KEMINNTEK LABORATORIES
WO/2021/038590	NOVEL POLYMORPH OF RIBOCICLIB SUCCINATE	MYLAN LABORATORIES LIMITED
WO/2021/044437	OLAPARIB CO-CRYSTALS AND PROCESS OF PREPARATION THEREOF	CIPLA LIMITED
WO/2021/044439	INDUCIBLE CYTOKINE SIGNALS & METHODS FOR IMMUNOTHERAPY	IMMUNOADAPTIVE CELL THERAPY PVT LTD.
WO/2021/044445	SOLVENT FREE CONTINUOUS PROCESS FOR THE SYNTHESIS OF METFORMIN HYROCHLORIDE	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/053690	AN IMPROVED PROCESS FOR THE PREPARATION OF BARICITINIB	NATCO PHARMA LIMITED
WO/2021/064753	PRODUCTION OF MALIC ACID USING TUBULAR AND STIRRED TANK REACTORS	THIRUMALAI CHEMICALS LIMITED
WO/2021/070202	A METHOD FOR PREPARING GLP-1 ANALOGUE BY SOLID-PHASE PEPTIDE SYNTHESIS	PRASAD, ALAPARTHI, Lakshmi
WO/2021/070203	STABLE FORMULATION OF INTEGRIN ANTIBODY	DR. REDDY'S LABORATORIES LIMITED
WO/2021/084552	MYCOBACTERIUM TUBERCULOSIS MIMIC FOR IMMUNIZATION AND ENHANCEMENT OF BCG VACCINE EFFICACY	INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
WO/2021/084556	Process for the preparation of tofacitinib and intermediates thereof	AARTI INDUSTRIES LIMITED
WO/2021/095054	A CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF METAL NANOWIRES USING BUBBLE COLUMN REACTOR	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/095059	A CONTINUOUS PROCESS FOR THE SYNTHESIS OF AZO DYES INVOLVING IN-SITU GENERATION OF DIAZONIUM SALTS	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/100059	PROCESS FOR PREPARING CHROMAN COMPOUNDS	LUPIN LIMITED
WO/2021/111462	AN IMPROVED PROCESS FOR THE PREPARATION OF OSIMERTINIB MESYLATE	NATCO PHARMA LIMITED
WO/2021/111465	NOVEL PROCESS FOR THE PREPARATION OF ACALABRUTINIB AND ITS INTERMEDIATES	NATCO PHARMA LIMITED
WO/2021/111475	PROCESS FOR PREPARING TRANEXAMIC ACID	KAWMAN PHARMA PRIVATE LIMITED
WO/2021/124354	A PROCESS FOR THE SYNTHESIS OF FURANDICARBOXYLIC ACID	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/130776	AN IMPROVED PROCESS FOR THE PREPARATION OF 4-({(1 <i>R</i>)-2-[5-(2-FLUORO-3METHOXYPHENYL)-3-{[2-FLUORO-6-(TRIFLUORO METHYL) PHENYL]METHYL}-4-METHYL-2,6-DIOXO-3,6DIHYDROPYRIMIDIN-1(2 <i>H</i>)-YL]-1-PHENYLETHYL}AMINO)BUTANOIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/137254	ANTIBODIES AGAINST LIPOCALIN-2 AND USES THEREOF	ADVANCED CENTRE FOR TREATMENT RESEARCH AND EDUCATION IN CANCER, TATA MEMORIAL CENTRE
WO/2021/137256	POLYMORPHIC FORMS OF GLECAPREVIR	MYLAN LABORATORIES LIMITED
WO/2021/140525	NOVEL CRYSTALLINE FORM OF 1-(2,2-DIFLUORO-2H-1,3BENZO DIOXOL-5-YL)-N-{1-[(2R)-2,3-DIHYDROXYPROPYL]-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL}CYCLOPROPANE-1-CARBOXAMIDE AND ITS PROCESS FOR THE PREPARATION THEREOF	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/144812	PROCESS FOR PREPARATION OF CYCLOPROPANE CARBOXYLIC ACIDS AND INTERMEDIATES THEREOF	SRF LIMITED
WO/2021/144813	PROCESS FOR PURIFICATION OF HYDROCARBONS	JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/144814	METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS	LUPIN LIMITED
WO/2021/152622	IMPROVED PROCESS FOR THE PREPARATION OF LIRAGLUTIDE	NEULAND LABORATORIES LIMITED
WO/2021/156893	PROCESS FOR PREPARATION OF 2,4,6-TRIFLUOROBENZOIC ACID	SRF LIMITED
WO/2021/161347	NOVEL SALTS OF NILOTINIB AND POLYMORPHIC FORMS THEREOF	CIPLA LIMITED
WO/2021/165995	NOVEL SALTS AND/OR CO-CRYSTALS OF TENOFOVIR ALAFENAMIDE	CIPLA LIMITED
WO/2021/171316	FIXED BED REACTOR WITH LAYERED DIMETHYL ETHER SYNTHESIS CATALYSTS	AMOL CARBONS PRIVATE LIMITED
WO/2021/171317	PROCESS FOR SYNTHESIS OF DIMETHYL ETHER	AMOL CARBONS PRIVATE LIMITED
WO/2021/176473	A PROCESS FOR THE PREPARATION OF UPADACITINIB AND ITS INTERMEDIATES	MYLAN LABORATORIES LIMITED
WO/2021/186459	AN IMPROVED PROCESS FOR PHOTOCATALYTIC HYDROCARBOXYLATION OF METHANOL WITH CO<sb>2</sb> TO PRODUCE ACETIC ACID	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)
WO/2021/181414	METHOD OF SEPARATING HIGH-MOLECULAR WEIGHT AGGREGATES OF AN Fc-FUSION PROTEIN	DR. REDDY’S LABORATORIES LIMITED
WO/2021/181415	METHOD TO CONTROL SIALYLATED ISOFORMS OF AN Fc-FUSION PROTEIN	DR. REDDY’S LABORATORIES LIMITED
WO/2021/181416	PROCESS FOR THE PREPARATION OF 1-BROMO-2,4,5-TRIFLUOROBENZENE	AARTI INDUSTRIES LIMITED
WO/2021/181417	METHOD OF PURIFYING AN Fc-FUSION PROTEIN	DR. REDDY'S LABORATORIES LIMITED
WO/2021/186478	BIOMARKER PANELS, SYSTEMS, AND METHODS FOR RISK STRATIFICATION OF A SUBJECT FOR ALZHEIMER'S DISEASE	URVOGELBIO PRIVATE LIMITED
WO/2021/205477	AN ANTIFUNGAL SYNTHETIC PEPTIDE DERIVED FROM OSMOTIN PROTEIN	RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY
WO/2021/210014	THERAPEUTIC NOVEL CHEMICAL ENTITIES AND METHOD THEREOF	SHIV NADAR UNIVERSITY
WO/2021/210018	APOPTOSIS INDUCING PEPTIDE (SSTP1)	RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY
WO/2021/214785	IMPROVED PROCESS FOR THE PREPARATION OF ROXADUSTAT	MYLAN LABORATORIES LIMITED
WO/2021/214789	NOVEL USES OF APREMILAST	APRAMITHA INNOVATIONS PRIVATE LIMITED
WO/2021/220295	IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING PALBOCICLIB	NATCO PHARMA LIMITED
WO/2021/220296	A FUNGICIDAL COMPOUND AND PROCESS OF PREPARATION THEREOF	UPL LIMITED
WO/2021/224942	POLYMORPHIC FORMS OF AMLODIPINE BENZOATE AND PROCESS FOR THE PREPARATION THEREOF	ALKEM LABORATORIES LTD.
WO/2021/229605	PROCESS FOR PREPARATION OF SAVOLITINIB AND ITS INTERMEDIATES	DR. REDDY'S LABORATORIES LIMITED
WO/2021/240547	METHODS FOR THE PREPARATION OF SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS AND SOLID FORMS THEREOF	CIPLA LIMITED
WO/2021/260721	A NEW COST EFFECTIVE AND SCALABLE PROCESS FOR SYNTHESIZING PURE BRIVARACETAM	CLININVENT RESEARCH PVT. LTD.
WO/2021/260722	DESIGN, SYNTHESIS OF NOVEL OXYINDOLE INHIBITORS OF DENV RNA DEPENDENT RNA POLYMERASE	TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE
WO/2021/245711	GROWTH FACTOR COMPOSITION FOR CELL CULTURE-PRODUCED MEAT	ORF LIFTAEKNI HF.
WO/2021/028952	ANTI-ZRFC ANTIBODY AND ZRFC PROTEIN OF <i>ASPERGILLUS</i> AND USES THEREOF IN IMMUNOTHERAPY AGAINST INVASIVE PULMONARY ASPERGILLOSIS	TAKIS S.R.L.
WO/2021/070208	METHOD FOR THE PREPARATION OF TRIS-(3-HYDROXYBUTYRATO)-GLYCERYL ESTER	DR. SCHÄR S.P.A.
WO/2021/070209	METHOD TO PURIFY TRIS-(3-HYDROXYBUTYRATO)-GLYCERYL ESTER	DR. SCHÄR S.P.A.
WO/2021/038637	NOVEL VITAMIN A DERIVATIVE AND METHOD FOR PRODUCING SAME	REFINE HOLDINGS CO., LTD.
WO/2021/044478	IONIC COMPOUND, ORGANIC ELECTRONICS MATERIAL, ORGANIC LAYER, ORGANIC ELECTRONICS ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY ELEMENT, LIGHTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC ELECTRONICS ELEMENT	SHOWA DENKO MATERIALS CO., LTD.
WO/2021/038889	METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE	MOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/059505	DIARYLETHENE COMPOUND, TEMPERATURE INDICATOR, TEMPERATURE DISPLAY DEVICE, AND PACKAGE	UNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/095091	AMINOARYL DERIVATIVE, INTERMEDIATE OF SAME, METHOD FOR PRODUCING SAID AMINOARYL DERIVATIVE, AND METHOD FOR PRODUCING SAID INTERMEDIATE	FUJIMOTO CHEMICALS CO., LTD.
WO/2021/100131	METHOD FOR PRODUCING ISOCYANATE	ASAHI KASEI KABUSHIKI KAISHA
WO/2021/106132	METHANOL PRODUCTION FACILITY AND METHANOL PRODUCTION METHOD	MITSUBISHI HEAVY INDUSTRIES ENGINEERING, LTD.
WO/2021/100210	METHOD FOR PRODUCING 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM PLANKTONS	WATANABE OYSTER LABORATORY, CO., LTD.
WO/2021/106230	NOVEL PHENOL COMPOUND OR SALT THEREOF	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/131030	ESTER COMPOUND, PRODUCTION METHOD THEREFOR, POLYMER, THERMALLY CURABLE RESIN COMPOSITION, AND CURED FILM	KYOEISHA CHEMICAL CO., LTD.
WO/2021/152856	METHOD FOR SCREENING SKIN TOXIC SUBSTANCE USING OBP	SHISEIDO COMPANY, LTD.
WO/2021/152868	PHOSPHININE DERIVATIVE AND USE FOR SAME	MARUBENI CORPORATION
WO/2021/186658	METHANOL PRODUCTION SYSTEM AND METHANOL PRODUCTION METHOD	HITACHI, LTD.
WO/2021/199310	METHOD FOR PRODUCING AROMATIC COMPOUND	N.E. CHEMCAT CORPORATION
WO/2021/186750	TREATMENT METHOD, PRODUCTION METHOD, AND HYDROXYAPATITE FILLER	HOYA TECHNOSURGICAL CORPORATION
WO/2021/005857	MONOCLONAL ANTIBODY AGAINST AMYLOID BETA, AND METHOD FOR MEASURING AMYLOID BETA-RELATED PEPTIDE USING SAID ANTIBODY	SHIMADZU CORPORATION
WO/2021/214927	ZINC CARBOXYLIC ACID SALT AND ZINC CARBOXYLATE SOLUTION CONTAINING SAME	NOF CORPORATION
WO/2021/009990	AUXIN-INDUCIBLE DEGRON SYSTEM KIT AND USE THEREOF	INTER-UNIVERSITY RESEARCH INSTITUTE CORPORATION RESEARCH ORGANIZATION OF INFORMATION AND SYSTEMS
WO/2021/220455	SYSTEM FOR PRODUCING HYDROCARBON USING VAPORIZATION	EUREKA ENGINEERING INC.
WO/2021/220500	PURIFICATION METHOD FOR CHARGED SUBSTANCE	HOYA TECHNOSURGICAL CORPORATION
WO/2021/220512	COMPOUND, RESIN PRECURSOR, CURED PRODUCT, OPTICAL ELEMENT, OPTICAL SYSTEM, INTERCHANGEABLE LENS FOR CAMERA, OPTICAL DEVICE, CEMENTED LENS AND METHOD FOR PRODUCING CEMENTED LENS	NIKON CORPORATION
WO/2021/019884	METAL COMPLEX AND LIGHT-EMITTING ELEMENT CONTAINING SAME	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/245776	ANTI-RNA VIRUS PARTICLE ANTIBODY OF HBV	RCMG INC.
WO/2021/039023	METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVES	MOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/002178	PERFLUOROPOLYETHER COMPOUND, LUBRICANT AND MAGNETIC DISK	MORESCO CORPORATION
WO/2021/006011	COMPOUND, POLYMER, ORGANIC MATERIAL, AND OPTICAL DEVICE, OPTICAL COMPONENT, AND IMAGE DISPLAY DEVICE ALL INCLUDING SAID ORGANIC MATERIAL	SONY CORPORATION
WO/2021/002237	COLORING COMPOSITION, FILM, COLOR FILTER AND SOLID-STATE IMAGING DEVICE	FUJIFILM CORPORATION
WO/2021/002257	METHOD FOR PURIFYING VIRUS OR VIRUS-LIKE PARTICLE	KANEKA CORPORATION
WO/2021/019983	METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX	JFE ENGINEERING CORPORATION
WO/2021/255943	METHOD FOR STABILIZING SANSHOOLS	YAMAMOTO, Yoshie
WO/2021/006075	METHOD FOR INDUCING NEURONAL SYNAPSE FORMATION AND MICROBEADS USED IN SAID METHOD	JIKSAK BIOENGINEERING INC.
WO/2021/019998	PERFLUOROPOLYETHER COMPOUND, LUBRICANT, AND MAGNETIC DISC	MORESCO CORPORATION
WO/2021/002343	ALKANE PRODUCTION METHOD	DAIKIN INDUSTRIES, LTD.
WO/2021/002344	METHOD FOR PRODUCING ALKANE	DAIKIN INDUSTRIES, LTD.
WO/2021/002403	METHOD FOR DETERMINING UNDERNUTRITION RISK AND/OR LOW BODY-WEIGHT CHILD BIRTH RISK IN SUBJECT	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/002407	FLUOROALKYL GROUP-CONTAINING COMPOUND AND PRODUCTION METHOD THEREFOR	AGC INC.
WO/2021/002408	PEPTIDE AND METHOD FOR MANUFACTURING SAME	AGC INC.
WO/2021/010183	PERFLUOROACYL PEROXIDE PRODUCTION METHOD, AND FLUOROALKYL IODIDE PRODUCTION METHOD	AGC INC.
WO/2021/029158	SULFONAMIDE COMPOUND, NONIONIC PHOTOACID GENERATOR, AND PHOTOLITHOGRAPHY RESIN COMPOSITION	SAN-APRO LTD.
WO/2021/006212	HYBRIDOMA AND METHOD FOR PRODUCING SAME, AND MONOCLONAL ANTIBODY AND METHOD FOR PRODUCING SAME	TERUMO KABUSHIKI KAISHA
WO/2021/002473	NRF2-ACTIVATING COMPOUND	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/002477	METHOD FOR OXIDIZING HYDROCARBON TO OXYGEN COMPOUND	THE UNIVERSITY OF TOKYO
WO/2021/006245	METHOD FOR PRODUCING ETHYLENE, AND METHOD FOR PRODUCING POLYMER	SEKISUI CHEMICAL CO., LTD.
WO/2021/024675	COMPOUND AND PRODUCTION METHOD THEREFOR	OSAKA UNIVERSITY
WO/2021/006250	METHOD FOR PRODUCING 1,3-BUTADIENE	SEKISUI CHEMICAL CO., LTD.
WO/2021/006252	1,3-BUTADIENE MANUFACTURING METHOD	SEKISUI CHEMICAL CO., LTD.
WO/2021/010221	PREPARATION METHOD FOR SAMPLE TO BE ANALYZED, ANALYSIS METHOD, AND KIT FOR PREPARATION OF SAMPLE TO BE ANALYZED	SHIMADZU CORPORATION
WO/2021/014988	METHOD FOR PRODUCING α-ACYLOXY CARBOXYLIC ACID ESTER	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/020066	FLUOROETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/039147	ALLERGEN DETECTION MARKER AND ALLERGEN DETECTION METHOD USING SAME	JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF HEALTH SCIENCES
WO/2021/010316	METHOD FOR RATIONALLY CREATING PEPTOID INHIBITING PROTEIN INTERACTION	THE UNIVERSITY OF TOKYO
WO/2021/020076	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/010331	LIGHT-EMITTING COMPOUND OR SALT THEREOF, AND POLARIZING LIGHT-EMITTING ELEMENT, POLARIZING LIGHT-EMITTING PLATE AND DISPLAY DEVICE INCLUDING SAME	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/010337	LIGHT-EMITTING COMPOUND OR SALT THEREOF, AND POLARIZED LIGHT-EMITTING ELEMENT, POLARIZED LIGHT-EMITTING PLATE, AND DISPLAY DEVICE CONTAINING SAME	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/010340	LUMINESCENT COMPOUND OR SALT THEREOF, AND POLARIZED LIGHT EMITTING ELEMENT, POLARIZED LIGHT EMITTING PLATE AND DISPLAY DEVICE EACH USING SAME	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/015020	PYRROMETHENE-BORON COMPLEX, COLOR CONVERSION COMPOSITION, COLOR CONVERSION FILM, LIGHT SOURCE UNIT, DISPLAY, AND LIGHTING DEVICE	TORAY INDUSTRIES, INC.
WO/2021/010363	METHOD FOR PRODUCING BINAPHTHYLS	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/015056	METHANE PRODUCTION APPARATUS, METHANE PRODUCTION METHOD, CARBON DIOXIDE RECOVERY DEVICE, AND CARBON DIOXIDE RECOVERY METHOD	TOKYO GAS CO.,LTD.
WO/2021/020114	COMPOUND, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM	FUJIFILM CORPORATION
WO/2021/015083	CRYSTAL OF 2, 2’-BIS(ETHOXYCARBONYLMETHOXY)-1, 1’-BINAPHTHYL	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/010447	PRODUCTION METHOD FOR CRYSTALLINE SORBITOL POWDER	MITSUBISHI CORPORATION LIFE SCIENCES LIMITED
WO/2021/029181	CLSP DERIVATIVE INCAPABLE OF BEING AFFECTED BY CLSP INHIBITING SUBSTANCE, AND CLSP ACTIVITY ENHANCING/PROTECTING AGENT	TOKYO MEDICAL UNIVERSITY
WO/2021/015108	METHOD FOR PRODUCING MORPHINAN DERIVATIVE	NIPPON CHEMIPHAR CO., LTD.
WO/2021/015109	METHOD FOR PRODUCING PHENOL DERIVATIVE	NIPPON CHEMIPHAR CO., LTD.
WO/2021/010481	ADHESIVE PROTEIN	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/010482	SEPARATED PEPTIDE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/015177	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/015219	METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/015220	METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/020258	METHOD FOR PRODUCING AROMATIC AMINOMETHYL	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/015237	INNOVATIVE PRODUCTION TECHNIQUE FOR ANTIBODY-ENZYME	JAPAN SCIENCE AND TECHNOLOGY AGENCY
WO/2021/020285	CYCLIC AZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT	TOSOH CORPORATION
WO/2021/015250	ALKANE DEHYDROGENATION CATALYST, AND HYDROGEN PRODUCTION METHOD USING SAME	OSAKA UNIVERSITY
WO/2021/020325	SILICON ISOCYANATE COMPOUND-CONTAINING COMPOSITION AND PRODUCTION METHOD THEREFOR	MATSUMOTO FINE CHEMICAL CO., LTD.
WO/2021/039230	METHOD FOR PRODUCING m-DIALKYLBENZALDEHYDE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/029210	PRIMARY AMINOSILOXANE COMPOUND AND METHOD FOR PRODUCING SAME	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/029215	BIS(ETHYLCYCLOPENTADIENYL) TIN, RAW MATERIALS FOR CHEMICAL VAPOR DEPOSITION, METHOD FOR PRODUCING THIN FILM CONTAINING TIN, AND METHOD FOR PRODUCING TIN OXIDE THIN FILM	KOJUNDO CHEMICAL LABORATORY CO., LTD.
WO/2021/039244	ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, RESIST FILM, AND ELECTRONIC DEVICE PRODUCTION METHOD	FUJIFILM CORPORATION
WO/2021/033504	METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND	FUJIFILM CORPORATION
WO/2021/033505	METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND	FUJIFILM CORPORATION
WO/2021/020421	CELL DEATH INHIBITOR AND CELL DEATH INHIBITION METHOD	UNIVERSITY OF TSUKUBA
WO/2021/020474	METHOD FOR PURIFYING ANTIBODY USING ADSORBENT	KYOWA KIRIN CO., LTD.
WO/2021/020516	NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME	SUNTORY HOLDINGS LIMITED
WO/2021/020521	DIBENZOPHOSPHOLE OXIDE DERIVATIVE AND PRODUCTION METHOD THEREFOR	KATAYAMA CHEMICAL INDUSTRIES CO., LTD.
WO/2021/039273	METHOD FOR RECOVERING OLEFIN	SHOWA DENKO K.K.
WO/2021/024925	CHEMICALLY AMPLIFIED POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM, PRODUCTION METHOD FOR PHOTOSENSITIVE DRY FILM, PRODUCTION METHOD FOR PATTERNED RESIST FILM, AND PRODUCTION METHOD FOR COMPOUND, PHOTO-ACID GENERATOR, AND N–ORGANOSULFONYLOXY COMPOUND	TOKYO OHKA KOGYO CO., LTD.
WO/2021/020561	PRIMER, APPARATUS FOR PRODUCING DOUBLE-STRANDED DNA USING SAME, AND METHOD FOR PRODUCING DOUBLE-STRANDED DNA	JAPAN SCIENCE AND TECHNOLOGY AGENCY
WO/2021/020585	HETEROCYCLIC COMPOUND	FIMECS, INC.
WO/2021/020586	HETEROCYCLIC COMPOUND	FIMECS, INC.
WO/2021/033530	METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX	NIHON MEDI-PHYSICS CO., LTD.
WO/2021/025009	OLEFIN COMPOUND PRODUCTION METHOD	DAIKIN INDUSTRIES, LTD.
WO/2021/025012	METHOD FOR PURIFYING PHOSPHORUS-CONTAINING OLEFIN COMPOUND SALT AND METHOD FOR PRODUCING OLEFIN COMPOUND USING PURIFIED PRODUCT OBTAINED THEREBY	DAIKIN INDUSTRIES, LTD.
WO/2021/025036	2-CYANOACRYLATE COMPOUND AND ADHESIVE COMPOSITION	TOAGOSEI CO., LTD.
WO/2021/029324	METHOD FOR PRODUCING CUMENE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/025126	PRODUCTION OF PROTEIN SOLID MATERIAL	TOKYO INSTITUTE OF TECHNOLOGY
WO/2021/025140	DUAL-SPECIFIC PROTEIN	ONO PHARMACEUTICAL CO., LTD.
WO/2021/029362	NOVEL FIRING TEMPERATURE REDUCING AGENT FOR CONDUCTIVE MATERIAL	OSAKA ORGANIC CHEMICAL INDUSTRY LTD.
WO/2021/029376	PROPYLENE TRIMER AND METHOD FOR PRODUCING PROPYLENE TRIMER	IDEMITSU KOSAN CO.,LTD.
WO/2021/029377	PROPYLENE TETRAMER AND METHOD FOR PRODUCING PROPYLENE TETRAMER	IDEMITSU KOSAN CO.,LTD.
WO/2021/025163	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME	IDEMITSU KOSAN CO.,LTD.
WO/2021/029395	COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMING METHOD, METHOD FOR FORMING INSULATING FILM, METHOD FOR PRODUCING COMPOUND, IODINE-CONTAINING VINYL POLYMER AND METHOD FOR PRODUCING ACETYLATED DERIVATIVE OF SAME	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/029406	URETHANE ALLYL COMPOUND, MONOMER COMPOSITION, MOLDED ARTICLE, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL	MITSUI CHEMICALS, INC.
WO/2021/039391	ACTIVE LIGHT RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE LIGHT RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, METHOD FOR FORMING PATTERN, AND METHOD FOR PRODUCING ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/029420	METHOD FOR PRODUCING 1,1,2-TRIFLUOROETHYLENE, HEXAFLUORO-1,3-BUTADIENE, OR 1,2-DICHLOROHEXAFLUOROCYCLOBUTANE	DAIKIN INDUSTRIES, LTD.
WO/2021/029422	RADIATION-SENSITIVE COMPOSITION AND METHOD FOR FORMING RESIST PATTERN	JSR CORPORATION
WO/2021/025177	COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF CANCER	ASTELLAS PHARMA INC.
WO/2021/131143	ALKENE MANUFACTURING METHOD	KUREHA CORPORATION
WO/2021/033638	METAL-BINDING PEPTIDE, AND USE THEREOF	THE UNIVERSITY OF TOKYO
WO/2021/033649	PRODUCTION METHOD FOR NITROGEN-CONTAINING FLUORINE-CONTAINING COMPOUND	AGC INC.
WO/2021/039463	DOPANT, ELECTROCONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME	THE UNIVERSITY OF TOKYO
WO/2021/033699	METHOD FOR ENRICHING CARDIAC MYOCYTES	KYOTO UNIVERSITY
WO/2021/033702	SALT	NIPPON SHINYAKU CO., LTD.
WO/2021/033724	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/033728	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/033729	SALT AND CRYSTAL FORM OF COMPOUND HAVING AGONISTIC ACTIVITY TO S1P5 RECEPTOR	ONO PHARMACEUTICAL CO., LTD.
WO/2021/033730	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/033731	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/039558	PHENOLIC RESIN, CURABLE RESIN COMPOSITION, AND CURED OBJECT OBTAINED THEREFROM	DIC CORPORATION
WO/2021/039654	ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMATION METHOD, AND ELECTRONIC DEVICE MANUFACTURING METHOD	FUJIFILM CORPORATION
WO/2021/039660	METHOD FOR PRODUCING ISOCYANATE COMPOUND	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/070494	METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/039789	REAGENT FOR MEASURING OXYGEN CONCENTRATION IN CELL AND TISSUE	NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
WO/2021/049293	METHOD FOR PRODUCING 1,1'-bi-2-NAPHTHOL COMPOUND	DKS CO. LTD.
WO/2021/049294	1,1'-BI-2-NAPHTHOL POWDER	DKS CO. LTD.
WO/2021/039817	CARBOXYLIC ACID FLUORIDE PRODUCTION METHOD	KANTO DENKA KOGYO CO., LTD.
WO/2021/044918	METHOD FOR PRODUCING 1,3-BUTADIENE	JSR CORPORATION
WO/2021/059834	METHOD FOR PRODUCING 1,3-BUTADIENE	JSR CORPORATION
WO/2021/044919	1,3-BUTADIENE PRODUCTION METHOD	JSR CORPORATION
WO/2021/039843	COMPOSITION FOR FORMING FILM FOR LITHOGRAPHY, RESIST PATTERN FORMING METHOD, CIRCUIT PATTERN FORMING METHOD AND PURIFICATION METHOD	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/039884	CELL MEMBRANE-PERMEABLE VESICLE	RIKEN
WO/2021/039901	METHOD FOR PRODUCING PEPTIDE COMPOUND	NISSAN CHEMICAL CORPORATION
WO/2021/049311	METHOD FOR PRODUCING A 1,5-BENZOTHIAZEPIN COMPOUND	ELOBIX AB
WO/2021/039929	IONIC METAL COMPLEX, ANION DETECTING AGENT, ANION DETECTION METHOD AND AROMATIC COMPOUND	NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY
WO/2021/039935	NUCLEIC ACID COMPOUND MANUFACTURING METHOD AND NUCLEIC ACID COMPOUND	FUJIFILM CORPORATION
WO/2021/039943	METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM LIVING BODY-DERIVED CELL SAMPLE CONTAINING MESENCHYMAL STEM CELLS	AJINOMOTO CO., INC.
WO/2021/079617	GLYCOSIDE COMPOUND, AMIDITE COMPOUND, AND PRODUCTION METHOD FOR POLYNUCLEOTIDE USING SAID COMPOUNDS	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/070507	METHOD FOR PRODUCING GLYCOSIDE COMPOUND	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/044983	METHOD FOR PRODUCING HYDROFLUOROOLEFIN	AGC INC.
WO/2021/049363	METHOD FOR PRODUCING ORGANIC SOLVENT-SOLUBLE LIGNIN	NIPPON STEEL ENGINEERING CO., LTD.
WO/2021/049364	METHOD FOR PRODUCING ORGANIC SOLVENT-SOLUBLE LIGNIN	NIPPON STEEL ENGINEERING CO., LTD.
WO/2021/045101	METHANE PRODUCING METHOD AND PRODUCTION SYSTEM	NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY
WO/2021/045141	OLIGONUCLEOTIDE DEPROTECTION METHOD	KNC LABORATORIES CO., LTD.
WO/2021/045145	ACETIC ACID PRODUCTION METHOD	CHIYODA CORPORATION
WO/2021/045148	1, 3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/045149	1, 3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/045150	1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/045153	METHOD FOR PRODUCING GAMMA-BUTYROLACTONE AND METHOD FOR PRODUCING N-METHYLPYRROLIDONE	SHOWA DENKO K.K.
WO/2021/045166	COMPOSITION CONTAINING THERMOSENSITIVE GEL AND OLIGOPEPTIDE, AND USE THEREOF	INTERNATIONAL FRONTIER TECHNOLOGY LABORATORY, INC.
WO/2021/054144	METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND	FUJIFILM CORPORATION
WO/2021/045179	ORGANIC THIN FILM, METHOD FOR PRODUCING ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, THIN FILM TRANSISTOR, PHOTOELECTRIC CONVERSION ELEMENT, COATING COMPOSITION AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS	NIPPON HOSO KYOKAI
WO/2021/065350	RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING SAME	JSR CORPORATION
WO/2021/045207	MECHANOREDOX REACTION USING PIEZOELECTRIC MATERIAL, AND PRODUCTION METHOD USING SAID REACTION	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/045224	PREDICTING IMMUNE-RELATED ADVERSE EVENTS DURING CANCER IMMUNOTHERAPY AND THE LIKE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/054161	FUSED POLYCYCLIC AROMATIC COMPOUND	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/049455	METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND AND METHOD FOR PRODUCING COPOLYMER	AGC INC.
WO/2021/049470	COMPOUND, ACID-GENERATING AGENT, COMPOSITION, CURED PRODUCT, PATTERN, AND METHOD FOR PRODUCING CURED PRODUCT AND PATTERN	ADEKA CORPORATION
WO/2021/065380	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/049489	COMPOUND, ACID-GENERATING AGENT, COMPOSITION, CURED PRODUCT, PATTERN, AND METHODS FOR PRODUCING CURED PRODUCT AND PATTERN	ADEKA CORPORATION
WO/2021/065382	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/054202	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/049503	DIAMINE COMPOUND AND METHOD FOR PRODUCING SAME	OKAMURA OIL MILL. LTD.
WO/2021/049522	ONIUM SALT OF NITROGEN-CONTAINING HETEROARYL COMPOUND AND PEST CONTROL AGENT	NIPPON SODA CO., LTD.
WO/2021/065395	METHOD FOR PRODUCING FIBRIN SHEET	OSAKA UNIVERSITY
WO/2021/049537	THREE-DIMENSIONAL CONTROL CATALYST USED IN RADICAL POLYMERIZATION, POLYMER PRODUCTION METHOD, AND ACRYLIC POLYMER	KYOTO UNIVERSITY
WO/2021/049552	METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTING GROUP, AND HYDRAZINE DERIVATIVE	FUJIFILM CORPORATION
WO/2021/049563	PHOTOBASE GENERATOR, COMPOUND, PHOTOREACTIVE COMPOSITION, AND REACTION PRODUCT	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/049564	PHOTOBASE GENERATOR, COMPOUND, PHOTOREACTIVE COMPOSITION, AND REACTION PRODUCT	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/049579	METHOD FOR PRODUCING ALKYL AROMATIC HYDROCARBON, METHOD FOR PRODUCING C8 AROMATIC HYDROCARBON, AND METHOD FOR FIXING CARBON DIOXIDE	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/049592	RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN FORMATION METHOD, AND RADIATION-SENSITIVE ACID GENERATOR	JSR CORPORATION
WO/2021/049597	INSECTICIDE AGENT FOR AGRICULTURAL OR HORTICULTURAL USE OR ANIMAL ECTOPARASITE OR ENDOPARASITE CONTROL AGENT EACH CONTAINING IMIDAZOPYRIDAZINE COMPOUND OR SALT THEREOF AS ACTIVE INGREDIENT, AND USE OF SAID INSECTICIDE AGENT AND SAID CONTROL AGENT	NIHON NOHYAKU CO., LTD.
WO/2021/049605	METHOD FOR PURIFYING FLUOROOLEFIN HAVING =CF2 OR =CHF STRUCTURE, HIGH PURITY FLUOROOLEFIN, AND MANUFACTURING METHOD THEREFOR	KANTO DENKA KOGYO CO., LTD.
WO/2021/070563	FLUOROSILANE COMPOUND, SURFACE TREATMENT AGENT, AND ARTICLE OBTAINED USING SAID SURFACE TREATMENT AGENT	HARVES CO., LTD.
WO/2021/049654	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/049662	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/049663	ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS	IDEMITSU KOSAN CO.,LTD.
WO/2021/060042	COMPOUND, COMPOSITION, FILM, STRUCTURAL BODY, AND ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/060048	METHOD FOR PRODUCING PEPTIDE COMPOUND	NISSAN CHEMICAL CORPORATION
WO/2021/065450	ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/054309	PRODUCTION METHOD FOR AROMATIC BISETHER COMPOUND	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/054337	COMPOSITION, RESIST UNDERLAYER FILM, METHOD FOR FORMING RESIST UNDERLAYER FILM, METHOD FOR PRODUCING PATTERNED SUBSTRATE, AND COMPOUND	JSR CORPORATION
WO/2021/065492	ORGANIC ELECTROLUMINESCENT ELEMENT	NIPPON STEEL CHEMICAL & MATERIAL CO., LTD.
WO/2021/054351	MEMBRANE PERMEATION ENHANCER AND METHOD FOR ENHANCING MEMBRANE PERMEATION	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/054378	COMPLEX PRODUCTION SYSTEM AND CARBON DIOXIDE PROCESSING SYSTEM	MITSUBISHI POWER, LTD.
WO/2021/095356	SULFONIUM SALT, ACID GENERATOR, RESIST COMPOSITION, AND METHOD FOR PRODUCING DEVICE	TOYO GOSEI CO., LTD.
WO/2021/054393	2,3-DIHYDROTHIENOPYRIMIDIN-4(H)-ONE COMPOUND AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE	NIPPON SODA CO., LTD.
WO/2021/060145	CHEMICAL REACTION METHOD AND CHEMICAL REACTION DEVICE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/054414	METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUNDS	AGC INC.
WO/2021/054421	CRYSTAL OF 1,3,5-TRIAZINE DERIVATIVE OR SOLVATE THEREOF AND METHOD FOR PRODUCING SAME	SHIONOGI & CO., LTD.
WO/2021/060193	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/054459	BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION	MITSUI CHEMICALS, INC.
WO/2021/060225	PYRIDAZINE COMPOUNDS AND HERBICIDES	NIPPON SODA CO., LTD.
WO/2021/060236	PYRIDAZINE COMPOUND AND HERBICIDE	NIPPON SODA CO., LTD.
WO/2021/060239	COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/060263	METHOD FOR PRODUCING PROPYLENE OXIDE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/060276	FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUNDS	AGC INC.
WO/2021/060277	AMINATING AGENT AND METHOD FOR PRODUCING AMINATED PRODUCT	AGC INC.
WO/2021/060335	METHOD FOR PRODUCING ADIPIC ACID	TORAY INDUSTRIES, INC.
WO/2021/065653	POWDER, POWDER PRODUCTION METHOD, AND SOLUTION PRODUCTION METHOD	CENTRAL GLASS COMPANY, LIMITED
WO/2021/060384	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/060450	IMMUNOASSAY FOR HEPATITIS B VIRUS CORE-RELATED ANTIGEN AND KIT THEREFOR	FUJIREBIO INC.
WO/2021/060506	PERFLUORO ALKYL GROUP-CONTAINING NUCLEIC ACID AND PRODUCTION METHOD THEREFOR	AGC INC.
WO/2021/060517	METHOD FOR PRODUCING DERIVATIVE OF ORGANIC SUBSTANCE AND METHOD FOR ANALYZING SAMPLE CONTAINING ORGANIC SUBSTANCE	AJINOMOTO CO., INC.
WO/2021/176755	DITHIENOPHOSPHORINE COMPOUND, AND COLORLESS NEAR-INFRARED ABSORBING MATERIAL AND ELECTROCHROMIC MATERIAL EACH USING SAME	KYOTO UNIVERSITY
WO/2021/070658	METHOD FOR PRODUCING CYCLOPENTANE COMPOUND, METHOD FOR PRODUCING LACTONE COMPOUND, METHOD FOR PRODUCING DIOL COMPOUND, AND COMPOUND	TOHOKU UNIVERSITY
WO/2021/065846	ANTIBODY BINDING TO ANTI-HIV-1 V3 ANTIBODY 1C10(0.5γ), ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION OF SAME	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/065885	IMINE COMPOUND OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, AND PEST CONTROL METHOD	NIHON NOHYAKU CO., LTD.
WO/2021/065908	METHOD FOR PRODUCING PROPIONIC ACID DERIVATIVE	DAIKIN INDUSTRIES, LTD.
WO/2021/065985	SOMATOSTATIN RECEPTOR	RIKEN BIO CO. LTD.
WO/2021/066043	METHOD FOR PRODUCING TRIONE COMPOUND	TOKUYAMA CORPORATION
WO/2021/075267	METHOD FOR PRODUCING PROPYLENE OLIGOMER	IDEMITSU KOSAN CO.,LTD.
WO/2021/060567	2-ISOINDOL-1,3,4-OXADIAZOLE DERIVATIVES USEFUL AS HDAC6 INHIBITORS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/090617	HYDROGEL MEMBRANE DRIED PRODUCT OR VITRIGEL MEMBRANE DRIED PRODUCT, APPARATUS AND METHOD FOR MANUFACTURING SAME, AND TYMPANIC MEMBRANE TREATMENT DEVICE AND INJURY PART TREATMENT DEVICE	NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/157129	METHOD FOR PRODUCING PHOSPHORIC DIESTER OR PHOSPHORIC TRIESTER	SAGA UNIVERSITY
WO/2021/066123	METAL COMPLEX AND ELECTRON TRANSPORTING MATERIAL COMPRISING SAME	DYDEN CORPORATION
WO/2021/066155	METHOD FOR PRODUCING PERFLUORO(2,4-DIMETHYL-2-FLUOROFORMYL-1,3-DIOXOLANE)	SAGAMI CHEMICAL RESEARCH INSTITUTE
WO/2021/066157	NOVEL FLUORESCENT PROTEIN AND UTILIZATION THEREOF	RIKEN
WO/2021/066159	SUGAR COMPOSITION CONTAINING CYCLIC TETRASACCHARIDE, USE THEREOF, AND PRODUCTION METHOD THEREFOR	HAYASHIBARA CO., LTD.
WO/2021/070804	ETHYLENE GENERATING CRACKING FURNACE OPERATION ASSIST SYSTEM AND ETHYLENE PRODUCTION APPARATUS	TOYO ENGINEERING CORPORATION
WO/2021/100342	ANTI-8-HYDROXY-2'-DEOXYGUANOSINE ANTIBODY OR ANTIBODY FRAGMENT THEREOF, PRODUCTION METHOD, KIT, MEASURING METHOD, AND DEVICE FOR MEASUREMENT	TDK CORPORATION
WO/2021/079743	COMPOUND, LIQUID CRYSTAL COMPOSITION AND HIGH-FREQUENCY PHASE SHIFTER	DIC CORPORATION
WO/2021/070906	FLUORESCENT PROBE FOR DETECTING PUROMYCIN-SENSITIVE AMINOPEPTIDASE OR BLEOMYCIN HYDROLASE	THE UNIVERSITY OF TOKYO
WO/2021/070939	METHOD FOR PRODUCING ISOPRENE	ENEOS CORPORATION
WO/2021/070963	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/070964	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/070965	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/075397	NOVEL TIN COMPOUND, THIN-FILM-FORMING RAW MATERIAL CONTAINING SAID COMPOUND, THIN FILM FORMED FROM SAID THIN-FILM-FORMING RAW MATERIAL, METHOD FOR PRODUCING SAID THIN FILM USING SAID COMPOUND AS PRECURSOR, AND METHOD FOR PRODUCING SAID THIN FILM	ADEKA CORPORATION
WO/2021/075417	CURING CATALYST TO BE USED FOR CURING OF POLYMER, MOISTURE CURABLE COMPOSITION AND METHOD FOR PRODUCING CURED PRODUCT	NITTO KASEI CO., LTD.
WO/2021/075423	PHOSPHORAMIDITE ACTIVATOR	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/085131	ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT	CANON KABUSHIKI KAISHA
WO/2021/085134	COMPOSITION COMPRISING 1-CHLORO-2,3,3-TRIFLUORO-1-PROPENE AND WATER, AND METHOD FOR STORING COMPOSITION	CENTRAL GLASS COMPANY, LIMITED
WO/2021/075456	PHOTOCHROMIC COMPOUND AND CURABLE COMPOSITION INCLUDING PHOTOCHROMIC COMPOUND	TOKUYAMA CORPORATION
WO/2021/075478	METHOD FOR QUANTIFYING AMINO GROUP-CONTAINING COMPOUND PROTECTED BY PROTECTING GROUP HAVING FMOC SKELETON	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/075479	AN ANTIBODY, A PHARMACEUTICAL COMPOSITION, AND A METHOD	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/075517	ALDEHYDE COMPOUND AND METHOD FOR PRODUCING SAME, AND FRAGRANCE COMPOSITION	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/075518	METHOD FOR PRODUCING 2,4-DIALKYLBENZALDEHYDE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/075526	METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE	JCR PHARMACEUTICALS CO., LTD.
WO/2021/075538	METHOD FOR PRODUCING BICYCLIC PHOSPHORAMIDITE	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/075546	METHOD FOR PRODUCING RADIOACTIVE METAL-LABELED ANTIBODY	NIHON MEDI-PHYSICS CO., LTD.
WO/2021/085210	NOVEL COMPOUND, THIN FILM-FORMING MATERIAL THAT CONTAINS SAID COMPOUND, AND THIN FILM MANUFACTURING METHOD	ADEKA CORPORATION
WO/2021/085263	CRYSTAL OF 3-(DIFLUOROMETHYL)-1-METHYL-N-(1,1,3-TRIMETHYL-2,3-DIHYDRO-1H-INDEN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/085268	METHOD FOR PRODUCING EPOXY COMPOUND	DAICEL CORPORATION
WO/2021/079915	TRIAZINE COMPOUND HAVING PYRIDYL GROUP AND PYRIDINE COMPOUND	TOSOH CORPORATION
WO/2021/085293	EXTERNAL SKIN PREPARATION FOR AMELIORATING CELLULITE AND METHOD FOR AMELIORATING CELLULITE	TOYO SUGAR REFINING CO., LTD.
WO/2021/085300	COMPOSITION, CURED PRODUCT, METHOD FOR MANUFACTURING CURED PRODUCT AND ADDITIVE	ADEKA CORPORATION
WO/2021/085317	MEDIUM ADDITIVE FOR SUSPENSION CULTURE, MEDIUM COMPOSITION AND CULTURE METHOD	DKS CO. LTD.
WO/2021/085319	2,6-NAPHTHALENEDIOL-BIS(TRIMELLITATE ANHYDRIDE) POWDER AND METHOD FOR PRODUCING SAME	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/079973	ONIUM SALT, CURING AGENT, CURING ACCELERATOR, CURABLE COMPOSITION, AND DEVICE MANUFACTURING METHOD	TOYO GOSEI CO., LTD.
WO/2021/106453	RECOMBINANT C-REACTIVE PROTEIN	TOYOBO CO., LTD.
WO/2021/080015	MODULATORS OF TREK (TWIK RELATED K<sp>+</sp> CHANNELS) CHANNEL FUNCTION	ONO PHARMACEUTICAL CO., LTD.
WO/2021/080019	NOVEL ORGANOGERMANIUM COMPOUND	ASAI GERMANIUM RESEARCH INSTITUTE CO., LTD.
WO/2021/085370	AZOLE DERIVATIVE AND USE THEREOF	KUMIAI CHEMICAL INDUSTRY CO., LTD.
WO/2021/080021	METHOD FOR PRODUCING OLIGONUCLEOTIDE	NITTO DENKO CORPORATION
WO/2021/085389	2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT	NIPPON SODA CO., LTD.
WO/2021/100419	FUSION PROTEIN, METHOD FOR PRODUCING SUBSTANCE, VECTOR, TRANSFORMED CELL, METHOD FOR MANUFACTURING PNEUMATIC TIRE, AND METHOD FOR MANUFACTURING RUBBER PRODUCT	SUMITOMO RUBBER INDUSTRIES, LTD.
WO/2021/085449	METHOD FOR PRODUCING DIFLUOROETHYLENE	DAIKIN INDUSTRIES, LTD.
WO/2021/152940	COMPOUND, ORGANIC THIN-FILM LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE	TORAY INDUSTRIES, INC.
WO/2021/085468	HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME	API CORPORATION
WO/2021/106480	METHOD FOR PRODUCING AROMATIC ALCOHOLS	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/085482	COMPOUND AND METHOD FOR PRODUCING SAME	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/124696	FIXED BED MULTI-TUBULAR REACTOR FOR PRODUCING ALKENYL ACETATE	SHOWA DENKO K.K.
WO/2021/085535	COMPOUND AND PRODUCTION METHOD THEREFOR	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/085550	FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR MANUFACTURING SAME	UNIMATEC CO., LTD.
WO/2021/085557	METHOD FOR PRODUCING SODIUM SALT OF PHENOLIC COMPOUND AND BISPHOSPHITE COMPOUND	MITSUBISHI CHEMICAL CORPORATION
WO/2021/002484	HERBICIDE AND PRODUCTION METHOD FOR INTERMEDIATE THEREOF	KUMIAI CHEMICAL INDUSTRY CO., LTD.
WO/2021/095577	FLUORINE-CONTAINING PYRAZOLE COMPOUND AND METHOD FOR PRODUCING SAME	UNIMATEC CO., LTD.
WO/2021/085631	METHOD FOR MANUFACTURING FLUOROACETIC ACID ESTER	DAIKIN INDUSTRIES, LTD.
WO/2021/085635	REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME	CHUBU UNIVERSITY EDUCATIONAL FOUNDATION
WO/2021/085636	REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME	CHUBU UNIVERSITY EDUCATIONAL FOUNDATION
WO/2021/090786	METHOD FOR DIAGNOSING HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1)-RELATED DISEASE	NEC CORPORATION
WO/2021/085651	ANTIBODY FOR DETECTING STAPHYLOCOCCUS AUREUS IN SAMPLE, METHOD FOR DETECTING STAPHYLOCOCCUS AUREUS USING SAID ANTIBODY, REAGENT, AND KIT	ASAHI KASEI KABUSHIKI KAISHA
WO/2021/090850	COMPOUND OR SALT THEREOF	SHIZUOKA PREFECTURAL UNIVERSITY CORPORATION
WO/2021/090855	CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/090856	METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/090865	OXADIAZOLINE COMPOUND OR SALTS THEREOF, AGRICULTURAL AND HORTICULTURAL BACTERICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME	NIHON NOHYAKU CO., LTD.
WO/2021/090909	HEART FAILURE MARKER	NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
WO/2021/090910	MOLECULAR STRUCTURE ALTERING AGENT FOR DETECTING PROTEIN AGGREGATES, DETECTION METHOD THEREOF, MEDICAL EQUIPMENT CLEANING AGENT, SOIL CLEANING AGENT AND SOIL CLEANING METHOD	CENTRAL GLASS COMPANY, LIMITED
WO/2021/090925	POLYPEPTIDE HAVING 4-AMINOBENZOIC ACID HYDROXYLATION ACTIVITY AND USE THEREOF	KAO CORPORATION
WO/2021/090940	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/117394	PYRIDYLOXYACETIC ACID COMPOUND AND USE OF SAME	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/106535	ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, AND ELECTRONIC DEVICE MANUFACTURING METHOD	FUJIFILM CORPORATION
WO/2021/106539	FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND METHOD FOR MANUFACTURING SAME	UNIMATEC CO., LTD.
WO/2021/111820	STANDARD SUBSTANCE FOR PSA QUANTIFICATION, PREPARATION METHOD THEREFOR, STANDARD SOLUTION FOR PSA QUANTIFICATION, AND PSA QUANTIFICATION METHOD	KONICA MINOLTA, INC.
WO/2021/095729	NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING PERFLUOROALKYL GROUP, AND USE THEREFOR	TOYOBO CO., LTD.
WO/2021/095762	ANTI–RS VIRUS N PROTEIN–RECOGNIZING ANTIBODY, IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT USING ANTI–RS VIRUS N PROTEIN–RECOGNIZING ANTIBODY	DENKA COMPANY LIMITED
WO/2021/095763	ANTIBODY RECOGNIZING ANTI-RS VIRUS, AND IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT USING SAME	DENKA COMPANY LIMITED
WO/2021/095797	METHOD FOR DETECTING UNDIFFERENTIATED CELLS	PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY
WO/2021/095801	AZABENZIMIDAZOLE COMPOUND AND MEDICINE	NIPPON SHINYAKU CO., LTD.
WO/2021/117410	QUINOPHTHALONE COMPOUND, PIGMENT COMPOSITION, AND COLOR FILTER	DIC CORPORATION
WO/2021/095824	METHOD, KIT, AND BIOMARKER FOR ASSISTING IN DIAGNOSIS OF COLON CANCER	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/090959	POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT	TAISHO PHARMACEUTICAL CO., LTD.
WO/2021/095842	LIBRARY OF BARCODED EXTRACELLULAR VESICLES	THE UNIVERSITY OF TOKYO
WO/2021/095874	METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND	NIPPON SHINYAKU CO., LTD.
WO/2021/095875	METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND	NIPPON SHINYAKU CO., LTD.
WO/2021/106652	COMPOUND, THIN FILM-FORMING MATERIAL, AND METHOD FOR PRODUCING THIN FILM	ADEKA CORPORATION
WO/2021/100654	COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL AND OPTICAL COMPONENT	MITSUBISHI CHEMICAL CORPORATION
WO/2021/100658	COMPOUND, MIXTURE, CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF, AND COMPOUND PRODUCTION METHOD	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/106678	ACYLPHOSPHINE COMPOSITION, POLYMERIZATION INITIATOR, POLYMERIZABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT	ADEKA CORPORATION
WO/2021/100714	RAPID TEST DRUG FOR ESTRUS IN MAMMALS	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/100715	ANTIBODY PRODUCTION METHOD	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/100730	METHOD FOR PRODUCING PYRROLIDINE COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/100745	OXADIAZOLE COMPOUND AND GERMICIDE FOR AGRICULTURAL AND HORTICULTURAL USE	NIPPON SODA CO., LTD.
WO/2021/100756	IMMUNE CHECKPOINT INHIBITING ANTIBODY	UNIVERSITY OF MIYAZAKI
WO/2021/100759	METHOD FOR PRODUCING ε-CAPROLACTAM	TORAY INDUSTRIES, INC.
WO/2021/100767	METHANATION REACTION DEVICE	MITSUBISHI POWER, LTD.
WO/2021/100797	CATIONIC POLYMERIZATION INITIATOR	KIRIN HOLDINGS KABUSHIKI KAISHA
WO/2021/100814	COMPOUND AND FLUORESCENTLY LABELED BIOMATERIAL USING SAME	FUJIFILM CORPORATION
WO/2021/100833	MODIFICATION OF TRNA T-STEM FOR ENHANCING N-METHYL AMINO ACID INCORPORATION	THE UNIVERSITY OF TOKYO
WO/2021/100855	METHOD FOR MEASURING β-1,3-1,6-GLUCAN	OLYMPUS CORPORATION
WO/2021/140761	RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN FORMATION METHOD, AND COMPOUND	JSR CORPORATION
WO/2021/111912	RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYMER, AND COMPOUND	JSR CORPORATION
WO/2021/111913	RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYMER, AND COMPOUND	JSR CORPORATION
WO/2021/106813	METHOD FOR PRODUCING ALKANE COMPOUND	DAIKIN INDUSTRIES, LTD.
WO/2021/140764	METHOD FOR PURIFYING NON-AQUEOUS SOLVENT, AND METHOD FOR PRETREATING ION EXCHANGE RESIN FOR PURIFICATION OF NON-AQUEOUS SOLVENT	ORGANO CORPORATION
WO/2021/124807	LOW-RESIDUE SILOXANE COMPOUND, AND LUBRICATING OIL COMPOSITION AND LUBRICANT USING THIS	MORESCO CORPORATION
WO/2021/106864	PROCESS FOR THE PREPARATION OF PRODUCING PYRAZOLO[1,5-A] PYRIMIDINE DERIVATIVES	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/106882	IMPROVED ADENO-ASSOCIATED VIRUS-BINDING PROTEIN, METHOD FOR PRODUCING SAME, AND ADENO-ASSOCIATED VIRUS ADSORBENT USING SAME	TOSOH CORPORATION
WO/2021/106942	CURING CATALYST USED FOR CURING OF POLYMER, MOISTURE CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT	NITTO KASEI CO., LTD.
WO/2021/106943	CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED ARTICLE	NITTO KASEI CO., LTD.
WO/2021/106982	METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND	MARUZEN PETROCHEMICAL CO., LTD.
WO/2021/107015	PREPARATION METHOD FOR 2,2'-BIS(CARBOXYMETHOXY)-1,1'-BINAPHTHYL	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/107016	METHOD FOR PRODUCING BINAPHTHYL CARBOXYLIC ACID	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/107017	COMPOSITION FOR RESIN STARTING MATERIAL	HONSHU CHEMICAL INDUSTRY CO., LTD.
WO/2021/107023	CYCLOALKYL UREA DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/107030	COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/107037	DEVELOPER AND THERMOSENSITIVE RECORDING MATERIAL	MITSUBISHI CHEMICAL CORPORATION
WO/2021/107046	DEHYDRATION METHOD FOR FLUORINE-BASED HYDROCARBON COMPOUND	DAIKIN INDUSTRIES, LTD.
WO/2021/107047	METHOD FOR PRODUCING 4-(AMINOMETHYL)CYCLOHEXANE CARBOXYLIC ACID	DNP FINE CHEMICALS CO., LTD.
WO/2021/107072	ANTIGEN-BINDING MOLECULE, NUCLEIC ACID COMPOSITION, VECTOR COMPOSITION AND METHOD FOR PURIFYING CELLS AND BIFIDOBACTERIUM LONGUM	KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/107113	BENZIMIDAZOLE COMPOUND OR SALTS THEREOF, AGRICULTURAL AND HORTICULTURAL INSECTICIDE/ACARICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME	NIHON NOHYAKU CO., LTD.
WO/2021/112014	BRONCHIAL EMBOLIZATION MATERIAL	KYOTO UNIVERSITY
WO/2021/131538	CHEMICALLY AMPLIFIED POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM, METHOD FOR PRODUCING PHOTOSENSITIVE DRY FILM, METHOD FOR PRODUCING PATTERNED RESIST FILM, METHOD FOR PRODUCING SUBSTRATE PROVIDED WITH TEMPLATE, AND METHOD FOR PRODUCING PLATED MODELED OBJECT	TOKYO OHKA KOGYO CO., LTD.
WO/2021/131549	METHOD FOR PRODUCING DIAMINOBIPHENYL COMPOUND	SEIKA CORPORATION
WO/2021/124901	PLASTICIZER FOR VINYL CHLORIDE RESINS, VINYL CHLORIDE RESIN COMPOSITION, AND MOLDED ARTICLE AND WIRING HARNESS EACH USING SAID VINYL CHLORIDE RESIN COMPOSITION	DIC CORPORATION
WO/2021/117609	N-VINYL ACETAMIDE-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME	SHOWA DENKO K.K.
WO/2021/107160	A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D MUTATION	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/112213	2,4-DIOXO-1,4-DIHYDROTHIENOPYRIMIDINE COMPOUND, AGRICULTURAL OR HORTICULTURAL FUNGICIDAL AGENT, OR MEDICAL/ANIMAL ANTIFUNGAL AGENT, CONTAINING THIS	NIPPON SODA CO., LTD.
WO/2021/117622	CONDENSED POLYCYCLIC AROMATIC COMPOUND	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/112249	METHOD FOR PRODUCING PEPTIDE HAVING PHYSIOLOGICAL ACTIVITY, AND PEPTIDE COMPRISING SHORT LINKER	AJINOMOTO CO., INC.
WO/2021/117652	ORGANOPOLYSILOXANE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND COMPOSITION INCLUDING SAID COMPOUND	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/117658	METHOD FOR PRODUCING N-VINYLACETAMIDE, AND PYROLYSIS DEVICE	SHOWA DENKO K.K.
WO/2021/131657	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/145099	METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX	JFE ENGINEERING CORPORATION
WO/2021/117710	ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/171731	DEVICE AND METHOD FOR TREATING FEED MATERIAL	EBARA ENVIRONMENTAL PLANT CO., LTD.
WO/2021/117733	ACRYLAMIDE COMPOUNDS	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/117741	GAS-STORING MATERIAL INCLUDING METAL/ORGANIC FRAMEWORK BONDED BY HYDROXAMIC ACID	RIKKYO EDUCATIONAL CORPORATION
WO/2021/131697	METAL COMPLEX, COMPOSITION CONTAINING SAME, AND LUMINESCENT ELEMENT	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/117759	HISTONE DEACETYLASE INHIBITOR HAVING NITROGEN-CONTAINING AROMATIC HETEROCYCLIC GROUP	SHIONOGI & CO., LTD.
WO/2021/117760	COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/140820	METHOD FOR PRODUCING BIS(2-HYDROXY-2-PROPYL)BENZENE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/117764	COMPOUND, METHOD FOR PRODUCING SAME, RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/117767	METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROARYLCARBOXAMIDE ACETIC ACID DERIVATIVE	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/192439	LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND	DIC CORPORATION
WO/2021/131751	1,3-BUTANEDIOL	SHOWA DENKO K.K.
WO/2021/131752	1,3-BUTANEDIOL	SHOWA DENKO K.K.
WO/2021/125050	METHODS FOR PRODUCING COMPOUND HAVING PYRIDINE RING STRUCTURE AND COMPOUND HAVING PYRROLE RING STRUCTURE	ASAHI KASEI KABUSHIKI KAISHA
WO/2021/199507	NOVEL LACTAM COMPOUND OR SALT THEREOF, COMPLEX, AND FERTILIZER AND PLANT GROWTH REGULATOR CONTAINING SAID COMPOUND OR SALT AND COMPLEX	AICHI STEEL CORPORATION
WO/2021/131766	ORGANIC ELECTROLUMINESCENT ELEMENT	NIPPON STEEL CHEMICAL & MATERIAL CO., LTD.
WO/2021/117852	DITHIAPOLYETHER DIOL, METHOD FOR PRODUCING SAME, SNAG PLATING SOLUTION CONTAINING DITHIAPOLYETHER DIOL, AND METHOD FOR FORMING PLATING FILM WITH USE OF SNAG PLATING SOLUTION	MITSUBISHI MATERIALS CORPORATION
WO/2021/125132	CARBAMOYL OXIME COMPOUND, AND POLYMERIZATION INITIATOR AND POLYMERIZABLE COMPOSITION CONTAINING SAID COMPOUND	ADEKA CORPORATION
WO/2021/153047	METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/125176	PROLIFERATIVE LIVER ORGANOID, METABOLICCALY ACTIVATED LIVER ORGANOID, AND USE THEREOF	JSR CORPORATION
WO/2021/125177	PRODUCTION METHOD FOR ORGANOID	JSR CORPORATION
WO/2021/131912	METHOD FOR MANUFACTURING BIS(AMINOMETHYL)CYCLOHEXANE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/131923	SUGAR-MODIFIED PROTEIN	SUNTORY HOLDINGS LIMITED
WO/2021/131924	NON-ALCOHOLIC BEER-FLAVORED BEVERAGE, RICH TASTE ENHANCING AGENT AND SOURNESS REDUCING AGENT FOR NON-ALCOHOLIC BEER-FLAVORED BEVERAGES, AND RICH TASTE ENHANCING METHOD AND SOURNESS REDUCING METHOD FOR NON-ALCOHOLIC BEER-FLAVORED BEVERAGES	SUNTORY HOLDINGS LIMITED
WO/2021/131927	PHOTOSENSITIVE COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT AND IMAGE DISPLAY DEVICE	FUJIFILM CORPORATION
WO/2021/161648	FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR	UNIMATEC CO., LTD.
WO/2021/131961	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/131993	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/132011	METHOD FOR PRODUCING FLUORINE-CONTAINING (CYCLO)ALKENYL ZINC HALIDE COMPOUND	DAIKIN INDUSTRIES, LTD.
WO/2021/140868	ORGANOZINC CATALYST	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/140869	METHOD FOR PRODUCING ORGANOZINC CATALYST	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/125322	METHOD FOR PRODUCING GUERBET ALCOHOL	KAO CORPORATION
WO/2021/149427	METHOD FOR IMPROVING ANTIBODY AFFINITY WITH ANTIGEN, AND USE THEREOF	SYSMEX CORPORATION
WO/2021/149428	METHOD FOR IMPROVING AFFINITY OF ANTIBODY TO ANTIGEN AND USE THEREOF	SYSMEX CORPORATION
WO/2021/125347	NOVEL COMPOUND, CROSSLINKING AGENT AND CROSSLINKED FLUOROELASTOMER	NICHIAS CORPORATION
WO/2021/171756	RESIN COMPOSIITON AND FLUIDITY IMPROVEMENT METHOD	OSAKA GAS CHEMICALS CO., LTD.
WO/2021/132239	METHOD FOR PRODUCING INDENE	THE UNIVERSITY OF KITAKYUSHU
WO/2021/176809	POLYROTAXANE, METHOD FOR MANUFACTURING SAME, AND CROSSLINKED POLYROTAXANE	TOYODA GOSEI CO., LTD.
WO/2021/132297	CARBACYCLIC PHOSPHATIDIC ACID COMPOUND	OTSUKA CHEMICAL CO., LTD.
WO/2021/132336	METHOD FOR PRODUCING PEPTIDE	OTSUKA CHEMICAL CO., LTD.
WO/2021/132340	1,3-BUTYLENE GLYCOL PRODUCT AND METHOD FOR PRODUCING 1,3-BUTYLENE GLYCOL	DAICEL CORPORATION
WO/2021/132342	METHOD FOR PRODUCING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132343	METHOD FOR MANUFACTURING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132352	METHOD FOR COLLECTING EXTRACELLULAR VESICLES DERIVED FROM NERVOUS SYSTEM CELLS	OSAKA UNIVERSITY
WO/2021/132354	METHOD FOR PRODUCING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132360	METHOD FOR PRODUCING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132361	METHOD FOR MANUFACTURING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132363	METHOD FOR MANUFACTURING HIGHLY POLYMERIZABLE N-VINYL CARBOXYLIC ACID AMIDE MONOMER	SHOWA DENKO K.K.
WO/2021/132364	METHOD FOR PRODUCING HIGHLY POLYMERIZABLE N-VINYLCARBOXAMIDE MONOMER	SHOWA DENKO K.K.
WO/2021/132365	METHOD FOR PRODUCING HIGHLY POLYMERIZABLE N-VINYL CARBOXYLIC ACID AMIDE MONOMER	SHOWA DENKO K.K.
WO/2021/132366	METHOD FOR PRODUCING HIGHLY POLYMERIZABLE N-VINYLCARBOXYLIC ACID AMIDE MONOMER	SHOWA DENKO K.K.
WO/2021/132367	METHOD FOR PRODUCING HIGHLY POLYMERIZABLE N-VINYLCARBOXAMIDE MONOMER	SHOWA DENKO K.K.
WO/2021/132368	METHOD FOR PRODUCING 1,3-BUTYLENE GLYCOL	DAICEL CORPORATION
WO/2021/132369	1,3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132370	1, 3-BUTYLENE GLYCOL PRODUCT	DAICEL CORPORATION
WO/2021/132373	RARE EARTH COMPLEX	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/161672	SILANE-CONTAINING COMPOUND AND MODIFIED HYDROGENATED PETROLEUM RESIN	IDEMITSU KOSAN CO.,LTD.
WO/2021/132390	METHOD FOR PRODUCING 1-CHLORO-2,3,3-TRIFLUOROPROPENE	AGC INC.
WO/2021/132422	PYRIDAZINYL THIAZOLECARBOXAMIDE COMPOUND	ASTELLAS PHARMA INC.
WO/2021/132489	METHOD FOR DETECTING PROTEIN IN EXTRACELLULAR VESICLES AND EXTRACELLULAR VESICLE MEMBRANE PERMEABILIZATION TREATMENT AGENT	TOSOH CORPORATION
WO/2021/153124	RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN FORMATION METHOD, AND RADIATION-SENSITIVE ACID GENERATOR	JSR CORPORATION
WO/2021/132545	METHOD FOR SYNTHESIZING PEPTIDE COMPOUND	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/132637	METHOD FOR PRODUCING CYCLIC SECONDARY AMINE	NIPPON CHEMIPHAR CO., LTD.
WO/2021/132640	METHOD FOR STABILIZING PERFLUORODIOXOLANE COMPOUND, COMPOSITION INCLUDING PERFLUORODIOXOLANE COMPOUND, AND METHOD FOR MANUFACTURING PERFLUORODIOXOLANE COMPOUND POLYMER	TOSOH CORPORATION
WO/2021/132693	CURABLE COMPOSITION	TOAGOSEI CO., LTD.
WO/2021/140981	ANTIBODY POPULATION UNIFORMLY INCLUDING ANTIBODIES HAVING LEFT-RIGHT ASYMMETRIC SUGAR CHAIN, AND METHOD FOR PRODUCING SAME	RIKEN
WO/2021/132733	POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND	IDEMITSU KOSAN CO., LTD.
WO/2021/186846	SULFONIUM SALT, PHOTOACID GENERATOR, CURABLE COMPOSITION, AND RESIST COMPOSITION	SAN-APRO LTD.
WO/2021/141002	(METH)ACRYLIC ACID ESTER COMPOUND HAVING ISOCYANATE GROUP, AND METHOD FOR PRODUCING SAME	SHOWA DENKO K.K.
WO/2021/145233	METHOD FOR PRODUCING ACRYLIC ACID	NIPPON SHOKUBAI CO., LTD.
WO/2021/153168	COMPOUND, LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING ELEMENT	KYOTO UNIVERSITY
WO/2021/141072	NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE	NITTO DENKO CORPORATION
WO/2021/145267	FORMIC ACID PRODUCTION METHOD AND FORMIC ACID PRODUCTION SYSTEM	IIDA GROUP HOLDINGS CO., LTD.
WO/2021/149502	COMPOSITION AND METHOD FOR PRODUCING SAME	DAICEL CORPORATION
WO/2021/141106	HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/141108	METHOD FOR AMPLIFYING NUCLEIC ACID	KAO CORPORATION
WO/2021/149510	PYRROMETHENE BORON COMPLEX, LIGHT-EMITTING ELEMENT CONTAINING SAME, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE	TORAY INDUSTRIES, INC.
WO/2021/192488	METHOD FOR PRODUCING AMIDE BOND-CONTAINING COMPOUND	KANEKA CORPORATION
WO/2021/141118	ARTIFICIAL EXCITATORY SYNAPSE CONNECTOR AND USE THEREOF FOR SPINAL CORD INJURY	KEIO UNIVERSITY
WO/2021/166485	METHOD FOR PRODUCING ALCOHOL	SHOWA DENKO K.K.
WO/2021/161703	MARKER FOR PULMONARY HYPERTENSION	NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
WO/2021/145319	CELL CULTURE MEDIUM COMPOSITION	AJINOMOTO CO., INC.
WO/2021/145401	SPIROHETEROCYCLIC DERIVATIVES AS CRHR2 ANTAGONIST	RAQUALIA PHARMA INC.
WO/2021/145403	FATTY ACID DERIVATIVE LABELED BY POSITRON-EMITTING NUCLIDE	ASTELLAS PHARMA INC.
WO/2021/145429	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/199589	METHOD FOR PRODUCING GLYCOLIC ACID SALT AND METHOD FOR PRODUCING GLYCOLIC ACID	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/149735	ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO., LTD.
WO/2021/149754	CRYSTALS OF BISNAPHTHOL HAVING FLUORENE SKELETON AND PRODUCTION METHOD THEREFOR	TAOKA CHEMICAL CO., LTD.
WO/2021/149765	METHOD FOR PRODUCING ORGANIC SUBSTANCE AND APPARATUS FOR PRODUCING ORGANIC SUBSTANCE	SEKISUI CHEMICAL CO., LTD.
WO/2021/149771	THIENOURACIL COMPOUND AND PEST CONTROL AGENT	NISSAN CHEMICAL CORPORATION
WO/2021/153422	METHOD FOR PRODUCING HALOGENATED HYDROCARBON MAGNESIUM COMPOUND AND METHODS FOR PRODUCING TERTIARY ALCOHOL COMPOUND AND ORGANOSILICON COMPOUND	TOKUYAMA CORPORATION
WO/2021/149788	METHOD FOR PURIFYING CARBOXYLIC ACID FLUORIDE	KANTO DENKA KOGYO CO., LTD.
WO/2021/149798	METHOD AND KIT FOR DETECTING HUMAN α-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/149801	FULLERENE DERIVATIVE, FULLERENE DERIVATIVE PRODUCTION METHOD, DEPOSIT, FILM, AND ELECTRONIC DEVICE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/166552	ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/166553	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE	IDEMITSU KOSAN CO.,LTD.
WO/2021/157421	METHOD FOR PRODUCING PROTEIN	AJINOMOTO CO., INC.
WO/2021/157425	METHOD FOR PRODUCING (METH)ACROLEIN AND METHOD FOR PRODUCING (METH)ACRYLIC ACID	MITSUBISHI CHEMICAL CORPORATION
WO/2021/153586	METHOD FOR PRODUCING trans, trans-MUCONIC ACID OR ALKYL ESTER THEREOF	TORAY INDUSTRIES, INC.
WO/2021/161789	PRESSURE-MEASURING SHEET SET, PRESSURE-MEASURING SHEET, METHOD FOR MANUFACTURING PRESSURE-MEASURING SHEET SET, METHOD FOR MANUFACTURING PRESSURE-MEASURING SHEET, SHEET, DISPERSION, DISPERSION SET, AND MICROCAPSULES	FUJIFILM CORPORATION
WO/2021/192591	BIOGAS-UTILIZING METHANATION SYSTEM	MITSUBISHI POWER, LTD.
WO/2021/192592	PROPYLENE OXIDE PRODUCTION APPARATUS AND PROPYLENE OXIDE PRODUCTION METHOD	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/153659	METHOD FOR QUANTIFYING ADENO-ASSOCIATED VIRUS (AAV)	AGC INC.
WO/2021/153687	NUCLEIC ACID COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/153689	COMPOSITE MATERIAL CONTAINING COF, HEAT DISSIPATION/STORAGE MEMBER, AND PRODUCTION METHOD FOR SAID COMPOSITE MATERIAL, AND COF MONOCRYSTAL AND PRODUCTION METHOD THEREFOR	JAPAN SCIENCE AND TECHNOLOGY AGENCY
WO/2021/153720	3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT	KUMIAI CHEMICAL INDUSTRY CO., LTD.
WO/2021/161807	METHOD FOR PRODUCING REDUCED COENZYME Q10 FORM II CRYSTALS	KANEKA CORPORATION
WO/2021/153743	CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF	TORAY INDUSTRIES, INC.
WO/2021/153770	PROCESS OF PREPARING NUCLEIC ACID OLIGOMER	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/153772	BLUE FLUORESCENT PROBE FOR DETECTING ALDEHYDE DEHYDROGENASE 1A1	THE UNIVERSITY OF TOKYO
WO/2021/153782	METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/161838	DIARYLAMINE COMPOUND, SURFACE-TREATED FILLER, AND POLYMER COMPOSITION	ZEON CORPORATION
WO/2021/181941	ISOCYANATE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND METHOD FOR PRODUCING ISOCYANATE GROUP-CONTAINING ORGANIC SILICON COMPOUND	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/157551	COMPOSITION FOR LITHOGRAPHY AND PATTERN-FORMING METHOD	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/186922	ORGAOPOLYSILOXANE AND CURABLE COMPOSITION CONTAINING SAME	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/181946	METHOD FOR PRODUCING ORGANIC SILICON COMPOUND HAVING KETIMINE STRUCTURE	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/157563	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/157580	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/157587	METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND	KOEI CHEMICAL COMPANY, LIMITED
WO/2021/157590	METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUND	AGC INC.
WO/2021/157591	METHOD FOR PRODUCING AROMATIC HETEROCYCLIC RING-SUBSTITUTED DIFLUOROACETIC ACID DERIVATIVE	AGC INC.
WO/2021/157599	COMPOUND, LIGHT-EMITTING MATERIAL, DELAYED FLUORESCENCE MATERIAL, AND ORGANIC OPTICAL DEVICE	KYULUX, INC.
WO/2021/157600	COMPOUND, LUMINESCENT MATERIAL, DELAYED FLUORESCENT MATERIAL, AND ORGANIC OPTICAL DEVICE	KYULUX, INC.
WO/2021/157635	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/157636	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/161887	COMPOUND	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/166664	FLUORINE-CONTAINING COPOLYMER COMPOSITION AND CROSS-LINKED PRODUCT THEREOF, AND COMPOUND	AGC INC.
WO/2021/157665	HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE	ASAHI KASEI KABUSHIKI KAISHA
WO/2021/157679	METHODS FOR PRODUCING AND/OR ENRICHING RECOMBINANT ANTIGEN-BINDING MOLECULES	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/157684	SULFONAMIDE OR SULFINAMIDE COMPOUND HAVING EFFECT OF INDUCING BRD4 PROTEIN DEGRADATION AND PHARMACEUTICAL USE THEREOF	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/171962	ISOCYANATE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND METHOD FOR PRODUCING ISOCYANATE GROUP-CONTAINING ORGANIC SILICON COMPOUND	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/157701	THIOURETHANE RESIN STARTING MATERIAL PRODUCTION METHOD AND USE THEREFOR, POLYTHIOL COMPOSITION PRODUCTION METHOD AND USE THEREFOR, AND POLYTHIOL COMPOSITION	MITSUI CHEMICALS, INC.
WO/2021/157702	POLYAMINE COMPOUND PRODUCTON METHOD AND USE THEREFOR	MITSUI CHEMICALS, INC.
WO/2021/161931	CURABLE RESIN COMPOSITION	AGC INC.
WO/2021/166702	METHOD FOR PRODUCING ALDEHYDE COMPOUND OR DERIVATIVE THEREOF	KURARAY CO., LTD.
WO/2021/161942	METHOD FOR PRODUCING ALKANEDISULFONIC ACID COMPOUND	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/161943	METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/161944	METHOD FOR PRODUCING ALKANE DISULFONIC ACID COMPOUND	SUMITOMO SEIKA CHEMICALS CO., LTD.
WO/2021/161974	IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE	MITSUBISHI CHEMICAL CORPORATION
WO/2021/176970	METHOD FOR PRODUCING FUEL GAS	OSAKA GAS CO., LTD.
WO/2021/192683	COMPOUND COMPRISING β-NICOTINAMIDE MONONUCLEOTIDE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF, AND METHOD FOR EVALUATING QUALITY AND METHOD FOR ASSESSING ENZYMATIC REACTIVITY OF SAID COMPOUND	ORIENTAL YEAST CO., LTD.
WO/2021/181994	EPITOPE OF ANTIBODY AGAINST STRUCTURAL PROTEIN OF SARS-COV-2, ANTIBODY REACTING WITH EPITOPE, METHOD FOR DETECTING SARS-COV-2 USING ANTIBODY, DETECTION KIT FOR SARS-COV-2 CONTAINING ANTIBODY, METHOD FOR DETECTING ANTI-SARS-COV-2 ANTIBODY CONTAINING POLYPEPTIDE OF EPITOPE, DETECTION KIT FOR ANTI-SARS-COV-2 ANTIBODY CONTAINING POLYPEPTIDE OF EPITOPE, VACCINE FOR SARS-COV-2 CONTAINING POLYPEPTIDE OF EPITOPE, AND THERAPEUTIC AGENT FOR SARS-COV-2 INFECTION CONTAINING ANTIBODY	DENKA COMPANY LIMITED
WO/2021/162057	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/162070	METHOD FOR PRODUCING MONOMER FOR NUCLEIC ACID PRODUCTION	TORAY INDUSTRIES, INC.
WO/2021/166802	COMPOUND AND LIQUID CRYSTAL COMPOSITION	FUJIFILM CORPORATION
WO/2021/162096	METHOD FOR PRODUCING ACYLTHIOUREA COMPOUND	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/162097	ANALOGOUS SUBSTANCES OF ACYL THIOUREA COMPOUND	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/162103	COMPOUND AND USE THEREOF	FELIQS CORPORATION
WO/2021/177000	METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN	THE UNIVERSITY OF TOKYO
WO/2021/162122	COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND	IDEMITSU KOSAN CO., LTD.
WO/2021/166854	METHOD FOR PRODUCING OLEFINS	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/166855	COLORING COMPOSITION, FILM, RED PIXEL, COLOR FILTER, SOLID-STATE IMAGE SENSING DEVICE, IMAGE DISPLAY APPARATUS, AND KIT	FUJIFILM CORPORATION
WO/2021/166856	COLORING COMPOSITION, FILM, RED PIXEL, COLOR FILTER, SOLID-STATE IMAGE SENSING DEVICE, IMAGE DISPLAY APPARATUS, AND KIT	FUJIFILM CORPORATION
WO/2021/166858	COLORED COMPOSITION, FILM, RED PIXEL, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND KIT	FUJIFILM CORPORATION
WO/2021/166859	COLORED COMPOSITION, FILM, RED PIXEL, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND KIT	FUJIFILM CORPORATION
WO/2021/172111	PATTERN FORMATION METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION	FUJIFILM CORPORATION
WO/2021/172112	ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, METHOD FOR FORMING PATTERN, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/166934	PRODUCTION METHOD FOR PYRROLIDINE COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/166935	ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO., LTD.
WO/2021/166985	SYSTEM FOR PRODUCING SYNTHETIC ARTICLE	MITSUBISHI POWER, LTD.
WO/2021/166990	COMPOUND, THERMOPLASTIC RESIN, OPTICAL MEMBER, AND OPTICAL LENS	MITSUBISHI CHEMICAL CORPORATION
WO/2021/167008	METHOD FOR PRODUCING AROMATIC ASTATINE COMPOUND	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/261008	MODIFIED GELATINS	FUJIFILM CORPORATION
WO/2021/167011	DEVICE FOR EVALUATING STATE OF SAMPLE, SYSTEM INCLUDING SAME, METHOD FOR EVALUATING STATE OF SAMPLE, AND LACTATE DEHYDROGENASE USED THEREFOR	KIKKOMAN CORPORATION
WO/2021/177050	ACTIVATABLE RAMAN PROBE	THE UNIVERSITY OF TOKYO
WO/2021/167022	NOVEL PHOTOSENSITIZER	THE UNIVERSITY OF TOKYO
WO/2021/167029	BRIDGED NUCLEOSIDE AND NUCLEOTIDE USING SAME	OSAKA UNIVERSITY
WO/2021/167038	COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT	IDEMITSU KOSAN CO.,LTD.
WO/2021/167045	COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENT	IDEMITSU KOSAN CO.,LTD.
WO/2021/167046	NOVEL CRYSTAL FORM OF 4,4’-BIS(2,3-DIBROMOPROPOXY)-3,3’,5,5’-TETRABROMODIPHENYL SULFONE AND PRODUCTION METHOD THEREFOR	MANAC INC.
WO/2021/167054	FLAVOR-IMPARTING AGENT COMPRISING 10-HYDROXY-4,8-DIMETHYL-4-DECENAL	T. HASEGAWA CO., LTD.
WO/2021/167055	FLAVORING AGENT CONTAINING HYDROXY ALDEHYDE COMPOUND	T. HASEGAWA CO., LTD.
WO/2021/172185	FUSED POLYCYCLIC AROMATIC COMPOUND	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/172191	PENETRANT SOLUTION USED IN PENETRANT TESTING, CLEANING AGENT, AND DEVELOPING AGENT	CENTRAL GLASS COMPANY, LIMITED
WO/2021/172204	METHOD FOR PRODUCING CAPPED RNA	JAPAN SCIENCE AND TECHNOLOGY AGENCY
WO/2021/229885	METHOD FOR PURIFYING PROTEIN, COLUMN, KIT AND ACTIVATED CARBON PARTICLES	KUREHA CORPORATION
WO/2021/172217	METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER	KANEKA CORPORATION
WO/2021/167095	OPTICALLY RESOLVED TROLOX INTERMEDIATE AND METHOD FOR PRODUCING SAME	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/172239	METHOD FOR PRODUCING 1,3-BUTADIENE	ENEOS CORPORATION
WO/2021/172292	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/167107	HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE	JCR PHARMACEUTICALS CO., LTD.
WO/2021/172300	FLUORENE DERIVATIVE, AND PRODUCTION METHOD AND USE FOR SAME	OSAKA GAS CHEMICALS CO., LTD.
WO/2021/172305	MANUFACTURING METHOD FOR HYDROFLUOROOLEFIN OR FLUOROOLEFIN	DAIKIN INDUSTRIES, LTD.
WO/2021/182101	COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT	IDEMITSU KOSAN CO.,LTD.
WO/2021/192791	METAL-ORGANIC FRAMEWORK, SEPARATION FILM, AND METHOD FOR PRODUCING METAL-ORGANIC FRAMEWORK	NITTO DENKO CORPORATION
WO/2021/182111	NOVEL STEROID COMPOUND	KYOTO UNIVERSITY
WO/2021/177123	ARTIFICIAL NUCLEIC ACID	UNIVERSITY OF TOYAMA
WO/2021/192795	COLOR CONVERSION COMPOSITION, COLOR CONVERSION FILM, LIGHT SOURCE UNIT, DISPLAY, AND LIGHTING INCLUDING SAME, AND COMPOUND	TORAY INDUSTRIES, INC.
WO/2021/172433	METAL-ORGANIC FRAMEWORK WITH CARBOXYLIC ACID ION HAVING TERPHENYL SKELETON AS LIGAND	RIKKYO EDUCATIONAL CORPORATION
WO/2021/172452	ARYLAMINE COMPOUND AND ELECTRONIC APPARATUS USING SAME	HODOGAYA CHEMICAL CO., LTD.
WO/2021/177144	NAPHTHYL SILOLE PRODUCTION METHOD, NAPHTHYL SILOLE HAVING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBONS HAVING HETEROCYCLIC GROUP	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/172482	METHOD FOR PRODUCING SUGAR ANHYDRIDE AND SACCHARIDE	KYOTO UNIVERSITY
WO/2021/172488	CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF	TORAY INDUSTRIES, INC.
WO/2021/172499	METHOD FOR PRODUCING PURIFIED PHTHALONITRILE AND METHOD FOR PURIFYING PHTHALONITRILE	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/177160	AZINYL AZOLE COMPOUND AND PEST CONTROL AGENT	NIPPON SODA CO., LTD.
WO/2021/187057	FORMATE PRODUCTION METHOD AND FORMATE PRODUCTION SYSTEM	NITTO DENKO CORPORATION
WO/2021/172523	STABILIZATION OF POLYSULFIDE	UNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/199818	SULFANYL SULFONIC ACID COMPOUND, VISCOELASTIC MODIFIER, RUBBER COMPOSITION, AND VULCANIZED RUBBER PRODUCTION METHOD	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/182144	MANUFACTURING METHOD AND MANUFACTURING DEVICE FOR ORGANIC ESTERS	ZEON CORPORATION
WO/2021/199823	METHOD FOR MANUFACTURING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/177209	LAMININ CROSS-LINKED PRODUCT, CULTURE MEDIUM INCLUDING LAMININ CROSS-LINKED PRODUCT, THREE-DIMENSIONAL CULTURING KIT, CULTURE SUBSTRATE, COMPOSITION, STRUCTURE, AND CULTURING METHOD	NIPPI, INCORPORATED
WO/2021/187075	POLYCYCLIC AROMATIC HYDROCARBON COMPOUND, CRYSTAL THEREOF AND PRODUCTION METHOD THEREOF	TEIJIN LIMITED
WO/2021/199841	ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, RESIST FILM, AND ELECTRONIC DEVICE PRODUCTION METHOD	FUJIFILM CORPORATION
WO/2021/177260	METHODS FOR PRODUCING IODOFLUOROALKANE AND FLUOROOLEFIN	DAIKIN INDUSTRIES, LTD.
WO/2021/177290	METHOD FOR PRODUCING MONO-CROSS-COUPLED AROMATIC COMPOUND HAVING LEAVING GROUP	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/192859	TECHNOLOGY FOR HIGH-PURITY REFINEMENT OF Gc PROTEIN	KABUSHIKI KAISHA MEDICALBIARA
WO/2021/177330	FUSED TRICYCLIC COMPOUND AND MEDICINAL USE THEREOF	JAPAN TOBACCO INC.
WO/2021/177334	NOVEL FLUOROALKANE DERIVATIVES AND GELLING AGENTS USING SAME	YAMAGUCHI UNIVERSITY
WO/2021/192861	IONIC LIQUID, SOLVENT, PREPARATION, AND TRANSDERMALLY ABSORBABLE AGENT	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/177336	PEPTIDE AND CELL MEMBRANE PERMEATION AGENT	AGC INC.
WO/2021/177339	METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/177343	METHOD FOR RELEASING COMPOUND	RIKEN
WO/2021/182238	1,1'-BI-2-NAPHTHOL COMPOSITION	DKS CO. LTD.
WO/2021/177390	COMPOUND AND RADIOACTIVE LABELING COMPOUND	NIHON MEDI-PHYSICS CO., LTD.
WO/2021/177410	PEST CONTROL AGENT	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/177417	AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC THIN FILM TRANSISTOR	TOSOH CORPORATION
WO/2021/177442	AZOLE DERIVATIVE, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND INDUSTRIAL MATERIAL PROTECTION AGENT	KUREHA CORPORATION
WO/2021/177447	KIT AND METHOD FOR DETERMINING DEMENTIA OR BRAIN FUNCTION	KANEKA CORPORATION
WO/2021/182422	COMPOUND PRODUCING METHOD, AND COMPOUND	KUREHA CORPORATION
WO/2021/187215	METHOD FOR PRODUCING DIPHENYLSULFONE COMPOUND	KONISHI CHEMICAL IND. CO., LTD.
WO/2021/182438	NOVEL BORATE COMPOUND-CONTAINING COMPOSITION	AGC INC.
WO/2021/182439	NOVEL BORATE COMPOUND-CONTAINING COMPOSITION	AGC INC.
WO/2021/182491	CRYSTAL OF HYPOXANTHINE COMPOUND	KISSEI PHARMACEUTICAL CO., LTD.
WO/2021/193069	NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION	KUROGANE KASEI CO.,LTD.
WO/2021/182530	METHOD FOR PRODUCING AZOLE DERIVATIVE, BROMOHYDRIN DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 1-CHLORO-3-(4-CHLOROPHENOXY)BENZENE	KUREHA CORPORATION
WO/2021/182555	ALDOSTERONE DETECTION ANTIBODY AND ALDOSTERONE IMMUNOASSAY METHOD	HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
WO/2021/210304	COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/210305	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/182587	TARGET MODULE FOR USE IN SEARCH FOR NOVEL PEPTIDE APTAMER UTILIZING PHOTOCROSSLINKABLE BASE, LINKER FOR USE IN SEARCH FOR NOVEL PEPTIDE APTAMER, AND METHOD FOR SEARCHING FOR NOVEL PEPTIDE APTAMER USING SAID TARGET MODULE OR SAID LINKER	EPSILON MOLECULAR ENGINEERING INC.
WO/2021/187341	PHOTOELECRIC CONVERSION ELEMENT AND PHOTOELECRIC CONVERSION DEVICE COMPRISING SAID PHOTOELECRIC CONVERSION ELEMENT	CANON KABUSHIKI KAISHA
WO/2021/182594	METHOD FOR PRODUCING HYDROXYLATED CHALCONES AND FLAVANONES	HOKURIKU UNIVERSITY
WO/2021/193128	LIGHT-ABSORBING MATERIAL, RECORDING MEDIUM EMPLOYING SAME, METHOD FOR RECORDING INFORMATION, AND METHOD FOR READING OUT INFORMATION	PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
WO/2021/187369	METHOD FOR PRODUCING (HYDRO)HALOCARBON	CENTRAL GLASS COMPANY, LIMITED
WO/2021/187406	ANTIBODY FOR DETECTING HELICOBACTER PYLORI	EIKEN KAGAKU KABUSHIKI KAISHA
WO/2021/193199	METHOD FOR ANALYZING SUGAR CHAIN	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/220648	RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN USING SAME, AND SULFONIC ACID SALT COMPOUND AND RADIATION-SENSITIVE ACID GENERATOR COMPRISING SAME	JSR CORPORATION
WO/2021/187486	OXADIAZOLE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/250967	INK FOR INKJET PRINTERS	HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD.
WO/2021/200131	ANTIBODY DRUG CONJUGATE	NATIONAL CANCER CENTER
WO/2021/187500	CHEMICALLY MODIFIED ARTIFICIAL PROTEIN FOR MOLDING MATERIAL AND METHOD FOR PRODUCING SAID PROTEIN	SPIBER INC.
WO/2021/187502	SYNTHETIC POLYMER AND METHOD FOR PRODUCING SAME, MOLDING MATERIAL, AND MOLDED BODY	SPIBER INC.
WO/2021/187507	COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE	KYULUX, INC.
WO/2021/187531	LUMINESCENT SUBSTRATE COMPOUND	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/200178	ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMATION METHOD, PHOTOMASK, ELECTRONIC DEVICE MANUFACTURING METHOD, AND COMPOUND	FUJIFILM CORPORATION
WO/2021/200179	ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, METHOD FOR FORMING PATTERN, AND METHOD FOR PRODUCING ELECTRONIC DEVICE	FUJIFILM CORPORATION
WO/2021/200219	ZINC COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM	ADEKA CORPORATION
WO/2021/187559	METHOD FOR PRODUCING 2-DEOXY-2-[18F]-FLUOROSORBITOL AND KIT FOR PRODUCING SAME	KYOTO PHARMACEUTICAL UNIVERSITY
WO/2021/187569	METHOD FOR PRODUCING EPIGALLOCATECHIN GALLATE CONJUGATE	KAO CORPORATION
WO/2021/200259	VIPR2 ANTAGONIST PEPTIDE	ICHIMARU PHARCOS CO., LTD.
WO/2021/193410	BENZAMIDE COMPOUND AND HERBICIDE	NIPPON SODA CO., LTD.
WO/2021/193432	METHOD FOR PRODUCING PRODUCTION INTERMEDIATE OF CYCLANILIPROLE	ISHIHARA SANGYO KAISHA, LTD.
WO/2021/193438	HYDROCARBON GENERATION SYSTEM AND HYDROCARBON GENERATION METHOD	IHI CORPORATION
WO/2021/193457	METHOD FOR PRODUCING 1,3-BUTADIENE AND DEVICE FOR PRODUCING 1,3-BUTADIENE	SEKISUI CHEMICAL CO., LTD.
WO/2021/215163	RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN	JSR CORPORATION
WO/2021/205851	PEPTIDE COMPOSITION AND METHOD FOR PRODUCING SAME	NITTA GELATIN INC.
WO/2021/193511	METHOD FOR PRODUCING PURIFIED ACETIC ACID	DAICEL CORPORATION
WO/2021/193543	COMPOUND, COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT	ADEKA CORPORATION
WO/2021/193553	METHOD FOR CREATING MULTIMERIC IgA ANTIBODY, AND MULTISPECIFIC MULTIMERIC IgA ANTIBODY	TOKO YAKUHIN KOGYO CO., LTD.
WO/2021/193565	PRODUCTION METHOD FOR CYCLIC COMPOUND OR DERIVATIVE THEREOF	SUMITOMO BAKELITE CO., LTD.
WO/2021/193589	TESTING METHOD, TESTING KIT, AND TESTING SYSTEM	SEKISUI CHEMICAL CO., LTD.
WO/2021/193594	HETEROCYCLIC COMPOUND OR SALT THEREOF, ACTIVE MATERIAL, ELECTROLYTE AND REDOX FLOW BATTERY	NIPPON KAYAKU KABUSHIKI KAISHA
WO/2021/193598	L-GLUTAMIC ACID OXIDAZE MUTANT	AJINOMOTO CO., INC.
WO/2021/193654	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/193685	FLUORINE-CONTAINING PYRIMIDINE COMPOUND, AND METHOD FOR PRODUCING SAME	UNIMATEC CO., LTD.
WO/2021/193708	COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT	JNC CORPORATION
WO/2021/193717	FLUORINE RESIN AND METHOD FOR PRODUCING SAME	TOSOH CORPORATION
WO/2021/200487	METHOD FOR PRODUCING TRISULFIDE COMPOUND OR SELENOTRISULFIDE COMPOUND	KYOWA PHARMA CHEMICAL CO., LTD.
WO/2021/193750	MONOCLONAL ANTIBODY, BACTERIA DETECTION METHOD, BACTERIA DETECTION KIT, AND HYBRIDOMA	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/200511	COMPOUND, METHOD FOR PRODUCING COMPOUND, AND CURABLE COMPOSITION	ADEKA CORPORATION
WO/2021/193786	6-(FLUOROALKYL)-3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLIC ACID ESTER DERIVATIVE, METHOD FOR PRODUCING DERIVATIVE, METHOD FOR PRODUCING 2-(FLUOROALKYL)NICOTINIC ACID ESTER DERIVATIVE, AND METHOD FOR PRODUCING 2-(FLUOROALKYL)NICOTINIC ACID DERIVATIVE	HOKKO CHEMICAL INDUSTRY CO., LTD.
WO/2021/193802	METHOD FOR PREDICTING EFFICACY OF TREATMENT OF LUNG CANCER PATIENT USING IMMUNE CHECKPOINT INHIBITOR	JSR CORPORATION
WO/2021/193818	CRYSTAL OF PHENANTHROLINE DERIVATIVE, METHOD FOR PRODUCING SAME AND LIGHT EMITTING ELEMENT USING SAME	TORAY INDUSTRIES, INC.
WO/2021/205900	METHOD FOR PRODUCING ALCOHOL	SHOWA DENKO K.K.
WO/2021/193870	REAGENT CONTAINING ANTIBODY HAVING PARTIAL DELETION OF FC REGION	DENKA COMPANY LIMITED
WO/2021/193897	SUBSTITUTED PYRIDAZINE COMPOUND	ASTELLAS PHARMA INC.
WO/2021/200640	METHOD FOR EVALUATING ACTIVITY OF FLUORINATING AGENT AND METHOD FOR MANUFACTURING ESTER COMPOUND	UBE INDUSTRIES, LTD.
WO/2021/200673	MULTISPECIFIC ANTIBODY AND METHOD FOR PRODUCING SAME	UNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/200689	CATALYST, METHOD FOR PRODUCING ISOBUTYLENE, METHOD FOR PRODUCING METHACRYLIC ACID, AND METHOD FOR PRODUCING METHYL METHACRYLATE	MITSUBISHI CHEMICAL CORPORATION
WO/2021/193951	SUGAR COMPOUND HAVING POLYETHYLENE GLYCOL CHAIN, AND PRECURSOR OF ANTIBODY-DRUG COMPLEX	THE NOGUCHI INSTITUTE
WO/2021/193952	COMPOUND, RESIN COMPOSITION, RESIN SHEET, RESIN CURED PRODUCT, AND MULTILAYER SUBSTRATE	TDK CORPORATION
WO/2021/193954	METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/205919	SURFACTIN DERIVATIVE AND SALT THEREOF	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/193963	ABSORPTION LIQUID FOR SEPARATING AND RECOVERING CARBON DIOXIDE FROM GAS CONTAINING CARBON DIOXIDE, AND CARBON DIOXIDE RECOVERY METHOD USING SAME	NIPPON STEEL CORPORATION
WO/2021/200783	AMIDATE COMPOUND, PRODUCTION METHOD THEREFOR, BLOCKING-AGENT DISSOCIATION CATALYST, AND THERMALLY CURABLE RESIN COMPOSITION	KOEI CHEMICAL COMPANY, LIMITED
WO/2021/200785	METHOD FOR PRODUCING PURIFIED ACETIC ACID	DAICEL CORPORATION
WO/2021/200795	METHOD FOR PRODUCING ISOBUTYLENE, METHOD FOR PRODUCING METHACRYLIC ACID, AND METHOD FOR PRODUCING METHYL METHACRYLATE	MITSUBISHI CHEMICAL CORPORATION
WO/2021/200797	QUANTIFICATION METHOD FOR MODIFIED HDL, AND ANALYSIS REAGENT FOR USE IN SAME METHOD	SHINSHU UNIVERSITY
WO/2021/200826	COMPOUND	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/200840	EPITOPE REGION-BRIDGING BIPARATOPIC ANTIBODY AND METHOD FOR PRODUCING SAME	NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND NUTRITION
WO/2021/210377	LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES	KONICA MINOLTA, INC.
WO/2021/200876	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/200896	IMMUNE ACTIVATING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/200898	DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/200934	ANTIMALARIAL DRUG	NAGASAKI UNIVERSITY
WO/2021/200939	CLAUDIN-6 TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/200952	THERMOPLASTIC RESIN HAVING CARBONATE BOND	MITSUBISHI CHEMICAL CORPORATION
WO/2021/201046	POLYHYDRIC HYDROXY RESIN, EPOXY RESIN, METHOD FOR PRODUCING SAME, EPOXY RESIN COMPOSITION USING SAME AND CURED PRODUCT	NIPPON STEEL CHEMICAL & MATERIAL CO., LTD.
WO/2021/201087	METHOD FOR PRODUCING MULTISPECIFIC ANTIGEN-BINDING MOLECULES	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/215210	METAL COMPLEX, COMPOSITION AND LIGHT EMITTING ELEMENT	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/201109	METAL-CARBOHYDRATE COMPLEX	ORBIO CORPORATION
WO/2021/201116	METHOD FOR SCREENING COMPOUND HAVING LYSOSOME-DAMAGE-REPAIRING ACTIVITY	OSAKA UNIVERSITY
WO/2021/205958	AMIDINATE COMPOUND, DIMER COMPOUND THEREOF, RAW MATERIAL FOR THIN FILM FORMATION, AND METHOD FOR PRODUCING THIN FILM	ADEKA CORPORATION
WO/2021/210408	METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/210409	COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/201191	SYSTEM AND METHOD FOR PRODUCING HYDROCARBON, AND METHOD FOR OPERATING SAID SYSTEM	OSAKA GAS CO., LTD.
WO/2021/201192	HYDROCARBON PRODUCTION SYSTEM	OSAKA GAS CO., LTD.
WO/2021/201287	ASYMMETRIC 1,2-BIS(DIARYLAMINO)BENZENE, METHOD FOR PRODUCING SAME, AND APPLICATION OF SAME	KYOTO UNIVERSITY
WO/2021/193983	GIF RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/206079	MYCOPLASMA PNEUMONIAE IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT	DENKA COMPANY LIMITED
WO/2021/206132	IMPROVED METHOD FOR PRODUCING O-METHYLISOUREA SULFATE	MITSUI CHEMICALS AGRO, INC.
WO/2021/210501	BORON-CONTAINING COMPOUND, LUMINESCENT MATERIAL, AND LUMINESCENT ELEMENT INCLUDING SAME	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/210534	URETHANE COMPOUND	DAIKIN INDUSTRIES, LTD.
WO/2021/210537	DIFFERENTIATION PEPTIDE	SHIMADZU CORPORATION
WO/2021/206182	COMPOUND, CONTRAST MEDIUM, AND METHOD FOR PRODUCING COMPOUND	ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE
WO/2021/210586	CONDENSED HETEROCYCLIC COMPOUND	NISSAN CHEMICAL CORPORATION
WO/2021/210630	ADENOVIRUS IMMUNIZATION MEASUREMENT METHOD AND IMMUNIZATION MEASUREMENT DEVICE	DENKA COMPANY LIMITED
WO/2021/210631	ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT	DENKA COMPANY LIMITED
WO/2021/210632	ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT	DENKA COMPANY LIMITED
WO/2021/210633	ADENOVIRUS IMMUNOASSAY METHOD AND ADENOVIRUS IMMUNOASSAY INSTRUMENT	DENKA COMPANY LIMITED
WO/2021/210638	DOPANT AND CONDUCTOR MATERIAL	THE UNIVERSITY OF TOKYO
WO/2021/210650	ARYL OR HETEROARYL DERIVATIVE	TEIJIN PHARMA LIMITED
WO/2021/210667	BISPECIFIC ANTIGEN-BINDING MOLECULE, COMPOSITION ASSOCIATED THEREWITH, AND USE, KIT, AND METHOD FOR PRODUCING COMPOSITION	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/215365	METHANE-PRODUCTION INHIBITOR COMPOSITION AND METHOD FOR INHIBITING METHANE PRODUCTION	KUMIAI CHEMICAL INDUSTRY CO., LTD.
WO/2021/215393	BENZAMIDE COMPOUND AND PEST CONTROL AGENT	NIPPON SODA CO., LTD.
WO/2021/261062	AQUEOUS SOLUTION CONTAINING STILBENE COMPOUND, AND SUPEROXIDE GENERATION INHIBITOR COMPRISING STILBENE COMPOUND	MASUOKA, Noriyoshi
WO/2021/215446	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC EQUIPMENT	IDEMITSU KOSAN CO.,LTD.
WO/2021/215450	METHOD FOR PRODUCING α-FLUOROACRYLIC ACID ESTER	DAIKIN INDUSTRIES, LTD.
WO/2021/215452	METHOD FOR PRODUCING α-FLUOROACRYLIC ACID ESTER	DAIKIN INDUSTRIES, LTD.
WO/2021/241086	ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, RESIST FILM, ELECTRONIC DEVICE MANUFACTURING METHOD, COMPOUND, AND COMPOUND PRODUCTION METHOD	FUJIFILM CORPORATION
WO/2021/235164	NONLINEAR OPTICAL MATERIAL, LIGHT-ABSORBING MATERIAL, RECORDING MEDIUM, METHOD FOR RECORDING INFORMATION, AND METHOD FOR READING INFORMATION	PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
WO/2021/235165	NONLINEAR OPTICAL MATERIAL, LIGHT-ABSORBING MATERIAL, RECORDING MEDIUM, METHOD FOR RECORDING INFORMATION, AND METHOD FOR READING OUT INFORMATION	PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
WO/2021/220930	VAPORIZATION-UTILIZING HYDROCARBON PRODUCTION SYSTEM WITH POWER GENERATION FACILITY	EUREKA ENGINEERING INC.
WO/2021/230035	NAPHTHOBISTHIADIAZOLE COMPOUND, PRODUCTION METHOD FOR SAME, AND ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE USING SAID COMPOUND	OSAKA UNIVERSITY
WO/2021/215514	COMPOUND AND LABELED BIOMATERIAL IN WHICH SAME IS USED	FUJIFILM CORPORATION
WO/2021/220952	NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF	TOYOBO CO., LTD.
WO/2021/215534	DUOCARMYCIN DERIVATIVE AND USE THEREOF	THE UNIVERSITY OF TOKYO
WO/2021/215537	2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/221011	TYROSINE RESIDUE MODIFICATION METHOD USING HIGHLY REACTIVE REAGENT	TOKYO INSTITUTE OF TECHNOLOGY
WO/2021/221036	METHOD FOR SUPPLYING COMPOSITION, COMPOSITION AND DRY ETCHING METHOD	CENTRAL GLASS COMPANY, LIMITED
WO/2021/221050	STRUCTURE, METHOD FOR PRODUCING SAME, ADSORBENT IN WHICH SAME IS USED, AND METHOD FOR PURIFYING BIOPARTICLES	KANEKA CORPORATION
WO/2021/221059	METHOD FOR PRODUCING MONOSULFOXIDE DERIVATIVE	KUMIAI CHEMICAL INDUSTRY CO., LTD.
WO/2021/221082	SARS-CoV-2-DERIVED NUCLEOCAPSID FRAGMENT, AND METHOD AND KIT FOR DETECTING ANTI-SARS-CoV-2-ANTIBODY USING SAME	PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY
WO/2021/221085	PURIFICATION METHOD FOR IMIDAZOLE DIPEPTIDES	TOKAI BUSSAN CO., LTD.
WO/2021/221097	NOVEL BICYCLIC COMPOUND	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/246095	FLUORINE-CONTAINING FUSED RING PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME	UNIMATEC CO., LTD.
WO/2021/221130	METHOD FOR SEARCHING FOR PROTEIN REFOLDING CONDITIONS, AND INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM FOR SUPPORTING SEARCH FOR PROTEIN REFOLDING CONDITIONS	AJINOMOTO CO., INC.
WO/2021/221136	ANTI-SARS-COV-2 ANTIBODY	KAO CORPORATION
WO/2021/215544	KRAS G12D PROTEIN INHIBITORS	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/230133	POLYCYCLIC AROMATIC COMPOUND	KWANSEI GAKUIN EDUCATIONAL FOUNDATION
WO/2021/256110	CYCLIC GUANAMINE COMPOUND	TOYOBO CO., LTD.
WO/2021/230141	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/230142	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO.,LTD.
WO/2021/230143	ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/251035	NOVEL ONIUM SALT AND PHOTOACID GENERATOR	SAN-APRO LTD.
WO/2021/230184	COMPOUND, PRODUCTION METHOD THEREFOR, ACID GENERATOR, COMPOSITION, RESIST FILM, UNDERLAYER FILM, PATTERN FORMATION METHOD, AND OPTICAL COMPONENT	THE SCHOOL CORPORATION KANSAI UNIVERSITY
WO/2021/230185	COMPOUND, PRODUCTION METHOD THEREFOR, COMPOSITION, RESIST FILM, AND PATTERN FORMATION METHOD	THE SCHOOL CORPORATION KANSAI UNIVERSITY
WO/2021/230198	COCRYSTAL OF DIHYDROQUINOLINONE COMPOUND	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/230255	FLUORINATED AMIDE COMPOUND, COMPOUND CONTAINING FLUORINATED NITROGEN-CONTAINING HETEROCYCLIC RING, AND FLUORINATED COMPOUND	DAIKIN INDUSTRIES, LTD.
WO/2021/230280	METHOD FOR PURIFYING ORGANIC COMPOUND AND METHOD FOR PRODUCING ORGANIC COMPOUND	TOKUYAMA CORPORATION
WO/2021/235309	METHOD FOR PRODUCING ETHER	OSAKA UNIVERSITY
WO/2021/241246	RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING PATTERN	JSR CORPORATION
WO/2021/230325	1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE	UBE INDUSTRIES, LTD.
WO/2021/235319	FLUORINE-CONTAINING ETHER COMPOUND, FLUORINE-CONTAINING ETHER COMPOSITION, COATING SOLUTION, HIGH OXYGEN SOLUBILITY LIQUID, AND ARTICLE	AGC INC.
WO/2021/235335	METHOD FOR PRODUCING ACETAMINOPHEN	API CORPORATION
WO/2021/230375	PEPTIDE MODIFIED WITH GLUT1-LIGAND-MODIFIED NON-CHARGED HYDROPHILIC POLYMER CLEAVABLY UNDER REDUCTIVE ENVIRONMENT OR LOW-PH ENVIRONMENT, AND ANTIBODY COMPRISING SAID PEPTIDE	KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION
WO/2021/235404	SARS-CoV-2 BINDING MOLECULE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/235420	FLUOROPYRIMIDINE COMPOUND AND FLUOROPYRIMIDINONE COMPOUND	UNIMATEC CO., LTD.
WO/2021/251086	ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMATION METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND COMPOUND	FUJIFILM CORPORATION
WO/2021/241371	METHOD FOR PRODUCING MONOFLUOROMETHANE	ZEON CORPORATION
WO/2021/241372	METHOD FOR PRODUCING MONOFLUOROMETHANE	ZEON CORPORATION
WO/2021/235518	METHOD FOR PRODUCING ESTER COMPOUND	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/235536	METHOD FOR PRODUCING FLUOROETHYLENE	DAIKIN INDUSTRIES, LTD.
WO/2021/241446	METHOD FOR DETECTING TARGET MOLECULE IN SPECIMEN, AND TARGET MOLECULE DETECTION KIT	YOKOGAWA ELECTRIC CORPORATION
WO/2021/235546	FLUORENYLIDENE-ACRIDANE DERIVATIVE, METHOD FOR PRODUCING FLUORENYLIDENE-ACRIDANE DERIVATIVE, MECHANOCHROMIC MATERIAL, CHARGE TRANSPORT MATERIAL, AND ELECTRONIC DEVICE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
WO/2021/235549	COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT	KYULUX, INC.
WO/2021/235553	MULTIPLE ANTIGENIC PEPTIDE AGAINST CORONAVIRUS, AND IMMUNOSTIMULATING COMPOSITION CONTAINING SAME	RIKEN
WO/2021/241528	CLEAVABLE DNA-ENCODED LIBRARY	NISSAN CHEMICAL CORPORATION
WO/2021/241557	TRANSFER FILM, METHOD FOR MANUFACTURING LAMINATE, AND A BLOCK ISOCYANATE COMPOUND	FUJIFILM CORPORATION
WO/2021/241596	COMPOUND FOR OPTICAL MATERIAL, CURABLE COMPOSITION, CURED BODY, AND OPTICAL ARTICLE	TOKUYAMA CORPORATION
WO/2021/241608	METHOD FOR PRODUCING FLUOROETHYLENE	DAIKIN INDUSTRIES, LTD.
WO/2021/241611	METHOD FOR PRODUCING HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/246265	S100A8-INHIBITING PEPTIDE AND THERAPEUTIC DRUG FOR DISEASE WHICH CONTAINING SAME	TOKYO WOMEN'S MEDICAL UNIVERSITY
WO/2021/241709	POLYFUNCTIONAL QUATERNARY AMMONIUM SALT OF SULFONIC ACID HAVING ACTIVE-HYDROGEN GROUPS	TOKUYAMA CORPORATION
WO/2021/241725	HIGH-PURITY N-(5-METHOXY-2-PHENOXYPHENYL)METHANESULFONAMIDE AND METHOD FOR PRODUCING SAME	FUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/241729	ANTI-CD73 ANTIBODY AND USE THEREOF	BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
WO/2021/246313	METHOD FOR ACTIVATING CO2 IN EXHAUST GAS FROM CEMENT PRODUCTION, AND CO2 ACTIVATION SYSTEM	MITSUBISHI MATERIALS CORPORATION
WO/2021/246314	METHOD FOR UTILIZING CO2 IN CEMENT PRODUCTION EXHAUST GAS, AND CO2 UTILIZATION SYSTEM	MITSUBISHI MATERIALS CORPORATION
WO/2021/246315	METHOD AND SYSTEM FOR UTILIZING CO2 IN CEMENT PRODUCTION EXHAUST GAS	MITSUBISHI MATERIALS CORPORATION
WO/2021/246316	METHOD FOR PRODUCING VALUABLE SUBSTANCES FROM CEMENT PRODUCTION EXHAUST GAS	MITSUBISHI MATERIALS CORPORATION
WO/2021/246317	METHOD FOR SEPARATING AND RECOVERING CO2 IN CEMENT PRODUCTION EXHAUST GAS, AND CO2 SEPARATION AND RECOVERY DEVICE	MITSUBISHI MATERIALS CORPORATION
WO/2021/246318	METHOD FOR PRODUCING METHANE FROM CO2 IN CEMENT PRODUCTION EXHAUST GAS, AND METHANATION APPARATUS	MITSUBISHI MATERIALS CORPORATION
WO/2021/241741	PHOTOELECTRIC CONVERSION ELEMENT, IMAGE SENSOR, OPTICAL SENSOR, COMPOUND	FUJIFILM CORPORATION
WO/2021/261172	NOVEL PRODUCTION METHOD FOR APIXABAN	DAITO PHARMACEUICAL CO., LTD.
WO/2021/241756	METHOD FOR PRODUCING ALIPHATIC GLYCOSIDE COMPOUND OR SUGAR FATTY ACID ESTER COMPOUND	TOHOKU UNIVERSITY
WO/2021/246349	METHOD FOR PRODUCING THIOL COMPOUND	SHOWA DENKO K.K.
WO/2021/246355	METHOD FOR PRODUCING EASILY POLYMERIZABLE COMPOUND	NIPPON SHOKUBAI CO., LTD.
WO/2021/246368	METHOD FOR PRODUCING EASILY POLYMERIZABLE COMPOUND	NIPPON SHOKUBAI CO., LTD.
WO/2021/246392	LACTIC ACID BACTERIA GROWTH PROMOTER	ASAHI GROUP HOLDINGS, LTD.
WO/2021/246408	COMPOUND OR SALT THEREOF, MEDICINE, ANTIDIURETIC DRUG, AND PROTEIN KINASE A-ACTIVATING AGENT	NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
WO/2021/261189	METHOD FOR PRODUCING PURIFIED TRANS-1, 2-DIFLUOROETHYLENE (HFO-1132(E)) AND/OR 1, 1, 2-TRIFLUOROETHYLENE (HFO-1123)	DAIKIN INDUSTRIES, LTD.
WO/2021/246471	EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/246479	DIHYDRAZIDE COMPOUND, CURABLE RESIN COMPOSITION, SEALING AGENT FOR LIQUID CRYSTAL DISPLAY ELEMENTS, VERTICALLY CONDUCTIVE MATERIAL, AND LIQUID CRYSTAL DISPLAY ELEMENT	SEKISUI CHEMICAL CO., LTD.
WO/2021/246485	CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/256297	BRIDGED NUCLEOSIDE AND NUCLEOTIDE	LIID PHARMACEUTICALS, INC.
WO/2021/251306	DROPLETS AND METHOD FOR PRODUCING SAME	TOHOKU UNIVERSITY
WO/2021/251318	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/251335	FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM	SHOWA DENKO K.K.
WO/2021/251358	MODIFIED FERRITIN AND METHOD FOR PRODUCING SAME	AJINOMOTO CO., INC.
WO/2021/251433	COMPOSITION AND COMPOUND	FUJIFILM CORPORATION
WO/2021/256351	PHOSPHORUS-CONTAINING PHENOL COMPOUND, CURABLE RESIN COMPOSITION CONTAINING SAME, AND CURED OBJECT OBTAINED THEREFROM	NIPPON STEEL CHEMICAL & MATERIAL CO., LTD.
WO/2021/251438	FUSION PROTEIN CONTAINING ERYTHROPOIETIN POLYPEPTIDE	BICA THERAPEUTICS INC.
WO/2021/261264	METHOD FOR PRODUCING CYCLIC OLEFIN COMPOUND	MITSUI CHEMICALS, INC.
WO/2021/251459	HUMANIZED ANTI-GPC-1 ANTIBODY	NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
WO/2021/251461	COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT	KYULUX, INC.
WO/2021/251467	CRYSTAL MORPHOLOGY OF 1-[(4-METHYL-QUINAZOLINE-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-(3-(R)-AMINO-PEPERIDINE-1-YL)-XANTHINE	YUKI GOSEI KOGYO CO., LTD.
WO/2021/251471	CO2 METHANATION REACTION APPARATUS PROVIDED WITH SELECTIVE OXIDATION CATALYST FOR CO, AND METOD FOR REMOVING CO FROM GAS	MITSUBISHI POWER, LTD.
WO/2021/251481	COMPOSITION FOR FORMING PROTECTIVE FILM CONTAINING DIOL STRUCTURE	NISSAN CHEMICAL CORPORATION
WO/2021/261355	GEL COMPOSITION AND PRODUCTION METHOD THEREFOR, AND THREE-DIMENSIONAL TISSUE BODY AND PRODUCTION METHOD THEREFOR	TOPPAN INC.
WO/2021/256524	IMMUNOGENICITY-REDUCED LOW-MOLECULAR ANTIBODY AND METHOD FOR PRODUCING SAME	KYOTO UNIVERSITY
WO/2021/261376	ELECTROCHEMICAL DEVICE	MURATA MANUFACTURING CO., LTD.
WO/2021/256544	METHOD FOR EXTRACTING CERAMIDE-CONTAINING MATERIAL OR CERAMIDE FROM WHOLE APPLES AND/OR APPLE JUICE EXTRACTION RESIDUE, AND COMPOSITION INCLUDING SAID CERAMIDE	NIHON HARUMA KABUSHIKI KAISHA
WO/2021/256551	HIGH-PURITY 4-HYDROXYSTYRENE SOLUTION, PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR 4-HYDROXYSTYRENE-BASED POLYMER	MARUZEN PETROCHEMICAL CO., LTD.
WO/2021/261393	METHOD FOR PRODUCING TETRAHYDROFURAN-2-CARBOXYLIC ACID	TORAY FINE CHEMICALS CO.,LTD.
WO/2021/261417	HYDROCARBON GENERATION SYSTEM	IHI CORPORATION
WO/2021/261447	PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND	FUJIFILM CORPORATION
WO/2021/261461	COMPOUNDS, MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES, ORGANIC ELECTROLUMINESCENT DEVICES, AND ELECTRONIC DEVICES	IDEMITSU KOSAN CO.,LTD.
WO/2021/261467	DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME	SASAKI CHEMICAL INDUSTRY CO., LTD.
WO/2021/261483	ADENOCARCINOMA DETECTION METHOD, AND EXAMINATION KIT	MITSUI CHEMICALS, INC.
WO/2021/261497	COMPOUND, INITIATOR, COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING CURED PRODUCT	ADEKA CORPORATION
WO/2021/261509	METHOD FOR CLEAVING DISULFIDE BOND IN PROTEIN AND DEVICE FOR CLEAVING DISULFIDE BOND IN PROTEIN	PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
WO/2021/261511	METHOD OF INACTIVATING ALLERGEN AND ALLERGEN INACTIVATION DEVICE	PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
WO/2021/261544	HETEROCYCLIC COMPOUND AS INHIBITOR FOR CASEIN KINASE 1δ AND/OR ACTIVIN RECEPTOR-LIKE KINASE 5	ALCHEMEDICINE, INC.
WO/2021/261546	PHOTOSENSITIZING DYE	THE UNIVERSITY OF TOKYO
WO/2021/261562	ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE CONTAINING SAME, AND METHOD FOR USE THEREOF	NIHON NOHYAKU CO., LTD.
WO/2021/261563	ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDE COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE	NIHON NOHYAKU CO., LTD.
WO/2021/261564	METHOD FOR PRODUCING DIPEPTIDE	KYOWA HAKKO BIO CO., LTD.
WO/2021/006375	POLYPEPTIDE DIMER CONTAINING HIGH AMOUNT OF SIALIC ACID AND INCLUDING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	GI INNOVATION, INC.
WO/2021/010531	NOVEL METHOD FOR PREPARING PROTEIN CONJUGATE	HANMI PHARM. CO., LTD.
WO/2021/010532	METHOD FOR PREPARING LONG-ACTING DRUG CONJUGATE THROUGH PREPARATION OF NOVEL INTERMEDIATE	HANMI PHARM. CO., LTD.
WO/2021/015333	METHOD FOR PRODUCING LIGNIN MODIFIED WITH EXPOXIDIZED SOYBEAN OIL, AND BIODEGRADABLE POLYMERIC COMPOSITE COMPRISING MODIFIED LIGNIN	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY
WO/2021/015336	SINGLE DOMAIN ANTIBODY TARGETING αVβ3 INTEGRIN	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/029450	NOVEL PYRIMIDINE SULFONAMIDE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/029463	ORGANIC MATERIAL AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME	DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION
WO/2021/029464	ORGANIC MATERIAL AND ORGANIC LIGHT EMITTING DIODE CONTAINING SAME	DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION
WO/2021/045279	BIOMARKER-BASED THERAPEUTIC COMPOSITION	WELLMARKER BIO CO., LTD.
WO/2021/006419	REFINING METHOD OF OPHTHALMIC PROTEIN PHARMACEUTICAL	SAM CHUN DANG PHARM. CO., LTD.
WO/2021/045292	CRM197 PROTEIN EXPRESSION METHOD	GENOFOCUS CO., LTD.
WO/2021/033829	PEPTIDE HAVING ACTIVITY OF IMPROVING SKIN CONDITION AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/033830	PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/033831	PEPTIDE HAVING SKIN WHITENING ACTIVITY AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/033832	PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/033833	PEPTIDE HAVING SKIN WHITENING ACTIVITY AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/070997	ANTI-SYNTAXIN 1A ANTIBODY FOR INHIBITING SNARE COMPLEX, AND USE THEREOF	HAUUL BIO
WO/2021/075618	ALKYLENE CARBONATE PRODUCTION SYSTEM, AND PRODUCTION METHOD USING SAME	GREEN CHEMICAL CO., LTD.
WO/2021/090985	STERIC EPITOPE OF CEACAM1, AND ANTI-CEACAM1 ANTIBODY, OR FRAGMENT THEREOF, THAT SPECIFICALLY BINDS TO SAME	GREEN CROSS CORPORATION
WO/2021/100942	THIENOTHIAZOLECARBOXAMIDE DERIVATIVE WHICH IS ANTITUBERCULOUS COMPOUND	INSTITUT PASTEUR KOREA
WO/2021/025239	ANTI-TYROSINASE ANTIBODY FOR INHIBITING TYROSINASE AND USE THEREOF	HAUUL BIO
WO/2021/132746	ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF	ABL BIO, INC.
WO/2021/125418	PHENOLIC COMPOUND, SKIN-WHITENING COSMETIC COMPOSITION COMPRISING SAME, AND SKIN-WHITENING COSMETIC PRODUCT	CELLINBIO CO.,LTD
WO/2021/132764	METHOD FOR SEPARATING AND PURIFYING FUCOXANTHIN FROM DIATOMS	JNC BIO FISHERIES COMPANY LIMITED
WO/2021/107260	BIODIESEL PRODUCTION SYSTEM COMPRISING PROCESS FOR PREPROCESSING HIGH ACID VALUE OIL USING BIODIESEL BY-PRODUCT	MOOJIN MACHINETOOL CO.,LTD.
WO/2021/141165	AMINO ALCOHOL-BORON-BINOL COMPOSITE AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE USING SAME	MOLECULES & MATERIALS CO., LTD.
WO/2021/066260	FUNCTIONAL GROUP-PROTECTED DIAZIDOGLYOXIME, SYNTHESIS METHOD THEREFOR, AND TKX-50 SYNTHESIS METHOD USING FUNCTIONAL GROUP-PROTECTED DIAZIDOGLYOXIME	AGENCY FOR DEFENSE DEVELOPMENT
WO/2021/112333	METHOD FOR PRODUCING HIGH-YIELD COLLAGEN WITH OFF-FLAVOR REMOVED THEREFROM	MEDICA KOREA CO., LTD.
WO/2021/071033	METHOD FOR PREPARING DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE	ASTECH. CO., LTD.
WO/2021/215568	NOVEL CELL-PENETRATING PEPTIDE AND USE THEREOF	IMNEWRUN BIOSCIENCES, INC.
WO/2021/221208	DIHYDROPYRANO[3,2-G]CROMEN-2-ONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS ACTIVE INGREDIENT	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/221217	COMPOUND FOR ORGANIC ELECTRONIC DEVICES, ORGANIC ELECTRONIC DEVICE INCLUDING SAME, AND DISPLAY APPARATUS INCLUDING ORGANIC ELECTRONIC DEVICE	CHOI, Donsoo
WO/2021/100992	METHOD FOR PREPARING ANTI-HELICOBACTER PYLORI EGG YOLK ANTIBODY	ADBIOTECH CO., LTD.
WO/2021/100993	METHOD FOR PRODUCING YOLK ANTIBODY FOR PREVENTION OR TREATMENT OF OBESITY THROUGH CHOLESTEROL ABSORPTION INHIBITION	ADBIOTECH CO., LTD.
WO/2021/153847	METHOD FOR ACIDIFYING TEREPHTHALYLIDENE DICAMPHOR SULFONATE	SERASU CO., LTD
WO/2021/230393	PEPTIDE FOR TREATING INFLAMMATORY SKIN DISEASES AND USE THEREOF	KINE SCIENCES CO., LTD.
WO/2021/153848	FACILITY AND METHOD FOR PRODUCING HIGH-CONCENTRATION BIO-ALCOHOL USING PERVAPORATION AND DISTILLATION PROCESSES	SEPRATEK INC.
WO/2021/210718	CELL-PENETRATING CEREBLON RECOMBINANT FUSION PROTEIN AND USE THEREOF	UPPTHERA
WO/2021/045347	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/241782	FUSION PROTEIN FOR CELL CULTURE CONTAINING EXTRACELLULAR MATRIX MOTIF AND USE THEREOF	PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
WO/2021/020715	ENVIRONMENTALLY FRIENDLY METHOD FOR PREPARING NICKEL-COBALT-MANGANESE COMPOSITE PRECURSOR BY USING METAL SOLUTION COMPRISING ORGANIC CHELATING AGENT	ROV CO.,LTD.
WO/2021/040203	SALTS AND CRYSTAL FORM OF BENZOPYRANONE COMPOUND, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	ILAB
WO/2021/015419	ANTIBODY SPECIFICALLY BINDING TO PHOSPHORYLATED BETA-CATENIN, AND USE THEREOF	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/137369	NOVEL COCRYSTAL OF EMPAGLIFLOZIN	UNICEL LAB CO., LTD.
WO/2021/125474	NOVEL CRYSTALLINE FORM OF EDOXABAN AND PREPARATION METHOD THEREFOR	UNICEL LAB CO., LTD.
WO/2021/235591	METHOD FOR PREPARING COLLAGEN HAVING REDUCED OFF-FLAVOR AND VISCOSITY, AND FOOD AND COSMETIC COMPOSITION USING SAME	BEAUTEE COLLAGEN CO., LTD.
WO/2021/010621	PEPTIDE THERAPEUTICS FOR AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101003	METHOD FOR SYNTHESIS OF GLIFLOZIN BY USING METHANESULFONYLATION INTERMEDIATE IN CONTINUOUS REACTION PROCESS	UNIVERSITY-INDUSTRY FOUNDATION, YONSEI UNIVERSITY
WO/2021/006532	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME	LG CHEM, LTD.
WO/2021/054583	NEUTRALIZATION/WATER SEPARATION TANK FOR ESTERIFICATION PRODUCT AND METHOD FOR NEUTRALIZATION/WATER SEPARATION OF ESTERIFICATION PRODUCT	LG CHEM, LTD.
WO/2021/054584	APPARATUS FOR NEUTRALIZATION/WATER REMOVAL OF ESTERIFICATION PRODUCTS AND METHOD FOR NEUTRALIZATION/WATER REMOVAL OF ESTERIFICATION PRODUCTS	LG CHEM, LTD.
WO/2021/002689	NOVEL METHOD FOR PRODUCING PERAMIVIR TRIHYDRATE, AND WATER-BASED DRYING THEREOF	CKD BIO CORPORATION
WO/2021/015440	A RECOMBINANT PROTEIN PRODUCED FROM CHOLINESTERASE GENE DERIVED FROM PSEUDOMONAS AERUGINOSA AND THE COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING A NEUROLOGICAL DISEASE	JILGYUNGYI CO., LTD.
WO/2021/002700	METHOD FOR CONTINUOUSLY PREPARING DIESTER-BASED MATERIAL	LG CHEM, LTD.
WO/2021/002702	DIESTER-BASED MATERIAL MANUFACTURING UNIT, AND DIESTER-BASED MATERIAL MANUFACTURING SYSTEM INCLUDING SAME	LG CHEM, LTD.
WO/2021/002705	UNIT FOR PREPARING DIESTER-BASED MATERIAL, AND SYSTEM FOR PREPARING DIESTER-BASED MATERIAL, COMPRISING SAME	LG CHEM, LTD.
WO/2021/002707	HEAT EXCHANGE SYSTEM AND DIESTER-BASED COMPOSITION PREPARATION SYSTEM COMPRISING SAME	LG CHEM, LTD.
WO/2021/002708	SYSTEM AND METHOD FOR PREPARING DIESTER-BASED COMPOSITION	LG CHEM, LTD.
WO/2021/010631	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/010638	METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN	ABION INC.
WO/2021/006598	METHOD FOR PURIFYING WASTE N-METHYL-2-PYRROLIDONE MIXTURE SOLUTION	JAEWON INDUSTRIAL CO., LTD
WO/2021/006599	POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	GI INNOVATION, INC.
WO/2021/060677	AMINOSILANE COMPOUND, AND SILICON-CONTAINING THIN FILM DEPOSITION COMPOSITION COMPRISING SAME	DUKSAN TECHOPIA CO., LTD.
WO/2021/006604	NOVEL FUSION PROTEIN AND USE OF SAME	PROGEN CO., LTD.
WO/2021/006605	NOVEL IL-10 VARIANT PROTEIN AND USE THEREOF	PROGEN CO., LTD.
WO/2021/006619	ANTIBODY BINDING SPECIFICALLY TO B7-H3 AND USE THEREOF	Y-BIOLOGICS INC.
WO/2021/006652	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/015458	TRANSITION METAL COMPOUND FOR OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION CATALYST COMPRISING SAME, AND POLYOLEFIN POLYMERIZED USING SAME	HANWHA SOLUTIONS CORPORATION
WO/2021/010681	METHOD FOR PREPARING (3R,5R)-7-(2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-((4-HYDROXYMETHYLPHENYLAMINO)CARBONYL)-PYRROLE-1-YL)-3,5-DIHYDROXY HEPTANOIC ACID HEMICALCIUM SALT, AND METHOD FOR PREPARING INTERMEDIATES USED THEREIN	DAE WON PHARMACEUTICAL CO., LTD
WO/2021/010690	COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE	FUGENBIO CO., LTD.
WO/2021/010700	COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM, BACKLIGHT UNIT, AND DISPLAY DEVICE	LG CHEM, LTD.
WO/2021/010701	COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM MANUFACTURED THEREFROM, BACKLIGHT UNIT, AND DISPLAY DEVICE	LG CHEM, LTD.
WO/2021/010703	COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM PREPARED USING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE	LG CHEM, LTD.
WO/2021/006714	COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING IMMUNE CHECKPOINT INHIBITOR-RESISTANT CANCER	GOOD T CELLS, INC.
WO/2021/010712	ANTI-TAU ANTIBODY AND USE OF SAME	ADEL, INC.
WO/2021/010723	MELANOPHILIN ANTISENSE OLIGONUCLEOTIDES	OLIPASS COSMECEUTICALS COMPANY
WO/2021/145520	7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/145521	PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND THERAPEUTIC PHARMACEUTIC COMPOSITION COMPRISING SAME	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/010731	BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/137375	ESTER-BASED COMPOUND AND USE THEREOF	HANWHA SOLUTIONS CORPORATION
WO/2021/137376	ESTER-BASED COMPOUND AND USE THEREOF	HANWHA SOLUTIONS CORPORATION
WO/2021/010767	COMPOUND, COATING COMPOSITION INCLUDING SAME, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/010770	NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	SFC CO., LTD.
WO/2021/020778	TRANSITION METAL COMPOUND FOR OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION CATALYST INCLUDING SAME, AND POLYOLEFIN POLYMERIZED USING SAME	HANWHA SOLUTIONS CORPORATION
WO/2021/015497	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/010785	COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREFOR	DUK SAN NEOLUX CO., LTD.
WO/2021/025328	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME	LG CHEM, LTD.
WO/2021/010799	ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF	JW BIOSCIENCE
WO/2021/010800	ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF	JW BIOSCIENCE
WO/2021/107316	PEPTIDES INHIBITING ANDROGEN RECEPTOR ACTIVITY, AND COSMETICS COMPOSITION USING SAME	SUPADELIXIR INC.
WO/2021/125484	PEPTIDE INHIBITING ACTIVITY OF ARYL HYDROCARBON RECEPTOR AND COSMETIC COMPOSITION USING SAME	SUPADELIXIR INC.
WO/2021/020788	METHOD FOR SYNTHESIZING 2-((6-(HYDROXYMETHYL)CHROMENE-5-YL)OXY)-1-PHENYLETHANONE DERIVATIVE	GLACEUM INC.
WO/2021/015522	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/020798	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/020799	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT	DUK SAN NEOLUX CO.,LTD.
WO/2021/015544	BENZOQUINOLIZINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND CONTRAST MEDIUM COMPOSITION COMPRISING SAME	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/015555	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT	DUK SAN NEOLUX CO., LTD.
WO/2021/020807	NOVEL SMALL MOLECULE COMPOUND INHIBITING SIGNAL TRANSMISSION PATH OF TLR7 AND TLR9 AND USE THEREOF	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/020845	ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF	ABL BIO INC.
WO/2021/020846	ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF	ABL BIO INC.
WO/2021/118003	HIGH-YIELD PREPARATION METHOD FOR NOVEL VASCULAR LEAKAGE BLOCKER	CURACLE CO., LTD.
WO/2021/025356	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME	LT MATERIALS CO.,LTD.
WO/2021/020872	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR	DUKSAN NEOLUX CO., LTD
WO/2021/020873	COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/020879	DINUCLEOTIDE COMPOUNDS FOR TREATING CANCERS AND MEDICAL USES THEREOF	PINOTBIO, INC.
WO/2021/060691	CRYSTALLINE FORM OF BENZOPYRANONE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	ILAB
WO/2021/085810	GROUP 4 TRANSITION METAL COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION, COMPRISING SAME, FOR DEPOSITING THIN FILM	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/020928	POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/020929	COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/020931	COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/025407	OXO-PYRIDINE FUSION RING DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	WELLMARKER BIO CO., LTD.
WO/2021/033957	METHOD FOR PREPARING ALPHA OLEFIN AND DEVICE FOR PREPARING ALPHA OLEFIN	LG CHEM, LTD.
WO/2021/025442	NOVEL METHOD FOR PRODUCING EPINASTINE	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
WO/2021/025444	METHOD FOR HIGH THROUGHPUT PREPARATION OF PLANT-DERIVED POLYPHENOL SALTS	HAIM BIO CO., LTD.
WO/2021/071073	ALDOL CONDENSATION REACTION APPARATUS	HANWHA SOLUTIONS CORPORATION
WO/2021/071074	CONTINUOUS STIRRED TANK REACTOR FOR ALDOL CONDENSATION REACTION	HANWHA SOLUTIONS CORPORATION
WO/2021/025447	NOVEL COMPOUND FOR INHIBITING HISTONE ACETYLTRANSFERASE P300 AND ANTI-FIBROSIS COMPOSITION COMPRISING SAME	REFURE LIFE SCIENCE INC.
WO/2021/025448	NOVEL COMPOUND FOR INHIBITING HISTONE ACETYLTRANSFERASE P300 AND ANTIFIBROTIC COMPOSITION COMPRISING SAME	REFURE LIFE SCIENCE INC.
WO/2021/029598	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/033966	TRANSITION METAL COMPOUND, CATALYST COMPRISING SAME AND METHOD FOR PREPARING SAME	HANWHA SOLUTIONS CORPORATION
WO/2021/033970	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/049764	COMPOSITION COMPRISING EXPRESSION CONSTRUCT OF LACTIC ACID BACTERIUM-DERIVED P8 PROTEIN FOR TREATMENT OR PREVENTION OF COLON DISEASE	CELL BIOTECH CO., LTD.
WO/2021/033971	OLIGOMER PREPARATION METHOD AND OLIGOMER PREPARATION DEVICE	LG CHEM, LTD.
WO/2021/033972	PROCESS FOR PRODUCING OLIGOMERS AND APPARATUS FOR PRODUCING OLIGOMERS	LG CHEM, LTD.
WO/2021/025527	MITOCHONDRIA TARGETING POLYPEPTIDE AND USE THEREOF	UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
WO/2021/029632	FUSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS	BISICHEM CO., LTD.
WO/2021/040267	METHOD OF EXTRACTING CAFFEIC ACID AND ROSEMARINIC ACID FROM ROSEMARY	UCL CO. LTD.
WO/2021/029634	NOVEL COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME	LG CHEM, LTD.
WO/2021/033980	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/075686	PROCESS FOR HYDROGENATION OF PHTHALATE COMPOUND	HANWHA SOLUTIONS CORPORATION
WO/2021/054606	METHOD FOR HYDROGENATING PHTHALATE COMPOUND	HANWHA SOLUTIONS CORPORATION
WO/2021/054607	METHOD FOR DECOMPOSING PHENOLIC BY-PRODUCT	LG CHEM, LTD.
WO/2021/054608	METHOD FOR DECOMPOSING PHENOLIC BY-PRODUCTS	LG CHEM, LTD.
WO/2021/075691	PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/029665	NOVEL IMIDAZOLE DERIVATIVE EXPRESSING FLT3 INHIBITORY ACTIVITY, AND USE THEREOF	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
WO/2021/033993	OLIGOMER PREPARATION METHOD AND OLIGOMER PREPARATION APPARATUS	LG CHEM, LTD.
WO/2021/029675	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE	DUKSAN NEOLUX CO., LTD
WO/2021/029698	EXENATIDE ANALOGUE AND USE THEREOF	ANYGEN CO., LTD.
WO/2021/034014	NOVEL SILYLCYCLODISILAZANE COMPOUND AND METHOD FOR MANUFACTURING SILICON-CONTAINING THIN FILM USING THE SAME	DNF CO., LTD.
WO/2021/034017	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/029715	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/118010	METHOD FOR PREPARING ACRYLONITRILE DIMER	LG CHEM, LTD.
WO/2021/034039	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/029740	METHOD FOR PREPARING BOTULINUM TOXIN	PROTOX INC.
WO/2021/066319	TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/085817	TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/034081	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/034087	NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND	CELLGENTEK CO., LTD
WO/2021/034089	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/040310	HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME	LT MATERIALS CO.,LTD.
WO/2021/034101	NOVEL INTERFERON LAMBDA VARIANT AND PRODUCTION METHOD THEREFOR	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/034111	NOVEL SESQUITERPENE DERIVATIVE AND USE THEREOF	MFC CO.,LTD.
WO/2021/034118	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/034143	SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS DERIVED IMMUNOGENIC POLYPEPTIDE FRAGMENT AND USE THEREOF	UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY WONJU CAMPUS
WO/2021/040333	COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS
WO/2021/040336	NOVEL POLYPEPTIDE SELECTIVELY BINDING TO HUMAN PROGRAMMED CELL DEATH PROTEIN (PD-1) AND USE THEREOF	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/034156	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/040349	NOVEL HEPSIN INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING METASTATIC CANCER	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS
WO/2021/040356	C-NUCLEOSIDES, C-NUCLEOTIDES AND THEIR ANALOGS, EQUIVALENTS AND PRODRUGS THEREOF FOR ECTONUCLEOTIDASE INHIBITION	KAINOS MEDICINE, INC.
WO/2021/251551	NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR TREATING OR PREVENTING NEURAL DAMAGE, NEURAL DISEASE, OR DEVELOPMENTAL DISORDER THROUGH PROMOTING PROLIFERATION, DIFFERENTIATION, AND/OR REGENERATION OF NEURAL CELLS	MIRAEBIOPHARM
WO/2021/125493	MICROORGANISM COMPRISING GENETIC MODIFICATION THAT INCREASES ACTIVITY OF MULTIDRUG TRANSPORTER, AND METHOD FOR PRODUCING TRYPTOPHAN METABOLITES BY USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/125494	MULTIDRUG EFFLUX PUMP VARIANT, POLYNUCLEOTIDE CODING VARIANT, MICROORGANISM COMPRISING VARIANT, AND METHOD FOR PRODUCING VIOLACEIN OR DEOXYVIOLACEIN USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/040393	INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	KUKJE PHARMA CO., LTD.
WO/2021/040422	NOVEL PYRIMIDO[4,5-D]PYRIMIDINE-2-ONE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/045444	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/060723	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/040441	METHOD FOR PREPARING BIGUANIDE-BASED COMPOUND	HAIM BIO CO., LTD.
WO/2021/040455	NOVEL ALUMINUM-BASED METAL-ORGANIC FRAMEWORK HAVING THREE DIMENSIONAL POROUS STRUCTURE AND COMPRISING AT LEAST TWO TYPES OF LIGANDS, PREPARATION METHOD THEREFOR, AND USE THEREOF	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/040467	NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/091059	INHIBITOR FOR CARBAPENEM HYDROLYSIS CLASS D BETA-LACTAMASE (CHDL) AND PREPARATION METHOD THEREOF	MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION
WO/2021/101030	NOVEL METALLO-BETA-LACTAMASE INHIBITOR CREATED IN MULTI-DRUG RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR	MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION
WO/2021/075707	PEPTIDE FOR IMPROVING MEMORY AND PREVENTING OR ALLEVIATING COGNITIVE IMPAIRMENT, COMPOSITION CONTAINING SAME AND PREPARATION METHOD THEREFOR	NATURESENSE CO,, LTD
WO/2021/045460	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/049799	ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME	LG DISPLAY CO.,LTD.
WO/2021/045466	COMPOUND, CORE-SHELL DYE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING SAME, AND COLOR FILTER	SAMSUNG SDI CO., LTD.
WO/2021/040502	IMIDAZOPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT	TSD LIFE SCIENCES CO., LTD.
WO/2021/045469	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/045470	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/045479	NOVEL PNA OLIGOMER, USE THEREOF FOR DETECTING DNA METHYLATION, AND METHOD FOR DETECTING DNA METHYLATION USING SAME	SEASUNBIO MATERIALS
WO/2021/045513	ANTIBODY SPECIFICALLY RECOGNIZING ITIH1, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR IMPROVING INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE	APHARMA
WO/2021/049819	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/045582	2,6-BIS-(2-AMINOPYRIMIDIN-4-YL)PYRIDIN-3-OL DIHYDROCHLORIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	BEYONDBIO INC.
WO/2021/045584	2'-AMINO-6-(2-AMINO-6-METHYLPYRIMIDINE-4-YL)-3'-FLUORO-[2,4'-BIPYRIDINE]-5-OL DIHYDROCHLORIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	BEYONDBIO INC.
WO/2021/045585	METHOD FOR PRODUCING PYRIMIDINYL BIPYRIDINE COMPOUND AND INTERMEDIATE THEREFOR	BEYONDBIO INC.
WO/2021/045586	2'-AMINO-6-(2-AMINO-6-(1-ISOPROPYLPIPERIDIN-4-YL)-5-METHYLPYRIMIDIN-4-YL)-3'-FLUORO-[2,4'-BIPYRIDINE]-5-OL 3-HYDROCHLORIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	BEYONDBIO INC.
WO/2021/085834	NOVEL ANTIBACTERIAL PROTEIN CPEL-1 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIUM PERFRINGENS	INTRON BIOTECHNOLOGY, INC.
WO/2021/045590	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/049830	YKL-40-TARGETING HUMAN MONOCLONAL ANTIBODY	OSONG MEDICAL INNOVATION FOUNDATION
WO/2021/049840	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/049843	COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/049866	L-THREONINE EXPORT PROTEIN VARIANT AND METHOD FOR PRODUCTION OF L-THREONINE USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/049876	METHOD FOR PRODUCING L-HOMOSERINE	CJ CHEILJEDANG CORPORATION
WO/2021/060746	PREPARATION SYSTEM AND PREPARATION METHOD FOR DIESTER-BASED COMPOSITION	LG CHEM, LTD.
WO/2021/060749	PREPARATION SYSTEM AND PREPARATION METHOD FOR DIESTER-BASED COMPOSITION	LG CHEM, LTD.
WO/2021/049889	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/075734	METHOD FOR SEPARATING DISODIUM 5'-INOSINATE	CJ CHEILJEDANG CORPORATION
WO/2021/066350	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/066351	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/054714	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/060777	ESTERIFICATION APPARATUS AND ESTERIFICATION METHOD	LG CHEM, LTD.
WO/2021/107359	COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/054774	TAG PROTEIN FOR INCREASING WATER SOLUBILITY AND HEAT STABILITY OF TARGET PROTEIN, AND FUSION PROTEIN COMPRISING SAME	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/054778	ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/071130	METHOD FOR PREPARING DISODIUM 5'-GUANYLATE HEPTAHYDRATE CRYSTAL	CJ CHEILJEDANG CORPORATION
WO/2021/054804	NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES	AUTOTAC INC.
WO/2021/060791	NANO-PERFORATOR HAVING IMPROVED ANTI-VIRAL ACTIVITY	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/060837	ANTI-MERS-COV ANTIBODY AND USE THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060861	METHOD FOR PREPARING DIESTER-BASED SUBSTANCE	LG CHEM, LTD.
WO/2021/060865	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/162194	CYCLIC PEPTIDE COMPOUND CONTAINING PIPERAZIC ACID, METHOD OF PRODUCING SAME, AND USES OF SAME	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060888	COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING NOVEL TRIFLUOROMETHYL PHENYL PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT	KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
WO/2021/060890	HETEROARYLAMIDOPYRIDINOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE	INNOVO THERAPEUTICS INC.
WO/2021/066397	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/060914	ANTI-CLAUDIN-3 CHIMERIC ANTIGEN RECEPTOR	LOGONE BIO CONVERGENCE RESEARCH FOUNDATION
WO/2021/060926	CHIMERIC CYTOKINE RECEPTOR CAPABLE OF IMMUNE SIGNAL CONVERSION, IMMUNE CELLS EXPRESSING SAME, AND ANTI-CANCER USE THEREOF	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/066420	CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD138, IMMUNE CELL EXPRESSING SAME, AND ANTICANCER USE THEREOF	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/060929	FUNCTIONALIZED METAL-ORGANIC FRAMEWORK, PRODUCTION METHOD THEREFOR AND METHOD FOR SELECTIVELY SEPARATING CARBON DIOXIDE USING SAME	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/060932	CHIMERIC ANTIGEN RECEPTOR COMPRISING ANTI C-MET ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, AND USE THEREOF	HELIXMITH CO., LTD
WO/2021/060947	NOVEL SYNTHESIS METHOD OF PSEUDOCERAMIDE, AND INTERMEDIATES THEREOF	DAEBONG LS, LTD
WO/2021/060948	METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM	DAEBONG LS, LTD
WO/2021/066435	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME	DUKSAN NEOLUX CO., LTD
WO/2021/085875	NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/241810	GLP-1 HAVING HSA SITE-SPECIFICALLY LINKED THERETO	PROABTECH CO., LTD.
WO/2021/157809	NOVEL COMPOSITION FOR NUCLEIC ACID MOLECULE DELIVERY, AND USE THEREOF	INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
WO/2021/066528	FLAVIN MONONUCLEOTIDE-BINDING PROTEIN VARIANTS HAVING IMPROVED FLUORESCENCE INTENSITY DERIVED FROM ARABIDOPSIS THALIANA	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/201352	NOVEL BENZIMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF AS ANTICANCER AGENT	BIOMETRIX TECHNOLOGY INC
WO/2021/261663	NOVEL BENZIMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF AS ANTICANCER OR ANTIVIRAL AGENT	BIOMETRIX TECHNOLOGY INC
WO/2021/066552	TISSUE ADHESION COMPOSITION WITH BIO-TISSUE ADHESIVENESS AND BONDING FORCE AND PREPARATION METHOD THEREFOR	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/066559	N-(1H-IMIDAZOL-2-YL)BENZAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT	KAINOS MEDICINE, INC.
WO/2021/066573	NOVEL COMPOUND AND USE THEREOF IN TREATING AUTOIMMUNE DISEASES	PARENCHYMA BIOTECH INC.
WO/2021/066578	BICYCLIC COMPOUND AND USE THEREOF	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/066608	COMPOUND FOR INDUCING EXPRESSION OF ANTI-AGING GENE KLOTHO AND USE THEREOF	KLOTHO SCIENCES
WO/2021/066612	TUMOR-TARGETING PROTEIN OR FRAGMENT THEREOF, ANTIBODY BINDING THERETO AND USE THEREOF	BIONOXX INC.
WO/2021/225233	NOVEL CRYSTALLINE FORM OF VASCULAR LEAKAGE BLOCKER COMPOUND	CURACLE CO., LTD.
WO/2021/075775	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/071248	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DIODE	LT MATERIALS CO.,LTD.
WO/2021/071255	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/075791	PEPTIDE FOR REDUCING HAIR LOSS AND PROMOTING HAIR GROWTH, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	INCOSPHARM CORPORATION
WO/2021/075792	PEPTIDE COMPOSITION FOR IMPROVING SCALP HEALTH AND ALLEVIATING HAIR LOSS	INCOSPHARM CORPORATION
WO/2021/085888	NOVEL HETEROCYCLIC-SUBSTITUTED PYRIMIDINE DERIVATIVE EXHIBITING CANCER CELL GROWTH INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	ONCOBIX CO., LTD.
WO/2021/071319	MULTISPECIFIC FUSION PROTEIN AND USE THEREOF	Y-BIOLOGICS INC.
WO/2021/071345	POLYCYCLIC COMPOUND AND ORGANOELECTRO LUMINESCENT DEVICE USING SAME	SFC CO., LTD.
WO/2021/075834	ANTI-SNAP 25 ANTIBODY FOR INHIBITING SNARE COMPLEX, AND USE THEREOF	HAUUL BIO
WO/2021/096075	METHOD FOR PREPARING ACRYLONITRILE DIMERS	LG CHEM, LTD.
WO/2021/075852	COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/075860	2-METHOXYESTRADIOL DERIVATIVES AND MEDICAL USES THEREOF	INSTITUT PASTEUR KOREA
WO/2021/080253	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/080254	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/075904	NOVEL TRIAZINE-BASED AMPHIPHILIC COMPOUND AND USE THEREOF	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
WO/2021/085906	MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES	FUSION BIOTECHNOLOGY CO., LTD.
WO/2021/075930	NEONATAL FC RECEPTOR BINDING AFFIMERS	LG CHEM, LTD.
WO/2021/080280	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/080282	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/085916	METHOD FOR PREPARING ASTAXANTHIN MONOESTER THROUGH TRANSESTERIFICATION	NATURAL BIO TREE CO.,LTD.
WO/2021/172690	MESOTHELIN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF	GREENCROSSCELL
WO/2021/080330	NICOTINAMIDE COMPOUND AND HERBICIDAL COMPOSITION COMPRISING COMPOUND	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/080333	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR	DUK SAN NEOLUX CO., LTD.
WO/2021/080334	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/080339	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE USING SAME	LG CHEM, LTD.
WO/2021/080340	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE USING SAME	LG CHEM, LTD.
WO/2021/080346	NOVEL PYRIDINYLTRIAZINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING CANCER COMPRISING SAME	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/080352	RADIOISOTOPE LABELED COMPOUND FOR IMAGING OR TREATMENT OF PROSTATE CANCER	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/080359	BICYCLIC COMPOUND AND USE THEREOF	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/080368	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/091131	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/080380	METHOD FOR PREPARING ARYL 2-TETRAZOL-2-YL KETONE WITH IMPROVED SELECTIVITY	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/085966	CYCLODODECANONE AND PREPARATION METHOD THEREFOR	HANWHA SOLUTIONS CORPORATION
WO/2021/085969	COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/096103	METHOD FOR HYDROGENATING PHTHALATE-BASED COMPOUND	HANWHA SOLUTIONS CORPORATION
WO/2021/112405	ISOMERIZATION METHOD OF CYCLOHEXANE DICARBOXYLIC ACID	HANWHA SOLUTIONS CORPORATION
WO/2021/085978	CYCLODODECANONE AND PREPARATION METHOD THEREFOR	HANWHA SOLUTIONS CORPORATION
WO/2021/112407	METHOD FOR PRODUCING LAUROLACTAM, DEVICE FOR SYNTHESIZING SAME, LAUROLACTAM COMPOSITION PRODUCED THEREBY, AND METHOD FOR PRODUCING POLYLAUROLACTAM USING SAME	HANWHA SOLUTIONS CORPORATION
WO/2021/085991	CINNAMIC AMIDE DERIVATIVE HAVING FXR ACTIVATING EFFECT, PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT, AND PREPARATION METHOD THEREFOR	KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION
WO/2021/086006	INDIUM PRECURSOR COMPOUND, METHOD FOR MANUFACTURING THIN FILM BY USING SAME, AND SUBSTRATE MANUFACTURED FROM SAME.	SOULBRAIN CO., LTD.
WO/2021/096112	PYRROLOPYRIMIDINE, PYRROLOPYRIDINE AND INDAZOLE COMPOUND DERIVATIVE, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION CONTAINING SAME	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/101112	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/086038	NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME	HOLOSMEDIC
WO/2021/086044	NOVEL COMPOUND FOR CROP PROTECTANT	LG CHEM, LTD.
WO/2021/086069	COMPOUND COMPRISING EZH2 INHIBITOR AND E3 LIGASE BINDER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EZH2-ASSOCIATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/086077	ISOQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION, COMPRISING SAME AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF POLY(ADP-RIBOSE)POLYMERASE-1 (PARP-1)-ASSOCIATED DISEASE	THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
WO/2021/086089	METHOD FOR PREPARING 1,3-CYCLOPENTANEDIOL	KOLON INDUSTRIES, INC.
WO/2021/101117	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/086099	ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/086101	USE OF NOVEL COMPOUND, FOR PREVENTING, IMPROVING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS	PRG S&TECH INC.
WO/2021/251564	ANTIBODY SPECIFICALLY BINDING TO GRP94 OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF	KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
WO/2021/086133	TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF	JD BIOSCIENCE INC.
WO/2021/086142	ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE	SOULBRAIN CO., LTD.
WO/2021/086143	ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE	SOULBRAIN CO., LTD.
WO/2021/091173	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/086148	POLYCYCLIC COMPOUND AND ORGANOELECTRO LUMINESCENT DEVICE USING SAME	SFC CO., LTD.
WO/2021/091182	FORMIC ACID MANUFACTURING PROCESS AND MANUFACTURING APPARATUS USING SYNTHETIC GAS	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/086158	DISEASE ANTIGEN-FUSED PROTEIN, AND USE THEREOF	CELLEMEDY CO.,LTD
WO/2021/086159	PROTEIN FUSED WITH MOLECULE CAPABLE OF BINDING TO IMMUNE CHECKPOINT MOLECULE AND USE OF SAME	CELLEMEDY CO.,LTD
WO/2021/091222	COMPOUND, BINDER RESIN, NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, AND DISPLAY DEVICE COMPRISING BLACK BANK FORMED USING SAME	LG CHEM, LTD.
WO/2021/101132	METHOD OF PREPARING EGG YOLK ANTIBODY FOR PREVENTING DEATH IN SHRIMP	ADBIOTECH CO., LTD.
WO/2021/101133	METHOD FOR PREPARING YOLK ANTIBODIES FOR PREVENTING OR TREATING SALMONID RICKETTSIAL SEPTICAEMIA	ADBIOTECH CO., LTD.
WO/2021/091238	TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) SMALL MOLECULE INHIBITOR	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/091247	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/091259	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE	LT MATERIALS CO.,LTD.
WO/2021/091283	MELANOCORTIN-4 RECEPTOR AGONISTS	LG CHEM, LTD.
WO/2021/125552	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME	LG CHEM, LTD.
WO/2021/132872	NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE	PRG S&TECH INC.
WO/2021/091304	NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF	KOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/091310	NOVEL HUMAN EPIDERMAL GROWTH FACTOR FUSION PROTEIN AND USE THEREOF	KOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/091324	ONE-DIMENSIONAL ELECTRICALLY CONDUCTIVE NI-ORGANIC STRUCTURE AND SUPER CAPACITOR ELECTRODE COMPRISING SAME	CENTER FOR ADVANCED META-MATERIALS
WO/2021/132876	METHOD FOR PRODUCING 1,4-CYCLOHEXANEDIMETHANOL	HANWHA SOLUTIONS CORPORATION
WO/2021/256623	METHOD FOR PRODUCING AROMATIC HYDROCARBON	LG CHEM, LTD.
WO/2021/107451	BRANCHED-CHAIN AMINO ACID CRYSTALLIZATION METHOD CAPABLE OF SUSTAINABLY CYCLING AMMONIA	CJ CHEILJEDANG CORPORATION
WO/2021/091358	PROSTAGLANDIN ANALOGS AND USES THEREOF	LIFEX BIOLABS, INC.
WO/2021/091359	EPITOPE OF REGULATORY T CELL SURFACE ANTIGEN, AND ANTIBODY SPECIFICALLY BINDING THERETO	GOOD T CELLS, INC.
WO/2021/096197	PEPTIDE FOR TREATING INFLAMMATION AND WOUNDS	NIBEC CO., LTD.
WO/2021/101157	COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/096238	NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME	YUHAN CORPORATION
WO/2021/096239	NOVEL DERIVATIVES HAVING 1,2,3,4-TETRAHYDRONAPHTHALENE MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME	YUHAN CORPORATION
WO/2021/096241	NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME	YUHAN CORPORATION
WO/2021/096273	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/096275	FUSION PROTEIN INCLUDING MODIFIED INTERLEUKIN-7 AND TGF BETA RECEPTOR II AND USE THEREOF	GENEXINE, INC.
WO/2021/145545	OLIGOMER MANUFACTURING APPARATUS	LG CHEM, LTD.
WO/2021/096284	GLP-1 RECEPTOR AGONIST AND USE THEREOF	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/096285	COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/096304	GLP-1 RECEPTOR AGONIST AND USE THEREOF	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/096314	NOVEL BENZIMIDAZOLE DERIVATIVE AND USE THEREOF	GGACHON UNIVERSITY OF INDUSTRYACADEMIC COOPERATION FOUNDATION
WO/2021/112444	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/107473	FGF2 POLYPEPTIDE WITH IMPROVED TEMPERATURE STABILITY AND PROTEASE RESISTANCE AND USE THEREOF	KOREA INSTITUTE OF OCEAN SCIENCE TECHNOLOGY
WO/2021/107474	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/107476	POLYMORPHS OF 1-(4-BENZYLOXY-BENZYL)-3-METHYL-THIOUREA	THERASID BIOSCIENCE INC.
WO/2021/107478	A METHOD FOR PREPARING NOVEL CRYSTALLINE FORMS OF 1-(4-BENZYLOXY-BENZYL)-3-METHYL-THIOUREA	THERASID BIOSCIENCE INC.
WO/2021/149900	DISUBSTITUTED ADAMANTYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CANCER GROWTH COMPRISING SAME AS ACTIVE INGREDIENT	DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/118086	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/101220	HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DEVICE	LT MATERIALS CO.,LTD.
WO/2021/101247	COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/101255	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/101264	AZOBENZENE COMPOUND COMPRISING NITROGEN-CONTAINING HETEROAROMATIC, AND BLUE HOLOGRAM RECORDING COMPOSITION COMPRISING SAME	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/112458	NOVEL CELL PERMEABLE PEPTIDE AND USES THEREOF	KAN ZEN CO.,LTD
WO/2021/101293	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/112461	SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE AGENT	LG CHEM, LTD.
WO/2021/107514	METHOD FOR PREPARING LIFITEGRAST	YONSUNG FINE CHEMICAL CO., LTD.
WO/2021/107519	BIOTIN MOIETY-CONJUGATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING THE SAME	D&D PHARMATECH INC.
WO/2021/132895	BENZAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/107522	COMPOSITION FOR PREPARING ALLULOSE AND METHOD FOR PREPARING ALLULOSE BY USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/101346	ANTI-ROR1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF	DONG-A ST CO., LTD.
WO/2021/261681	METHOD FOR DECOMPOSING PHENOLIC BY-PRODUCT	LG CHEM, LTD.
WO/2021/101349	ANTIBODY THAT BINDS TO ROR1 AND B7-H3, ANTIBODY-DRUG CONJUGATE CONTAINING SAME, AND USE THEREOF	ABL BIO, INC.
WO/2021/107566	ANTIBODY AGAINST C-KIT AND USE THEREOF	NOVELTY NOBILITY INC.
WO/2021/261682	METHOD FOR PREPARING ISOPROPYL ALCOHOL	LG CHEM, LTD.
WO/2021/107590	NOVEL TRIAZOLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/112478	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/107603	LONG-ACTING GDF15 FUSION PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	YUHAN CORPORATION
WO/2021/107646	METHOD FOR PRODUCING MAXACALCITOL, AND INTERMEDIATE THEREFOR	YONSUNG FINE CHEMICAL CO., LTD.
WO/2021/107656	NOVEL QUERCETIN REDOX DERIVATIVE AND USE THEREOF AS BET INHIBITOR	BENOBIO CO., LTD.
WO/2021/107657	NOVEL QUINAZOLINE REDOX DERIVATIVE, AND USE AS BET INHIBITOR	BENOBIO CO., LTD.
WO/2021/112496	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/112497	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/107660	MULTIFUNCTIONAL MULTISPECIFIC MULTIMERIC BIOMOLECULE POLYMER HAVING PROLONGED IN-VIVO DURATION	ONEGENE BIOTECHNOLOGY INC.
WO/2021/107674	NOVEL COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
WO/2021/157830	TCR-LIKE ANTIBODY SPECIFIC TO CMV PP65 PEPTIDE/HLA-A*02 COMPLEX, AND USE THEREOF	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/107678	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/107680	COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/107681	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/107686	EDARAVONE PRODRUG COMPOUND AND PHARMACEUTICAL USE THEREOF FOR TREATING OR ALLEVIATING NEURODEGENERATIVE OR MOTOR NEURON DISEASES	J2H BIOTECH INC.
WO/2021/107694	ORGANIC LIGHT-EMITTING ELEMENT	LG CHEM, LTD.
WO/2021/107705	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/107711	POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/221259	ORGANIC-INORGANIC PEROVSKITE COMPOUND HAVING ENHANCED STABILITY	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/107725	COBLL1 PROTEIN-SPECIFIC ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/107726	CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD 300C ANTIGEN OR RECEPTOR THEREOF	CENTRICS BIO
WO/2021/107728	ORGANIC LIGHT-EMITTING DEVICE	LG CHEM, LTD.
WO/2021/107730	SYNTHETIC-BAICALEIN-DERIVATIVE AS CHEMOTHERAPEUTIC AGENT	INSTITUTE FOR BASIC SCIENCE
WO/2021/107736	ORGANIC LIGHT-EMITTING ELEMENT	LG CHEM, LTD.
WO/2021/107737	ORGANIC LIGHT-EMITTING ELEMENT	LG CHEM, LTD.
WO/2021/125622	COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND DISPLAY DEVICE	SK MATERIALS CO., LTD.
WO/2021/112538	GLP-1 RECEPTOR AGONIST	HYUNDAI PHARM CO., LTD.
WO/2021/112540	CHO CELL-DERIVED PROTEIN SECRETORY FACTOR AND EXPRESSION VECTOR COMPRISING SAME	LG CHEM, LTD.
WO/2021/118156	SWITCHING BINDER, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION, ASSAY KIT, AND ANTIGEN AND ANTIBODY ASSAY METHOD, EACH USING SAME	OPTOLANE TECHNOLOGIES INC.
WO/2021/112574	A PROCESS FOR PREPARING ISOINDOLINONE DERIVATIVE, NOVEL INTERMEDIATES USED FOR THE PROCESS, AND A PROCESS FOR PREPARING THE INTERMEDIATES	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/118159	HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/132930	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE	LT MATERIALS CO.,LTD.
WO/2021/118171	(ARYLOXY)ALKYL GROUP-SUBSTITUTED COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
WO/2021/112620	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF SARCOPENIA OR MUSCLE ATROPHY	GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/125648	NOVEL COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME	LG CHEM, LTD.
WO/2021/112626	NOVEL INDIRUBIN DERIVATIVE AND USE THEREOF	PELEMED CO., LTD.
WO/2021/112640	ANTI-TM4SF4 ANTIBODY AND USE THEREOF	KOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/118217	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/132952	COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND DISPLAY DEVICE	SK MATERIALS CO., LTD.
WO/2021/118233	BISMALEIMIDE-DERIVED EPOXY COMPOUND CONTAINING POLYCYCLIC STRUCTURE AND PREPARATION METHOD THEREFOR	KUK DO CHEMICAL CO., LTD.
WO/2021/118234	NOVEL FURAN-BASED COMPOUND, NOVEL EPOXY COMPOUND, AND METHOD FOR PREPARING SAME	KUK DO CHEMICAL CO., LTD.
WO/2021/132956	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/132957	METHOD FOR PURIFYING FOLLICLE STIMULATING HORMONE	LG CHEM, LTD.
WO/2021/132958	METHOD FOR PURIFYING FOLLICLE-STIMULATING HORMONE	LG CHEM, LTD.
WO/2021/118246	ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF	ABL BIO, INC.
WO/2021/118256	FUSION POLYPEPTIDE COMPRISING GDF15 AND POLYPEPTIDE REGION CAPABLE OF O-GLYCOSYLATION	LG CHEM, LTD.
WO/2021/125708	NICOTINAMIDE RIBOSIDE DERIVATIVE CONJUGATED TO FATTY AMINE	HUMEDIX CO., LTD.
WO/2021/118318	NOVEL INDOLE DERIVATIVE AND USE THEREOF	METACEN THERAPEUTICS
WO/2021/118329	ANTI-CANCER PRODRUG FOR OVERCOMING MULTIDRUG RESISTANCE	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/125758	NOVEL DEUTERIUM-SUBSTITUTED PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	ONCOBIX CO., LTD.
WO/2021/162227	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/125787	MONOCLONAL ANTIBODY SPECIFIC TO DCR1	SCIMMNUE INC.
WO/2021/125791	NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME	I-SENS, INC.
WO/2021/125802	NOVEL INDAZOLE DERIVATIVE, AND USE THEREOF	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/125803	NOVEL PYRIMIDIN DERIVATIVE AND USE THEREOF	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/125813	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/125814	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/125819	METHOD FOR PREPARING URIDINE 5'-DIPHOSPHATE (UDP), SALT THEREOF OR HYDRATE THEREOF	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/125821	COMPOUND, BINDER RESIN, NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, AND DISPLAY DEVICE COMPRISING BLACK BANK FORMED USING SAME	LG CHEM, LTD.
WO/2021/132981	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE	LT MATERIALS CO.,LTD.
WO/2021/132982	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DIODE	LT MATERIALS CO.,LTD.
WO/2021/132984	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DIODE	LT MATERIALS CO.,LTD.
WO/2021/125834	COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/125835	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/167222	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/125896	MUTANT OF INNER MEMBRANE PROTEIN, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/125905	NOVEL THIAZOLE DERIVATIVE AND USE THEREOF	GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/133016	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT	LT MATERIALS CO.,LTD.
WO/2021/137500	REAL-TIME FLUORESCENCE IMAGING SENSOR FOR MEASURING GLUTATHIONE IN ENDOPLASMIC RETICULUM AND METHOD USING SAME	CELL2IN, INC.
WO/2021/133030	MICROORGANISM FOR PRODUCING L-AMINO ACID HAVING INCREASED CYTOCHROME C ACTIVITY, AND L-AMINO ACID PRODUCTION METHOD USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/133032	MODIFIED GAMMA-CARBON SKELETON COMPOUND AND PREPARATION METHOD THEREFOR	SEASUNBIO MATERIALS
WO/2021/133033	METHOD FOR PRODUCING PNA OLIGOMER IN SOLUTION PROCESS	SEASUNBIO MATERIALS
WO/2021/133035	NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF	LG CHEM, LTD.
WO/2021/133036	ANTI-LILRB1 ANTIBODY AND USES THEREOF	LG CHEM, LTD.
WO/2021/133037	PYRROLIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BETA-AMYLOID OR TAU PROTEIN-ASSOCIATED DISEASES CONTAINING SAME	YONSEI UNIVERSITY, UNIVERSITY - INDUSTRY FOUNDATION (UIF)
WO/2021/133038	NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF	LG CHEM, LTD.
WO/2021/133049	CHLOROPLAST TRANSIT PEPTIDES AND USE THEREOF	FARMHANNONG CO., LTD.
WO/2021/133080	YTTRIUM/LANTHANIDE METAL PRECURSOR COMPOUND, COMPOSITION COMPRISING SAME FOR FORMING FILM, AND METHOD FOR FORMING YTTRIUM/LANTHANIDE METAL-CONTAINING FILM USING COMPOSITION	UP CHEMICAL CO., LTD.
WO/2021/133085	PREPARATION METHOD FOR ORGANIC HALIDE FOR PREPARATION OF PEROVSKITE, PEROVSKITE PREPARED THEREBY, AND SOLAR CELL	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/133129	NOVEL DIHYDROINDENO[1,2-C]PYRAZOLE-3-CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEVELOPMENTAL DISORDERS OR NEURODEGENERATIVE DISEASES, COMPRISING SAME	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/133136	METHOD FOR PRODUCING 1,4-CYCLOHEXANE DICARBOXYLIC ACID	HANWHA SOLUTIONS CORPORATION
WO/2021/133137	METHOD FOR PREPARING 1,4-CYCLOHEXANEDIMETHANOL	HANWHA SOLUTIONS CORPORATION
WO/2021/133138	METHOD FOR PREPARATION OF 1, 4-CYCLOHEXANEDIMETHANOL	HANWHA SOLUTIONS CORPORATION
WO/2021/133144	NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME	I-SENS, INC.
WO/2021/157861	NOVEL SACUBITRIL CALCIUM/VALSARTAN CO-CRYSTAL AND CO-AMORPHOUS FORM	UNICEL LAB CO., LTD.
WO/2021/137565	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER	LT MATERIALS CO.,LTD.
WO/2021/256646	NOVEL GAIN-OF-FUNCTION MUTANT OF BMPR2 GENE AND USE THEREOF	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/256647	MUTATION COMPLEX INCLUDING GAIN-OF-FUNCTION MUTANT OF BMPR2 GENE, INDUCED PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS DERIVED FROM MUTANT, AND USE THEREOF	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/137646	PYRROLOBENZODIAZEPINE DERIVATIVE AND LIGAND-LINKER CONJUGATE THEREOF	LEGOCHEM BIOSCIENCES, INC.
WO/2021/137655	ANTIBODY FOR SUPER-REPRESSOR IKB, AND USE THEREOF	ILIAS BIOLOGICS, INCORPORATED
WO/2021/080400	OENANTHE JAVANICA-DERIVED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	GANGNEUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION GROUP
WO/2021/015603	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/029757	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/034173	NOVEL LOBARIC ACID DERIVATIVE HAVING PTP-1B INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF	SNBIOSCIENCE INC.
WO/2021/096335	NOVEL QUINOLINE COMPOUND AND USE THEREOF	MBD CO., LTD.
WO/2021/137665	1, 2, 3-TRIAZOLE DERIVATIVE COMPOUND AS HSP90 INHIBITOR, AND USE THEREOF	EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/145598	METHOD FOR PREPARING ACRYLONITRILE DIMER	LG CHEM, LTD.
WO/2021/141356	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/141370	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
WO/2021/141378	POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANOELECTROLUMINESCENT DEVICE USING SAME	SFC CO., LTD.
WO/2021/230460	FUSION PROTEIN COMPRISING PD-L1 PROTEIN AND MONOMERIC IL-10 VARIANT AND USE THEREOF	GENEXINE, INC.
WO/2021/141382	FLUORENE-BASED COMPOUND, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR	LG CHEM, LTD.
WO/2021/141428	BISANTHRACENE DERIVATIVES HAVING SOLUBILIZING SUBSTITUENT, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME	LG CHEM, LTD.
WO/2021/145641	N-PHENOLBENZOTHIAZOL-2-AMINE COMPOUND HAVING ANTI-ANGIOGENETIC EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/157885	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/145649	NOVEL N-HETEROCYCLIC CARBENE, TRANSITION METAL COMPLEX THEREOF, AND METHOD FOR PREPARING SAME	POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
WO/2021/145651	COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/145655	NOVEL PYRAZOLE DERIVATIVE	APTABIO CO., LTD.
WO/2021/153931	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/145704	RECOMBINANT VECTOR COMPRISING CODON-OPTIMIZED TIF1Γ POLYNUCLEOTIDE, AND USE THEREOF	NEO GENE PHARM INC.
WO/2021/149971	NOVEL COMPOUND AND USE THEREOF	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/145711	ORGANIC LIGHT-EMITTING DEVICE	LG CHEM, LTD.
WO/2021/215624	NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	HEXAPHARMATEC CO., LTD.
WO/2021/145729	NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/145743	MITOCHONDRIA-TARGETING PROTEIN AND USE THEREOF	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/149998	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME	DUK SAN NEOLUX CO., LTD.
WO/2021/150026	POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	SFC CO., LTD.
WO/2021/150043	METHOD FOR PREPARING ORGANIC-ORGANIC COMPOSITE CARBONACEOUS NANOPLATE AT ATMOSPHERIC PRESSURE, AND ORGANIC-ORGANIC COMPOSITE CARBONACEOUS NANOPLATE PREPARED THEREBY	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/153946	PEPTIDE INHIBITING FORMATION OF SNARE COMPLEX AND USE THEREOF	MEDYTOX INC.
WO/2021/150049	NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/150052	NOVEL GADOLINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND MRI CONTRAST AGENT CONTAINING SAME	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/150069	NOVEL QUINAZOLINE COMPOUND AS THERAPEUTIC AGENT FOR METABOLIC DISORDERS	BIOWAY, INC.
WO/2021/150080	POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	SFC CO., LTD.
WO/2021/167256	EPISULFIDE COMPOUND FOR OPTICAL MATERIAL, COMPOSITION FOR HIGH REFRACTIVE INDEX OPTICAL MATERIAL CONTAINING SAME, AND METHOD FOR MANUFACTURING OPTICAL MATERIAL	KOC SOLUTION CO., LTD.
WO/2021/162284	ESTER-BASED COMPOUND PRODUCTION METHOD	HANWHA SOLUTIONS CORPORATION
WO/2021/187748	METHOD FOR SELECTIVELY MODIFYING NUCLEOTIDES	UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
WO/2021/153984	BENZOSELENOPHENE-BASED COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND ANTIBODY-DRUG CONJUGATE	AIMED BIO INC.
WO/2021/167262	NUCLEOSIDE HYDROLASE INHIBITOR, COMPOSITION COMPRISING SAME FOR INHIBITING TOXICITY OF PATHOGENIC MICROORGANISM, METHOD FOR INHIBITING TOXICITY OF PATHOGENIC MICROORGANISM, USING SAME, AND A METHOD FOR SCREENING NUCLEOSIDE HYDROLASE INHIBITOR	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/154041	COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR	LG CHEM, LTD.
WO/2021/154046	PH-SENSITIVE FC VARIANT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/157973	PEGYLATED IGE-DEPENDENT HISTAMINE-RELEASING FACTOR (HRF)-BINDING PEPTIDE AND USE THEREOF	EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/246611	METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/162347	NOVEL BORON COMPOUND, AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	SFC CO., LTD.
WO/2021/158046	PHARMACEUTICAL COMPOSITION COMPRISING GOSSYPOL OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF NEUROLOGICAL DISORDER	HAIM BIO CO., LTD.
WO/2021/167275	NON-PROTEIN A PURIFICATION METHOD FOR ADALIMUMAB	PRESTIGE BIOPHARMA PTE LTD.
WO/2021/167276	OPTIMIZED METHOD FOR BEVACIZUMAB PURIFICATION	PRESTIGE BIOPHARMA PTE. LTD.
WO/2021/158073	FUSION ANTIBODY FOR PRESENTING ANTIGEN-DERIVED T CELL ANTIGEN EPITOPE OR PEPTIDE CONTAINING SAME ON CELL SURFACE, AND COMPOSITION COMPRISING SAME	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/158092	NOVEL POLYPEPTIDE CAPABLE OF BINDING TO COMPLEMENT COMPONENT C3A, AND USES THEREOF	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/162384	COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/162394	CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGEN AND USE THEREOF	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/162459	MICROORGANISM COMPRISING VARIANT LYSE AND METHOD OF L-AMINO ACID PRODUCTION USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/162493	PROTEIN KINASE DEGRADATION INDUCING COMPOUND, AND USE THEREOF	VORONOI CO.,LTD
WO/2021/162505	COMPOUND ISOLATED FROM TORILIDIS FRUCTUS, AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT	PHARMA-GENE CO., LTD.
WO/2021/162521	IMMUNE CELLS OVEREXPRESSING CELL SIGNALING REGULATORY FACTOR INTRODUCED FROM OUTSIDE AND USE THEREOF	IMMUNOTECH BIOPHARM KOREA INC.
WO/2021/167317	METHOD FOR PREPARING PEPTIDE BY USING SOLID PHASE SYNTHESIS METHOD	EYEBIO KOREA
WO/2021/167324	IMPROVED CELL-PERMEABLE NUCLEAR IMPORT INHIBITOR SYNTHETIC PEPTIDE FOR INHIBITION OF CYTOKINE STORM OR INFLAMMATORY DISEASE AND USE THEREOF	CELLIVERY THERAPEUTICS, INC.
WO/2021/177631	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/177632	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/177633	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/177634	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF	DUKSAN NEOLUX CO., LTD
WO/2021/221283	CHROMIUM COMPOUND, AND METHOD FOR PRODUCING SAME	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/172842	METHOD FOR PREPARING PEROVSKITE COMPOUND WITH IMPROVED COLOR PURITY AND PEROVSKITE PHOTOELECTRIC DEVICE COMPRISING SAME	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/172870	NOVEL PEPTIDES FOR PREVENTING OR TREATING ATOPIC DERMATITIS	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/172871	NOVEL IMIDAZOLE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND USE THEREOF	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
WO/2021/177650	COMPOUND AND OPTICAL FILM COMPRISING SAME	LG CHEM, LTD.
WO/2021/177653	NOVEL OXIME ESTER CARBAZOLE DERIVATIVE COMPOUND	TECHNIUM CO., LTD.
WO/2021/177654	NOVEL OXIME ESTER CARBAZOLE DERIVATIVE COMPOUND	TECHNIUM CO., LTD.
WO/2021/187766	COMPOUND HAVING P38 REMOVAL CAPABILITY, PREPARATION METHOD THEREFOR AND COMPOSITION FOR TREATING CHRONIC INFLAMMATORY DISEASE, COMPRISING SAME	PRAZERTHERAPEUTICS INC.
WO/2021/172886	1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/172887	1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/172889	METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS	NATIONAL CANCER CENTER
WO/2021/172890	MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO TIM-3 AND USES THEREOF	NATIONAL CANCER CENTER
WO/2021/172898	APPARATUS AND METHOD FOR MANUFACTURING PROPYLENE GLYCOL METHYL ETHER ACETATE	INDUSTRY ACADEMIC COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY
WO/2021/172922	METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/172929	METHOD FOR HIGHLY PURIFYING ANHYDROSUGAR ALCOHOL DIETHERS	SAMYANG CORPORATION
WO/2021/172931	3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/172940	METHOD FOR PREPARING ANHYDROSUGAR ALCOHOL DIETHERS WITH IMPROVED YIELD	SAMYANG CORPORATION
WO/2021/172955	INTERMEDIATE USEFUL FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PREPARING SGLT INHIBITOR USING SAME	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/172957	METHOD FOR PREPARING CRYSTALLINE FORM A OF P1, P4-DI(URIDINE 5'-)TETRAPHOSPHATE SODIUM SALT TETRAHYDRATE	CKD BIO CORPORATION
WO/2021/172965	POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANOELECTROLUMINESCENT DEVICE USING SAME	SFC CO., LTD.
WO/2021/210774	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/172971	VARICELLA ZOSTER VIRUS FUSION PROTEIN AND IMMUNOGENIC COMPOSITION COMPRISING SAME	CELLTRION INC.
WO/2021/177748	COMPOUND AND OPTICAL FILM COMPRISING SAME	LG CHEM, LTD.
WO/2021/177750	COMPOUND AND OPTICAL FILM COMPRISING SAME	LG CHEM, LTD.
WO/2021/201449	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME	DUKSAN NEOLUX CO., LTD
WO/2021/187780	PRODUCTION METHOD FOR TRANSITION METAL COMPOUND	HANWHA SOLUTIONS CORPORATION
WO/2021/182803	NOVEL OXIDIZED LAPPACONITINE DERIVATIVE AND USE THEREOF	QGENETICS CO.,LTD.
WO/2021/182806	NOVEL LAPPACONITINE DERIVATIVE AND USE THEREOF	QGENETICS CO.,LTD.
WO/2021/177786	METAL-ORGANIC FRAMEWORK HAVING VARIABLE STRUCTURE AND PRODUCTION METHOD THEREFOR	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/182833	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/182834	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/187796	SEPARATION MEMBRANE SEPARATION PROCESS FOR CARBONIC ACID-CONTAINING DIAMINO ALKANE SOLUTION	CJ CHEILJEDANG CORPORATION
WO/2021/246620	METAL COMPOUND HAVING PHASE TRANSFORMATION, AND PREPARATION METHOD THEREOF	WEBIOTREE CO., LTD
WO/2021/215656	BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT	JMACKEM CO., LTD
WO/2021/221303	COMPOUND, ANTI-REFLECTION FILM COMPRISING SAME, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/221304	COMPOUND, ANTI-REFLECTIVE FILM INCLUDING SAME, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/182888	AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	SFC CO., LTD.
WO/2021/215659	COMPOUND, ANTI-REFLECTIVE FILM COMPRISING SAME, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/182896	INDUCED BROWN FAT DIFFERENTIATION COMPOSITION COMPRISING ISOLIQUIRITIGENIN DERIVATIVE	CATHOLIC KWANDONG UNIVERSITY INDUSTRY FOUNDATION
WO/2021/182898	COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND	ANYGEN CO., LTD.
WO/2021/182899	NOVEL PHENANTHROLINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	SFC CO., LTD.
WO/2021/182914	NOVEL CDK7 INHIBITORY COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	YUNGJIN PHARM. CO., LTD.
WO/2021/182918	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING AZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	YUNGJIN PHARM. CO., LTD.
WO/2021/194144	NOVEL PYRIMIDINE DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER, COMPRISING SAME	WHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/182928	NOVEL BISPECIFIC PROTEIN AND USE THEREOF	SL METAGEN
WO/2021/182929	BCMA-SPECIFIC ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR	CUROCELL INC.
WO/2021/215669	ORGANIC OPTOELECTRONIC ELEMENT COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPOSITION, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/187868	COMPOUND, PHOTOSENSITIZER COMPRISING SAME, COMPOSITION FOR DIAGNOSING OR TREATING TUMOR TARGETING MITOCHONDRIA, AND PHOTODYNAMIC TREATMENT METHOD USING COMPOSITION	KYTECBIO CO., LTD.
WO/2021/187878	COMPOUND FOR INHIBITING MUTAGENIC TRK FUSION PROTEIN, AND PHARMACEUTICAL USE AND MANUFACTURING METHOD THEREOF	J2H BIOTECH INC.
WO/2021/187879	METHOD FOR CONVERSION OF HYDROCARBON-BASED MATERIAL INTO ACETYLENE OR ETHYLENE AND APPARATUS THEREFOR	KOREA INSTITUTE OF MACHINERY & MATERIALS
WO/2021/187886	GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME	LG CHEM, LTD.
WO/2021/206305	COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR	DUK SAN NEOLUX CO.,LTD.
WO/2021/187904	FUSION PROTEIN COMPRISING IL-2 PROTEIN AND CD80 PROTEIN FRAGMENT OR VARIANT THEREOF, AND USES THEREOF	GI INNOVATION, INC.
WO/2021/187928	COMPOSITION AND KIT FOR REMOVING LIPOPOLYSACCHARIDE	DANDI BIOSCIENCE INC.
WO/2021/187939	NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	SFC CO., LTD.
WO/2021/187959	GLYCEROL GLUCOSIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME FOR ULTRAVIOLET LIGHT SHIELD OR ANTI-INFLAMMATION	ATHENA CO., LTD.
WO/2021/194186	COMPOSITION COMPRISING VGLL1 PEPTIDE FOR TREATMENT OF CANCER	ONECUREGEN CO., LTD.
WO/2021/194188	BINDING MOLECULE HAVING NEUTRALIZING ACTIVITY AGAINST SARS-CORONAVIRUS-2	CELLTRION, INC.
WO/2021/210800	METHOD FOR PREPARING DEUTERATED COMPOUND	LG CHEM, LTD.
WO/2021/194216	POLYCYCLIC AROMATIC COMPOUND AND ORGANOELECTROLUMINESCENT DEVICE USING SAME	SFC CO., LTD.
WO/2021/194244	NOVEL METHOD FOR PREPARING INOTODIOL	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/194257	CELL-PERMEABLE PEPTIDE DIMER, METHOD OF PREPARING SAME, AND CARGO DELIVERY SYSTEM USING SAME	UPPTHERA
WO/2021/194261	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/194291	POLYMORPHIC FORM OF (-)-CIBENZOLINE SUCCINATE	CELLTRION INC.
WO/2021/194298	NANOPARTICLES COMPRISING DRUG DIMERS, AND USE THEREOF	THERABEST CO.,LTD
WO/2021/194318	PLK1 SELECTIVE DEGRADATION INDUCING COMPOUND	UPPTHERA
WO/2021/194319	VANILLIN DERIVATIVE COMPOUNDS INDUCING SELECTIVE DEGRADATION OF PLK1	UPPTHERA
WO/2021/194320	PYRAZOLO QUINAZOLINE DERIVATIVE COMPOUNDS INDUCING SELECTIVE DEGRADATION OF PLK1	UPPTHERA
WO/2021/194321	BENZIMIDAZOLE THIOPHENE DERIVATIVE COMPOUNDS INDUCING SELECTIVE DEGRADATION OF PLK1	UPPTHERA
WO/2021/194326	AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS	DONG-A ST CO., LTD.
WO/2021/201571	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING ANTIBODY AGAINST IGSF1 AS ACTIVE INGREDIENT, AND METHOD FOR TREATING CANCER USING SAME	WELLMARKER BIO CO., LTD.
WO/2021/201574	METHOD FOR PRODUCING COMPOUND AS PI3K INHIBITOR, AND INTERMEDIATE COMPOUND FOR PRODUCTION THEREOF	BORYUNG PHARMACEUTICAL CO., LTD
WO/2021/201576	BENZOTHIAZOLE DERIVATIVE COMPOUND	INNOCURE THERAPEUTICS, INC.
WO/2021/201577	HMG-COA REDUCTASE DEGRADATION INDUCING COMPOUND	UPPTHERA
WO/2021/210812	RECOMBINANT FUSION PROTEIN FOR PREVENTING OR TREATING FIBROTIC DISEASES	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/215687	ANTIBACTERIAL PROTEIN CDL200 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIOIDES DIFFICILE	INTRON BIOTECHNOLOGY, INC.
WO/2021/201585	NOVEL COMPOUND FOR TREATING CANCER, AND COMPOSITION CONTAINING SAME	HAIM BIO CO., LTD.
WO/2021/201615	NOVEL IMMUNOACTIVE INTERLEUKIN 2 ANALOG	HANMI PHARM. CO., LTD.
WO/2021/235681	TRIMERIZATION MIXTURE OF ALPHA-OLEFINS, METHOD FOR PREPARING SAME AND LUBRICATING OIL COMPRISING SAME	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/206375	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/241875	SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/241876	CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/206428	ROSMARINIC ACID DERIVATIVE, ROSMARINIC ACID-DERIVED PARTICLES, AND COMPOSITION COMPRISING SAME FOR TREATING INFLAMMATORY DISEASE	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/206432	NOVEL FLUORESCENT MATERIAL, NANOBEADS COMPRISING SAME, AND DIAGNOSTIC KIT USING SAME	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/256674	METHOD FOR INCREASING STABILITY OF TARGET PROTEIN IMMOBILIZED IN SILICA NANOPARTICLE THROUGH SALT TREATMENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
WO/2021/221338	INFLUENZA VIRUS PRODUCTION METHOD USING DISPOSABLE CULTURE PROCESS SYSTEM, AND TEST FOR QUICKLY CHECKING CONDITIONS FOR INFLUENZA VIRUS ANTIGEN PURIFICATION	SK BIOSCIENCE CO., LTD.
WO/2021/206477	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/206478	COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME	DUK SAN NEOLUX CO., LTD.
WO/2021/206488	NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	SFC CO., LTD.
WO/2021/206504	ORGANIC LIGHT-EMITTING DEVICE	LG CHEM, LTD.
WO/2021/206513	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR WEAKNESS-RELATED DISEASES COMPRISING ALVERINE, 4-HYDROXY ALVERINE, DERIVATIVE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/256679	PREPARATION METHOD OF 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER	HANA PHARM. CO. LTD.
WO/2021/210857	1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/235696	CD22-SPECIFIC ANTIBODY AND USE THEREOF	INNOBATION BIO CO., LTD.
WO/2021/235697	CD22-SPECIFIC ANTIBODY AND USE THEREOF	INNOBATION BIO CO., LTD.
WO/2021/246637	ANTIBODY SPECIFIC TO CD22, AND USE THEREOF	INNOBATION BIO CO., LTD.
WO/2021/210868	NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/215729	FUSION PROTEIN COMPRISING CELL-PENETRATING PEPTIDE AND FKBP12 AND USE THEREOF	HANLIM PHARMACEUTICAL CO., LTD.
WO/2021/210878	CRBN-BINDING PEPTIDE AND COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE USING SAME	GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/210885	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/210894	NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	SFC CO., LTD.
WO/2021/210898	COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO., LTD.
WO/2021/210910	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/210911	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/210920	METHOD FOR PRODUCING RAMELTEON, AND INTERMEDIATE COMPOUND USED FOR SAME	J2H BIOTECH INC.
WO/2021/210924	AFRICAN SWINE FEVER VACCINE COMPOSITION	PLUMBLINE LIFE SCIENCES, INC.
WO/2021/210925	COMPOSITION FOR TREATMENT, PREVENTION, OR AMELIORATION OF LYMPHEDEMA	GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR
WO/2021/230508	NOVEL DERIVATIVE OF BETA-APOPICROPODOPHYLLIN AND PREPARATION METHOD THEREFOR	J&C SCIENCES
WO/2021/221359	LONG-ACTING GLP-1 AND GLUCAGON RECEPTOR DUAL AGONIST	DONG-A ST CO., LTD.
WO/2021/241882	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/210931	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/215742	HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER	LT MATERIALS CO.,LTD.
WO/2021/210934	LITHIUM DIFLUOROBIS(OXALATO)PHOSPHATE 1,4-DIOXANE SOLVATE, METHOD FOR PREPARING SAME, AND ELECTROLYTE COMPOSITION COMPRISING SAME	CHEMTROS CO., LTD.
WO/2021/210939	ANTI-HER2 AFFIBODY, AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE	ABCLON INC.
WO/2021/210948	LIGAND COMPOUND, TRANSITION METAL COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME	LG CHEM, LTD.
WO/2021/230511	BENZAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/230512	BENZAZOLE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/230513	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	LAPTO CO.,LTD.
WO/2021/215765	3-AZABICYCLOALKYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	LG CHEM, LTD.
WO/2021/210970	PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS	DONG-A ST CO., LTD.
WO/2021/215782	ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/215792	MONONUCLEAR TRANSITION METAL COMPLEX AND PHOTOCATALYST FOR CARBON DIOXIDE REDUCTION COMPRISING SAME	EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
WO/2021/215828	PROTEIN VARIANT HAVING GLP-1 INDUCING ACTIVITY AND USE THEREOF	KOBIOLABS, INC.
WO/2021/221418	ALLULOSE EPIMERASE VARIANT, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING ALLULOSE USING SAME	DAESANG CORPORATION
WO/2021/221444	COMPOUND AS UBR-BOX DOMAIN LIGAND	AUTOTAC INC.
WO/2021/221445	COMPOUND AS UBR BOX DOMAIN LIGAND	AUTOTAC INC.
WO/2021/235723	COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE	SAMSUNG SDI CO., LTD.
WO/2021/221470	RECOMBINANT PROTEIN HAVING FUSED INTERFERON-BETA MUTEIN AND ANTIBODY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	GENOPHARM INC.
WO/2021/241900	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/221485	HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT	ABION INC.
WO/2021/221486	VACCINE COMPOSITION FOR PREVENTING OR TREATING INFECTION OF SARS-COV-2	SK BIOSCIENCE CO., LTD.
WO/2021/225344	PEPTIDE FOR SUPPRESSING CORONAVIRUS AND USE THEREOF	INDUSTRY ACADEMIC COOPERATION FOUNDATION, HALLYM UNIVERSITY
WO/2021/225365	ANTAGONISTIC SMALL MOLECULE COMPOUND HAVING TOLL-LIKE RECEPTOR 7/9 INHIBITORY FUNCTION	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/230561	CRYSTALLINE SALT OF ERIBULIN	YONSUNG FINE CHEMICAL CO., LTD.
WO/2021/225378	PD-1 VARIANTS HAVING INCREASED PD-L1 AFFINITY	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/225399	CHIMERIC ANTIGEN RECEPTOR FOR TREATMENT OF CANCER	SMT BIO
WO/2021/225407	NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE INHIBITORY ACTIVITY, AND USE THEREOF	TXINNO BIOSCIENCE INC.
WO/2021/261762	ANTI-RSV ANTIBODY AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
WO/2021/241913	PHENYLENE DIBENZAMIDE COMPOUND, AND PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING CANCER DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT	HEDGEHOG, INC.
WO/2021/241915	ANTIBACTERIAL SUBSTANCE HAVING LYTIC ACTIVITY AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE AND METHOD FOR PRODUCING SAME	INTRON BIOTECHNOLOGY, INC.
WO/2021/246670	ANTIBACTERIAL PROTEIN HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIOIDES DIFFICILE	INTRON BIOTECHNOLOGY, INC.
WO/2021/230638	MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF	LG CHEM, LTD.
WO/2021/230653	ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	SFC CO., LTD.
WO/2021/230654	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/230655	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/235767	METHOD FOR OBTAINING COLLAGEN PEPTIDE FROM STARFISH, ELASTIC LIPOSOME COMPRISING STARFISH-DERIVED COLLAGEN PEPTIDE, AND COSMETIC COMPOSITION COMPRISING SAME	STARS TECH CO.,LTD
WO/2021/230668	HIGH-POTENCY SARS CORONAVIRUS 2 ANTIGEN AND VACCINE COMPOSITION COMPRISING SAME	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/230681	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEM, LTD.
WO/2021/251633	METHOD AND SYSTEM FOR MANUFACTURING DICARBOXYLIC ACID AROMATIC HETEROCYCLIC COMPOUND	KOLON INDUSTRIES, INC.
WO/2021/230688	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/230689	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/230690	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/230691	METHOD FOR PRODUCING AZILSARTAN USING ENVIRONMENT-FRIENDLY SOLVENT AND KEY INTERMEDIATE COMPOUND RELATED THERETO	DAEBONG LS CO., LTD.
WO/2021/230705	NOVEL RECOMBINANT FUSION PROTEIN AND USE THEREOF	PROGEN CO., LTD.
WO/2021/241928	STRUCTURALLY MODIFIED CHIMERIC POLYPEPTIDE OF HUMAN PAPILLOMAVIRUS, RECOMBINANT PROTEIN COMPRISING SAME POLYPEPTIDE, AND USE OF SAME PROTEIN	GENEMATRIX INC.
WO/2021/230710	NOVEL IDO/TDO INHIBITOR, ANTICANCER USE THEREOF, AND ANTICANCER COMBINATION THERAPY THEREOF	SYNTEKABIO, INC.
WO/2021/230733	TRICYCLIC COMPOUND AND MEDICINAL USE THEREOF	J2H BIOTECH INC.
WO/2021/235806	METHOD FOR PREPARING LIRAGLUTIDE USING ENVIRONMENT-FRIENDLY SOLVENT	DAEBONG LS CO., LTD.
WO/2021/235830	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/235894	Anti-HER2 Antibody or Antigen-binding Fragment thereof, and Chimeric Antigen Receptor Comprising Same	GREEN CROSS LAB CELL CORPORATION
WO/2021/246698	COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF	DUK SAN NEOLUX CO.,LTD.
WO/2021/235906	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/241965	NOVEL FUSION PROTEIN FOR CRYSTALLIZING IL-33, AND CRYSTALLIZING METHOD USING SAME	AZCURIS CO., LTD.
WO/2021/241969	COMPOSITION FOR NEUTRALIZING CORONAVIRUS	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/241982	5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/246713	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/251661	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/246720	BISPECIFIC ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR	MUSTBIO CO., LTD.
WO/2021/256724	CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA AND USE THEREOF	NATIONAL CANCER CENTER
WO/2021/242045	NOVEL ANTI-INFLAMMATORY PEPTIDE DERIVED FROM NLRX1 AND USE THEREOF	MITO QUEST CO., LTD.
WO/2021/242046	NOVEL ANTI-INFLAMMATORY PEPTIDE AND USE THEREOF	MITO QUEST CO., LTD.
WO/2021/246773	GFRAL-ANTAGONISTIC ANTIBODY AND USE THEREOF	DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/246779	AMIDE DERIVATIVE COMPRISING PROBENECID AND ARGININE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME	SAMOH FARMACHEM CO., LTD.
WO/2021/246781	PYRIDINE DERIVATIVES AS IMMUNOMODULATORS	KAINOS MEDICINE, INC.
WO/2021/246809	REACTION CONTROL METHOD IN CONTINUOUS MANUFACTURING PROCESS OF DIESTER-BASED COMPOSITION	LG CHEM, LTD.
WO/2021/246815	RECOMBINANT HERPES SIMPLEX VIRUS HAVING EXPRESSION CASSETTE CAPABLE OF EXPRESSING FUSION PROTEIN OF EXTRACELLULAR DOMAIN OF HVEC AND CANCER CELL-TARGETING DOMAIN, AND USE THEREOF	GENCELLMED INC.
WO/2021/246846	NOVEL MORPHOLINO OLIGONUCLEOTIDE DERIVATIVES	NEXOLIGO CO., LTD.
WO/2021/251725	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/251726	REGENTIDE-034 AND COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING SAME	NINEBIOPHARM CO.,LTD.
WO/2021/251727	REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION	NINEBIOPHARM CO.,LTD.
WO/2021/251728	COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION	NINEBIOPHARM CO.,LTD.
WO/2021/251734	O-PHOSPHOSERINE EXPORT PROTEIN VARIANT AND METHOD FOR PRODUCING O-PHOSPHOSERINE, CYSTEINE, AND DERIVATIVE THEREOF BY USING SAME	CJ CHEILJEDANG CORPORATION
WO/2021/251750	MODIFIED μ-OXO CENTERED-MULTINUCLEAR METAL COMPLEX AND USE THEREOF	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/251791	PEPTIDE EXHIBITING BOTULINUM TOXIN-LIKE ACTIVITY, AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/256795	EPITOPE OF NEW CORONAVIRUS AND USE THEREOF	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/256836	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/256861	NOVEL ACID SECRETION INHIBITOR AND USE THEREOF	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/256871	ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/256880	ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/256881	ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/256883	ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME	SOLUS ADVANCED MATERIALS CO., LTD.
WO/2021/256888	METHOD FOR PREPARING HIGHLY PURE LITHIUM BISOXALATOBORATE, AND SECONDARY BATTERY NON-AQUEOUS ELECTROLYTE USING SAME	EP CHEMTECH CO., LTD.
WO/2021/261849	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LT MATERIALS CO.,LTD.
WO/2021/256894	NOVEL PROLYLFK506 DERIVATIVES HAVING NEURITE GROWTH AND SYNAPSE FORMATION ACTIVITIES AND USES THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/256899	NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/256900	NOVEL OXOPYRIDAZINYL-PHENYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/256902	CARBONOHYDRAZONOYL DICYANIDE COMPOUND INCLUDING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY NOVEL LINKER, AND USE THEREOF	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/261856	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/261857	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/261906	ANTI-PCSK9 ANTIBODY AND USE THEREOF	BIOSTREAM TECHNOLOGIES CO., LTD.
WO/2021/261925	COMPOUND, COMPOSITION COMPRISING SAME, AND FLUORESCENCE SENSOR FOR DETECTING ACETYLCHOLINESTERASE ACTIVITY	EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/261946	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LT MATERIALS CO.,LTD.
WO/2021/261969	PREPARATION METHOD FOR NOVEL COMPOUND	HOLOSMEDIC
WO/2021/261970	NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESISTANT CANCER, COMPRISING SAME	HOLOSMEDIC
WO/2021/150091	COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME	LG CHEM, LTD.
WO/2021/150094	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEM, LTD.
WO/2021/215900	METHOD FOR PRODUCING BENZOPYRANONE COMPOUND AND NOVEL INTERMEDIATE USED THEREIN	ILAB
WO/2021/235921	SPERMIDINE DERIVATIVE COMPOUND, USE THEREOF AND METHOD FOR PREPARING SAME	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/080410	ELECTRONIC MONEY TILL FOR THE COLLECTION OF FARES ON BOARD BUSES	IDEAR ELECTRóNICA, S.A. DE C.V.
WO/2021/112662	PEPTIDE WITH ANTICANCER ACTIVITY AGAINST BREAST CANCER	UNIVERSIDAD NACIONAL AUTóNOMA DE MéXICO
WO/2021/201669	POLYMERIC AMPHOTERIC SURFACTANT COMPOUND	PETROLIAM NASIONAL BERHAD (PETRONAS)
WO/2021/006730	ONCOLYTIC NON-HUMAN ADENOVIRUSES AND USES THEREOF	ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
WO/2021/010835	PEPTIDES FOR USE IN THE TREATMENT OF CHOLERA	TECHNISCHE UNIVERSITEIT EINDHOVEN
WO/2021/015622	SYNTHESIS OF 6-AZIDO-6-DEOXY-2-<i>N</i>-ACETYL-HEXOSAMINE-NUCLEOSIDE DIPHOSPHATE	SYNAFFIX B.V.
WO/2021/025555	MODIFIED HUMAN VARIABLE DOMAINS	MERUS N.V.
WO/2021/034194	TREATMENT OF CANCER WITH A COMBINATION OF AN ANTIBODY THAT BINDS LGR5 AND EGFR AND A TOPOISOMERASE I INHIBITOR.	MERUS N.V.
WO/2021/040519	INHIBITION OF MYCOBACTERIAL TYPE VII SECRETION	STICHTING VUMC
WO/2021/060980	ANTIBIOTIC COMPOUNDS	UNIVERSITEIT LEIDEN
WO/2021/066658	ACIDIC ELIMINATION FOR BIO-BASED AROMATICS	NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO
WO/2021/080426	PRODUCTION OF AROMATIC ACIDS AND PHENOLICS	NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO
WO/2021/080428	MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER	MERUS N.V.
WO/2021/080433	COMPOSITIONS FOR PATIENT SPECIFIC IMMUNOTHERAPY	VITROSCAN B.V.
WO/2021/133170	ANTI-HUMAN HVEM (TNFRSF14) ANTIBODIES AND USES THEREOF	CLUSTER270 THERAPEUTICS B.V.
WO/2021/137699	UREA PLANT WITH CHILLED CONDENSATION SECTION	STAMICARBON B.V.
WO/2021/137700	AMMONIA REMOVAL FROM UREA FINISHING	STAMICARBON B.V.
WO/2021/141492	EPITHELIAL CADHERIN-SPECIFIC ANTIBODIES	KLING BIOTHERAPEUTICS B.V.
WO/2021/154073	MEANS AND METHOD FOR MODULATING IMMUNE CELL ENGAGING EFFECTS.	MERUS N.V.
WO/2021/158103	SERUM-FREE MEDIUM FOR CULTURING A BOVINE PROGENITOR CELL.	MOSA MEAT B.V.
WO/2021/158110	PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ANTIBODIES, CONJUGATES, COMPOSITIONS, AND USES THEREOF	BIORION TECHNOLOGIES B.V.
WO/2021/206561	NOVEL ALPHA-SYNUCLEIN BINDING ANTIBODIES, OR ANTIGEN BINDING PORTIONS THEREOF	SYNGLE THERAPEUTICS B.V.
WO/2021/215919	HUMANIZED ANTI-HUMAN CD89 ANTIBODIES AND USES THEREOF	POLPHARMA BIOLOGICS UTRECHT B.V.
WO/2021/215926	TREATMENT OF CANCERS WITH AN ANTIBODY THAT BINDS LGR5 AND EGFR	MERUS N.V.
WO/2021/261999	THERMAL STRIPPING UREA PLANT AND PROCESS	STAMICARBON B.V.
WO/2021/187992	SYNTHESIS OF CAPSAICIN DERIVATIVES	AXICHEM AS
WO/2021/071372	PROCESS OF VITAMIN K2 DERIVATIVES PREPARATION	SIEĆ BADAWCZA ŁUKASIEWICZ - INSTYTUT FARMACEUTYCZNY
WO/2021/118371	NUCLEOTIDE SEQUENCES CODING THE AMINO ACID SEQUENCES OF THE RECOMBINANT BIOLOGICAL NANOSTRUCTURE AND PLATFORMS FOR INSERTING AND PRESENTING OF FOREIGN ANTIGENS, AMINO ACID SEQUENCES OF THE RECOMBINANT BIOLOGICAL NANOSTRUCTURE AND PLATFORMS WITH RESTRICTION SITES FOR INSERTING AND PRESENTING OF FOREIGN ANTIGENS, PRIMERS FOR THE INSERTING ANTIGENS IN RESTRICTION SITES, AND USE OF AMINO ACID SEQUENCES FOR PRESENTING OF FOREIGN ANTIGENS, ESPECIALLY AS AN IMMUNOGEN INDUCING HUMORAL RESPONSE, IN THE PRODUCTION OF ANTIBODIES AND REFERENCE ANTIGENS IN DIAGNOSTICS	UNIWERSYTET GDANSKI
WO/2021/262013	BST-NEC DNA FUSION POLYMERASE FOR USE IN ISOTHERMAL REPLICATION OF SPECIFIC SARS COV-2 VIRUS SEQUENCES	GENEME SP. Z O.O.
WO/2021/141508	ANTIVIRAL AROMATIC SULPHONAMIDES DERIVATIVES, THEIR METHOD OF SYNTHESIS AND USE	UNIWERSYTET JAGIELLOŃSKI
WO/2021/215943	XANTHONE DERIVATIVES, UV PROTECTIVE COMPOSITION CONCENTRATE, METHOD OF PREPARATION OF UV PROTECTIVE COMPOSITION CONCENTRATE, USE OF UV PROTECTIVE COMPOSITION CONCENTRATE AND COSMETIC UV PROTECTIVE PRODUCT	UNIWERSYTET JAGIELLONSKI
WO/2021/162566	NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE	UNIWERSYTET WARSZAWSKI
WO/2021/162567	NOVEL MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE	UNIWERSYTET WARSZAWSKI
WO/2021/125989	METHODS OF PRODUCING DIMETHYL CARBONATE	QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY DEVELOPMENT
WO/2021/086219	LIGHT-GATED PENTAMERIC CHANNEL - A NEW OPTOGENETIC TOOL	FORSCHUNGSZENTRUM JüLICH, INSTITUTE OF COMPLEX SYSTEMS
WO/2021/137712	DEVICE AND METHOD FOR PURIFYING COMPLEX ESTERS	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/137713	PROCESS FOR TRIMERIZATION OF ETHYLENE AND APPARATUS FOR TRIMERIZATION OF ETHYLENE	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/145785	BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF EXHIBITING AN ANTI-GERIATRIC EFFECT	FARBER, Boris Slavinovich
WO/2021/187997	NORADRENERGIC AND SPECIFIC SEROTONERGIC ANXIOLYTIC AND ANTIDEPRESSANT, AND METHOD FOR PRODUCING SAME AND USING SAME	IVACHTCHENKO, Alexandre Vasilievich
WO/2021/020998	METHOD FOR PRODUCING ROXADUSTAT	FAZYLOV, Marat Felixovich
WO/2021/021000	METHOD FOR PRODUCING AVATROMBOPAG	FAZYLOV, Marat Felixovich
WO/2021/080458	PANGENOTYPIC INHIBITOR OF HEPATITIS C VIRUS NS5A PROTEIN	IVACHTCHENKO, Alexandre Vasilievich
WO/2021/101407	CONJUGATE MONOMETHYL AURISTATIN E TO OBTAIN A COMPOSITION FOR TREATMENT OF PROSTATE CANCER	OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU IZVARINO FARMA
WO/2021/215958	METHOD FOR PRODUCING 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) AND 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE PRODUCED BY SAID METHOD	OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU NAUCHNO-PROIZVODSTVENNOE PREDPRIIATIE "KF"
WO/2021/025593	METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY	OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "PLANTA"
WO/2021/021004	3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION	OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "KIU EM FARMA"
WO/2021/034227	COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3, AND BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING SAID CDRS	LIMITED LIABILITY COMPANY "INTERNATIONAL BIOTECHNOLOGY CENTER "GENERIUM"
WO/2021/086234	NOVEL CHEMICAL COMPOUND L-LYSINE 9-OXOACRIDINYL-10-ACETATE	SCIENTIFIC TECHNOLOGICAL PHARMACEUTICAL FIRM "POLYSAN" LTD.
WO/2021/101420	NOVEL POLYOL DERIVATIVES, USE THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON	LTD "VALENTA-INTELLEKT"
WO/2021/225466	ANTI-CORONAVIRUS THERAPEUTIC AGENT - SUBSTITUTED 7-HYDROXY-3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE FOR PROPHYLAXIS AND TREATMENT OF COVID-19	IVACHTCHENKO, Alexandre Vasilievich
WO/2021/167495	PYRIMIDINE-BASED BICYCLES AS ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION	PHARMASYNTEZ, JOINT STOCK COMPANY
WO/2021/154122	L-, U-MODIFICATIONS OF 5-CHLORO-N-({(5S)-2-OXO-3-[4-3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHENECARBOXAMIDE AND SOLVATE THEREOF WITH DIMETHYL SULFOXIDE	ZAKRYTOE AKCIONERNOE OBSHHESTVO "ALMAZ FARM"
WO/2021/194379	METHOD FOR PRODUCING A CRYSTALLINE FORM OF CALCIUM CIS-2,3-EPOXYSUCCINATE	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/194380	METHOD FOR PRODUCING A CRYSTALLINE FORM OF CALCIUM CIS-2,3-EPOXYSUCCINATE	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/194381	CRYSTALLINE CALCIUM EPOXYSUCCINATE, METHOD FOR PRODUCING SAME AND USE THEREOF	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/194383	METHOD FOR PRODUCING A FINE CRYSTALLINE FORM OF CALCIUM CIS-2,3-EPOXYSUCCINATE	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/194384	METHOD FOR PRODUCING THE CRYSTALLINE FORM OF CALCIUM CIS-2,3-EPOXYSUCCINATE	PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING")
WO/2021/246910	SARS-COV-2 VIRUS RBD RECOMBINANT PROTEIN AND METHOD FOR PRODUCING SAME	FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE "NATSIONALNY ISSLEDOVATELSKY TSENTR EPIDEMIOLOGII I MIKROBIOLOGII IMENI POCHETNOGO AKADEMIKA N.F. GAMALEI" MINISTERSTVA ZDRAVOOKHRANENIA ROSSYSKOY FEDERATSII
WO/2021/158146	RECOMBINANT GROWTH DIFFERENTIATION FACTOR 11 (GDF11)	LIMITED LIABILITY COMPANY "SCIENTIFIC AND PRODUCTION CORPORATION IN-VET"
WO/2021/211020	PREPARATION FOR TREATING BACTERIAL DISEASES	TETS, Georgy Viktorovich
WO/2021/221544	NOVEL COMPOUND [2-(DIMETHYLAMINO)-2-PHENYLBUTYL]-3,4,5-TRIMETHOXYBENZOATE 4-METHYL-2Н-CHROMEN-2-ON-7-YL SULPHATE AND USE THEREOF	LTD "VALENTA-INTELLEKT"
WO/2021/246921	AQUEOUS PHARMACEUTICAL COMPOSITION OF LEVILIMAB	JOINT STOCK COMPANY "BIOCAD"
WO/2021/262041	METHOD OF PRODUCING A HIGHLY PURIFIED RECOMBINANT INHIBITOR OF HUMAN C1 ESTERASE	LIMITED LIABILITY COMPANY "INTERNATIONAL BIOTECHNOLOGY CENTER "GENERIUM"
WO/2021/262043	METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY	YAMPOL'SKIY, Il'ya Viktorovich
WO/2021/251850	SPECIFIC PEPTIDE INHIBITORS OF CYSTEINE CATHEPSINS	FEDERAL STATE AUTONOMOUS EDUCATIONAL INSTITUTION OF HIGHER EDUCATION I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY OF THE MINISTRY OF HEALTHCARE OF THE RUSSIAN FEDERATION (SECHENOV UNIVERSITY)
WO/2021/010878	USE OF A METHOD FOR REDUCTION OF HEAVY END FORMATION AND CATALYST LOSS IN A HYDROFORMYLATION PROCESS COMPRISING A BIDENTATE PHOSPHITE LIGAND	PERSTORP AB
WO/2021/006792	USE OF AN EPOXIDE IN ORDER TO REDUCE THE FORMATION OF HEAVY ENDS IN A HYDROFORMYLATION PROCESS	PERSTORP AB
WO/2021/006795	A METHOD FOR REDUCING HEAVY END FORMATION AND CATALYST LOSS IN A HYDROFORMYLATION PROCESS	PERSTORP AB
WO/2021/154143	METHOD AND PROCESS PLANT FOR TREATMENT OF A STREAM OF MIXED COMPOUNDS	SÖDRA SKOGSÄGARNA EKONOMISK FÖRENING
WO/2021/188032	PEPTIDE SYNTHESIS AND SYSTEM THEREOF	PEPTISYSTEMS AB
WO/2021/230792	ANTI-IL13Rα2 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS AND USES THEREOF	ELICERA THERAPEUTICS AB
WO/2021/256977	NOVEL METHODS AND COMPOUNDS FOR PROTEIN DEGRADATION	SUBRAMANIAM, Agatheeswaran
WO/2021/096421	METHOD FOR PURIFICATION OF META-PHENYLENEDIAMINE	POLYWIN PTE. LTD.
WO/2021/002805	INHIBITORS OF RNA EDITING AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/006817	CARDIAC THERAPEUTIC	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/006819	EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) LIGANDS	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/015675	A SERIES OF INJECTABLE HYDROGELS SELF-ASSEMBLED FROM SHORT PEPTIDES FOR VARIOUS BIOMEDICAL APPLICATIONS	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/054896	PROCESS FOR PREPARING ELAGOLIX SODIUM AND INTERMEDIATES THEREOF	SCINOPHARM TAIWAN, LTD.
WO/2021/061053	THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR)
WO/2021/066751	ANTIGEN SPECIFIC BINDING DOMAINS AND ANTIBODY MOLECULES	ASLAN PHARMACEUTICALS PTE. LTD.
WO/2021/080511	METHODS OF BORYLATION AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/107872	COMPOSITES, METHODS AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/107876	COMPOUNDS FOR TREATING TUBERCULOSIS	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/126080	A NEW METHOD OF <sp>18</sp>F LABELLING AND INTERMEDIATE SALTS	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/150170	AMINE COMPOUND, REACTIVE COALESCING AGENT, COATING COMPOSITION, COATING LAYER AND RELATED METHODS	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/154156	ANTI-AXL ANTIBODY AND USES THEREOF	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/158178	ANTIGEN-BINDING MOLECULES AGAINST ALPPL2 AND/OR ALPP AND USES THEREOF	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/162633	PREPARATION OF CATIONIC AND NEUTRAL FUSED N-HETEROCYCLES WITH OR WITHOUT ADDITIONAL HETEROATOMS	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/173080	SEROLOGICAL TEST FOR ZIKA VIRUS	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/173082	PYRIDOPYRIMIDINE DERIVATIVES USEFUL IN MODULATION OF AHR SIGNALLING	JAGUAHR THERAPEUTICS PTE LTD
WO/2021/194420	GOLD(III)-BIGUANIDE PRODRUGS, METHODS OF PREPARATION AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/201777	EPITOPES OF SARS-COV-2	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/206636	ANTIGEN-BINDING PROTEIN TO SARS-CoV-2	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/206638	VACCINE AND/OR ANTIBODY FOR VIRAL INFECTION	INTRA-IMMUSG PRIVATE LIMITED
WO/2021/211058	FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/211059	KERATIN FILAMENT NETWORKS	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/221565	HUMANIZED MONOCLONAL ANTIBODY AGAINST cANGPTL4	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/246961	ISOLATED PEPTIDE FOR A PEPTIDE COACERVATE, AND METHODS OF USE THEREOF	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/262095	CHIMERIC VIRAL VACCINE	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/183061	ANTIMICROBIAL PEPTIDES FOR INHIBITION OF PATHOGENIC MICROORGANISMS IN DIGESTIVE AND RESPIRATORY TRACTS IN ANIMAL	VET PRODUCTS RESEARCH AND INNOVATION CENTER COMPANY LIMITED
WO/2021/211066	FLUORENE DERIVATIVES, POLYMERS OBTAINED FROM SAID FLUORENE DERIVATIVES AND METHOD FOR PREPARING THE SAME	IRPC PUBLIC COMPANY LIMITED
WO/2021/225532	A CHIMERIC ANTIGEN RECEPTOR AND MODIFIED CELLS CARRYING THE RECEPTOR	MAHIDOL UNIVERSITY
WO/2021/133272	LYCOPENE EXTRACTION FROM WATERMELON BY USING NON-TOXIC ECO-FRIENDLY MATERIALS	CUKUROVA UNIVERSITESI REKTORLUGU
WO/2021/133280	AN IMPROVED PROCESS FOR PREPARATION OF SCOPINE HYDROBROMIDE	DEVA HOLDING
WO/2021/162650	5-FLUORO/5-TRIFLUOROMETHOXY-1H-INDOLE-2,3-DIONE 3-(4-PHENYLTHIOSEMICARBAZONE) DERIVATIVES AS INTERLEUKIN 1 (IL-1) ANTAGONISTS AND ANTI-PYRETIC AND/OR ANTI-INFLAMMATORY AGENTS FOR USE IN TREATING E.G. BEHÇET'S DISEASE	ISTANBUL UNIVERSITESI
WO/2021/246974	2-(3-(2-METHYL-6-(P-TOLYL) PYRIDINE-3-YL) UREIDO) BENZENESULFONAMIDE AND DERIVATIVES AS INHIBITOR OF CARBONIC ANHYDRASE IX FOR THE TREATMENT OF CANCER	YEDITEPE UNIVERSITESI
WO/2021/015704	COLLAGEN NANOPARTICLES FROM SCALY FISH SKIN	BOZ, Ezgi
WO/2021/076079	A COLLAGEN PRODUCTION PROCESS	BUGAMED BIYOTEKNOLOJI SANAYI VE TICARET ANONIM SIRKETI
WO/2021/167559	NOVEL TRIAZINE-BASED PLASTICIZERS	YILDIZ TEKNIK UNIVERSITESI
WO/2021/126120	3/4-((2E,6E)-3,7,11-TRIMETHYLDODECA-2,6,10-TRIENYLTHIO)BENZAMIDE DERIVATIVE COMPOUNDS	ANKARA üNİVERSİTESİ REKTÖRLüĞü
WO/2021/162665	PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167570	DRG-MDM2-1 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/054927	GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS	SOUTH DAKOTA BOARD OF REGENTS
WO/2021/029854	SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF	PFIZER INC.
WO/2021/040703	ATYPICAL SPLIT INTEINS AND USES THEREOF	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/045728	TUMOR SPECIFIC ANTIBODY CONJUGATES AND USES THEREFOR	THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
WO/2021/050059	DNA-PK INHIBITING COMPOUNDS	PROVINCIAL HEALTH SERVICES AUTHORITY
WO/2021/054962	PROCESS FOR ISOBUTANOL PRODUCTION FROM ETHANOL AND SYNGAS	UOP LLC
WO/2021/091544	PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL	EASTMAN CHEMICAL COMPANY
WO/2021/091575	BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY	NURIX THERAPEUTICS, INC.
WO/2021/096496	METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS	COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/101508	SALTS OF TRANEXAMIC ACID ESTERS	ACTERA INGREDIENTS, INC.
WO/2021/076169	METHOD OF PREPARING PHOSPHORUS-CONTAINING FLAME RETARDANTS AND THEIR USE IN POLYMER COMPOSITIONS	LANXESS SOLUTIONS US INC.
WO/2021/137845	METHOD FOR PREPARING NUCLEIC ACID SEQUENCES USING ENZYME	DNA SYNTECH INC.
WO/2021/054997	COMPOSITIONS AND METHODS FOR GENERATING MODIFIED CRYO-POOR PLASMA	PLASMA TECHNOLOGIES, LLC
WO/2021/054998	COMPOSITIONS AND METHODS FOR HIGH EFFICIENCY PROTEIN PRECIPITATION	PLASMA TECHNOLOGIES, LLC
WO/2021/150223	SYSTEMS AND METHODS FOR PREPARING TAILORED RADIOACTIVE ISOTOPE SOLUTIONS	RADTRAN LLC
WO/2021/173111	POTENT HUMAN NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS	NORTHWESTERN UNIVERSITY
WO/2021/066873	CONDENSED HETEROCYCLES AS BCL-2 INHIBITORS	NEWAVE PHARMACEUTICAL INC.
WO/2021/177980	COMBINATION THERAPY FOR CANCER COMPRISING PD-1 AXIS BINDING ANTAGONIST AND IL6 ANTAGONIST	GENENTECH, INC.
WO/2021/194495	CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/150258	ISOTOPICALLY LABELLED SELECTIVE CXCR4 BINDING PEPTIDE CONJUGATE AND METHODS FOR MAKING AND USING THE SAME	MAINLINE BIOSCIENCES LLC
WO/2021/216029	PROCESS FOR PREPARING DTEA HCI	AMSA, INC.
WO/2021/021260	METHOD FOR VIRAL INACTIVATION	REGENERON PHARMACEUTICALS, INC.
WO/2021/080645	HFO-1234ZE, HFO-1225ZC AND HFO-1234YF COMPOSITIONS AND PROCESSES FOR PRODUCING AND USING THE COMPOSITIONS	THE CHEMOURS COMPANY FC, LLC
WO/2021/021263	DEHYDROGENATION PROCESS AND SYSTEM WITH REACTOR RE-SEQUENCING	TPC GROUP LLC
WO/2021/221690	MODIFIED BACTERIAL STRAINS FOR IMPROVED FIXATION OF NITROGEN	PIVOT BIO, INC.
WO/2021/112915	METHODS OF PRODUCING ISOMERIZATION CATALYSTS	SAUDI ARABIAN OIL COMPANY
WO/2021/162725	PIVOTING ELECTRODYNAMIC COMPOSITION AND MEDICAMENT	BUTZLOFF, Peter, Robert
WO/2021/236091	IL1-R1 DERIVED INHIBITOR OF IL-1B AND USE THEREOF	R-PHARM OVERSEAS, INC.
WO/2021/061204	NOVEL SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/002986	BAX INHIBITORS AND USES THEREOF	CASE WESTERN RESERVE UNIVERSITY
WO/2021/080649	METHODS FOR ANALYZING CHAIN MISPAIRING IN MULTISPECIFIC BINDING PROTEINS	SANOFI
WO/2021/029938	PROCESSES FOR PRODUCING POLY ALPHA OLEFINS AND METHOD OF ANALYSIS AND APPARATUSES THEREFOR	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/029939	PROCESSES FOR PRODUCING POLY ALPHA OLEFINS AND APPARATUSES THEREFOR	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/251977	SOLUBIZATION OF RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES	ELC MANAGEMENT LLC
WO/2021/015898	PROCESSES FOR CONVERTING AROMATIC HYDROCARBONS VIA ALKYL-DEMETHYLATION	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/015900	ISOMERIZATION PROCESSES FOR CONVERTING AROMATIC HYDROCARBONS COMPRISING ALKYL-DEMETHYLATION	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/015901	TRANSALKYLATION PROCESSES FOR CONVERTING AROMATIC HYDROCARBONS COMPRISING ALKYL-DEMETHYLATION	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/145919	RECOVERY OF ETHYLENE OXIDE FROM STERILIZATION PROCESS	DUFF, Joseph
WO/2021/003050	CD38-BINDING AGENTS AND USES THEREOF	KLEO PHARMACEUTICALS, INC.
WO/2021/173177	CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES	NORTHWESTERN UNIVERSITY
WO/2021/262173	PEPTIDES FOR TREATMENT OF MEDICAL DISORDERS	HUMANWELL PHARMACEUTICAL US
WO/2021/021350	ARTIFICIAL MELANIN NANOPARTICLES AND METHODS INCLUDING POROUS MELANIN MATERIALS	NORTHWESTERN UNIVERSITY
WO/2021/003078	INHIBITORS OF PROTEIN ARGININE DEIMINASE 1 AND METHODS OF PREPARATION AND USE THEREOF	UNIVERSITY OF MASSACHUSETTS
WO/2021/003082	ANTI-CLAUDIN 18.2/ANTI-CD47 BISPECIFIC ANTIBODIES AND USES THEREOF	PHANES THERAPEUTICS, INC.
WO/2021/007061	GAS PHASE PROCESS FOR CHLOROTRIFLUOROETHYLENE	HONEYWELL INTERNATIONAL INC.
WO/2021/021366	PROCESS AND SYSTEM TO MAKE OLEFIN EPOXIDES	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/003157	EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS	EFFECTOR THERAPEUTICS, INC.
WO/2021/003162	FRUSTRATED LEWIS PAIR-IMPREGNATED POROUS MATERIALS AND USES THEREOF	UNIVERSITY OF SOUTH FLORIDA
WO/2021/003171	INHIBITORS OF IL-15 AND THEIR USE IN TREATING AUTOIMMUNE/INFLAMMATORY DISORDERS	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/003207	COMPOSITIONS AND METHODS FOR SYNTHESIS OF 2,3-DICHLORO-1,1,1,2-TETRAFLUOROPROPANE AND 2,3,3,3-TETRAFLUOROPROPENE	THE CHEMOURS COMPANY FC, LLC
WO/2021/003238	HIGH AFFINITY MONOCLONAL ANTIBODIES FOR DETECTING AMANITINS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
WO/2021/003272	USE OF LRP2 AGONISTS FOR GENERATING MYELOID-DERIVED SUPPRESSOR CELLS	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/003284	ANTIBODIES AND ASSAYS FOR CCL14	ASTUTE MEDICAL, INC
WO/2021/003295	MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/003297	MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/003300	MESENCHYMAL STEM CELLS OR STROMAL CELLS HARBORING MODIFIED RNAS ENCODING VEGF AND BMP POLYPEPTIDES	CHIEN, Kenneth R.
WO/2021/003310	HETEROCYCLIC COMPOUNDS AS BET INHIBITORS	NUVATION BIO INC.
WO/2021/029981	NON-AROMATIC COMPOUND REMOVAL SYSTEMS FOR PARA-XYLENE PRODUCTION	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/086454	PROCESS FOR PRODUCING SUBSTITUTED LACTONES	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/021384	PROCESS AND SYSTEM TO MAKE SUBSTITUTED LACTONES	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/007101	METHOD AND MOLECULES	MEDIMMUNE, LLC
WO/2021/003398	INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/003399	ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS	ICONIC THERAPEUTICS, INC.
WO/2021/034418	NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES	TRUSTEES OF TUFTS COLLEGE
WO/2021/007110	METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/003413	SELF-ASSEMBLING CIRCULAR TANDEM REPEAT PROTEINS WITH INCREASED STABILITY	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/003416	MONOSPECIFIC ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE	SURROZEN, INC.
WO/2021/003417	TYROSINE KINASE NON-RECEPTOR 1 (TNK1) INHIBITORS AND USES THEREOF	SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/003425	METHODS OF INDUCING HEMATOPOIESIS	CODIAK BIOSCIENCES, INC.
WO/2021/003428	IMMUNOTHERAPY TARGETING CELL SURFACE MARKER CD72 FOR THE TREATMENT OF B-CELL MALIGNANCIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/003445	EXTRACELLULAR VESICLES TARGETING T CELLS AND USES THEREOF	CODIAK BIOSCIENCES, INC.
WO/2021/003456	ARTHROSPIRA PLATENSIS NON-PARENTERAL THERAPEUTIC DELIVERY PLATFORM	LUMEN BIOSCIENCE, INC.
WO/2021/003462	CATIONIC LIPIDS AND USES THEREOF	FACTOR BIOSCIENCE INC.
WO/2021/003463	SIALIDASE-CD20-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF	PALLEON PHARMACEUTICALS INC.
WO/2021/003464	SIALIDASE-PD-L1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF	PALLEON PHARMACEUTICALS INC.
WO/2021/003465	SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF	PALLEON PHARMACEUTICALS INC.
WO/2021/007141	PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES	BASF CORPORATION
WO/2021/007150	MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS	AMGEN INC.
WO/2021/029983	HYDROFORMYLATION SYSTEM WITH VENT REACTOR RECYCLE TO PRIMARY REACTOR	OQ CHEMICALS CORPORATION
WO/2021/007158	MODIFIED BCL9 MIMETIC PEPTIDES	SAPIENCE THERAPEUTICS, INC.
WO/2021/007170	COMPOSITIONS AND METHODS FOR ENHANCING CELL CULTURE	LIFE TECHNOLOGIES CORPORATION
WO/2021/007171	NOVEL BIO-BASED DIOLS FROM SUSTAINABLE RAW MATERIALS, USES THEREOF TO MAKE DIGLYCIDYL ETHERS, AND THEIR COATINGS	NDSU RESEARCH FOUNDATION
WO/2021/007190	PROCESSES FOR PREPARING PLASMA KALLIKREIN INHIBITORS	REZOLUTE, INC.
WO/2021/021394	METHODS FOR REDUCING FOULING IN UPGRADING REACTORS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/007236	NON-NATIVE O-GLCNAC MODIFICATION OF PEPTIDE HORMONES YIELDS POTENT GPCR AGONISTS WITH IMPROVED SERUM STABILITY	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/007260	ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/007266	METHOD OF ELIMINATING HEMATOPOIETIC STEM CELLS/HEMATOPOIETIC PROGENITORS (HSC/HP) IN A PATIENT USING BI-SPECIFIC ANTIBODIES	HEMOGENYX LLC
WO/2021/007269	BICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/007276	TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES	NEW YORK UNIVERSITY
WO/2021/007285	ANTI-HIV VACCINE ANTIBODIES WITH REDUCED POLYREACTIVITY	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/007307	BCL-2 PROTEIN INHIBITORS	RECURIUM IP HOLDINGS, LLC
WO/2021/007339	OXYHALIDE PRECURSORS	ENTEGRIS, INC.
WO/2021/007350	BCAT MODULATION	ICAGEN, LLC
WO/2021/007365	METHODS OF MAKING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES	CRAPAUD BIO, INC.
WO/2021/007366	G-PROTEIN BIASED OPIOID RECEPTOR AGONIST/ANALGESICS WITH REDUCED ARRESTIN RECRUITMENT	ST. LOUIS COLLEGE OF PHARMACY
WO/2021/007371	DLL3-TARGETING ANTIBODIES AND USES THEREOF	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/007428	MOLECULES, COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER	THE JOHNS HOPKINS UNIVERSITY
WO/2021/007433	PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES	PROTAGONIST THERAPEUTICS, INC.
WO/2021/007435	PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS	CYBREXA 2, INC.
WO/2021/007439	BISPECIFIC ANTIBODIES TO TNF-ALPHA AND IL-1BETA AND USES THEREOF	TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/007453	NON-VIRAL IMMUNO-TARGETING	UNIVERSITY OF WASHINGTON
WO/2021/007458	NOVEL NUCLEOTIDE ANALOGUES AND METHODS FOR USE	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/011334	DEUTERATED DERIVATIVES OF 6,8-BIS(BENZYLSULFANYL)OCTANOIC ACID	RAFAEL PHARMACEUTICALS, INC.
WO/2021/007477	INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS	E-SCAPE BIO, INC.
WO/2021/007478	SULFONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES	CURA THERAPEUTICS, LLC
WO/2021/011345	CRYSTALLINE LORLATINIB : FUMARIC ACID AND SOLID STATE FORM THEREOF	PLIVA HRVATSKA D.O.O
WO/2021/007484	PROCESS FOR ISOLATING A HIGH PURITY PROTEIN PREPARATION FROM PLANT MATERIAL AND PRODUCTS THEREOF	PLANTIBLE FOODS, INC.
WO/2021/011353	IL-2 COMPOSITIONS AND METHODS OF USE THEREOF	PROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/007503	TARGETING GALECTIN-9 AS A THERAPEUTIC STRATEGY FOR T-CELL EXHAUSTION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/055083	APPARATUSES SYSTEMS AND METHODS USING CORE-SHELL-SHELL MAGNETIC BEADS	APOSTLE, INC.
WO/2021/011413	METHODS FOR ISOLATING ESSENTIAL OILS, PHYTOCHEMICALS AND PHARMACEUTICALLY ACTIVE COMPONENTS FROM BIOMASS AND RECONSTITUTING SYNTHETIC FORMULATIONS COMPRISING SAME	ATLAS HEMP COMPANY LLC.
WO/2021/011417	CHEMICALLY CONTROLLED MONOCLONAL ANTIBODY TARGET ENGAGEMENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/007565	PROTEIN COMPOSITIONS AND CONSUMABLE PRODUCTS THEREOF	CLARA FOODS CO.
WO/2021/011428	HETEROCYCLIC KINASE INHIBITORS	GB005, INC.
WO/2021/015977	ORAL HEALTHCARE TREATMENT AND RELATED COMPOSITIONS	DUPONT NUTRITION BIOSCIENCES APS
WO/2021/011474	MODULAR DIMERIZATION THERMOSWITCHES AND RELATED MONOMERS, DIMERS, CONSTRUCTS, DIMERIC COMPLEXES, VECTORS, CELLS, SURFACES, DEVICES COMPOSITIONS, METHODS AND SYSTEMS	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/011482	METHOD TO ISOLATE TCR GENES	NEOGENE THERAPEUTICS B.V.
WO/2021/011492	L-Y-METHYLENEGLUTAMINE COMPOUNDS AND METHODS OF USE	UNIVERSITY OF MISSISSIPPI
WO/2021/007580	SYSTEM AND METHODS RELATING TO CHIMERIC AUTOANTIBODY RECEPTORS	VALKYR, INC.
WO/2021/011513	PRODRUGS IN THE MODULATION OF INTERLEUKIN	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/011586	POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE	MYOKARDIA, INC.
WO/2021/011608	METALLOTHIONEIN ANTIBODIES AND THEIR USE	UNIVERSITY OF CONNECTICUT
WO/2021/011631	FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/011636	COMPOSITIONS AND METHODS OF TREATMENT FOR BREAST CANCER INVOLVING A NOVEL CAPERα-MLL1 COMPLEX	GEISINGER HEALTH
WO/2021/011641	CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS	CRINETICS PHARMACEUTICALS, INC.
WO/2021/011670	ADENOSINE A2A RECEPTOR ANTAGONISTS AND USES THEREOF	TEON THERAPEUTICS, INC.
WO/2021/011673	NEUTRALIZING ANTI-AMYLOID BETA ANTIBODIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE	JIN, Ming
WO/2021/011678	ANTI-TREM-1 ANTIBODIES AND USES THEREOF	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/011681	ANTIBODIES AGAINST HUMAN TREM-1 AND USES THEREOF	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/011689	CD73 INHIBITORS	ORIC PHARMACEUTICALS, INC.
WO/2021/011692	CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS	NUCORION PHARMACEUTICALS, INC.
WO/2021/011713	IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/011720	ANTI-OSTEOARTHRITIS COMPOUNDS AND RELATED COMPOSITIONS AND METHODS	AVIDENCE THERAPEUTICS, INC.
WO/2021/011723	ANTI-OSTEOARTHRITIS HYDANTOIN COMPOUNDS AND RELATED COMPOSITIONS AND METHODS	AVIDENCE THERAPEUTICS, INC.
WO/2021/011724	TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/011727	PYRAZOLO[3,4-d]PYRROLO[1,2-b]PYRIDAZINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/011796	INHIBITORS OF CYCLIN-DEPENDENT KINASES	KINNATE BIOPHARMA INC.
WO/2021/011798	ANTI-GRP78 ANTIBODIES AND METHOD OF USE THEREOF	WASHINGTON UNIVERSITY
WO/2021/021458	MICROORGANISMS WITH IMPROVED NITROGEN TRANSPORT FOR ETHANOL PRODUCTION	NOVOZYMES A/S
WO/2021/011810	EXTRACTION AND PURIFICATION OF NATURAL FERULATE AND COUMARATE FROM BIOMASS	SPERO RENEWABLES, LLC
WO/2021/011827	ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE	AKSTON BIOSCIENCES CORPORATION
WO/2021/011834	ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF	SILVERBACK THERAPEUTICS, INC.
WO/2021/016062	CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/011864	METHODS AND COMPOSITIONS FOR TARGETING TGF-β SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/016079	COMPOSITION AND METHODS OF TARGETING THE PRE-B CELL RECEPTOR FOR THE TREATMENT OF LEUKEMIAS AND LYMPHOMAS	PASCAL BIOSCIENCES (US), INC.
WO/2021/011868	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/011876	MODULATORS OF EXCITATORY AMINO ACID TRANSPORTERS AND METHODS USING SAME	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/016089	METHODS FOR DETECTING HEREDITARY CANCERS	QUEST DIAGNOSTICS INVESTMENTS LLC
WO/2021/011885	CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016128	IMMUNOMODULATORY ANTIBODIES AND METHODS OF USE THEREOF	ONCORESPONSE, INC.
WO/2021/011927	COMPLEMENT INHIBITOR DOSING REGIMENS	APELLIS PHARMACEUTICALS, INC.
WO/2021/016133	PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES	WASHINGTON UNIVERSITY
WO/2021/016182	CONJUGATION OF MCR1 LIGAND WITH CYTOTOXIC DRUGS FOR TREATING SKIN CANCER	ARIZONA BOARD OF REGENTS ON BEHALF OFTHE UNIVERSITY OF ARIZONA
WO/2021/016191	C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF	REATA PHARMACEUTICALS, INC.
WO/2021/016220	SYNTHESIS OF SUBSTITUTED FURANS	BP CORPORATION NORTH AMERICA INC.
WO/2021/016233	HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER	SEAGEN INC.
WO/2021/016254	ESTROGEN RECEPTOR-MODULATING COMPOUNDS	RADIUS PHARMACEUTICALS, INC.
WO/2021/016256	ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS	ANGION BIOMEDICA CORP.
WO/2021/016263	CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/016280	TRICYCLIC DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS	NIKANG THERAPEUTICS, INC.
WO/2021/016289	THIENOPYRIDINYL AND THIAZOLOPYRIDINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/016299	INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/016316	MULTIMERIC PROTEIN DOMAINS FOR MULTIFUNCTIONALITY AND ENHANCED SECRETION OF THERAPEUTIC PROTEINS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/016317	MODULATORS OF TREX1	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/016339	MODULAR CHEMICAL PROBE FOR DETECTION OF AMINO ACID CITRULLINE IN PHYSIOLOGICAL SAMPLES	WISYS TECHNOLOGY FOUNDATION, INC.
WO/2021/016413	SYNTHESIS OF BICYCLIC INHIBITORS OF HISTONE DEACETYLASE	ALKERMES, INC.
WO/2021/016425	MIRNAS FOR REDUCING VENTRICLE ENLARGEMENT	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/016449	BICYCLIC CX3CR1 RECEPTOR AGONISTS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/016509	MALARIA IMMUNOGEN AND METHODS FOR USING SAME	UNM RAINFOREST INNOVATIONS
WO/2021/021605	HUMAN MONOCLONAL ANTIBODIES TO ENTEROVIRUS D68	VANDERBILT UNIVERSITY
WO/2021/021606	INTERLEUKIN-2 AGENTS AND USES THEREOF	VISTERRA, INC.
WO/2021/016534	ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF	AGENUS INC.
WO/2021/016535	LOW FREE 2-MERCAPTOETHANOL ESTER AND USES THEREOF	PMC ORGANOMETALLIX, INC.
WO/2021/021632	METHODS OF PREPARING SYNTHETIC CANNABINOL AND HOMOLOGS THEREOF	PURISYS LLC
WO/2021/021634	NANOMATERIALS CONTAINING CONSTRAINED LIPIDS AND USES THEREOF	GEORGIA TECH RESEARCH CORPORATION
WO/2021/016571	METHODS OF TREATING ANTIBODY-MEDIATED DISORDERS WITH FCRN ANTAGONISTS	GENZYME CORPORATION
WO/2021/016585	CHIMERIC ANTIGEN RECEPTORS WITH MAGE-A4 SPECIFICITY AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/021676	ANTI-IL13 ANTIGEN BINDING PROTEINS	AMGEN INC.
WO/2021/016599	IL-2 CYTOKINE PRODRUGS COMPRISING A CLEAVABLE LINKER	TRUTINO BIOSCIENCES INC
WO/2021/016602	POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE	TALIS BIOMEDICAL CORPORATION
WO/2021/016606	CHIMERIC ANTIGEN RECEPTOR T CELLS AND USES THEREOF	EUREKA THERAPEUTICS, INC.
WO/2021/021694	CIRCULAR ECONOMIC METHODS FOR FRAGRANCE INGREDIENTS	INTERNATIONAL FLAVORS AND FRAGRANCES INC.
WO/2021/021699	TARGETED NITROXIDE COMPOUNDS AND THEIR USE IN TREATING FERROPTOSIS-RELATED DISEASES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/021706	INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/021758	DISODIUM LAURYL SULFOSUCCINATE COMPOSITION	COLONIAL CHEMICAL, INC.
WO/2021/021761	UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION	NURIX THERAPEUTICS, INC.
WO/2021/021775	SOLID STATE FORMS OF RISDIPLAM AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/021797	MULTIKINASE DEGRADERS	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/025903	NON-COORDINATING ANION TYPE ACTIVATORS FOR USE WITH POLYOLEFIN POLYMERIZATION CATALYSTS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/021825	METHODS AND COMPOSITIONS FOR INDUCING NOTCH SIGNALING IN TUMOR MICROENVIRONMENTS	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/021830	ANTIBODIES TO <i>CANDIDA </i>AND USES THEREOF	THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/021840	ELECTROACTIVE COMPOUNDS	DUPONT ELECTRONICS, INC.
WO/2021/021847	RECYCLE CONTENT (C<sb>4</sb>)ALKANAL	EASTMAN CHEMICAL COMPANY
WO/2021/021849	RECYCLE CONTENT (C<sb>4</sb>)ALKANOIC ACID	EASTMAN CHEMICAL COMPANY
WO/2021/021882	NEAR-INFRARED (NIR) PHOTOIMMUNOTHERAPY (PIT) FOR THE TREATMENT OF CANCERS USING ANTI-CD25 ANTYBODY-PHTHALOCYANINE DYE CONJUGATE AND ANTI-PD1 ANTIBODY	RAKUTEN MEDICAL, INC.
WO/2021/021931	MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/021932	FLOW REACTION PROCESS FOR MANUFACTURE OF BORON-CONTAINING AGROCHEMICALS	BORAGEN, INC.
WO/2021/021953	DOPAMINE RECEPTOR D1 AGONISTS AND METHODS OF USE	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/021979	HDAC6 INHIBITORS AND USES THEREOF	EIKONIZO THERAPAPEUTICS, INC.
WO/2021/021986	HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38	RIBON THERAPEUTICS, INC.
WO/2021/021991	COMBINED INHIBITION OF SEMAPHORIN-4D AND TGFB AND COMPOSITIONS THEREFOR	VACCINEX,INC.
WO/2021/022008	VIRUS-LIKE PARTICLE VACCINES	VERNDARI, INC.
WO/2021/022067	PARVOVIRUS ANTIBODIES FOR VETERINARY USE	KINDRED BIOSCIENCES, INC.
WO/2021/022072	METHODS AND COMPOSITIONS FOR REDUCING IMMUNOGENICITY BY NON-DEPLETIONAL B CELL INHIBITORS	PROVENTION BIO, INC.
WO/2021/025962	RUBISCO-BINDING PROTEIN MOTIFS AND USES THEREOF	PRINCETON UNIVERSITY
WO/2021/025969	SOLID STATE FORMS OF BEROTRALSTAT	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/025973	HUMAN AMINOSTEROL ENT-03 COMPOUNDS, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME	ENTERIN, INC.
WO/2021/025974	HUMAN SQUALAMINE DERIVATIVES, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME	ENTERIN, INC.
WO/2021/025975	PYRIMIDINE-5-CARBOXAMIDE COMPOUND	ELI LILLY AND COMPANY
WO/2021/022111	β-ARRESTIN-MODULATING COMPOUNDS AND METHODS OF USING SAME	DUKE UNIVERSITY
WO/2021/022139	RELAXIN ANALOGS AND METHODS OF USING THE SAME	ELI LILLY AND COMPANY
WO/2021/022149	INSULIN ANALOGS AND METHODS OF USING THE SAME	ELI LILLY AND COMPANY
WO/2021/022163	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/026009	BIS-[N-((5-CARBAMOYL)-1H-BENZO[D]IMIDAZOL-2-YL)-PYRAZOL-5-CARBOXAMIDE] DERIVATIVES AND RELATED COMPOUNDS AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS FOR THE TREATMENT OF CANCER	MERSANA THERAPEUTICS, INC.
WO/2021/022178	SUBSTITUTED SULFONAMIDE PYRROLOPYRIDINES AS JAK INHIBITORS	ACLARIS THERAPEUTICS, INC.
WO/2021/026011	SOLID-STATE FORMS OF RELUGOLIX	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/022187	COMPOSITIONS AND METHODS FOR BINDING ANTIBODIES AND INHIBITING NEUTRALIZING ANTIBODIES	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/026016	FUSED POLYCYCLIC DIMERS	ANKH LIFE SCIENCES LIMITED
WO/2021/022212	OXIDATION-RESISTANT SERPINS	SERPLUS TECHNOLOGY LLC
WO/2021/022218	TREATMENT OF IMMUNE EVASIVE TUMORS	COUR PHARMACEUTICALS DEVELOPMENT CO., INC.
WO/2021/026047	HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS	MERCK SHARP & DOHME CORP.
WO/2021/022245	GLYPHOSATE BIOSENSOR	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/026059	7,8-DIHYDRO-4H-PYRAZOLO[4,3-c]AZEPINE-6-ONE COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/026064	COMPOSITIONS AND METHODS FOR TREATING SERPIN B13 DISORDERS	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/030091	COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026098	KIF18A INHIBITORS	AMGEN INC.
WO/2021/026099	KIF18A INHIBITORS	AMGEN INC.
WO/2021/026101	KIF18A INHIBITORS	AMGEN INC.
WO/2021/026109	DEGRADERS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/086467	NON-COORDINATING ANION ACTIVATORS CONTAINING A CATION WITH LONG CHAIN ALKOXY FUNCTIONALIZATION	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/026159	ETHYL ACETATE REMOVAL DURING VAM PRODUCTION	LYONDELLBASELL ACETYLS, LLC
WO/2021/026175	PEPTIDES THAT BLOCK PRESENTATION OF ANTIGENIC ISLET PEPTIDES BY HLA-DQ8 AND METHODS FOR TREATING TYPE-1 DIABETES	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/026179	AGONISTS OF ROR GAMMAt	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/026180	SOLID FORMS OF AN HPK1 INHIBITOR	INCYTE CORPORATION
WO/2021/026181	BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/026182	PROCESS-SCALE SYNTHESIS OF A PLASMA KALLIKREIN INHIBITOR	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/026205	METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST	REGENERON PHARMACEUTICALS, INC.
WO/2021/026245	RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/026254	COMPOSITIONS AND METHODS FOR PREPARING FACTOR XA AND DERIVATIVES	PORTOLA PHARMACEUTICALS, INC.
WO/2021/026257	PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME	EMPIRICO INC.
WO/2021/026294	METHODS AND COMPOSITIONS FOR RECONSTITUTING MICROGLIA	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/026307	PROCESSES FOR THE PREPARATION OF ROXADUSTAT AND INTERMEDIATES THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/026316	ACID-LABILE SURFACTANTS	PROMEGA CORPORATION
WO/2021/026335	METHODS FOR IDENTIFYING AND TREATING URINARY TRACT INFECTIONS	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/030142	THIENOPYRIMIDINE DERIVATIVES AS ACC INHIBITORS AND USES THEREOF	GILEAD SCIENCES, INC.
WO/2021/030149	CELL-SURFACE RECEPTORS RESPONSIVE TO LOSS OF HETEROZYGOSITY	A2 BIOTHERAPEUTICS, INC.
WO/2021/026372	METHODS AND COMPOSITIONS FOR STABILIZED RECOMBINANT FLAVIVIRUS E PROTEIN DIMERS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/026376	COMPOSITION AND USE OF HUMORAL IMMUNE SUPPRESSOR ANTAGONISTS FOR THE TREATMENT OF HUMORAL IMMUNO-SUPPRESSED DISEASES	NAVROGEN. INC.
WO/2021/030153	ENGINEERED T CELL RECEPTORS AND USES THEREOF	A2 BIOTHERAPEUTICS, INC.
WO/2021/126316	MACROCYCLIC COMPOUNDS	ZENO MANAGEMENT, INC.
WO/2021/026409	NOVEL ANTIGEN BINDING MOLECULE FORMATS	REGENERON PHARMACEUTICALS, INC.
WO/2021/030162	SALTS OF A PD-1/PD-L1 INHIBITOR	INCYTE CORPORATION
WO/2021/030174	TRUNCATED ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF	UNIVERSITY OF CONNECTICUT
WO/2021/030179	ANTI-SCLEROSTIN ANTIBODY FORMULATIONS	AMGEN INC.
WO/2021/026436	A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF	AGIOS PHARMACEUTICALS, INC.
WO/2021/026475	METHODS OF TREATING TEXTILES WITH FOAM AND RELATED PROCESSES	KEMIN INDUSTRIES, INC.
WO/2021/026479	SMALL MOLECULE INHIBITORS OF S1P2 RECEPTOR AND USES THEREOF	SANCHEZ, Teresa
WO/2021/030209	THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/026508	ANTI-NAMPT ANTIBODIES AND USES THEREOF	AQUALUNG THERAPEUTICS
WO/2021/030222	MODULATORS OF PARATHYROID HORMONE RECEPTOR (PTHR1)	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/030238	METHOD OF SYNTHESIS OF COMPOUND FOR DUAL INHIBITION OF JAK2 AND BET	OHM ONCOLOGY
WO/2021/034526	PROCESS FOR PURIFIYING SILICON COMPOUNDS	DOW SILICONES CORPORATION
WO/2021/041011	PREPARATION OF AN AQUEOUS DISPERSION OF ACRYLATE-SILOXANE COPOLYMER PARTICLES	ROHM AND HAAS COMPANY
WO/2021/030240	TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS	AGENSYS, INC.
WO/2021/030241	IMMUNOMODULATORY COMPOUNDS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030251	METHODS AND COMPOSITIONS FOR PROMOTING AND POTENTIATING T-CELL MEDIATED IMMUNE RESPONSES THROUGH ADCC TARGETING OF CD39 EXPRESSING CELLS	PURINOMIA BIOTECH, INC.
WO/2021/030257	CAR-T CELLS SPECIFIC FOR MODIFIED PROTEINS IN EXTRACELLULAR SPACES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030262	NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF	CRINETICS PHARMACEUTICALS, INC.
WO/2021/030267	COMPOSITIONS AND METHODS FOR INCREASED PROTEIN PRODUCTION IN <i>BACILLUS LICHENIFORMIS</i>	DANISCO US INC
WO/2021/030271	METHODS AND APPARATUSES FOR MANUFACTURING FOR REMOVING MATERIAL FROM A THERAPEUTIC COMPOSITION	NUTCRACKER THERAPEUTICS, INC.
WO/2021/030278	BICYCLIC COMPOUNDS	ALIGOS THERAPEUTICS, INC.
WO/2021/041021	PROCESSES FOR ISOMERIZING C8 AROMATIC HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/041022	PROCESSES FOR ISOMERIZING C8 AROMATIC HYDROCARBONS USING SERIAL REACTORS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/030349	METHODS OF CONTROLLING SURFACE TENSION	LYONDELLBASELL ACETYLS, LLC
WO/2021/034550	SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/030374	MODIFIED INTERLEUKIN 2 (IL-2) POLYPEPTIDES, CONJUGATES AND USES THEREOF	CYTIMM THERAPEUTICS, INC.
WO/2021/030379	BICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/030386	SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR	BLUEPRINT MEDICINES CORPORATION
WO/2021/030401	PROCESS FOR MAKING [1.1.1]PROPELLANE	RECURIUM IP HOLDINGS, LLC
WO/2021/030423	TETRANECTIN-TARGETING MONOCLONAL ANTIBODIES TO FIGHT AGAINST LETHAL SEPSIS AND OTHER PATHOLOGIES	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
WO/2021/030427	INTRAGEL WELL SAMPLE LOADING SYSTEM	YALE UNIVERSITY
WO/2021/030450	NOVEL LOX-1 ANTIBODY COMPOSITIONS, LOX1 NEUTRALIZATION ASSAY AND METHODS OF TREATMENT USING SAME	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/236139	NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF	CONCERT PHARMACEUTICALS, INC.
WO/2021/030483	IL-2 FUSION PROTEINS THAT PREFERENTIALLY BIND IL-2RALPHA	ASKGENE PHARMA, INC.
WO/2021/030484	IL1RAP ANTIBODIES	CITY OF HOPE
WO/2021/030537	IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS	INCYTE CORPORATION
WO/2021/030551	COMPOUNDS AND COMPOSITIONS FOR DIFFERENTIAL MODULATION OF NICOTINAMIDE ADENINE DINUCLEOTIDE	METRO INTERNATIONAL BIOTECH, LLC
WO/2021/030552	CRYSTALLINE FORMS OF CFTR MODULATORS	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/030554	PROCESS OF MAKING CFTR MODULATORS	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/030555	MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/030556	MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/030602	INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS	AMGEN INC.
WO/2021/030615	METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF	WASHINGTON UNIVERSITY
WO/2021/030620	HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS	NUVATION BIO INC.
WO/2021/030623	HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS	NUVATION BIO INC.
WO/2021/030633	ENGINEERED INTERLEUKIN-2 RECEPTOR BETA AGONISTS	ELPIS BIOPHARMACEUTICALS
WO/2021/041049	SEPARATION OF 1-BUTENE FROM 2-BUTENE USING FRAMEWORK OPEN METAL SITES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030657	MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS	JANSSEN BIOTECH, INC.
WO/2021/034639	HIGH CONCENTRATION ANTI-C5 FORMULATIONS	REGENERON PHARMACEUTICALS, INC.
WO/2021/034646	MULTIMERIC BISPECIFIC ANTI-CD123 BINDING MOLECULES AND USES THEREOF	IGM BIOSCIENCES, INC.
WO/2021/030680	MULTISPECIFIC ANTIGEN-BINDING MOLECULES FOR CELL TARGETING AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/030688	IMMUNOSTIMULATORY MULTIMERIC BINDING MOLECULES	IGM BIOSCIENCES, INC.
WO/2021/030690	LOW-PRESSURE DEPOLYMERIZATION OF LIGNOCELLULOSIC BIOMASS	EBIKADE, Elvis, O.
WO/2021/030711	ALKYNYL QUINAZOLINE COMPOUNDS	BLACK DIAMOND THERAPEUTICS, INC.
WO/2021/030743	SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030764	AAV CAPSID VARIANTS FOR GENE THERAPY	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/034727	COMPOSITIONS, FORMULATIONS, AND INTERLEUKIN PRODUCTION AND PURIFICATION	APPLIED MOLECULAR TRANSPORT INC.
WO/2021/030778	LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF	IONIS PHARMACEUTICALS, INC.
WO/2021/034742	FAST PREPARATION OF LOW PRIMARY AMINE CONTAINING POLYASPARTIC ESTERS AND USE OF THESE POLYASPARTIC ESTERS IN SLOW REACTIVITY POLYUREA SYSTEMS	COVESTRO LLC
WO/2021/076218	METHODS FOR PREVENTION AND TREATMENT OF FIBROMYALGIA BY CONTACT VASODILATORS	WEINBERG, Assa
WO/2021/034796	PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE	GLYCOMIMETICS, INC.
WO/2021/034809	BIS(PHOSPHINO)-PHENOXY NICKEL(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND ACRYLATE MONOMERS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/034815	METHODS OF MAKING INCRETIN ANALOGS	ELI LILLY AND COMPANY
WO/2021/112923	ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME	REGENERON PHARMACETUCALS, INC.
WO/2021/112925	ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME	REGENERON PHARMACEUTICALS, INC.
WO/2021/112927	ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME	REGENERON PHARMACEUTICALS, INC.
WO/2021/112929	ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME	REGENERON PHARMACEUTICALS, INC.
WO/2021/034904	PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID DERIVATIVES OF 3-BROMO-4,5-DIHYDRO-1H-PYRAZOLES	FMC CORPORATION
WO/2021/041107	COMPOUNDS FOR SELECTIVE BINDING TO ESTROGEN RECEPTORS ALPHA/BETA RELATIVE TO GPER/GPR30	UNM RAINFOREST INNOVATIONS
WO/2021/034913	ENGINEERING PH-DEPENDENT ANTIGEN BINDING ACTIVITY INTO ANTI-HIV ANTIBODIES WITH IMPROVED PHARMACOKINETICS	THE ROCKEFELLER UNIVERSITY
WO/2021/034976	T-CELL IMMUNOTHERAPY SPECIFIC FOR WT-1	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/035028	FORMULATION OPTIMIZATION FOR BISPECIFIC ANTIBODIES	REGENERON PHARMACEUTICALS, INC.
WO/2021/035033	AMYLOID-BETA ANTIBODIES	THE CURATORS OF THE UNIVERSITY OF MISSOURI
WO/2021/035045	METTL16 INHIBITORS AND USES THEREOF	CITY OF HOPE
WO/2021/035059	TARGETING SLC38A2 IN PANCREATIC CANCER	NEW YORK UNIVERSITY
WO/2021/035096	COMPOSITIONS AND METHODS FOR TARGETING CELLULAR MOLECULES	KUMQUAT BIOSCIENCES INC.
WO/2021/041177	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AUTOIMMUNE INDUCED CARDIAC LONG QT SYNDROME	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
WO/2021/035120	ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/035129	USE OF BRAZIKUMAB TO TREAT CROHN'S DISEASE	ASTRAZENECA COLLABORATION VENTURES, LLC
WO/2021/041194	NON-OPIOID COMPOSITIONS AND THERAPIES FOR PAIN MANAGEMENT	UNM RAINFOREST INNOVATIONS
WO/2021/041201	CATALYST COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF	BASF CORP.
WO/2021/035157	ORGANIC COMPOUNDS	INTRA-CELLULAR THERAPIES, INC.
WO/2021/041237	THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS	TERNS, INC.
WO/2021/041238	MATERIALS AND METHODS FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES	NORTHWESTERN UNIVERSITY
WO/2021/035170	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS	PRECISION BIOSCIENCES, INC.
WO/2021/035174	ANTI-CD22 ANTIBODIES AND USES THEREOF	ELPIS BIOPHARMACEUTICALS
WO/2021/035176	PIGMENTED AND FLUORESCENT COMPOUNDS DERIVED FROM THE ADDITION OF A PRIMARY OR SECONDARY AMINE TO AN ALDEHYDE	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/035179	COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES	CODA BIOTHERAPEUTICS, INC.
WO/2021/035184	METHODS FOR IMPROVED EXTRACTION OF SPIDER SILK PROTEINS	BOLT THREADS, INC.
WO/2021/041276	HETEROCYCLIC PYRAZOLE DERIVATIVES AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS	DEVELOPMENT CENTER FOR BIOTECHNOLOGY
WO/2021/041300	BISPECIFIC ANTIBODIES AND USES THEREOF	AB THERAPEUTICS, INC.
WO/2021/080682	MONOCLONAL ANTIBODIES THAT BIND HUMAN CD161 AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/041319	CRYSTALLINE FORMS OF A CD73 INHIBITOR	ELI LILLY AND COMPANY
WO/2021/041336	IGG ANTIBODY COMPOSITIONS AND METHODS OF MAKING THE SAME	CITY OF HOPE
WO/2021/041360	TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS	INCYTE CORPORATION
WO/2021/045927	EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS	EASTMAN CHEMICAL COMPANY
WO/2021/041373	TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FAB	REGENXBIO INC.
WO/2021/041407	ALKYL QUARTERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES	CAAMTECH LLC
WO/2021/041450	ORGANIC SEMICONDUCTING COMONOMER	PHILLIPS 66 COMPANY
WO/2021/041474	METHODS OF IMPROVING DROUGHT AND SALT RESISTANCE IN A PLANT AND GENETICALLY ENGINEERED PLANTS WITH SAID IMPROVEMENTS	UT-BATTELLE, LLC
WO/2021/041481	COST-EFFECTIVE LAUNDRY DETERGENT COMPOSITIONS COMPRISING GREEN COMPONENTS	FREY BROTHERS, INC.
WO/2021/041486	CHIMERIC ANTIGEN RECEPTOR SYSTEM AND USES THEREOF	JANSSEN BIOTECH, INC.
WO/2021/041536	BENZIMIDAZOLE AND HYDROGENATED CARBAZOLE DERIVATIVES AS GPX4 INHIBITORS	FERRO THERAPEUTICS, INC.
WO/2021/041539	PYRIDO-INDOLE ANALOGUES AS GPX4 INHIBITORS	FERRO THERAPEUTICS, INC.
WO/2021/041569	NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS	ARBOR BIOTECHNOLOGIES, INC.
WO/2021/041575	COMPOSITIONS AND USES FOR ENGINEERED THERAPEUTIC MICROBES AND ASSOCIATED RECEPTORS	QUINTANA, Francisco J.
WO/2021/041588	SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/041650	METHOD AND APPARATUS FOR FILTERING HEAT TRANSFER FLUID FROM A MONOETHYLENE GLYCOL STREAM	SCHLUMBERGER TECHNOLOGY CORPORATION
WO/2021/041704	ANTIBODIES AND BLOCKING THE INTERACTION OF VISTA AND ITS BINDING PARTNER	TRUEBINDING, INC.
WO/2021/041715	COMPOSITIONS INCLUDING IGG FC MUTATIONS AND USES THEREOF	UNIVERSITY OF KANSAS
WO/2021/041731	ASSAYS FOR DETECTING AND QUANTIFYING A BIOMARKER OF PERICYTE INJURY	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/041756	LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF	DICERNA PHARMACEUTICALS, INC.
WO/2021/041770	PCSK9 ANTAGONIST COMPOUNDS	MERCK SHARP & DOHME CORP.
WO/2021/045969	HEPATITIS B VIRUS VACCINES	VIR BIOTECHNOLOGY, INC.
WO/2021/041822	METHODS OF INCREASING VACCINE EFFICACY	GENOME PROTECTION. INC.
WO/2021/041825	SPHINGOLIPID-BASED SELENIUM COMPOUNDS, METHODS FOR THEIR PREPARATION, AND PHARMACEUTICAL USES THEREOF, INCLUDING AS ANTITUMOR AGENTS	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/041852	GLYCOSYLATED DIPHYLLIN AS A BROAD-SPECTRUM ANTIVIRAL AGENT AGAINST ZIKA VIRUS AND COVID-19	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/041861	N-(2-AMINOPHENYL)-PROP-2-ENAMIDE DERIVATIVES, AND USES THEREOF IN THE TREATMENT OF CANCER	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/041874	BIOFUNCTIONAL THIOPHENE MONOMERS	MARTIN, David, C.
WO/2021/041878	PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16 FOR CANCER TREATMENT	DRAGONFLY THERAPEUTICS, INC.
WO/2021/041886	MODIFIED N-810 AND METHODS THEREFOR	NANTBIO, INC.
WO/2021/041898	PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS	RIGEL PHARMACEUTICALS, INC.
WO/2021/045975	CS1 ANTIBODY AND ANTI-CS1-CAR-T CELLS	PROMAB BIOTECHNOLOGIES, INC.
WO/2021/041934	PROTEASE SENSITIVE GVPC AND RELATED GAS VESICLE GENE CLUSTERS, EXPRESSION SYSTEMS, CONSTRUCTS, VECTORS, GENETIC CIRCUITS, CELLS, COMPOSITIONS, METHODS AND SYSTEMS FOR CONTRAST-ENHANCED IMAGING	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/041951	ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/041953	GENE FRAGMENT OVEREXPRESSION SCREENING METHODOLOGIES, AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041954	TARGETED DELIVERY OF TUMOR MATRIX MODIFYING ENZYMES	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/041958	CHIMERIC PROTEINS IN AUTOIMMUNITY	SHATTUCK LABS. INC.
WO/2021/041970	PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS	HIBERCELL, INC.
WO/2021/041973	PERK INHIBITING COMPOUNDS	HIBERCELL, INC.
WO/2021/041975	PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS	HIBERCELL, INC.
WO/2021/041976	PERK INHIBITING INDOLINYL COMPOUNDS	HIBERCELL, INC.
WO/2021/042022	SEPTIN INHIBITORS FOR TREATMENT OF CANCERS	UNIVERSITY OF ROCHESTER
WO/2021/046006	AROMATIC ENOL ETHERS	EASTMAN CHEMICAL COMPANY
WO/2021/046007	AROMATIC ENOL ETHERS	EASTMAN CHEMICAL COMPANY
WO/2021/046010	A PROCESS TO MAKE AROMATIC ENOL ETHERS AND OLEFIN ISOMERS OF AROMATIC ENOL ETHERS	EASTMAN CHEMICAL COMPANY
WO/2021/046011	METHOD OF MAKING A DIALDEYHDE	EASTMAN CHEMICAL COMPANY
WO/2021/046014	SOLID STATE FORMS OF PAMIPARIB AND PROCESS FOR PREPARATION THEREOF	TEVA CZECH INDUSTRIES S.R.O
WO/2021/046046	METHOD OF MAKING A DIALDEYHDE	EASTMAN CHEMICAL COMPANY
WO/2021/046072	PROTEINS COMPRISING T-CELL RECEPTOR CONSTANT DOMAINS	ELI LILLY AND COMPANY
WO/2021/046121	METHOD TO SEQUENCE MRNA IN SINGLE CELLS IN PARALLEL WITH QUANTIFICATION OF INTRACELLULAR PHENOTYPE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046159	CD8 BINDING AGENTS AND USES THEREOF	GENENTECH, INC.
WO/2021/055174	ETHYLENE OXIDE PURIFICATION	PETRON SCIENTECH, INC.
WO/2021/046194	TRYPTOLINE-BASED BENZOTHIAZOLES AND THEIR USE AS ANTIBIOTICS AND ANTIBIOTIC RESISTANCE-MODIFYING AGENTS	THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE
WO/2021/046207	SELF-ASSEMBLING PROTEIN NANOSTRUCTURES DISPLAYING PARAMYXOVIRUS AND/OR PNEUMOVIRUS F PROTEINS AND THEIR USE	UNIVERSITY OF WASHINGTON
WO/2021/046225	METHODS AND COMPOSITIONS FOR TREATING CANCER	FLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/046234	PROCESSES FOR THE PREPARATION OF ALPHA-HYDROXY ESTERS BY ESTERIFICATION OF ALPHA-HYDROXY ACIDS	KEMIN INDUSTRIES, INC.
WO/2021/046244	CROSS-REACTIVE EPITOPE FOR MULTIPLE SCLEROSIS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/046245	ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF	UNIVERSITY OF MASSACHUSETTS
WO/2021/046246	CONJUGATED HEPCIDIN MIMETICS	PROTAGONIST THERAPEUTICS, INC.
WO/2021/046261	ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE	POSEIDA THERAPEUTICS, INC.
WO/2021/046286	HEPATITIS B ANTIVIRAL AGENTS	TAIGEN BIOTECHNOLOGY CO., LTD.
WO/2021/046289	DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS AGONISTIC ANTIBODY AND IPILIMUMAB	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/046290	PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT	CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS
WO/2021/046293	DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS AGONISTIC ANTIBODY AND TREMELIMUMAB	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/046331	ANTI-STEAP1 ANTIBODIES AND USES THEREOF	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/046355	TREATING MITOCHONDRIAL DNA DEPLETION DISORDERS	MITORAINBOW THERAPEUTICS, INC.
WO/2021/046357	COMPOSITIONS CONTAINING ADENOSINE TRIPHOSPHATE (ATP) AND METHODS OF USE	JIANGYIN TSI PHARMACEUTICAL CO., LTD.
WO/2021/046361	USE OF CALCINEURIN INHIBITOR FREE CTLA4-IG + ANTI-IL6/IL6R FOR LONG TERM IMMUNOSUPPRESSION IN SOLID ORGAN TRANSPLANT RECIPIENTS	CEDARS-SINAI MEDICAL CENTER
WO/2021/046382	RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME	RIGEL PHARMACEUTICALS, INC.
WO/2021/046389	COMPOSITIONS AND METHODS FOR USING SILK-ELASTINLIKE PROTEIN-BASED POLYMERS	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/046407	RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME	RIGEL PHARMACEUTICALS, INC.
WO/2021/046437	RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME	RIGEL PHARMACEUTICALS, INC.
WO/2021/046442	NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS	ARBOR BIOTECHNOLOGIES, INC.
WO/2021/046447	HETEROCYCLIC RIP1 KINASE INHIBITORS	RIGEL PHARMACEUTICALS, INC.
WO/2021/046498	MITIGATION OF PERI-IMPLANTITIS BY DESIGN AND STABILITY OF BIFUNCTIONAL PEPTIDES WITH ANTIMICROBIAL PROPERTIES	UNIVERSITY OF KANSAS
WO/2021/046515	INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/046523	COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES	KYULUX, INC.
WO/2021/050463	METHOD OF PREPARING ALKOXY-FUNCTIONAL ORGANOSILICON COMPOUNDS	DOW SILICONES CORPORATION
WO/2021/050473	IN SILICO DISCOVERY OF EFFECTIVE ANTIMICROBIALS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/050555	COMPOSITIONS AND USES THEREOF	X-CHEM, INC.
WO/2021/050583	TREATMENT OF TRAUMATIC ENCEPHALOPATHY BY FIBROBLASTS AND THERAPEUTIC ADJUVANTS	FIGENE, LLC
WO/2021/050612	COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS	CIDARA THERAPEUTICS, INC.
WO/2021/050640	PURIFICATION METHOD FOR BISPECIFIC ANTIGEN-BINDING POLYPEPTIDES WITH ENHANCED PROTEIN L CAPTURE DYNAMIC BINDING CAPACITY	AMGEN INC.
WO/2021/050654	PROCESS FOR THE PREPARATION OF A MEDICAMENT CONTAINING AN OXEPANE RING.	GENENTECH, INC.
WO/2021/050656	COMPOSITIONS AND METHODS COMPRISING PROSTATE STEM CELL ANTIGEN (PSCA) CHIMERIC ANTIGEN RECEPTORS (CARS)	THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/055220	PRODUCTION OF ACROLEIN OR ACRYLIC ACID FROM ALLYL ALCOHOL WITH HIGH YIELD AND LOW IMPURITY	ROHM AND HAAS COMPANY
WO/2021/050660	HEXASUBSTITUTED BENZENES, SURFACES MODIFIED THEREWITH, AND ASSOCIATED METHODS	COUNTERTRACE LLC
WO/2021/050672	KINASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES	OHIO STATE INNOVATION FOUNDATION
WO/2021/050681	REVERSIBLE MODIFICATION OF NUCLEOTIDES	OMNIOME, INC.
WO/2021/050749	REMOVING ORGANIC ACIDS IN MONOETHYLENE GLYCOL RECOVERY	SCHLUMBERGER TECHNOLOGY CORPORATION
WO/2021/050789	CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION	OBSIDIAN THERAPEUTICS, INC.
WO/2021/050801	NANOPARTICLE-ENHANCED ACTIVITY OF A POTASSIUM CHANNEL-BLOCKING PEPTIDE	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY
WO/2021/050857	ANTI-CD371 ANTIBODIES AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/050871	ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF	MYTHIC THERAPEUTICS, INC.
WO/2021/050915	MTA-COOPERATIVE PRMT5 INHIBITORS	MIRATI THERAPEUTICS, INC.
WO/2021/050925	METHODS FOR MAKING AUDITORY PROGENITOR CELLS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055253	ANTI-TNFR2 ANTIBODIES AND METHODS OF USE	APEXIGEN, INC.
WO/2021/050977	PROCESSES FOR THE SYNTHESIS OF VALBENAZINE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/050989	ZIKA ANTIBODIES AND THEIR USE	DUKE UNIVERSITY
WO/2021/050992	USP30 INHIBITORS AND USES THEREOF	VINCERE BIOSCIENCES, INC.
WO/2021/071624	SYNTHESIS OF NANOPOROUS POLYPHENOL-BASED COORDINATION POLYMER FRAMEWORKS AND METHODS OF USE THEREOF	UNIVERSITY OF NORTH CAROLINA AT GREENSBORO
WO/2021/051034	RAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS	BIOTHERYX, INC.
WO/2021/055270	CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS	CHEVRON PHILIPS CHEMICAL COMPANY LP
WO/2021/055271	CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS	CHEVRON PHILLIPS CHEMICAL COMPANY LP
WO/2021/055272	CHROMIUM-CATALYZED PRODUCTION OF DIOLS FROM OLEFINS	CHEVRON PHILLIPS CHEMICAL COMPANY LP
WO/2021/055295	BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE	NOVARTIS AG
WO/2021/055326	AZOLE-FUSED PYRIDAZIN-3(2H)-ONE DERIVATIVES	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/055333	SYNTHETIC IMMUNE CELLS AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055342	IMMUNOTHERAPY COMPOUNDS AND METHODS	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/055349	A METHOD OF ENGINEERING NATURAL KILLER-CELLS TO TARGET BCMA-POSITIVE TUMORS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/055350	RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING	REGENERON PHARMACEUTICALS, INC.
WO/2021/055367	ENGINEERED RECEPTORS FOR HUMAN CYTOMEGALOVIRUS AND USES THEREOF	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/055372	CHIMERIC RECEPTOR PROTEINS AND USES THEREOF	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/055376	IL-17A MODULATORS AND USES THEREOF	DICE ALPHA, INC.
WO/2021/055388	2,5-DIMERCAPTO-1,3,4-THIADIAZOLE ("DMTD") DERIVATIVES	THE LUBRIZOL CORPORATION
WO/2021/055408	ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF	OPSIDIO, LLC
WO/2021/076259	PRODUCTION OF ALKYLAROMATIC COMPOUNDS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/076260	PRODUCTION OF ALKYLAROMATIC COMPOUNDS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/055502	IDENTIFICATION OF COMPOUNDS THAT INHIBIT STRESS GRANULE FORMATION AND TAU AGGREGATION BY TARGETING TIA1	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/055538	METHODS OF USE FOR KV7 CHANNEL ACTIVATORS	KNOPP BIOSCIENCES LLC
WO/2021/055568	IL-2 COMPOSITIONS AND METHODS OF USE THEREOF	PROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/055577	ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND METHODS OF USE	GENENTECH, INC.
WO/2021/055591	SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS	BIAL-BIOTECH INVESTMENTS, INC.
WO/2021/055612	SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS	BIAL-BIOTECH INVESTMENTS, INC.
WO/2021/055614	ANTIBODY GENE THERAPY FOR TREATMENT AND PREVENTION OF INFECTION BY RABIES LYSSAVIRUS	AUBURN UNIVERSITY
WO/2021/055621	PLASMA KALLIKREIN INHIBITORS AND USES THEREOF	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/055627	SUBSTITUTED <i>N</i>-HETEROCYCLIC CARBOXAMIDES AS ACID CERAMIDASE INHIBITORS AND THEIR USE AS MEDICAMENTS	BIAL- BIOTECH INVESTMENTS, INC.
WO/2021/055630	SUBSTITUTED, SATURATED AND UNSATURATED <i>N</i>-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS	BIAL- BIOTECH INVESTMENTS, INC.
WO/2021/061504	METHODS AND COMPOSITIONS COMPRISING AN ANTI-CTLA4 MONOCLONAL ANTIBODY WITH REDUCED HOST CELL PROTEINS AND INCREASED POLYSORBATE-80 STABILITY	MERCK SHARP & DOHME CORP.
WO/2021/055669	FC VARIANTS WITH REDUCED EFFECTOR FUNCTION	ADIMAB, LLC
WO/2021/055679	CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME	ACADEMIA SINICA
WO/2021/055694	DOSING FOR ANTI-TRYPTASE ANTIBODIES	GENENTECH, INC.
WO/2021/055696	METHODS FOR PRODUCING D-TRYPTOPHAN AND SUBSTITUTED D-TRYPTOPHANS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055698	ANTIBODIES BINDING TO VISTA AT ACIDIC PH	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/055705	BIAMINOQUINOLINES AND NANOFORMULATIONS FOR CANCER TREATMENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055714	COMPOSITIONS AND METHODS FOR TREATING PRION DISEASE	EIP PHARMA, INC.
WO/2021/055728	SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT	MERCK SHARP & DOHME CORP.
WO/2021/055752	BENZOXABOROLE POLYMERS AND METHODS OF USE	GLYSCEND, INC.
WO/2021/055759	SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE	GLYSCEND, INC.
WO/2021/055765	MULTIMERIC ANTIBODIES WITH ENHANCED SELECTIVITY FOR CELLS WITH HIGH TARGET DENSITY	IGM BIOSCIENCES, INC.
WO/2021/055797	SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)	PRELUDE THERAPEUTICS, INCORPORATED
WO/2021/055798	INFLUENZA NEUTRALIZING ANTIBODIES AND THEIR USES	DUKE UNIVERSITY
WO/2021/055816	PD-L1 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS	MOLECULAR TEMPLATES, INC.
WO/2021/055830	VASCULOGENIC FIBROBLASTS	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/055833	BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS	MODERNATX, INC.
WO/2021/055835	CARBONATE CONTAINING LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS	MODERNATX, INC.
WO/2021/055849	HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS	MODERNATX, INC.
WO/2021/055855	COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL	THE BROAD INSTITUTE, INC.
WO/2021/061537	VACCINE THERAPY FOR RAN PROTEIN DISEASES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/055880	DETECTION OF ANTIBODIES AGAINST RAN PROTEINS FROM SERUM AND TISSUE LYSATES	UNIVERSITY OF FLORIDA RESEARCHFOUNDATION, INCORPORATED
WO/2021/055881	ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE THEREOF	DENALI THERAPEUTICS INC.
WO/2021/055892	COMPOSITIONS AND METHODS COMPRISING IONIZABLE LIPID NANOPARTICLES ENCAPSULATING BARCODED MRNA	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/055894	MATERIALS AND METHODS FOR DIFFERENTIAL CHARACTERIZATION OF MOLECULAR CONJUGATES AND CONJUGATION	JANSSEN BIOTECH, INC.
WO/2021/055905	META-DIAMIDE INSECTICIDES	FMC CORPORATION
WO/2021/061545	A PROCESS FOR THE SYNTHESIS OF AROMATIC DICARBOXYLIC ACIDS	UOP LLC
WO/2021/055942	CAR-T CELL COMPOSITIONS, METHODS OF USE THEREOF	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/055960	PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS	THE UNIVERSITY OF CHICAGO
WO/2021/061594	METHOD FOR MEASURING NUCLEIC ACID CONTENT IN LIPID NANOPRTICLES USING ULTRAVIOLET SPECTROMETRY	MERCK SHARP & DOHME CORP.
WO/2021/067077	METHODS OF ETHERIFICATION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/067079	METHODS OF ETHERIFICATION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/061706	SHP2 PHOSPHATASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME	RELAY THERAPEUTICS, INC.
WO/2021/061716	HONEY BEE-SAFE ACARICIDAL COMPOUNDS	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/061752	PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES	NEONC TECHNOLOGIES, INC.
WO/2021/061778	DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP)	THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/061791	NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061823	CHEMICAL COMPOUNDS	BORAGEN, INC.
WO/2021/061829	VARIANT NUCLEIC ACID LIBRARIES FOR CRTH2	TWIST BIOSCIENCE CORPORATION
WO/2021/061842	VARIANT NUCLEIC ACID LIBRARIES FOR SINGLE DOMAIN ANTIBODIES	TWIST BIOSCIENCE CORPORATION
WO/2021/061858	TARGETED AUTOPHAGY CONJUGATES AND METHODS	FRONTIER MEDICINES CORPORATION
WO/2021/061859	NOVEL RECEPTORS FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061898	ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS	NOVARTIS AG
WO/2021/108023	PENICILLIN-BINDING PROTEIN INHIBITORS	VENATORX PHARMACEUTICALS, INC.
WO/2021/061969	METHODS FOR OPERATING CONTINUOUS, UNMODULATED, MULTIPLE CATALYTIC STEP PROCESSES	IOWA CORN PROMOTION BOARD
WO/2021/062033	FUSION POLYPEPTIDES BINDING ANTIBODY FC DOMAINS AND INTEGRIN AND METHODS OF USE	PROVIDENCE HEALTH & SERVICES - OREGON
WO/2021/188148	CRYSTALLINE FORMS OF SQUALAMINE	ENTERIN, INC.
WO/2021/062082	SYSTEM AND METHOD FOR INCREASED ALCOHOL TOLERANCE AND PRODUCTION IN YEAST	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/062085	DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-PD-L1 ANTAGONIST ANTIBODIES	GENENTECH, INC.
WO/2021/062119	NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/062168	SYNTHETIC SPHINGOLIPID INSPIRED MOLECULES WITH HETEROAROMATIC APPENDAGES, METHODS OF THEIR SYNTHESIS AND METHODS OF TREATMENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/062184	PD-L1 TARGETED CHIMERIC PROTEINS AND USES THEREOF	ORIONIS BIOSCIENCES, INC.
WO/2021/062199	INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/062204	BISPHOSPHONATE LOADED STARCH NANOPARTICLE	GREENMARK BIOMEDICAL INC.
WO/2021/062231	CANNABINOID PRODRUG COMPOUNDS	FIRSTLIGHT PHARMACEUTICALS LLC
WO/2021/062237	ASTAXANTHIN ESTERS AND METHODS OF USE THEREOF	CARDAX, INC.
WO/2021/062244	ANTI-IL-27 ANTIBODIES AND USES THEREOF	SURFACE ONCOLOGY, INC.
WO/2021/062245	PYRIDONE COMPOUNDS AND METHODS OF USE IN THE MODULATION OF A PROTEIN KINASE	EXELIXIS, INC.
WO/2021/062261	PROGNOSTIC MARKERS OF METASTATIC CANCER	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/062323	ANTIBODIES SPECIFIC TO GLYCOSYLATED CTLA-4 AND METHODS OF USE THEREOF	STCUBE & CO.
WO/2021/062327	FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF	JUBILANT BIOSYS LIMITED
WO/2021/062332	COMBINATION OF INHIBITORS OF IL4 SIGNALING AND IMMUNE CHECKPOINTS FOR TREATING CANCER	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/062361	MONOSPECIFIC AND MULTI-SPECIFIC ANTIBODIES	BEIJING STARMAB BIOMED TECHNOLOGY LTD
WO/2021/062371	TNFRSF25-MEDIATED TREATMENTS OF IMMUNE DISEASES AND DISORDERS	PELICAN THERAPEUTICS, INC.
WO/2021/062372	METHODS OF PRODUCING ANTIBODY COMPOSITIONS	AMGEN INC.
WO/2021/062382	HETERODIMERIC PROTEINS	AGENUS INC.
WO/2021/062389	PEPTIDE FOR TREATING CANCER	SAINT LEO UNIVERSITY
WO/2021/062406	CYTOKINE PRODRUGS AND DUAL-PRODRUGS	ASKGENE PHARMA, INC.
WO/2021/067215	PIPERIDINE COMPOUNDS AS MENIN INHIBITORS	AGIOS PHARMACEUTICALS, INC.
WO/2021/067223	METALLOSILICATE CATALYST SOLVENTS FOR THE FORMATION OF ALKYLENE GLYCOL MONOALKYL ETHERS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/067242	AMIDE-LINKED, AMINOBENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF	BOLT BIOTHERAPEUTICS, INC.
WO/2021/067266	PYRROLIDINYL-BASED COMPOUNDS	RECURIUM IP HOLDINGS, LLC
WO/2021/067294	SIMULTANEOUS DEHYDRATION, DIMERIZATION, AND METATHESIS OF C2-C5 ALCOHOLS	GEVO, INC.
WO/2021/067301	DERIVATIVES OF MENTHOL AND USES THEREOF	BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY
WO/2021/067326	SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/067347	DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES	BLUEBIRD BIO, INC.
WO/2021/067374	BICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/067379	THERMAL CONDENSATION REACTOR	DOW SILICONES CORPORATION
WO/2021/067387	ELABELA-DERIVED CONJUGATES AND METHODS OF USE	ON TARGET THERAPEUTICS, LLC
WO/2021/067405	NEUROPROTECTIVE COMPOUNDS AND METHODS OF USE THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/080754	PRODUCTION OF ALKYLAROMATIC COMPOUNDS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/067460	BIOCATALYTIC SYNTHESIS OF CRYPTOPHYCIN ANTICANCER AGENTS	THE REGENTS OF THE UNIVERSITY OFMICHIGAN
WO/2021/067466	RECOMBINANT BOTULINUM NEUROTOXIN WITH IMPROVED SAFETY MARGIN AND REDUCED IMMUNOGENICITY	NEW YORK UNIVERSITY
WO/2021/067483	NUCLEOTIDE PROBES	SONY CORPORATION
WO/2021/067490	COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY	LIU, Jingwen
WO/2021/067606	BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE	ARVINAS OPERATIONS, INC.
WO/2021/067626	GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION	INTIMA BIOSCIENCE, INC.
WO/2021/067628	CONFORMATION-SPECIFIC ANTIBODIES THAT BIND NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/067640	GENETICALLY MODIFIED PLANTS AND METHODS OF MAKING THE SAME	INTIMA BIOSCIENCE, INC.
WO/2021/067645	GENETICALLY MODIFIED PLANTS AND METHODS OF MAKING THE SAME	INTIMA BIOSCIENCE, INC.
WO/2021/067657	SUBSTITUTED CARBAZOLE COMPOUNDS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/067664	METHODS FOR TARGETED CELL DEPLETION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/067670	PROCESS FOR PREPARING AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR	BLUEPRINT MEDICINES CORPORATION
WO/2021/067687	VCX/Y PEPTIDES AND USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/067709	TRIIODOSILYLAMINE PRECURSOR COMPOUNDS	ENTEGRIS, INC.
WO/2021/067772	AXL INHIBITOR FORMULATIONS	SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/067776	ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES	SEAGEN INC.
WO/2021/067785	STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE	JANSSEN VACCINES & PREVENTION B.V
WO/2021/067791	OXALAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY	IFM DUE, INC.
WO/2021/067801	COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY	IFM DUE, INC.
WO/2021/067805	OXALAMIDE HETEROBYCYCLIC COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY	IFM DUE, INC.
WO/2021/067815	ORGANIC ELECTRO-OPTIC CHROMOPHORES	UNIVERSITY OF WASHINGTON
WO/2021/067827	MCL1 INHIBITORS AND USES THEREOF	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/067836	CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES	STEALTH BIOTHERAPEUTICS CORP
WO/2021/067870	SMALL MOLECULE NON-MORPHINAN OPIOID COMPOSITIONS	KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES
WO/2021/067871	ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING ALPHA-SYNUCLEIN EXPRESSION	SANGAMO THERAPEUTICS, INC.
WO/2021/067875	CHIMERIC TIM4 RECEPTORS AND USES THEREOF	CERO THERAPEUTICS, INC.
WO/2021/067970	REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME	CENTRILLION TECHNOLOGIES, INC.
WO/2021/071809	DOSAGES FOR HDAC TREATMENT WITH REDUCED SIDE EFFECTS	VIRACTA THERAPEUTICS, INC.
WO/2021/071815	CO-PRODUCTION OF HIGH PURITY ISOBUTANE AND BUTENE-1 FROM MIXED C4S	LUMMUS TECHNOLOGY LLC
WO/2021/071837	GPR119 AGONISTS	KALLYOPE, INC.
WO/2021/154345	TRIFLAZOLES AND METHODS OF MAKING THE SAME	TRINAPCO, INC.
WO/2021/071843	MUSCARINIC ACETYLCHOLINE M<sb>1</sb> RECEPTOR ANTAGONISTS	PIPELINE THERAPEUTICS, INC.
WO/2021/071890	2'-DEOXY-2',2'-DIFLUOROTETRAHYDROURIDINES WITH HIGH PURITY AND METHODS OF MAKING THE SAME	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/071908	PROCESS FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID ACIDS	BERKOWITZ, Barry, A.
WO/2021/071962	ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF	FATE THERAPEUTICS, INC.
WO/2021/071981	COMPOUNDS FOR MODULATING SPLICING	SKYHAWK THERAPEUTICS, INC.
WO/2021/071983	COMPOUNDS FOR MODULATING SPLICING	SKYHAWK THERAPEUTICS, INC.
WO/2021/071984	COMPOUNDS FOR MODULATING SPLICING	SKYHAWK THERAPEUTICS, INC.
WO/2021/072005	IMMUNOGLOBULIN PURIFICATION PEPTIDES AND THEIR USE	NORTH CAROLINA STATE UNIVERSITY
WO/2021/072056	P53 PEPTIDE DISRUPTERS OF F0X04:P53 PROTEIN BINDING, VARIANTS AND CONJUGATES THEREOF.	PORTAGE GLASGOW LIMITED
WO/2021/072127	ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/137913	4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO	EMORY UNIVERSITY
WO/2021/072137	HEPARIN-INSENSITIVE ASSAY FOR FACTOR XIa	BAXALTA INCORPORATED
WO/2021/072140	PRODRUGS OF MYELOPEROXIDASE INHIBITORS	BIOHAVEN THERAPEUTICS LTD.
WO/2021/072156	ORAL COMPLEMENT FACTOR D INHIBITORS	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/072181	QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD	ECOLAB USA INC.
WO/2021/072182	METHODS FOR PRODUCING RANIBIZUMAB	COHERUS BIOSCIENCES, INC.
WO/2021/072196	COMPOSITIONS AND METHODS FOR MEASURING AND INHIBITING CALPAIN-5 ACTIVITY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/072197	MODIFIED AAV CAPSIDS AND USES THEREOF	SOLID BIOSCIENCES INC.
WO/2021/072207	SYSTEMS AND PROCESSES TO DEOLEFINATE AROMATIC-RICH HYDROCARBON STREAMS	SAUDI ARABIAN OIL COMPANY
WO/2021/072210	METHODS OF PURIFYING RANIBIZUMAB OR A RANIBIZUMAB VARIANT	COHERUS BIOSCIENCES, INC.
WO/2021/072212	PROTEASOME INHIBITORS	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/072232	BICYCLIC AMINES AS CDK2 INHIBITORS	INCYTE CORPORATION
WO/2021/072244	ANTI-TN ANTIBODIES AND USES THEREOF	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/072277	ANTIBODIES SPECIFIC TO GLYCOSYLATED LAG3 AND METHODS OF USE THEREOF	STCUBE & CO.
WO/2021/072284	CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/072300	PHOSPHOLIPID-FLAVAGLINE CONJUGATES AND METHODS OF USING THE SAME FOR TARGETED CANCER THERAPY	CELLECTAR BIOSCIENCES, INC.
WO/2021/072307	SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR	XENON PHARMACEUTICALS INC.
WO/2021/072339	METHOD FOR PRODUCING PURIFIED STEVIOL PRODUCT USING SIMULATED MOVING BED CHROMATOGRAPHY	OROCHEM TECHNOLOGIES INC.
WO/2021/072355	CONTINUOUS BIOMASS EXTRACTION SYSTEM AND PROCESS	BOULDER CREEK TECHNOLOGIES, LLC
WO/2021/076455	NOVEL INSECT RESISTANT GENES AND METHODS OF USE	BASF AGRICULTURAL SOLUTIONS SEED US LLC
WO/2021/072392	ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/076480	PROCESS FOR SEPARATING COMPONENTS OF AZEOTROPIC MIXTURES USING IONIC LIQUIDS	UNIVERSITY OF KANSAS
WO/2021/076545	CLEC12A ANTIBODY FRAGMENT SEQUENCES AND METHODS	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/076554	ANTIBODIES TARGETING FLT3 AND USE THEREOF	DRAGONFLY THERAPEUTICS, INC.
WO/2021/076559	HUMAN BROADLY NEUTRALIZING ANTIBODIES AGAINST THE MEMBRANE-PROXIMAL EXTERNAL REGION OF HIV ENV FOR VACCINE DESIGN AND INTERVENTION	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/076564	PROTEINS BINDING NKG2D, CD16 AND FLT3	DRAGONFLY THERAPEUTICS, INC.
WO/2021/076570	CHAGAS DISEASE VACCINE ANTIGENS WITH IMPROVED STABILITY AND DECREASED AGGREGATION	BAYLOR COLLEGE OF MEDICINE
WO/2021/076617	BROAD SPECTRUM ANTI-CANCER COMPOUNDS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076633	POLYMORPHS OF D9-THC NAPHTHOYLESTER	PURISYS LLC
WO/2021/076771	CURCUMINOID COMPOSITION AND ITS THERAPEUTIC POTENTIAL IN MANAGING LUNG FIBROSIS	MAJEED, Muhammed
WO/2021/076805	MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF	MODERNA TX, INC.
WO/2021/076831	METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID	FMC CORPORATION
WO/2021/076832	METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID	FMC CORPORATION
WO/2021/076835	METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID	FMC CORPORATION
WO/2021/076838	METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID	FMC CORPORATION
WO/2021/076839	METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID	FMC CORPORATION
WO/2021/076886	3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076887	CAL-T CONSTRUCTS AND USES THEREOF	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/076895	GENETIC TOOLS USEFUL FOR IMPROVING A PLANT'S STRESS TOLERANCE	PURDUE RESEARCH FOUNDATION
WO/2021/076902	INHIBITING HUMAN INTEGRIN <i>α</i><sb><i>4</i></sb><i>β</i><sb><i>7</i></sb>	MORPHIC THERAPEUTIC, INC.
WO/2021/076911	AAV TRANSFER CASSETTE	STRIDEBIO, INC.
WO/2021/076922	PHARMACEUTICAL FORMULATIONS	FIRST WAVE BIO, INC.
WO/2021/076925	ADENO-ASSOCIATED VIRAL VECTORS FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C	STRIDEBIO, INC.
WO/2021/076931	ANTIBODIES AND USES THEREOF	CENTIVAX, INC.
WO/2021/076938	TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS	AMBYS MEDICINES, INC.
WO/2021/076951	REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE	THE PENN STATE RESEARCH FOUNDATION
WO/2021/076958	USE OF TIM-3 CYTOPLASMIC TAIL IN CHIMERIC ANTIGEN RECEPTORS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/077010	BIFUNCTIONAL MOLECULES CONTAINING AN E3 UBIQUITINE LIGASE BINDING MOIETY LINKED TO A BCL6 TARGETING MOIETY	ARVINAS OPERATIONS, INC.
WO/2021/077051	IMPROVED LAMP CONSTRUCTS COMPRISING CANCER ANTIGENS	IMMUNOMIC THERAPEUTICS, INC
WO/2021/080920	COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS	ARCH ONCOLOGY, INC.
WO/2021/077102	NOVEL ANTIPARASITIC COMPOUNDS AND METHODS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/077110	BIOMATERIAL SENSOR SYSTEMS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/077117	ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF	FATE THERAPEUTICS, INC.
WO/2021/086675	CONVERSION OF CANNABIDIOL OR DELTA-9 TETRAHYDROCANNABINOLIC ACID TO DELTA-9 TETRAHYDROCANNABINOL AND DELTA-8 TETRAHYDROCANNABINOL IN NONTOXIC HETEROGENEOUS MIXTURES	PURE TONIC CONCENTRATES, LLC
WO/2021/080931	SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND SALTS THEREOF, AND COMPOSITIONS COMPRISING THE SAME AND THEIR USE	CELGENE CORPORATION
WO/2021/080948	VARIANT MALTOPENTAOSE/MALTOHEXAOSE-FORMING ALPHA-AMYLASES	DANISCO US INC
WO/2021/080950	METHODS FOR TREATING A HEMATOLOGICAL CANCER AND THE USE OF COMPANION BIOMARKERS FOR 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE	CELGENE CORPORATION
WO/2021/080980	PYRIMIDINE AMIDE COMPOUNDS AND USE THEREOF	ALPHALA CO., LTD.
WO/2021/080991	AAV3B VARIANTS WITH IMPROVED PRODUCTION YIELD AND LIVER TROPISM	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/080997	3-(4-(11H-DIBENZO[B,E][1,4]AZEPIN-6-YL)PIPERAZIN-1-YL)- AND 3-(4-(DIBENZO[B,F][1,4]OXAZEPIN/THIAZEPIN/DIAZEPIN-11-YL)PIPERAZIN-1-YL)-PROPANO IC ACID DERIVATIVES AS H1 AND 5-HT2A-RECEPTOR MODULATORS FOR THE TREATMENT OF SLEEP DISORDERS	ALAIRION, INC.
WO/2021/081023	FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE	THE JOHNS HOPKINS UNIVERSITY
WO/2021/081074	BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/081101	ANTI-BETA-AMYLOID ANTIBODY FOR TREATING ALZHEIMER'S DISEASE	BIOGEN MA INC.
WO/2021/081147	GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS, METHODS OF MAKING, AND USES THEREOF	NEUROCYCLE THERAPEUTICS, INC.
WO/2021/081207	GLP-1R MODULATING COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/081211	METTL3 MODULATORS	ACCENT THERAPEUTICS, INC.
WO/2021/081212	PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS KRAS G12C AND KRAS G12D INHIBITORS IN THE TREATMENT OF CANCER	AMGEN INC.
WO/2021/081222	RECOMBINANT CELL, EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR PRODUCTION OF BIOACTIVE PLANT METABOLITE	BRIGHTSEED, INC.
WO/2021/081239	T-CELL MODULATORY CHIMERIC MOLECULES AND METHODS OF USE THEREOF	CUE BIOPHARMA, INC.
WO/2021/081267	QUINOLONE CARBOXYLIC DERIVATIVES	TAIGEN BIOTECHNOLOGY CO., LTD
WO/2021/081272	PROGRANULIN MODULATORS AND METHODS OF USING THE SAME	ARKUDA THERAPEUTICS
WO/2021/081277	DOSING REGIMENS FOR TREATING OR PREVENTING C5-ASSOCIATED DISEASES	REGENERON PHARMACEUTICALS, INC.
WO/2021/081303	ANTI-CD40 BINDING MOLECULES AND BI-SPECIFIC ANTIBODIES COMPRISING SUCH	LYVGEN BIOPHARMA (SUZHOU) CO., LTD.
WO/2021/081330	ANTI-IDIOTYPIC ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF	KITE PHARMA, INC.
WO/2021/081335	NOVEL MINI-INSULIN WITH EXTENDED C-TERMINAL A CHAIN	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/081345	BI-PEPTIDE WITH AFFINITY TO EXTRACELLULAR MATRIX PROTEINS OR CELLS AND TO GROWTH FACTORS FOR TISSUE HEALING AND REGENERATION	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/081411	METHODS AND COMPOSITIONS FOR TREATING IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA	ALLAKOS INC.
WO/2021/091706	TREATMENT FOR SJÖGREN'S SYNDROME	NOVARTIS AG
WO/2021/081420	CONJUGATES AND METHODS FOR TREATING ACROMEGALY	GENEVANT SCIENCES GMBH
WO/2021/081437	COMPOSITIONS COMPRISING V2 OPT HIV ENVELOPES	DUKE UNIVERSITY
WO/2021/081480	IMPROVED VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS FOR USING THE SAME	INOVIO PHARMACEUTICALS, INC.
WO/2021/081523	FLUORINE SUBSTITUTED CECLOHEXENE ANALOGOUES OF GAMMA-AMINOBUTYRIC ACID (GABA)	NORTHWESTERN UNIVERSITY
WO/2021/081528	SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS	NORTHWESTERN UNIVERSITY
WO/2021/086805	SOLID STATE FORMS OF FEZAGEPRAS AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/086816	GALECTIN-3 INHIBITING C-GLYCOSIDES	GLYCOMIMETICS, INC.
WO/2021/086833	SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT	MERCK SHARP & DOHME CORP.
WO/2021/086874	HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS	GYANRX SCIENCES, INC.
WO/2021/086882	SOLID STATE FORMS OF ARRY-797 AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/086899	ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/086926	DIMER SELECTIVE METALLOCENE CATALYSTS, NON-AROMATIC HYDROCARBON SOLUBLE ACTIVATORS, AND PROCESSES TO PRODUCE POLY ALPHA-OLEFIN OLIGMERS THEREWITH	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/086944	MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS	GENOMATICA, INC.
WO/2021/086948	MRNA-ENCODED ANTIBODIES FOR CONTRACEPTION	GEORGIA TECH RESEARCH CORPORATION
WO/2021/086957	AN EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE	FMC CORPORATION
WO/2021/086966	SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS	BIOGEN MA INC.
WO/2021/086977	RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES	BECKMAN COULTER, INC.
WO/2021/091747	ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTS	MERCK SHARP & DOHME CORP.
WO/2021/087016	DOSING REGIMEN OF ANTI-CD27 ANTIBODIES FOR TREATMENT OF CANCER	MERCK SHARP & DOHME CORP.
WO/2021/087020	METHOD FOR ALCOHOL UPGRADING TO JET, DIESEL, GASOLINE, AND VALUABLE CO-PRODUCTS	UT-BATTELLE, LLC
WO/2021/108067	HYDROCARBYLOXY-FUNCTIONAL ARYLSILANES AND THEIR USE AS PROMOTERS FOR PLATINUM CATALYZED HYDROSILYLATION REACTIONS	DOW SILICONES CORPORATION
WO/2021/087056	IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/087077	SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
WO/2021/087084	COMPOUNDS AND MODULES FOR INHIBITION OF PRE-miR-21 AND THEIR USE IN TREATMENT OF CERTAIN CANCERS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/087086	CONDENSED PYRIDAZINE OR PYRIMIDINE AS BTK INHIBITORS	BIOGEN MA INC.
WO/2021/087087	N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS	MITOBRIDGE INC.
WO/2021/087112	CONDENSED BI-HETEROCYCLES AS INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE	BIOGEN MA INC.
WO/2021/087136	CD73 INHIBITORS	ORIC PHARMACEUTICALS, INC.
WO/2021/087160	COMPOSITIONS AND METHODS OF USING FINE MINERAL MATTER AS A CATALYST FOR CHEMICAL RECYCLING	RADICAL PLASTICS, INC.
WO/2021/087163	METHODS AND SYSTEMS OF UPGRADING HEAVY AROMATICS STREAM TO PETROCHEMICAL FEEDSTOCK	SAUDI ARABIAN OIL COMPANY
WO/2021/087183	METHODS AND COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR TARGETING CANCER CELLS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/087245	PROTEASE SWITCH FOR DUAL TARGETS CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/087268	NOVEL SELECTIVE KAPPA OPIOID RECEPTOR ANTAGONISTS AND METHODS RELATED THERETO FOR TREATMENT OF ADDICTION AND NEUROPATHIC PAIN	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/087292	PROCESSES FOR PREPARING AN S1P-RECEPTOR MODULATOR	E-SCAPE BIO, INC.
WO/2021/087296	COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS	DECIBEL THERAPEUTICS, INC.
WO/2021/087299	SOLID FORMS OF AN S1P-RECEPTOR MODULATOR	E-SCAPE BIO, INC.
WO/2021/087305	CD20 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE FOR IMMUNOTHERAPY	PRECISION BIOSCIENCES, INC.
WO/2021/087338	DEGRADATION OF SURFACE PROTEINS USING BISPECIFIC BINDING AGENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/087344	THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS	CEDARS-SINAI MEDICAL CENTER
WO/2021/087352	SOLID-LIQUID SEPARATION PROCESSES	BP CORPORATION NORTH AMERICA INC.
WO/2021/087356	FIBRONECTIN TARGETING CHIMERIC ANTIGEN RECEPTORS (CARS)	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/087368	ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF	MAGENTA THERAPEUTICS, INC.
WO/2021/087379	LHRH-PRODIGIOSIN CONJUGATES AND METHODS OF USE	WORCESTER POLYTECHNIC INSTITUTE
WO/2021/087424	METHOD AND APPARATUS FOR ENHANCING RETENTION TIME OF BLEACHED AND COLORED STATES OF ELECTROCHROMIC DEVICES	SDK NEW MATERIALS, INC.
WO/2021/087431	GOLD NANOPARTICLES/NANOSHELLS IMMUNE CONJUGATES FOR ENHANCED IMMUNOTHERAPY AND PHOTOTHERMAL THERAPY FOR HEMATOLOGIC MALIGNANCIES	NORTHWESTERN UNIVERSITY
WO/2021/087440	FIBROBLAST-BASED THERAPY FOR TREATMENT OF SCLEROSING CHOLANGITIS	FIGENE, LLC
WO/2021/091819	SALTS AND FORMS OF AN ESTROGEN RECEPTOR MODULATOR	RECURIUM IP HOLDINGS, LLC
WO/2021/087462	RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/087463	IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF	CORVUS PHARMACEUTICALS, INC.
WO/2021/091858	REFERENCE SLIDE	RARECYTE, INC.
WO/2021/091868	A RODENT MODEL OF INCREASED BONE MINERAL DENSITY	REGENERON PHARMACEUTICALS, INC.
WO/2021/091885	SIGLEC-9 ECD FUSION MOLECULES AND METHODS OF USE THEREOF	ALECTOR LLC
WO/2021/091932	HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-REALATED IMPURITIES	AMGEN INC.
WO/2021/091933	HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-REALATED IMPURITIES	AMGEN INC.
WO/2021/091945	BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA	JANSSEN BIOTECH, INC.
WO/2021/091956	RAS INHIBITORS	REVOLUTION MEDICINES, INC.
WO/2021/091957	DIHYDROXYLATION OF OLEFINS USING OSMATE (VI) SALTS	INTERNATIONAL FLAVORS & FRAGRANCES INC.
WO/2021/091960	METHODS OF TREATING CANCER WITH ANTI-PD-1 ANTIBODIES	JOUNCE THERAPEUTICS, INC.
WO/2021/092019	COMBINATION THERAPY TO TREAT BRAIN CANCER	INOVIO PHARMACEUTICALS, INC.
WO/2021/092035	SILICON CONTAINING DETECTABLE COMPOUNDS AND USES THEREOF	SINGULAR GENOMICS SYSTEMS, INC.
WO/2021/092043	COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH LEKTI	AZITRA INC
WO/2021/092053	MCL-1 INHIBITOR MACROCYCLE COMPOUNDS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER	UNITY BIOTECHNOLOGY, INC.
WO/2021/092061	COMBINATION TREATMENT FOR SENESCENCE-ASSOCIATED DISEASES	UNITY BIOTECHNOLOGY, INC.
WO/2021/092075	IL-2RβγC BINDING COMPOUNDS	MEDIKINE INC.
WO/2021/092081	DUAL IL-2R AND IL-7R BINDING COMPOUNDS	MEDIKINE, INC.
WO/2021/092115	BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF	REVOLUTION MEDICINES, INC.
WO/2021/092148	PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE	NOCION THERAPEUTICS, INC.
WO/2021/092217	DOSAGE REGIMEN FOR ANTI-EGFRVIII AGENTS	AMGEN INC.
WO/2021/092264	MrgprX2 ANTAGONISTS AND USES THEREOF	DERMIRA, INC.
WO/2021/092291	RECYCLE CONTENT GLYCOL ESTERS	EASTMAN CHEMICAL COMPANY
WO/2021/092293	RECYCLE CONTENT OXO GLYCOLS	EASTMAN CHEMICAL COMPANY
WO/2021/092298	VIRAL CAPSID POLYPEPTIDES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/092300	VIRAL CAPSID POLYPEPTIDES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/092305	RECYCLE CONTENT MIXED ESTERS AND SOLVENTS	EASTMAN CHEMICAL COMPANY
WO/2021/092306	RECYCLE CONTENT ALPHA OLEFINS AND FATTY ALCOHOLS	EASTMAN CHEMICAL COMPANY
WO/2021/092309	RECYCLE CONTENT PROPANOL	EASTMAN CHEMICAL COMPANY
WO/2021/092311	RECYCLE CONTENT GLYCOL ETHER AND GLYCOL ETHER ESTER COMPOSITONS	EASTMAN CHEMICAL COMPANY
WO/2021/092313	RECYCLE CONTENT ETHYLENE OXIDE OR ALKYLENE GLYCOLS	EASTMAN CHEMICAL COMPANY
WO/2021/092320	RECYCLE CONTENT ALKANOLAMINES	EASTMAN CHEMICAL COMPANY
WO/2021/092321	RECYCLE CONTENT OXO ALCOHOLS & OXO PLASTICIZERS	EASTMAN CHEMICAL COMPANY
WO/2021/092322	CANCER TREATMENTS TARGETING CANCER STEM CELLS	REMEDY PLAN, INC.
WO/2021/092331	TARGETING CIRCULAR PCMTD1 IN LEUKEMIAS WITH P53 MUTATIONS AND/OR BCR/ABL FUSIONS	OHIO STATE INNOVATION FOUNDATION
WO/2021/092336	HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS	RIGEL PHARMACEUTICALS, INC.
WO/2021/092355	ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IGG MOLECULES	AMGEN INC.
WO/2021/092358	MODIFIED FOLLICLE-STIMULATING HORMONE AND METHODS OF USING THE SAME	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/092382	COMPOSITIONS COMPRISING ANTIMICROBIAL PEPTIDES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/108109	MODULATORS OF T-CELL ACTIVITY	BEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/092426	TARGETED DELIVERY OF NANOCARRIER-CONJUGATED DOXORUBICIN	UNIVERSITY OF MIAMI
WO/2021/092456	LINKING GENOMES AND METABOLOMES IN FUNGI	NORTHWESTERN UNIVERSITY
WO/2021/092482	COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR 1 TARGETING	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/092500	INHIBITOR OF APOPTOSIS (IAP) PROTEIN ANTAGONISTS	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/092514	RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS
WO/2021/092525	WDR5 INHIBITORS AND MODULATORS	VANDERBILT UNIVERSITY
WO/2021/113020	BRANCHED OXYDISILANE/SILOXANE OLIGOMERS AND METHODS FOR THEIR PREPARATION AND USE AS HEAT TRANSFER FLUIDS	DOW SILICONES CORPORATION
WO/2021/096811	TUCARESOL DERIVATIVES AND USES THEREOF	BEYONDSPRING PHARMACEUTICALS, INC.
WO/2021/092580	PEPTIDES AND METHODS OF TREATING SEPSIS, ATHEROSCLEROSIS, THROMBOSIS, STROKE, HEART ATTACK AND INFLAMMATION	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/092581	GENERATION OF ENGINEERED REGULATORY T CELLS	SANGAMO THERAPEUTICS, INC.
WO/2021/096829	HUMAN MONOCLONAL ANTIBODIES TO HANTAVIRUS AND METHODS OF USE THEREFOR	VANDERBILT UNIVERSITY
WO/2021/096849	SALTS AND CRYSTALLINE FORMS OF A PD-1/PD-L1 INHIBITOR	INCYTE CORPORATION
WO/2021/096903	METHODS FOR THE PREPARATION OF ETHYL 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-1H-PYRAZOLE-5-CARBOXYLATE	FMC CORPORATION
WO/2021/126421	PROCESSES FOR PREPARING ISOPRENE AND MONO-OLEFINS COMPRISING AT LEAST SIX CARBON ATOMS	DOW TECHNOLOGY INVESTMENTS LLC
WO/2021/096968	RADIOHALOGEN PROSTHETIC MOIETIES AND RADIOLABELED BIOMOLECULES	DUKE UNIVERSITY
WO/2021/096988	CRYSTALLINE SALT FORMS OF (Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE)METHYL)FURAN-2-YL)BENZOIC ACID	GB006, INC.
WO/2021/097012	ONE STEP SYNTHESIS FOR ALKYL 2-FLUOROACRYLATES	RELYPSA, INC.
WO/2021/097023	PROCESS FOR CONVERTING METHANOL TO FORMALDEHYDE	CELANESE INTERNATIONAL CORPORATION
WO/2021/097046	ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS	NUVATION BIO INC.
WO/2021/097054	6-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING DISEASES AND CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY	GENZYME CORPORATION
WO/2021/097057	5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY	GENZYME CORPORATION
WO/2021/097085	MICROFLUIDIC DEVICE AND USES THEREOF	CASE WESTERN RESERVE UNIVERSITY
WO/2021/097107	CRYSTALLINE FORMS OF A MAGL INHIBITOR	LUNDBECK LA JOLLA RESEARCH CENTER, INC.
WO/2021/097110	THERAPEUTIC COMPOUNDS AND METHODS OF USE	GENENTECH, INC.
WO/2021/097116	NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/097117	NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/097139	CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL	RECURIUM IP HOLDINGS, LLC
WO/2021/097155	modRNAS THAT EXPRESS ANTI MULLERIAN HORMONE (AMH) AND USES THEREOF	CORNELL UNIVERSITY
WO/2021/097157	TREATMENT OF HEREDITARY ANGIOEDEMA WITH LIVER-SPECIFIC GENE THERAPY VECTORS	BIOMARIN PHARMACEUTICAL INC.
WO/2021/097186	BARCODED XTEN POLYPEPTIDES AND COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THE SAME	AMUNIX PHARMACEUTICALS, INC.
WO/2021/097190	MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF	FORESEE PHARMACEUTICALS CO., LTD.
WO/2021/097192	LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF	CONTRAFECT CORPORATION
WO/2021/097200	ALKYLATION CATALYST COMPOSITION AND RELATED METHODS	UNIVERSITY OF KANSAS
WO/2021/097207	IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND	AMGEN INC.
WO/2021/097212	IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND	AMGEN INC.
WO/2021/194560	SYSTEMS AND PROCESSES INTEGRATING STEAM CRACKING WITH DUAL CATALYST METATHESIS FOR PRODUCING OLEFINS	SAUDI ARABIAN OIL COMPANY
WO/2021/097256	CXCR4 ANTAGONIST PEPTIDES	COHBAR, INC.
WO/2021/101810	PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS	ARCHER DANIELS MIDLAND COMPANY
WO/2021/126435	ANTI-INTERLEUKIN-23 P19 ANTIBODIES AND METHODS OF USE THEREOF	NOVAROCK BIOTHERAPEUTICS, LTD.
WO/2021/097325	ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF	ELSTAR THERAPEUTICS, INC.
WO/2021/097326	ARYL AMINOPYRIMIDINES AS DUAL MERTK AND TYRO3 INHIBITORS AND METHODS THEREOF	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/097338	COMPOSITIONS AND METHODS FOR ACTIVATION OF INTEGRINS	PLIANT THERAPEUTICS, INC.
WO/2021/097339	CRYSTALLINE FORMS OF C-C CHEMOKINE RECEPTOR TYPE 4 ANTAGONIST AND USES THEREOF	RAPT THERAPEUTICS, INC.
WO/2021/097344	METHOD FOR REDUCED AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BISPECIFIC ANTIGEN-BINDING MOLECULES	AMGEN INC.
WO/2021/097352	ISOXAZOLE DERIVATIVES TARGETING TACC3 AS ANTICANCER AGENTS	A2A PHARMACEUTICALS, INC.
WO/2021/097360	MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/097365	ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS	GRITSTONE ONCOLOGY, INC.
WO/2021/097369	COMPOSITIONS AND METHODS REGULATING FOLLICULOGENESIS FOR THE TREATMENT OF OVARIAN SENESCENCE	CELMATIX INC.
WO/2021/097376	ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF	WEREWOLF THERAPEUTICS, INC.
WO/2021/101823	TREM2 ANTIBODIES AND USES THEREOF	ELI LILLY AND COMPANY
WO/2021/097407	NOVEL PEPTIDE COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL INJURY	REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/101834	PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS	ARCHER DANIELS MIDLAND COMPANY
WO/2021/097433	USE OF ANTI-EPCAM ANTIBODIES IN CANCER THERAPY	ACADEMIA SINICA
WO/2021/113068	NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF	SPARX THERAPEUTICS, INC.
WO/2021/101867	SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
WO/2021/101875	COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION	KARUNA THERAPEUTICS, INC.
WO/2021/101919	COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/108179	PROCESS SULFONATION OF AMINOETHYLENE SULFONIC ESTER TO PRODUCE TAURINE	ARCHER DANIELS MIDLAND COMPANY
WO/2021/101968	NANOVACCINE FOR HEART FAILURE	THE METHODIST HOSPITAL SYSTEM
WO/2021/101991	ANTI-B7-H3 MONOCLONAL ANTIBODY AND METHODS OF USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108191	AROMATIC SUBSTITUTED ALKANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS	FACEBOOK TECHNOLOGIES, LLC
WO/2021/102049	NOVEL MULTISPECIFIC ANTIBODY FORMAT	AMGEN INC.
WO/2021/102055	ANTI-ROR-2 ANTIBODIES AND METHODS OF USE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/108198	INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/141682	MACROCYCLIC PEPTIDES AS PD-L1 INHIBITORS AND IMMUNOMODULATORS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/108204	AROMATIC SUBSTITUTED ETHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS	FACEBOOK TECHNOLOGIES, LLC
WO/2021/102131	BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND CTLA4 WITH ENHANCED CYTOTOXIC EFFECTS ON TUMOR CELLS	BROWN UNIVERSITY
WO/2021/141684	IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/102143	MACROCYCLIC PEPTIDES AS PD-L1 INHIBITORS AND IMMUNOMODULATORS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/102151	MULTIFUNCTIONAL CYCLIC PEPTIDE POLYMER NANOMATERIALS	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY
WO/2021/102153	STRUCTURE-BASED DESIGN OF THERAPEUTICS TARGETING RNA HAIRPIN LOOPS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102173	ANTIBODIES DIRECTED TO TIE-2 AND METHODS OF USE	DAMIANO, Jason
WO/2021/102197	ANTI-ALPHA-SYNUCLEIN MONOCLONAL ANTIBODIES, AND METHODS USING SAME	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/108232	ANTHRAQUINONE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS	FACEBOOK TECHNOLOGIES, LLC
WO/2021/102221	DEUTERATED ANALOGS OF AN IDH1 INHIBITOR	AGIOS PHARMACEUTICALS, INC.
WO/2021/108237	ON-LINE ULTRA PERFORMANCE HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR MONITORING AT LEAST ONE PRODUCT ATTRIBUTE	MERCK SHARP & DOHME CORP.
WO/2021/102250	GROWTH FACTOR RESTORATION	LUPPINO, Francesco
WO/2021/102266	DI ALKENYL SUCCINIC AMIDE ACIDS AND PROCESSES FOR MAKING AND USING SAME	ECOLAB USA INC.
WO/2021/108254	PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS	GILEAD SCIENCES, INC.
WO/2021/102276	BBB-SHUTTLING-VNARS CONJUGATED TO NEUROTROPHIC AGONIST ANTIBODIES TO TREAT NEURODEGENERATIVE DISEASES AND CONDITIONS	OSSIANIX, INC.
WO/2021/102283	CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/102286	COMPOSITIONS COMPRISING TRISCYANOHEXANE	ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
WO/2021/102300	PIPERAZINE COMPOUNDS FOR INHIBITING CPS1	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/102308	ANTIBODY PRODUCING MICROFLUIDIC DEVICES	EMULATE INC.
WO/2021/102327	EXPRESSION OF ELECTRICALLY CONDUCTIVE PROTEIN NANOWIRES IN <i>ESCHERICHIA COLI</i>	UNIVERSITY OF MASSACHUSETTS
WO/2021/102341	COMPOUNDS FOR MODULATING BETA GLOBIN EXPRESSION	IONIS PHARMACEUTICALS, INC.
WO/2021/102345	COMPOSITIONS AND METHODS FOR DEREPRESSING RE1 SILENCING TRANSCRIPTION FACTOR TARGET GENES	ALCAMENA STEM CELL THERAPEUTICS, LLC
WO/2021/102346	ETHYLENE MAXIMIZATION WITH PROPYLENE METATHESIS	LUMMUS TECHNOLOGY LLC
WO/2021/102348	CONVERSION OF PROPYLENE TO ETHYLENE	LUMMUS TECHNOLOGY LLC
WO/2021/102359	TASPASE1 INHIBITORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102363	METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/102393	PROCESS FOR THE SYNTHESIS OF (3-CHLORO-2-PYRIDYL)HYDRAZINE	FMC CORPORATION
WO/2021/108282	AROMATIC SUBSTITUTED METHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS	FACEBOOK TECHNOLOGIES, LLC
WO/2021/102404	LUNG TARGETED ANTICANCER THERAPIES WITH LIPOSOMAL ANNAMYCIN	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/102410	NAPHTHO[2,1 -D]THIAZOLE DERIVATIVES, COMPOSITIONS THEREOF AND METHODS OF TREATING DISORDERS	REVERIE LABS, INC.
WO/2021/102411	IONIZABLE LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF	GENERATION BIO CO.
WO/2021/108317	NON-FULLERENE ACCEPTORS (NFAS) AS INTERFACIAL LAYERS IN PEROVSKITE SEMICONDUCTOR DEVICES	HUNT PEROVSKITE TECHNOLOGIES, L.L.C.
WO/2021/102430	GENETICALLY-DIRECTED SPARSE AND COMPLETE LABELING OF BRAIN CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102434	SPLIT-ENZYME SYSTEM TO DETECT SPECIFIC DNA IN LIVING CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102435	MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH THE IGHMBP2 GENE	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/113115	COMPOSITIONS AND METHODS FOR ON-DEMAND RELEASE OF ANTIMICROBIAL AGENTS	UNIVERSITY OF MASSACHUSETTS
WO/2021/113116	COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY	UNIVERSITY OF MASSACHUSETTS
WO/2021/108404	HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE	AMGEN INC.
WO/2021/108448	ANTI-YELLOW FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE	MABLOC, LLC
WO/2021/108467	NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES AND EVADE THE HUMORAL IMMUNE RESPONSE	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/108511	METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS WITH TREFOIL FACTOR FAMILY MEMBER 2 MODULATORS	ALKAHEST, INC.
WO/2021/108518	CITRATE-FUNCTIONALIZED POLYMERIC SURFACTANTS BASED UPON ALKYL POLYGLUCOSIDES	COLONIAL CHEMICAL, INC.
WO/2021/108528	POLYMORPHIC CARBAZOLE DERIVATIVES AND USES THEREOF	IKENA ONCOLOGY, INC.
WO/2021/133509	HETEROCYCLIC COMPOUNDS AS MTOR INHIBITORS	ANGEX PHARMACEUTICAL, INC.
WO/2021/108579	MACROCYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF	COMET THERAPEUTICS, INC.
WO/2021/108597	THIOPHOSPHATE AND PHOSPHINE SULFIDE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS	FACEBOOK TECHNOLOGIES, LLC
WO/2021/108628	SUBSTITUTED MACROCYCLIC COMPOUNDS AND RELATED METHODS OF TREATMENT	ALKERMES, INC.
WO/2021/108637	COMPOSITIONS AND METHODS FOR TREATING DISEASES AND CONDITIONS BY DEPLETION OF MITOCHONDRIAL OR GENOMIC DNA FROM CIRCULATION	CEDARS-SINAI MEDICAL CENTER
WO/2021/108674	MODULATING PHOTOSENSITIVE PROTEINS WITH MECHANOLUMINESCENT PARTICLES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/108691	METHODS OF TREATMENT	INTRA-CELLULAR THERAPIES, INC.
WO/2021/108755	MICRODYSTROPHIN GENE THERAPY CONSTRUCTS AND USES THEREOF	REGENXBIO INC.
WO/2021/113152	DETECTION AND ELIMINATION OF ABERRANT CELLS	VIOME, INC.
WO/2021/113233	COMBINATION THERAPY USING GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY	MEDIMMUNE, LLC
WO/2021/113236	REDUCING ENERGY CONSUMPTION IN MEG RECLAMATION	SCHLUMBERGER TECHNOLOGY CORPORATION
WO/2021/118827	VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
WO/2021/113260	DIESTER CONTAINING COMPOUNDS FOR TREATING HYPERHIDROSIS	DERMIRA, INC.
WO/2021/113263	CRF RECEPTOR ANTAGONISTS AND METHODS OF USE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/113282	PROCESS FOR SYNTHESIS OF A 2-THIOALKYL PYRIMIDINE	FMC CORPORATION
WO/2021/113284	PROCESS FOR SYNTHESIS OF A 2-(5-ISOXAZOLYL)-PHENOL	FMC CORPORATION
WO/2021/113290	NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA)	ALAMAR BIOSCIENCES, INC.
WO/2021/113297	PEPTIDE-MHC II PROTEIN CONSTRUCTS AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/113307	ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/133523	SYNTHESIS GAS TO HYDROCARBON PROCESSES WITH NEUTRAL OR NEGATIVE CARBON DIOXIDE-SELECTIVITY	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/113339	MACROCYCLES FOR USE IN TREATING DISEASE	TURNING POINT THERAPEUTICS, INC.
WO/2021/113354	PARATHYROID HORMONE ATTENUATES LOW BACK PAIN AND OSTEOARTHRITIC PAIN	THE JOHNS HOPKINS UNIVERSITY
WO/2021/113362	SSTR5 ANTAGONISTS	KALLYOPE, INC.
WO/2021/113363	SSTR5 ANTAGONISTS	KALLYOPE, INC.
WO/2021/113365	NANOMATERIALS	GUIDE THERAPEUTICS, INC.
WO/2021/113368	SSTR5 ANTAGONISTS	KALLYOPE, INC.
WO/2021/113432	CELLS EXPRESSING C-KIT MUTATIONS AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/113445	PEPTIDES THAT ENHANCE NMDA RECEPTOR FUNCTION AND USE THEREOF	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/113462	DERIVATIVES OF AN FGFR INHIBITOR	INCYTE CORPORATION
WO/2021/113464	PROTEIN BLOCKING ASSEMBLY AND METHODS OF MAKING AND USING	FRIEDMAN, Simon
WO/2021/113479	TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/126538	BISPECIFIC ANTIBODIES WITH ALTERNATIVELY MATCHED INTERCHAIN CYCTEINES AND USES THEREOF	PHANES THERAPEUTICS, INC.
WO/2021/113495	ANTIBACTERIAL CARBOHYDRATE VACCINE	UNIVERSITY OF MONTANA
WO/2021/137994	SYNTHESIS OF THE GRAPE MEALYBUG PHEROMONE TRANS-ALPHA-NECRODYL ISOBUTYRATE	TRéCé INC.
WO/2021/113527	ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF	TRUEBINDING, INC.
WO/2021/126543	METHOD FOR FORMING A POLYARYLENE SULFIDE	TICONA LLC
WO/2021/113577	INTERLEUKIN 15 FUSION PROTEINS AND PRODRUGS, AND COMPOSITIONS AND METHODS THEREOF	IMMUNE TARGETING INC.
WO/2021/113597	METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX	SPECTRUM PHARMACEUTICALS, INC.
WO/2021/113598	POPTAG PEPTIDE AND USES THEREOF	CHAN ZUCKERBERG BIOHUB, INC.
WO/2021/113610	AROMATIC ALKYLATION PROCESS	UOP LLC
WO/2021/113627	SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/113633	FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PIKFYVE KINASE USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES	VERGE ANALYTICS, INC.
WO/2021/126549	MAGNESIUM CITRATE GLYCINATE CO-SALT	JOST CHEMICAL CO.
WO/2021/113643	METHODS AND COMPOSITIONS FOR SYNTHESIS OF THERAPEUTIC NANOPARTICLES	DANTARI, INC.
WO/2021/113644	COMBINATIONS COMPRISING A CD8+ T CELL ENHANCER, AN IMMUNE CHECKPOINT INHIBITOR AND RADIOTHERAPY FOR TARGETED AND ABSCOPAL EFFECTS FOR THE TREATMENT OF CANCER	MULTIVIR INC.
WO/2021/113655	METHODS OF USE OF ANTI-TREM2 ANTIBODIES	ALECTOR LLC
WO/2021/113661	AMORPHOUS AND POLYMORPHIC FORM OF A SPECIFIC CHK1 INHIBITOR	SEAGEN INC.
WO/2021/113667	SIRTUIN 6 PROTEIN DEACYLASE (SIRT6) ACTIVATORS	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/113679	DIMERIC COMPOUNDS AS STING AGONISTS	MERSANA THERAPEUTICS, INC.
WO/2021/113690	MASP-2 INHIBITORS AND METHODS OF USE	OMEROS CORPORATION
WO/2021/113698	MASP-2 INHIBITORS AND METHODS OF USE	OMEROS CORPORATION
WO/2021/113700	MHC CLASS II MOLECULE-BASED PEPTIDE EXCHANGE SYSTEM AND METHOD	MBL INTERNATIONAL CORP.
WO/2021/118887	CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY	ELI LILLY AND COMPANY
WO/2021/113736	SINGLE-DOMAIN ANTIBODY TO CHLORAMPHENICOL	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/113739	FORMULATIONS OF ANTI-CD38 ANTIBODIES FOR SUBCUTANEOUS ADMINISTRATION	BALLET, Thomas
WO/2021/113754	USE OF ISATUXIMAB FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA	SANOFI
WO/2021/113765	OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME	PRECISION BIOSCIENCES, INC.
WO/2021/113772	PARTICLE DELIVERY SYSTEMS	SCRIBE THERAPEUTICS INC.
WO/2021/113776	ANTI-IDIOTYPIC ANTIBODIES TO BCMA-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS	JUNO THERAPEUTICS, INC.
WO/2021/113780	ANTI-IDIOTYPIC ANTIBODIES TO GPRC5D-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS	JUNO THERAPEUTICS, INC.
WO/2021/118906	PROCESS AND INTERMEDIATE FOR THE PREPARATION OF OXETAN-2-YLMETHANAMINE	ELI LILLY AND COMPANY
WO/2021/118922	CAR T CELLS THAT TARGET ASPERGILLUS ASSOCIATED ANTIGENS	ATARA BIOTHERAPEUTICS, INC.
WO/2021/113806	ARYLAMIDES AND METHODS OF USE THEREOF	GENZYME CORPORATION
WO/2021/113808	CFTR-MODULATING ARYLAMIDES	GENZYME CORPORATION
WO/2021/113809	ARYLAMIDES AND METHODS OF USE THEREOF	GENZYME CORPORATION
WO/2021/118930	ANTI-PD-L1 ANTIBODY FORMULATIONS	GENENTECH, INC.
WO/2021/126584	ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE	AKSTON BIOSCIENCES CORPORATION
WO/2021/113853	MODULATORS OF THE IMMUNE ESCAPE MECHANISM FOR UNIVERSAL CELL THERAPY	VYCELLIX, INC.
WO/2021/118963	PROTEIN BIOPROCESS	NUTRITION & BIOSCIENCES USA 1, LLC
WO/2021/118968	ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/126593	ELECTROACTIVE COMPOUNDS	DUPONT ELECTRONICS, INC.
WO/2021/118996	LYSINE-SPECIFIC HISTONE DEMETHYLASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS	IMAGO BIOSCIENCES, INC.
WO/2021/118999	ANTI-C5 ANTIBODY FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER	ALEXION PHARMACEUTICALS, INC.
WO/2021/119004	PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED LACTAMS AND AMIDES	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/119062	VIRUS AND ANTIGEN PURIFICATION AND CONJUGATION	KENTUCKY BIOPROCESSING, INC.
WO/2021/119078	CATALYSED SYNTHESIS OF FLUORINATED ALKENES AND FLUORINATED ALKENE COMPOSITIONS	THE CHEMOURS COMPANY FC, LLC
WO/2021/119093	PNEUMATIC ESTHESIOMETER WITH GAS PULSE-CONDITIONER	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/183195	ANTI-CORONAVIRUS ANTIBODIES AND METHODS OF USE	1.ABCELLERA BIOLOGICS INC.
WO/2021/119128	ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE	SYNDAX PHARMACEUTICALS, INC.
WO/2021/119136	SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION	ACCELERON PHARMA INC.
WO/2021/119157	SMALL MOLECULE INHIBITORS OF VOLTAGE-GATED SODIUM CHANNEL 1.7 AND METHODS OF USING SAME	DUKE UNIVERSITY
WO/2021/119183	TRICYCLIC COMPOUNDS WITH OMA1/OPA1 MODULATORY PROPERTIES	712 NORTH, INC.
WO/2021/119223	SOLID STATE FORM OF LEMBOREXANT	TEVA CZECH INDUSTRIES S.R.O.
WO/2021/119236	PREPARATION OF A CHK1 INHIBITOR COMPOUND	SEAGEN INC.
WO/2021/119242	REPLICATION PROTEIN A (RPA)-DNA INTERACTION INHIBITORS	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/119249	CYCLOPHILIN D INHIBITORS AND USES THEREOF	THE BROAD INSTITUTE, INC.
WO/2021/119268	METHODS FOR CELL IMAGING	THE GENERAL HOSPITAL CORPORATION
WO/2021/126657	BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS	TESARO, INC.
WO/2021/133563	SPIROCYCLIC PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF	CRINETICS PHARMACEUTICALS, INC.
WO/2021/126661	CATALYSTS FOR PET METHANOLYSIS	EASTMAN CHEMICAL COMPANY
WO/2021/119304	MICROORGANISM FOR IMPROVED PENTOSE FERMENTATION	NOVOZYMES A/S
WO/2021/119325	S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS	ALIGOS THERAPEUTICS, INC.
WO/2021/119333	METHODS, COMPOSITIONS, AND KITS FOR HIGH-THROUGHPUT RELEASE, LABELING, AND ANALYSIS OF O-GLYCANS PRESENT ON A GLYCOCONJUGATE	AGILENT TECHNOLOGIES, INC.
WO/2021/119335	GENE TRANSFER SYSTEM	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/119351	PREPARATION OF TRIFAROTENE AND INTERMEDIATES AND POLYMORPHS THEREOF	TARO PHARMACEUTICAL INDUSTRIES LTD.
WO/2021/119357	GENE THERAPY OF HEMOPHILIA A USING VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION	BAXALTA INCORPORATED
WO/2021/119397	METAL SALTS AND USES THEREOF	RGENIX, INC.
WO/2021/119400	METHODS OF USE OF ANTI-CD33 ANTIBODIES	ALECTOR LLC
WO/2021/119404	INTENSIFIED VIRUS FILTRATION USING DIAFILTRATION BUFFER	EMD MILLIPORE CORPORATION
WO/2021/126693	GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF	CRINETICS PHARMACEUTICALS, INC.
WO/2021/126695	INCRETIN ANALOGS AND USES THEREOF	ELI LILLY AND COMPANY
WO/2021/119437	PROCESSES FOR SYNTHESIZING UNSYMMETRICAL DISILOXANES	DOW SILICONES CORPORATION
WO/2021/119443	PROCESS FOR SYNTHESIZING ALKENYL DISILOXANE	DOW SILICONES CORPORATION
WO/2021/119467	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLUENZA	VISTERRA, INC.
WO/2021/119489	LILRB1-BASED CHIMERIC ANTIGEN RECEPTOR	A2 BIOTHERAPEUTICS, INC.
WO/2021/119531	ANTI-SERUM ALBUMIN ANTIBODIES	CULLINAN MANAGEMENT, INC.
WO/2021/119551	ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS	CULLINAN ONCOLOGY, INC.
WO/2021/119571	PDE4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS	BIOTHERYX, INC.
WO/2021/126731	PRMT5 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/126752	PROCESSES FOR EFFICIENT AND SUSTAINED PRODUCTION OF C<sb>2</sb> TO C<sb>4 </sb>OLEFINS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/126779	INHIBITORS OF LIN28 AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119606	FLOW CHEMISTRY SYNTHESIS OF ISOCYANATES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119633	TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME	MILLIKEN & COMPANY
WO/2021/126806	DETECTION OF MOLECULAR INTERACTIONS	ORIONIS BIOSCIENCES, INC.
WO/2021/126827	STRUCTURALLY-STABILIZED ONCOLYTIC PEPTIDES AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/126856	METHODS, KITS AND COMPOSITIONS FOR REDUCING CARDIOTOXICITY ASSOCIATED WITH CANCER THERAPIES	BARUCH S. BLUMBERG INSTITUTE
WO/2021/126923	CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
WO/2021/126930	METHODS FOR IDENTIFYING MODULATORS OF G PROTEIN-COUPLED RECEPTORS	UNIVERSITY OF MIAMI
WO/2021/126931	SALTS OF R-KETOROLAC	REVERE PHARMACEUTICALS, INC.
WO/2021/126939	METHOD FOR PRODUCING DIMETHYL TEREPHTHALATE FROM POLYESTER METHANOLYSIS DEPOLYMERIZATION SYSTEMS	EASTMAN CHEMICAL COMPANY
WO/2021/133601	THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/138054	PROCESS FOR MAKING HIGH PURITY SALTS OF CIS-1,2-CYCLOHEXANDICARBOXYLIC ACID	MILLIKEN & COMPANY
WO/2021/126987	RECOMBINANT ALGAE HAVING HIGH LIPID PRODUCTIVITY	SYNTHETIC GENOMICS, INC.
WO/2021/127028	ALKYLATED NAPHTHALENE COMPOSITIONS OBTAINED THROUGH BLENDING OR PROCESSING OF MONOALKYLATED AND DIALKYLATED NAPHTHALENE FRACTIONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/133623	SURFACTANTS FROM ALDEHYDES	SIRONIX RENEWABLES, INC.
WO/2021/127102	FEED MATERIAL FOR THREE-DIMENSIONAL PRINTING CONTAINING A POLYOXYMETHYLENE POLYMER	TICONA LLC
WO/2021/127179	CATALYST PARTICLES AND METHODS FOR DEHYDROGENATIVE SILYLATION	DOW SILICONES CORPORATION
WO/2021/127182	SELECTIVE PREPARATION OF VINYL- AND ETHYL-FUNCTIONALIZED CHLOROSILANES	DOW SILICONES CORPORATION
WO/2021/127184	MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING	THE JOHNS HOPKINS UNIVERSITY
WO/2021/127188	ISOXAZOLINE DERIVATIVES AS PESTICIDES	ELANCO TIERGESUNDHEIT AG
WO/2021/127200	ILT3-BINDING AGENTS AND METHODS OF USE THEREOF	NGM BIOPHARMACEUTICALS, INC.
WO/2021/127234	TERLIPRESSIN-OCTADECANEDIOIC ACID CONJUGATE FOR VASOCONSTRICTIVE THERAPY	NORTHWESTERN UNIVERSITY
WO/2021/127250	RAR-ALPHA COMPOUNDS FOR INFLAMMATORY DISEASE AND MALE CONTRACEPTION	ORPHAGEN PHARMACEUTICALS, INC.
WO/2021/127262	DUAL INTERLEUKIN-2 /TNF RECEPTOR AGONIST FOR USE IN THERAPY	AMGEN INC.
WO/2021/127265	COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN	CHDI FOUNDATION, INC.
WO/2021/127273	1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS	GB004, INC.
WO/2021/127283	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/138073	PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/138075	PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/127301	4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS	IKENA ONCOLOGY, INC.
WO/2021/127302	2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS	IKENA ONCOLOGY, INC.
WO/2021/127303	PROGRANULIN MODULATORS AND METHODS OF USING THE SAME	ARKUDA THERAPEUTICS
WO/2021/133642	STAPLED LACTAM CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS	MERCK SHARP & DOHME CORP.
WO/2021/127397	NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE	BLACK DIAMOND THERAPEUTICS, INC.
WO/2021/127443	COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR	ARVINAS OPERATIONS, INC.
WO/2021/127461	METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID	XW LABORATORIES LIMITED
WO/2021/127480	SYNTHETIC TRITERPENOIDS WITH NITROGEN-BASED SUBSTITUENTS AT C-17 AND METHODS OF USE THEREOF	REATA PHARMACEUTICALS, INC.
WO/2021/127482	SYNTHESIS OF COMPOUNDS TO PROMOTE HAIR GROWTH	THE REGENT OF THE UNIVERSITY OFCALIFORNIA
WO/2021/127489	HEAVY CHAIN ANTIBODIES BINDING TO CD38	TENEOBIO, INC.
WO/2021/127493	STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/127495	NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/127499	PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF	CALICO LIFE SCIENCES LLC
WO/2021/127505	ANTI-MUC1 COMPOSITIONS AND METHODS OF USE	POSEIDA THERAPEUTICS, INC.
WO/2021/127528	MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS	AMGEN INC.
WO/2021/127539	CRYSTALLINE HYDROBROMIDE SALT OF A EZH2 INHIBITOR, ITS PREPARATION AND PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF CANCER	EPIZYME, INC.
WO/2021/127543	BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT	AGENEBIO, INC.
WO/2021/127547	MONOCLONAL ANTIBODY FUSIONS	QUIDEL CORPORATION
WO/2021/127586	PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF	CALICO LIFE SCIENCES LLC
WO/2021/127621	COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION	OVERA, INC.
WO/2021/257115	SYSTEMS AND PROCESSES FOR PRODUCING OLEFINS	SAUDI ARABIAN OIL COMPANY
WO/2021/127642	SELECTIVE VALORIZATION OF BIOMASS SUGARS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/127648	MICROBIAL ESTER PRODUCTION	AUBURN UNIVERSITY
WO/2021/133748	SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/133749	SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/133750	SUBSTITUTED BICYCLIC PIPERIDINE DERIVATIVES USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/133751	SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/133752	SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/133776	METHODS FOR TREATING OR PREVENTING ALLERGIC ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST AND/OR AN IL-4R ANTAGONIST	SANOFI BIOTECHNOLOGY
WO/2021/133809	INHIBITORS OF MUTANT FORMS OF EGFR	BLUEPRINT MEDICINES CORPORATION
WO/2021/133817	1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES	GUANGZHOU LUPENG PHARMACEUTICAL COMPANY LTD.
WO/2021/133829	CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133831	COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE	OHIO STATE INNOVATION FOUNDATION
WO/2021/133833	COMPOSITIONS FOR USE IN THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE	OHIO STATE INNOVATION FOUNDATION
WO/2021/133839	METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE	SYNTHORX, INC.
WO/2021/133846	COMPOSITIONS AND METHODS FOR ENHANCED UPTAKE OF ACTIVE INGREDIENTS FOR ANIMAL HEALTH AND NUTRITION	AGROSPHERES, INC.
WO/2021/133859	METHODS AND KITS FOR DETECTION OF N-4-ACETYLDEOXYCYTIDINE IN DNA	ACTIVE MOTIF, INC.
WO/2021/133886	COMBINATIONS OF ESTROGEN RECEPTOR DEGRADERS AND CYCLIN-DEPENDENT KINASE INHIBITORS FOR TREATING CANCER	ACCUTAR BIOTECHNOLOGY
WO/2021/133894	BTK INHIBITORS	BIOGEN MA INC.
WO/2021/133907	PROGRANULIN VARIANTS	DENALI THERAPEUTICS INC.
WO/2021/133915	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/133916	COMPOSITIONS AND METHODS FOR DETECTING PICOBIRNAVIRUS	ABBOTT LABORATORIES
WO/2021/133921	CHEMICALLY INDUCED ASSOCIATION AND DISSOCIATION OF THERAPEUTIC FC COMPOSITIONS AND CHEMICALLY INDUCED DIMERIZATION OF T CELL ENGAGER WITH HUMAN SERUM ALBUMIN	SOTERIA BIOTHERAPEUTICS, INC.
WO/2021/133924	GALECTIN-3 INHIBITING C-GLYCOSIDE KETONES, ETHERS, AND ALCOHOLS	MAGNANI, John L.
WO/2021/133928	ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF PSEUDOMONAS AND ACINETOBACTER INFECTIONS	TECHULON INC.
WO/2021/138215	TREATMENT OF CANCER WITH CDK12/13 INHIBITORS	KINNATE BIOPHARMA INC.
WO/2021/134004	CYCLIC COMPOUNDS AND METHODS OF USING SAME	SCHRODINGER, INC.
WO/2021/134028	TOPICAL CYCLOSPORINE FOR TREATING PSORIASIS AND OTHER AILMENTS	AMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/141789	STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES	ONCOLYZE, INC.
WO/2021/138264	METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES	SEAGEN INC.
WO/2021/154440	OLIGOMERIZATION OF ISOBUTANOL IN THE PRESENCE OF MWW ZEOLITE SOLID ACID CATALYSTS	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/141801	TWO BED LIQUID PHASE ISOMERIZATION PROCESS	UOP LLC
WO/2021/138331	SMALL MOLECULE INHIBITORS OF ULK1	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/138346	COMPOSITION AND USE OF ENGINEERED MONOCLONAL ANTIBODIES REFRACTORY TO TUMOR IMMUNO-SUPPRESSIVE FACTORS	NAVROGEN, INC.
WO/2021/138392	AMINOPYRIMIDINE COMPOUNDS	TYRA BIOSCIENCES, INC.
WO/2021/138397	LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES	OHIO STATE INNOVATION FOUNDATION
WO/2021/138407	MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF	MARENGO THERAPEUTICS, INC.
WO/2021/138409	ANTI-CD160 BINDING MOLECULES FOR TREATING DISEASES	MEDSTAR HEALTH, INC.
WO/2021/138419	COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY	IFM DUE, INC,
WO/2021/138434	COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY	IFM DUE, INC.
WO/2021/138443	DEXTROMETHADONE AS A DISEASE-MODIFYING TREATMENT FOR NEUROPSYCHIATRIC DISORDERS AND DISEASES	UNIVERSITY OF PADOVA
WO/2021/138474	ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF	MARENGO THERAPEUTICS, INC.
WO/2021/138486	PROCESS FOR RECOVERING ADIPONITRILE	ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
WO/2021/138491	TRICYANOHEXANE PURIFICATION METHODS	ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
WO/2021/138497	PROCESS FOR SEPARATING TRICYANOHEXANE	ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
WO/2021/138512	COMBINATION THERAPY COMPRISING A2A/A2B AND PD-1/PD-L1 INHIBITORS	INCYTE CORPORATION
WO/2021/138540	POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER	BERG LLC
WO/2021/138549	METHODS FOR THE PRODUCTION OF FERULIC ACID	INVENTURE RENEWABLES, INC.
WO/2021/138610	COCRYSTALS OF CANNABINOIDS	PURISYS LLC
WO/2021/003501	CHEMICAL COMPOUNDS	BORAGEN, INC.
WO/2021/022304	BISPECIFIC ANTI LRRC15 AND CD3EPSILON ANTIBODIES	QLSF BIOTHERAPEUTICS, INC.
WO/2021/030843	SOLID-STATE FORMS OF ABEMACICLIB, THEIR USE AND PREPARATION	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/051136	METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS	THE UNIVERSITY OF CHICAGO
WO/2021/056025	ANTI-EPHA10 ANTIBODIES AND METHODS OF USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127667	HEAT AND OXIDATION RESISTANT 9 TETRAHYDROCANNOBINOL (THC) AND CANNABINIOL (CBD) COMPOUND AND METHOD OF MANUFACTURING THE SAME	VUONG, Dieu, Cam
WO/2021/077132	METHODS AND COMPOSITIONS COMPRISING MODIFIED FAB SCAFFOLDS AND PROTEIN G FAB BINDING DOMAINS	THE UNIVERSITY OF CHICAGO
WO/2021/097475	RECRYSTALLIZED HI-6 DIMETHYLSULFATE	SOUTHWEST RESEARCH INSTITUTE
WO/2021/102468	SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/108803	FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/108809	APOE GENE THERAPY	CORNELL UNIVERSITY
WO/2021/127682	METHODS AND SYSTEMS OF MONITORING FLAMMABILITY OF VARIOUS STREAMS DURING VINYL ACETATE PRODUCTION	CELANESE INTERNATIONAL CORPORATION
WO/2021/188187	MULTIVALENT CHEMOKINE RECEPTOR BINDING COMPLEXES	CITY OF HOPE
WO/2021/141839	METHOD FOR REACTIVATING A PRECIOUS METAL-IRON CATALYST AND PERFORMING A CHEMICAL REACTION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/138660	UTILIZATION OF NITRATE TRANSPORT PROTEINS TO ENHANCE PLANT GROWTH	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/138685	MHC CLASS I COMPOSITIONS AND METHODS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/138688	SYSTEMS AND METHODS FOR IDENTIFICATION OF MHC-I PEPTIDE EPITOPES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/138694	HETEROARYL COMPOUNDS AS INHIBITORS OF PROGRAMMED NECROSIS PATHWAY, COMPOSITION AND METHOD USING THE SAME	ZHANG, Xiaohu
WO/2021/141871	INTEGRATED PERCHLOROETHYLENE DECOMPOSITION REACTOR DESIGN	UOP LLC
WO/2021/141872	OXYGENATE REMOVAL FOR PARA-XYLENE PURIFICATION VIA ADSORPTION SEPARATION	UOP LLC
WO/2021/141907	ANTI-TNFR2 ANTIBODY AND USES THEREOF	HIFIBIO (HONG KONG) LIMITED
WO/2021/141969	NANOMATERIALS	GUIDE THERAPEUTICS, INC.
WO/2021/141979	<i>C</i>-GLYCOSIDE AMINE DERIVATIVES AND METHODS OF MAKING	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
WO/2021/141984	SUBSTITUTED TRIAZINE COMPOUNDS AND USES THEREOF	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/141996	SINGLE- AND MULTI-CHAIN POLYPEPTIDES THAT BIND SPECIFICALLY TO CD3 EPSILON	CYTOMX THERAPEUTICS, INC.
WO/2021/142006	INHIBITORS OF SARM1	DISARM THERAPEUTICS, INC.
WO/2021/142022	COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES	QUANTA THERAPEUTICS, INC.
WO/2021/142029	AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUNDS, AND METHODS OF USE THEREOF	CYTOMX THERAPEUTICS, INC.
WO/2021/142062	FUMARATE ESTER DOSAGE FORMS WITH ENHANCED GASTROINTESTINAL TOLERABILITY	BANNER LIFE SCIENCES LLC
WO/2021/142065	ACRIDIN-9-YL-AMINE, QUINOLIN-9-YL-AMINE, 1 -AMINO-9H-THIOXANTHENE-9-ONE AND BENZO[B][1,5]NAPHTHYRI DIN-10-YL-AMINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR TREATING CANCER	REYOUNG CORPORATION
WO/2021/142131	CRYSTALLINE FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)- 1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/142144	MEK INHIBITORS AND THERAPEUTIC USES THEREOF	IMMUNEERING CORPORATION
WO/2021/142155	PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS	ORFAN BIOTECH INC.
WO/2021/142170	MODIFIED PYRROLO- AND PYRAZOLO- PYRIMIDINES FOR PROSTATE CANCER THERAPY	UNIVERSITY OF WASHINGTON
WO/2021/142203	NLRP3 MODULATORS	INNATE TUMOR IMMUNITY, INC.
WO/2021/142221	COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/150382	MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY	DYNE THERAPEUTICS, INC.
WO/2021/142252	TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS	INCYTE CORPORATION
WO/2021/142253	ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) BINDING PROTEINS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/183207	COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY OF NPM1c-POSITIVE CANCER	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/142281	LIGANDS FOR TRANSITION METAL CATALYSTS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/142289	COMPLEXES OF N-HETEROCYCLIC CARBENES FOR TRANSITION METAL CATALYSIS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/142307	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES	DYNE THERAPEUTICS, INC.
WO/2021/142312	METHODS AND COMPOSITIONS RELATED TO HEPARINOIDS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS
WO/2021/142313	MUSCLE-TARGETING COMPLEXES AND USES THEREOF	DYNE THERAPEUTICS, INC.
WO/2021/142333	INHIBITORS OF MICROBIALLY INDUCED AMYLOID	AXIAL THERAPEUTICS, INC.
WO/2021/142344	METHODS FOR THE PREPARATION OF ETHYL 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-1H-PYRAZOLE-5-CARBOXYLATE	FMC CORPORATION
WO/2021/142345	SMALL MOLECULE MODULATORS KSR-BOUND MEK	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/142351	MULTI-FUNCTIONAL CHIMERIC MOLECULES	THE BROAD INSTITUTE, INC.
WO/2021/142366	COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES	CAROGEN CORPORATION
WO/2021/142376	COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF TRANSCRIPTION	OBSIDIAN THERAPEUTICS, INC.
WO/2021/142377	CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES	LYCIA THERAPEUTICS, INC.
WO/2021/173238	XYLENE SEPARATION PROCESSES USING A MEMBRANE SEPARATOR	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/142443	COMPOUNDS FOR CHRONIC DISORDERS	PILLAI UNIVERSAL LLC
WO/2021/142445	ANTIBODIES TO PFGARP KILL <i>PLASMODIUM FALCIPARUM </i>MALARIA PARASITES AND PROTECT AGAINST INFECTION AND SEVERE DISEASE	RHODE ISLAND HOSPITAL
WO/2021/142471	NOVEL MASKED CYTOKINES AND METHODS OF USE THEREOF	ASKGENE PHARMA, INC.
WO/2021/146168	METHODS AND SYSTEMS FOR AMPLIFYING LOW CONCENTRATIONS OF NUCLEIC ACIDS	FLUENT BIOSCIENCES INC.
WO/2021/142477	NEUROACTIVE STEROIDS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME	BRII BIOSCIENCES, INC.
WO/2021/146211	NANOPARTICLE COMPOSITIONS	JANUARY THERAPEUTICS, INC.
WO/2021/146218	ANTI-GAL3 ANTIBODIES AND METHODS OF USE	TRUEBINDING, INC.
WO/2021/146256	ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF	DENALI THERAPEUTICS INC.
WO/2021/194610	COMBINED ANTI-CYTOKINE THERAPY TO REDUCE METASTATIC CANCER	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/146305	SLURRY PHASE REACTOR WITH INTERNAL CYCLONES	KELLOGG BROWN & ROOT LLC
WO/2021/146320	ANTIBODY MOLECULES TO C5AR1 AND USES THEREOF	VISTERRA, INC.
WO/2021/146323	CCR5 BINDING AGENT FOR TREATMENT OF CCR5 POSITIVE METASTATIC CANCER	CYTODYN INC.
WO/2021/146341	PLATELET STORAGE METHODS AND COMPOSITIONS	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/146370	MAP4K1 INHIBITORS	BLUEPRINT MEDICINES CORPORATION
WO/2021/146383	ANTI-TLR7 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME	BIOLEGEND, INC.
WO/2021/146386	COMPOSITIONS AND METHODS FOR TARGETED PROTEIN STABILIZATION BY REDIRECTING ENDOGENOUS DEUBIQUITINASES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/146391	REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C–P BONDS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/146424	BICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/146438	SYSTEM AND METHOD OF TREATING NEUROLOGICAL DISORDERS	ENCLEAR THERAPIES, INC.
WO/2021/146440	TETO TO INCREASE ODORANT RECEPTOR REPRESENTATION IN THE OLFACTORY SYSTEM	RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
WO/2021/146441	PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES	JANSSEN BIOTECH, INC.
WO/2021/146454	PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES	JANSSEN BIOTECH, INC.
WO/2021/146455	CYTOKINE IL-2 PRODRUGS COMPRISING A CLEAVABLE LINKER	TRUTINO BIOSCIENCES INC.
WO/2021/146458	PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES	PROTAGONIST THERAPEUTICS, INC.
WO/2021/146488	4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF	DICERNA PHARMACEUTICALS, INC.
WO/2021/146492	PLASMID FOR BACILLUS EXPRESSING FLUORESCENT REPORTER GENES	NOVOZYMES BIOAG A/S
WO/2021/146522	FUNGICIDAL AMIDES	FMC CORPORATION
WO/2021/146536	THERAPEUTIC AGENTS AND METHODS OF TREATMENT	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/146543	INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE AND USES THEREOF	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/146562	ANTI-MAA IMMUNOGLOBULIN ISOTYPES IN INFLAMMATORY BOWEL DISEASE: DIAGNOSTIC IMPLICATIONS FOR ULCERATIVE COLITIS	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/146572	ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/167723	CHIMERIC SCAVENGER RECEPTORS TARGETED TO PHOSPHORYLATED TAU (PTAU) AND USES THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/146590	PRO-ANTIBODY THAT REDUCES OFF-TARGET TOXICITY	AETIO BIOTHERAPY, INC.
WO/2021/146614	ANTIBODIES THAT BIND INTEGRIN AVB8 AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146620	CHIMERIC ANTIGEN RECEPTORS FOR REMOVAL OF AMYLOID	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/146630	HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR VIRAL CLEARANCE	REGENERON PHARMACEUTICALS, INC.
WO/2021/150486	ANTI-IL- 1β ANTIBODIES	ELI LILLY AND COMPANY
WO/2021/154534	PLAP-CD3 EPSILON BISPECIFIC ANTIBODIES	PROMAB BIOTECHNOLOGIES, INC.
WO/2021/154543	TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13Rα2 POSITIVE MALIGNANCIES	CITY OF HOPE
WO/2021/150581	IMMUNOLOGICALLY OPTIMIZED BOTULINUM TOXIN LIGHT CHAIN VARIANTS	TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/150613	SPIRO COMPOUNDS AS INHIBITORS OF KRAS	INCYTE CORPORATION
WO/2021/150614	COMPOUNDS AND METHODS FOR SELECTIVE C-TERMINAL LABELING	QUANTUM-SI INCORPORATED
WO/2021/150673	GIP/GLP1 CO-AGONIST COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/150674	METHODS OF PURIFICATION	ALKERMES, INC.
WO/2021/150697	N-SUBSTITUTED-3-TRICYCLYL PIPERIDINE DERIVATIVES AS ANTICANCER AND NEUROPROTECTIVE AGENTS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/150700	N-SUBSTITUTED-3-TRICYCLYL PIPERIDINE DERIVATIVES AS ANTICANCER AND NEUROPROTECTIVE AGENTS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/150702	ANTI-PD-L1 ANTIBODIES	BOLT BIOTHERAPEUTICS, INC.
WO/2021/150723	CRYSTALLINE FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/154582	AMINO ACID SURFACTANTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/154583	AMINO ACID SURFACTANTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/154584	AMINO ACID SURFACTANTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/154585	AMINO ACID SURFACTANTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/154587	AMINO ACID SURFACTANTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/150792	NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS	MICURX PHARMACEUTICALS, INC.
WO/2021/150795	EXPRESSION AND PURIFICATION OF RECOMBINANT HUMAN ISOFERRITINS USING A NOVEL EXPRESSION SYSTEM	THE RESEARCH FOUNDATION FOR SUNY
WO/2021/150796	MULTIVALENT PHARMACOPHORE FOR HIGH AVIDITY AND OVEREXPRESSED-TARGET SPECIFIC BINDING AND USES THEREOF	CHEN, Jun
WO/2021/150801	SYNTHESIS OF (E)-1,1,1,4,5,5,5-HEPTAFLUORO-4-(TRIFLUOROMETHYL)PENT-2-ENE	THE CHEMOURS COMPANY FC, LLC
WO/2021/150803	TRICYCLIC SULFONES AS ROR GAMMA MODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/150804	PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) T CELL RECEPTORS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/150824	COMBINATIONS OF ANTIBODY CONSTRUCTS AND INHIBITORS OF CYTOKINE RELEASE SYNDROME AND USES THEREOF	AMGEN RESEARCH (MUNICH) GMBH
WO/2021/150850	ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SVCS.
WO/2021/158376	MUCIN-BINDING FUSION PROTEINS	CODEXIS, INC.
WO/2021/150885	CANNABINOID DERIVATIVES	PERKINELMER HEALTH SCIENCES, INC.
WO/2021/150910	PEPTIDE IMMUNOGENS TARGETING PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF MIGRAINE	UBI IP HOLDINGS
WO/2021/150918	4,5,6,7-TETRAHYDROTHIENO[2,3-<i>C</i>]PYRIDINE SUMO INHIBITORS AND USES THEREOF	ONCOVALENT THERAPEUTICS INC.
WO/2021/150936	ONCOLYTIC VIRUS COMPOSITIONS INCLUDING IL-15 COMPLEX AND METHODS FOR THE TREATMENT OF CANCER	CITY OF HOPE
WO/2021/150942	METHANOL PRODUCTION METHOD	ZONEFLOW REACTOR TECHNOLOGIES, LLC
WO/2021/150959	ANIMAL-FREE DIETARY COLLAGEN	GELTOR, INC.
WO/2021/150965	REDEFINING LIVESTOCK MILK BY REMOVING FOLATE RECEPTOR PROTEIN TO DECREASE FOLATE RECEPTOR AUTOIMMUNE DISORDER IN PREGNANCY AND AUTISM	MIRITAUR LLC
WO/2021/150970	BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND INTERLEUKIN 6 RECEPTOR	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/150990	SMALL RNA DISEASE CLASSIFIERS	SRNALYTICS, INC.
WO/2021/150996	METHODS FOR HARVESTING BIOMOLECULES	AMGEN INC.
WO/2021/151001	CHIMERIC POLYPEPTIDES	OUTPACE BIO, INC.
WO/2021/151012	ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING TAU EXPRESSION	SANGAMO THERAPEUTICS, INC.
WO/2021/151020	CONDITIONALLY ACTIVE ANTI-HER2 ANTIBODIES, ANTIBODY FRAGMENTS THEIR IMMUNOCONJUGATES AND USES THEREOF	BIOATLA, INC.
WO/2021/151034	MESOIONIC INSECTICIDES	FMC CORPORATION
WO/2021/154636	APPLICATION OF FRAGRANCE TO FABRIC SUBSTRATES USING FOAM	LINDBERG, Lisa
WO/2021/151059	COMPOUNDS AND METHODS FOR TREATING OR REDUCING PRURITUS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
WO/2021/151073	UNCONSTRAINED GENOME TARGETING WITH NEAR-PAMLESS ENGINEERED CRISPR-CAS9 VARIANTS	THE GENERAL HOSPITAL CORPORATION
WO/2021/151085	CRISPR-CAS ENZYMES WITH ENHANCED ON-TARGET ACTIVITY	THE GENERAL HOSPITAL CORPORATION
WO/2021/154661	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154662	1<i>H</i>-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154663	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154664	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154665	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154666	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154667	C3-SUBSTITUTED 1<i>H</i>-PYRAZOLO[4,3-<i>d</i>]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154668	1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/154669	1<i>H</i>-PYRAZOLO[4,3-<i>d</i>]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/194623	8-SUBSTITUTED DIARYL XANTHINES AS DUAL A <sb>2A</sb>-A <sb>2B</sb> ANTAGONISTS	INSPYR THERAPEUTICS, INC.
WO/2021/154796	GLP-1R MODULATING COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/154837	BIO-BASED BRANCHED ESTOLIDE COMPOUNDS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
WO/2021/154842	COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING	PROTEGO BIOPHARMA, INC.
WO/2021/154877	MITOCHONDRIA-TARGETED ISOKETAL/ISOLEVUGLANDIN SCAVENGERS AND USES THEREOF	VANDERBILT UNIVERSITY
WO/2021/154901	PROCESSES FOR THE PREPARATION OF GLASDEGIB AND SALT THEREOF AND SOLID STATE FORMS OF GLASDEGIB MALEATE AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/154902	COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF	ANIMA BIOTECH INC.
WO/2021/154904	SOLID STATE FORMS OF MAVACAMTEN AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/158413	NOVEL LILRB2 ANTIBODIES AND USES THEREOF	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/154931	DEPOLYMERIZATION OF OLIGOMERS AND POLYMERS COMPRISING CYCLOBUTANE UNITS	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/154947	PEPTIDE IMMUNOGENS TARGETING PCSK9 AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF PCSK9-MEDIATED DISORDERS	UBI IP HOLDINGS
WO/2021/154978	HUMAN BLOOD-BRAIN BARRIER TARGETING ANTIBODIES	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/154987	SOLID STATE FORMS OF MITAPIVAT AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/154993	GENOME ENGINEERING THE HUMAN IMMUNOGLOBULIN LOCUS TO EXPRESS RECOMBINANT BINDING DOMAIN MOLECULES	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/154997	INHIBITORS OF APOL1 AND METHODS OF USING SAME	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/155006	INHIBITORS OF CYCLIN-DEPENDENT KINASES AND USES THEREOF	LES LABORATOIRES SERVIER SAS
WO/2021/155028	ANTI-MDR1 ANTIBODIES AND USES THEREOF	KENJOCKETY BIOTECHNOLOGY, INC.
WO/2021/155065	BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME	THE BROAD INSTITUTE, INC.
WO/2021/155071	CD28 SINGLE DOMAIN ANTIBODIES AND MULTIVALENT AND MULTISPECIFIC CONSTRUCTS THEREOF	INHIBRX, INC.
WO/2021/155078	GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF	ECOLAB USA INC.
WO/2021/155084	SUPPRESSION OF SHADE AVOIDANCE RESPONSE IN PLANTS	PAIRWISE PLANTS SERVICES, INC.
WO/2021/155106	PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS	FMC CORPORATION
WO/2021/155112	COMPOSITIONS AND METHODS OF T CELL RECEPTOR VB FAMILY MEMBER TARGETING FOR THE TREATMENT OF T CELL ASSOCIATED DISEASE	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/155132	DE NOVO STABLE, MODULAR PD-1 BINDING PROTEINS AND OLIGOMERIC VARIANTS	UNIVERSITY OF WASHINGTON
WO/2021/155137	MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF	GENZYME CORPORATION
WO/2021/155141	ANTIBODY-BASED COMPOSITIONS FOR TARGETING TROPOMYOSIN RECEPTOR KINASE B (TRKB) ISOFORMS	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/155144	USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/155151	MULTIVALENT LIGANDS TARGETING CELL SURFACE RECEPTORS AND FORCE MEASUREMENT PLATFORM FOR MAKING THE SAME	THE METHODIST HOSPITAL SYSTEM
WO/2021/155157	PROCESS FOR RECOVERING & PURIFYING HUMAN MILK OLIGOSACCHARIDES	DSM IP ASSETS B.V.
WO/2021/155167	BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES	THE JOHNS HOPKINS UNIVERSITY
WO/2021/155180	COMBINATIONS OF EGFR INHIBITORS AND ROR1 INHIBITORS FOR THE TREATMENT OF CANCER	ONCTERNAL THERAPEUTICS, INC.
WO/2021/155185	AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS	SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/155192	COMPOSITIONS AND METHODS OF USING CYANINE DYES TO TARGET CANCER AND MITOCHONDRIA	THOMAS JEFFERSON UNIVERSITY
WO/2021/155194	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/155196	MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2	THE GENERAL HOSPITAL CORPORATION
WO/2021/155227	INDAZOLE DERIVATIVES AS CANNABANOID RECEPTOR PARTIAL AGONISTS	RTI INTERNATIONAL, INC.
WO/2021/158444	RESIN REACTORS IN SERIES PEPTIDE SYNTHESIZER	ELI LILLY AND COMPANY
WO/2021/155295	ANTI-MüLLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE	THE CLEVELAND CLINIC FOUNDATION
WO/2021/155305	METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST	APEXIMMUNE THERAPEUTICS INC.
WO/2021/155307	ANTI-B7-H4 CONSTRUCTS AND USES THEREOF	APEXIMMUNE THERAPEUTICS INC.
WO/2021/155317	ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS	AVILAR THERAPEUTICS, INC.
WO/2021/155321	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155323	COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUS INFECTION-SARS-COV-2 VACCINES	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/155354	REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE	UNM RAINFOREST INNOVATIONS
WO/2021/158481	SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME	ARBUTUS BIOPHARMA, INC.
WO/2021/155367	NEGATIVE ALLOSTERIC MODULATION OF GLUN3-CONTAINING N-METHYL-D-ASPARTATE RECEPTORS	EMORY UNIVERSITY
WO/2021/194635	COMBINATORIAL AFFINITY-BASED ANALYSIS ASSEMBLIES AND METHODS	MCGREW, Stephen, P.
WO/2021/155369	SYSTEMS AND METHODS TO IDENTIFY GENETIC SILENCERS AND APPLICATIONS THEREOF	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/173307	TRISPECIFIC T CELL ENGAGERS	GENSUN BIOPHARMA INC.
WO/2021/155380	BISPECIFIC T CELL ENGAGERS	GENSUN BIOPHARMA INC.
WO/2021/158495	BENZO[5,6][1,4]DIOXINO[2,3-B]PYRIDINE COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/158498	TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/158502	FACULTATIVE PROTEIN SELENYLATION FOR MODULATING METABOLISM	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/158521	ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME	VIR BIOTECHNOLOGY, INC.
WO/2021/158523	ANTI-DINITROPHENOL CHIMERIC ANTIGEN RECEPTORS	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE)
WO/2021/178088	PROCESSES FOR UPGRADING ALKANES AND ALKYL AROMATIC HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/158586	SOLID STATE FORMS OF BLARCAMESINE SALTS	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/158595	ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS	AGROFRESH INC.
WO/2021/158619	IL-7Rα BINDING COMPOUNDS	MEDIKINE, INC.
WO/2021/158623	IL-7Rαγc BINDING COMPOUNDS	MEDIKINE, INC.
WO/2021/158638	ARYLAZO-HETEROARYL COMPOUNDS AND THEIR USE FOR LONG-TERM THERMAL ENERGY STORAGE	BRANDEIS UNIVERSITY
WO/2021/158640	CRYSTALLINE FORM OF 3-((1 R,5S,9R)-9-ETHOXY-3-AZABICYCLO[3.3.1]NONAN-9-YL)-BENZAMIDE HYDROCHLORIDE AS MU-OPIOID RECEPTOR (MOR) AGONIST FOR THE TREATMENT OF PAIN	ALKERMES, INC.
WO/2021/158660	ANTI-HEPSIN ANTIBODIES AND USES THEREOF	NAVAUX, INC.
WO/2021/158663	COMPOSITIONS FOR TREATMENT OF OCULAR DISEASES	PERFUSE THERAPEUTICS, INC.
WO/2021/158666	SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/162918	ALLOSTERIC MODULATORS OF CANNABINOID RECEPTORS AND METHODS OF TREATING NEUROPATHIC PAIN	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/158675	VARIANT ACTRIIB PROTEINS AND USES THEREOF	ACCELERON PHARMA INC.
WO/2021/158695	COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION	ACCELERON PHARMA INC.
WO/2021/158698	MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/158707	METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE	DESIGN THERAPEUTICS, INC.
WO/2021/158829	INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF	STINGRAY THERAPEUTICS, INC.
WO/2021/158840	MACROCYCLIC PAD4 INHIBITORS USEFUL AS IMMUNOSUPPRESSANT	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/162942	7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/158878	POLYPEPTIDES USEFUL FOR DETECTING ANTI-RHABDOVIRUS ANTIBODIES	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/158890	CARBONATE-PROMOTED CARBOXYLATION AT HIGH RATES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/158891	SALTS AND SOLID FORMS AND PROCESSES OF PREPARING A PI3K INHIBITOR	INCYTE CORPORATION
WO/2021/158938	IL-10 AND USES THEREOF	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/158948	QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS	NEWAVE PHARMACEUTICAL INC.
WO/2021/158986	METHODS FOR THE TREATMENT OF HUNTER SYNDROME	DENALI THERAPEUTICS INC.
WO/2021/159015	NAMPT MODULATORS	CYTOKINETICS, INC.
WO/2021/159024	TAT PEPTIDE BINDING PROTEINS AND USES THEREOF	LARIMAR THERAPEUTICS, INC.
WO/2021/159029	ANTI-ROR1 ANTIBODIES AND COMPOSITIONS	VELOSBIO INC.
WO/2021/159037	PROBE FOR DETECTION OF CATHEPSIN ACTIVITY	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/159090	COMPOSITIONS AND METHODS FOR RAPID RNA-ADENYLATION AND RNA SEQUENCING	CORNELL UNIVERSITY
WO/2021/163018	NOVEL CELLULAR RECEPTORS AND USES THEREOF	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/167813	TOLUENE DISPROPORTIONATION USING AN ENHANCED UZM-44 ALUMINOSILICATE ZEOLITE	UOP LLC
WO/2021/163031	CRYSTALLIZATION OF ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS	ELI LILLY AND COMPANY
WO/2021/163035	ANTI-THYMOCYTE GLOBULIN	SAB, LLC.
WO/2021/163076	ANTl-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS	REGENERON PHARMACEUTICALS, INC.
WO/2021/163086	PREPARATION OF AQUEOUS DISPERSION OF ACRYLATE-SILOXANE COPOLYMER PARTICLES	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/178115	PROCESSES FOR UPGRADING ALKANES AND ALKYL AROMATIC HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/163097	TANDEM REPEAT CANCER-TARGETING PEPTIDES FOR MOLECULAR CONJUGATION OR ENGINEERING AND USES THEREOF IN CANCER THERANOSTICS	CHANG GUNG MEMORIAL HOSPITAL
WO/2021/163120	MULTIFUNCTIONAL SMART PARTICLES	SYNMATTER LLC
WO/2021/173345	NON-CRYOGENIC SYNTHESIS OF HETEROATOM-BRIDGE PRECURSORS OF METAL-LIGAND COMPLEX CATALYSTS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/163170	ANTI-ACVR1 ANTIBODIES AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/163209	SYSTEM FOR DETERMINING AN UNDERLYING CAUSE OF ANEMIA	QUEST DIAGNOSTICS INVESTMENTS LLC
WO/2021/163239	PEPTIDE IMMUNOGENS TARGETING ISLET AMYLOID POLYPEPTIDE (IAPP) FOR PREVENTION AND TREATMENT OF DISORDERS RELATED TO AGGREGATED IAPP	UBI IP HOLDINGS
WO/2021/163249	MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI	KRAIG BIOCRAFT LABORATORIES, INC.
WO/2021/163254	HETEROCYCLIC PAD4 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/163265	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV- 2)	VANDERBILT UNIVERSITY
WO/2021/167829	SIDE CHAMBER PROCESS MONITOR FOR ADSORPTIVE SEPARATION PROCESS	UOP LLC
WO/2021/163298	METHODS OF ACTIVATING REGULATORY T CELLS	HCW BIOLOGICS, INC.
WO/2021/163299	CHROMATOGRAPHY RESIN AND USES THEREOF	HCW BIOLOGICS, INC.
WO/2021/163344	NOVEL PRMT5 INHIBITORS	AMGEN INC.
WO/2021/163348	LOW TOXICITY NMP SUBSTITUTES AND THEIR PREPARATION	ANGUS CHEMICAL COMPANY
WO/2021/163355	FORMULATIONS AND METHODS OF TREATING CONDITIONS RELATED TO THE S1P<sb>1</sb> RECEPTOR	ARENA PHARMACEUTICALS, INC.
WO/2021/163366	BISPECIFIC BINDING MOLECULES	ABBVIE INC.
WO/2021/163369	METHODS OF TREATING AGE-RELATED AND INFLAMMATORY DISEASES	HCW BIOLOGICS, INC.
WO/2021/163371	CORONAVIRUS T CELL EPITOPES AND USES THEREOF	LA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/167840	SULFOXIDE AND SULFONE GLUCOKINASE ACTIVATORS AND METHODS OF USE THEREOF	VTV THERAPEUTICS LLC
WO/2021/163397	SOLID STATE FORMS OF AVASOPASEM MANGANESE AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/163419	METHODS OF KILLING OR INHIBITING THE GROWTH OF CANCER CELLS	TISSUETECH, INC.
WO/2021/163434	HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163445	COMPLEX STRUCTURES FROM STIMULI-RESPONSIVE PROTEINS	DUKE UNIVERSITY
WO/2021/163477	HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163481	POLYPEPTIDES AND THEIR USE	UNIVERSITY OF WASHINGTON
WO/2021/163493	COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/163495	RECOMBINANT SILK SOLIDS AND FILMS	BOLT THREADS, INC.
WO/2021/163519	SUBSTITUTED 5,6-DIPHENYL-3(2H)-PYRIDAZINONES FOR USE AS FUNGICIDES	FMC CORPORATION
WO/2021/163538	HEPADNAVIRUS CAPSID PROTEIN HETERODIMERS AND VIRUS-LIKE PARTICLES	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/163588	TREATMENT OF ATOPIC DERMATITIS WITH ANTI-TSLP ANTIBODY	AMGEN INC.
WO/2021/163613	METHOD OF DECREASING AMYLOID BETA MONOMER LEVELS IN PATIENTS WITH COGNITIVE DECLINE	COGNITION THERAPEUTICS, INC.
WO/2021/163616	CHIMERIC ANTIGEN RECEPTORS WITH CD2 ACTIVATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/163637	METAGENOMIC LIBRARY AND NATURAL PRODUCT DISCOVERY PLATFORM	ZYMERGEN INC.
WO/2021/221760	LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING	NORTHWESTERN UNIVERSITY
WO/2021/163676	METHODS OF PREPARING CHIRAL BENZODIAZEPINONE DERIVATIVES	AYALA PHARMACEUTICALS INC.
WO/2021/163701	MELANOMA THERAPEUTICS	ESCAPE THERAPEUTICS, INC.
WO/2021/216174	HIGH YIELD SYNTHESIS OF METAL-ORGANIC FRAMEWORKS	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/167908	METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/167919	AAV CAPSID-PROMOTER INTERACTIONS AND CELL SELECTIVE GENE EXPRESSION	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/167948	METHODS FOR MODULATING CALORIE CONSUMPTION	DUKE UNIVERSITY
WO/2021/167987	DIFLUOROMETHYL IODO COMPOUNDS AND METHODS	RECURIUM IP HOLDINGS, LLC
WO/2021/168000	CAR T CELLS TARGETING THE INTEGRIN ALPHAv BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/168038	ANTIVIRAL COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/168072	EFFICIENT AND SELECTIVE ROUTE FOR THE SYNTHESIS OF ALKYL 2-BENZOYLBENZOATE	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/168074	MACROCYCLIC COMPOUNDS AND USES THEREOF	THESEUS PHARMACEUTICALS, INC.
WO/2021/168079	TISSUE TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR	PANDION OPERATIONS, INC.
WO/2021/168128	COMPOSITIONS AND METHODS FOR ALLOGENEIC TRANSPLANTATION	MAGENTA THERAPEUTICS, INC.
WO/2021/168148	MANNAN BINDING LECTIN SERINE PEPTIDASE 2 (MASP2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF	ALNYLAM PHARMACEUTICALS, INC.
WO/2021/168193	PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS	BETA PHARMA, INC.
WO/2021/168197	BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF	NURIX THERAPEUTICS, INC.
WO/2021/168228	METHOD OF PREPARING SILANOLS WITH SELECTIVE CYTOCHROME P450 VARIANTS AND RELATED COMPOUNDS AND COMPOSITIONS	DOW SILICONES CORPORATION
WO/2021/168270	PROTEIN-BASED PURIFICATION MATRICES AND METHODS OF USING THE SAME	ISOLERE BIO, INC.
WO/2021/168292	EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/168298	INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES	SENTI BIOSCIENCES, INC.
WO/2021/168305	DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19)	UBI IP HOLDINGS
WO/2021/168309	TOXIN GENE AND METHODS FOR ITS USE	BASF AGRICULTURAL SOLUTIONS SEED US LLC
WO/2021/168311	PROCESSES FOR ISOTOPIC MODIFICATION OF POLYUNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF	RETROTOPE, INC.
WO/2021/168313	SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES	EPIZYME, INC.
WO/2021/168314	QUINAZOLINONE COMPOUNDS AND RELATED COMPOUNDS	PLEXIUM, INC.
WO/2021/168317	INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES	SENTI BIOSCIENCES, INC.
WO/2021/168320	HETEROARYL COMPOUNDS FOR TREATMENT OF COMPLEMENT FACTOR D MEDIATED DISORDERS	ACHILLION PHARMACEUTICALS, INC.
WO/2021/168341	SOLID FORMS OF 1-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)PYRIDIN-3-YL)-N,N-DIMETHYLMETHANAMINE	SAMUMED, LLC
WO/2021/168355	ANTIGEN-BINDING PROTEINS TARGETING KKLC-1 SHARED ANTIGEN	GRITSTONE BIO, INC.
WO/2021/173471	ANTI-HUMAN CD19 ANTIBODIES	ELI LILLY AND COMPANY
WO/2021/168399	NOVEL METHODS FOR CREATING ALPHA-N-METHYLATED POLYPEPTIDES	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/168402	MECHANOCATALYTIC DEPOLYMERIZATION OF PLASTICS	GEORGIA TECH RESEARCH CORPORATION
WO/2021/173522	TETRACYCLIC COMPOUNDS FOR TREATING HIV INFECTION	GILEAD SCIENCES, INC.
WO/2021/173545	GENETICALLY ENGINEERED MICROORGANISMS THAT OVEREXPRESS MICROCIN-MGE AND METHODS OF PURIFICATION AND USE	UNIVERSITY OF MASSACHUSETTS
WO/2021/173565	METHODS OF USE OF ANTI-TREM2 ANTIBODIES	ALECTOR LLC
WO/2021/173582	SYSTEMS AND METHODS FOR THE DETECTION AND TREATMENT OF ASPERGILLUS INFECTION	THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS
WO/2021/216195	COMPOUNDS FOR THE TREATMENT OF SARS	PURDUE RESEARCH FOUNDATION
WO/2021/173591	COMPOUNDS AND METHODS OF USE	EXELIXIS, INC.
WO/2021/173612	ACTIVATABLE ANTIGEN BINDING PROTEINS WITH UNIVERSAL MASKING MOIETIES	SORRENTO THERAPEUTICS, INC.
WO/2021/173615	OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT	INTEGRATED DNA TECHNOLOGIES, INC.
WO/2021/173616	RECOMBINANT FIBCD1 AND USE THEREOF IN THE TREATMENT OF MUSCLE ATROPHY	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/173630	BCMA CAR-T CELLS WITH ENHANCED ACTIVITIES	ALLOGENE THERAPEUTICS, INC.
WO/2021/173670	RECOMBINANT ANTIMICROBIAL PEPTIDE AS DIETARY FEED SUPPLEMENT FOR USE IN IMPROVING GROWTH PERFORMANCE AND IMMUNE RESPONSE	ACADEMIA SINICA
WO/2021/173674	POLYPEPTIDES TARGETING MAGE-A3 PEPTIDE-MHC COMPLEXES AND METHODS OF USE THEREOF	A2 BIOTHERAPEUTICS, INC.
WO/2021/173726	WNT SUPER AGONISTS	SURROZEN, INC.
WO/2021/173753	ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME	VIR BIOTECHNOLOGY, INC.
WO/2021/173794	MAP KINASE KINASE (MKK7) INHIBITORS AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/173823	PROCESS AND APPARATUS FOR SEPARATING METHANOL FROM OTHER OXYGENATES	UOP LLC
WO/2021/173844	C19 C38 BISPECIFIC ANTIBODIES	BIOGRAPH 55, INC.
WO/2021/173902	HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/173903	CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN THERAPY	FIVE PRIME THERAPEUTICS, INC.
WO/2021/173916	NOCICEPTOR NEURONS CONTROL CANCER IMMUNOSURVEILLANCE	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/173917	INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/173952	COMPOSITIONS AND METHODS FOR DETECTING BCL2L14 AND ETV6 GENE FUSIONS FOR DETERMINING INCREASED DRUG RESISTANCE	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/173977	ACTIVATION OF LYTIC GENES IN CANCER CELLS	THE JACKSON LABORATORY
WO/2021/173989	CRYSTALLINE BIS-MIPROCIN FUMARATE	CAAMTECH, INC.
WO/2021/174023	SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/174035	INTERCELLULAR AND INTRACELLULAR PROXIMITY-BASED LABELING COMPOSITIONS AND SYSTEMS	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/174046	GPR40 AGONISTS	KALLYOPE, INC.
WO/2021/174048	GPR40 AGONISTS	KALLYOPE, INC.
WO/2021/174091	TRANSGLUTAMINASE-MEDIATED CONJUGATION	TALLAC THERAPEUTICS, INC.
WO/2021/174121	VEGFR-3-ACTIVATING AGENTS AND ONCOLYTIC VIRUSES AND USES THEREOF FOR THE TREATMENT OF CANCER	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/174124	DIMERIC ANTIGEN RECEPTORS (DAR) THAT BIND CD20	SORRENTO THERAPEUTICS, INC.
WO/2021/174127	ANTI-SIRPA ANTIBODIES AND METHODS OF USE	APEXIGEN, INC.
WO/2021/174163	FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174170	PYRIDAZINE DERVATIVES FOR MODULATING NUCLEIC ACID SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174174	THIOPHENYL DERIVATIVES USEFUL FOR MODULATING NUCLEIC ACID SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174176	PYRIDAZINE DERVATIVES FOR MODULATING NUCLEIC ACID SPLICING	REMIX THERAPEUTICS INC.
WO/2021/178259	A CRYSTALLINE FORM (R)-TERBUTALINE HYDROCHLORIDE	TAN, Wen
WO/2021/178271	1,2,4-TRIAZOLINONE CB1 INHIBITORS	GOLDFINCH BIO, INC.
WO/2021/178277	PROCESS FOR PRODUCTION OF MIXED BUTANOL AND DIISOBUTENES AS FUEL BLENDING COMPONENTS	SAUDI ARABIAN OIL COMPANY
WO/2021/178281	ZIKA VIRUS POLYPEPTIDES	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/174199	METHODS AND COMPOSITIONS FOR IDENTIFYING TRAITS USING A CELL-FREE SYSTEM	SYNVITROBIO, INC.
WO/2021/221783	METHODS FOR IDENTIFYING CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/174208	METHODS FOR EX VIVO ENRICHMENT AND EXPANSION OF TUMOR REACTIVE T CELLS AND RELATED COMPOSITIONS THEREOF	MYST THERAPEUTICS, LLC
WO/2021/178329	SEPARATION OF FURAN-CONTAINING COMPOUNDS	SIRONIX RENEWABLES, INC.
WO/2021/174209	SULFATED PILLARARENES, METHODS OF MAKING SAME, AND USES THEREOF	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/178339	HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS	GENENTECH, INC.
WO/2021/178350	ANTIVIRAL CHIMERIC PEPTIDES	INNATE IMMUNITY LLC
WO/2021/178362	HEPATITIS B CAPSID ASSEMBLY MODULATORS	VENATORX PHARMACEUTICALS, INC.
WO/2021/178393	METHOD AND SYSTEM FOR OXIDIZING CUMENE AND HYDROCARBONS	SABIC GLOBAL TECHNOLOGIES B.V.
WO/2021/178405	OPIOID RECEPTOR ANTAGONISTS	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/183323	PROCESS FOR INCREASING THE CONCENTRATION OF NORMAL HYDROCARBONS IN A STREAM	UOP LLC
WO/2021/178420	COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS	TWENTYEIGHT-SEVEN, INC.
WO/2021/178430	CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/178432	RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/178442	NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-NCOV INFECTIONS	CEL-SCI CORPORATION
WO/2021/178448	COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY	MOTOR LIFE SCIENCES, LLC
WO/2021/178468	HIGH SOLIDS ALKALINE OXIDATION AND BIOMETHANE CONVERSION OF RESIDUAL LIGNIN	CASAD, Robert, C.
WO/2021/178483	PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION	DUKE UNIVERSITY
WO/2021/178486	PROCESSES FOR PRODUCING AMIDE COMPOUNDS, AND THEIR CRYSTALLINE AND SALT FORM	ALPHALA CO., LTD.
WO/2021/178507	PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES	THE CHEMOURS COMPANY FC, LLC
WO/2021/178545	PROTEOMIC SCREENING FOR DISEASES	SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
WO/2021/178597	ANTIBODIES COMPRISING SITE-SPECIFIC GLUTAMINE TAGS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE	SUTRO BIOPHARMA, INC.
WO/2021/178611	METHODS FOR TREATING CANCER OR INFECTION USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY, AN ANTI-CTLA4 ANTIBODY, AND AN ANTI-TIGIT ANTIBODY	MERCK SHARP & DOHME CORP.
WO/2021/183359	ANTI-CORONAVIRUS ANTIBODIES AND METHODS OF USE	ABCELLERA BIOLOGICS INC.
WO/2021/178682	METHODS OF MAKING HYPER-SIALYLATED IMMUNOGLOBULIN	MOMENTA PHARMACEUTICALS, INC.
WO/2021/178690	THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/178695	ANTI-IDIOTYPE ANTIBODIES BINDING TO ANTI-CD123 ANTIBODIES OR CHIMERIC ANTIGEN RECEPTORS (CARS) AND METHODS OF USING THE SAME	MUSTANG BIO, INC.
WO/2021/178721	SUBSTITUTED N-BENZHYDRYLACETAMIDE INHIBITORS OF JUMANJI DOMAIN HISTONE DEMETHYLASES FOR THE TREATMENT OF CANCER	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/178749	ANTI-CCR8 AGENTS	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/183377	IMPROVED PARAFFIN UTILIZATION OF LINEAR ALKYL BENZENE PRODUCTION	UOP LLC
WO/2021/178804	SERUM ALBUMIN BINDING NANOBODY COMPOSITIONS AND METHODS FOR USING THE SAME	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/178814	ANTI-GITR ANTIBODIES AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/178833	DESIGNED IL-2 VARIANTS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/178842	RNA TARGET ENRICHMENT OR DEPLETION OF BIOLOGICAL SAMPLES	ALTRATECH LIMITED
WO/2021/178844	ZIKA AND FLAVIVIRUS IMMUNOGENIC COMPOSITIONS AND THEIR USE	ALTIMMUNE, INC
WO/2021/183390	PROCESS FOR PRODUCING ETHYLENE OXIDE FROM ETHANE BY OXIDATIVE DEHYDROGENATION AND EPOXIDATION WITH SPLIT RECYCLE	SABIC GLOBAL TECHNOLOGIES, B.V.
WO/2021/183391	PROCESS FOR PRODUCING ETHYLENE OXIDE FROM ETHANE BY OXIDATIVE DEHYDROGENATION AND EPOXIDATION WITH LOW ETHANE CONCENTRATION IN OXIDATIVE DEHYDROGENATION EFFLUENT	SABIC GLOBAL TECHNOLOGIES, B.V.
WO/2021/183392	PROCESS FOR PRODUCING ETHYLENE OXIDE FROM ETHANE BY OXIDATIVE DEHYDROGENATION AND EPOXIDATION USING A RECYCLE REACTOR DESIGN	SABIC GLOBAL TECHNOLOGIES, B.V.
WO/2021/178896	ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES	GO THERAPEUTICS, INC.
WO/2021/183428	ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/178960	COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER	ALETA BIOTHERAPEUTICS, INC.
WO/2021/183439	SUBSTITUTED FURO[3,2-D]PYRIMIDINES AND USES THEREOF	VERGE ANALYTICS, INC.
WO/2021/183456	METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY	HUMANIGEN, INC.
WO/2021/183542	EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE	SIGMA-ALDRICH CO., LLC
WO/2021/183555	OCULAR DRUG DEPOT FOR COMPLEMENT-MEDIATED DISORDERS	ACHILLION PHARMACEUTICALS, INC.
WO/2021/183560	SURFACTANTS FOR AGRICULTURAL PRODUCTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/188337	PENTAVALENT DIMERIC GROUP 6 TRANSITION METAL COMPLEXES AND METHODS FOR USE THEREOF	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/183639	CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE	NOCION THERAPEUTICS, INC.
WO/2021/183669	METHODS FOR CATALYTIC HYDROSILYLATION	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/183705	DETECTION AND TREATMENT OF VIRAL DISEASES AND CANCER	SIESS, Harold, E.
WO/2021/183709	SOLID STATE FORMS OF AVAPRITINIB AND PROCESS FOR PREPARATION THEREOF	TEVA CZECH INDUSTRIES S.R.O
WO/2021/183717	PROTEINACEOUS THERAPEUTICS	NANTCELL, INC.
WO/2021/183721	FUNGICIDAL MIXTURES CONTAINING PYRAZOLE DERIVATIVES.	FMC CORPORATION
WO/2021/183750	METHODS OF PREPARING 1'-CYANO NUCLEOSIDES	GILEAD SCIENCES, INC.
WO/2021/183754	IMMUNOMODULATING TRIFLUOROMETHYL-AMINAL AZALIDES	ZOETIS SERVICES LLC
WO/2021/183755	DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT	CITY OF HOPE
WO/2021/183758	IMMUNOMODULATING UREA AZALIDES	ZOETIS SERVICES LLC
WO/2021/183759	IMMUNOMODULATING IMINE-OXAZOLINE AZALIDES	ZOETIS SERVICES LLC
WO/2021/183761	METHODS AND COMPOSITION FOR GENE DELIVERY USING AN ENGINEERED VIRAL PARTICLE	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/183762	IMMUNOMODULATING O-HET-ARYL AZALIDES	ZOETIS SERVICES LLC
WO/2021/183774	TREATING ACUTE RESPIRATORY DISTRESS	ANGION BIOMEDICA CORP.
WO/2021/183783	CHIMERIC CRISPR/CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183795	CHIMERIC STIMULATORY RECEPTORS AND METHODS OF USE IN T CELL ACTIVATION AND DIFFERENTIATION	POSEIDA THERAPEUTICS, INC.
WO/2021/183825	ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/183839	NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS	IMMUNE-ONC THERAPEUTICS, INC.
WO/2021/183845	MATERIALS AND METHODS FOR MODULATING DELTA CHAIN MEDIATED IMMUNITY	JANSSEN BIOTECH, INC.
WO/2021/183849	ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF	GENENTECH, INC.
WO/2021/183861	METHOD FOR TREATMENT AND PROPHYLAXIS OF CRS IN PATIENTS COMPRISING A COMBINATION OF BISPECIFC ANTIBODIES BINDING TO CDS X CANCER CELL AND TNFALPHA OR IL-6 INHIBITOR	AMGEN INC.
WO/2021/188374	INTERLEUKIN-2 RECEPTOR ΒETA (IL-2RΒ) BINDING POLYPEPTIDES	NEOLEUKIN THERAPEUTICS, INC.
WO/2021/183879	ASSESSING AND TREATING ALCOHOL-ASSOCIATED LIVER DISEASE	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/183881	METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/183896	METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES	DSM IP ASSETS, B.V.
WO/2021/183922	STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C<sb>2</sb>H<sb>2</sb>	LAM RESEARCH CORPORATION
WO/2021/194772	METHODS FOR CRYSTALLIZATION OF DRUGS	BOSTON SCIENTIFIC SCIMED, INC.
WO/2021/188389	CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS	GENEVANT SCIENCES GMBH
WO/2021/183947	MOLECULES THAT BIND TO SARS-CoV-2	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/183949	HIGH-TEMPERATURE SHOCK HEATING FOR THERMOCHEMICAL REACTIONS	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/183960	TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13RαA2 POSITIVE MALIGNANCIES	CITY OF HOPE
WO/2021/183970	NON-ATP/CATALYTIC SITE P38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/211240	PROCESSES FOR CONVERTING C8 AROMATIC HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/183980	SUBSTITUTED PYRIMIDINES AND TRIAZINES AS HERBICIDES	FMC CORPORATION
WO/2021/188404	SOLID STATE FORMS OF OTESECONAZOLE AND PROCESS FOR PREPARATION THEREOF	ASSIA CHEMICAL INDUSTRIES LTD
WO/2021/188414	FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS	ENANTA PHARMACEUTICALS, INC.
WO/2021/188417	COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA	FLASH THERAPEUTICS, LLC
WO/2021/183994	PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES AS CDK INHIBITORS	PROSENESTAR LLC
WO/2021/188431	METHOD OF TREATING GLIOMA CANCER USING TARP GAMMA 8-DEPENDENT AMPA RECEPTOR ANTAGONISTS	ES THERAPEUTICS LLC
WO/2021/188480	IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/188523	NOVEL SMALL MOLECULE ANTICANCER AGENTS, COMBINATIONS AND USES THEREOF	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/188549	SOFTWARE-BASED ECOSYSTEM FOR USE WITH A RAPID TEST	DETECT INC.
WO/2021/188590	T-CELL BISPECIFIC BINDING PROTEINS	MAGENTA THERAPEUTICS, INC.
WO/2021/188591	ANTI-GLYCAN ANTIBODIES AND USES THEREOF	PTM THERAPEUTICS, INC.
WO/2021/206876	INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION	COCRYSTAL PHARMA, INC.
WO/2021/188613	TALL OIL DERIVED GLYCIDYL ESTERS AND PROCESS OF MAKING THE SAME	INGEVITY SOUTH CAROLINA, LLC
WO/2021/188620	PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION	COCRYSTAL PHARMA INC.
WO/2021/188639	IMPROVED SYNTHESIS OF 4-AMINO-6-(HETEROCYCLIC)PICOLINATES	CORTEVA AGRISCIENCE LLC
WO/2021/188654	IMPROVED SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES	CORTEVA AGRISCIENCE LLC
WO/2021/188700	BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF	QPEX BIOPHARMA, INC.
WO/2021/188727	USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED WITH CORONAVIRUS (COVID-19) INFECTION	VITAERIS INC.
WO/2021/188728	SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/188732	NANO PARTICLE AGGLOMERATE REDUCTION TO PRIMARY PARTICLE	FRANK, David L.
WO/2021/188736	MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF	SYSTIMMUNE, INC.
WO/2021/188737	GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF	SYSTIMMUNE, INC.
WO/2021/194828	COMPOUNDS USEFUL IN HIV THERAPY	VIIV HEALTHCARE COMPANY
WO/2021/194831	ALKYLATION OF TRANSITION METAL COORDINATION CATALYST COMPLEXES	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/188769	TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA	ARCUS BIOSCIENCES, INC.
WO/2021/188778	NEUROACTIVE STEROIDS AND THEIR METHODS OF USE	SAGE THERAPEUTICS, INC.
WO/2021/194839	MULTISPECIFIC BINDING PROTEINS AND METHODS OF DEVELOPING THE SAME	ELI LILLY AND COMPANY
WO/2021/202114	ANTIVIRAL COMPOUNDS AND METHOD FOR TREATING RNA VIRAL INFECTION, PARTICULARLY COVID-19	SENHWA BIOSCIENCES, INC.
WO/2021/202115	ANTIVIRAL COMPOUNDS AND METHOD FOR TREATING HEPATOTROPIC VIRAL INFECTION, PARTICULARLY HEPATITIS B AND HEPATITIS D	SENHWA BIOSCIENCES, INC.
WO/2021/194860	TOCILIZUMAB AND REMDESIVIR COMBINATION THERAPY FOR COVID-19 PNEUMONIA	GENENTECH, INC.
WO/2021/194861	BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA	GENENTECH, INC.
WO/2021/188851	ANTIBODIES AGAINST MUCIN 17 AND USES THEREOF	AMGEN INC.
WO/2021/194865	METHOD FOR TREATING PNEUMONIA, INCLUDING COVID-19 PNEUMONIA, WITH AN IL6 ANTAGONIST	GENENTECH, INC.
WO/2021/188864	NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS	EUMENTIS THERAPEUTICS, INC.
WO/2021/188869	DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE	AMGEN INC.
WO/2021/194873	COMBINE HARVESTER CONCAVE THRESHING BAR	ROBERTSON, Brian G.
WO/2021/194879	INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE	ARVINAS OPERATIONS, INC.
WO/2021/188936	PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND USE	AKEBIA THERAPEUTICS, INC.
WO/2021/188938	PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND USE	AKEBIA THERAPEUTICS, INC.
WO/2021/188940	ALDEHYDE GENERATION VIA ALKENE HYDROFORMYLATION	NORTH CAROLINA STATE UNIVERSITY
WO/2021/188944	PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USE	AKEBIA THERAPEUTICS, INC.
WO/2021/194886	ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 3BGF	CENTIVAX, INC.
WO/2021/188959	PRODRUGS OF 4'-C-SUBSTITUTED-2-HALO-2'-DEOXYADENOSINE NUCLEOSIDES AND METHODS OF MAKING AND USING THE SAME	GILEAD SCIENCES, INC.
WO/2021/194891	ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM CR3022	CENTIVAX, INC.
WO/2021/194896	ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 2GHW	CENTIVAX, INC.
WO/2021/188993	METHOD OF ENGINEERING AND ISOLATING ADENO-ASSOCIATED VIRUS	DIGNITY HEALTH
WO/2021/188996	COMPOSITIONS AND METHODS FOR ENHANCED LENTIVIRAL PRODUCTION	THE BROAD INSTITUTE, INC.
WO/2021/189008	NOVEL RECOMBINANT CELL SURFACE MARKERS	LYELL IMMUNOPHARMA, INC.
WO/2021/189015	METHODS OF DETECTING AND TREATING IMMUNE RESPONSES ASSOCIATED WITH VIRAL INFECTION	FORSYTH DENTAL INFIRMARY FOR CHILDREN, d/b/a THE FORSYTH INSTITUTE
WO/2021/194910	METHOD FOR TREATING SARS AND TREATING OR PREVENTING ARDS	AARDVARK THERAPEUTICS INC.
WO/2021/194913	TIE2-BINDING AGENTS AND METHODS OF USE	GENENTECH, INC.
WO/2021/194914	SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/202137	THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HUR	UNIVERSITY OF KANSAS
WO/2021/194942	ANTI-CCR8 ANTIBODIES FOR TREATING CANCER	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/189038	ANG 1-7 AS A THERAPEUTIC FOR CORONAVIRUS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/194951	ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 2DD8	CENTIVAX, INC.
WO/2021/194965	SUPERHUMAN ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF	CENTIVAX, INC.
WO/2021/189047	EXTRACELLULAR VESICLES FOR THERAPY	CODIAK BIOSCIENCES, INC.
WO/2021/194978	PAN-ISOTYPE IMMUNOGLOBULIN FINGERPRINTING	CDI LABORATORIES, INC.
WO/2021/194985	ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 6NB6	CENTIVAX, INC.
WO/2021/194999	MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF	AMGEN INC.
WO/2021/195000	PROCESS SULFONATION OF AMINOETHYLENE SULFONIC ESTER WITH CARBON DIOXIDE ADDITION TO PRODUCE TAURINE	ARCHER DANIELS MIDLAND COMPANY
WO/2021/189059	CIRCULAR RNA COMPOSITIONS AND METHODS	ORNA THERAPEUTICS, INC.
WO/2021/195001	PROCESS SULFONATION TO PRODUCE TAURINE	ARCHER DANIELS MIDLAND COMPANY
WO/2021/195066	KCNT1 INHIBITORS AND METHODS OF USE	PRAXIS PRECISION MEDICINES, INC.
WO/2021/195067	BI-SPECIFIC ANTIBODIES FOR USE IN PRODUCING ARMED IMMUNE CELLS	CYTOARM CO. LTD.
WO/2021/195089	FC-CORONAVIRUS ANTIGEN FUSION PROTEINS, AND NUCLEIC ACIDS, VECTORS, COMPOSITIONS AND METHODS OF USE THEREOF	SORRENTO THERAPEUTICS, INC.
WO/2021/195098	METHODS OF USING A TGF BETA KNOCKOUT CELL LINE AND COMPOSITIONS RESULTING THEREFROM	BIO-TECHNE CORPORATION
WO/2021/195177	QTY FC FUSION WATER SOLUBLE RECEPTOR PROTEINS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/202186	QTY FC FUSION RECEPTOR PROTEINS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/195183	COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE	EXO THERAPEUTICS, INC.
WO/2021/195206	POLYMORPHIC FORMS AND RELATED USES	BLACK DIAMOND THERAPEUTICS, INC.
WO/2021/195211	QUINOLINE COMPOUNDS FOR TREATING RESPIRATORY DISORDERS AND VIRAL INFECTIONS	ALDEYRA THERAPEUTICS, INC.
WO/2021/195257	BIODEGRADABLE TEXTILE FIBERS WITH INHERENT COLOR AND PROPERTIES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/195279	SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/195328	PHARMACEUTICAL FORMULATIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF	INSMED INCORPORATED
WO/2021/195360	PLXDC2 LIGANDS	LANDOS BIOPHARMA, INC.
WO/2021/195361	COMPOSITIONS AND METHODS FOR MODULATING MYOSIN SUBFRAGMENT-2 COILED COIL STABILITY AND METHODS FOR USING THEM	UNIVERSITY OF NORTH TEXAS
WO/2021/195362	METHODS OF TREATING MULTIPLE MYELOMA	SEAGEN INC.
WO/2021/202235	MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES	UNIVERSITY OF ROCHESTER
WO/2021/195385	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)	VANDERBILT UNIVERSITY
WO/2021/211279	SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/195396	SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS	RECEPTOS LLC
WO/2021/195397	SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS	RECEPTOS LLC
WO/2021/195403	DEUTERATED SGC STIMULATORS	CYCLERION THERAPEUTICS, INC.
WO/2021/195413	SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS	RECEPTOS LLC
WO/2021/195418	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)	VANDERBILT UNIVERSITY
WO/2021/195456	METHODS FOR IMPROVING RESISTANCE TO SOYBEAN RUST	PAIRWISE PLANTS SERVICES, INC.
WO/2021/195458	METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT	PAIRWISE PLANTS SERVICES, INC.
WO/2021/195472	BI-SPECIFIC FUSION PROTEINS FOR DEPLETION OF REGULATORY T CELLS	AETIO BIOTHERAPY, INC.
WO/2021/206932	ANTIVIRAL BIOMIMETIC PEPTIDES AND USES THEREOF	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/202270	PROCESSES FOR REMOVING AND/OR REDUCING PERMANGANATE REDUCING COMPOUNDS AND ALKYL IODIDES	CELANESE INTERNATIONAL CORPORATION
WO/2021/195481	SMALL MOLECULE STAT PROTEIN DEGRADERS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/195485	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)	VANDERBILT UNIVERSITY
WO/2021/195492	REGULATORY T CELL EPITOPES	EPIVAX, INC.
WO/2021/195503	T CELL RECEPTORS	2SEVENTY BIO, INC.
WO/2021/195508	TREGITOPE CONSTRUCTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 1 DIABETES	EPIVAX, INC.
WO/2021/202284	MODULATORS OF HEMOGLOBIN	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/195517	COMPOSITIONS AND METHODS FOR RECOMBINANT BIOSYNTHESIS OF CANNABINOIDS	WILLOW BIOSCIENCES, INC.
WO/2021/195529	NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF	GENERATION BIO CO.
WO/2021/195530	METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST	REGENERON PHARMACEUTICALS, INC.
WO/2021/195548	OLEOYLETHANOLAMIDE COMPOUNDS	TRAVECTA THERAPEUTICS, PTE. LTD.
WO/2021/195557	MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202312	SILICON HYDRAZIDO PRECURSOR COMPOUNDS	ENTEGRIS, INC.
WO/2021/202315	PRECURSORS AND METHODS FOR PREPARING SILICON-CONTAINING FILMS	ENTEGRIS, INC.
WO/2021/202343	ENHANCED YIELD, STRUCTURAL CONTROL, AND TRANSPORT PROPERTIES OF POLYNORBORNENES FOR NATURAL GAS UPGRADING THROUGH MIZOROKI-HECK CROSS-COUPLINGS	SAUDI ARABIAN OIL COMPANY
WO/2021/202373	A METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION FROM C-1 INHIBITOR DEPLETED PLASMA	BAXALTA INCORPORATED
WO/2021/202382	COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR TREATING RNA VIRUS INFECTIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/202427	ACE2-DERIVED COMPOSITION AND USE THEREOF	R-PHARM OVERSEAS, INC.
WO/2021/202452	PREPARATION OF MCL-1 INHIBITING COMPOUND BY METHYLATION IN THE PRESENCE OF WATER	AMGEN INC.
WO/2021/202460	BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/202463	ANTI-RSV ANTIBODIES	DANISCO US INC
WO/2021/202473	ENGINEERED ANTIBODIES	DANISCO US INC
WO/2021/202476	RECOMBINANT PEPTIDE TO TREAT FIRE BLIGHT	INNATE IMMUNITY LLC
WO/2021/202480	COMPOUNDS TARGETING PRMT5	ALIGOS THERAPEUTICS, INC.
WO/2021/202494	AAV CAPSIDS VARIANTS AND USES THEREOF	UNIVERSITY OF MASSACHUSETTS
WO/2021/202495	ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-PAB), AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/202501	IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/202547	METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTION	TRITERPENOID THERAPEUTICS, INC.
WO/2021/202574	ACTIVATED AMINO CONTAINING METAL ORGANIC FRAMEWORK (MOF) COMPOSITIONS, PROCESS OF MAKING AND PROCESS OF USE THEREOF	NUMAT TECHNOLOGIES INC.
WO/2021/202590	ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF	ALECTOR LLC
WO/2021/202595	IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER	WASHINGTON UNIVERSITY
WO/2021/202600	SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/202621	MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS	NEUBASE THERAPEUTICS, INC.
WO/2021/202625	METHOD FOR QUENCHING PEROXYCARBOXYLIC ACID RUNAWAY REACTIONS	ECOLAB USA INC.
WO/2021/202643	COMPOSITIONS AND METHODS FOR TREATING DYSREGULATED WOUND HEALING	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/230987	REDIRECTION OF TROPISM OF AAV CAPSIDS	VOYAGER THERAPEUTICS, INC.
WO/2021/202649	METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHT	AEVI GENOMIC MEDICINE, LLC
WO/2021/202651	REDIRECTION OF TROPISM OF AAV CAPSIDS	VOYAGER THERAPEUTICS, INC.
WO/2021/202673	MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS	XILIO DEVELOPMENT, INC.
WO/2021/202688	PROCESS FOR PREPARING A COT INHIBITOR COMPOUND	GILEAD SCIENCES, INC.
WO/2021/202694	PHENOLIC ACID LIPID BASED CATIONIC LIPIDS	TRANSLATE BIO, INC.
WO/2021/202770	HUMAN ANTI-CD33 ANTIBODIES AND USES THEREOF	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202775	N-(HETEROCYCLYL AND HETEROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE DERIVATIVES AS SSTR4 AGONISTS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/202781	N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/202787	ATROPISOMERS OF PYRIDAZINONE DERIVATIVES AS HERBICIDES	FMC CORPORATION
WO/2021/202788	MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF	IONIS PHARMACEUTICALS, INC.
WO/2021/202793	CHIMERIC ANTIGEN RECEPTORS TARGETING CD33	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202796	PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/202799	CHIMERIC ANTIGEN RECEPTORS TARGETING CD33	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202807	PROTEOMIC SCREENING FOR LYSOSOMAL STORAGE DISEASES	SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
WO/2021/202839	NOVEL POLYMORPHIC FORMS OF METOPIMAZINE	NEUROGASTRX, INC.
WO/2021/202872	COMPOSITIONS AND METHODS RELATED TO ISOMERS OF CURCUMIN	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/202883	METHODS FOR PRODUCTION OF OLIGOSACCHARIDES	ZIMITECH, INC.
WO/2021/202900	1,6-NAPHTHYRIDINE COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR	PLEXXIKON INC.
WO/2021/202907	REMDESIVIR AND REMDESIVIR ANALOGS, SOLUTIONS, AND NANOPARTICLE, LIPOSOMAL, AND MICROPARTICLE COMPOSITIONS FOR TREATING VIRAL INFECTIONS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/202926	METHODS AND COMBINATIONS FOR DUAL TARGETING OF TNF FAMILY MEMBERS	LA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/202955	METHODS OF TREATING SYSTEMIC SCLEROSIS	HORIZON THERAPEUTICS IRELAND DAC
WO/2021/207014	REAGENTS AND METHODS FOR PREVENTING, TREATING OR LIMITING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) CORONAVIRUS INFECTION	PHYLEX BIOSCIENCES, INC.
WO/2021/202964	ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES ASSOCIATED WITH P13K MODULATION	PETRA PHARMA CORPORATION
WO/2021/202986	COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA	STEALTH BIOTHERAPEUTICS CORP
WO/2021/203007	SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/203010	PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/203011	RIP1K INHIBITORS	RIGEL PHARMACEUTICALS, INC.
WO/2021/203014	PYRANO[4,3-B]L NDOLE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD)	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/207031	METHODS OF TREATING AND PREVENTING CORONAVIRUS INFECTIONS USING INHIBITORS OF COAGULATION FACTOR XA	COAGULO MEDICAL TECHNOLOGIES, INC.
WO/2021/203023	INDOLE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD)	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/203025	1 H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1 H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD)	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/203028	7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD)	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/203030	METHODS OF USE OF ANTI-TREM2 ANTIBODIES	ALECTOR LLC
WO/2021/203034	ALIMENTARY AND SYSTEMIC ANTIVIRAL THERAPEUTICS	FIREBREAK, INC.
WO/2021/203053	IMMUNOTHERAPY TARGETING A CONSERVED REGION IN SARS CORONAVIRUSES	VIR BIOTECHNOLOGY, INC.
WO/2021/203058	COMBINATION THERAPY INVOLVING ANTI-CD39 ANTIBODIES AND ADOPTIVE CELL THERAPY	TRISHULA THERAPEUTICS, INC.
WO/2021/207062	METHODS FOR DETECTING TARGET NUCLEIC ACIDS BY <i>IN SITU </i>HYBRIDIZATION AND A KIT THEREOF	ADVANCED CELL DIAGNOSTICS, INC.
WO/2021/207074	MODULAR SYNTHETIC RECEPTORS AND METHODS OF USE	LUNG BIOTECHNOLOGY PBC
WO/2021/207085	SYNTHETIC ELABORATION OF NATIVE DNA BY RASS (SENDR)	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/207135	COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207150	GENETICALLY MODIFIED IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR AND HAVING REDUCED PROINFLAMMATORY CYTOKINE SIGNALING	CELLEDIT LLC
WO/2021/207171	B7-H3 CHIMERIC ANTIGEN RECEPTORS	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/207186	CD38 INHIBITORS	MITOBRIDGE INC.
WO/2021/207194	SYNTHESIS OF TRIFLUOROACETYL IODIDE (TFAI) FROM TRIFLUOROACETYL CHLORIDE (TFAC) AND HYDROGEN IODIDE (HI) IN A LIQUID PHASE REACTION	HONEYWELL INTERNATIONAL INC.
WO/2021/207207	DE NOVO PROTEIN DECOYS OF ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2)	NEOLEUKIN THERAPEUTICS, INC.
WO/2021/207209	PEPTIDES FOR DETECTION AND DIFFERENTIATION OF ANTIBODY RESPONSES TO SARS-COV-2 AND OTHER HUMAN CORONA VIRUSES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/207210	METHODS FOR SYNTHESIS OF CHK1 INHIBITORS	SIERRA ONCOLOGY, INC.
WO/2021/207216	M/TIO <sb>2</sb> CATALYSTS AND METHODS OF USE	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/207242	ANTI-MESOTHELIN ANTIGEN-BINDING MOLECULES AND USES THEREOF	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/207302	INDAZOLE DERIVATIVES AS INHIBITORS OF SARM1	DISARM THERAPEUTICS, INC.
WO/2021/207308	CONDENSED PYRAZOLE DERIVATIVES AS INHIBITORS OF SARM1	DISARM THERAPEUTICS, INC.
WO/2021/207310	MENIN INHIBITORS AND METHODS OF USE FOR TREATING CANCER	AGIOS PHARMACEUTICALS, INC.
WO/2021/207335	COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS OF USE THEREOF	SYNDAX PHARMACEUTICALS, INC.
WO/2021/207408	PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY	GLO PHARMA, INC.
WO/2021/207409	SMALL MOLECULE INHIBITORS OF SARS-COV-2 VIRAL REPLICATION AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
WO/2021/207411	TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION	CHRYSALIS BIOTHERAPEUTICS
WO/2021/207433	EPITOPES OF SARS-COV-2 NEUTRALIZING ANTIBODIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207449	AFFINITY MATURED ANTI-LAP ANTIBODIES AND USES THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/207453	COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE	PTC THERAPEUTICS, INC.
WO/2021/207460	METHODS FOR ASSEMBLING PEPTIDES INTO PEPTIDE AMPHIPHILE NANOFIBERS	NORTHWESTERN UNIVERSITY
WO/2021/207511	MEAYAMYCIN ANALOGUES AND METHODS OF USE	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/207517	MODIFIED HR2 PEPTIDE INHIBITORS OF CORONAVIRUS FUSION	SAPIENCE THERAPEUTICS, INC.
WO/2021/207530	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/207531	MONOCLONAL ANTIBODIES AND USES THEREOF	NANOPIN TECHNOLOGIES, INC.
WO/2021/207532	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/207549	KINASE INHIBITORS	GB005, INC.
WO/2021/207550	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/207581	CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT	ABBVIE INC.
WO/2021/216302	COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION IN FILAMENTOUS FUNGAL CELLS	DANISCO US INC
WO/2021/207599	ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE	AKSTON BIOSCIENCES CORPORATION
WO/2021/207605	METHODS FOR PREPARING CANNABINOIDS AND RELATED INSTRUMENTS	3BC, LLC
WO/2021/207611	COMPOSITIONS COMPRISING RECOMBINANT EPO AND METHODS OF USE THEREOF	UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF VETERANS AFFAIRS
WO/2021/207613	FRB ANTIBODIES	2SEVENTY BIO, INC.
WO/2021/207615	COMPOSITIONS COMPRISING THREE OSPA FUSION PROTEINS FOR MEDICAL USE	VALNEVA AUSTRIA GMBH
WO/2021/211380	CRYSTALLINE RET INHIBITOR	LOXO ONCOLOGY, INC.
WO/2021/207636	COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEIN AGGREGATION DISORDERS	SOLA BIOSCIENCES LLC
WO/2021/225747	PROCESSES AND SYSTEMS FOR UPGRADING ALKANES AND ALKYL AROMATIC HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/252068	COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION	HEALTH RESEARCH, INC.
WO/2021/207659	CRYSTALLINE FORMS OF (9<i>R</i>, 135<i>S</i>)-13- {4-[5-CHLORO-2-(4-CHLORO-1<i>H</i>,2,3- TRIAZOL- 1 -YL)PHENYL] -6-OXO- 1,6-DIHYDROPYRIMIDIN- 1-YL}-3-(DIFLUOROMETHYL)-9-METHYL-3,4,7,15- TETRAAZATRICYCLO [ 12.3.1.0<sp>2·6</sp>] OCTADECA- 1(18), 2(6), 4, 14, 16-PENTAEN-8-ONE	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/207682	PI3 KINASE INHIBITORS AND USES THEREOF	LOW, Philip Stewart
WO/2021/211408	SUBSTITUTED {1,2,4,} TRIAZOLO{1,5-A} PYRIMIDINE COMPOUNDS AND USE IN STABILIZING MICROTUBULES	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/211430	TREATMENT OF RESPIRATORY DISEASE	ELI LILLY AND COMPANY
WO/2021/211436	IDEBENONE COMPOUNDS	TRAVECTA THERAPEUTICS PTE. LTD.
WO/2021/211455	HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/216323	GUANIDINE-MODIFIED C-TERMINUS VANCOMYCIN COMPOUNDS, COMPOSITIONS AND METHODS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/211663	CHIMERIC MYD88 RECEPTORS	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/211681	COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION	NEUMENTUM, INC.
WO/2021/211741	SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES	GOSSAMER BIO SERVICES, INC.
WO/2021/211765	HYDROGENATION OF NEPETALACTONE	ZYMERGEN INC.
WO/2021/211786	THYCLOTIDES	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/211849	RAPID EXTRACTION AND PURIFICATION OF RNA	CHHALLIYIL, Pradheep
WO/2021/211913	DIRECT THROMBIN INHIBITORS AND METHODS OF USE THEREOF	BAYLOR COLLEGE OF MEDICINE
WO/2021/211922	SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN	PRELUDE THERAPEUTICS, INCORPORATED
WO/2021/211930	FORMS AND COMPOSITIONS OF INHIBITORS OF PLASMA KALLIKREIN	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/211938	SOLID FORMS OF INHIBITORS OF PLASMA KALLIKREIN	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/211944	COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS	HONEYBRAINS, LLC
WO/2021/211948	MODIFIED CCR POLYPEPTIDES AND USES THEREOF	2SEVENTY BIO, INC.
WO/2021/211956	BIOSYNTHETIC GLYCOPROTEIN POPULATIONS	JANSSEN BIOTECH, INC.
WO/2021/212023	LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE	INTARCIA THERAPEUTICS, INC.
WO/2021/216374	PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE	ELI LILLY AND COMPANY
WO/2021/212053	THERAPEUTIC MUSK ANTIBODIES	NEWYORK UNIVERSITY
WO/2021/212062	HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASES	NIKANG THERAPEUTICS, INC.
WO/2021/212081	CANINE ANTIBODY VARIANTS	ZOETIS SERVICES LLC
WO/2021/212084	FELINE ANTIBODY VARIANTS	ZOETIS SERVICES LLC
WO/2021/212085	PEPTIDE-RECEPTIVE MHC-I COMPLEX COMPOSITIONS AND METHODS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216402	METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND RESPIRATORY DISTRESS	NUVOX PHARMA LLC
WO/2021/216413	METHOD AND SYSTEM FOR EXTRACTING METHANE GAS, CONVERTING THE GAS TO CLATHRATES, AND TRANSPORTING THE GAS FOR USE	KEZIRIAN, Michael
WO/2021/216417	COMPOSITIONS AND METHODS FOR VACCINATION AND THE TREATMENT OF INFECTIOUS DISEASES	JOUNCE THERAPEUTICS, INC.
WO/2021/216427	NUCLEOTIDE PRODRUG COMPOUNDS	LIGAND PHARMACEUTICALS, INC.
WO/2021/216431	BENZYLOXY PHOSPH(ON)ATE COMPOUNDS	LIGAND PHARMACEUTICALS, INC.
WO/2021/216440	NOVEL PROTEIN KINASE INHIBITORS	TENOVA PHARMACEUTICALS INC.
WO/2021/216458	HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF	GENZYME CORPORATION
WO/2021/212123	FUSION PROTEINS OF CTL ANTIGENS FOR TREATING MELANOMA	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/216478	HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER	MERCK SHARP & DOHME CORP.
WO/2021/216487	TRIAZINANES POSSESSING THIOSULFONATE END-GROUPS AND METHODS OF MAKING THEM	FLEXSYS AMERICA L.P.
WO/2021/216488	IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/216529	β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF	TREVENA, INC.
WO/2021/216576	ON-PURPOSE PROPYLENE PRODUCTION FROM BUTENES	LYONDELL CHEMICAL TECHNOLOGY, L.P.
WO/2021/216619	ACYCLIC CUCURBITURILS, METHODS OF MAKING SAME, AND USES THEREOF	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/216621	PROTEOLYTICALLY STABLE U1-AGATOXIN-TA1B VARIANT POLYPEPTIDES FOR PEST CONTROL	VESTARON CORPORATION
WO/2021/216628	SOLID STATE FORMS OF TRIFAROTENE AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/216629	PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS	CORTEVA AGRISCIENCE LLC
WO/2021/216635	SELECTING CHROMATOGRAPHY PARAMETERS FOR MANUFACTURING THERAPEUTIC PROTEINS	AMGEN INC.
WO/2021/216656	5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV	ASSEMBLY BIOSCIENCES, INC.
WO/2021/216660	5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV	ASSEMBLY BIOSCIENCES, INC.
WO/2021/216665	COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF	ANIMA BIOTECH INC.
WO/2021/216670	INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4	UNIVERSITY OF ROCHESTER
WO/2021/216671	PREPARATION OF AN SELECTIVE ESTROGEN RECEPTOR DEGRADER	RECURIUM IP HOLDINGS, LLC
WO/2021/216705	GPR52 MODULATORS AND METHODS OF USE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/216739	OVERCOMING THE TUMOR MICROENVIRONMENT FOR CELL THERAPY BY TARGETING MYELOID DERIVED SUPPRESSOR CELLS THROUGH A TRAIL-R2 SPECIFIC RECEPTOR	BAYLOR COLLEGE OF MEDICINE
WO/2021/216743	CORONAVIRUS VACCINES, COMPOSITIONS, AND METHODS RELATED THERETO	EMORY UNIVERSITY
WO/2021/216753	FLUORINATED DERIVATIVES OF GABAPENTIN AND METHODS OF USE THEREOF	THE GENERAL HOSPITAL CORPORATION
WO/2021/216757	RNA-BINDING PROTEIN MULTIMERIZATION INHIBITORS AND METHODS OF USE THEREOF	THE UAB RESEARCH FOUNDATION
WO/2021/216770	SUBSTITUTED TETRAHYDROQUINAZOLINE COMPOUNDS AS KRAS INHIBITORS	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/216776	CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF	GRITSTONE BIO, INC.
WO/2021/216845	ANTIVIRAL STRUCTURALLY-STABILIZED ACE2 HELIX 1 PEPTIDES AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/216849	PEPTIDE PLATINUM COMPLEXES AND METHODS OF USE THEREOF	ONCOVOLUTION, LLC
WO/2021/216876	ANTIBODIES TO CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216898	COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR	PLEXXIKON INC.
WO/2021/216899	IL4/IL13 RECEPTOR MOLECULES FOR VETERINARY USE	KINDRED BIOSCIENCES, INC.
WO/2021/216913	ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF	IMMUNEXT, INC.
WO/2021/216949	CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	VANDERBILT UNIVERSITY
WO/2021/216951	CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	VANDERBILT UNIVERSITY
WO/2021/216954	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRUS INFECTION	ALPHA BETA HOLDINGS, LLC
WO/2021/225798	SUBSTITUTED {5-METHOXY-6-[(5-METHOXYPYRIDIN-2-YL)METHOXY]PYRIDIN-3-YL}METHYL COMPOUNDS AS CSF-1R INHIBITORS	ELI LILLY AND COMPANY
WO/2021/216956	COMPOSITIONS AND METHODS FOR TREATING CANCER	ALPHA BETA HOLDINGS, LLC
WO/2021/216972	ANTI-CD3 ANTIBODIES AND USES THEREOF	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/222017	COMPOUNDS USEFUL FOR INHIBITING RET KINASE	ELI LILLY AND COMPANY
WO/2021/222018	TRANSITION METAL-COMPLEX CATALYSTS HAVING APPENDED GROUP 13 LEWIS ACIDS AND RELATED POLYMERIZATION METHODS	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/217040	CARBAMATE AND UREA DERIVATIVES	IMMVENTION THERAPEUTIX
WO/2021/217041	N-SUBSTITUTED ALPHA-AMINO AND ALPHA-HYDROXY CARBOXAMIDE DERIVATIVES	IMMVENTION THERAPEUTIX
WO/2021/217047	EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222032	PLANT REGULATORY ELEMENTS AND USES THEREOF	MONSANTO TECHNOLOGY LLC
WO/2021/217051	METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES	GENENTECH, INC.
WO/2021/217083	MEMORY DIMERIC ANTIGEN RECEPTORS	SORRENTO THERAPEUTICS, INC.
WO/2021/217085	MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF	MARENGO THERAPEUTICS, INC.
WO/2021/217113	COMPOSITIONS AND METHODS OF TREATING A CORONAVIRUS INFECTION BY USE OF AN INTERFERON FUSION PROTEIN	EAST CAROLINA UNIVERSITY
WO/2021/217115	CD25-TARGETED IL-2 FOR INCREASING CD4 T CELL FORMATION AND TREATMENT OF INFECTIONS	UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/222069	METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM INFECTIONS, INCLUDING COVID-19, BY INHIBITING CCR5/CCL5 INTERACTION	INCELLDX, INC.
WO/2021/222083	CONCENTRATED LIQUID ESTERQUAT COMPOSITIONS	STEPAN COMPANY
WO/2021/217136	HFO-1234ZE, HFO-1225ZC AND HFO-1234YF CONTAINING COMPOSITIONS AND PROCESSES FOR PRODUCING AND USING THE COMPOSITIONS	THE CHEMOURS COMPANY FC, LLC
WO/2021/222114	BCL-2 PROTEIN INHIBITORS	RECURIUM IP HOLDINGS, LLC
WO/2021/222120	PROTEIN A CHROMATOGRAPHY PURIFICATION OF AN ANTIBODY	ALEXION PHARMACEUTICALS, INC.
WO/2021/225820	FUSION PROTEINS FOR IMMUNOTHERAPY AGAINST CANCER AND INFECTIOUS DISEASES	NAVICURE BIOPHARMACEUTICALS LIMITED
WO/2021/222128	NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST COVID-19	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/222137	COMPOSITION OF IMMUNOMODULATING SERPIN, SERP-1	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/222150	INTERLEUKIN-2 POLYPEPTIDES AND FUSION PROTEINS THEREOF, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS	ANWITA BIOSCIENCES, INC.
WO/2021/225823	SYNTHESIS OF VINYLIC PROTECTED ALCOHOL INTERMEDIATES	AMGEN INC.
WO/2021/222153	SUBSTITUTED N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE OR N-(METHYL-D3)-NICOTINAMIDE COMPOUNDS AS IL-12, IL-23 AND/OR IFNALPHA MODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/222168	COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES	SOLA BIOSCIENCES LLC
WO/2021/222181	ISOFORM-INDEPENDENT ANTIBODIES TO LIPOPROTEIN(A)	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222188	ANTI-CD40 ANTIBODY COMBINATION TREATMENT FOR CANCER	SEAGEN INC.
WO/2021/222332	MINIATURIZED DYSTROPHINS HAVING SPECTRIN FUSION DOMAINS AND USES THEREOF	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/222333	KRAS SPECIFIC ANTIBODIES AND USES THEREOF	GENENTECH, INC.
WO/2021/225833	SYNTHESIS OF SULFONAMIDE INTERMEDIATES	AMGEN INC.
WO/2021/225835	SYNTHESIS OF VINYLIC ALCOHOL INTERMEDIATES	AMGEN INC.
WO/2021/222336	COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICALLY ACTIVE AGENTS	MEDIMMUNE, LLC
WO/2021/222350	METHODS OF USE FOR SINGLE MOLECULE COMPOUNDS PROVIDING MULTI-TARGET INHIBITION TO TREAT COVID-19	SIGNALRX PHARMACEUTICALS, INC.
WO/2021/222353	MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES	GILEAD SCIENCES, INC.
WO/2021/222359	THIENO PYRIMIDINES AS FERROPORTIN INHIBITORS	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/222363	CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/222365	SELF‑TANNING COMPOSITIONS CONTAINING AN AROMATIC SULFONATE AND METHODS THEREOF	KAO CORPORATION
WO/2021/222404	IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17	JANSSEN BIOTECH, INC.
WO/2021/231089	PROCESSES FOR THE PYROLYSIS OF CARBOHYDRATES	ARCHER DANIELS MIDLAND COMPANY
WO/2021/222421	ULTRA-SENSITIVE STEP-FUNCTION OPSIN FOR MINIMALLY INVASIVE OPTOGENETIC STIMULATION	THE BROAD INSTITUTE, INC.
WO/2021/222438	COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS	ABREXA PHARMACEUTICALS, INC.
WO/2021/222442	SYNTHESIS OF HETEROCYCLIC COMPOUNDS	PLEXXIKON INC.
WO/2021/222466	HETEROCYCLIC COMPOUNDS AS BET INHIBITORS	NUVATION BIO INC.
WO/2021/222522	CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/222524	METHODS OF TREATING MULTIPLE MYELOMA WITH A TRIPLET THERAPY OF CARFILZOMIB, DEXAMETHASONE, AND AN ANTIBODY THAT SPECIFICALLY RECOGNIZES CD38.	ONYX PHARMACEUTICALS, INC.
WO/2021/222542	5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/222544	ILT-BINDING AGENTS AND METHODS OF USE THEREOF	NGM BIOPHARMACEUTICALS, INC.
WO/2021/222556	PI3K-α INHIBITORS AND METHODS OF USE THEREOF	RELAY THERAPEUTICS, INC.
WO/2021/222567	MODIFIED BACTERIAL STRAINS FOR IMPROVED FIXATION OF NITROGEN	PIVOT BIO, INC.
WO/2021/222576	PAG1 FUSION PROTEINS AND METHODS OF MAKING AND USING SAME	A2 BIOTHERAPEUTICS, INC.
WO/2021/222587	ANTI-CD26 PROTEINS AND USES THEREOF	HCW BIOLOGICS, INC.
WO/2021/222609	METHODS OF PREPARING SYNTHETIC CANNABICHROMENE AND CANNABICITRAN AND DERIVATIVES THEREOF	PURISYS, LLC
WO/2021/222614	INHIBITOR OF APOPTOSIS (IAP) PROTEIN ANTAGONISTS	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/222620	HIGH AFFINITY VIRAL CAPTURE HUMAN DECOY BASED PROTEINS FOR DETECTION AND PROTECTION AGAINST SARS-COV-2 AND ZOONOTIC THREATS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222637	KRüPPEL-LIKE FACTOR 15 (KLF15) SMALL MOLECULE AGONISTS IN KIDNEY DISEASE	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
WO/2021/222673	PROCESSES FOR THE PREPARATION OF A KINASE INHIBITOR	EXELIXIS, INC.
WO/2021/222687	METHODS FOR TREATING COVID-19	MEDSTAR HEALTH
WO/2021/222706	MODIFIED IMMUNOGENIC PROTEINS	INTERNATIONAL AIDS VACCINE INITIATIVE
WO/2021/225878	4-(2,6-DIFLUOROPHENOXY)-6-(TRIFLUOROMETHYL)PYRI ML DIN-2 -AMINE DERIVATIVES AS POTENTIATORS OF TH HMRGX1 RECEPTOR FOR THE TREATMENT OF PAIN	ELI LILLY AND COMPANY
WO/2021/222719	METHODS OF PRODUCING FULL-LENGTH ANTIBODIES USING E.COLI	SUTRO BIOPHARMA, INC.
WO/2021/222746	THERAPEUTIC SIRPα ANTIBODIES	ARCH ONCOLOGY, INC.
WO/2021/222758	METHODS OF TREATING INFECTIONS	SIWA CORPORATION
WO/2021/222761	MODULATORS OF TREX1	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/222762	ACTIVATABLE IL2 COMPOSITION AND METHODS OF USE	AETIO BIOTHERAPY, INC.
WO/2021/222767	CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS	GLYCOMIMETICS, INC.
WO/2021/222772	COMPOSITIONS AND METHODS FOR CORONAVIRUS DETECTION	THE JOHNS HOPKINS UNIVERSITY
WO/2021/222777	CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS	MAGNANI, John L.
WO/2021/222798	QUANTITATIVE BLOCKER DISPLACEMENT AMPLIFICATION (QBDA) SEQUENCING FOR CALIBRATION-FREE AND MULTIPLEXED VARIANT ALLELE FREQUENCY QUANTITATION	WILLIAM MARSH RICE UNIVERSITY
WO/2021/222806	COMPOSITIONS AND METHODS FOR PREVENTING, DETECTING, AND TREATING INFLAMMATORY BOWEL DISEASE	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/222809	COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ZINC FINGERS	NEW YORK UNIVERSITY
WO/2021/222858	ANTAGONISTS OF GPR39 PROTEIN	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/247177	ALCOHOLS PRODUCTION	SCION HOLDINGS LLC
WO/2021/231111	PROCESSES FOR PREPARING C-4 SUGARS AND KETOSE SUGARS	ARCHER DANIELS MIDLAND COMPANY
WO/2021/225921	MODIFIED ADENO-ASSOCIATED VIRUS VECTORS THAT EVADE NEUTRALIZING ANTIBODIES AND USES THEREOF	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/222888	CYCLODEXTRIN BASED ANTI-MICROBIAL THERAPY	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/225954	INHIBITING ANTI-ENPP1 ANTIBODIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/225955	IAP ANTAGONIST COMPOUNDS AND INTERMEDIATES AND METHODS FOR SYNTHESIZING THE SAME	ASTEX PHARMACEUTICALS, INC.
WO/2021/225956	METHODS FOR SYNTHESIZING ANHYDROUS LACTIC ACID	ASTEX PHARMACEUTICALS, INC.
WO/2021/225961	CANINE PD-1-BINDING POLYPEPTIDES AND USES THEREOF	INHIBRX, INC.
WO/2021/222899	CONTROLLED MODIFICATION OF ADENO-ASSOCIATED VIRUS (AAV) FOR ENHANCED GENE THERAPY	TRUSTEES OF BOSTON COLLEGE
WO/2021/225968	LUMINALLY-ACTING <i>N</i>-(PIPERIDIN-4-YL)BENZAMIDE DERIVATIVES	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/226002	SMALL MOLECULE INHIBITORS OF GALECTIN-3	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/226003	IL4I1 INHIBITORS AND METHODS OF USE	MERCK SHARP & DOHME CORP.
WO/2021/226008	MODIFIED ADENO-ASSOCIATED VIRUS 5 CAPSIDS AND USES THEREOF	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/226009	SYNTHESIS OF VINYL CYCLOBUTYL INTERMEDIATES	AMGEN INC.
WO/2021/226020	POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE	APNIMED, INC. (DELAWARE)
WO/2021/226026	VACCINES AGAINST VIRAL PATHOGENS	HEXAMER THERAPEUTICS, INC.
WO/2021/226038	PRODUCTION OF JASMONATES IN FILAMENTOUS FUNGI	CONAGEN INC.
WO/2021/226063	CAR COMPRISING CD28 ZETA AND CD3 ZETA	REGENERON PHARMACEUTICALS, INC.
WO/2021/226114	BORONIC ACID DERIVATIVES AND SYNTHESIS, POLYMORPHIC FORMS, AND THERAPEUTIC USES THEREOF	QPEX BIOPHARMA, INC.
WO/2021/226123	RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF	ACADEMIA SINICA
WO/2021/226140	CDK INHIBITORS	QILU REGOR THERAPEUTICS INC.
WO/2021/226149	SYNTHESIS OF OPTICALLY ACTIVE INDOLINE DERIVATIVES VIA RUTHENIUM(II)-CATALYZED ENANTIOSELECTIVE C-H FUNCTIONALIZATION	MISSISSIPPI STATE UNIVERSITY
WO/2021/226163	ANTIBODIES TARGETING CLEC12A AND USE THEREOF	DRAGONFLY THERAPEUTICS, INC.
WO/2021/226166	PRODRUG OF ITRACONAZOLE AND USE THEREOF	LIANG, Guibai
WO/2021/226167	AAV VARIANTS FROM SECOND ROUND LIBRARIES WITH TROPISM FOR CENTRAL NERVOUS SYSTEM TISSUES	VOYAGER THERAPEUTICS, INC.
WO/2021/226168	RING CLOSING SYNTHESIS OF MACROCYCLIC MCL-1 INHIBITOR INTERMEDIATES	AMGEN INC.
WO/2021/226169	INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS	VACCINEX, INC.
WO/2021/226179	ANTI-SARS-COV-2 SPIKE PROTEIN ANTIBODIES AND METHODS OF USE	UNIVERSITY OF MASSACHUSETTS
WO/2021/236325	COVID-19 VACCINE USING NON-INTEGRATING LENTIVIRAL VECTORS	VIGENE BIOSCIENCES, INC.
WO/2021/226229	VARIANT SARS-COV-2 PROTEINS AND USES THEREOF	GINKGO BIOWORKS, INC.
WO/2021/226243	PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF	VEGA THERAPEUTICS, INC.
WO/2021/226245	PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF	VEGA THERAPEUTICS, INC.
WO/2021/226247	SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION	GENENTECH, INC.
WO/2021/226249	NEUTRALIZING ANTIBODIES THAT BIND THE SARS-COV-2 S PROTEIN	SORRENTO THERAPEUTICS, INC.
WO/2021/226260	POLYMORPHS OF PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/226261	6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS	AJAX THERAPEUTICS, INC.
WO/2021/226262	BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF	NURIX THERAPEUTICS, INC.
WO/2021/226276	NAMPT MODULATORS	CYTOKINETICS, INC.
WO/2021/226318	NOVEL PROTEIN, AND THERAPEUTIC AND COSMETIC USES THEREOF	QUORUM INNOVATIONS, LLC
WO/2021/226321	ANTI-TUMOR ASSOCIATED ANTIGEN ANTIBODIES AND USES THEREOF	PHANES THERAPEUTICS, INC.
WO/2021/226327	NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF	SINGULAR GENOMICS SYSTEMS, INC.
WO/2021/231174	METHODS OF MANUFACTURING A BIFUNCTIONAL COMPOUND, ULTRAPURE FORMS OF THE BIFUNCTIONAL COMPOUND, AND DOSAGE FORMS COMPRISING THE SAME	ARVINAS OPERATIONS, INC.
WO/2021/226351	METHODS AND SYSTEMS FOR STABILIZING PROTEINS USING INTELLIGENT AUTOMATION	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/226407	FREE BASE CRYSTALS	INTRA-CELLULAR THERAPIES, INC.
WO/2021/226413	MODIFIED MRNA FOR MULTICELL TRANSFORMATION	MORPHOGENESIS, INC.
WO/2021/231191	FACTOR XI ACTIVATION INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/231196	PREPARATION OF COMPOUNDS HAVING PESTICIDAL ACTIVITY	CORTEVA AGRISCIENCE LLC
WO/2021/226429	COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION AND WOUND HEALING	ALASTIN SKINCARE, INC.
WO/2021/226431	DIMERS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
WO/2021/226439	ENGINEERED RELAXINS AND METHODS OF USE THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/231213	ANTI-BCMA ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS	CELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/226460	IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/226463	COMPOSITION AND METHODS FOR TREATMENT OF PRIMARY CILIARY DYSKINESIA	TRANSLATE BIO, INC.
WO/2021/226517	AKT3 MODULATORS	GEORGIAMUNE LLC
WO/2021/226519	AKT3 MODULATORS	GEORGIAMUNE LLC
WO/2021/226521	SYSTEMS AND METHODS FOR USE OF ADENOSINE TRIPHOSPHATE (ATP) TO RELIEVE SYMPTOMS OF COVID-19 AND RELATED INFECTIONS	ABRAHAM, Edward H.
WO/2021/226551	APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF	ALPINE IMMUNE SCIENCES, INC.
WO/2021/226559	RADIO-AND CHEMO-PROTECTIVE COMPOUNDS	TONIX PHARMACEUTICALS, INC.
WO/2021/226560	ANTIBODIES AGAINST SARS-COV-2	VIR BIOTECHNOLOGY, INC.
WO/2021/231237	ANTIBODIES FOR SARS-COV-2 AND USES THEREOF	AUGMENTA BIOWORKS, INC.
WO/2021/231243	SMALL MOLECULE INHIBITORS OF GALECTIN-3	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/231271	PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE	GENOMATICA, INC.
WO/2021/226576	SIRP ALPHA AND SIRP BETA 1 ANTIBODIES AND USES THEREOF	ELECTRA THERAPEUTICS, INC.
WO/2021/231286	CORONAVIRUS IGG/IGM MULTIPLEXED DUAL PATH IMMUNOASSAY DEVICE	CHEMBIO DIAGNOSTIC SYSTEMS, INC.
WO/2021/226591	SIRP ALPHA, SIRP BETA 1, AND SIRP GAMMA ANTIBODIES AND USES THEREOF	ELECTRA THERAPEUTICS, INC.
WO/2021/231322	CRYSTALLINE FORMS AND FORMULATIONS OF A VCP/P97 INHIBITOR	CLEAVE THERAPEUTICS, INC.
WO/2021/231323	VCP/<sb>P</sb>97 INHIBITOR FOR THE TREATMENT OF CANCER	CLEAVE THERAPEUTICS, INC.
WO/2021/231356	ELECTROCEUTICAL FABRIC FOR ERADICATING CORONAVIRUS	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/231366	ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/231376	MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF	CUE BIOPHARMA, INC.
WO/2021/231400	BIS-ARYL ETHERS CONTAINING N-ACYL AZETIDINE AS EGFR/HER2 INHIBITORS	ACCUTAR BIOTECHNOLOGY, INC.
WO/2021/231424	METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS	ENERGESIS PHARMACEUTICALS, INC.
WO/2021/231447	NOVEL IL10 AGONISTS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/231464	COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE	INVETX INC.
WO/2021/231476	GLUTATHIONE TRISULFIDE (GSSSG) IN NEUROPROTECTION	THE GENERAL HOSPITAL CORPORATION
WO/2021/231526	FUSED PYRIMIDINE COMPOUNDS AS KRAS INHIBITORS	INCYTE CORPORATION
WO/2021/231553	SMALL MOLECULE INHIBITORS OF CAV3.2 ACTIVITY AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
WO/2021/231556	CO-PRODUCTION OF MONOMERS, INCLUDING AT LEAST ONE BIO-BASED MONOMER	ARCHER DANIELS MIDLAND COMPANY
WO/2021/231569	DUAL PROMOTER SYSTEMS	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE)
WO/2021/231571	HTT MODULATORS FOR TREATING HUNTINGTON'S DISEASE	CHDI FOUNDATION, INC.
WO/2021/231582	NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA	EUMENTIS THERAPEUTICS, INC.
WO/2021/236394	CB-0406 TROMETHAMINE SALT	CYMABAY THERAPEUTICS, INC.
WO/2021/236395	CB-0406 CHOLINE SALT	CYMABAY THERAPEUTICS, INC.
WO/2021/231651	SARS-COV2 NEUTRALIZING SINGLE DOMAIN ANTIBODY CONSTRUCTS	THE REGENTS OF THE UNIVERSITY OFCALIFORNIA
WO/2021/231653	MONO- AND COMBINATION THERAPIES	RECURIUM IP HOLDINGS, LLC
WO/2021/231655	CHIMERIC ANTIGEN RECEPTOR SPACERS	LYELL IMMUNOPHARMA, INC.
WO/2021/236401	NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/252123	CONTINUOUS FLOW SONOGASHIRA COUPLING SYNTHESIS METHOD	PURDUE RESEARCH FOUNDATION
WO/2021/236405	NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/247215	LPA RECEPTOR ANTAGONISTS AND USES THEREOF	GILEAD SCIENCES, INC.
WO/2021/231726	ENPP1 MODULATORS AND USES THEREOF	VIR BIOTECHNOLOGY, INC.
WO/2021/231737	SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN	PRELUDE THERAPEUTICS, INCORPORATED
WO/2021/231741	ANTI-PD-L1 ANTIBODIES AND ANTI-PD-L1/IL10 FUSION PROTEINS	ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/231751	FUCOSYLATED OLIGOSACCHARIDES FOR PREVENTION OF CORONAVIRUS INFECTION	GLYCOSYN LLC
WO/2021/231767	RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/231803	BINDING MOLECULES FOR COVID-19 TREATMENT	ABCORE, INC.
WO/2021/252134	REACTIVE FLAME RETARDANTS FOR FLEXIBLE POLYURETHANE FOAMS	ICL-IP AMERICA INC.
WO/2021/231892	CERTAIN CHEMICAL COMPOSITIONS AND METHODS OF USE THEREOF	ALGEN BIOTECHNOLOGIES, INC.
WO/2021/231920	NANOPORE UNZIPPING-SEQUENCING FOR DNA DATA STORAGE	THE CURATORS OF THE UNIVERSITY OF MISSOURI
WO/2021/236479	NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF	GENERATION BIO CO.
WO/2021/236546	ANTIBODY VARIANTS WITH IMPROVED PHARMACOKINETIC PROPERTIES	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/236548	ENGINEERED T CELL RECEPTORS AND METHODS OF USE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/236577	COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL STORAGE DISORDERS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/236578	CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION	SALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/236586	PROCESSES FOR THE HYDROGENOLYSIS OF GLYCEROL	ARCHER-DANIELS-MIDLAND COMPANY
WO/2021/236617	AMPK ACTIVATORS	KALLYOPE, INC.
WO/2021/236638	MAGEB2 BINDING CONSTRUCTS	AMGEN INC.
WO/2021/236645	ENGINEERED ANTI-PROSTATE STEM CELL ANTIGEN FUSION PROTEINS AND USES THEREOF	CITY OF HOPE
WO/2021/236650	CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS	G1 THERAPEUTICS, INC.
WO/2021/236676	ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF	WEREWOLF THERAPEUTICS, INC.
WO/2021/236691	COMPOSITION FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA	JUMAA-WEINACHT, Hassan
WO/2021/236695	BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR	MONTELINO THERAPEUTICS, INC.
WO/2021/236709	SOLID STATE FORMS OF TAPINAROF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/242581	ANTHELMINTIC HETEROCYCLIC COMPOUNDS	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/236717	FUSED IMIDAZOLE DERIVATIVES AS AHR ANTAGONISTS	SENDA BIOSCIENCES, INC.
WO/2021/236721	METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION	BROWN UNIVERSITY
WO/2021/236724	HUMAN ENDOTHELIN RECEPTOR A (ET<sb>A</sb>R) ANTAGONIST ANTIBODIES	REMD BIOTHERAPEUTICS, INC.
WO/2021/236759	CRYSTALLINE 4-HYDROXY-N,N-DI-N-PROPYLTRYPTAMMONIUM (4-HO-DPT) SALTS	CAAMTECH, INC.
WO/2021/236764	METHODS OF ARENE ALKENYLATION	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/236765	HYPER-SIALYLATED IMMUNOGLOBULIN	MOMENTA PHARMACEUTICALS, INC.
WO/2021/236769	PREPARATION AND PURIFICATION OF HYPERSIALYLATED IGG	MOMENTA PHARMACEUTICALS, INC.
WO/2021/236771	METHODS AND COMPOSITIONS FOR TARGETING PD-L1	ALIGOS THERAPEUTICS, INC.
WO/2021/236775	SMALL MOLECULE DEGRADERS OF SHP2 PROTEIN	THE REGENTS OF THE UNIVERSITY OFMICHIGAN
WO/2021/236809	MULTI-EPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE	OTHAIR PROTHENA LIMITED
WO/2021/236818	HALOGENATED BENZOTHIADIAZINES FOR THE TREATMENT OF CANCER	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/236876	RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS	CERTEGO THERAPEUTICS INC.
WO/2021/236911	LINCOSAMIDE ANTIBIOTICS AND USES THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/236915	PROCESSES FOR PRODUCING ETHERS AND OLEFINS FROM PRIMARY ALCOHOLS	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/236920	SOLID STATE FORMS OF AMG-510 AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/236923	PROCESSES FOR PRODUCING ALCOHOLS FROM BIOMASS AND FURTHER PRODUCTS DERIVED THEREFROM	EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
WO/2021/242602	COMPOUNDS USEFUL FOR INHIBITING CDK7	ELI LILLY AND COMPANY
WO/2021/236953	CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH ENDOGENOUS GROUPS	SAVAGE, Paul B.
WO/2021/236971	EFFICIENT AND SELECTIVE CONVERSION OF HIGH-DENSITY POLYETHYLENE INTO VALUABLE HYDROCARBONS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/242614	CIRCULATING B CELL SUBPOPULATIONS IN INDOLENT B CELL LYMPHOMA	ALEXION PHARMACEUTICALS, INC.
WO/2021/236981	ENGINEERED PARKIN AND USES THEREOF	SPACECRAFT SEVEN, LLC
WO/2021/236995	POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/236996	POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/236997	POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/236998	POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/237004	SOLID STATE FORMS OF APROCITENTAN AND PROCESS FOR PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/237038	COMPETITIVE AND NONCOMPETITIVE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5	VANDERBILT UNIVERSITY
WO/2021/237051	SARS-CoV-2 ANTIBODY AND RELATED METHODS	JECHO LABORATORIES, INC.
WO/2021/237055	FUNCTIONAL LIPID DERIVATIVES AND USES THEREOF	OHIO STATE INNOVATION FOUNDATION
WO/2021/242636	PROCESSES FOR PRODUCING CYCLIC OLEFINS FROM POLYMERS AND RE-POLYMERIZATION THEREOF	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/237111	NOTCH INHIBITORS AND USES THEREOF	STEMSYNERGY THERAPEUTICS, INC.
WO/2021/237112	NOTCH INHIBITORS AND USES THEREOF	STEMSYNERGY THERAPEUTICS, INC.
WO/2021/242663	ANTI-PD-1 ANTIBODIES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/242674	QUANTIFICATION OF DYSTROPHIN	PTC THERAPEUTICS, INC.
WO/2021/242677	TRKA INHIBITOR	ELI LILLY AND COMPANY
WO/2021/237207	BIOBASED ALKYL GLYCERYL ETHERS AND METHODS OF MAKING AND USING THE SAME	INOLEX INVESTMENT CORPORATION
WO/2021/237223	OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF	WAVE LIFE SCIENCES LTD.
WO/2021/252169	METHODS OF MANUFACTURE OF DIANHYDRIDES	CHAULAGAIN, Mani
WO/2021/242740	POLYMERASE ENZYME	QIAGEN BEVERLY LLC
WO/2021/232028	FUNCTIONAL LIGANDS TO SARS-COV-2 SPIKE PROTEIN	BASE PAIR BIOTECHNOLOGIES, INC.
WO/2021/242756	PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM	INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
WO/2021/242770	DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES	UNIVERSITY OF WASHINGTON
WO/2021/242776	METHODS OF TREATING INFLAMMATORY DISEASES BY BLOCKING GALECTIN-3	TRUEBINDING, INC.
WO/2021/242780	MODULAR AND GENERALIZABLE BIOSENSOR PLATFORM BASED ON DE NOVO DESIGNED PROTEIN SWITCHES	UNIVERSITY OF WASHINGTON
WO/2021/242790	NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF	BAYLOR COLLEGE OF MEDICINE
WO/2021/242806	INTERMEDIATES AND METHODS FOR PREPARING A GLP-1 RECEPTOR AGONIST	VTV THERAPEUTICS LLC
WO/2021/242807	METHODS FOR PREPARING METHYL (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)PROPIONATE AND HYDROCHLORIC ACID SALTS THEREOF	VTV THERAPEUTICS LLC
WO/2021/242815	ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS	REGENERON PHARMACEUTICALS, INC.
WO/2021/242817	SALT AND CRYSTAL FORMS OF GLP-1R AGONISTS AND USES THEREOF	QILU REGOR THERAPEUTICS INC.
WO/2021/242844	GRK2 INHIBITORS AND USES THEREOF	CYGNAL THERAPEUTICS, INC.
WO/2021/242876	ANTI-HUMAN LAG-3 ANTIBODIES AND THEIR USE IN IMMUNOHISTOCHEMISTRY (IHC)	AGILENT TECHNOLOGIES, INC.
WO/2021/242955	FUSED AZOLE HETEROCYCLES AS AHR ANTAGONISTS	SENDA BIOSCIENCES, INC.
WO/2021/242962	PROCESS FOR PRODUCING MIXED ALCOHOLS FROM PURGE STREAM CONTAINING OCTENE	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/242971	COMPOSITION WITH MIXED C<sb>8</sb>-C<sb>18</sb> ALCOHOLS AND SURFACTANTS THEREOF	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/242982	GALECTIN-3 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/242987	ORGANIC CATALYST FOR NON-AQUEOUS ALDOL CONDENSATION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/243001	SUBSTITUTED BENZAMIDES AS MODULATORS OF TREX1	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/243002	PCSK9 INHIBITORS AND METHODS OF USE THEREOF TO TREAT CHOLESTEROL-RELATED DISORDERS	AMGEN INC.
WO/2021/243005	AEROSOLIZED MUCUS-TETHERING NANOBODIES TO PROTECT AGAINST VIRAL AND MICROBIAL CONTAMINATION IN CLOSED AND SEMI-ENCLOSED SPACES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/243014	METHODS FOR THE TREATMENT OF IDIOPATHIC ORBITAL INFLAMMATION AND RELATED CONDITIONS	HORIZON THERAPEUTICS IRELAND DAC
WO/2021/243018	SUBSTITUTED INDOLES WITH INHIBITORY ACTIVITY	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/243042	METHODS OF TREATING CFTR RELATED DISEASES AND DISORDERS	ARIEL PRECISION MEDICINE, INC.
WO/2021/243050	MODULAR PLATFORM FOR PROGRAMMABLE SPATIOTEMPORAL BIOMOLECULE CLUSTERING WITH APPLICATIONS INCLUDING ENHANCED METABOLIC YIELD	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/243057	ENGINEERED INTERLEUKIN-10 POLYPEPTIDES AND USES THEREOF	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257264	METALLOCENE CATALYSTS FOR PRODUCING VINYL-TERMINATED POLYALPHAOLEFINS AND METHODS ASSOCIATED THEREWITH	EXXONMOBIL CHEMICAL PATENTS INC.
WO/2021/243122	ENGINEERED CORONAVIRUS SPIKE (S) PROTEIN AND METHODS OF USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/243137	PROCESS FOR THE STEPWISE SYNTHESIS OF SILAHYDROCARBONS	MOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/243149	PROTEIN COVARIANCE NETWORKS REVEAL INTERACTIONS IMPORTANT TO THE EMERGENCE OF SARS CORONAVIRUSES AS HUMAN PATHOGENS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/243169	ANTI-VSIG4 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFLAMMATORY PHENOTYPES AND USES THEREOF	VERSEAU THERAPEUTICS, INC.
WO/2021/243185	SARS-COV-2 BINDING AGENTS AND USES THEREOF	AVANTGEN, INC.
WO/2021/243192	SOLID FORMS OF PRALSETINIB	BLUEPRINT MEDICINES CORPORATION
WO/2021/243203	BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF	FUJIFILM CELLULAR DYNAMICS, INC.
WO/2021/243219	ADENOVIRUS-BASED SARS-COV-2 VACCINE	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
WO/2021/243230	ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/243275	CAR-TREG-BASED THERAPIES TARGETING MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) FOR TREATING NEURODEGENERATIVE DISEASES	AZTHERAPIES, INC.
WO/2021/243320	ADVERSE EFFECTS-MITIGATING ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING TO CD33 AND CD3	AMGEN INC.
WO/2021/247457	METHODS FOR MAKING EXTRACELLULAR VESICLES AND USES THEREOF	GENENTECH, INC.
WO/2021/243323	KAPPA OPIOID RECEPTOR AGONIST-THERAPEUTIC ANTIGEN BINDING PROTEIN CONJUGATE (KTAC) COMPOUNDS	CARA THERAPEUTICS, INC.
WO/2021/247474	SSTR-BINDING CHIMERIC ANTIGEN RECEPTORS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/247525	DUAL EGFR-MUC1 CHIMERIC ANTIGEN RECEPTOR T CELLS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/247531	METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATES	BALCHEM CORPORATION
WO/2021/247583	SYNTHESIS OF PHEROMONE DERIVATIVES VIA Z-SELECTIVE OLEFIN METATHESIS	PROVIVI, INC.
WO/2021/247588	RABBIT ANTIBODIES TO HUMAN IMMUNOGLOBULINS G	GENZYME CORPORATION
WO/2021/247591	ANTIBODIES TO TIGIT	ARCUS BIOSCIENCES, INC.
WO/2021/247607	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE	ABEXXA BIOLOGICS, INC.
WO/2021/247608	ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE	ABEXXA BIOLOGICS, INC.
WO/2021/247654	ISOLATED ANTIBODIES AND FRAGMENTS THEREOF WITH SPECIFICITY FOR OSTEOPONTIN-C	WEBER, Georg F.
WO/2021/252236	NATIVE CELL MEMBRANE NANOPARTICLE AND METHODS OF USE THEREOF	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/247667	OXIRANE-FUNCTIONAL VINYL MONOMERS AND METHODS FOR MAKING THE SAME	SWIMC LLC
WO/2021/247668	PROCESSES OF PREPARING A JAK1 INHIBITOR	INCYTE CORPORATION
WO/2021/247717	2-INDOLYL IMIDAZO [4,5-D] PHENANTHROLINE POLYMORPHS AND COMPOSITIONS REGARDING THE SAME	APTOSE BIOSCIENCES INC.
WO/2021/247722	NOVEL SELENO-NSAID ANALOGS AND USES THEREOF	THE PENN STATE RESEARCH FOUNDATION
WO/2021/247732	3-(2-(BENZO[D]THIAZOL-2-YL)-2-(PHENYLSUFONAMIDO)ETHYL)BENZIMIDAMIDE DERIVATIVES AND RELATED COMPOUNDS AS TMPRSS2 INHIBITORS FOR THE TREATMENT OF VIRAL INFECTIONS	TOPSPIN THERAPEUTICS, INC.
WO/2021/247761	METHODS AND COMPOSITIONS FOR IN VITRO AFFINITY MATURATION OF MONOCLONAL ANTIBODIES	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/247779	METHODS FOR TREATING OR PREVENTING SARS-CoV-2 INFECTIONS AND COVID-19 WITH ANTI-SARS-CoV-2 SPIKE GLYCOPROTEIN ANTIBODIES	REGENERON PHARMACEUTICALS, INC.
WO/2021/247789	IMMUNOMODULATORY COMPOUNDS	LEIDOS, INC.
WO/2021/247812	BISPECIFIC BINDING CONSTRUCTS	AMGEN INC.
WO/2021/247837	METHOD FOR DETERMINING ANTIBODY DISSOCIATION RATE	ACCESS MEDICAL SYSTEMS, LTD.
WO/2021/247847	ISOTOPIC THYROMIMETIC COMPOUNDS	AUTOBAHN THERAPEUTICS, INC.
WO/2021/247853	PROCESS FOR ACETIC ACID PRODUCTION BY REMOVING PERMANGANATE REDUCING COMPOUNDS	CELANESE INTERNATIONAL CORPORATION
WO/2021/247854	PRODUCTION AND PURIFICATION OF ACETIC ACID	CELANESE INTERNATIONAL CORPORATION
WO/2021/247855	REMOVAL OF ACETALS FROM PROCESS STREAMS	CELANESE INTERNATIONAL CORPORATION
WO/2021/247859	PYRIDOPYRIMIDINES AND METHODS OF THEIR USE	YUMANITY THERAPEUTICS, INC.
WO/2021/247936	CONFORMATIONALLY-CONSTRAINED α- -RGIA ANALOGUES	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/252273	CONTINUOUS PHOTOCHEMICAL PRODUCTION OF HIGH PURITY LINEAR MERCAPTAN AND SULFIDE COMPOSITIONS	ARKEMA INC.
WO/2021/247989	ENHANCED HAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS	B-MOGEN BIOTECHNOLOGIES, INC.
WO/2021/248005	ANTI-BCMA ANTIBODY-DRUG CONJUGATES AND METHODS OF USE	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/248019	SYSTEMS AND METHODS FOR PRODUCING LIGNOCELLULOSIS ALKANES	TECHNIP PROCESS TECHNOLOGY, INC.
WO/2021/248038	COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES	SOLA BIOSCIENCES LLC
WO/2021/248049	OXYSTEROL COMPOUNDS AND USES THEREOF	MAX BIOPHARMA, INC.
WO/2021/248059	IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/248065	TRAIL COMPOSITIONS WITH REDUCED IMMUNOGENICITY	THERALY FIBROSIS, INC.
WO/2021/252295	PROCESS OF MAKING ROXADUSTAT	SUZHOU PENGXU PHARMATECH CO., LTD.
WO/2021/248079	HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF	SPARCBIO LLC
WO/2021/248082	HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF	SPARCBIO LLC
WO/2021/248083	HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF	SPARCBIO LLC
WO/2021/248090	HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF	SPARCBIO LLC
WO/2021/248095	HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF	SPARCBIO LLC
WO/2021/252301	METHODS AND COMPOSITIONS FOR MODULATING TOLL-LIKE RECEPTOR 7 (TLR7) FUNCTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/252302	METHODS AND COMPOSITIONS FOR MODULATING TOLL-LIKE RECEPTOR 9 (TLR9) FUNCTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/252303	METHODS AND COMPOSITIONS FOR MODULATING TOLL-LIKE RECEPTOR 3 (TLRS) FUNCTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/252304	METHODS AND COMPOSITIONS FOR MODULATING TOLL-LIKE RECEPTOR 5 (TLRS) FUNCTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/252339	SUBSTITUTED PURINE-2,6-DIONE COMPOUNDS AS KRAS INHIBITORS	ACCUTAR BIOTECHNOLOGY, INC.
WO/2021/252352	RED MUD AS A CATALYST FOR THE ISOMERIZATION OF OLEFINS	SAUDI ARABIAN OIL COMPANY
WO/2021/252368	FLUORENYL CYANINE DYES	BIOTIUM, INC.
WO/2021/252391	METHODS AND VECTORS FOR ENHANCING EXPRESSION AND/OR INHIBITING DEGRADATION OF PROTEIN	ACADEMIA SINICA
WO/2021/252392	COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS	VIKING THERAPEUTICS, INC.
WO/2021/252420	SYNTHESIS OF N-(2,4-DINITROPHENYL)-4-NITROBENZAMIDE (TNBA) USING SOLID ACID CATALYSTS	DUPONT SAFETY & CONSTRUCTION, INC.
WO/2021/252446	FUMARYL DIKETOPIPERIDINE PRODRUGS OF TREPROSTINIL	UNITED THERAPEUTICS CORPORATION
WO/2021/252475	QUINAZOLINE DERIVATIVES USEFUL AS SELECTIVE HDAC6 INHIBITORS	ANNJI PHARMACEUTICAL CO., LTD.
WO/2021/252488	INHIBITORS OF NEK7 KINASE	HALIA THERAPEUTICS, INC.
WO/2021/252491	ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS	ALIGOS THERAPEUTICS, INC.
WO/2021/252494	USE OF MULTI-KINASE INHIBITORS TO TREAT RNA VIRUS INFECTIONS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/252551	ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS	MINERVA BIOTECHNOLOGIES CORPORATION
WO/2021/252555	COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF	ANIMA BIOTECH INC.
WO/2021/252607	BETA-PROPIOLACTONE COMPOUNDS AND RING OPENED BETA-PROPIOLACTONE COMPOUNDS AND USES FOR SAME	NOVOMER, INC.
WO/2021/252620	DNA ENCODED ANTIBODIES FOR USE AGAINST SARS-COV-2	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/252640	ASPARAGINE DERIVATIVES AND METHODS OF USING SAME	SENDA BIOSCIENCES, INC.
WO/2021/252644	INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF	PARDES BIOSCIENCES, INC.
WO/2021/252666	BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE	PRELUDE THERAPEUTICS, INCORPORATED
WO/2021/252667	METHODS OF MAKING WEE1 INHIBITOR COMPOUNDS	RECURIUM IP HOLDINGS, LLC
WO/2021/252678	HETEROARYL ALKYLENE SUBSTITUTED 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS	IDEAYA BIOSCIENCES, INC.
WO/2021/252679	2-AMINOQUINAZOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS	IDEAYA BIOSCIENCES, INC.
WO/2021/252680	4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS	IDEAYA BIOSCIENCES, INC.
WO/2021/252681	QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS	IDEAYA BIOSCIENCES, INC.
WO/2021/252688	METHOD OF ASSEMBLYING TWO-COMPONENT VIRUS-LIKE PARTICLE	ICOSAVAX, INC.
WO/2021/252691	TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF	DELIX THERAPEUTICS, INC.
WO/2021/252692	ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF	DELIX THERAPEUTICS, INC.
WO/2021/252749	METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER	THE PENN STATE RESEARCH FOUNDATION
WO/2021/252775	HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN	CHDI FOUNDATION, INC.
WO/2021/252781	IMIDAZOPYRIDAZINE COMPOUNDS WITH ACTIVITY AS ALK2 INHIBITORS	INCYTE CORPORATION
WO/2021/252820	CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS	AMGEN INC.
WO/2021/252822	HETEROALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS	AMGEN INC.
WO/2021/252829	PROCESS FOR PREPARING A GLP-1/GLUCAGON DUAL AGONIST	ELI LILLY AND COMPANY
WO/2021/252835	DOSING OF POLYOMAVIRUS NEUTRALIZING ANTIBODIES	AMPLYX PHARMACEUTICALS, INC.
WO/2021/252849	INHIBITORS OF APOL1 AND USE OF THE SAME	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/252859	INHIBITORS OF APOL1 AND USE OF THE SAME	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/252863	SOLID FORMS OF APOL1 INHIBITOR AND USING THE SAME	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/252876	CRYSTALLINE FORMS OF OMADACYCLINE, METHODS OF SYNTHESIS THEREOF AND METHODS OF USE THEREOF	PARATEK PHARMACEUTICALS, INC.
WO/2021/252878	ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION	VIR BIOTECHNOLOGY, INC.
WO/2021/252975	SPLIT INTEIN-BASED SELECTION FOR PEPTIDE BINDERS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/252990	METHOD AND SYSTEM FOR NEOANTIGEN ANALYSIS	COMPLETE OMICS INC.
WO/2021/253002	RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF	GIGAGEN, INC.
WO/2021/257490	2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/257497	ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF	SAREPTA THERAPEUTIS, INC.
WO/2021/257512	HUMANIZED ACE2-FC FUSION PROTEIN FOR TREATMENT AND PREVENTION OF SARS-COV-2 INFECTION	ACADEMIA SINICA
WO/2021/257525	CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES	BIOATLA, INC.
WO/2021/257539	ANTIBODIES TO INTERLEUKIN-1β AND USES THEREOF	ACADEMIA SINICA
WO/2021/257542	CONDITIONALLY ACTIVE ANTI-CD46 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF	BIOATLA, INC.
WO/2021/257552	PRECISION RADIOIMMUNOTHERAPEUTIC TARGETING OF THE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) FOR TREATMENT OF SEVERE COVID-19 DISEASE	MONOPAR THERAPEUTICS, INC.
WO/2021/262483	METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION	PMV PHARMACEUTICALS, INC.
WO/2021/257614	HETEROCYCLIC INHIBITORS OF ENPP1	VOLASTRA THERAPEUTICS, INC.
WO/2021/257641	DEVICES HAVING A RARE EARTH (OXY) FLUORIDE COATING FOR IMPROVED RESISTANCE TO CORROSIVE CHEMICAL ENVIRONMENTS AND METHODS FOR MAKING AND USING THESE DEVICES	L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE
WO/2021/257650	TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/257665	HUMAN MONOCLONAL ANTIBODY THAT TARGETS A CONSERVED SITE ON THE <i>PLASMODIUM FALCIPARUM</i> CIRCUMSPOROZOITE PROTEIN	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/262499	PD-L1-SPECIFIC ANTIBODY AND ANTI-PD-L1-CAR-T CELLS	PROMAB BIOTECHNOLOGIES, INC.
WO/2021/257679	MATERIALS AND METHODS FOR THE MANUFACTURE OF PLURIPOTENT STEM CELLS	JANSSEN BIOTECH, INC.
WO/2021/257695	METHODS AND COMPOSITIONS RELATED TO NEUTRALIZING ANTIBODIES AGAINST HUMAN CORONAVIRUS	HIFIBIO (HK) LIMITED
WO/2021/257717	METHOD FOR MAKING BIO-BASED ACRYLIC ACID	NITTO DENKO CORPORATION
WO/2021/257790	RED LIGHT-CONTROLLED PROTEIN DIMERIZATION SYSTEMS	UNIVERSITY OF WASHINGTON
WO/2021/257808	ANTIBODIES TO FIBROBLAST ACTIVATION PROTEIN AND B7H3	PROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/257820	ASSESSING AND TREATING BIOLOGICAL AGING	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/257822	BISPECIFIC ANTIBODIES TARGETING HUMAN CLAUDIN 18.2 AND PROGRAMMED DEATH-LIGAND 1 (PD-L1)	SPARX THERAPEUTICS, INC.
WO/2021/257828	SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE	SHY THERAPEUTICS, LLC
WO/2021/257834	THYROMIMETICS	AUTOBAHN THERAPEUTICS, INC.
WO/2021/257849	NITROSATION REAGENTS AND METHODS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/257851	THYROMIMETICS	AUTOBAHN THERAPEUTICS, INC.
WO/2021/257857	NAPHTHYRIDINONE COMPOUNDS AS JAK2 V617F INHIBITORS	INCYTE CORPORATION
WO/2021/257863	PYRROLOTRIAZINE COMPOUNDS AS JAK2 V617F INHIBITORS	INCYTE CORPORATION
WO/2021/257890	PREDICTIVE RESPONSE BIOMARKER DISCOVERY PROCESS	HIFIBIO (HK) LIMITED
WO/2021/257905	OLFACTORY RECEPTORS FOR USE AS TARGETS FOR ANTIGEN BINDING MOLECULES TO DETECT AND TREAT CANCER	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/257922	NEW METHODS FOR HYDRODEALKENYLATION	P2 SCIENCE, INC.
WO/2021/262541	COMPANION DIAGNOSTIC TOOL FOR MUTANT P53 REACTIVATING COMPOUNDS	PMV PHARMACEUTICALS, INC.
WO/2021/257950	ACETONE RECOVERY AND PURIFICATION	KELLOGG BROWN & ROOT LLC
WO/2021/257977	ARYLSULFONYL DERIVATIVES AND THEIR USE AS MUSCARINIC ACETYLCHOLINE RECEPTOR M5 INHIBITORS	VANDERBILT UNIVERSITY
WO/2021/262548	A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/258010	OXIME COMPOUNDS USEFUL AS T CELL ACTIVATORS	GOSSAMER BIO SERVICES, INC.
WO/2021/262564	USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SYNDROME	VACCINEX, INC.
WO/2021/262587	QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/262597	LAIR-1-BINDING AGENTS AND METHODS OF USE THEREOF	NGM BIOPHARMACEUTICALS, INC.
WO/2021/262621	CHROMENONE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS	FMC CORPORATION
WO/2021/262684	METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION	PMV PHARMACEUTICALS, INC.
WO/2021/262693	METHOTREXATE ANALOGS AND METHODS OF USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/262708	PRODRUGS OF MITOCHODRIA-TARGETING OLIGOPEPTIDES	STEALTH BIOTHERAPEUTICS CORP.
WO/2021/262710	PRODRUGS OF MITOCHODRIA-TARGETING OLIGOPEPTIDES	STEALTH BIOTHERAPEUTICS CORP.
WO/2021/262723	COMPOSITIONS AND METHODS FOR TREATING CANCER WITH TSLPR-CD19 OR TSLPR-CD22 IMMUNOTHERAPY	LENTIGEN TECHNOLOGY, INC.
WO/2021/262763	OPIOID RECEPTOR MODULATOR AND USE THEREOF	ARRIBA BIOPHARMA, INC.
WO/2021/262783	APOPTOSIS RESISTANT CELL LINES	GENENTECH, INC.
WO/2021/262826	1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF	GILEAD SCIENCES, INC.
WO/2021/262829	HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/262836	3.ALPHA.-HYDROXY, 17.BETA.-C(O)-N-ARYL SUBSTITUTED NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF	SAGE THERAPEUTICS, INC.
WO/2021/262915	2,3-DISUBSTITUTED PYRIDO[3,4-<i>B</i>]PYRAZINE-CONTAINING COMPOUNDS AS KINASE INHIBITORS	PURDUE RESEARCH FOUNDATION
WO/2021/262969	MATERIALS AND METHODS OF TREATING CANCER	THE GENERAL HOSPITAL CORPORATION
WO/2021/262990	CAPSID INHIBITORS FOR THE TREATMENT OF HIV	GILEAD SCIENCES, INC.
WO/2021/262999	ANTIBODY MOLECULES TO APRIL AND USES THEREOF	VISTERRA, INC.
WO/2021/263039	AMPK ACTIVATORS	KALLYOPE, INC.
WO/2021/263058	HER-2 TARGETED BISPECIFIC COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME	AMUNIX PHARMACEUTICALS, INC.
WO/2021/263069	CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE	LI, Fengqiao
WO/2021/263079	TREX1 INHIBITORS AND USES THEREOF	TEMPEST THERAPEUTICS, INC.
WO/2021/263105	ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE	UNIVERSITY OF MASSACHUSETTS
WO/2021/263126	COMPOSITIONS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS	THE UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/263164	NONLINEAR OPTICAL CHROMOPHORES COMPRISING A DIAMONDOID GROUP	LIGHTWAVE LOGIC, INC.
WO/2021/263166	ANTI-PD1 ANTIBODIES AND USES THEREOF	SORRENTO THERAPEUTICS, INC.
WO/2021/263167	IL-10 MUTEINS AND FUSION PROTEINS THEREOF	AMGEN INC.
WO/2021/263169	ONCOLYTIC HERPES SIMPLEX VIRUSES (HSV) EXPRESSING IMMUNOMODULATORY FUSION PROTEINS	SORRENTO THERAPEUTICS, INC.
WO/2021/263176	AMPLICON COMPREHENSIVE ENRICHMENT	WILLIAM MARSH RICE UNIVERSITY
WO/2021/263194	INHIBITION OF <i>N</i>-GLYCOSYLATED GRP94	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/263203	CXCR4 INHIBITORS AND USES THEREOF	X4 PHARMACEUTICALS, INC.
WO/2021/263211	ANTIGEN-SPECIFIC T CELL RECEPTORS AND CHIMERIC ANTIGEN RECEPTORS, AND METHODS OF USE IN IMMUNE SIGNALING MODULATION FOR CANCER IMMUNOTHERAPY	HOUSTON METHODIST HOSPITAL
WO/2021/151119	CHIMERIC ANTIGEN RECEPTORS TO HER2 AND METHODS OF USE THEREOF	EXUMA BIOTECH CORP.
WO/2021/178991	CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/195671	PROCESS FOR PREPARING TRIENTINE DIHYDROCHLORIDE	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/203131	SUBSTITUTED PYRIMIDINES AND METHODS OF USE	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/217180	NOVEL FORMS OF PRACINOSTAT DIHYDROCHLORIDE	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/217187	SMALL MOLECULE INHIBITORS THAT BLOCK THE BUDDING OF ENVELOPED VIRUSES	NORTHWESTERN UNIVERSITY
WO/2021/232050	NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/253041	NAPHTHYRIDINE DERIVATIVES USEFUL AS ALK5 INHIBITORS	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/263278	REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS	THE SCRIPPS RESEARCH INSTITUTE

转载本文请联系原作者获取授权，同时请注明本文来自陈立新科学网博客。

链接地址：https://wap.sciencenet.cn/blog-681765-1365813.html?mobile=1

分享到:

当前推荐数：0

推荐到博客首页

网友评论0 条评论

该博文允许注册用户评论请点击登录